EdgeMode Highlights 2025 Milestones Including 1000% Stock Performance, Transformative M&A, and Nasdaq Uplisting Plans
- Strategic acquisitions in Sweden and Spain expand European presence and support aggressive growth strategy Fort Lauderdale, September 29, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – EdgeMode (OTC: EDGM), a next-generation AI and digital infrastructure company, today announced that 2025 has been a landmark year, highlighted by two strategic acquisitions that
- 09/29/2025
|
Matador Technologies Inc. Provides U.S. Listing and Leadership Update
- TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA, OTCQB: MATAF, FSE: IU3), announces that it has confidentially submitted a draft registration statement on Form 20-F with the U.S. Securities and Exchange Commission (“SEC”) in connection with the Company's plan to pursue a listing on The Nasdaq Stock Market (“Nasdaq”) as part of its long-term capital markets strategy.
- 09/29/2025
|
NDAQ Outperforms Industry, Trades at a Discount: How to Play the Stock
- Nasdaq is set to grow on its increasing on-trading revenue base, impressive organic growth, and investments in proprietary data, supported by a solid capital position.
- 09/26/2025
|
US stocks open in the green: Nasdaq climbs 0.3%, Dow up 100 points
- US stocks edged higher on Wednesday as Nvidia clawed back some of its steep losses from the previous session, helping steady the broader market after renewed doubts about the sustainability of the AI trade. The S&P 500 rose 0.2%, the Nasdaq Composite gained 0.3%, and the Dow Jones Industrial Average advanced 102 points, or 0.2%.
- 09/25/2025
|
Nasdaq Calypso Infrastructure Now Available on AWS Cloud
- Financial institutions can now deploy Nasdaq Calypso capital markets and treasury infrastructure on the AWS cloud. The capability is enabled by an expanded partnership in which AWS will offer this infrastructure as a fully managed service while Nasdaq will manage the underlying infrastructure, the companies said in a Thursday (Sept.
- 09/25/2025
|
Corrected: ECD Automotive Design Granted Continued Listing by the Nasdaq Hearings Panel
- KISSIMMEE, Fla., Sept. 25, 2025 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (“ECD” or the “Company”) is re-issuing in its entirety the press release for its continued listing on The Nasdaq Stock Market issued on September 22, 2025 at 8:05 a.m. ET, to correct a statement in the press release regarding the amount of debt that was converted to preferred equity. The correct amount of debt that was converted to preferred equity is $13.7 million, not $15.5 million. The corrected release in its entirety is set forth below.
- 09/25/2025
|
Nasdaq and AWS to Advance Capital Markets and Banking Infrastructure Across the Financial System
- Strategic cloud deployment of Nasdaq Calypso on AWS will empower institutions to modernize end-to-end infrastructure, enhance resilience and unlock innovation at scale Strategic cloud deployment of Nasdaq Calypso on AWS will empower institutions to modernize end-to-end infrastructure, enhance resilience and unlock innovation at scale
- 09/25/2025
|
Delisting of Securities from The Nasdaq Stock Market
- NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the warrants of Digital Brands Group, Inc. Digital Brands Group, Inc.'s warrants were suspended on December 18, 2024 and have not traded on Nasdaq since that time.
- 09/24/2025
|
Nasdaq Tumbles Over 200 Points As Nvidia Shares Decline: Investor Sentiment Falls, But Fear Index Remains In 'Greed' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Greed” zone on Tuesday.
- 09/24/2025
|
BTQ Technologies: The Speculative Bet On Blockchain And PQC
- BTQ is upgraded to a Buy, as it achieves a Nasdaq uplisting while building a post-quantum tech portfolio that spans multiple addressable markets. BTQ's Nasdaq uplisting boosts visibility and access to capital, but also raises dilution risk as management may pursue bolder equity raises. Despite paltry revenue and cash burn, the early licensing deal validates BTQ's commercial potential to some extent.
- 09/23/2025
|
New Nasdaq China Rules Could Benefit the STAR Market
- Earlier this month, the Nasdaq announced rule changes in regards to how small China companies go public in the United States. Once these rules are set into stone, China-based companies will now need at least $25 million to list on the exchange.
- 09/23/2025
|
Palantir stock price forecast amid heightened valuation risks
- The Palantir stock price has surged this year and is the best-performing company in the Nasdaq 100 Index this year. It has jumped by 395% in the last 12 months, bringing its market capitalization to over $432 billion.
- 09/23/2025
|
US stocks open in the red: S&P 500 slips 0.2%, Dow down over 150 points
- US stocks declined on Monday following a strong performance last week, during which the Dow Jones Industrial Average and S&P 500 closed at record highs. The Dow fell 161 points, or 0.3%, while the S&P 500 slipped 0.2% and the Nasdaq Composite lost 0.1%.
- 09/23/2025
|
Evening digest: Nvidia, Apple lead market to ATH, Oracle to oversee Tiktok algo
- US financial markets saw a mix of enthusiasm and caution on Monday, driven by major corporate announcements in technology and artificial intelligence alongside ongoing volatility in cryptocurrencies. Gains in tech stocks helped push the S&P 500 and Nasdaq to intraday record highs, while Bitcoin and other digital assets faced sharp declines amid heavy liquidations. Apple's
- 09/23/2025
|
Here's Why Nasdaq (NDAQ) is a Strong Growth Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 09/23/2025
|
Pioneering Digital Asset Treasury Investor Evo Fund to Invest in Super League, Positioning Company to Increase Shareholder Value and Satisfy Nasdaq Shareholders Equity Requirement
- Pioneering Digital Asset Treasury Investor Evo Fund to Invest in Super League, Positioning Company to Increase Shareholder Value and Satisfy Nasdaq Shareho
- 09/22/2025
|
HyOrc Files SEC Form 10 in preparation for Nasdaq uplist
- HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTCID: HYOR), a company focused on clean energy innovation, today announced that it has filed a Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC) pursuant to the Securities Exchange Act of 1934.
- 09/22/2025
|
GIBO Holdings Limited Regains Compliance with Nasdaq Continued Listing Requirements
- HONG KONG , Sept. 22, 2025 /PRNewswire/ -- GIBO Holdings Limited ("GIBO" or the "Company"), a unique and integrated AIGC animation streaming platform, today announced that it received a letter, dated September 18, 2025 (the "Letter") from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Nasdaq has confirmed that the Company has regained compliance with Listing Rule 5450(a)(1).
- 09/22/2025
|
Nasdaq (NDAQ) Loses 5.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Nasdaq (NDAQ) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- 09/19/2025
|
Galata Acquisition Corp. II Announces the Pricing of $150,000,000 Initial Public Offering
- Nashville, Tennessee, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Galata Acquisition Corp. II (the “Company”) announced today the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market (“Nasdaq”) and begin trading on September 19, 2025, under the ticker symbol “LATAU.” Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “LATA” and “LATAW,” respectively. The offering is expected to close on September 22, 2025, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 units at the initial public offering price to cover over-allotments, if any.
- 09/18/2025
|
Nasdaq set to jump as Fed cut digested, Intel rockets on Nvidia deal
- US stocks are set to trot higher on Thursday as investors continue to chew over the previous day's Federal Reserve rate cut, while Intel shares are likely to lead the way after a new deal with Nvidia. Led by a 29% premarket surge for the Santa Clara-based computer component company and a 3% gain for the chip colossus, futures for the Nasdaq were up 1.1%.
- 09/18/2025
|
Chenghe Acquisition III Co. Announces Closing of $126.5 Million Initial Public Offering, Including Full Exercise of the Underwriter's Overallotment Option
- SINGAPORE, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Chenghe Acquisition III Co. (“the Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, announced today the closing of its initial public offering of 12,650,000 units at a price of $10.00 per unit, which includes 1,650,000 units pursuant to the full exercise of the overallotment option granted to the underwriter, resulting in total gross proceeds of the offering of $126.5 million. The units have been listed for trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CHECU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on Nasdaq under the symbols “CHEC” and “CHECW,” respectively.
- 09/17/2025
|
Long-term vs. short-term focus: Former Nasdaq CEO on the debate over quarterly reports
- Robert Greifeld, Cornerstone Investment Capital co-founder and managing partner rand former Nasdaq chairman and CEO, joins 'Squawk Box' to discuss the debate over whether public companies should issue quarterly results.
- 09/16/2025
|
Chenghe Acquisition III Co. Announces the Pricing of $110 Million Initial Public Offering
- SINGAPORE, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Chenghe Acquisition III Co. (“the Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, announced today the pricing of its initial public offering of 11,000,000 units at a price of $10.00 per unit. The units are expected to be listed for trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CHECU” on September 16, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on Nasdaq under the symbols “CHEC” and “CHECW,” respectively.
- 09/15/2025
|
Legence Announces Closing of Initial Public Offering and Partial Exercise of Overallotment Option
- SAN JOSE, Calif., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Legence Corp. (“Legence”) announced today the closing of its initial public offering (the “offering”) of 26,000,000 shares of its Class A common stock (the “Common Stock”) at a price to the public of $28.00 per share. In addition, the underwriters partially exercised their option and purchased 3,487,627 additional shares of Common Stock. The Common Stock began trading on the Nasdaq Global Select Market (“Nasdaq”) on September 12, 2025 under the ticker symbol “LGN.”
- 09/15/2025
|
Trailblazer Acquisition Corp. Announces the Pricing of Upsized $240,000,000 Initial Public Offering
- New York, NY, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Trailblazer Acquisition Corp. (the “Company”) announced today the pricing of its upsized initial public offering of 24,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading on September 10, 2025, under the ticker symbol “BLZRU.” Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “BLZR” and “BLZRW,” respectively. The offering is expected to close on September 11, 2025, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,600,000 units at the initial public offering price to cover over-allotments, if any.
- 09/09/2025
|
Nasdaq to Invest $50 Million in Cryptocurrency Exchange Gemini
- Nasdaq has reportedly agreed to buy $50 million in shares of cryptocurrency exchange Gemini Space Station. The company will buy the shares in a private placement at the time of Gemini's initial public offering, which is set for Friday (Sept.
- 09/09/2025
|
The Big 3: NDAQ, BLK, AVGO
- Nasdaq (NDAQ) is seeking SEC approval to use tokenized securities, something Jessica Inskip sees serving as a next leg up for the stock. She sees a similar theme forming in Blackrock (BLK) as it reinforces a focus on crypto.
- 09/09/2025
|
Talon Capital Corp. Announces Pricing of $225 Million Initial Public Offering
- HOUSTON, TX, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Talon Capital Corp. (the “Company”) announced the pricing of its initial public offering of 22,500,000 units at a price of $10.00 per unit on September 8, 2025. The units are expected to be listed for trading on the Nasdaq Stock Market LLC under the ticker symbol “TLNCU” beginning September 9, 2025. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on the Nasdaq Stock Market LLC under the symbols “TLNC” and “TLNCW,” respectively. The offering is expected to close on September 10, 2025, subject to customary closing conditions.
- 09/08/2025
|
Wall Street Roundup: Jobs Data, Gold Highs, AI + Tariff Impact
- Jobs data is softening, making a September Fed rate cut highly likely, but inflation remains stubbornly high, creating tension for markets. Gold and silver are surging as investors seek inflation hedges, while most equities struggle and stock picking becomes more important.
- 09/05/2025
|
Puro.earth Secures €11 M Series B Financing Led by Nasdaq with Participation from Fortum Innovation & Venturing to strengthen its supplier infrastructure
- HELSINKI, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Puro.earth, a leading carbon-crediting platform for engineered carbon dioxide removal (CDR), today announced it has raised €11 million in a Series B funding round led by Nasdaq with participation from Fortum Innovation & Venturing.
- 09/04/2025
|
Stardust Power Announces Reverse Stock Split to Regain Nasdaq Compliance and Position for Long-Term Growth
- GREENWICH, Conn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Stardust Power Inc. (“Stardust Power” or the “Company”), an American developer of battery-grade lithium products, today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's common stock.
- 09/04/2025
|
Nasdaq Surges 1% As Alphabet, Apple Gain: Investor Sentiment Edges Lower, Fear & Greed Index Remains In 'Neutral' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Neutral” zone on Wednesday.
- 09/04/2025
|
Spring Valley Acquisition Corp. III Announces Pricing of $200 Million Initial Public Offering
- DALLAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Spring Valley Acquisition Corp. III (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit on September 3, 2025. The units are expected to be listed for trading on the Nasdaq Global Market under the ticker symbol “SVACU” beginning September 4, 2025. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on the Nasdaq Global Market under the symbols “SVAC” and “SVACW,” respectively. The offering is expected to close on September 5, 2025, subject to customary closing conditions.
- 09/04/2025
|
Nasdaq Proposes Changes to its Listing Standards
- NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Today, Nasdaq proposed a new set of enhancements to its initial and continued listing standards, reinforcing its long-standing commitment to capital formation while ensuring investor protection and upholding market integrity. These proposed updates introduce enhanced requirements for minimum company public float and capital raised during initial public offerings, alongside stricter suspension and delisting procedures for companies failing to meet Nasdaq's continued listings standards.
- 09/03/2025
|
Portfolio Positioning For An Uncertain Market With Next Gen Investors
- Rob Isbitts from Sungarden Investors Club talks again to analysts Julia Ostian, Jack Bowman, and Kenio Fontes. Market risks are rising as valuations stretch, yield curves steepen, and concentration in mega-cap tech increases vulnerability.
- 09/03/2025
|
Prediction: These 2 Schwab ETFs Will Crush the Nasdaq in 2025
- You don't have to pick individual stocks to outperform the stock market. A single ETF can do the trick, and Schwab has a few options to consider.
- 09/03/2025
|
Nasdaq Down Over 1%; Alibaba Shares Jump Following Q1 Results
- U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Friday.
- 08/29/2025
|
American Bitcoin targets trading in September on Nasdaq
- American Bitcoin, the bitcoin miner owned by Hut 8 Mining Corp (TSX:HUT) and two of US President Donald Trump's sons, could begin trading on the Nasdaq as soon as September, Hut 8 CEO Asher Genoot told Reuters recently. American Bitcoin's merger with publicly traded Gryphon Digital Mining is expected to be finalized shortly.
- 08/28/2025
|
Aptera Motors Corp. Files for Proposed Direct Listing on Nasdaq
- CARLSBAD, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (“Aptera” or the “Company”), a technology company creating a new class of highly efficient solar electric vehicles, announced today it has publicly filed a registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed direct listing of its Class B common stock.
- 08/27/2025
|
NDAQ Outperforms Industry, Trades Near 52-Week High: Time to Buy?
- Nasdaq is set to grow on its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
- 08/27/2025
|
CSLM Digital Asset Acquisition Corp III, Ltd $200 Million Initial Public Offering
- FT. LAUDERDALE, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- CSLM Digital Asset Acquisition Corp III, Ltd (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 20,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. The units are expected to trade on The Nasdaq Global Market (“Nasdaq”) under the ticker symbol “KOYNU” beginning on August 27, 2025. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “KOYN” and “KOYNW,” respectively.
- 08/26/2025
|
US stocks open in the red: Nasdaq down 0.3%, Dow slips 100 points
- US equities eased on Monday as investors took a breather following last week's rally and looked ahead to a series of key earnings and economic data. The Dow Jones Industrial Average slipped 89 points, or 0.2%, after surging to both intraday and closing records on Friday.
- 08/25/2025
|
New Fortress Energy discloses notice from Nasdaq on delayed quarterly filing
- New Fortress Energy said on Friday it had received a notice from Nasdaq regarding the delayed filing of its quarterly report.
- 08/22/2025
|
Stocks closed mixed, Nasdaq slides for a second day, what's next for gold prices
- Market Domination Overtime anchor Josh Lipton breaks down the latest market moves for August 20, 2025. The Nasdaq falls for a second day.
- 08/20/2025
|
US stocks mixed at open as investors await Fed minutes: Nasdaq down 0.3%
- US stocks were little changed on Wednesday as investors assessed a fresh round of retail earnings and awaited the release of the Federal Reserve's July meeting minutes. The Dow Jones Industrial Average rose 69 points, or 0.2%.
- 08/20/2025
|
5 Securities & Exchanges Stocks to Track as Industry Dynamics Evolve
- SPGI, ICE, CME, NDAQ and CBOE gain from rising crypto adoption, trading volumes, accelerating the non-trading revenue base and tech investments as the Zacks industry ranks in the top 21%.
- 08/19/2025
|
T1 Announces Instant Cash Rewards & $1M USD in Funding For Skilled Traders
- SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- T1, a proprietary trading firm, today announced a revolutionary approach that enables skilled traders to earn immediate cash rewards and secure sponsorship to trade with substantial institutional capital. What is Proprietary Trading? Traditional trading requires investors to risk their own capital when buying and selling stocks, crypto, currencies, or commodities. T1 offers an alternative: for assessment fees as low as $99, traders gain access to a trading account to take a trading challenge. Those who can demonstrate profitability and risk management skills get to trade through the firm's institutional capital network while keeping up to 90% of the profits. At the heart of T1's innovation is its instant cash bounty system. As traders achieve predetermined profit milestones during their Futures Challenge, they receive immediate cash rewards of up to $20,000. Traders who successfully complete the Futures Challenge by achieving all milestones are then sponsored to continue trading. Sargon Petros, CEO of T1, explains: "We're giving talented traders recognition, professional tools and access to institutional funding. Whether you're a beginner or advanced trader, you can choose from four different trading platforms: cTrader, MatchTrader, DXTrade & Rithmic, along with real-time global market data feeds, and instant cash rewards for hitting profit targets.As a trader myself, I know that finding the right trading firm isn't just about the price - it's about having access to the specific technology that matches your trading style. Every successful trader has developed their own edge, and we provide the infrastructure to amplify that edge." Based in Singapore's iconic SGX Centre, T1 operates from one of Asia's premier financial centers. Singapore's strategic position as a global trading hub provides access to Asian, European, and American markets across multiple time zones, while the city-state's robust regulatory framework ensures institutional-grade operational standards. T1 provides 6 account types designed for every trading style – from scalpers to swing traders and quantitative traders. Users can trade across diverse markets including cryptocurrencies like Bitcoin and Ethereum, major indices such as the S&P 500 and Nasdaq 100, as well as commodities like Oil and Gold. Each challenge features clear rules and realistic targets.T1 supports all trading approaches, including trading bots, automated strategies, copy trading, and algorithmic trading for quantitative traders. T1 harnesses the combined expertise of its trading community through its proprietary AI platform, capturing insights from successful traders across the network. This system delivers valuable analysis on market patterns, risk management techniques, and profitable trading strategies. Ready to Transform Your Trading Career? T1 is now accepting applications from skilled traders worldwide. The evaluation process begins immediately upon registration. Those interested in joining T1's community of funded traders can learn more about account types, challenge requirements, and begin their application at T1trader.com. For media inquiries and partnership opportunities, contact [email protected] Contact: Sargon Petros +6597441832
- 08/19/2025
|
“KYIV” Ticker Goes Live on Nasdaq as Kyivstar Group Commences Trading
- Landmark listing makes Kyivstar the first and only publicly listed pure-play Ukrainian investment opportunity in the U.S. Stock Markets
- 08/15/2025
|
Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering
- MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock, par value $0.001 per share, at a price of $4.00 per share. The offering is expected to yield approximately $4 million in gross proceeds before offering expenses and underwriting discounts and commissions.
- 08/14/2025
|
Trust Stamp files its 2025 Q2 10-Q and announced continued growth in OL Platform Registrations and a Key Performance Metric
- Trust Stamp announced that it filed its 2025 Q2 10-Q after the Nasdaq market closed on August 14th, 2025, together with announcing strong growth in customer enrollment and user completions on its SaaS Orchestration Layer Trust Stamp announced that it filed its 2025 Q2 10-Q after the Nasdaq market closed on August 14th, 2025, together with announcing strong growth in customer enrollment and user completions on its SaaS Orchestration Layer
- 08/14/2025
|
Final Trade: KWEB, PNFP, BABA & NDAQ
- The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
- 08/13/2025
|
Highview Merger Corp. Announces Completion of $230,000,000 Initial Public Offering
- Delray Beach, FL, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Highview Merger Corp. (the “Company”) announced today the closing of its initial public offering of 23,000,000 units, including 3,000,000 units sold pursuant to the full exercise of the underwriter's over-allotment option, at a price of $10.00 per unit. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants will be exercisable. The units are listed on The Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “HVMCU” as of August 12, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “HVMC” and “HVMCW,” respectively.
- 08/13/2025
|
Highview Merger Corp. Announces Pricing of $200,000,000 Initial Public Offering
- Delray Beach, FL, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Highview Merger Corp. (the “Company”) announced today that it priced its initial public offering of 20,000,000 units at a price of $10.00 per unit. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants will be exercisable. The units will be listed on The Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “HVMCU” beginning August 12, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “HVMC” and “HVMCW,” respectively. The offering is expected to close on August 13, 2025, subject to customary closing conditions.
- 08/11/2025
|
McKinley Acquisition Corp Announces Pricing of $150 Million Initial Public Offering
- NEEDHAM, Mass, Aug. 11, 2025 (GLOBE NEWSWIRE) -- McKinley Acquisition Corporation (the “Company”), announced the pricing of its initial public offering of 15,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-tenth (1/10) of one Class A ordinary share upon consummation of the Company's initial business combination. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the symbol “MKLYU” beginning on August 12, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights will be traded on Nasdaq under the symbols “MKLY” and “MKLYR,” respectively.
- 08/11/2025
|
RiverPark Funds: AI Momentum And Healthcare Headwinds Drive Portfolio Shifts In Q2 2025
- NVIDIA, Microsoft, and Netflix were top contributors, driven by strong earnings, AI leadership, and robust subscriber/ad growth, reinforcing our long-term conviction in these names. UnitedHealth and Apple underperformed due to margin pressures, regulatory uncertainty, and mixed AI sentiment, but we remain confident in their multi-year value propositions. Our short position in QQQ detracted as tech stocks rallied, but it served as a portfolio hedge without forcing sales of core long holdings.
- 08/11/2025
|
Nasdaq Hits Record As Earnings Beat Forecasts; CPI, PPI Reports Ahead
|
4 Stocks to Bet on as Nasdaq's Northbound Journey Continues
- Nasdaq's record rally, fueled by AI momentum and big tech investments, puts the spotlight on Microsoft, Broadcom, Netflix and Shopify as top picks.
- 08/11/2025
|
BTQ Technologies Files a Form 40-F Registration Statement
- VANCOUVER, BC , Aug. 8, 2025 /PRNewswire/ -- BTQ Technologies Corp. ("BTQ" or the "Company") (CBOE CA: BTQ) (FSE: NG3) (OTCQX: BTQQF), a global quantum technology company focused on securing mission-critical networks, is pleased to announce that it filed today a Form 40-F Registration Statement ("Form 40-F") with the United States Securities and Exchange Commission (the "SEC"), in connection with its application to list its common shares ("Shares") on the Nasdaq Capital Market (the "Nasdaq"). The listing of the Company's Shares on the Nasdaq remains subject to the approval of the Nasdaq Stock Market LLC and the satisfaction of all applicable listing and regulatory requirements, including the Form 40-F being declared effective by the SEC.
- 08/08/2025
|
Caduceus Software Systems Corp. Outlines Strategic Roadmap Toward Nasdaq Capital Market Listing and Corporate Rebranding
- Audit, SEC Registration, and Corporate Rebranding Initiatives Underway as McLovin's Pet Brand Gains National Retail Traction CHINO, Calif. , Aug. 6, 2025 /PRNewswire/ -- Caduceus Software Systems Corp. ("CSOC" or the "Company"), a growth-stage consumer pet brand platform and parent company of McLovin's Pet, today announced a strategic multi-phase roadmap to strengthen its public company profile and support future up-listing to senior exchanges.
- 08/06/2025
|
Delisting of Securities from The Nasdaq Stock Market
- NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the American depositary shares of Secoo Holding Limited. Secoo Holding Limited's security was suspended on April 26, 2024 and has not traded on Nasdaq since that time.
- 08/05/2025
|
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Performant Healthcare, Inc. (Nasdaq - PHLT)
- BALA CYNWYD, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Performant Healthcare, Inc. (“Performant Healthcare” or the “Company”) (Nasdaq - PHLT) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Machinify. Under the terms of the transaction, Machinify will acquire all outstanding shares of Performant Healthcare for $7.75 per share in cash.
- 08/01/2025
|
4 Highly Rated Dividend Picks Among Nasdaq's Best in 2026
- Dividend stocks are known for their cash flow and stability. However, if you want a dividend stock that can beat the market, you may have to sacrifice a high yield.
- 07/31/2025
|
2 High-Yield ETFs That Can Outpace the Nasdaq This Quarter
- The Nasdaq has enjoyed an incredible recovery run off the Trump tariff-fueled sell-off that dragged stocks into a correction earlier in the year.
- 07/31/2025
|
Looking for a Growth Stock? 3 Reasons Why Nasdaq (NDAQ) is a Solid Choice
- Nasdaq (NDAQ) possesses solid growth attributes, which could help it handily outperform the market.
- 07/30/2025
|
Nasdaq (NDAQ) is a Great Momentum Stock: Should You Buy?
- Does Nasdaq (NDAQ) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 07/30/2025
|
Final Trade: DAL, INTC, NVDA, NDAQ
- The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
- 07/29/2025
|
Nasdaq grants Graphjet Technology's request to continue its listing
- KUALA LUMPUR, Malaysia, July 28, 2025 (GLOBE NEWSWIRE) -- Graphjet Technology (“Graphjet” or “the Company”) announced today that it received a decision letter (the “Letter”) from the Nasdaq Hearings Panel (the “Panel”) on July 25, 2025 granting the Company's request to continue its listing on The Nasdaq Stock Market (“Nasdaq”).
- 07/28/2025
|
4 Stocks to Boost Your Portfolio as Nasdaq Continues to Rally
- Nasdaq's rally gains steam as tech giants like AMZN, META, V and MSFT show strong earnings momentum and AI tailwinds.
- 07/25/2025
|
NASDAQ CEO reveals where AI is a 'real opportunity'
- NASDAQ chair and CEO Adena Friedman discusses new companies going public and incorporating AI into the company's products on 'The Claman Countdown.'#foxbusiness #foxbusinessnews #politics #investing #usnews #markets
- 07/25/2025
|
Nasdaq Q2 Revenue Jumps 13 Percent
- Nasdaq (NDAQ 5.91%), a global technology company powering capital markets and financial services, reported its Q2 2025 results on July 24, 2025. The company delivered GAAP revenue of $1.31 billion and non-GAAP earnings per share (EPS) of $0.85, both surpassing consensus estimates of $1.28 billion and $0.81, respectively.
- 07/24/2025
|
NDAQ Beats Q2 Earnings & Revenue Estimates, Tweaks Expense View
- NDAQ beats Q2 estimates with 24% EPS growth and 13% revenue rise. It also revises the full-year expense outlook slightly.
- 07/24/2025
|
Nasdaq (NDAQ) Q2 Earnings and Revenues Surpass Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.69 per share a year ago.
- 07/24/2025
|
Remote Monitoring and Control Provider Acorn Approved for Listing on Nasdaq Capital Market
- WILMINGTON, Del., July 23, 2025 (GLOBE NEWSWIRE) -- Acorn Energy, Inc. (OTCQB: ACFN), a provider of remote monitoring and control solutions for backup power generators, gas pipelines and air compressors, today announced that its common stock has been approved for listing on the Nasdaq Capital Market, and that it expects its shares to commence trading on the Nasdaq Capital Market on Thursday, July 24, 2025.
- 07/23/2025
|
Will Nasdaq Pull Off a Surprise This Earnings Season?
- NDAQ's Q2 results are likely to reflect higher subscription revenues, growth in trading volume, and improved analytics revenues.
- 07/22/2025
|
S&P, Nasdaq Close at New Record Highs, Ignore Weakness in LEI
- Bond yields have cooled from last week, as well: +4.38% on the 10-year, +3.86% on the 2-year and back below +5% on the 30-year bond.
- 07/21/2025
|
Ahead of Nasdaq (NDAQ) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
- Evaluate the expected performance of Nasdaq (NDAQ) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 07/21/2025
|
Nasdaq statement on the preliminary proxy filed by Invesco QQQ Trust and the proposals contained within it
- NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Today, Nasdaq issued the following statement on the preliminary proxy filed by Invesco QQQ Trust and the proposals contained within it.
- 07/18/2025
|
Nasdaq (NDAQ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/17/2025
|
Nasdaq Bull Market: 3 Historically Cheap Stocks That Can Easily Double Your Money
- Though volatility is inherent in Wall Street, some years are more of a roller-coaster ride than others.
- 07/16/2025
|
Nasdaq climbs as Nvidia stock soars on plans to resume chip sales in China
- Nvidia eyes a fresh record close on plans to resume AI chips sales in China. Inflation ticks higher in June with CPI rising 2.7% on an annual basis.
- 07/15/2025
|
Nasdaq Gains Over 100 Points; Wells Fargo Earnings Top Views
- U.S. stocks traded mixed midway through trading, with the Nasdaq gaining more than 100 points on Tuesday.
- 07/15/2025
|
Markets Close in the Green; Nasdaq at Fresh Highs
- We get started with a new CPI report and Q2 earnings results on Tuesday ahead of the open.
- 07/14/2025
|
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Monogram Technologies Inc. (Nasdaq - MGRM), Veritex Holdings, Inc. (Nasdaq - VBTX), ESSA Pharma Inc. (Nasdaq - EPIX), Waters Corporation (NYSE - WAT)
- BALA CYNWYD, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
- 07/14/2025
|
Delisting of Securities from The Nasdaq Stock Market
- NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of NKGen Biotech, Inc. NKGen Biotech, Inc.'s securities were suspended on March 5, 2025 and have not traded on Nasdaq since that time.
- 07/11/2025
|
NDAQ Outperforms Industry, Trades at Premium: How to Play the Stock
- Nasdaq is set to grow on its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
- 07/10/2025
|
Nasdaq Keeps The Bulls Charging, Proving It Can Grow And Profit Amid Volatility
- I'm reaffirming my prior buy rating on Nasdaq from summer 2023, seeing continued longer-term upside potential in this firm. Despite a share price topping its 5-year high, further investor bullishness can come from strong profit margins, top-line growth factors, and a sector getting tailwind from trading volume and volatility. Dividend investors will like the proven dividend growth and strong operating cash flow to support it.
- 07/09/2025
|
Delisting of Securities from The Nasdaq Stock Market
- NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the American Depositary Shares of Advanced Health Intelligence Ltd. Advanced Health Intelligence Ltd.'s security was suspended on July 30, 2024 and has not traded on Nasdaq since that time.
- 07/02/2025
|
Indigo Acquisition Corp. Announces Pricing of $100,000,000 Initial Public Offering
- NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Indigo Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. The Company's units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, July 1, 2025, under the ticker symbol “INACU.” Each unit consists of one ordinary share and one right entitling its holder to receive one tenth of one ordinary share upon the Company's completion of an initial business combination, subject to adjustment. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “INAC” and “INACR,” respectively.
- 06/30/2025
|
The Death Of Buy And Hold Has Been Greatly Exaggerated
- Market indices are strong, but underlying breadth and momentum are weakening, notes David Keller, suggesting limited upside and a better buying opportunity later in the year. Tech remains the leading sector, though valuations are stretched.
- 06/30/2025
|
Senti Bio Participates in Nasdaq Amplify Spotlight Series
- Access the segment here
- 06/30/2025
|
FIGX Capital Acquisition Corp. Announces the Pricing of $131,000,000 Initial Public Offering
- Tiburon, CA, June 26, 2025 (GLOBE NEWSWIRE) -- FIGX Capital Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 13,100,000 units. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading tomorrow, June 27, 2025, under the ticker symbol “FIGXU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “FIGX” and “FIGXW,” respectively. The offering is expected to close on June 30, 2025, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 1,965,000 units at the initial public offering price to cover over-allotments, if any.
- 06/26/2025
|
LightWave Acquisition Corp. Announces Closing of $215,625,000 Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option
- Dallas, TX, June 26, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial public offering of 21,562,500 units at an offering price of $10.00 per unit. This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 2,812,500 units. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “LWACU”. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “LWAC” and “LWACW,” respectively.
- 06/26/2025
|
Nasdaq and QCP Set New Standard of Capital Efficiency by Connecting Canton Network to Nasdaq Calypso
- Use case demonstrates the ability to enhance institutional risk management by integrating on-chain capabilities Use case demonstrates the ability to enhance institutional risk management by integrating on-chain capabilities
- 06/26/2025
|
Non-Tech Markets Lose Steam; Nasdaq Approaches Record High
- The Dow slipped 106 points, -0.25%, while the Nasdaq gained +61 points, +0.31% -- approaching new highs.
- 06/25/2025
|
Trade It of Fade It: JPM, GEV, IBM, CRWD, NDAQ
- 'Fast Money' traders talk if they would trade or fade stocks that are hitting or nearing record highs.
- 06/25/2025
|
LightWave Acquisition Corp. Announces Pricing of $187,500,000 Initial Public Offering
- Dallas, TX, June 24, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 18,750,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “LWACU” beginning June 25, 2025. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “LWAC” and “LWACW,” respectively.
- 06/24/2025
|
Oxley Bridge Acquisition Limited Announces the Pricing of $220,000,000 Initial Public Offering
- Vancouver, BC, June 24, 2025 (GLOBE NEWSWIRE) -- Oxley Bridge Acquisition Limited (the “Company”) announced today the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading on June 25, 2025, under the ticker symbol “OBAWU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “OBA” and “OBAWW,” respectively. The offering is expected to close on June 26, 2025, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,300,000 units at the initial public offering price to cover over-allotments, if any.
- 06/24/2025
|
Nasdaq Surges 1%; TD Synnex Posts Upbeat Earnings
- U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 1% on Tuesday.
- 06/24/2025
|
Buy 5 High-Flying Non-Tech Nasdaq-Listed Stocks of H1 to Gain in H2
- Nasdaq is flat in first-half 2025, but SFM, RGLD, TRI, WWD and EXEL are soaring, each up over 20% and primed for the second half.
- 06/24/2025
|
Nasdaq likely to extend rally after Trump hails Israel-Iran ceasefire, sending oil prices tumbling
- US stock futures are set to extend their gains on Tuesday, after Donald Trump oversaw a ceasefire deal agreement between Israel and Iran that sent oil prices tumbling. Futures contracts for the S&P 500 were up 0.7%, while those for the tech-heavy Nasdaq gained almost 1% and Dow Jones futures were up 0.6%.
- 06/24/2025
|
Brera Holdings Announces Reverse Share Split to Regain Compliance with Nasdaq's Minimum Bid Price Rule
- Dublin, Ireland, June 24, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men's and women's sports clubs through a multi-club ownership (“MCO”) strategy, today announced a 1-for-10 reverse share split (the “Reverse Share Split”) of the Company's ordinary shares, wherein the 50,000,000 Class A Ordinary Shares of nominal value $0.005 each will be consolidated on a 1-for-10 basis into 5,000,000 Class A Ordinary Shares of nominal value $0.05 each and the 250,000,000 Class B Ordinary Shares of nominal value $0.005 each will be consolidated on a 1-for-10 basis into 25,000,000 Class B Ordinary Shares of nominal value $0.05 each.
- 06/24/2025
|
Garden Stage Limited Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
- Hong Kong, June 24, 2025 (GLOBE NEWSWIRE) -- Garden Stage Limited (NASDAQ: GSIW) (“GSIW” or the “Company”), today announced that on June 23, 2025, the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2).
- 06/24/2025
|
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in connection with the appointment of Anne Marie Cook as Chief Legal Officer and Corporate Secretary, the Company's Board of Directors has approved the grant of inducement awards.
- 06/23/2025
|
3 Best Dividend Stocks in the Nasdaq Composite
- Digging deep into the Nasdaq Composite will reveal hidden dividend-paying gems. Investors should focus on financially secure businesses as much as eye-catching dividend yields.
- 06/23/2025
|
Lottery.com Regains Nasdaq Compliance as Stock Trading Activity Soars
- FORT WORTH, Texas, June 23, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (NASDAQ: LTRY; LTRYW) (“Lottery.com” or “the Company”) received formal notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5450(a)(1), which requires a minimum bid price of $1.00 (the “Rule”). The Company met this requirement by maintaining a closing bid price of $1.00 or higher for twenty consecutive business days from May 21 through June 18, 2025. Nasdaq has officially closed the matter.
- 06/23/2025
|
Arrive AI Celebrates Nasdaq Debut by Ringing Opening Bell with Early Supporters, Pioneering the Future of Autonomous Delivery
- INDIANAPOLIS, INDIANA / ACCESS Newswire / June 23, 2025 / Arrive AI (NASDAQ:ARAI) - a pioneering autonomous delivery network anchored by Arrive Points™ - is set to mark a pivotal moment in its journey by ringing Nasdaq's opening bell on July 3, 2025. More than 300 of the company's foundational investors, alongside team members, will join the celebration, highlighting the incredible support that fueled Arrive AI's ascent to the public market.
- 06/23/2025
|
S&P500 and Nasdaq 100: Futures Set for Volatile Open After U.S. Strikes Iran
- S&P500 and Nasdaq futures face pressure as Iran strike triggers oil surge. Expect energy gains, defense rotation, and heightened volatility ahead.
- 06/22/2025
|
FEMTO Common Shares to Delist from Nasdaq as of June 23, 2025
- Vancouver, BC - June 20, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO), a pioneering Femtech company formerly known as BYND Cannasoft Enterprises Inc., announced today that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the common shares of the Company from The Nasdaq Stock Market (“Nasdaq”) at the open of trading on June 23, 2025. Starting on that day the Company's common shares will be trading on the OTC under the symbol “FMTOF”. The Company is reviewing all available options, including appealing the delisting determination, and a potential listing on a Canadian or European exchange. Regardless, the Company believes that because of its stable financial condition, the delisting will not impact on its operations and its ability to execute its business plan.
- 06/20/2025
|
Pioneer Acquisition I Corp Announces Closing of $253,000,000 Initial Public Offering
- BROOKLYN, N.Y., June 20, 2025 (GLOBE NEWSWIRE) -- Pioneer Acquisition I Corp (Nasdaq: PACHU) (the “Company”) today announced that it closed its initial public offering of 25,300,000 units at $10.00 per unit, including the issuance of 3,300,000 units as result of the underwriters' exercise of its over-allotment option in full. The gross proceeds from the offering were $253 million before deducting underwriting discounts and estimated offering expenses. The units began trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “PACHU” on June 18, 2025.
- 06/20/2025
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 48,731 restricted stock units of the company's common stock to 26 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of June 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/20/2025
|
NaaS Technology Inc. Received Nasdaq Notification Regarding Minimum Market Value Deficiency
- BEIJING , June 20, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that it has received written notification (the "MVLS Notice") from the Nasdaq Stock Market LLC ("Nasdaq") dated June 13, 2025, notifying the Company that it is currently not in compliance with the minimum market value of listing securities (the "MVLS") of US$35 million for continued listing of the Company's Class A ordinary shares on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(2) (the "MLVS Requirement"). Nasdaq calculates the MVLS based upon the most recent total shares outstanding multiplied by the closing bid price.
- 06/20/2025
|
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., June 20, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for autoimmune diseases, today announced that on June 16, 2025 (the “Grant Date”), the Compensation Committee of the Company's Board of Directors granted a non-qualified stock option to purchase 112,000 shares of the Company's common stock to a newly hired employee of the Company as an inducement material to such employee's entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
- 06/20/2025
|
Marin Software Incorporated Receives Nasdaq Notification Regarding Delisting From Nasdaq
- SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marin Software Incorporated (NASDAQ: MRIN) (“Marin,” “we,” “our,” or the “Company”), a provider of digital marketing software for performance-driven advertisers and agencies, announces that, on June 17, 2025, the Company received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that Nasdaq had determined that the Company did not provide a definitive plan evidencing its ability to achieve.
- 06/20/2025
|
Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
- PITTSBURGH, June 20, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet needs, today announced that the Nasdaq Hearings Panel has determined to delist the Company's common stock from The Nasdaq Capital Market. Trading in the common stock was suspended at the open of business today.
- 06/20/2025
|
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
- SEATTLE, WASHINGTON / ACCESS Newswire / June 20, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced the closing of its previously announced offering of (i) 2,465,000 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 12,325,000 shares of its common stock (the "Common Warrants") at a purchase price of $3.25 per share and associated Common Warrants in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock is being offered together with five Common Warrants, each to purchase one share of common stock.
- 06/20/2025
|
This Nasdaq ETF Could Turn $500 Monthly Into $1 Million
- The $1 million mark is a significant financial milestone for many people. There's something about seven figures that feels like you have achieved a real level of financial security.
- 06/20/2025
|
Dot Ai, Innovator in Asset Intelligence Technology, Completes Business Combination; Will Begin Trading on Nasdaq Stock Market
- LAS VEGAS & KENNESAW, Ga.--(BUSINESS WIRE)--Dot Ai, Innovator in Asset Intelligence Technology, Completes Business Combination; Will Begin Trading on Nasdaq Stock Market.
- 06/20/2025
|
Here's How Much a $30,000 Investment in the Nasdaq 100 Today Could Be Worth in 30 Years
- Growth stocks can generate returns far superior to those of value stocks or dividend stocks in the long run. These are the types of companies that investors are drawn to because if they're growing, they are expanding their operations and likely innovating and potentially diversifying along the way.
- 06/20/2025
|
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FRIENDSWOOD, Texas, June 19, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2025, the Compensation Committee of its Board of Directors granted restricted stock units (RSUs) to 66 employees covering an aggregate of 135,978 shares of common stock as an inducement material to their entering into employment with Castle Biosciences. The RSUs were granted pursuant to the Company's 2022 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/19/2025
|
History Says the Nasdaq Will Soar: 1 Brilliant AI Stock to Buy Now, According to Wall Street
- Earlier this year, the Nasdaq Composite (^IXIC 0.13%) dropped into market correction territory as investors reacted to the prospect of sweeping tariffs. However, the index has historically rebounded sharply following those incidences, producing an average 12-month return of 21% following corrections since 2010.
- 06/19/2025
|
Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut
- On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq's opening bell in New York, marking the company's awaited initial public offering.
- 06/18/2025
|
Slide Insurance IPO: Stock price will be closely watched today as insurtech firm debuts on the Nasdaq
- Slide Insurance Holdings is set to debut on the Nasdaq today. The residential insurance company out of Florida will make its initial public offering for $17 per share.
- 06/18/2025
|
Hoth Therapeutics Regains Nasdaq Compliance - Clears Key Listing Hurdle, Reaffirms Path Toward Growth
- NEW YORK , June 18, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on breakthrough therapies, today announced that it has regained full compliance with Nasdaq's minimum bid price requirement. On June 18, 2025, the Company received formal notice from the Nasdaq Listing Qualifications Department confirming that Hoth's common stock closed at or above the $1.00 minimum bid price for 10 consecutive trading sessions—from June 4th through June 17- satisfying the requirement under Listing Rule 5550(a)(2).
- 06/18/2025
|
Sixth Street-backed Caris Life valued at $7.66 billion in strong Nasdaq debut
- Caris Life Sciences' shares jumped nearly 29% in their New York debut on Wednesday, fetching the cancer diagnostic firm a valuation of $7.66 billion and signaling a growing investor appetite for new listings in 2025.
- 06/18/2025
|
Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules
- SEATTLE, WA / ACCESS Newswire / June 18, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced that it has entered into securities purchase agreements with certain healthcare-focused and institutional investors to purchase (i) 2,465,000 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 12,325,000 shares of its common stock (the "Common Warrants") at a purchase price of $3.25 per share and associated Common Warrants in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock is being offered together with five Common Warrants, each to purchase one share of common stock.
- 06/18/2025
|
Pioneer Acquisition I Corp Announces Pricing of $220,000,000 Initial Public Offering
- BROOKLYN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- Pioneer Acquisition I Corp (Nasdaq: PACHU) (the “Company”) announced today the pricing of its initial public offering of 22,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “PACHU” beginning June 18, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “PACH” and “PACHW”, respectively. The underwriter has been granted a 45-day option to purchase up to an additional 3,300,000 units offered by the Company to cover over-allotments, if any. The offering is expected to close on June 20, 2025, subject to customary closing conditions.
- 06/17/2025
|
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on June 16, 2025, it granted stock options to purchase an aggregate of 37,200 shares of common stock to two new.
- 06/17/2025
|
Republic Digital Acquisition Company Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 23, 2025
- New York, NY, June 17, 2025 (GLOBE NEWSWIRE) -- Republic Digital Acquisition Company (Nasdaq: RDAGU) (the “Company”) announced today that, commencing June 23, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “RDAG” and “RDAGW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “RDAGU.”
- 06/17/2025
|
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
- CONSHOHOCKEN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on June 15, 2025 to 36 new non-executive employees as equity inducement awards under the terms of Madrigal's 2023 Inducement Plan. The equity awards were approved by Madrigal's independent Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/17/2025
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on June 6, 2025, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 187,664 shares of common stock and 89,582 restricted stock units (“RSUs”) to forty one new employees under Acadia's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' e.
- 06/17/2025
|
The Big 3: VRT, RDDT, NDAQ
- Jessica Inskip will be listening to Fed chair Jerome Powell's interest rate commentary Wednesday as markets flip-flop on bearish and bullish sentiment. She also talks about how macro developments are impacting today's Big 3.
- 06/17/2025
|
Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge
- Shares of Regencell Bioscience, a Hong Kong-based developer of traditional Chinese herbal treatments that it says can treat childhood ADHD and autism, more than tripled Monday. The stock soared more than 280% after a 38-for-1 stock split.
- 06/17/2025
|
Take-Two Stock Is Crushing the Nasdaq in 2025. Is It a Buy?
- Take-Two Interactive (TTWO 3.67%) stock is up 27% year to date, significantly outperforming the broader market. By comparison, the Nasdaq Composite (NASDAQINDEX: ^IXIC) is up just 0.59% at the time of writing.
- 06/16/2025
|
Graphjet Technology Discloses Stay of Suspension and Nasdaq Hearing Date
- Innovative technological leader to oversee all technical, operational, customer support and business development initiatives
- 06/16/2025
|
Nasdaq Announces Results from 2025 Annual Meeting of Shareholders
- All 12 Nominated Directors Elected Nasdaq Board Re-elects Adena T. Friedman as Chair of the Board NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) shareholders elected all nominated directors at the company's Annual Meeting of Shareholders on Wednesday, June 11, 2025.
- 06/16/2025
|
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- DUBLIN, June 16, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to two new employees to purchase 9,600 ordinary shares under Avadel's 2021 Inducement Plan. In addition, effective as of May 13, 2025, the Compensation Committee of Avadel's Board of Directors approved a grant of non-statutory options to Susan Rodriguez, Avadel's newly appointed Chief Operating Officer, to purchase 300,000 ordinary shares under Avadel's 2021 Inducement Plan.
- 06/16/2025
|
Robin Energy Ltd. Announces Pricing of $5.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- LIMASSOL, Cyprus, June 16, 2025 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (NASDAQ:RBNE) ("Robin Energy" or the "Company"), an international ship-owning company providing energy transportation services globally, today announced that it has entered into a securities purchase agreement with several institutional investors to purchase 965,000 common shares at an offering price of $5.25, for gross proceeds of approximately $5.1 million (the “Offering”), before deducting commissions and offering expenses, in a registered direct offering priced at-the-market under Nasdaq rules.
- 06/16/2025
|
SUNation Energy Retains Nasdaq Listing
- RONKONKOMA, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE) (“the Company”), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that, by a decision dated June 10, 2025, the Nasdaq Hearings Panel (the “Panel”) made a finding that the Company is not in violation of Nasdaq Listing Rules 5100 and 5550(a)(2), the “Public Interest Concern” and “Bid Price Rule”, respectively, which were the bases of the non-compliance and delisting notices previously provided to and disclosed by the Company.
- 06/16/2025
|
21Shares Expands Nasdaq Stockholm Offering with Five New Crypto ETP Listings
- New listings reflect growing demand for regulated crypto investment products in the Nordic region Zurich, 16 June 2025 – 21Shares AG, one of the world's largest issuers of cryptocurrency exchange-traded products (ETPs), today announced the crosslisting of five additional products on Nasdaq Stockholm, further solidifying its presence in the Nordic region and reinforcing its commitment to providing investors with regulated, transparent, and simple access to digital assets. The newly listed products include: 21Shares Uniswap ETP (Ticker: AUNI) 21Shares Avalanche ETP (Ticker: AVAX) 21Shares Bitcoin Gold ETP (Ticker: BOLD) 21Shares Solana Core Staking ETP (Ticker: CSOL) 21Shares Ethereum Core ETP (Ticker: ETHC) These products join an existing suite of 21Shares products already available on Nasdaq Stockholm: the 21Shares Bitcoin ETP (ABTC), 21Shares Ethereum ETP (AETH), 21Shares Solana ETP (ASOL), 21Shares XRP ETP (AXRP), and 21Shares Bitcoin Core ETP (CBTC).
- 06/16/2025
|
QQDN: Brand New, For Trading, Not Holding, Nasdaq
- QQDN is a new leveraged ETF targeting -2x daily performance of the Nasdaq-100 Mega Index, designed for short-term speculation or hedging. Leveraged ETFs like QQDN are not suitable for long-term holding due to daily resets, derivative time decay, and volatility drag. Liquidity and trading volume are currently limited, so bid/ask spreads may be wide until the fund gains size and activity.
- 06/14/2025
|
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- LEXINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants on June 2, 2025, of (i) 160,000 restricted stock units (“RSUs”) of the Company's Class A common stock (“Common Stock”) and (ii) non-qualified stock options to purchase an aggregate of 250,000 shares of Common Stock (the “Options”) as a material inducement to employment to a new employee. All such equity awards were made under the Company's Inducement Plan, as amended (the “Inducement Plan”) and were approved by a majority of the independent directors of the Board of Directors or a duly authorized committee thereof in accordance with Nasdaq Listing Rule 5635(c)(4). The equity awards are subject to the terms and conditions of the Inducement Plan, and the terms and conditions of the applicable stock option and RSU award agreements covering the grants.
- 06/13/2025
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that the company granted inducement equity awards covering an aggregate of 309,700 shares of its common stock to 11 newly hired employees, consisting of inducement stock options to purchase an aggregate of.
- 06/13/2025
|
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases, today announced that on June 10, 2025, the company granted inducement awards to seventeen new employees. The grants were made pursuant to Nurix's 2024 Equity Inducement Plan as an inducement material to the employees' acceptance of employment with Nurix and were approved by the Compensation Committee of Nurix's Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/13/2025
|
Lattice Semiconductor Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- HILLSBORO, Ore.--(BUSINESS WIRE)---- $LSCC #FPGA--Lattice Semiconductor Corporation (Nasdaq: LSCC), the low power programmable leader, today announced that on June 10, 2025 (“Grant Date”), Lattice Semiconductor granted a total of 88,848 restricted stock units (“RSUs”) to 29 new non-executive employees who began their employment with Lattice Semiconductor during May 2025. These inducement grants were granted pursuant to Lattice Semiconductor's 2025 Inducement Equity Incentive Plan (“Inducement Plan”). The RSUs.
- 06/13/2025
|
S&P 500 and Nasdaq: Tech Stocks Drop—Nvidia, Apple Down; Oil Powers Exxon Higher
- US stocks slide today on Middle East tensions. S&P 500 and Nasdaq dip as Nvidia, Visa fall; oil stocks like Exxon and Halliburton see gains.
- 06/13/2025
|
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)
- BALA CYNWYD, Pa., June 13, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
- 06/13/2025
|
Nasdaq 100 and S&P500: Oil News Lifts Energy, Defense Shares, Drags Down Travel and Tech Stocks
- Geopolitical oil news lifts energy and defense shares. Nasdaq 100 and S&P500 futures fall as travel and tech stocks face pressure before market open.
- 06/13/2025
|
These Were the 2 Worst-Performing Stocks in the Nasdaq-100 in May 2025
- The Nasdaq-100 market index holds a lot of volatile stocks. Some of its top performers seem overvalued today, while others seem to have room for further growth.
- 06/13/2025
|
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company's Board of Directors granted non-qualified stock options to purchase an aggregate of 26,000 shares of the Company's stock (the “Inducement Grant”) to newly hired employees on June 10, 2025 (the “Grant Date”), in connection with the commencement of employment.
- 06/13/2025
|
Chime's Nasdaq Debut Reignites FinTech IPO Momentum With 37% Stock Surge
- Chime's debut on the Nasdaq stock exchange Thursday was resoundingly positive, as the shares closed more than 37% higher. [contact-form-7] The shares went public at $27, and opened at more than $43 at the start of trading before closing at $37.11.
- 06/12/2025
|
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on June 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to 15 new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 81,100 shares of its common stock. These inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan and were granted as in.
- 06/12/2025
|
Chime shares jump in Nasdaq debut
- CNBC's Leslie Picker reports on Chime's Nasdaq debut.
- 06/12/2025
|
Chime IPO: Stock price today as financial services startup makes closely watched Nasdaq debut
- Chime Financial is expected to debut on the Nasdaq today. The fintech company's initial public offering (IPO) is one of the most anticipated of 2025, and investors and market watchers will be eagerly waiting to see how the newly public stock performs on its first day of trading.
- 06/12/2025
|
Chime opens at $43 in Nasdaq debut after pricing IPO above expected range
- Chime began trading Thursday on the Nasdaq under the ticker symbol CHYM, marking one of the most closely watched fintech debuts in recent years. The online banking provider priced its IPO at $27 per share, above the expected range.
- 06/12/2025
|
Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results
- U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday.
- 06/12/2025
|
S&P500 and Nasdaq 100: Oracle Powers Tech Stocks Today on AI Optimism and Forecast
- Oracle's earnings lift S&P500 and Nasdaq 100, while Boeing and trade concerns limit Dow gains. Traders eye inflation data and US indices forecast today.
- 06/12/2025
|
Chime set to debut on Nasdaq
- Ahead of its Nasdaq trading debut on Thursday, Chime CEO Chris Britt sat down with CNBC's David Faber on Wednesday. The online banking services provider is a five-time CNBC Disruptor 50 company.
- 06/12/2025
|
Casella Celebrates 50 Years at Nasdaq Opening Bell on Global Garbageman Day
- RUTLAND, Vt., June 12, 2025 (GLOBE NEWSWIRE) -- Casella Waste Systems, Inc. (“Casella”) (Nasdaq: CWST), a regional solid waste, recycling, and resource management services company, today announced that it will ring the Opening Bell at the Nasdaq MarketSite in Times Square on Tuesday, June 17, 2025.
- 06/12/2025
|
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules
- $6 million upfront with up to an additional $9.8 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants CRANFORD, N.J. , June 12, 2025 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase of an aggregate of 4,920,000 shares of its common stock (or pre-funded warrants in lieu thereof) and accompanying short-term warrants to purchase up to an aggregate of 9,840,000 shares of its common stock, at a purchase price of $1.22 per share (or pre-funded warrant in lieu thereof) and accompanying short-term warrant.
- 06/12/2025
|
Jeff's' Brands Announces 1-for-17 Reverse Share Split
- Following the reverse share split the Company will have approximately 553,385 outstanding shares Tel Aviv, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs' Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that it intends to effect a one-for-seventeen (1-for-17) reverse split (the "Reverse Share Split") of the Company's issued and outstanding ordinary shares, no par value per share (the "Ordinary Shares"). The Ordinary Shares are expected to begin trading on the Nasdaq Capital Market on a post-split basis at the opening of trading on June 16, 2025, under the Company's existing trading symbol “JFBR”, with a new CUSIP number of M61472144.
- 06/12/2025
|
Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
- GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announces that its Board of Directors have approved a proposed reverse stock split of its common stock at a ratio of 25-for-1. The proposed action remains subject to approval by Nasdaq and, if approved, the Company will issue a subsequent announcement disclosing the effective date.
- 06/12/2025
|
Nasdaq Confirms Full Compliance of HUB Cyber Security with Nasdaq's Listing Standards
- TEL AVIV, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and advanced secured data fabric technology, today announced that it is in full compliance with all applicable listing requirements of the Nasdaq Capital Market.
- 06/12/2025
|
Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market
- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (OTC: SPRB) (“Spruce”), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced that it has received approval from The Nasdaq Stock Market LLC (“Nasdaq”) to resume trading of its common stock on the Nasdaq Capital Market subject to Spruce regaining compliance with Nasdaq's minimum bid price requirement on or bef.
- 06/12/2025
|
UMB Financial Corporation Announces Full Redemption of Its Series A Preferred Stock; Nasdaq UMBFP
- KANSAS CITY, Mo.--(BUSINESS WIRE)--UMB Financial Corporation (the “Company”) (Nasdaq: UMBF), a financial services company, announced today that it will redeem all outstanding shares of the Company's 7.00% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A, $0.01 par value per share (“Series A Preferred Stock”). All 11,500 outstanding shares of the Series A Preferred Stock (CUSIP: 902788 306) will be redeemed at a price of $10,000 per share of preferred stock on the dividend pay.
- 06/12/2025
|
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
- MAINZ and TÜBINGEN, Germany, June 12, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases based on messenger ribonucleic acid (“mRNA”). The all-stock transaction will bring together two highly complementary companies based in Germany and will build on BioNTech's proven track record and established position in the global mRNA industry.
- 06/12/2025
|
Chime prices IPO at $27 per share, valuing fintech company at $11.6 billion ahead of Nasdaq debut
- Chime's decision to go public comes after a steep valuation cut and years of private market delays across the fintech sector. The company provides online banking services.
- 06/11/2025
|
New Providence Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 16, 2025
- Palm Beach, FL, June 11, 2025 (GLOBE NEWSWIRE) -- New Providence Acquisition Corp. III (Nasdaq: NPACU) (the “Company”) announced today that, commencing June 16, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “NPAC” and “NPACW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “NPACU.”
- 06/11/2025
|
Inflection Point Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on or about June 16, 2025
- NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Inflection Point Acquisition Corp. III (Nasdaq: IPCXU) (the “Company”) announced that holders of the units sold in the Company's initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the exercise by the underwriters of their overallotment option, completed on April 28, 2025 (the “Offering”) may elect to separately trade the Class A ordinary shares and rights included in the units commencing on or about June 16, 2025. Any units not separated will continue to trade on The Nasdaq Global Market under the symbol “IPCXU”, and each of the Class A ordinary shares and rights will separately trade on The Nasdaq Global Market under the symbols “IPCX” and “IPCXR,” respectively. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into Class A ordinary shares and rights.
- 06/11/2025
|
Delisting of Securities of Blue Star Foods Corp.; Altamira Therapeutics Ltd.; Evergreen Corporation; Fresh2 Group Limited; Coliseum Acquisition Corp.; The Real Good Food Company, Inc.; Mynaric AG; byNordic Acquisition Corporation; Avinger Inc.; MultiMetaVerse Holdings Limited; Nature's Miracle Holding Inc.; and SPI Energy Co., Ltd.
- NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Blue Star Foods Corp. Blue Star Foods Corp.'s stock was suspended on December 20, 2024 and has not traded on Nasdaq since that time.
- 06/11/2025
|
Should You Buy the 2 Highest-Paying Dividend Stocks in the Nasdaq?
- The Nasdaq 100 market index is home to many market darlings. The entire roster of "Magnificent 7" stocks is found here, setting the tone for Wall Street as a whole.
- 06/11/2025
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 06/10/2025
|
Australian Oilseeds Holdings Limited Announces Receipt of Nasdaq Notification Regarding Filing Delinquency
- COOTAMUNDRA, Australia, June 10, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited (the “Company”) (NASDAQ: COOT), a manufacturer and seller of sustainable edible oils to customers globally, announced that it has received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it has not regained compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Global Market. Nasdaq Listing Rule 5450(b)(1) requires listed companies to maintain stockholders' equity of at least $10,000,000 (the “Stockholders' Equity Requirement”).
- 06/10/2025
|
Graphjet Technology Discloses Notice from Nasdaq
- Innovative technological leader to oversee all technical, operational, customer support and business development initiatives
- 06/10/2025
|
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 74,000 shares of its common stock and granted an aggregate of 48,850 restricted stock unit (“RSU”) awards to 20 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/10/2025
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 30, 2025
- NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of May 30, 2025, short interest in 3,184 Nasdaq Global MarketSM securities totaled 13,504,275,894 shares compared with 13,735,568,588 shares in 3,168 Global Market issues reported for the prior settlement date of May 15, 2025. The mid-May short interest represents 2.19 days compared with 2.41 days for the prior reporting period.
- 06/10/2025
|
American Resources Corporation Reaffirms Compliance With Nasdaq Listing Standards
- FISHERS, IN / ACCESS Newswire / June 10, 2025 / American Resources Corporation (NASDAQ:AREC) ("American Resources"), a leader in the critical mineral supply chain, reaffirms compliance with Nasdaq Listing Standards as outlined in the Company's Form 8-K filed on May 30, 2025 with the U.S. Securities and Exchange Commission. As stated in the in the referenced filing: On May 29, 2025, American Resources Corporation (or the "Company") received a letter from the Nasdaq Stock Market indicating that the company's Form 10-Q for the fiscal year ended March 31, 2025 has not been timely filed according to Nasdaq's Listing Rules.
- 06/10/2025
|
Lincoln Electric to Ring the Nasdaq Opening Bell on June 10, 2025
- CLEVELAND--(BUSINESS WIRE)-- #LEA--Lincoln Electric Holdings, Inc. (Nasdaq: LECO) (“the Company”), the leading global manufacturer of advanced arc welding solutions, announced today that the Company will ring the Nasdaq Stock Market opening bell on Tuesday, June 10, 2025, which will begin at approximately 9:15am ET. Chair, President and CEO, Steven B. Hedlund, along with members of the Company's Board of Directors and its leadership team, will participate in the ceremonial bell ringing at the Nasdaq M.
- 06/10/2025
|
Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules
- $6 million upfront with up to an additional $9.8 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants CRANFORD, N.J. , June 10, 2025 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive agreements for the purchase of an aggregate of 4,920,000 shares of its common stock (or pre-funded warrant in lieu thereof) and accompanying short-term warrants to purchase up to an aggregate of 9,840,000 shares of its common stock, at a purchase price of $1.22 per share (or pre-funded warrant in lieu thereof) and accompanying short-term warrant in a registered direct offering priced at-the-market under Nasdaq rules.
- 06/10/2025
|
Great News for Stock Market Investors! U.S. Economy Adds 139,000 Jobs in May
- The robust increase in jobs decreases the likelihood that the U.S. economy is heading into a recession.
- 06/10/2025
|
The 3 Best Nasdaq-100 Stocks in 2025: Wall Street Says Buy One and Sell the Others
- The Nasdaq-100 measures the performance of 100 large non-financial companies listed on the Nasdaq Stock Exchange. Year to date, the three best-performing stocks in the index are Palantir Technologies (PLTR 3.36%), Zscaler (ZS -0.98%), and MercadoLibre (MELI -1.36%) as of June 8.
- 06/10/2025
|
S&P 500 and Nasdaq close higher, why the US and China trade war is a losing game
- Market Domination Overtime anchors Julie Hyman and Josh Lipton break down the day's market moves for June 9, 2025. Stocks closed mixed.
- 06/09/2025
|
Lulus Announces Approval of Equity Listing Transfer to Nasdaq Capital Market
- CHICO, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU), the attainable luxury brand for women, today announced that the Company has received approval from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) to transfer the listing of the Company's common stock from the Nasdaq Global Market to the Nasdaq Capital Market.
- 06/09/2025
|
Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- $1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants $1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants
- 06/09/2025
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on June 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 124,000 shares of Class A common stock and restricted stock units (RSUs) for 65,925 shares of Class A common stock to seventeen (17) new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/09/2025
|
NDAQ Hits 52-Week High, Trades at a Discount: How to Play the Stock
- Nasdaq is set to grow on its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
- 06/09/2025
|
ScanTech AI Systems Appoints Security Industry Veteran Brad Buswell as Chairman of the Board
- Leadership Transition Strengthens Board Oversight and Strategic Alignment Following Nasdaq Listing Leadership Transition Strengthens Board Oversight and Strategic Alignment Following Nasdaq Listing
- 06/09/2025
|
Nasdaq Grants AGM Group Holdings Inc. Continued Listing on The Nasdaq Stock Market Subject to Conditions
- Beijing, June 09, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, today announced that the Nasdaq Hearings Panel issued a decision granting the Company's request for continued listing on The Nasdaq Capital Market subject to the Company's compliance with certain conditions, including compliance with the $1.00 bid price requirement by June 16, 2025, and continued compliance with all applicable criteria for continued listing on the Capital Market tier through at least September 29, 2025.
- 06/09/2025
|
Prediction: 2 Nasdaq Stocks Will Be Worth More Than Palantir Technologies in 3 Years
- Palantir Technologies stock has advanced 435% in the past year, bringing its market value to $300 billion as of June 7. But two Nasdaq stocks, Shopify (SHOP 6.17%) and Intuitive Surgical (ISRG -0.19%), are growing quickly enough to top that figure in three years.
- 06/08/2025
|
QQA: New Option Strategy ETF In The Nasdaq 100
- The Invesco QQQ Income Advantage ETF offers an 8.63% yield from option strategies in the Nasdaq 100. QQA has 3/4 of assets in Nasdaq 100 stocks and delegates option income generation to equity-linked notes. QQA's short track record shows a total return nearly matching QQQ, but the price return is flat.
- 06/07/2025
|
The Nasdaq Bounces Back: 2 Artificial Intelligence (AI) Stocks Worth Buying Right Now
- Technology stocks are surging once again, especially artificial intelligence stocks. But don't think it's too late to buy in.
- 06/07/2025
|
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective June 5th, 2025, to three non-executive employees of non-qualified stock op.
- 06/06/2025
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 71,275 shares of common stock. Awards were made to seven new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committ.
- 06/06/2025
|
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to a new employee. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employee entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/06/2025
|
iOThree Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Singapore, June 06, 2025 (GLOBE NEWSWIRE) -- iOThree Limited ("iOThree" or the "Company") (NASDAQ: IOTR), a leading provider of maritime digital technologies including satellite connectivity and digitalization solutions in Singapore with a focus on facilitating the maritime industry towards digital transformation, today announced that it has received a written notification from the Nasdaq Stock Market LLC (“Nasdaq”) on June 3, 2025, indicating that the Company was not in compliance with the $1.00 closing bid price requirement for the last 30 consecutive business days from April 21, 2025 to June 2, 2025 under the Nasdaq Listing Rule 5550(a)(2).
- 06/06/2025
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 61,100 shares of the Company's common stock to three new employees (the “Inducement Grants”) on June 3, 2025 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/06/2025
|
BloomZ Granted 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
- TOKYO, JAPAN / ACCESS Newswire / June 6, 2025 / BloomZ Inc. (NASDAQ:BLMZ) ("BloomZ" or the "Company"), a Japanese audio production, VTuber, entertainment, and voice actor management company, announced it has received a letter form the Nasdaq Listing Qualification Staff (the "Staff") granting it a second 180 calendar day period, or until December 1, 2025, to regain compliance with the minimum $1.00 per share bid price requirement for continued listing on The Nasdaq Capital Market, pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(ii). The Company was initially notified on December 2, 2024, that it did not meet the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), and was provided 180 calendar days, or until June 2, 2025, to regain compliance.
- 06/06/2025
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 72,000 restricted stock units of Arcutis' common stock to nine newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of June 2, 2025, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/06/2025
|
Omada Health IPO: CEO explains why the digital health company went public now
- Telehealth provider Omada Health raised $150 million in its IPO as the company makes its public debut on the Nasdaq on Friday. Omada Health CEO Sean Duffy sits down with Yahoo Finance senior health reporter Anjalee Khemlani at the Nasdaq MarketSite to speak more about Omada's approach to treating chronic diseases, like diabetes, and its relationship with patients and pharmaceutical companies.
- 06/06/2025
|
Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- $1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants $1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants
- 06/06/2025
|
B. Riley Financial Granted Extension From Nasdaq Regarding Listing Rules
- Announces Notification of Additional Delinquency with Nasdaq for Late Filing of Annual Report on Form 10-K for the period ended December 31, 2024 and its Quarterly Report on Form 10-Q for the period ended March 31, 2025 Expects to Return to Normal Filing Cadence by Fall 2025 LOS ANGELES , June 6, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B.
- 06/06/2025
|
Classover Approved for Options Trading
- NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Classover Holdings, Inc. (Nasdaq:KIDZ)(Nasdaq:KIDZW) ("Classover" or the "Company"), a leading provider of live, interactive online learning, today announced that it has been notified by Nasdaq that options on its Class B common stock have been approved for trading on multiple U.S. options exchanges. The options, which will trade under the ticker symbol "KIDZ", will feature a range of standard expiration dates and strike prices.
- 06/06/2025
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 2, 2025, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 401,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/06/2025
|
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 27 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of Jelmyto® (mitomycin) for pyelocalyceal solution, UroGen's first approved product, and the c.
- 06/06/2025
|
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on June 2, 2025, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 79,200 shares of common stock to five (5) new employees under the Company's 2023 Inducement Option Plan, as amended. The Compensation Committee approved the stock options as an inducement material to such employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/06/2025
|
Codere Online Regains Compliance with Nasdaq Listing Requirements
- Luxembourg, Grand Duchy of Luxembourg, June 6, 2025 (GLOBE NEWSWIRE) – Codere Online Luxembourg, S.A. (Nasdaq: CDRO / CDROW) (the “Company” or “Codere Online”), a leading online gaming operator in Spain and Latin America, today announced that it has received formal notification from the Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Capital Market's listing requirements. As a result, the Company's securities will continue to be listed and traded on the Nasdaq Capital Market and are no longer subject to a delisting process.
- 06/06/2025
|
Kyivstar Group Reaches Nasdaq Listing Milestone with Public Filing of Registration Statement on Form F-4
- KYIV, Ukraine, June 05, 2025 (GLOBE NEWSWIRE) -- Kyivstar Group Ltd., Ukraine's leading digital operator (“Kyivstar Group” or “the Company”) and a subsidiary of VEON Ltd. (Nasdaq: VEON) (“VEON Group” or “VEON”), today announced the public filing of its Registration Statement on Form F-4 (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”).
- 06/05/2025
|
Kyivstar Group Reports First Quarter 2025 Financial Results in Conjunction with its Nasdaq Listing Process
- KYIV, Ukraine, June 05, 2025 (GLOBE NEWSWIRE) -- Kyivstar Group, Ukraine's leading digital operator (“Kyivstar Group” or “the Company”) and a subsidiary of VEON Ltd. (Nasdaq: VEON) (“VEON Group” or “VEON”), today announced its unaudited financial and operating results for the first quarter ended March 31, 2025.
- 06/05/2025
|
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 2, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,500 shares of common stock at a per share exercise price of $11.45, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation.
- 06/05/2025
|
Kyivstar Group Reports First Quarter 2025 Financial Results in Conjunction with its Nasdaq Listing Process
- KYIV, Ukraine, June 5, 2025 – Kyivstar Group, Ukraine's leading digital operator (“Kyivstar Group” or “the Company”) and a subsidiary of VEON Ltd. (Nasdaq: VEON) (“VEON Group” or “VEON”), today announced its unaudited financial and operating results for the first quarter ended March 31, 2025.
- 06/05/2025
|
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 9,740 shares of common stock and restricted stock units (RSUs) for 4,870 shares of common stock to two new employees under Adverum's 2017 Inducement Plan. These awards were approved as an inducement material to the new employees entering into employment with Adverum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/05/2025
|
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on June 1, 2025, it awarded an inducement grant to six new employees under Intellia's 2024 Inducement Plan as a material inducement to employment.
- 06/05/2025
|
3 Upcoming Dividend Increases
- I focus on companies with a strong track record of dividend growth, using data from Dividend Champions and NASDAQ to identify reliable opportunities. This week's highlighted stocks average a 7.3% dividend increase and 11-year streaks, with NDAQ and HWBK outperforming the SCHD benchmark over ten years. My investment strategy prioritizes stocks with significant alpha over SCHD, strong earnings, and consistent dividend growth, not just marginal outperformance.
- 06/05/2025
|
Columbus Circle Capital Corp I Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 9, 2025
- New York, NY, June 05, 2025 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp I (Nasdaq: CCCMU) (the “Company”) announced today that, commencing June 9, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “CCCM” and “CCCMW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “CCCMU.”
- 06/05/2025
|
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
- FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the entry into definitive agreements to raise $2.5 million from the sale of shares of the company's common stock priced at-market for Nasdaq purposes. The closing of the offering is expected to occur on or about June 6, 2025, subject to satisfaction of customary closing conditions.
- 06/05/2025
|
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on June 3, 2025 to 19 new employees under Pacira's Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee's entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the People & Compensation Committee of the Board of Directors (the “Committee”) without stockholder approval.
- 06/05/2025
|
Bowman to Ring Nasdaq Opening Bell in Honor of 30th Anniversary
- RESTON, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd.
- 06/05/2025
|
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company's Board of Directors, made up entirely of independent directors, approved the grant of non-qualified stock options to purchase an aggregate of 23,400 shares of the company's common stock to one new employee (th.
- 06/05/2025
|
Australian Oilseeds Holdings Limited Announces Receipt of Nasdaq Notification Regarding Filing Delinquency
- COOTAMUNDRA, Australia, June 04, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited (the “Company”) (NASDAQ: COOT), a manufacturer and seller of sustainable edible oils to customers globally, announced that it has received written notification from the Nasdaq Stock Market LLC (“Nasdaq”) on May 27, 2025 stating that the Company was delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2025. The Company previously filed a Form 12b-25 with the U.S. Securities and Exchange Commission on May 14, 2025, disclosing that it was unable to file the Form 10-Q within the prescribed time period without unreasonable effort or expense. The Nasdaq Letter provided that under Nasdaq rules, the Company has 60 calendar days to submit a plan to regain compliance with respect to the Delinquent Filing.
- 06/04/2025
|
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 2, 2025, the Compensation Committee of Puma's Board of Directors approved the grant of inducement restricted stock unit awards covering 18,250 shares of Puma common stock to three new non-executive employees. The awards were granted under Puma's 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity award.
- 06/04/2025
|
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, June 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on June 2, 2025, the Compensation Committee of Praxis' Board of Directors granted a restricted stock unit award covering 750 shares of its common stock to one new non-executive employee under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit award was granted as inducement material to the employee's entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/04/2025
|
Renatus Tactical Acquisition Corp I Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on June 9, 2025
- CORAL GABLES, Fla.--(BUSINESS WIRE)---- $RTAC #SPAC--Renatus Tactical Acquisition Corp I (Nasdaq: RTACU) (the “Company”) today announced that, commencing on June 9, 2025, holders of the units (the “Units”) sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares (the “Ordinary Shares”) and warrants (the “Warrants”) included in the Units. The Ordinary Shares and Warrants received from the separated Units will trade on the Nasdaq Global Market (“Nasdaq”) u.
- 06/04/2025
|
Smith-Midland Announces Receipt of Nasdaq Letter
- MIDLAND, VA / ACCESS Newswire / June 4, 2025 / Smith-Midland Corporation (NASDAQ:SMID) (the "Company"), a provider of innovative, high-quality proprietary and patented precast concrete products and systems, today announced it received a letter from Nasdaq, dated May 29, 2025, indicating that the Company has regained compliance as it relates to its Annual Report on Form 10-K ("10-K") for the year ended December 31, 2024. The Company's 10-K was filed on May 27, 2025.
- 06/04/2025
|
Nasdaq Turns Positive in 2025: ETFs to Ride the Rally
- Nasdaq claws back gains in 2025 on AI-fueled tech strength and easing trade fears. ETFs like QQQ and QQQM ride the wave.
- 06/04/2025
|
Nasdaq Launches Exclusive Access to Nasdaq Private Market's Tape D® API to Deliver Advanced Visibility into Private Markets
- Real-Time Private Company Dataset Offers Critical Pricing and Valuation Insights for Private Companies, Investors, and Advisors Real-Time Private Company Dataset Offers Critical Pricing and Valuation Insights for Private Companies, Investors, and Advisors
- 06/04/2025
|
American Resources Corporation Featured in Nasdaq Amplify Issuer Spotlight
- Reestablishing United States Dominance in the Critical Mineral Supply Chain FISHERS, IN / ACCESS Newswire / June 4, 2025 / American Resources Corporation (NASDAQ:AREC) ("American Resources"), a leader in the critical mineral supply chain, developing innovative solutions both upstream and downstream of the refining process, and through its holding in ReElement Technologies Corporation ("ReElement" or "RTC"), a leading U.S. innovator in rare earth element (REE) and critical mineral refining, today announced that Mark Jensen, Chairman and Chief Executive Officer, was recently featured in Nasdaq Amplify Issuer Spotlight interview series at the Nasdaq MarketSite. The Nasdaq Issuer Spotlight interview series explores how industry leaders within the small-cap community are evolving and navigating challenges in various industries.
- 06/04/2025
|
Cognizant to Present at the Nasdaq Investor Conference in Partnership with Jefferies
- TEANECK, N.J. , June 4, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading provider of information technology, consulting, and business process services, today announced a presentation at the following investor conference: Nasdaq Investor Conference in Partnership with Jefferies Presenter: Jatin Dalal, Chief Financial Officer Date: Wednesday, June 11, 2025 Time: 2:00PM GMT | 9:00 AM EDT A live audio webcast of the presentation will be available at Cognizant's website: http://investors.cognizant.com A replay of the webcasts will remain available on the company's website for 90 days.
- 06/04/2025
|
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
- Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq's Equity Rule requirement Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq's Equity Rule requirement
- 06/04/2025
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to 11 new employees to purchase an aggregate of 322,000 shares of the Company's common stock, effective as of June 2, 2025. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/03/2025
|
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective June 1, 2025, the company granted non-qualified stock options to purchase 181,300 shares of its common stock to five new employees under Xilio Therapeutics' 2022 Inducement Stock Incentive Plan.
- 06/03/2025
|
Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq
- GEELONG, Australia, June 03, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that the Company has received a notification letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the Company's annual report on Form 20-F for the fiscal year ended June 30, 2024 which was filed with the Securities and Exchange Commission on May 14, 2025, the Company is not in compliance with the minimum stockholder's equity requirement for continued listing set forth in Nasdaq Listing Rule 5450(b)(1)(A), which requires companies listed on the Nasdaq Global Select Market to maintain a minimum of $10,000,000 in stockholders' equity for continued listing. The Letter has no immediate effect on the listing or trading of the Company's ordinary shares or warrants on Nasdaq. The Letter stated that, under Nasdaq rules, the Company has 45 calendar days to submit a plan to regain compliance, and that if a plan is submitted and accepted, Nasdaq could grant the Company an exception of up to 180 calendar days from May 30, 2025, or until November 26, 2025, to regain compliance. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.
- 06/03/2025
|
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
- KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has received a letter (the “Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (“Nasdaq”) dated June 3, 2025, informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).
- 06/03/2025
|
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 62,000 shares of Astria's common stock on June 2, 2025 under Astria's 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were granted.
- 06/03/2025
|
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on June 2, 2025, the Compensation Committee of the company's Board of Directors granted to seven new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 57,700 ordinary shares. These awards were made under Bicycle Therapeutics' 2024 Inducement Plan and approved by the Compensation Committee as an inducement material to the employees entering i.
- 06/03/2025
|
Nasdaq Reports May 2025 Volumes
- NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for May 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics .
- 06/03/2025
|
Presidio Regains Compliance with Nasdaq Minimum Bid Price Requirement
- SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (“Presidio” or the “Company”) (NASDAQ: SQFT; SQFTP; SQFTW), an internally managed, diversified real estate investment trust (“REIT”), today announced that it has received formal notice from Nasdaq stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The Company's common stock will continue to be listed and traded on Nasdaq.
- 06/03/2025
|
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista's board of directors granted five newly-hired employees inducement options to purchase an aggregate of 50,000 shares of KalVista common stock on June 1, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock on.
- 06/03/2025
|
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
- FRAMINGHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that in connection with the hiring of a senior leader, that the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted an inducement award.
- 06/03/2025
|
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CHARLESTOWN, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 34,550 restricted stock units (“RSUs”) to two newly hired employees.
- 06/03/2025
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted seven newly-hired employees restricted stock units (RSUs) covering an aggregate of 47,250 shares of BioCryst common stock. The RSUs were granted as of June 2, 2025, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/03/2025
|
Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F
- Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International Ltd. (NASDAQ:SELX) (“SELX” or the “Company”) announced that it received a delinquency notification letter on May 27, 2025 (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasdaq”) notifying the Company that it is no longer in compliance with the Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) for continued listing due to its failure to timely file its annual report on Form 20-F for the year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.
- 06/02/2025
|
Dow, S&P 500, and Nasdaq all close higher; Magnificent 7's gains; Zscaler CEO on earnings and growth
- Asking for a Trend, anchor Josh Lipton breaks down the day's market trends for June 2, 2025. Markets shrugged off a flare-up of US-China trade tensions, as all three major indexes closed higher on Monday, June 2.
- 06/02/2025
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that on June 2, 2025, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 137,400 shares of the Company's common stock to four (4) newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/02/2025
|
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 23,820 restricted stock units (“RSUs”) to six newly-hired non-executive employees under the Company's 2025 Inducement Equity Plan (the “Inducement Plan”), effective as of June 1, 2025. The inducement grants were previously approved by the Compensation Committee of the Company's Board of Directors, as a material inducement to the new employees' entry into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/02/2025
|
Chime Financial IPO: Digital banking service sets target stock price as Nasdaq listing date nears
- Ding, ding, ding! Chime Financial is finally ready to go public.
- 06/02/2025
|
Black Spade Acquisition II Co Announces Intention to Voluntarily Delist from The Nasdaq Stock Market LLC, Conditional Upon Consummation of its Pending Business Combination with The Generation Essentials Group
- HONG KONG--(BUSINESS WIRE)--Black Spade Acquisition II Co (the “Company”) today announced that, in connection with its proposed business combination (the “Business Combination”) with The Generation Essentials Group (“TGE”), it intends to voluntarily delist its units, Class A ordinary shares and warrants from The Nasdaq Stock Market LLC (“Nasdaq”), subject to the closing of the Business Combination. The Company's decision to voluntarily delist its units, Class A ordinary shares and warrants from.
- 06/02/2025
|
Broadway Financial Corporation Announces Notification from Nasdaq regarding late filing of Form 10-Q
- LOS ANGELES , June 2, 2025 /PRNewswire/ -- Broadway Financial Corporation ("Broadway", "we", or the "Company") (NASDAQ: BYFC), parent company of City First Bank, National Association, announced today it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), dated May 28, 2025, informing the Company that it no longer complies with Nasdaq Listing Rule 5250(c)(1) ("Rule 5250(c)(1)") for continued listing on The Nasdaq Capital Market because its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the "Form 10-Q") was not filed within the time period prescribed by the Securities and Exchange Commission ("SEC") rules. Nasdaq's notice has no immediate effect on the listing or trading of the Company's shares on the Nasdaq Capital Market, although there can be no assurances that further delays in the filing of the Form 10-Q or the Company's other SEC reports will not have an impact on the listing or trading of the Company's common stock.
- 06/02/2025
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted three newly-hired employees options to purchase an aggregate of 137,000 shares of Akebia's common stock on May 30, 2025. The options were granted as an inducement material to each employee entering into employment with Akebia. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/02/2025
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , June 2, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 566 restricted stock units (RSUs) to two newly-hired employees.
- 06/02/2025
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on May 30, 2025, the company granted equity awards to four new employees, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/02/2025
|
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on May 30, 2025, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 5,545 shares of X4's common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by X4's Compensation Committee of the Board of Directors.
- 06/02/2025
|
AB Akola Group presentation during the Nasdaq Vilnius Stock Exchange's traditional event, “CEO Meets Investors”
- On June 2, 2025, AB Akola Group's CFO, Mažvydas Šileika, shared a slide presentation with the investment community during the Nasdaq Vilnius Stock Exchange's traditional event, “CEO Meets Investors”.
- 06/02/2025
|
CLIK Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Hong Kong, June 02, 2025 (GLOBE NEWSWIRE) -- Click Holdings Limited (NASDAQ: CLIK) (“Click”, or the “Company”) announced that, on May 30, 2025, the Company received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from April 16, 2025 to May 29, 2025, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.
- 06/02/2025
|
Nasdaq set to slide as market chews Trump TACO trade, Campbell Soup earnings
- US stocks are expected to start the month of June on the back foot as markets chew over whether the TACO trade (Trump Always Chickens Out) will prove the correct bet. Dow Jones futures were down 0.2%, those for the S&P 500 were 0.35% lower and Nasdaq 100 futures were 0.5% in the red.
- 06/02/2025
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, June 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/02/2025
|
Information to be delivered by Artea Bank at the Nasdaq Vilnius conference "CEO Meets Investors"
- On June 2, 2025 at the traditional online webinar of listed companies' executives with investors, hosted by Nasdaq Vilnius, Vytautas Sinius, CEO of Artea Bank will provide information on bank`s strategy, operation, financial outlook and future perspectives.
- 06/02/2025
|
China Liberal Education Holdings Limited Announces Suspension of Nasdaq Trading
- BEIJING , June 1, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), a China-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that on May 30, 2025, the Company received notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company's securities will be suspended from trading on Nasdaq effective June 3, 2025. The suspension is due to the Company's failure to submit a request for an extended stay or otherwise address the delinquency in filing its annual report on Form 20-F for the fiscal year ended December 31, 2024, in its written submissions to the Nasdaq Hearings Panel (the "Panel").
- 06/01/2025
|
2 Nasdaq Stocks to Buy in June
- It's not surprising that the Nasdaq Composite's return of 275% outpaces the S&P 500 return of 178% over the last 10 years. The Nasdaq is full of tech-centric companies that are driving change and innovation in the economy, which is where you'll find stocks with monster growth potential.
- 06/01/2025
|
Oak Woods Acquisition Corporation Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
- New York, May 30, 2025 (GLOBE NEWSWIRE) -- Oak Woods Acquisition Corporation. (Nasdaq: OAKU) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on May 27, 2025, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Quarterly Report”). The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”). This notification has no immediate effect on the listing of the Company's securities on Nasdaq.
- 05/30/2025
|
9F Inc. Announces Receipt of Nasdaq Notification Regarding Late Filing of Form 20-F
- BEIJING , May 30, 2025 /PRNewswire/ -- 9F Inc. ("9F" or the "Company") (Nasdaq: JFU), a digital technology service provider aiming to empower institutional partners with advanced financial technologies, today announced that it received a notification letter dated May 23, 2025 (the "Notification Letter") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq"), indicating that the Company is not in compliance with the requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) since the Company did not timely file its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "2024 Form 20-F") with the Securities and Exchange Commission (the "SEC"). The Notification Letter has no immediate effect on the listing of the Company's American depositary shares on Nasdaq.
- 05/30/2025
|
VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing
- SAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of p.
- 05/30/2025
|
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced equity inducement grants to seven new non-officer employees consisting of an aggregate of 53,550 share options. All of the foregoing share options were approved by the Compensation Committee of the Company's Board of Directors with an effective date of May 29, 2025 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/30/2025
|
FiEE, Inc. Announces Reinitiation of Trading on Nasdaq
- Company will resume trading under its existing symbol "MINM" HONG KONG , May 30, 2025 /PRNewswire/ -- FiEE, Inc. ("FiEE, Inc." or the "Company"), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, is pleased to announce that following a hearing before the Nasdaq Hearings Panel (the "Panel") on May 13, 2025, the Panel issued a decision on May 29, 2025, stating that Nasdaq will reinstate trading of the Company's common stock on the Nasdaq Capital Market at the open of business on Monday, June 2, 2025 under the ticker symbol "MINM". Rafael Li, Chief Executive Officer of FiEE, commented, "We are honored to announce the reinitiation of trading of our common stock on Nasdaq, a significant milestone that reflects our unwavering commitment to operational excellence and strategic growth.
- 05/30/2025
|
The Nasdaq Bounces Back: These AI Stocks Could Be the Smartest Buys of the Year
- The Nasdaq Composite is only at about breakeven for the year, as of this writing, but it's made a powerful comeback in recent weeks. The tech-heavy index is now down less than 1% year to date, a massive improvement from the drop of more than 20% it recorded in early April.
- 05/30/2025
|
Aimfinity Investment Corp. I Announces Transition from Nasdaq to OTC Markets and New Monthly Extension for Business Combination
- Wilmington, DE, May 30, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from May 28, 2025 to June 28, 2025, on May 28, 2025, I-Fa Chang, manager of the sponsor of the Company, has deposited into its trust account (the “Trust Account”) an aggregate of $55,823.8, or for $0.05 per Class A ordinary share held by public shareholders (the “Monthly Extension Payment”).
- 05/30/2025
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , May 30, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on May 29, 2025, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 664,600 shares of the Company's common stock to nine newly hired employees.
- 05/30/2025
|
Cycurion, Inc. Receives Expected Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
- MCLEAN, Va., May 29, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on May 22, 2025 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the "Form 10-Q"), as described more fully in the Company's Form NT 10-Q Notification of Late Filing (the "Form NT 10-Q") filed with the Securities and Exchange Commission (the "SEC") on May 15, 2025. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.
- 05/29/2025
|
Digital Asset Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about June 2, 2025
- PRINCETON, NEW JERSEY, May 29, 2025 (GLOBE NEWSWIRE) -- Digital Asset Acquisition Corp. (Nasdaq: DAAQU) (the “Company”) announced that holders of the units sold in the Company's initial public offering of 17,250,000 units, which includes 2,250,000 units issued pursuant to the exercise by the underwriters of their overallotment option in full, completed on April 30, 2025 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about June 2, 2025. Any units not separated will continue to trade on The Nasdaq Global Market under the symbol “DAAQU,” and each of the Class A ordinary shares and warrants will separately trade on The Nasdaq Global Market under the symbols “DAAQ” and “DAAQW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Efficiency, the Company's transfer agent, at dwacrequests@useefficiency.com in order to separate the units into Class A ordinary shares and warrants.
- 05/29/2025
|
Real Asset Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about June 2, 2025
- PRINCETON, NEW JERSEY, May 29, 2025 (GLOBE NEWSWIRE) -- Real Asset Acquisition Corp. (Nasdaq: RAAQU) (the “Company”) announced that holders of the units sold in the Company's initial public offering of 17,250,000 units, which includes 2,250,000 units issued pursuant to the exercise by the underwriters of their overallotment option in full, completed on April 30, 2025 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about June 2, 2025. Any units not separated will continue to trade on The Nasdaq Global Market under the symbol “RAAQU,” and each of the Class A ordinary shares and warrants will separately trade on The Nasdaq Global Market under the symbols “RAAQ” and “RAAQW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Efficiency, the Company's transfer agent at dwacrequests@useefficiency.com, in order to separate the units into Class A ordinary shares and warrants.
- 05/29/2025
|
Zeo Energy Corp. Receives Nasdaq Notice on Late Filing of its Form 10-Q
- NEW PORT RICHEY, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) “Zeo Energy” or the “Company”), announced today that, as expected, it received a notice (the “Notice”) from Nasdaq on May 22, 2025, notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company's Quarterly Report on Form 10-Q for the for the three months ended March 31, 2025 (the “10-Q”) was not filed with the Securities and Exchange Commission (the “SEC”) by the required due date of May 15, 2025.
- 05/29/2025
|
ChampionsGate Acquisition Corporation Announces Closing of $74,750,000 Initial Public Offering
- Monterey, CA, May 29, 2025 (GLOBE NEWSWIRE) -- ChampionsGate Acquisition Corporation (Nasdaq: CHPGU), a Cayman Islands exempted company (the “Company”), today announced that it closed its initial public offering of 7,475,000 units at $10.00 per unit, which includes the full exercise of the underwriter's over-allotment option. The gross proceeds from the offering were $74.75 million before deducting underwriting discounts and estimated offering expenses. The units began trading on the Nasdaq Global Market ("Nasdaq") under the ticker symbol "CHPGU” on May 28, 2025.
- 05/29/2025
|
ScanTech AI Announces Receipt of Nasdaq Deficiency Letters
- Atlanta, GA, May 29, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI), a leading innovator in advanced security screening technologies, today announced that the Company received two letters from Nasdaq Listing Qualifications of The Nasdaq Stock Market LLC (“Nasdaq”), related to non-compliance with certain listing requirements. Neither notice has an immediate effect on the listing of the Company's common stock on The Nasdaq Global Market.
- 05/29/2025
|
Kochav Defense Acquisition Corp. Announces Completion of $253 Million IPO
- New York, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Kochav Defense Acquisition Corp. (NASDAQ: KCHVU) (the “Company”) today announced the closing of its initial public offering of 25,300,000 units, at a price of $10.00 per unit, which includes 3,300,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full, resulting in gross proceeds of $253,000,000. The Company's units are listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “KCHVU” and began trading on May 28, 2025. Each unit issued in the offering consists of one Class A ordinary share of the Company and one right to receive one seventh (1/7) of a Class A ordinary share upon the consummation of the Company's initial business combination. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on Nasdaq under the symbols “KCHV” and “KCHVR,” respectively.
- 05/29/2025
|
The Baldwin Group: Companies May Be Over-Insuring Directors & Officers (D&O) Coverage by Millions, Study with Nasdaq Finds
- TAMPA, Fla.--(BUSINESS WIRE)--The Baldwin Group, in collaboration with Nasdaq, Inc. (“Nasdaq”), today released its 2025 Directors & Officers (D&O) Benchmarking Report, offering one of the most comprehensive views to date of D&O insurance trends across public companies by industry and market capitalization. Now in its fourth year, the report confirms a continuing decline in premium rates and retentions—but also reveals a growing disconnect between what companies are buying and what t.
- 05/29/2025
|
S&P500 and Nasdaq 100: US Indices Rise on Nvidia Surge and Trump Tariff Reversal
- Nvidia's strong earnings and a court ruling against Trump's tariffs lift tech stocks and US indices. Traders eye inflation data and Fed signals next.
- 05/29/2025
|
Nasdaq heading for strong start after Nvidia numbers, gains trimmed as illegal tariff ruling weighed
- Wall Street stocks are expected to start higher on Thursday, boosted by strong results from Nvidia overnight but with the market weighing the likely fall-out from a US court declaring that President Trump's tariffs illegal. Dow Jones futures were pointing to a 0.3% gain with under an hour and a half before the opening bell, having been up 1.4% a couple of hours earlier.
- 05/29/2025
|
Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price
- CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced it has regained compliance with Nasdaq minimum bid price.
- 05/29/2025
|
B. Riley Financial Announces Notification of Delinquency with Nasdaq
- LOS ANGELES , May 28, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (Nasdaq: RILY) ("BRF" or the "Company") today announced it received an expected delinquency notification letter from Nasdaq on May 21, 2025, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2025.
- 05/28/2025
|
Nasdaq 100 Forecast: Nvidia Gains Despite Export Curbs, Salesforce Boosts Revenue View
- Nvidia beats Q1 forecasts with strong AI chip sales, but export curbs to China hit guidance. Salesforce lifts 2026 outlook on rising AI cloud demand.
- 05/28/2025
|
Brooge Energy Voluntarily Delists from Nasdaq
- DUBAI, May 28, 2025 (GLOBE NEWSWIRE) -- Brooge Energy Limited, ("BEL" or the “Company”) (NASDAQ: BROG), a Cayman Islands-based infrastructure provider, which is engaged in Clean Petroleum Products and Biofuels and Crude Oil storage and related services, today announced that it has provided notification to The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to voluntarily delist the Company's ordinary shares (the “Shares”), from the Nasdaq Capital Market and subsequently deregister with the Securities and Exchange Commission (the “SEC”). The Company intends to file a Form 25 (Notification of Removal from Listing) with the SEC and Nasdaq relating to the delisting of its Shares on or about June 9, 2025. As a result, the Company expects the last day of quotation of its Shares on Nasdaq will be on or about June 19, 2025. The Company does not intend to list the Shares on another securities exchange.
- 05/28/2025
|
Nasdaq Executives to Present at Upcoming Investor Conferences
- NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in June with webcasts available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 05/28/2025
|
Outdoor Holding Company Announces Settlement and Leadership Transition
- Board Appoints Steve Urvan, Founder of GunBroker.com and Largest Shareholder, as Chairman and CEO Announces Regained Compliance with Nasdaq Listing Rule Regarding Timely Periodic Reporting SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- Outdoor Holding Company (Nasdaq: POWW, POWWP) (“Outdoors Online,” “we,” “us,” “our” or the “Company”), the owner of GunBroker.com, the largest online marketplace for firearms, hunting and related products, today announced that Steve Urvan will serve as the Company's Chief Executive Officer and Chairman of the Board following the recent closing of the divestiture of the Company's ammunition manufacturing division and in connection with the settlement of litigation between Mr.
- 05/28/2025
|
La Rosa Holdings Corp. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- Celebration, FL, May 28, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced that on May 21, 2025, it received a delinquency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Nasdaq Listing Rule”) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Filing”). The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”).
- 05/28/2025
|
VivoPower Announces XRP-Focused Digital Asset Treasury Strategy and US$121 Million Private Placement Priced at US$6.05 Per Share, Above Last Market Closing Price Under NASDAQ Rules
- Capital raise led by His Royal Highness, Prince Abdulaziz bin Turki Abdulaziz Al Saud of Saudi Arabia Adam Traidman, former Ripple board member and CEO of SBI Ripple Asia, has also invested and joined as Chairman of the Board of Advisors VivoPower believed to be first public company in the world executing on an XRP-focused digital asset treasury and decentralized finance strategy Funds raised will be used to buy and hold XRP, building out the treasury and DeFi team, as well as for debt reduction and working capital Energi takeover due diligence continuing with a focus on Tembo LONDON, May 28, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR, the “Company”) is pleased to announce that it has reached agreement with certain investors in relation to a private capital raise priced at US$6.05 per share, above the last market closing price of US$6.04 under Nasdaq rules. In connection therewith, the Company has entered into securities purchase agreements (Subscription Agreement) with the investors for the purchase and sale of an aggregate of 20,000,000 ordinary shares of the Company at a price of US$6.05 per share for aggregate gross proceeds of approximately US$121 million, before deducting placement agent fees and other offering expenses.
- 05/28/2025
|
Pathward Financial, Inc. Receives Expected Notice of Deficiency From Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- SIOUX FALLS, S.D.--(BUSINESS WIRE)--Pathward Financial, Inc. ("Pathward Financial" or the “Company”) (Nasdaq: CASH) received an expected notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) on May 22, 2025. The Notice indicated that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q (“Form 10-Q”) for the fiscal quarter ended Mar.
- 05/28/2025
|
3 Nasdaq-Listed Tech Stocks Flying-High in 2025 Signaling More Upside
- CYBR, LRCX, and MNDY defy 2025 tech slump with double-digit gains and Zacks buy ranks, signaling more room to run on the Nasdaq.
- 05/28/2025
|
Nasdaq flips from red to green ahead of the open, with expectations high for Nvidia earnings
- New York stock futures turned from red to green as US investors awoke on Wednesday and assessed the market ahead of keenly awaited earnings from Nvidia this evening. In sync with subdued blue-chip shares in Europe, S&P 500 and Dow Jones futures were indicating around a 0.3% decline but quickly flipped into positive territory with around two hours before the opening bell.
- 05/28/2025
|
Kochav Defense Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering
- New York, NY, May 27, 2025 (GLOBE NEWSWIRE) -- Kochav Defense Acquisition Corp. (NASDAQ: KCHVU) (the “Company”) today announced the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The Company's units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “KCHVU” beginning May 28, 2025. Each unit to be issued in the offering consists of one Class A ordinary share of the Company and one right to receive one seventh (1/7) of a Class A ordinary share upon the consummation of the Company's initial business combination. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on Nasdaq under the symbols “KCHV” and “KCHVR,” respectively. The closing of the offering is expected to close on May 29, 2025, subject to customary closing conditions.
- 05/27/2025
|
ChampionsGate Acquisition Corporation Announces Pricing of $65,000,000 Initial Public Offering
- Monterey, CA , May 27, 2025 (GLOBE NEWSWIRE) -- ChampionsGate Acquisition Corporation (Nasdaq: CHPGU) (the “Company”) announced today the pricing of its initial public offering of 6,500,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “CHPGU” beginning May 28, 2025. Each unit consists of one Class A ordinary share and one right to receive one-eighth of one Class A ordinary share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on Nasdaq under the symbols “CHPG” and “CHPGR”, respectively. The underwriter has been granted a 45-day option to purchase up to an additional 975,000 units offered by the Company to cover over-allotments, if any. The offering is expected to close on May 29, 2025, subject to customary closing conditions.
- 05/27/2025
|
Cambium Networks receives deficiency notice from Nasdaq
- HOFFMAN ESTATES, Ill. , May 27, 2025 /PRNewswire/ -- Cambium Networks (NASDAQ: CMBM), a leading global provider of networking solutions, announced today that on May 22, 2025, it received a delinquency letter (the "deficiency notice") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it continues to be out of compliance with Nasdaq's continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1) due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the three months ended March 31, 2025.
- 05/27/2025
|
New Fortress Energy discloses notice from Nasdaq
- U.S. LNG company New Fortress Energy on Tuesday said it received a notice from Nasdaq on non-compliance with the stock market's listing rule for not submitting its quarterly reports with the U.S. Securities and Exchange Commission.
- 05/27/2025
|
New Fortress Energy Discloses Notice from Nasdaq
- NEW YORK--(BUSINESS WIRE)--New Fortress Energy Inc. (Nasdaq: NFE) (“NFE” or the “Company”) today announced its receipt of an expected notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) because the Company has not yet filed its Form 10-Q for the period ended March 31, 2025 (“Form 10-Q”) with the U.S. Securities and Exchange Commission (the “SEC”). The.
- 05/27/2025
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 15, 2025
- NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of May 15, 2025, short interest in 3,168 Nasdaq Global MarketSM securities totaled 13,735,568,588 shares compared with 13,300,707,903 shares in 3,156 Global Market issues reported for the prior settlement date of April 30, 2025. The mid-May short interest represents 2.41 days compared with 2.40 days for the prior reporting period.
- 05/27/2025
|
23andMe to delist from Nasdaq, deregister with SEC
- 23andMe to delist from Nasdaq, deregister with SEC
- 05/27/2025
|
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
- SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file a Form 25 Notification of Delisting with the Securities and Exchange Commission (the “SEC”) on or about June 6, 2025, which will remove its securities from listing and registration on Nasdaq. Nasdaq previously suspended the trading of 23andMe's Class A common stock, $0.0001 par value per share (the “Common Stock”), at the opening of business on March 31, 2025 and notified the Company that a Form 25 would be filed. However, as Nasdaq has not yet made the filing, the Company is doing so voluntarily to permit it to file a Form 15 to deregister with the SEC.
- 05/27/2025
|
4 Stocks to Watch From the Prospering Securities and Exchanges Industry
- ICE, CME, NDAQ and CBOE gain from rising crypto adoption, trading volumes, and tech investments as the Zacks industry ranks in the top 5%.
- 05/27/2025
|
Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings
- U.S. stocks traded higher this morning, with the Nasdaq Composite surging more than 300 points on Tuesday. President Donald Trump announced the extension of the 50% tariffs on Sunday till July 9, which he had initially announced on Friday.
- 05/27/2025
|
Are These 3 Top-Performing Tech Stocks in the Nasdaq-100, Up 33% to 64% in 2025, Still a Buy Now?
- The U.S. stock market has been volatile in 2025. The Nasdaq-100, which includes many of America's leading technology companies, is roughly flat year to date.
- 05/25/2025
|
The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now
- The stock market is anything but normal right now. Not even halfway through the year, the broader benchmark S&P 500 index fell nearly 20% from highs made in February, only to make a full recovery for the year (as of May 22).
- 05/24/2025
|
IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- $3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
- 05/23/2025
|
urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- LAFAYETTE, COLORADO / ACCESS Newswire / May 23, 2025 / urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), an integrated professional services and Design-Build firm offering solutions to the Controlled Environment Agriculture ("CEA") and other commercial sectors, today announced that the Company received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") on May 21, 2025, stating that because the Company had not yet filed its its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 (the "Form 10-Q") and its Annual Report on Form 10-K for the fiscal quarter ended December 31, 2024 (the "Form 10-K"), the Company continues to be out of compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.
- 05/23/2025
|
Triller Group Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- Palm Beach, FL, May 23, 2025 (GLOBE NEWSWIRE) -- Triller Group Inc. (“Triller”, “Triller Group” or “the Company”) today announced that on May 20, 2025, it received a delinquency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Filing”). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”).
- 05/23/2025
|
Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
- HOUSTON, May 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on May 21, 2025, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Quarterly Report”). The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”).
- 05/23/2025
|
Polyrizon Announces Receipt of Nasdaq Delisting Notice
- Raanana, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), stating that based on its review of the Company's public filings with the Securities and Exchange Commission (the “SEC”), its staff has determined to delist the Company's securities pursuant to its discretionary authority under Listing Rule 5101. The receipt of the Nasdaq notification letter does not result in the immediate delisting of the Company's ordinary shares and has no current immediate effect on the listing or trading of the Company's ordinary shares on the Nasdaq Capital Market, under symbol “PLRZ.”
- 05/23/2025
|
Marin Software Incorporated Receives Nasdaq Notification Regarding Late Form 10-Q Filing and Continued Listing Requirements
- SAN FRANCISCO--(BUSINESS WIRE)--Marin Software Incorporated (NASDAQ: MRIN) (“Marin,” “we,” “our,” or the “Company”), a provider of digital marketing software for performance-driven advertisers and agencies, on May 21, 2025, received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the delinquency in the timely filing of the Company's quarterly report on Form 10-Q for the fiscal quarter ended March 31, 20.
- 05/23/2025
|
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to four new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and.
- 05/23/2025
|
Delisting of Securities from The Nasdaq Stock Market
- Delisting of Securities of Bruush Oral Care Inc., IX Acquisition Corp., BAIYU Holdings, Inc., DUET Acquisition Corp., ENGlobal Corporation, Perception Capital Corp. III, Biora Therapeutics, Inc., Akoustis Technologies, Inc., iLearningEngines, Inc., Welsbach Technology Metals Acquisition Corp., Cartica Acquisition Corp, CSLM Acquisition Corp., Broad Capital Acquisition Corp, Technology & Telecommunication Acquisition Corporation, Western Acquisition Ventures Corp., Papaya Growth Opportunity Corp. I, Canoo Inc., and CSLM Acquisition Corp., from The Nasdaq Stock Market
- 05/23/2025
|
Nasdaq 100 and Dow Jones: Apple Drops, VIX Jumps as Tech Stocks Weigh on US Stocks Today
- Trump's EU and Apple tariff threats hit tech stocks; Apple slides, VIX spikes, and US indices drop ahead of Memorial Day. Traders brace for more volatility.
- 05/23/2025
|
Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results
- U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Friday.
- 05/23/2025
|
Nasdaq leads opening slide as Trump threatens EU, Apple tariffs
- 9:52am: Tariff tweets shake markets—again Wall Street woke up to a rough start Friday morning, with major indexes tumbling as renewed trade tensions and inflation concerns rattled investor confidence. The Dow sank 380 points, or 0.9%, while the S&P 500 slid 1.1%.
- 05/23/2025
|
Altisource Shares to Be Consolidated at a Ratio of 1-for-8
- Action Expected to Allow the Company to Regain Compliance with Nasdaq Minimum Bid Price Requirement Action Expected to Allow the Company to Regain Compliance with Nasdaq Minimum Bid Price Requirement
- 05/23/2025
|
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual Report
- BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 16, 2025 (the “Notification Letter”) from Nasdaq Listing Qualifications (“Nasdaq”), stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) since the Company did not timely file its annual report on Form 20-F for the year ended December 31, 2024 (the “2024.
- 05/22/2025
|
Renatus Tactical Acquisition Corp I to Ring Nasdaq Stock Market Opening Bell on May 23, 2025
- CORAL GABLES, Fla.--(BUSINESS WIRE)--Renatus Tactical Acquisition Corp I (the “Company” or “RTAC”), a special purpose acquisition company, today announced that the Company's Chief Executive Officer, Eric Swider, will ring the Nasdaq Stock Market Opening Bell on Friday, May 23, 2025 in celebration of RTAC's listing on the Nasdaq Global Market. About RTAC RTAC is a special purpose acquisition company, that was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acqui.
- 05/22/2025
|
China Liberal Education Holdings Limited Receives Additional Nasdaq Staff Determination Letter of Delinquency
- BEIJING , May 22, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), a China-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that on May 21, 2025, it received an additional staff determination notice (the "Additional Staff Determination Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is delinquent in filing its Annual Report on Form 20-F for the fiscal year ended December 31, 2024 (the "Form 20-F") and that this matter serves as an additional basis for delisting the Company's securities from The Nasdaq Stock Market. The failure to timely file the Form 20-F is a violation of Nasdaq Listing Rule 5250(c)(1).
- 05/22/2025
|
Codere Online Receives Delisting Notice from Nasdaq and Submits Appeal
- Luxembourg, Grand Duchy of Luxembourg, May 22, 2025 - (GLOBE NEWSWIRE) Codere Online Luxembourg, S.A. (“Codere Online” or the “Company”) (Nasdaq: CDRO / CDROW), today announced that, on May 16, 2025, it received a staff determination letter (the "Letter"), from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company of the determination from the Nasdaq Staff (the "Staff") to delist the Company's securities from The Nasdaq Stock Market, given the Company had not filed its Form 20-F for the year ended December 31, 2024 (the “2024 Form 20-F”) in accordance with continued Listing Rule 5250(c)(1) (the “Public Reports Rule”).
- 05/22/2025
|
Nasdaq Gains Over 100 Points; BJ's Wholesale Earnings Top Views
- U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday.
- 05/22/2025
|
The Nasdaq Bounces Back: 2 Artificial Intelligence (AI) Stocks to Buy Before They Soar
- The tech-laden Nasdaq Composite index has been under pressure this year and is slightly in the red as of this writing. This is due to weakness in technology stocks on account of the tariff-fueled turmoil and other factors such as questions surrounding the viability of huge investments being made in artificial intelligence (AI) infrastructure.
- 05/22/2025
|
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
- NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound development, announces that, following confirmation of compliance with the Bid Price and Equity Requirements as detailed in the announcement dated May 21, 2025, the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company's application to transfer the listing of its common stock to The Nasdaq Capital Market has been approved and the Company's securities will be transferred to The Nasdaq Capital Market at the opening of business on May 23, 2025.
- 05/22/2025
|
Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as part of Nasdaq Compliance Plan
- SEATTLE, WA / ACCESS Newswire / May 22, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares of common stock, par value $0.001 per share ("Common Stock"), at a ratio of 1-for-20 (the "Reverse Stock Split"). The Reverse Stock Split is expected to become effective on May 23, 2025, at 5:01 p.m.
- 05/22/2025
|
Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule
- NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, announces that it has received a notice from Nasdaq confirming that the Company has regained compliance with The Nasdaq's Capital Market's minimum bid price requirement of $1.00 per share and the minimum stockholders' equity requirement of $2.5 million.
- 05/22/2025
|
Philippine Stock Exchange Adopts Nasdaq Eqlipse Trading to Enhance Market Infrastructure
- Upgrade to Nasdaq Eqlipse Trading will enhance liquidity and resilience of Philippine marketplace Expands Nasdaq's deep technology footprint across the country's financial services industry MANILA and NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) and The Philippine Stock Exchange, Inc. (PSE) today announced a significant expansion of their technology partnership, which will see PSE upgrade its trading infrastructure to Nasdaq's most advanced platform, Nasdaq Eqlipse Trading. Nasdaq Eqlipse represents Nasdaq's investments to modernize, standardize, and strengthen its platform capabilities, application architecture, APIs, and product integration.
- 05/22/2025
|
2 Nasdaq-100 Stocks I'd Buy Without Hesitation Right Now
- The Nasdaq-100 plunged earlier this year following the Liberation Day tariffs, sinking into a bear market. Over the past few weeks, however, the index has come roaring back and now sits less than 5% below the peak it hit in February.
- 05/22/2025
|
Oyster Enterprises II Acquisition Corp Announces the Upsized Pricing of $220,000,000 Initial Public Offering
- Miami, Florida, May 21, 2025 (GLOBE NEWSWIRE) -- Oyster Enterprises II Acquisition Corp (the “Company”) announced today the upsized pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and begin trading tomorrow, May 22, 2025, under the ticker symbol “OYSEU.” Each unit consists of one Class A ordinary share and one right (the “Share Right”) to receive one tenth (1/10) of one Class A ordinary share upon the consummation of an initial business combination. There are no warrants issued publicly or privately in connection with this offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and Share Rights are expected to be listed on Nasdaq under the symbols “OYSE” and “OYSER,” respectively. The offering is expected to close on May 23, 2025, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,300,000 units at the initial public offering price to cover over-allotments, if any.
- 05/21/2025
|
Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs
- PITTSBURGH, May 21, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we,” “us,” or “our”), a company focused on extending human longevity and healthy aging through innovative products in regenerative bio-aesthetics, diagnostics, and nutrition, today announced that it has received a favorable decision from the Nasdaq Hearings Panel (the “Panel”) granting the Company's request to continue its listing on The Nasdaq Stock Market (“Nasdaq”) subject to the satisfaction of the Nasdaq initial listing rules for the combined company following the proposed merger with 20/20 BioLabs, Inc. (“20/20”) on or before September 2, 2025. This decision follows the Panel's comprehensive review of the Company's recent business developments, financial disclosures, and proposed merger with 20/20.
- 05/21/2025
|
NaaS Technology Inc. Receives Notification of Non-Compliance from Nasdaq Regarding Late Filing of Annual Report on Form 20-F
- BEIJING , May 21, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S. listed EV charging service company in China, today announced that it received a Notice of Non-Compliance (the "Notice") from Nasdaq Stock Market LLC ("Nasdaq") on May 20, 2025, due to the late filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "Annual Report"). The Notice indicates that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely submission of periodic financial reports to the U.S. Securities and Exchange Commission.
- 05/21/2025
|
Mingzhu Logistics Holdings Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- Shenzhen, China, May 21, 2025 (GLOBE NEWSWIRE) -- Mingzhu Logistics Holdings Limited (“Mingzhu” or the “Company”) (Nasdaq: YGMZ), an elite provider of logistics and transportation services to businesses, announced today that it received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) on May 20, 2025, that the Company has regained compliance with Listing Rule 5550(a)(2) (the “Bid Price Rule”), as required by the Nasdaq Hearings Panel's (“Panel”) decision dated March 31, 2025.
- 05/21/2025
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , May 21, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on May 20, 2025, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 71,000 shares of its common stock and 35,000 restricted stock units ("RSUs") to sixteen (16) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/21/2025
|
Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets
- The Company Intends to Appeal the Delisting Determination NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces that it has received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock from Nasdaq. At the open of trading on Thursday, May 22, 2025, Petros' securities will be suspended on Nasdaq and are expected to begin trading on the OTC Markets under the ticker "PTPI".
- 05/21/2025
|
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
- Conduit regains compliance with Bid Price and Equity Requirements CDT will continue to be listed and traded on The Nasdaq Stock Market NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound development, announced that the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq's minimum bid price requirement (the “Bid Price Requirement”) set forth in Nasdaq Listing Rule 5550(a)(2), as well as Nasdaq's stockholders' equity requirement (“Equity Requirement”) set forth in Nasdaq Listing Rule 5550(b)(1).
- 05/21/2025
|
Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- SAN FRANCISCO, CA / ACCESS Newswire / May 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced that it has entered into definitive agreements for the purchase and sale of 246,306 shares of common stock at a purchase price of $6.09 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company agreed to issue to investors unregistered warrants to purchase up to 492,612 shares of common stock at an exercise price of $5.84 per share that will be immediately exercisable upon issuance and will expire on the earlier of (i) 24 months from the date of issuance, (ii) the consummation of a fundamental transaction and (iii) the consummation of a liquidation event.
- 05/21/2025
|
ProCap Acquisition Corp Announces the Pricing of Upsized $220,000,000 Initial Public Offering
- NEW YORK , May 20, 2025 /PRNewswire/ -- ProCap Acquisition Corp (the "Company") announced today the pricing of its upsized initial public offering of 22,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Stock Market LLC ("Nasdaq") and begin trading tomorrow, May 21, 2025, under the ticker symbol "PCAPU.
- 05/20/2025
|
Nvidia Q1 Preview: Stable Nasdaq Alpha At A Sentiment Inflection
- Nvidia's strength affirms why it anchors my Nasdaq High-Alpha Black Swan Portfolio, which is now outpacing the Nasdaq-100 since inception, despite my ~15–30% cash position depending on macro factors. NVDA's valuation is rich, but leadership this dominant warrants holding through volatility and trimming at euphoric peaks. Portfolio agility and downside protection are crucial, as geopolitical shifts and capex-related revenue contraction can quickly reshape the growth narrative.
- 05/19/2025
|
The Nasdaq Just Soared 30% From Its 2025 Low: 3 Vanguard ETFs to Buy Now
- The Nasdaq Composite (^IXIC 0.52%) closed Wednesday at 19,146.81 -- a staggering 29.5% rally from its 52-week intraday low of 14,784.03 on April 7.
- 05/18/2025
|
Should You Buy These Beaten-Down Nasdaq-100 Stocks?
- The tech-focused Nasdaq-100 is home to some of the most innovative and fastest-growing companies around. As of May 14, most of the stocks in the index are up year to date.
- 05/18/2025
|
Could Investing $100 a Month Into the Nasdaq-100 Be Your Ticket to Becoming a Millionaire?
- Investing in growth stocks can be a great way to generate outsize gains and bolster your portfolio. However, one of the more daunting aspects of investing is choosing individual stocks and figuring out when to cash out your positions.
- 05/18/2025
|
Galaxy Digital CEO Mike Novogratz talks Nasdaq debut and crypto regulation
- Crypto investment firm and asset manager Galaxy Digital (GLXY) debuted on the Nasdaq on Friday, moving from the Toronto Stock Exchange. Galaxy Digital founder and CEO Mike Novogratz comes on Market Domination to talk more extensively about the transition to a US-listed company, the cryptocurrency industry at large amid legislative reviews for stablecoin adoption, the chief executive's outlook on regulation as bitcoin's (BTC-USD) market cap continues growing, and the Trump administration's positive influence for the crypto community.
- 05/16/2025
|
Renatus Tactical Acquisition Corp I Announces Closing of Upsized $241.5 Million Initial Public Offering
- CORAL GABLES, Fla.--(BUSINESS WIRE)---- $RTACU #IPO--Renatus Tactical Acquisition Corp I (Nasdaq: RTACU) (the “Company”) today announced the closing of its upsized initial public offering of 24,150,000 units at $10.00 per unit, including 3,150,000 units issued pursuant to the full exercise of the underwriters' over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $241,500,000. The units began trading on The Nasdaq Global Market (“Nasdaq”) under the ticker symbol “RTA.
- 05/16/2025
|
Caliber Regains Compliance with Nasdaq Minimum Bid Price Requirement
- SCOTTSDALE, Ariz., May 16, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced that on May 16, 2025, it received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) which requires that companies listed on Nasdaq maintain a minimum bid price of $1.00 per share.
- 05/16/2025
|
S&P 500, Nasdaq 100 Close Higher | Closing Bell
- Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Alix Steel, Scarlet Fu, Carol Massar and Tim Stenovec. -------- More on Bloomberg Television and Markets Like this video?
- 05/16/2025
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 94,050 shares of common stock. Awards were made to nine new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committe.
- 05/16/2025
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that the company granted inducement equity awards covering an aggregate of 105,700 shares of its common stock to 14 newly hired employees, consisting of inducement stock options to purchase an aggregate of.
- 05/16/2025
|
4DMT Announces New Employment Inducement Grants
- EMERYVILLE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on May 13, 2025, the compensation committee of the Company's board of directors granted eight new non-executive employees 31,800 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company's 2025 Employment Inducement Award Plan, which was approved by the Company's board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.
- 05/16/2025
|
AirNet Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency
- BEIJING, May 16, 2025 (GLOBE NEWSWIRE) -- AirNet Technology Inc. ("AirNet" or the "Company") (Nasdaq: ANTE), today announced that on May 13, 2025, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is no longer in compliance with the requirement of maintaining a minimum of $2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(b)(1) based on the Company's reported stockholders' equity in its Form 20-F for the year ended December 31, 2024, which is below the foregoing requirement of minimum stockholders' equity. In addition, the Company does not currently meet the alternative standards of compliance from its market value of listed securities or net income from continuing operations.
- 05/16/2025
|
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the Compensation Committee of aTyr's Board of Directors has granted two employees nonstatutory stock options to purchase an aggregate of 36,200 shares of aTyr's common stock, each with an exercise price of $3.00 per share, which is equal to the closing price of aTyr's common stock on the Nasdaq Capital Market on May 15, 2025, the effective date of the grants. These stock awards were granted as an inducement material to the new employees entering into employment with aTyr in accordance with Nasdaq Listing Rule 5635(c)(4) and were made pursuant to the aTyr Pharma, Inc. 2022 Inducement Plan.
- 05/16/2025
|
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, May 16, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases, today announced that on May 13, 2025, the company granted inducement awards to thirteen new employees. The grants were made pursuant to Nurix's 2024 Equity Inducement Plan as an inducement material to the employees' acceptance of employment with Nurix and were approved by the Compensation Committee of Nurix's Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/16/2025
|
Mike Novogratz's Galaxy Digital debuts on Nasdaq in bumper week for crypto
- Galaxy Digital, founded by Mike Novogratz, made its Nasdaq debut on Friday, capping off a momentous week for cryptocurrency in public markets, with Coinbase joining the S&P 500 and retail brokerage eToro also going public.
- 05/16/2025
|
Nasdaq Resumes Trading in Damon Inc.
- NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume in Damon Inc. (Nasdaq: DMN) at 9:00 a.m. Eastern Time on May 19, 2025. Trading in the company's stock was halted on April 29, 2025 at 2:01:07 p.m. Eastern Time.
- 05/16/2025
|
S&P500 and Nasdaq Index: Consumer Data Sinks Sentiment, Super Micro, Moderna Rally
- S&P 500 and Nasdaq edge higher mid-session as weak sentiment data tempers gains. Traders assess inflation risks and tariff uncertainty.
- 05/16/2025
|
Nasdaq Index: Bullish Forecast as Adobe, Alphabet, AMD Lead Weekly Stock Market Gains
- Nasdaq 100 climbs over 6% this week as easing inflation and tariff relief fuel tech stock gains, with traders watching options expiry and sector rotation.
- 05/16/2025
|
Sleep Number Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) today announced that it granted equity awards on May 15, 2025, as a material inducement to the employment of the company's newly-hired Executive Vice President and Chief Marketing Officer, Amber Minson. In connection with the appointment of Minson as Executive Vice President and Chief Marketing Officer effective May 5, 2025, Sleep Number granted Minson employment inducement awards consisting of: (i) 21,724 shares in a perform.
- 05/16/2025
|
Damon Announces Plan to Resume Trading
- VANCOUVER, BC , May 16, 2025 /PRNewswire/ - Damon Inc. (Nasdaq: DMN) ("Damon" or the "Company"), a designer and developer of electric motorcycles and other personal mobility products that seek to empower the personal mobility sector through innovation, data intelligence and strategic collaborations, today announced that the Company has determined to forego its right to appeal Nasdaq's delisting determination, to enable the Company's common shares to begin trading on an alternative market. The Nasdaq staff has informed the Company that its common shares will resume trading on Nasdaq for one trading day, on May 19, 2025, prior to suspending the common shares as of the following trading day.
- 05/16/2025
|
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company's Board of Directors granted a non-qualified stock option to purchase an aggregate of 26,000 shares of the Company's stock (the “Inducement Grant”) to a newly hired employee on May 13, 2025 (the “Grant Date”), in connection with the commencement of employment.
- 05/16/2025
|
eToro CEO talks IPO, Robinhood, and becoming the investment app of younger generation
- Israel-based trading platform eToro (ETOR) debuted on the Nasdaq on Wednesday, its stock opening on the exchange at over 34% its original IPO price. eToro co-founder and CEO Yoni Assia sits down with Yahoo Finance executive editor Brian Sozzi at the Nasdaq for a conversation about the IPO, investor sentiments amid tariff headwinds, and crypto trading.
- 05/15/2025
|
Wen Acquisition Corp Announces the Pricing of $261,000,000 Initial Public Offering
- New York, NY, May 15, 2025 (GLOBE NEWSWIRE) -- Wen Acquisition Corp (the “Company”) announced today the pricing of its initial public offering of 26,100,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading on May 16, 2025, under the ticker symbol “WENNU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “WENN” and “WENNW,” respectively. The offering is expected to close on May 19, 2025, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,915,000 units at the initial public offering price to cover over-allotments, if any.
- 05/15/2025
|
Nasdaq snaps 6-day win streak, Robinhood's chief brokerage officer on retail trading amid volatility
- Asking for a Trend, anchor Josh Lipton breaks down the latest market trends of the day for May 15, 2025. Nasdaq snaps its 6-day winning streak as the S&P 500 extends gains.
- 05/15/2025
|
eToro soars in Nasdaq debut, signalling renewed investor optimism
- Israel-based stock brokerage platform eToro Group Ltd made a striking debut on the Nasdaq overnight, with its shares surging as much as 42% above the initial public offering (IPO) price after the upsized deal raised almost US$620 million. The Robinhood competitor's strong market entry reflects renewed investor optimism as the IPO market beings to experience a broader rebound, driven by easing US-China trade tensions and the recent Wall Street rally.
- 05/15/2025
|
Nasdaq notches 6th day of gains as chip stocks lead the tech rally, Nvidia rips higher
- Asking for a Trend anchor Josh Lipton breaks down the latest market moves for May 14, 2025. Tech stocks give life to the Nasdaq with chip stocks Nvidia and AMD helping to boost the index.
- 05/14/2025
|
Texas Ventures Acquisition III Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing May 16, 2025
- New York, NY, May 14, 2025 (GLOBE NEWSWIRE) -- Texas Ventures Acquisition III Corp (Nasdaq: TVACU) (the “Company”) announced today that, commencing May 16, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “TVA” and “TVACW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “TVACU.”
- 05/14/2025
|
Nasdaq 100: Cisco Pops After Hours on AI Boost and Upbeat Stock Market Forecast
- Strong Q3 earnings and rising AI demand boost Cisco's forecast, lifting Nasdaq 100 and US stocks in after-hours trading. Key support for tech sentiment.
- 05/14/2025
|
Nasdaq Announces 2025 Annual Meeting of Shareholders
- NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) has scheduled its 2025 Annual Meeting of Shareholders for June 11, 2025, at 8:00 AM ET. The virtual meeting website can be accessed 15 minutes prior to the meeting start by visiting: www.virtualshareholdermeeting.com/NDAQ2025.
- 05/14/2025
|
Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
- Completed reverse merger and commenced trading on Nasdaq as JBIO Closed financing, raising approximately $300 million to date, providing cash runway through 2027 Lead candidate JADE101 expected to enter the clinic in second half of 2025, with interim biomarker-rich data expected in first half of 2026 SAN FRANCISCO and VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced financial results for the quarter ending March 31, 2025, and provided a corporate update. “The start to 2025 marked a defining period for Jade Biosciences as we successfully completed our reverse merger, commenced trading as JBIO on Nasdaq, and closed a significant private financing led by a premier syndicate of healthcare investors,” said Tom Frohlich, Chief Executive Officer of Jade.
- 05/14/2025
|
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on May 9, 2025, the compensation committee of BridgeBio's board of directors approved equity grants to 36 new employees in restricted stock units for an aggregate of 101,974 shares of the Company's common stock.
- 05/14/2025
|
Nasdaq Applauds Signing of Senate Bill 29, Strengthening Texas' Standing as a National Leader in Corporate Governance and Innovation
- AUSTIN, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- Today, Nasdaq issued a statement in support of Texas Senate Bill 29 after Governor Abbott signed the bill into law. This legislation, which codifies the Business Judgment Rule and promotes predictability in corporate governance litigation, enhances Texas' competitiveness as a jurisdiction for incorporation and business growth. Nasdaq's Executive Vice Chairman Ed Knight joined Governor Abbott, leadership from the Texas legislature, and other Texas business community leaders for the signing ceremony.
- 05/14/2025
|
Newly issued eToro shares jump in Nasdaq debut. It's a bullish sign for IPOs.
- The trading platform's stock is on a run in its first day of trading, elevating hopes for other stock-market debuts.
- 05/14/2025
|
Stock trading app eToro opens at $69.69 in Nasdaq debut
- Shares of eToro popped in their Nasdaq debut on Wednesday. The stock and crypto trading app raised almost $310 million in its IPO late Tuesday, selling shares above the expected range.
- 05/14/2025
|
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings
- U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Wednesday.
- 05/14/2025
|
Primech Regains Compliance with Nasdaq's Minimum Bid Price Requirement
- SINGAPORE, May 14, 2025 (GLOBE NEWSWIRE) -- Primech Holdings Limited ("Primech" or the "Company") (Nasdaq: PMEC), an established technology-driven facility services provider in the public and private sectors operating mainly in Singapore, today announced that it has received notice from the Nasdaq Stock Market ("Nasdaq") on May 13, 2025 informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on The Nasdaq Capital Market.
- 05/14/2025
|
S&P500 and Nasdaq 100: Super Micro, Nvidia Lead Tech Stock Surge in US Indices Rebound
- Nasdaq 100 and S&P 500 rise as bullish sentiment grows on U.S.-China tariff truce and AI-driven tech stock surge, led by Nvidia, AMD, and Apple.
- 05/14/2025
|
eToro Group IPO: Crypto and stock trading platform's ETOR shares make Nasdaq debut today after delay
- The day has finally arrived for those hoping to get in on shares of crypto and stock trading firm eToro Group Ltd. The fintech company is holing its initial public offering, with its shares expected to begin trading on the Nasdaq Wednesday after a monthslong delay.
- 05/14/2025
|
Nvidia and other Nasdaq tech stocks to drive Wall Street gains amid Mid-East dealmaking
- Nasdaq stocks are set to power gains for Wall Street on Wednesday, buoyed by deals struck by the sector on Donald Trump's tech-led trade trip to the Middle East. Futures for the S&P 500 were up 0.1% and for the Dow Jones were flat, while those for the Nasdaq were up 0.3%.
- 05/14/2025
|
eToro prices IPO at $52 per share ahead of Nasdaq debut
- CNBC's Andrew Ross Sorkin reports on the latest news.
- 05/14/2025
|
Nasdaq Rises 300 Points Amid Surge In Nvidia Shares; Investor Sentiment Improves, Fear & Greed Index Remains In 'Greed' Zone
- The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index remained in the “Greed” zone on Tuesday.
- 05/14/2025
|
Ligand to Ring the Nasdaq Opening Bell on May 19, 2025
- JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market Opening Bell on Monday, May 19, 2025.
- 05/14/2025
|
Affimed Announces Receipt of Nasdaq Delisting Notice
- MANNHEIM, Germany, May 14, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it has received a written notice from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) notifying the Company that, in accordance with Nasdaq Listing Rule 5101, 5110(b) and IM-5101-1, the trading of the Company's common shares will be suspended at the opening of business on May 20, 2025, and a Form 25 Notification of Delisting will be filed with the U.S. Securities Exchange Commission to delist the Company's securities from The Nasdaq Stock Market (“Nasdaq”).
- 05/14/2025
|
A Nasdaq Bull Market Is Coming: 3 Tariff-Resistant Growth Stocks to Confidently Buy Right Now
- The Nasdaq Composite (^IXIC 1.61%) technology index was down by as much as 24% from its all-time high in April, placing it in a bear market. The sell-off was triggered by President Donald Trump's "Liberation Day" tariffs, which sparked fears of a sharp economic slowdown.
- 05/14/2025
|
Green Notes of AKROPOLIS GROUP, UAB are planned to be listed on Euronext Dublin and Nasdaq Vilnius stock exchanges
- NOT FOR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, THE UNITED STATES OR TO ANY U.S. PERSON, OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.
- 05/14/2025
|
Stock and crypto trading site eToro prices IPO at $52 per share ahead of Nasdaq debut
- Israel-based stock brokerage platform eToro said it has priced shares at $52 for its IPO, above its expected range of $46 to $50. The retail trading platform filed for an IPO in March, but as tariff uncertainty rattled markets, the company temporarily shelved ITS plans.
- 05/13/2025
|
Stock Market Rally Shows No Quit; Nasdaq Jumps On Nvidia News As Palantir Joins Breakout Ranks
- The stock market rally continued unabated Tuesday, helped by a big gains for large cap techs like Palantir, Nvidia and Broadcom.
- 05/13/2025
|
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on May 7, 2025, the Board of Directors granted a non-qualified stock option award to purchase 100,000 shares of its common stock to one new non-executive employee under the Company's Amended and Restated 2024 Inducement Equity Incentive Plan (the “2024 Inducement Plan”). The stock options were granted as an inducement material to the employee entering into employment with Skye in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/13/2025
|
S&P500 and Nasdaq: Soft CPI Boosts Nvidia and Coinbase; UNH Falls
- Easing CPI and a U.S.-China tariff pause push S&P500 and Nasdaq higher, while UnitedHealth drags Dow. Tech stocks and Coinbase lead US stock market gains.
- 05/13/2025
|
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales
- U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 250 points on Monday.
- 05/13/2025
|
Odyssey Marine Exploration Reports Q1 2025 Results, Regains Nasdaq Compliance, and Announces New Capital Infusion
- TAMPA, Fla.--(BUSINESS WIRE)---- $OMEX--Odyssey Marine Exploration, Inc. (NASDAQ: OMEX), an ocean exploration pioneer engaged in the discovery, development and extraction of critical minerals that provide solutions to global challenges, today announced its results for the first quarter ended March 31, 2025, highlighted by the successful resolution of its Nasdaq listing compliance and the continued financial support of its long-term investors. “We are encouraged by the dedicated support of our long-term i.
- 05/13/2025
|
An Innovative Way To Hedge Exposure To The Nasdaq-100
- These strategies seek to mitigate market risk while participating in gains by combining long equity positions with hedging instruments such as options. Invesco QQQ Hedged Advantage ETF (QQHG) is designed to provide participation in the Nasdaq-100 Index with downside protection. QQHG is a single-ticker solution that mitigates path dependency through the use of laddered options, providing a rolling hedge to maintain protection.
- 05/13/2025
|
Perimeter Acquisition Corp. I Announces Pricing of Upsized $210,000,000 Initial Public Offering
- NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Perimeter Acquisition Corp. I (Nasdaq: PMTRU) (the “Company”), a special purpose acquisition company, today announced the pricing of its upsized initial public offering of 21,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “PMTRU” beginning May 13, 2025. Each unit consists of one ordinary share and one-half of one redeemable warrant. Once the securities comprising the units begin separate trading, the ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “PMTR” and “PMTRW”, respectively.
- 05/12/2025
|
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 35,900 shares of its common stock. These inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan and were granted as in.
- 05/12/2025
|
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on May 1, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 5,000 shares of common stock at a per share exercise price of $14.46, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to two newly hired non-executive employees. The grants were made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, were approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), were made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation.
- 05/12/2025
|
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context has granted non-qualified stock option awards to purchase an aggregate of 160,000 shares of its common stock to two new employees as an inducement material for accepting employment with Context.
- 05/12/2025
|
Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
- MORRISTOWN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases which has transitioned to a developer and distributor of diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B and RSV), H. pylori and HCC, today announced that on May 9, 2025, the Company received written notice (the “Notice”) from the Office of General Counsel of The Nasdaq Stock Market (“Nasdaq”) indicating that the Nasdaq Hearings Panel has determined to delist the Company's shares from Nasdaq due to the Company's failure to meet Nasdaq's continued listing standards. As previously disclosed, the Company has not been compliant with the requirements under Nasdaq Listing Rule 5550(a)(2) to maintain a minimum bid price of $1.00 per share and Nasdaq Listing Rule 5101 indicating that Nasdaq believes the Company is a public shell. The Notice indicated that trading in the Company's shares of common stock (the “Common Stock”) on Nasdaq will be suspended effective at the open of trading on Tuesday, May 13, 2025.
- 05/12/2025
|
VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing
- SAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on April 25, 2025, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”), the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchang.
- 05/12/2025
|
China Liberal Education Holdings Limited Receives Staff Determination Notice from Nasdaq and Plans to Appeal
- BEIJING , May 12, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), a China-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that the Company received a staff determination notice (the "Staff Determination Notice") from the Listings Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on May 7, 2025, notifying the Staff's decision pursuant to its discretionary authority under Listing Rule 5101 to delist the Company based on public interest concerns raised by the Company's substantial issuance of its ordinary shares ("Ordinary Shares") in December 2024. Specifically, the Staff has determined that the Company's issuance of certain Ordinary Shares and warrants pursuant to an investment agreement with certain individual investors (the "Purchasers") dated December 23, 2024 (the "Private Placement") and a warrant exchange agreement with the Purchasers dated December 31, 2024, as described in the Company's prior SEC filings, raises public interest concerns because the issuance resulted in substantial dilution for its shareholders.
- 05/12/2025
|
Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 152,475 shares of its common stock and granted an aggregate of 101,800 restricted stock unit (“RSU”) awards to 35 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/12/2025
|
American Bitcoin Announces Go-Public Transaction through Strategic Merger with Nasdaq-Listed Entity
- Positions American Bitcoin to become a publicly traded vehicle for low-cost Bitcoin accumulation at scale MIAMI , May 12, 2025 /PRNewswire/ -- American Bitcoin Corp. ("American Bitcoin" or the "Company"), a Bitcoin accumulation platform focused on building America's Bitcoin infrastructure backbone, today announced that it has entered into a definitive merger agreement with Gryphon Digital Mining, Inc. (Nasdaq: GRYP) ("Gryphon") pursuant to which Gryphon will acquire American Bitcoin in a stock-for-stock merger transaction. Upon closing, the combined company will operate under the American Bitcoin brand, led by the management and board of directors of American Bitcoin.
- 05/12/2025
|
Nasdaq Recovery: 3 Artificial Intelligence (AI) Stocks That Are Still Too Cheap to Ignore
- In case you missed it, tech stocks are rallying again.
- 05/11/2025
|
Shopify Inc to Join the Nasdaq-100 Index® Beginning May 19, 2025
- NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Shopify Inc. (Nasdaq: SHOP), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®) and the Nasdaq-100 Equal Weighted™ Index (Nasdaq: NDXE™) prior to market open on Monday, May 19, 2025. Shopify Inc. will replace MongoDB, Inc. (Nasdaq: MDB) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index.
- 05/09/2025
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 05/09/2025
|
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company's Compensation Committee, as material inducements to eleven individuals whose employment commenced in March and April of 2025. The grants resulted in the right to purchase 111,000 shares of the Company's.
- 05/09/2025
|
FEMTO Receives Nasdaq Delisting Determination and Plans to Appeal
- May 9, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO), a pioneering Femtech company formerly known as BYND Cannasoft Enterprises Inc., announced today that it has received on May 8, 2025 a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”), stating that based on its review of the Company's recent private placement transaction that was completed on February 26, 2025 (the “Placement”), Nasdaq has determined to delist the Company's securities pursuant to its discretionary authority under Listing Rule 5101. As set forth in its letter, Nasdaq's staff (the “Staff”) determined that the Company's issuance of large numbers of shares upon the cashless exercise and “alternative exercise” of the Warrants issued in the Placement resulted in significant dilution of existing shareholders thereby triggering the Staff's determination.
- 05/09/2025
|
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/09/2025
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, May 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 183,885 shares of the Company's common stock to seven new employees (the “Inducement Grants”) on May 6, 2025 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/09/2025
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 30, 2025
- NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 30, 2025, short interest in 3,156 Nasdaq Global MarketSM securities totaled 13,300,707,903 shares compared with 13,211,633,004 shares in 3,143 Global Market issues reported for the prior settlement date of April 15, 2025. The mid-April short interest represents 2.40 days compared with 1.76 days for the prior reporting period.
- 05/09/2025
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 5, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 111,750 shares of Class A common stock and restricted stock units (RSUs) for 62,575 shares of Class A common stock to eleven (11) new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/09/2025
|
MetaVia Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
- CAMBRIDGE, Mass. , May 9, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA) ("MetaVia"), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a private placement that MetaVia estimates will result in gross proceeds of approximately $10.0 million, before deducting the placement agent's fees and other offering expenses payable by the company.
- 05/09/2025
|
KWESST Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Ottawa, Ontario--(Newsfile Corp. - May 8, 2025) - KWESST Micro Systems Inc. (TSXV: KWE) (TSXV: KWE.WT.U) (NASDAQ: KWE) (NASDAQ: KWESW ("KWESST" or the "Company") is pleased to announce that it has received a notification letter (the "Notification Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the "Nasdaq Minimum Bid Price Requirement"). The Notification Letter confirmed that the Company evidenced a closing bid price at or greater than the USD$1.00 per common share minimum requirement for 10 consecutive business days from April 24, 2025 to May 7, 2025 and that the Company has regained compliance with the Nasdaq Minimum Bid Price Requirement.
- 05/08/2025
|
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- DUBLIN, May 08, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to nine (9) new employees to purchase 51,700 ordinary shares under Avadel's 2021 Inducement Plan. The awards were granted as an inducement material to the employee's acceptance of employment with Avadel in accordance with Nasdaq Listing Rule 5635(c)(4). The options have a ten-year term and vest over four years, with 25% vesting on the one-year anniversary of each new employee's respective start date and 25% vesting on the second, third, and fourth anniversary thereafter. The options are subject to the terms and conditions of Avadel's 2021 Inducement Plan approved by the Board of Directors in November 2021 and the terms and conditions of award agreements covering the grants.
- 05/08/2025
|
CERo Therapeutics Holdings, Inc. Regains Compliance with Nasdaq Listing Rule 5550(b)(1)
- SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders' equity of $2.5 million (the “Equity Rule”)
- 05/08/2025
|
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)---- $GOSS--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective May 5, 2025, to three non-executive employees of non-qualified stock optio.
- 05/07/2025
|
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on April 22, 2025, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units (“RSUs”) representing 157,466 shares of its common stock to 139 new non-executive employees and two non-qualified stock option awards to purchase 19,295 shares of its common stock to two new non-executive employees with a grant date of May 2.
- 05/07/2025
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, May 07, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/07/2025
|
ConnectM Regains Compliance with Nasdaq Listing Requirement
- MARLBOROUGH, Mass. , May 7, 2025 /PRNewswire/ -- ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) (" ConnectM " or the " Company "), a high-growth technology company on the leading edge of the energy economy, today announced that it has received formal notice from the Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum market value of publicly held shares ("MVPHS") requirement set forth in Nasdaq Listing Rule 5450(b)(1)(C).
- 05/07/2025
|
Digital Ally Receives Positive Listing Determination from Nasdaq
- Overland Park, KS, May 07, 2025 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”) today reported that by decision dated May 1, 2025, the Nasdaq Hearings Panel (the “Panel”) granted the Company's request for continued listing on The Nasdaq Stock Market LLC (“Nasdaq”). The Company's continued listing on Nasdaq is subject to, among other conditions, the Company's compliance with certain criteria for continued listing on The Nasdaq Capital Market, namely the $2.5 million stockholders' equity requirement by May 20, 2025, and the $1.00 bid price requirement by June 6, 2025, and the Company's continued compliance with all other applicable listing criteria through September 2, 2025.
- 05/07/2025
|
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 5, 2025, the Compensation Committee of Puma's Board of Directors approved the grant of inducement restricted stock unit awards covering 12,875 shares of Puma common stock to two new non-executive employees. The awards were granted under Puma's 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards t.
- 05/06/2025
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, today announced that the company granted inducement equity awards to R. Keith Woods, its newly named Chief Operating Officer and Vikas Sinha, its newly named Chief Financial Officer, covering an aggregate of up to 1,420,134 shares of its common stock, con.
- 05/06/2025
|
Vast Announces Voluntary Nasdaq Delisting and Strategic Leadership Changes
- SYDNEY, May 06, 2025 (GLOBE NEWSWIRE) -- Vast Renewables Limited (Vast) (Nasdaq: VSTE), a leading Australian clean energy technology company, today announced that it has notified The Nasdaq Stock Market LLC (Nasdaq) of its intention to voluntarily delist its ordinary shares and public warrants from Nasdaq. Delisting from Nasdaq marks the first step in Vast's broader strategy to cease its public reporting obligations in the U.S. The decision to delist and deregister is a strategic step by Vast to simplify its corporate structure, reduce regulatory and administrative costs, and align its governance with the scale and needs of its business. As a growth-stage enterprise focused on long-term infrastructure development, Vast believes that redirecting resources toward executing its business plan will better position Vast for long-term success.
- 05/06/2025
|
Jin Medical International Ltd. – Nasdaq Minimum Bid Price Non-Compliance
- Changzhou City, China, May 06, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (NASDAQ: ZJYL) (the “Company”) today announced that on May 2, 2025, it received a deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”). The Notice informed the Company that, based upon the closing bid price of the Company's ordinary shares (“Ordinary Shares”) over the 30 consecutive business day period between March 20, 2025 and May 1, 2025, the Company is not in compliance with the requirement to maintain a minimum bid price of $1.00 per share of its Ordinary Shares for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).
- 05/06/2025
|
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on May 1, 2025, it awarded an inducement grant to eight new employees under Intellia's 2024 Inducement Plan as a material inducement to employment.
- 05/06/2025
|
Altisource Announces Listing of Warrants on Nasdaq Global Select Market with Trading to Commence on May 7, 2025
- Cash Exercise Stakeholder Warrants to Trade on the Nasdaq Global Select Market Under the Ticker “ASPSZ” Net Settle Stakeholder Warrants to Trade on the Nasdaq Global Select Market Under the Ticker “ASPSW” LUXEMBOURG, May 06, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that the Warrants (defined below) that were distributed on April 3, 2025 have been approved for listing on the Nasdaq Global Select Market and trading of the Warrants will commence on May 7, 2025.
- 05/06/2025
|
Nasdaq 100: Palantir Tumbles, US Stocks Slip on Fed Uncertainty and Trade Risks
- US stocks dropped as the Nasdaq 100 and Palantir tumbled, with traders eyeing Fed policy signals and unresolved global trade negotiations.
- 05/06/2025
|
Nasdaq set to tumble on Palantir, Ford updates and Fed meeting begins
- Wall Street stocks have been tipped to extend their losses on Tuesday, as markets mull the start of the Federal Reserve meeting and digest another major auto manufacturer withdrawing guidance due to tariff risks and uncertainties. Ford Motor Company (NYSE:F) said overnight that it expected a $1.5 billion impact from tariffs in 2025 and pulled its financial guidance due to the associated uncertainty.
- 05/06/2025
|
QTOP: Risky Play On Nasdaq-100 Top 30 Stocks, But Worth A Look
- iShares Nasdaq Top 30 Stocks ETF offers exposure to top Nasdaq stocks with lower concentration risk compared to TOPT, but has underperformed recently due to high valuations. QTOP's performance hinges on market conditions: it could excel if the market normalizes but may suffer in a recession. Investors should consider balancing QTOP with short and long-term treasuries if they choose to invest.
- 05/06/2025
|
Nasdaq 100: AMD Earnings in Focus as Data Center Growth Faces Tariff Headwinds
- AMD Q1 earnings preview: Strong data center growth expected, but China tariffs and gaming weakness may weigh on guidance. Here's what traders need to know.
- 05/06/2025
|
Nasdaq Reports April 2025 Volumes
- NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for April 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics .
- 05/05/2025
|
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on May 1, 2025, the Compensation Committee of the company's Board of Directors granted to 13 new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 79,500 ordinary shares. These awards were made under Bicycle Therapeutics' 2024 Inducement Plan and approved by the Compensation Committee as an inducement material to the employees entering into.
- 05/05/2025
|
Nasdaq Falls Over 100 Points; Tyson Foods Posts Downbeat Sales
- U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Monday.
- 05/05/2025
|
Palvella Therapeutics to Ring the Nasdaq Opening Bell on May 12, 2025
- WAYNE, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, announced today that the Company will ring the opening bell at the Nasdaq Stock Market (Nasdaq) on Monday, May 12, 2025 in New York City.
- 05/05/2025
|
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on May 1, 2025, the Compensation Committee of Praxis' Board of Directors granted restricted stock unit awards covering an aggregate of 3,688 shares of its common stock to five new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock units were granted as inducements material to the employees' entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/02/2025
|
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced equity inducement grants to four new non-officer employees consisting of an aggregate of 78,600 share options and 1,800 performance share units (“PSUs”). All of the foregoing share options and PSUs were approved by the Compensation Committee of the Company's Board of Directors with an effective date of May 2, 2025 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/02/2025
|
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective May 1, 2025, the company granted a non-qualified stock option to purchase 5,000 shares of its common stock to one new employee under Xilio Therapeutics' 2022 Inducement Stock Incentive Plan.
- 05/02/2025
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, May 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to four new employees to purchase an aggregate of 104,400 shares of the Company's common stock, effective as of May 1, 2025. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/02/2025
|
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 33,650 shares of Astria's common stock on May 1, 2025 under Astria's 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were granted.
- 05/02/2025
|
Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
- XI'AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, 2025, the Company received a letter (the “Notification Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”), notifying the Company that it was not in compliance with Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”), as the Company's closing bid price for its Class A ordinary shares, par value US$0.001 per share was below $1.00 per share for the prior thirty (30) consecutive business days, which matter serves as a basis for delisting the Company's securities from Nasdaq. Additionally, the Company's securities had a closing bid of $0.10 or less for the last ten consecutive trading days, and accordingly, is subject to the provisions under Listing Rule 5810(c)(3)(A)(iii).
- 05/02/2025
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON , May 02, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on April 30, 2025, the company granted equity awards to seven new employees, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/02/2025
|
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 32,620 shares of common stock and restricted stock units (RSUs) for 16,310 shares of common stock to seven new employees under Adverum's 2017 Inducement Plan. These awards were approved as an inducement material to the new employees entering into employment with Adverum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/02/2025
|
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on May 1, 2025 the Company granted restricted stock units (RSUs) representing 30,400 shares of its common stock to two newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employees being continuously employed by the Company through each vesting date.
- 05/02/2025
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, the Netherlands and MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 197,000 of NewAmsterdam's ordinary shares to eleven non-executive new hires. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/02/2025
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 26,500 restricted stock units of Arcutis' common stock to three newly hired employees.
- 05/02/2025
|
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 300 points on Friday.
- 05/02/2025
|
Nasdaq Index: Dexcom, Meta, ON Semi Lead US Stocks Rebound on Trade Optimism
- Nasdaq jumps as Dexcom, Palantir, and ON Semi soar. Jobs report beats forecasts, easing inflation fears and driving US stock market optimism.
- 05/02/2025
|
Phoenix Motor Inc. Announces Receipt of Nasdaq Listing Delinquency Letter
- ANAHEIM, CA / ACCESS Newswire / May 2, 2025 / Phoenix Motor Inc. (NASDAQ:PEV) (the "Company") today announced that it received a notice (the "Notice") from the Nasdaq Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is no longer in compliance with Listing Rule 5250(c)(1) due to its failure to file its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"). This matter serves as an additional basis for delisting the Company's securities from Nasdaq.
- 05/02/2025
|
Thesis*-Backed Fold Celebrates First Bitcoin Financial Services Listing on Nasdaq with Opening Bell Ceremony
- The listing marks a major milestone for Thesis* as it continues to pioneer Bitcoin-native financial innovation, aimed at providing access to crypto products to average consumers NEW YORK , May 2, 2025 /PRNewswire/ -- Fold, Inc. (NASDAQ: FLD), the leading Bitcoin rewards and payments platform, today celebrates its recent public listing by ringing the Nasdaq Opening Bell at the Nasdaq MarketSite in Times Square. The ceremony marks a significant milestone in the company's mission to integrate Bitcoin into everyday financial activity.
- 05/02/2025
|
SIMPPLE Ltd. Regains Compliance with Nasdaq's Minimum Bid Price Requirement
- Singapore, May 02, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, today announced that on April 28, 2025, the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq Capital Market's continued listing standard for the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.
- 05/02/2025
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on May 1, 2025, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 45,000 shares of the Company's common stock in connection with their employment. The stock option was granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individual entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/02/2025
|
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on May 1, 2025, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 433,950 shares of common stock to sixteen (16) new employees under the Company's 2023 Inducement Option Plan, as amended. The Compensation Committee approved the stock options as an inducement material to such employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/02/2025
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., May 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted seven newly-hired employees restricted stock units (RSUs) covering an aggregate of 48,000 shares of BioCryst common stock. The RSUs were granted as of May 1, 2025, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/02/2025
|
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista's board of directors granted three newly-hired employees inducement options to purchase an aggregate of 14,000 shares of KalVista common stock on May 1, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock on.
- 05/02/2025
|
Nasdaq 100: Apple, Amazon Slide After Hours as Forecasts Miss Street Expectations
- Apple and Amazon dropped after hours as weak Q2 forecasts rattled traders despite strong Q1 results. Tech stocks face pressure from tariffs and cloud risks.
- 05/01/2025
|
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that on May 1, 2025, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 14,000 shares of the Company's common stock to one (1) newly hired employee. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/01/2025
|
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
- CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on April 24, 2025 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c) (the “Listing Rule”) as a result of its failure to timely file its Annual Report on Form 10-K for the annual period ended December 31, 2024 (the “2024 Form 10-K”), as described more fully in the Company's Form 12b-25 Notification of Late Filing (the “Form 12b-25”) filed with the Securities and Exchange Commission (the "SEC") on April 1, 2025. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.
- 05/01/2025
|
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FLORHAM PARK, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in connection with the appointment of Jonathan Bentley as Senior Vice President, Head of Sales, the Company's Board of Directors has approved the grant of inducement awards.
- 05/01/2025
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted eight newly-hired employees options to purchase an aggregate of 148,000 shares of Akebia's common stock on April 30, 2025. The options were granted as an inducement material to each employee entering into employment with Akebia. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/01/2025
|
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent grants of inducement non-qualified stock options and restricted stock units (RSUs) to six newly-hired employees.
- 05/01/2025
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , May 1, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 983 restricted stock units (RSUs) to two newly-hired employees.
- 05/01/2025
|
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CHARLESTOWN, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 81,000 restricted stock units (“RSUs”) to seven newly hired employees.
- 05/01/2025
|
Nasdaq 100: Bullish Rebound in Tech Stocks Today on Strong Microsoft, Meta Earnings
- Tech stocks rally as Microsoft and Meta post strong earnings, lifting the Nasdaq 100 and boosting confidence in AI despite weak U.S. economic data.
- 05/01/2025
|
Beat the Nasdaq With This Cash-Gushing Dividend Stock
- Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence. Biotech giant Amgen (AMGN 0.82%) exemplifies this strategy with its 3.3% dividend yield, supported by steady growth and rock-solid fundamentals.
- 05/01/2025
|
Nasdaq to head Wall Street rally after Microsoft and Meta earnings beats
- Technology stocks are anticipated to lead a Wall Street rally to start the month of May on Thursday, following earnings from Microsoft and Meta Platforms overnight and ahead of more from Apple and Amazon after the close. Futures markets are calling the Nasdaq 100 around 1.7% higher, ahead of the opening bell, with S&P 500 futures up 1.2% and those for the Dow Jones rising 0.8%.
- 05/01/2025
|
Top KingWin Ltd Announces 1-For-25 Reverse Share Split
- Guangzhou, China, May 01, 2025 (GLOBE NEWSWIRE) -- Top KingWin Ltd (“Top KingWin” or the “Company”) (Nasdaq: WAI) today announced that it will effect a reverse share split of its outstanding class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), at a ratio of 1-for-25, to be effective at the open of business on Monday, May 5, 2025. Our Ordinary Shares will begin trading on a reverse share split-adjusted basis at the opening of The Nasdaq Capital Market (“Nasdaq”) on or around Monday, May 5, 2025.
- 05/01/2025
|
3 Best Nasdaq Stocks to Buy in May
- Despite Wall Street's optimistic outlook for big tech in 2025, most technology stocks have struggled significantly during the first four months of the year. The Nasdaq-100, which consists of the 100 largest nonfinancial companies listed on the Nasdaq stock exchange, has declined by nearly 7% year-to-date at the time of this writing.
- 05/01/2025
|
Aimfinity Investment Corp. I Announces Transition from Nasdaq to OTC Markets and New Monthly Extension for Business Combination
- Wilmington, DE, April 30, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMAU), a special purpose acquisition company, today announced that, as anticipated, AIMA received a notice from The Nasdaq Stock Market LLC (“Nasdaq” or the “Exchange”), stating that in accordance with Nasdaq rules, its securities will be delisted from the Exchange. At the open of trading on Monday, May 5, 2025, AIMA's securities will be suspended on Nasdaq and are expected to begin trading on the OTC Markets under the tickers “AIMAU,” “AIMBU,” and “AIMAW”, for its units, new units and warrants, respectively.
- 04/30/2025
|
Oak Woods Acquisition Corporation Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
- New York, April 30, 2025 (GLOBE NEWSWIRE) -- Oak Woods Acquisition Corporation. (Nasdaq: OAKU) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on April 24, 2025, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Annual Report on Form 10-K for the period ended December 31, 2024 (the “Annual Report”). The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”). This notification has no immediate effect on the listing of the Company's securities on Nasdaq.
- 04/30/2025
|
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on April 30, 2025. Three individuals were hired by Adicet in April 2025. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 206,800 shares of Adicet's common stock with an exercise price of $0.66 per.
- 04/30/2025
|
Wellchange Holdings Company Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- New York, April 30, 2025 (GLOBE NEWSWIRE) -- Wellchange Holdings Company Limited (NASDAQ: WCT) ("Wellchange Holdings Company" or the "Company") is an enterprise software solution services provider headquartered in Hong Kong with diversified expansion strategies, today announced that it has received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on April 28, 2025, indicating that the Company is not in compliance with Nasdaq's minimum bid price requirement.
- 04/30/2025
|
Delisting of Securities of TLGY Acquisition Corporation; Target Global Acquisition I Corp.; Inception Growth Acquisition Limited; Healthcare AI Acquisition Corp.; Globalink Investment Inc.; BurTech Acquisition Corp; Mountain & Co. I Acquisition Corp.; Pearl Holdings Acquisition Corp; Alpha Star Acquisition Corporation; CF Acquisition Corp. VII; Kairous Acquisition Corp. Limited; Finnovate Acquisition Corp.; Exela Technologies, Inc.; Investcorp Europe Acquisition Corp I; Molecular Templates, Inc.
- NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A common stock of Alpine 4 Holdings, Inc. Alpine 4 Holdings, Inc.'s stock was suspended on October 18, 2024 and has not traded on Nasdaq since that time.
- 04/30/2025
|
Nasdaq 100: Tech Stocks Dive on GDP Miss, MSFT and Meta in Spotlight
- US GDP contracts 0.3%, rattling markets. Dow drops 300+ points as traders brace for key Meta and MSFT earnings.
- 04/30/2025
|
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
- KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC), a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today announced that it has received official notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming the Company has regained full compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share.
- 04/30/2025
|
Heramba Electric plc Announces Receipt of Notice from Nasdaq Regarding Delisting
- DÜSSELDORF, GERMANY, ATLANTA, GA, AND NEW YORK, NY / ACCESS Newswire / April 28, 2025 / As previously disclosed, and pursuant to the terms and conditions set forth in the Share Purchase Agreement, dated as of July 25 and 26, 2023, by and among Heramba GmbH ("Heramba"), Heramba Holdings, Inc. ("Heramba Holdings"), Knorr-Bremse Systeme für Schienenfahrzeuge GmbH ("KB GmbH") and Knorr-Brake Holding Corporation ("KB US"), as amended pursuant to the Amendment Agreement to Share Purchase Agreement, dated as of January 31, 2024, on February 6, 2024, (i) KB GmbH, as sole shareholder of Kiepe Electric GmbH, sold and transferred 85% of the equity interests in Kiepe GmbH, as well as certain receivables and shareholder loans, to Heramba, and (ii) KB US, as the sole member of Kiepe Electric LLC ("Kiepe US" and together with Kiepe GmbH, "Kiepe"), sold and transferred all ownership interests in Kiepe US, as well as certain receivables, to Heramba Holdings. As previously disclosed, and pursuant to the terms and conditions set forth in the Business Combination Agreement, dated as of October 2, 2023, by and among Project Energy Reimagined Acquisition Corp., Heramba Electric plc, Heramba Merger Corp., Heramba Limited and Heramba, effective as of July 26, 2024, the business combination contemplated by the Business Combination Agreement was consummated resulting in, among other matters, each of Heramba, Heramba Holdings, Kiepe GmbH and Kiepe US becoming direct or indirect subsidiaries of the Company.
- 04/28/2025
|
Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance
- GIG HARBOR, Wash., April 28, 2025 (GLOBE NEWSWIRE) -- Heritage Distilling Holding Company, Inc. (“HDC” or “Heritage” or the “Company”) (Nasdaq: CASK), a leading craft distiller of innovative premium brands, today reported it regained compliance with the Nasdaq regarding the filing of periodic reports after filing its 2024 Annual Report of Form 10-K with the Securities and Exchange Commission on April 28, 2025.
- 04/28/2025
|
BriaCell Therapeutics Announces Closing of $13.8 million Public Offering
- PHILADELPHIA and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the closing of its previously announced underwritten public offering of 3,066,666 units, including 399,999 units sold upon the full exercise of the underwriter's option to purchase additional units. Each unit consists of one common share (or pre-funded warrant (“Pre-Funded Warrant”) in lieu thereof) and one warrant (the “Warrants”). Each unit was sold to the public at a price of $4.50 per unit (inclusive of the Pre-Funded Warrant exercise price) for gross proceeds of approximately $13.8 million, before deducting underwriting discounts and offering expenses. The Warrants included in the units were approved for listing on the Nasdaq Capital Market and commenced trading under the symbol “BCTXZ” on April 25, 2025. Each Warrant is immediately exercisable, entitles the holder to purchase one common share at an exercise price of $5.25 per share and expires five years from the date of issuance. The Company is relying upon the exemption set forth in Section 602.1 of the TSX Company Manual, which provides that the TSX will not apply its standards to certain transactions involving eligible interlisted issuers on a recognized exchange, such as Nasdaq.
- 04/28/2025
|
5 Stocks That Powered Nasdaq ETF's Outperformance Last Week
- Here we present five of the best stocks that powered the Nasdaq ETF last week.
- 04/28/2025
|
Nasdaq 100: Tech Stocks Weigh Heavy Today as Nvidia Slips on China AI News
- Nasdaq 100 falls today as tech stocks weigh on US indices; traders eye key earnings reports, payrolls, and PCE inflation data for market direction.
- 04/28/2025
|
Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
- Company is advancing portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases Lead candidate JADE-001 on track to enter the clinic in second half of 2025, with initial data expected in first half of 2026 The combined company will operate as “Jade Biosciences, Inc.” and will trade on Nasdaq under the ticker symbol “JBIO” SAN FRANCISCO and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the completion of its previously announced merger with Aerovate Therapeutics, Inc. (“Aerovate”). The combined company will operate as Jade Biosciences, Inc., with its shares expected to begin trading on the Nasdaq Capital Market on April 29, 2025, under the ticker symbol “JBIO.
- 04/28/2025
|
3 Industry Behemoths Are Rewarding Investors With Dividend Bumps
- In a market where investors are increasingly seeking stability and reliable returns, several industry giants have stepped up with significant dividend increases. Johnson & Johnson NYSE: JNJ, Costco Wholesale NASDAQ: COST, and NASDAQ NASDAQ: NDAQ have each announced meaningful hikes to their quarterly payouts, reinforcing their commitment to shareholder value even amid broader market volatility.
- 04/28/2025
|
3 Beaten-Down ETFs I'm Buying Hand Over Fist Now
- The S&P 500 and Nasdaq-100 indices are still significantly below their recent highs but are now firmly out of bear market territory. As of this writing, the S&P 500 is about 10% below its 2025 peak, while the Nasdaq is still about 13% lower.
- 04/28/2025
|
Nasdaq: Take The Bet On Solutions
- Nasdaq, Inc. reported robust Q1 2025 results, beating analyst estimates and maintaining an "Outperform" rating, with shares responding positively. Market Services saw a 19% YoY organic growth, but future growth is limited; derivatives likely to cushion any cash equity volume drops. Solutions segment shows promise, with Financial Technology and Capital Access Platforms growing; Adenza synergies expected to drive future growth.
- 04/28/2025
|
2 Monster Stocks to Buy in the Wake of the Nasdaq Correction
- Wall Street fears a recession on the horizon, which has rattled the markets in 2025. The Nasdaq Composite is down 16% year to date at the time of writing.
- 04/26/2025
|
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on April 23, 2025, the Board of Directors granted a non-qualified stock option award to purchase 19,000 shares of its common stock to one new non-executive employee under the Company's Amended and Restated 2024 Inducement Equity Incentive Plan (the “2024 Inducement Plan”). The stock options were granted as an inducement material to the employee entering into employment with Skye in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/25/2025
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 15, 2025
- NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 15, 2025, short interest in 3,143 Nasdaq Global MarketSM securities totaled 13,211,633,004 shares compared with 13,072,444,217 shares in 3,140 Global Market issues reported for the prior settlement date of March 31, 2025. The mid-April short interest represents 1.76 days compared with 2.64 days for the prior reporting period.
- 04/25/2025
|
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to five new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and.
- 04/25/2025
|
Digital Ally, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
- Lenexa, KS, April 25, 2025 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on April 23, 2025, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Annual Report on Form 10-K for the period ended December 31, 2024 (the “Annual Report”). The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”). This notification has no immediate effect on the listing of the Company's securities on Nasdaq.
- 04/25/2025
|
Nasdaq 100: Tech Stocks Power Higher Today as Alphabet and Tesla Drive Optimism
- Alphabet and Tesla lead gains today as tech stocks rally; Nasdaq 100 outlook strengthens despite tariff concerns and cautious consumer sentiment.
- 04/25/2025
|
These Analysts Revise Their Forecasts On Nasdaq After Better-Than-Expected Earnings
- Nasdaq Inc NDAQ reported better-than-expected earnings for its first quarter on Thursday.
- 04/25/2025
|
Nasdaq Is Not A Typical Stock Exchange Business
- Nasdaq Inc. delivered exceptional Q1 results, with revenues and EPS growing at double-digit and higher margins. During the quarter, Shopify Inc., Domino's Pizza, and Thomson Reuters switched their listing from the NYSE to the Nasdaq. Nasdaq is at the forefront of technological innovation, and the market is not assigning it a premium despite higher growth compared to its peers.
- 04/25/2025
|
Nasdaq 100: Tesla and Alphabet Lead Today's Charge—Is the Tech Rally Just Starting?
- Tech stocks lead US indices higher with Alphabet and Tesla rallying. Traders eye a bullish Nasdaq 100 forecast into next week's earnings.
- 04/25/2025
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , April 25, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 24, 2025, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 185,400 shares of the Company's common stock to four newly hired employees.
- 04/25/2025
|
PicoCELA Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- TOKYO , April 24, 2025 /PRNewswire/ -- PicoCELA Inc. ("PicoCELA" or the "Company," Nasdaq: PCLA), a Tokyo-based provider of enterprise wireless mesh solutions, today announced that the Company received a letter (the "Notification Letter") from the Listings Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") on April 22, 2025, notifying the Company that it is not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon the receipt of a deficiency notification.
- 04/24/2025
|
Nasdaq 100: Alphabet Jumps 4% on Earnings Surprise, Massive Buyback Ignites Bullish Sentiment
- Alphabet stock jumps 4% post-Q1 beat, unveils $70B buyback and dividend hike. Ad revenue holds strong as cloud growth slows but margins improve.
- 04/24/2025
|
NDAQ Beats on Q1 Earnings, Tweaks Expense View, Raises Dividend
- Nasdaq's Q1 results reflect higher revenues across divisions and organic growth, partially offset by higher expenses.
- 04/24/2025
|
Nasdaq 100: ServiceNow Soars, Alphabet Earnings in Focus as Tech Stocks Drive Gains
- Tech stocks drive US indices higher today, led by ServiceNow's surge and Alphabet's awaited earnings, as tariff relief signals lift trader sentiment.
- 04/24/2025
|
Nasdaq, Inc. (NDAQ) Q1 2025 Earnings Call Transcript
- Nasdaq, Inc. (NASDAQ:NDAQ ) Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ET Company Participants Ato Garrett - SVP and IR Officer Adena Friedman - Chair and CEO Sarah Youngwood - EVP and CFO Conference Call Participants Simon Clinch - Redburn Atlantic Craig Siegenthaler - Bank of America Alexander Blostein - Goldman Sachs Patrick Moley - Piper Sandler Benjamin Budish - Barclays Ashish Sabadra - RBC Kyle Voigt - KBW Dan Fannon - Jefferies Brian Bedell - Deutsche Bank Alex Kramm - UBS Owen Lau - Oppenheimer Operator Good day, and thank you for standing by. Welcome to Nasdaq First Quarter 2025 Results Conference Call.
- 04/24/2025
|
Nasdaq and AWS Partner to Take Global Capital Markets to the Cloud
- Global stock markets are heading to the cloud. Nasdaq and Amazon Web Services (AWS) partnered to modernize the infrastructure of capital markets to help market operators transition to cloud-based systems while maintaining data sovereignty, according to a Thursday (April 24) press release.
- 04/24/2025
|
Here's What Key Metrics Tell Us About Nasdaq (NDAQ) Q1 Earnings
- The headline numbers for Nasdaq (NDAQ) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 04/24/2025
|
Nasdaq Market Correction: Grab the Growth QQQ ETF While Stocks Crash
- The Nasdaq 100 has been hit incredibly hard. There's an intriguing contrarian case for not giving up on the group.
- 04/24/2025
|
Nasdaq (NDAQ) Q1 Earnings and Revenues Top Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.63 per share a year ago.
- 04/24/2025
|
Nasdaq CEO Adena Friedman on Q1 earnings, market volatility and IPO landscape
- Nasdaq CEO and chair Adena Friedman joins 'Squawk Box' to discuss the company's quarterly earnings results, what to make of market volatility, IPO landscape, future capital flows, regional HQ expansion in Texas, and more.
- 04/24/2025
|
Nasdaq and Dow Jones reverse course as Japan plays hardball over trade, Hasbro earnings impress
- US stock indices seemed to be heading for a moderately positive start to trading on Thursday, before reports emerged from Japan that dented the market's confidence. Futures for the S&P 500 were down 0.25% at the time of publication, having been up almost as much the other way an hour earlier.
- 04/24/2025
|
Nasdaq Bear Market: Is AMD or Nvidia the Best Buy Now?
- Nvidia (NVDA 3.86%) and AMD (AMD 4.81%) are two of the biggest providers of artificial intelligence (AI) computing hardware, but Nvidia is much larger and more successful than AMD in this regard. However, after the latest market sell-off, each is still well off its all-time highs, with AMD down around 60% and Nvidia down 30%.
- 04/24/2025
|
Nasdaq Announces 13% Increase in Quarterly Dividend to $0.27 Per Share
- NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.27 per share on the company's outstanding common stock, a 13% increase from the previous quarter. The dividend is payable on June 27, 2025 to shareholders of record at the close of business on June 13, 2025.
- 04/24/2025
|
Nasdaq and AWS Unlock New Era of Growth for Global Capital Markets with Next Generation Infrastructure Solutions
- Nasdaq and AWS announce modernization blueprint to drive the benefits of cloud into local market infrastructures through flexible deployment while maintaining data sovereignty and resilience
- 04/24/2025
|
Nasdaq Reports First Quarter 2025 Results; Diversified Business Model Driving Broad-Based Revenue Growth
- NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the first quarter of 2025.
- 04/24/2025
|
CoreWeave: IPO Stumble Out Of Nasdaq Rodeo Chute May Be An Opportunity
- CoreWeave's stock movement is linked to OpenAI's $40B funding from SoftBank and new AI benchmarks with Nvidia chips. Despite current market setbacks, the AI bull market remains intact, with CoreWeave benefiting from AI sector positioning. CoreWeave's IPO debut at $40 per share, backed by Nvidia, offers a long-term bullish outlook despite short-term volatility.
- 04/24/2025
|
FOUR LEAF ACQUISITION CORPORATION ANNOUNCES RECEIPT OF NASDAQ DELISTING DETERMINATIONS
- LOS ALTOS, Calif. , April 23, 2025 /PRNewswire/ -- Four Leaf Acquisition Corporation (Nasdaq: FORL), a publicly-listed special purpose acquisition company (the "Company"), today announced that it received a notice (the "Notice") from the staff of the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC ("Nasdaq") on April 17, 2025 stating that the Company's failure to file its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"), serves a basis for delisting the Company's securities from Nasdaq.
- 04/23/2025
|
ConnectM Receives Nasdaq Notice on Late Filing of its Form 10-K
- MARLBOROUGH, Mass. , April 23, 2025 /PRNewswire/ -- ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) (" ConnectM " or the " Company "), a high-growth technology company on the leading edge of the energy economy, today announced it received a notice (the " Letter ") from Nasdaq on April 17, 2025, notifying the Company that it is not in compliance with the Securities and Exchange Commission (the " SEC ") periodic reporting requirements for continued listing, as set forth in Nasdaq Listing Rule 5250(c)(1), because the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the " 2024 10-K "), was not filed with the SEC by the required due date.
- 04/23/2025
|
ScanTech AI Announces Receipt of Nasdaq Deficiency Letter
- Atlanta, GA, April 23, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (Nasdaq: STAI) (the “Company” or “ScanTech AI”), a leading publicly-traded innovator of next-generation checkpoint security scanning products and technology, today announced that the Company received a letter from Nasdaq, dated April 17, 2025, stating that the Company is not in compliance with the requirements of Nasdaq Listing Rule 5250(c)(1) as a result of not having timely filed with the U.S. Securities and Exchange Commission its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Annual Report”). The Notice has no immediate effect on the listing of the Company's common stock on The Nasdaq Global Market.
- 04/23/2025
|
Triller Group Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- Palm Beach, FL, April 23, 2025 (GLOBE NEWSWIRE) -- Triller Group Inc. (“Triller”, “Triller Group” or “the Company”) today announced that on April 17, 2025, it received a delinquency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of the Company's failure to timely file its Annual Report on Form 10-K for the period ended December 31, 2024 (the “Filing”). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”).
- 04/23/2025
|
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 450,471 shares of X4's common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by X4's Compensation Committee of the Board of Directors.
- 04/23/2025
|
S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?
- The S&P 500 Index, as tracked by SPDR S&P 500 ETF Trust NYSEARCA: SPY, and the Nasdaq-100 Index, as tracked by the Invesco QQQ NASDAQ: QQQ, have both triggered a widely-followed bearish chart pattern known as the Death Cross.
- 04/23/2025
|
Nasdaq in the driving seat as Wall Street futures point to extended gains, Tesla up premarket
- US stock futures were sharply higher ahead of Wednesday's opening bell, building on a powerful rebound the day before as markets respond positively to a marked shift in tone from the Trump administration on trade. Dow Jones futures were pointing to a gain of 623 points or 1.58% ahead of the open, while S&P 500 futures were up 2.29%, while the Nasdaq was leading with a 2.69% jump.
- 04/23/2025
|
Newegg Regains Compliance with Nasdaq Minimum Bid Price Requirement
- DIAMOND BAR, Calif.--(BUSINESS WIRE)--Newegg Commerce, Inc. (NASDAQ: NEGG) (the “Company” or “Newegg”) today announced that it has received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Capital Market notifying the Company that it had regained compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the “Nasdaq Minimum Bid Price Requirement”). The Notification Letter confirmed that the Company.
- 04/23/2025
|
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
- ZURICH, Switzerland, and BROOKLYN, New York, April 23, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the “Company”), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands exempted company and special purpose acquisition company targeting the healthcare sector (NASDAQ: VACH, “Voyager” or the “SPAC”), announced today that they have entered into a definitive business combination agreement (the "Business Combination Agreement"). The proposed business combination (the "Business Combination") would create a publicly traded, clinical-stage biopharmaceutical company focused on the development of a comprehensive pipeline of next-generation cancer therapies. Upon closing of the transaction, VERAXA Biotech AG is expected to list on NASDAQ under the proposed ticker symbol “VERX.”
- 04/23/2025
|
Nasdaq 100: Tesla Surges 5% Pre-Market as Musk Vows to Refocus After Weak Earnings
- Tesla stock jumps 5% pre-market after weak earnings as Elon Musk pledges to refocus on the EV giant. Traders eye his renewed commitment to growth.
- 04/22/2025
|
Tariff Turmoil: 1 Unstoppable Stock to Buy With $1,000 During the Nasdaq Bear Market
- The Nasdaq-100 index was recently down by as much as 23% from its all-time high, placing it in bear market territory. Global trade tensions, which were sparked by a series of tariffs President Donald Trump enacted on imported goods from the United States' major trading partners, have rattled the markets.
- 04/22/2025
|
Above Food Ingredients Appeal Staff Determination Notice from Nasdaq
- Regina, Saskatchewan--(Newsfile Corp. - April 22, 2025) - Above Food Ingredients Inc. (NASDAQ: ABVE) ("the Company") announced that on April 21, 2025, the Company requested a hearing and extended stay in response to a staff determination notice received from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on April 14, 2025. The hearing is scheduled to take place on May 22, 2025, and the Company is confident of regaining compliance with all applicable requirements for continued listing well in advance of this date.
- 04/22/2025
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 36,831 restricted stock units of the company's common stock to 21 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of April 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/22/2025
|
Charles & Colvard, Ltd. Announces Delisting from Nasdaq
- RESEARCH TRIANGLE PARK, N.C. , April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd.
- 04/22/2025
|
Marin Software Incorporated Receives Nasdaq Notification Regarding Late Form 10-K Filing and Continued Listing Requirements
- SAN FRANCISCO--(BUSINESS WIRE)--Marin Software Incorporated (NASDAQ: MRIN) (“Marin,” “we,” “our,” or the “Company”), a provider of digital marketing software for performance-driven advertisers and agencies, on April 16, 2025, received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the delinquency in the timely filing of the Company's annual report on Form 10-K for the fiscal year ended December 31, 202.
- 04/22/2025
|
Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, announced the closing of its previously announced offering of 2,324,000 shares of the Company's common stock in a registered direct offering (the "offering") at a purchase price of $0.862 per share. Roth Capital Partners acted as the exclusive placement agent for the offering.
- 04/22/2025
|
Nasdaq Gears Up to Report Q1 Earnings: Here's What to Expect
- NDAQ's Q1 results are likely to reflect new customer acquisitions, higher analytics revenues, eVestment product offerings, as well as growth in trading volume.
- 04/22/2025
|
Femto Technologies Announces Reverse Split Implemented
- The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market April 22, 2025 – TheNewswire – Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera, a feminine wellness product, has today announced that the previously announced 1-for-500 reverse stock split of its outstanding subordinate voting shares has been made effective today, April 22, 2025. This reverse split was approved by the board of directors of the Company on April 10, 2025.
- 04/22/2025
|
Nasdaq Dips Over 400 Points Amid Plunge In Tesla, Nvidia Shares: Greed Index Remains In 'Extreme Fear' Zone
- The CNN Money Fear and Greed index showed some easing in overall fear level, while the index remained in the “Extreme Fear” zone on Monday.
- 04/22/2025
|
Cambium Networks receives deficiency notice from Nasdaq
- HOFFMAN ESTATES, Ill. , April 21, 2025 /PRNewswire/ -- Cambium Networks (NASDAQ: CMBM), a leading global provider of networking solutions, announced today that on April 16, 2025, it received an additional delinquency letter (the "second deficiency notice") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it continues to be out of compliance with Nasdaq's continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1) due to the Company's failure to timely file its Form 10-K for the year ended December 31, 2024 (the "Form 10-K").
- 04/21/2025
|
1 Under-the-Radar Stock to Buy Hand Over Fist During the Nasdaq Bear Market
- Stock market volatility can be very unsettling for investors, especially when major U.S. market indexes like the Nasdaq Composite (NASDAQINDEX: ^IXIC) plunge by more than 20% (and into bear territory) in the span of just a few months.
- 04/19/2025
|
Sleep Number Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) today announced that it granted equity awards on April 15, 2025, as a material inducement to the employment of the company's newly-hired President and Chief Executive Officer, Linda A. Findley. As previously disclosed, in connection with the appointment of Findley as President and Chief Executive Officer effective April 7, 2025, Sleep Number granted Findley employment inducement awards consisting of: (i) 362,057 shares in a t.
- 04/18/2025
|
urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- LAFAYETTE, COLORADO / ACCESS Newswire / April 18, 2025 / urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), an integrated professional services and Design-Build firm offering solutions to the Controlled Environment Agriculture ("CEA") and other commercial sectors, today announced that the Company received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") on April 16, 2025, stating that because the Company had not yet filed its Annual Report on Form 10-K for the fiscal quarter ended December 31, 2024 (the "Form 10-K"), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.
- 04/18/2025
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, today announced that the company granted inducement equity awards covering an aggregate of 156,650 shares of its common stock to 19 newly hired employees, consisting of inducement stock options to purchase an aggregate of 89,515 shares of common stock and.
- 04/18/2025
|
Zeo Energy Corp. Receives Nasdaq Notice on Late Filing of its Form 10-K
- NEW PORT RICHEY, Fla., April 18, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo Energy” or the “Company”), announced today that, as expected, it received a notice (the “Notice”) from Nasdaq on April 17, 2025, notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (“Fiscal Year 2024 10-K”) was not filed with the Securities and Exchange Commission (the “SEC”) by the required due date of March 31, 2025.
- 04/18/2025
|
Curious about Nasdaq (NDAQ) Q1 Performance? Explore Wall Street Estimates for Key Metrics
- Besides Wall Street's top -and-bottom-line estimates for Nasdaq (NDAQ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
- 04/18/2025
|
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- CALGARY, Alberta, April 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease and gout, announces receipt of notification from the Nasdaq Stock Market LLC Listing Qualifications Department that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rule 5550(a)(2) since the closing bid price for the Company's common shares listed on Nasdaq was below US$1.00 for 30 consecutive business days. Nasdaq Rule 5550(a)(2) requires the shares to maintain a minimum bid price of US$1.00 per share, and Nasdaq Rule 5810(c)(3)(A) provides that failure to meet such a requirement exists when the bid price of the shares is below US$1.00 for a period of 30 consecutive business days.
- 04/17/2025
|
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- THE WOODLANDS, TX, April 17, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that the Compensation Committee of Autonomix's Board of Directors approved the grant of an inducement stock option on April 17, 2025 to purchase 5,000 shares of the Company's common stock, to a new non-executive employee pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception, as a component of the individual's employment compensation and was granted as an inducement material to their start of employment with the Company.
- 04/17/2025
|
Motorsport Games Regains Compliance With Nasdaq Listing Rules
- MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (“Motorsport Games” or “the Company”), the racing game developer and publisher of prominent simulation racing (or “sim racing”) titles including Le Mans Ultimate, is pleased to announce that it has regained compliance with the stockholders' equity requirement of the Nasdaq Stock Market (“Nasdaq”) as set forth in Nasdaq Listing Rule 5550(b)(1).
- 04/17/2025
|
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC
- Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025
- 04/17/2025
|
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for autoimmune diseases, today announced that on April 15, 2025 (the “Grant Date”), the Compensation Committee of the Company's Board of Directors (the “Committee”) granted non-qualified stock options to two newly hired officers of the Company, each as an inducement material to each officer's entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/17/2025
|
Nvni Group Receives Non-Compliance Notice from Nasdaq
- NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private SaaS B2B companies in Latin America, has received notice from the listing qualifications department staff of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1 per share, and Listing Rule 5550(b)(2), which requires listed securities to maintain a minimum Market Value of Listed Securities (MVLS) of $35 million.
- 04/17/2025
|
RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
- The Notification Letter has no immediate effect on the Company's listing on the Nasdaq Capital Market at this time, nor are the Company's business operations affected by receipt of the Notification Letter TEL AVIV, Israel and RALEIGH, N.C. , April 17, 2025 /PRNewswire/ -- RedHill Biopharma Ltd.
- 04/17/2025
|
CHAGEE Rings the Opening Bell on The Nasdaq
- Company Celebrates Transition to a Public Company; Shares Trade Under “CHA” Ticker Company Celebrates Transition to a Public Company; Shares Trade Under “CHA” Ticker
- 04/17/2025
|
Nasdaq 100: Tech Stocks Slammed Again Today After Alphabet Antitrust Ruling and Nvidia Hit
- Nasdaq pressured by tech losses, S&P 500 vulnerable. Google faces DOJ breakup risk, while traders brace for Netflix earnings after market close today.
- 04/17/2025
|
Nasdaq (NDAQ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/17/2025
|
The Rise of US ESG Reporting Software Market: A $0.71 billion Industry Dominated by Tech Giants -Nasdaq, Workiva, and Diligent | MarketsandMarkets™
- Delray Beach, FL, April 17, 2025 (GLOBE NEWSWIRE) -- The US ESG Reporting Software Market is expected to reach USD 0.71 billion in 2029 from USD 0.35 billion in 2024, at a CAGR of 15.2% during the forecast period, according to a new report by MarketsandMarkets™.
- 04/17/2025
|
Cadrenal Therapeutics to Present at Inaugural Centri Capital Conference at Nasdaq
- PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #CadrenalTherapeutics--Cadrenal Therapeutics to present at inaugural Centri Capital Conference at Nasdaq on April 22, 2025.
- 04/17/2025
|
These Were the 2 Top-Performing Stocks in the Nasdaq-100 in March 2025
- March 2025 was a rough month for the stock market. Only 23 stocks on the tech-heavy Nasdaq-100 index posted positive returns, leaving 76 tickers in negative territory for the month.
- 04/17/2025
|
1 Screaming Bargain Investors Can't Afford to Miss Out On During the Nasdaq Bear Market
- While many stocks have been affected by the marketwide sell-off, few stocks have had as much bad luck as The Trade Desk (TTD -1.60%). The Trade Desk has been hit by two sell-offs, the first being self-inflicted.
- 04/17/2025
|
Nasdaq 100: Apple's Tariff Win Fuels Rally—Can It Sustain Market Momentum?
- Apple's 2% jump on tariff relief lifted the Nasdaq 100, but with market fragility in focus, traders are watching to see if the rally has real staying power.
- 04/15/2025
|
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to three new employees. The awards were approved by Dyne's Compensation Committee and made as an inducement material to the new employees' acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/14/2025
|
S&P500 and Nasdaq 100: Apple Powers Tech Rebound, Stock Market Forecast Mixed
- US indices rebound as Apple, Dell, and Intel surge on tech tariff relief. Volatile market raises questions about sustainability.
- 04/14/2025
|
7 tech stocks to consider buying now, after the Nasdaq's slump
- Tech is one of the best places to look for bargain-priced stocks now, because the sector has been hit so hard. The worst of the tariff storm could be behind us.
- 04/14/2025
|
Intelligent Protection Management to Present at Centri Capital Conference
- At Nasdaq Marketsite in New York City on April 22 JERICHO, NEW YORK / ACCESS Newswire / April 14, 2025 / Intelligent Protection Management Corp. ("IPM," the "Company," "we," "our" or "us") (Nasdaq:IPM), a managed technology solutions provider focused on cybersecurity and cloud infrastructure, today announced their attendance and participation at the Centri Capital Conference at the Nasdaq Marketsite in New York City, New York on Tuesday, April 22, 2025 The conference will feature presentations from public and private companies across a variety of industry sectors. Jason Katz, Chairman and CEO of IPM, is scheduled to present at 10:00am ET and will be available for one-on-one meetings on Tuesday, April 22, to discuss IPM's managed technology solutions focused on cybersecurity and cloud infrastructure.
- 04/14/2025
|
Nasdaq set to lead further Wall Street rally, Apple climbs on tariff exemption, Goldman reports
- US stock indices are expected to continue rallying on Monday, where they left off last week, following the exemption from 'reciprocal' tariffs for smartphones and computers. Tech companies were predicted to lead the gains at the start of the week, with Nasdaq 100 futures rising 1.7%, followed by a 1.5% gain for S^P 500 futures and 1% for the Dow Jones.
- 04/14/2025
|
La Rosa Holdings Corp. Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
- Celebration, FL, April 14, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding company for six agent-centric, technology-integrated, cloud-based, multi-service real estate segments, today announced that it had received written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") that the Company is eligible for a 180-day extension to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule"). The Company now has until October 6, 2025 to meet the requirement. The notification has no immediate effect on the listing of the Company's common stock, and the common stock will continue to trade on the Nasdaq Capital Market under the symbol "LRHC."
- 04/14/2025
|
Nasdaq Bear Market: 3 Unstoppable Stocks You Can Buy With $300 Right Now
- Over the previous seven trading sessions -- i.e., since President Donald Trump announced his "Liberation Day" tariffs -- Wall Street has experienced some of the wildest volatility since the COVID-19 crash in February-March 2020.
- 04/14/2025
|
Nasdaq set to lead Dow, S&P 500 higher on tech tariff pause amid mixed signals
- Nasdaq-100 futures indicated tech stocks would lead U.S. stocks higher as a new week of trading got under way Sunday night, though investors noted confusion remained after mixed signals from the Trump administration over tariffs on smartphones and other consumer electronics.
- 04/13/2025
|
Nasdaq Bear Market: 2 No-Brainer Stocks to Buy Right Now
- Although the market rebounded sharply on Wednesday on news that President Trump was pausing tariffs and only levying a flat 10% rate, except for China, the Nasdaq is still in a bear market. Bear markets start when an index drops 20% from its all-time high and technically remain in bear market status until a new all-time high is reached, which then kicks off a bull market.
- 04/13/2025
|
Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades
- "May you live in interesting times."
- 04/12/2025
|
Hang Seng Tumbles on Trade War Jitters; Nasdaq Soars on Tariff U-Turn – Weekly Recap
- US-China trade war rattled Asian markets—Hang Seng plunged, ASX wobbled, but the Nikkei rallied as Tokyo escaped harsher tariffs.
- 04/11/2025
|
Foremost Clean Energy Receives Nasdaq Notification Regarding Minimum Bid Price Requirement
- VANCOUVER, British Columbia, April 11, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) announces that on April 7, 2025, it received a notification letter (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not currently in compliance with Nasdaq Listing Rule 5550(a)(2). This rule requires listed securities to maintain a minimum bid price of US$1.00 per share, and the Company's common shares have closed below this threshold for 31 consecutive business days from February 21, 2025, to April 4, 2025.
- 04/11/2025
|
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on April 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 31,100 shares of its common stock. These inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan and were granted as.
- 04/11/2025
|
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to its newly appointed Executive Director, Payer Access, Thomas J. Cella, and one other newly hired non-executive employee. The awards were made as inducements material to the individual's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/11/2025
|
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/11/2025
|
Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements
- Raanana, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that on April 8, 2025, the Company received a written notice from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the Company's closing bid price for its ordinary shares was below $1.00 per share for the last 30 consecutive business days.
- 04/11/2025
|
4DMT Announces New Employment Inducement Grants
- EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on April 8, 2025, the compensation committee of the Company's board of directors granted three new non-executive employees 16,500 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company's 2025 Employment Inducement Award Plan, which was approved by the Company's board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.
- 04/11/2025
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on April 3, 2025, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 172,637 shares of common stock and 64,791 restricted stock units (“RSUs”) to twenty-two new employees under Acadia's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees'.
- 04/11/2025
|
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on April 9, 2025, the compensation committee of BridgeBio's board of directors approved equity grants to 20 new employees in restricted stock units for an aggregate of 77,652 shares of the Company's common stock. One-fourth of the shares underlying each employee's restricted stock units will vest on May 16, 2026, with one-twelfth of the remaining shares underlying each such employee's restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee's continued employment with the Company or one of its subsidiaries on such vesting dates. All of the above-described awards were made under BridgeBio's Amended and Restated 2019 Inducement Equity Plan (the “Plan”).
- 04/11/2025
|
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases, today announced that on April 8, 2025, the company granted inducement awards to sixteen new employees. The grants were made pursuant to Nurix's 2024 Equity Inducement Plan as an inducement material to the employees' acceptance of employment with Nurix and were approved by the Compensation Committee of Nurix's Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/11/2025
|
Nasdaq Gains Over 50 Points; JPMorgan Posts Upbeat Earnings
- U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 50 points on Friday.
- 04/11/2025
|
Nasdaq Bear Market: Could Buying Nvidia Today Set You Up for Life?
- With the Nasdaq Composite in bear market territory, many stocks look like absolute bargains compared to their previous values. One of those stocks is Nvidia (NVDA 2.65%), which has been practically the No.
- 04/11/2025
|
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
- ATLANTA, April 11, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders, today announced that it has received written confirmation from Nasdaq that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders' equity of $2.5 million.
- 04/11/2025
|
Blink Charging Co. Regains Compliance with Nasdaq Periodic Filing Requirement
- Bowie, MD., April 11, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (Nasdaq: BLNK) (“Blink” or the “Company”), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, today announced that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), dated April 10, 2025, informing the Company that it has regained compliance with Nasdaq's periodic filing requirement under Nasdaq Listing Rule 5250(c)(1).
- 04/11/2025
|
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th
- DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ: PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025.
- 04/11/2025
|
Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
- TORONTO, April 11, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 386,700 shares of common stock at a purchase price of $4.06 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about April 14, 2025, subject to the satisfaction of customary closing conditions.
- 04/11/2025
|
Nasdaq Bear Market: Should You Buy ASML Stock Right Now?
- ASML (ASML -5.42%) navigates a worldwide supplier and distribution network, making it vulnerable to increasing trade barriers.
- 04/11/2025
|
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting of inducement awards on April 2, 2025 to 18 new employees under Pacira's Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee's entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the People & Compensation Committee of the Board of Directors (the “Committee”) without stockholder approval.
- 04/11/2025
|
If I Could Buy Only 1 Stock in This Nasdaq Bear Market, This Would Be It
- The stock market has taken investors on a roller coaster ride. Sharp up and down movements in the market follow the constant announcements from the Trump administration about tariffs, with the S&P 500 up over 10% on Wednesday and down 3.5% on Thursday.
- 04/11/2025
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 04/10/2025
|
Paranovus Entertainment Technology Limited Received Nasdaq Notification Letter Related to Late Filing of Form 6-K Reporting Interim Financial Information
- NEW YORK , April 10, 2025 /PRNewswire/ -- Paranovus Entertainment Technology Limited ("PAVS" or the "Company"), (NASDAQ: PAVS) announced today that it has received a letter from the Nasdaq Stock Market LLC ("Nasdaq"), dated April 9, 2025 (the "Deficiency Letter"), notifying the Company that it is not in compliance with the requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(2) because it did not timely file its Form 6-K (the "Filing") for the period ended September 30, 2024, reporting interim financial information for the six-month period there ended. In accordance with Nasdaq Listing Rules, the Company has 60 calendar days from the date of the Deficiency Letter to submit a plan to regain compliance with Nasdaq Listing Rules (the "Compliance Plan").
- 04/10/2025
|
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 124,950 shares of its common stock and granted an aggregate of 84,725 restricted stock unit (“RSU”) awards to 26 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/10/2025
|
S&P 500, Down Jones, Nasdaq All Down | Closing Bell
- Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Vonnie Quinn, Alix Steel, Scarlet Fu, Carol Massar and Tim Stenovec. -------- More on Bloomberg Television and Markets Like this video?
- 04/10/2025
|
Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
- TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 328,573 shares of common stock at a purchase price of $3.50 per share.
- 04/10/2025
|
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- DUBLIN, April 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to nine (9) new employees to purchase 48,400 ordinary shares under Avadel's 2021 Inducement Plan. The awards were granted as an inducement material to the employee's acceptance of employment with Avadel in accordance with Nasdaq Listing Rule 5635(c)(4). The options have a ten-year term and vest over four years, with 25% vesting on the one-year anniversary of each new employee's respective start date and 25% vesting on the second, third, and fourth anniversary thereafter. The options are subject to the terms and conditions of Avadel's 2021 Inducement Plan approved by the Board of Directors in November 2021 and the terms and conditions of award agreements covering the grants.
- 04/10/2025
|
Semiconductors Leading Nasdaq's Bounce-Back: ETFs in Focus
- Semiconductor stocks led the Nasdaq recovery on April 9.
- 04/10/2025
|
Nasdaq (NDAQ) Surges 8.4%: Is This an Indication of Further Gains?
- Nasdaq (NDAQ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 04/10/2025
|
CURRENC Group Inc. Regains Full Compliance with Nasdaq's Continued Listing Rule
- SINGAPORE, April 10, 2025 (GLOBE NEWSWIRE) -- CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced that on April 9, 2025, it received written notice from Nasdaq stating that the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) has determined that for at least the last ten consecutive business days, the Company's ordinary shares have maintained a minimum market value of publicly held shares (“MVPHS”) of $5,000,000 or greater, satisfying The Nasdaq Global Market's continued listing requirement set forth in Listing Rule 5450(b)(1)(C) (the “Rule”). Accordingly, the Company has regained compliance with the Rule, and this matter is now closed by Nasdaq.
- 04/10/2025
|
Nasdaq and S&P 500 to give back some of massive tariff reprieve rally gains
- A portion of the previous day's huge tariff reprieve rally on Wall Street is predicted to be trimmed on Thursday, with trade tensions between the US and China continuing to rumble. Dow Jones futures were pointing to a loss of around 460 points or 1.15%, while S&P 500 futures were showing a 1.6% deficit and those for the Nasdaq indicated a 1.95% drop.
- 04/10/2025
|
1 Nasdaq-100 Subscription-Based Business That Could Succeed Under the New Tariff Environment (Hint: I'm Not Talking About Netflix)
- The capital markets have been in turmoil since U.S. President Donald Trump announced his sweeping new tariff policies on April 2, declaring it "Liberation Day." Among some of the hardest-hit stocks over the last week are technology businesses -- many of which are now vulnerable to new tariffs.
- 04/10/2025
|
Nasdaq Bear Market: Why I'm Buying This High-Yielding Nasdaq ETF Hand Over Fist as the Market Sells Off
- At the time of this writing, the Nasdaq Composite index is experiencing a ferocious bear market, cratering nearly 25% from its peak late last year. The sell-off has intensified recently due to growing concerns about how the Trump administration's "reciprocal tariff" policies will affect the global economy.
- 04/10/2025
|
These 2 Insiders Bought Millions in Stock of Their AI-Focused Companies As the Nasdaq Plunged Into a Bear Market -- and Each Has a Strong Track Record of Timing Such Buys
- Amid big downdrafts in stocks, it's always interesting to see if company insiders are buying the dip.
- 04/10/2025
|
Nasdaq Bear Market: Buy the Dip on This "Magnificent Seven" Stock That's Down 29%
- The Nasdaq-100 and Nasdaq Composite indexes have officially entered bear market territory, down by more than 20% from their all-time highs. Many of their component stocks are down even more than that, including technology giant Alphabet (GOOG 10.08%), which is trading 29% below its peak as of this writing.
- 04/10/2025
|
Tianci International, Inc. Announces Nasdaq Uplisting and Pricing of $7 Million Public Offering
- HONG KONG and RENO, Nev., April 09, 2025 (GLOBE NEWSWIRE) -- Tianci International, Inc. (the "Company” or “Tianci”), a global logistics service provider specializing in ocean freight forwarding, today announced the pricing of its public offering (the “Offering”) of an aggregate of 1,750,000 shares of common stock at a public offering price of US$4.00 per share, for total gross proceeds of $7,000,000, before deducting underwriting discounts, commissions, and other related expenses. The shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on April 10, 2025, under the ticker symbol “CIIT.”
- 04/09/2025
|
Primis Financial Corp. Receives Nasdaq Notice Regarding Delayed 10-K Filing
- MCLEAN, Va. , April 9, 2025 /PRNewswire/ -- Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") announced today that, as expected, it received a notice on April 3, 2025 (the "Notice") from Nasdaq indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires listed companies to timely file all periodic reports with the Securities and Exchange Commission (the "SEC"), as it has failed to timely file its Form 10-K for the period ending December 31, 2024 (the "Form 10-K"), which the Company previously disclosed on Form 12b-25, as filed with the SEC on April 1, 2025, as amended.
- 04/09/2025
|
Venus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
- TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 328,573 shares of common stock at a purchase price of $3.50 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about April 10, 2025, subject to the satisfaction of customary closing conditions.
- 04/09/2025
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on April 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 211,250 shares of Class A common stock and restricted stock units (RSUs) for 105,125 shares of Class A common stock to sixteen (16) new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/09/2025
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 31, 2025
- NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of March 31, 2025, short interest in 3,140 Nasdaq Global MarketSM securities totaled 13,072,444,217 shares compared with 13,066,514,117 shares in 3,124 Global Market issues reported for the prior settlement date of March 14, 2025. The mid-March short interest represents 2.64 days compared with 2.14 days for the prior reporting period.
- 04/09/2025
|
1 "Magnificent Seven" Stock to Buy Hand Over Fist in the Nasdaq Bear Market
- As of market close on April 7, the Nasdaq Composite has fallen by 19% so far this year, falling further into bear market territory.
- 04/09/2025
|
Nasdaq Index: Forecast for US Stocks Improves as Tech Rebounds, Dollar Weakens
- Tech stocks rebound, lifting US indices mid-session, while tariffs drive bond selloff and weaken the dollar. Traders eye earnings and Treasury auctions.
- 04/09/2025
|
Here's 1 Nasdaq ETF to Consider Even as the Index Enters Into a Bear Market
- Well, it's official: The Nasdaq Composite has entered bear territory. A bear market occurs when a major index drops over 20% from recent highs, and that's precisely what has happened with the Nasdaq Composite, which is down around 24% from its Dec. 16 high.
- 04/09/2025
|
Nasdaq Composite Futures Sink After China Retaliates: Apple Magnificent 7 Stocks Drop
- One expectation for this earnings season is that you'll see many companies pull guidance amidst tariff uncertainty.
- 04/09/2025
|
Edible Garden Regains Compliance with Nasdaq Bid Price Requirement
- BELVIDERE, NJ, April 09, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that on April 8, 2025, it received formal notice from Nasdaq that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”), as required by the decision of the Nasdaq Hearings Panel (the “Panel”) dated February 12, 2025. Additionally, pursuant to the notice, the Company will be subject to a Panel Monitor, as defined by Nasdaq Listing Rule 5815(d)(4)(A), through April 8, 2026.
- 04/09/2025
|
Nasdaq Bear Market: 2 Artificial Intelligence (AI) Stocks to Confidently Buy With $650
- The Nasdaq Composite (^IXIC -2.15%) includes almost every company listed on the Nasdaq stock exchange, so it's often a good proxy for the performance of the broader technology industry. As of the close on Friday, April 5, the index was down by 22% from its all-time high, which officially places it in a bear market.
- 04/09/2025
|
The Nasdaq Plunged 10% While Palantir Soared In Q1. Here's Why.
- The market saw red for much of the first quarter of 2025. Shares of Palantir Technologies (PLTR -0.62%), however, bucked the trend.
- 04/08/2025
|
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective April 7, 2025, to one non-executive employee of non-qualified stock option.
- 04/08/2025
|
Blink Charging Co. Announces Notification from Nasdaq regarding late filing of Form 10-K
- Bowie, MD., April 08, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, announced today it received a letter from the Nasdaq Stock Market LLC (“Nasdaq”), dated April 2, 2025, informing the Company that it no longer complies with Nasdaq Listing Rule 5250(c)(1) because Blink had not filed its Form 10-K for the year ended December 31, 2024 (the “Form 10-K”) by the time period prescribed by Securities and Exchange Commission rules.
- 04/08/2025
|
Josh Brown Called the Nasdaq a “Meat Grinder” But These 3 Tech Stocks Are Surefire Winners
- Wealth manager Josh Brown issued a stark warning about volatile technology stocks.
- 04/08/2025
|
Nasdaq 100: Apple Slide Pressures Tech Stocks as Financials Lift US Indices
- Apple's decline pressures Nasdaq 100; tech rally stalls. Financials lead gains as traders weigh tariff news and prep for key earnings releases.
- 04/08/2025
|
5 Stocks in Nasdaq ETF Fueling Index's Big Comeback Since 2008
- Nasdaq witnesses its largest intraday comeback since Oct. 10, 2008. We highlight five stocks at the forefront of the rebound.
- 04/08/2025
|
Nasdaq (NDAQ) Upgraded to Buy: What Does It Mean for the Stock?
- Nasdaq (NDAQ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 04/08/2025
|
Nasdaq Bear Market: Should You Buy Meta Platforms Stock on the Dip?
- Meta Platforms' (META 2.30%) stock price has been beaten down even more severely than the broader market over the past few weeks. The stock is down nearly 30% from the all-time high it reached in February, while the S&P 500 is off by almost 18%, and the Nasdaq Composite is down almost 23%, firmly in bear market territory.
- 04/08/2025
|
Nasdaq Bear Market: I Just Bought Nvidia Stock
- The Nasdaq bear market created an opportunity for me to buy Nvidia (NVDA 3.38%) stock at what I feel is a bargain price.
- 04/08/2025
|
1 Undervalued Growth Stock You Can Buy Now During the Tariff-Induced Nasdaq Bear Market
- This company is unlikely to be directly impacted by the worldwide tariffs implemented by President Donald Trump.
- 04/08/2025
|
Nasdaq Sell-Off: 2 Solid Artificial Intelligence (AI) Stocks to Buy Hand Over Fist Before They Soar 70% to 85%, According to Wall Street
- Technology stocks have taken a big beating in recent months as the Trump administration's policies have led investors to press the panic button amid concerns that the tariff-fueled global trade war could hurt the U.S. economy and may even send it into a recession.
- 04/08/2025
|
European Wax Center, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PLANO, Texas, April 07, 2025 (GLOBE NEWSWIRE) -- European Wax Center, Inc. (NASDAQ: EWCZ) (the “Company” or “European Wax Center”), the leading franchisor and operator of out-of-home waxing services in the United States, announced that effective as of April 7, 2025, and in connection with the previously announced appointment of Thomas Kim as the Company's Chief Financial Officer, the Company's Board of Directors approved grants of (i) restricted stock units (“RSUs”) covering 200,000 shares of the Company's Class A common stock (the “Kim RSUs”), (ii) non-qualified stock option awards to purchase 310,000 shares of the Company's Class A common stock with an exercise price of $3.51, which is equal to the closing price of the Company's Class A common stock on the Nasdaq Stock Market on April 7, 2025, (iii) non-qualified stock option awards to purchase 212,500 shares of the Company's Class A common stock with an exercise price of $9.00, and (iv) non-qualified stock option awards to purchase 212,500 shares of the Company's Class A common stock with an exercise price of $12.00 ((ii), (iii) and (iv) collectively, the “Kim Options”).
- 04/07/2025
|
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis (“OA”) Pain Management and Regenerative Solutions space focused on early intervention orthopedics, today announced that on April 1, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 3,800 shares of common stock at a per share exercise price of $15.03, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation.
- 04/07/2025
|
Nasdaq Reports March 2025 Volumes and 1Q25 Statistics
- NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for March 2025, as well as quarterly volumes, estimated revenue capture, number of listings, and index statistics for the quarter ended March 31, 2025, on its Investor Relations website.
- 04/07/2025
|
NDAQ Stock Trades Below 50-Day SMA: What Should You Do Now?
- NDAQ is set to grow on its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
- 04/07/2025
|
Nasdaq in Bear Market: Buy the Dip in ETFs?
- President Donald Trump introduced and enacted a two-step tariff strategy on April 2, marking the beginning of his 'Liberation Day' plans. A baseline tariff of 10% was imposed on imports from various countries starting April 5 (read: 6 Trade-Resilient ETFs for Investors).
- 04/07/2025
|
S&P 500 and Nasdaq 100: Apple Crashes, VIX Soars—Is the Tech Selloff Signaling a Deeper Slide?
- S&P 500 and Nasdaq 100 drop sharply as Apple tanks and volatility surges. Traders weigh recession risks and Fed cuts.
- 04/07/2025
|
The Market's Tariff Tumble: 2 Stocks to Buy During This Nasdaq Correction
- The stock market is going through a major correction. As of market close on Friday, April 4, the Nasdaq 100 Index is actually down 21.6% from all-time highs, which means it has officially entered a bear market.
- 04/07/2025
|
SuRo Capital Corp. First Quarter 2025 Preliminary Investment Portfolio Update
- SuRo Capital Portfolio Investment CoreWeave Completes Largest Tech IPO Since 2021 SuRo Capital Portfolio Investment OpenAI Closes Largest Venture Raise with $300 Billion Valuation Net Asset Value Anticipated to be $6.50 to $7.00 Per Share NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS ) today provided the following preliminary update on its investment portfolio for the first quarter ended March 31, 2025. “The past few months have been marked by some of the most volatile market conditions since the onset of COVID-19, culminating in the Nasdaq's worst quarter since 2022, and its worst week since 2020.
- 04/07/2025
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that on April 1, 2025, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 140,000 shares of the Company's common stock to three (3) newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/01/2025
|
Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market
- CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it has given formal notice to the Nasdaq Stock Market of its intention to voluntarily delist its common stock from the Nasdaq Capital Market.
- 04/01/2025
|
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in connection with the appointment of Steven Basta as President and Chief Executive Officer, the Company's Board of Directors has approved the grant of inducement awards.
- 04/01/2025
|
Brera Holdings Regains Compliance with Nasdaq Listing Rule 5620(a)
- Dublin, Ireland, April 01, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland-based, Nasdaq-listed, international holding company focused on expanding its global portfolio of men's and women's sports clubs through a multi-club ownership (“MCO”) approach, today announced that on March 31, 2025, the Company received formal notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) that, as a result of holding its annual meeting on March 28, 2025, the Company is now in compliance with the annual meeting requirement set forth in Nasdaq Listing Rule 5620(a) (the “Annual Meeting Rule”). The Company had received notice of non-compliance with the Annual Meeting Rule on February 3, 2025. Nasdaq has now closed the matter.
- 04/01/2025
|
Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules
- SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / April 1, 2025 / Jaguar Health, Inc. ( NASDAQ:JAGX ) ("Jaguar" or "the Company"), today announced the closing of its previously announced private placement. Jaguar's president and chief executive officer Lisa Conte, as well as other members of the Company's board of directors and other C-suite and senior executives of Jaguar along with selected institutional and accredited investors (each, an "Investor") entered into securities purchase agreements in connection with this private placement, pursuant to which the Company issued approximately $3.448 million aggregate principal amount of convertible promissory notes (collectively, the "Notes") to such Investors in a private placement priced at-the-market under Nasdaq rules.
- 04/01/2025
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , April 1, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 1,850 restricted stock units (RSUs) to two newly-hired employees.
- 04/01/2025
|
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on March 23, 2025, the compensation committee of Biomea's board of directors granted two new employees non-qualified stock options to purchase an aggregate of 30,000 shares of the Company's common stock. The shares underlying each employee's stock options will vest 1/16 on a quarterly basis over four years, in each case subject to each such employee's continued employment with the Company on such vesting dates. All of the above-described awards were made under Biomea's 2023 Inducement Equity Plan (the “Plan”).
- 04/01/2025
|
S&P, Nasdaq rise as investors await US tariff clarity; Johnson & Johnson slips, PVV Corp jumps
- The S&P 500 experienced volatility on Tuesday and was in the green. Investors were awaiting clarity from US President Donald Trump regarding tariff policy, and weaker-than-expected economic data also put pressure on Wall Street.
- 04/01/2025
|
US Indices Forecast for Q2 2025 – S&P 500, Nasdaq and Dow Dips Are a Buy Opportunity
- US Indices continued to see selling pressures in Q1 due to tariff threats, geopolitical concerns, and fear of a US recession. However, Q2 could very well see a rebound if history tells us anything.
- 04/01/2025
|
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CHARLESTOWN, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 43,374 restricted stock units (“RSUs”) to three newly hired employees.
- 04/01/2025
|
GD Culture Group Limited Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
- NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- GD Culture Group Limited (“GDC” or the “Company”) (Nasdaq: GDC), and its subsidiary, AI Catalysis Corp. (“AI Catalysis”), today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") dated March 20, 2025, notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) requires companies on the Nasdaq Capital Market to maintain a minimum of $2.5 million in stockholders' equity for continued listing, however, based on the Company's Form 10-K for the fiscal year ended December 31, 2024, dated March 18, 2025, the Company reported stockholders' equity of $2,643.
- 04/01/2025
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, April 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 04/01/2025
|
Siddhi Acquisition Corp. Announces Pricing of Upsized $240 Million Initial Public Offering
- NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Siddhi Acquisition Corp. (“Siddhi Acquisition” or the “Company”) announced today that it priced its upsized initial public offering of 24,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “SDHIU” beginning April 1, 2025. Each unit consists of one Class A ordinary share and one right entitling the holder thereof to receive one tenth of one Class A ordinary share upon the consummation of an initial business combination. The Class A ordinary shares and rights comprising the units are expected to begin separate trading no later than the 52nd day following this date. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on Nasdaq under the symbols “SDHI” and “SDHIR”, respectively.
- 03/31/2025
|
1 High-Tech ETF Down 25% You Can Buy Right Now
- Thanks to a combination of factors, such as weak economic data, tariff concerns, higher-than-expected inflation, and fears about AI capital expenditures, the stock market has been beaten down in recent months. And while the overall market has taken a hit, the tech-heavy Nasdaq has been the worst performer of the major indices, with the Nasdaq Composite nearly 15% below its recent high.
- 03/31/2025
|
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 31, 2025 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta's 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 39 individuals hired by Sarepta in the first quarter of 2025. The equity awards were approved in accordance with Nasdaq Listing Rule.
- 03/31/2025
|
Energys Group Announces Pricing of $10.125 Million Initial Public Offering and Nasdaq Listing
- UNITED KINGDOM, March 31, 2025 (GLOBE NEWSWIRE) -- Energys Group Limited (NASDAQ: ENGS) (“Energys Group” or the “Company”), a vertically integrated energy efficiency and decarbonization solutions provider for the build environment, today announced the pricing of its initial public offering (the “Offering”) of 2,250,000 ordinary shares (the “Ordinary Shares”) at a public offering price of US$4.50 per Ordinary Share, for total gross proceeds of US$10,125,000 before deducting underwriting discounts and other offering expenses.
- 03/31/2025
|
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on March 31, 2025. Two individuals were hired by Adicet in March 2025. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 38,600 shares of Adicet's common stock with an exercise price of $0.76 per sh.
- 03/31/2025
|
European Wax Center, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PLANO, Texas, March 31, 2025 (GLOBE NEWSWIRE) -- European Wax Center, Inc. (NASDAQ: EWCZ) (the “Company” or “European Wax Center”), the leading franchisor and operator of out-of-home waxing services in the United States, announced that effective as of March 31, 2025, the Company's Board of Directors approved grants of (i) restricted stock units covering 84,000 shares of the Company's Class A common stock (the “RSUs”), (ii) non-qualified stock option awards to purchase 130,000 shares of the Company's Class A common stock with an exercise price of $3.95, which is equal to the closing price of the Company's Class A common stock on the Nasdaq Stock Market on March 31, 2025, (iii) non-qualified stock option awards to purchase 95,000 shares of the Company's Class A common stock with an exercise price of $9.00, and (iv) non-qualified stock option awards to purchase 95,000 shares of the Company's Class A common stock with an exercise price of $12.00 ((ii), (iii) and (iv) collectively, the “Options”) to one new employee.
- 03/31/2025
|
Nasdaq 100: Tech Selloff Intensifies on Nvidia Plunge While Defensive US Stocks Find Support
- US indices retreat on tariff worries as VIX jumps to 22.44. Nvidia drops 3.9%, Microsoft falls 2.2%, while defensive sectors provide limited market support.
- 03/31/2025
|
Live Nasdaq Composite: ORLY, AZO Gain in Face of Unrelenting Tariffs
- The stock market continues to suffer on tariff-related uncertainty but the major indexes are off their worst levels of the morning.
- 03/31/2025
|
Nasdaq Sell-Off: 3 Stocks to Buy That Billionaire Money Managers Also Love
- News flash: stocks can go down just as easily as they can climb. Every now and then, investors are given a wake-up call that the stock market wouldn't be a "market" without the ability for equities to move in both directions.
- 03/18/2025
|
Beat the Nasdaq With This Cash-Gushing Dividend Stock
- If you're looking for market-beating stocks, it can sometimes be good to travel a bit off the beaten path to find more unusual options. Innovative Industrial Properties (IIPR -7.61%) offers just such an option.
- 03/18/2025
|
Nasdaq and nuam Strengthen Technology Partnership to Drive Capital Market Integration in Latin America
- NEW YORK AND SANTIAGO, March 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) and nuam (NUAM: nuam), the merger of Santiago, Lima, and Colombia stock exchanges, today announced an extension of their strategic technology partnership, which will see all three exchanges' central securities depositories (CSD) adopt Nasdaq's CSD platform to optimize post-trade processing in the region. The agreement expands Nasdaq's existing relationship with nuam, with the exchanges currently consolidating their trading infrastructures on Nasdaq's platform to help attract global sources of liquidity.
- 03/18/2025
|
District Receives Exemptive Relief from Canadian Securities Regulators in Connection with Listing on the Nasdaq First North Growth Market in Sweden
- Vancouver, British Columbia--(Newsfile Corp. - March 18, 2025) - District Metals Corp. (TSXV: DMX) (Nasdaq First North: DMXSE SDB) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company") is pleased to report that the previously announced application for exemptive relief from the applicable Canadian securities regulators has been reviewed, and an order granting exemptive relief effective March 14, 2025, has been granted to the Company (the "Decision"). The Decision provides the Company with exemptive relief to continue to be a "venture issuer" for the purposes of Canadian securities laws, despite the listing of its depositary receipts on the Nasdaq First North Growth Market.
- 03/18/2025
|
Heramba Electric plc Announces Receipt of Notice from Nasdaq Regarding the Minimum Bid Price Requirement
- DUSSELDORF, GERMANY AND ATLANTA, GA / ACCESS Newswire / March 17, 2025 / As previously disclosed, and pursuant to the terms and conditions set forth in the Share Purchase Agreement, dated as of July 25 and 26, 2023, by and among Heramba GmbH ("Heramba"), Heramba Holdings, Inc. ("Heramba Holdings"), Knorr-Bremse Systeme für Schienenfahrzeuge GmbH ("KB GmbH") and Knorr-Brake Holding Corporation ("KB US"), as amended pursuant to the Amendment Agreement to Share Purchase Agreement, dated as of January 31, 2024, on February 6, 2024, (i) KB GmbH, as sole shareholder of Kiepe Electric GmbH, sold and transferred 85% of the equity interests in Kiepe GmbH, as well as certain receivables and shareholder loans, to Heramba, and (ii) KB US, as the sole member of Kiepe Electric LLC ("Kiepe US" and together with Kiepe GmbH, "Kiepe"), sold and transferred all ownership interests in Kiepe US, as well as certain receivables, to Heramba Holdings. As previously disclosed, and pursuant to the terms and conditions set forth in the Business Combination Agreement, dated as of October 2, 2023, by and among Project Energy Reimagined Acquisition Corp., Heramba Electric plc, Heramba Merger Corp., Heramba Limited and Heramba, effective as of July 26, 2024, the business combination contemplated by the Business Combination Agreement was consummated resulting in, among other matters, each of Heramba, Heramba Holdings, Kiepe GmbH and Kiepe US becoming direct or indirect subsidiaries of the Company.
- 03/17/2025
|
Moolec Received Nasdaq Staff Determination Letter
- LUXEMBOURG, LU / ACCESS Newswire / March 17, 2025 / Moolec Science SA (NASDAQ:MLEC), a public limited liability company (société anonyme) governed by the laws of the Grand Duchy of Luxembourg, having its registered office at 17, Boulevard F.W. Raiffeisen, L-2411 Luxembourg, Grand Duchy of Luxembourg, and registered with the Luxembourg Register of Commerce and Companies (Registre de Commerce et des Sociétés de Luxembourg) under registration number B268440 ("Moolec," the "Company," "we," "us" or "our") received a letter on March 11, 2025 (the "Determination Letter"), from the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, as the closing bid price of its listed securities has remained at less than $1.00 per share over 30 consecutive business days as of September 10, 2024, and has not increased to $1.00 for more than 10 consecutive business days thereafter, the Company has not regained compliance with Nasdaq Listing Rule 5550(a)(2).
- 03/17/2025
|
ConnectM Requests Nasdaq Hearing for Continued Listing
- MARLBOROUGH, Mass. , March 17, 2025 /PRNewswire/ -- ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) ("ConnectM" or the "Company"), a high-growth technology company on the leading edge of the electrification economy, today announced The Nasdaq Stock Market LLC ("Nasdaq") granted the Company's request for a hearing before a Nasdaq Hearings Panel (the "Panel").
- 03/17/2025
|
Trump Tariffs and the Nasdaq Correction Have Been No Match for These Stock Market Sectors
- The S&P 500 (SNPINDEX: ^GSPC) is cooling off after rip-roaring gains of over 20% in both 2023 and 2024.
- 03/17/2025
|
Live Nasdaq Composite: INTC Climbs 7 Percent, PEP's Merger Monday
- After starting with gains across the board, the markets have turned mixed, with the Nasdaq Composite lagging the Dow Jones Industrial Average and S&P 500.
- 03/17/2025
|
Millicom (Tigo) share repurchase activity
- Millicom (Tigo) share repurchase activity Luxembourg, March 17, 2025 - Pursuant to the share repurchase program announced on November 29, 2024, Millicom repurchased 315,930 of its Swedish Depository Receipts (SDRs) and 736,800 of its common shares between March 10, 2025, and March 14, 2025, as detailed in the table below. Exchange Nasdaq Stockholm Nasdaq Stock Market Trade Date Number of SDRs repurchased Average price paid* (SEK) Repurchase amount* (SEK) Number of shares repurchased Average price paid* (USD) Repurchase amount* (USD) 2025-03-10 103 000 295.3982 30 426 015 161 700 29.1766 4 717 856 2025-03-11 102 930 301.0125 30 983 217 161 700 29.6205 4 789 635 2025-03-12 110 000 297.8792 32 766 712 161 700 29.8143 4 820 972 2025-03-13 161 700 29.6426 4 793 208 2025-03-14 90 000 30.2072 2 718 648 * Excluding commissions All purchases were carried out on Nasdaq Stockholm and on the Nasdaq Stock Market by Citigroup Global Markets Limited and Citigroup Global Markets Inc. respectively, on behalf of Millicom.
- 03/17/2025
|
SaverOne Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Petah Tikvah, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), today announced that it received formal written confirmation from The Nasdaq Stock Market, LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq's minimum bid price requirement. The regaining of compliance is a result of the Company's closing bid price of the Company's American Depository Shares (ADS) being at least $1.00 for at least the preceding 10 consecutive business days.
- 03/17/2025
|
Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
- SAN DIEGO and TORONTO, March 17, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), today announced that it received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it is in compliance with Nasdaq's minimum bid price requirement. On March 14, 2025, Nasdaq confirmed that, for ten consecutive business days, the closing bid price of the Company's common shares has been $1.00 per share or greater.
- 03/17/2025
|
Digi Power X Announces Nasdaq Ticker Symbol Change to DGXX
- MIAMI, March 17, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGHI, DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge data centers, is pleased to announce the Company's stock ticker symbol on the Nasdaq Stock Exchange (the “NASDAQ”) will change from “DGHI” to “DGXX” effective as of market open on Tuesday, March 18, 2025.
- 03/17/2025
|
Nasdaq Sell-Off: Buy This Unstoppable Stock at a Discount
- After remarkable performances in 2023 and 2024, the Nasdaq Composite seems to have hit a roadblock in 2025. The technology-heavy index closed at 17,436.10 on March 11, or 13.6% below its all-time high of 20,173.89 on Dec. 16 last year.
- 03/17/2025
|
Opinion: Billionaire Stanley Druckenmiller, After Dropping This AI Giant Last Year, Could Be Coming Back to It During the Nasdaq Correction
- With the S&P 500 and Nasdaq in correction territory, you may not be feeling very optimistic about investing. But now is actually an excellent time to buy stocks because many of yesterday's highfliers are today's dirt cheap deals.
- 03/16/2025
|
Got $1,000? 1 Underrated Artificial Intelligence Stock to Buy During the Nasdaq's Latest Correction
- Less than three months ago, the Nasdaq Composite hit an all-time high, continuing a solid run that began two years ago. Since that mark, the index is down over 13%, including a 9% drop this year, and is in correction mode (as of March 11).
- 03/16/2025
|
2 No-Brainer Hypergrowth Stocks to Buy During This Nasdaq Market Correction
- Bear markets can happen quickly. One day, the stock market is trading at all-time highs, and the next thing you know, your portfolio is in a 20% drawdown.
- 03/16/2025
|
These 3 Artificial Intelligence (AI) Chip Stocks Tumbled During the Nasdaq Sell-Off, Losing $1.16 Trillion in Market Cap. Here's the 1 Worth Buying Right Now.
- It's been a long time since investors have had to face the reality that stock prices can, indeed, decline. You have to go back all the way to Oct. 2023 to find the last time one of the major stock indexes fell more than 10% from its all-time high, marking what's known as a correction.
- 03/16/2025
|
Nasdaq Sell-Off: 2 AI Stocks That Are on Sale in 2025
- The Nasdaq Composite has had a dream run in the past two years, buoyed by declining inflation, interest rate cuts, and a solid artificial intelligence (AI) boom. However, that momentum seems lost now, considering the tech-heavy index has declined about 10% in 2025.
- 03/15/2025
|
Nasdaq Correction: 2 "Magnificent Seven" Stocks Down 19% and 21% You'll Regret Not Buying on the Dip
- The Nasdaq-100 is made up of 100 of the largest nonfinancial companies listed on the Nasdaq stock exchange. It has delivered a return of 343% over the past decade, doubling the gain of the more diversified S&P 500 thanks to its high concentration of the world's largest tech stocks.
- 03/15/2025
|
1 Spectacular Tech Stock Down 42% to Buy Hand Over Fist During the Nasdaq Sell-Off
- With the Nasdaq Composite (^IXIC 2.61%) down roughly 12% from its highs, many tech-related stocks have sold off heavily.
- 03/15/2025
|
3 Stocks on Sale in the Nasdaq Correction
- The stock market recently dipped into correction territory, which is defined as a decline of 10% to 20% from its recent peak. At the time of this writing, the Nasdaq Composite is down 9% year-to-date.
- 03/15/2025
|
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement
- DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice today from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), requiring that listed securities maintain a minimum bid price of US $1.00 per share, based on the closing bid price of the Company's American depositary shares (“ADSs”) for the last 30 consecutive business days. The Company also received notice today that the Company no longer meets the requirement in Nasdaq Listing Rule 5450(b) that listed securities maintain a minimum market value of publicly held shares (“MVPHS”) of US $15,000,000, based on Nasdaq's review of the Company's MVPHS for the last 30 consecutive business days.
- 03/14/2025
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 122,650 shares of common stock. Awards were made to 12 new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committee.
- 03/14/2025
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 113,800 shares of its common stock to seven newly hired employees, consisting of inducement stock options to p.
- 03/14/2025
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on March 5, 2025, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 71,981 shares of common stock and 42,159 restricted stock units (“RSUs”) to thirteen new employees under Acadia's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' em.
- 03/14/2025
|
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company's Compensation Committee, as material inducements to six individuals whose employment commenced in January and February of 2025. The grants resulted in the right to purchase 264,000 shares of the Company'.
- 03/14/2025
|
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, March 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases, today announced that on March 11, 2025, the company granted inducement awards to thirteen new employees. The grants were made pursuant to Nurix's 2024 Equity Inducement Plan as an inducement material to the employees' acceptance of employment with Nurix and were approved by the Compensation Committee of Nurix's Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4).
- 03/14/2025
|
The Nasdaq Just Hit Correction Territory: Buy This Unstoppable Stock at a Discount
- Down over 13% from its all-time high (achieved in December), the Nasdaq Composite is officially in a correction, which is defined as a drawdown of at least 10%.
- 03/14/2025
|
This Chip Company Is a No-Brainer Dividend Stock to Buy on the Nasdaq Correction
- The tech sector has been getting hammered so far this year, down 10.5% at the time of this writing, which is slightly worse than the Nasdaq Composite. The Nasdaq is in a correction -- down over 13% from its all-time high at the time of this writing.
- 03/14/2025
|
Nasdaq 100: Nvidia Jumps 4%, Tesla Gains— But Is the Tech Sector Out of Trouble?
- Nasdaq 100 rebounds as Nvidia jumps 4% and Tesla gains. Can tech stocks sustain momentum, or is more volatility ahead?
- 03/14/2025
|
Nasdaq leads early rebound, S&P 500 attempts recovery after entering correction territory
- 10:05am: Markets bounce back Stocks are rallying in early trading on Friday as markets attempt to rebound from a tumultuous week that saw the S&P 500 enter correction territory. Just after the open, the Dow Jones is up 260 points or 0.6%, trading at 41,073.
- 03/14/2025
|
Live Nasdaq Composite: TSLA, NVDA and PLTR Rise
- After a bright start to the last trading day of the week, inflation threatened to spoil the party.
- 03/14/2025
|
How to Extract Income From the Nasdaq-100 Index
- The Nasdaq-100 Index (NDX) is known for a lot of things — lengthy outperformance of the S&P 500 among them — but income isn't part of that list. Just look at the Invesco QQQ Trust (QQQ) and the Invesco NASDAQ 100 ETF (QQQM), both of which follow the NDX.
- 03/14/2025
|
Nasdaq Surges 1.5%; Ulta Beauty Posts Upbeat Results
- U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 1.5% on Friday.
- 03/14/2025
|
Nasdaq Hearings Panel Extends HUB Cyber Security's Bid Price Compliance Deadline to April 14, 2025, Following Review of HUB's Developments
- TEL AVIV, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and advanced secured data fabric technology, announced that it has received a 14-day extension from the Nasdaq Hearings Panel (the “Panel”) to evidence compliance with the minimum bid price requirement. The Company now has through April 14, 2025, to achieve 10 consecutive trading days of at least $1 per share.
- 03/14/2025
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that on March 3, 2025, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 50,000 shares of the Company's common stock and 25,000 restricted stock units to one newly hired employee. The stock options and restricted stock units were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 03/03/2025
|
Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
- RESEARCH TRIANGLE PARK, N.C. , March 3, 2025 /PRNewswire/ -- Charles & Colvard, Ltd.
- 03/03/2025
|
Meiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
- Shenzhen, China, March 03, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited (“WNW” or the “Company”), (NASDAQ: WNW) announced today that on February 27, 2025, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).
- 03/03/2025
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , March 3, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 3,316 restricted stock units (RSUs) to five newly-hired employees.
- 03/03/2025
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on February 28, 2025, the company granted equity awards to four new employees, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 03/03/2025
|
NewHold Investment Corp III Announces Closing of $201,250,000 Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option
- New York, New York, March 03, 2025 (GLOBE NEWSWIRE) -- NewHold Investment Corp III (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial public offering of 20,125,000 units at an offering price of $10.00 per unit. This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 2,625,000 units. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are listed on the Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “NHICU”. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “NHIC” and “NHICW,” respectively.
- 03/03/2025
|
Nasdaq Appoints Brandis DeSimone as New Head of East Coast Listings
- The appointment strengthens Nasdaq's commitment to supporting companies throughout their corporate lifecycle
- 03/03/2025
|
Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq Rules
- BOSTON and LONDON, March 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody drug conjugates (ADCs) for the treatment of cancer, today announced the successful pricing of a private placement financing round. This transaction is expected to raise an aggregate of approximately $7.6 million in gross proceeds.
- 03/03/2025
|
Nasdaq to power Wall Street ahead as March trading begins, bitcoin up on Trump reserve order
- US stock indexes are tipped to head higher on the first trading day of March, led by the tech-powered Nasdaq. S&P 500 futures pointed to a 0.5% rise, with Nasdaq 100 futures rising 0.7% and those for the Dow Jones up 0.35%.
- 03/03/2025
|
Nasdaq Stockholm approved the delisting of Millicom (Tigo) SDRs and set the last day of trading on March 17, 2025
- Nasdaq Stockholm approved the delisting of Millicom (Tigo) SDRs and set the last day of trading on March 17, 2025 Luxembourg, March 3, 2025 – Millicom International Cellular S.A. (“Millicom” or the “Company”), today formally applied for delisting of its Swedish Depository Receipts (“SDRs”) from Nasdaq Stockholm.
- 03/03/2025
|
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on March 3, 2025, the compensation committee of Biomea's board of directors granted one new employee non-qualified stock options to purchase an aggregate of 25,000 shares of the Company's common stock. The shares underlying the employee's stock options will vest 1/16 on a quarterly basis over four years, subject to the employee's continued employment with the Company on such vesting dates. The above-described award was made under Biomea's 2023 Inducement Equity Plan (the “Plan”).
- 03/03/2025
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, March 03, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 03/03/2025
|
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025
- BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (Neuphoria or Company), ”), a clinical-stage biotechnology developing impactful treatments for neuropsychiatric disorders, bringing new hope and tangible improvements to patients' lives, announced today that it will ring the Opening Bell at the Nasdaq MarketSite in Times Square, New York City on Monday, March 3rd, 2025.
- 03/03/2025
|
Wall Street legend says US stocks are in a bubble: 3 Nasdaq 100 shares to sell
- The Nasdaq 100 index surged to a record high of $22,220 in February and then suffered a harsh reversal to a low of $20,500 last week. This retreat happened as concerns about Donald Trump's tariffs and after NVIDIA published mixed financial results.
- 03/03/2025
|
Nasdaq Jumps 300 Points As Nvidia, Tesla Stocks Surge: Investor Sentiment Improves, But Greed Index Remains In 'Extreme Fear' Zone
- The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Extreme Fear” zone on Friday.
- 03/02/2025
|
3 Tech Stocks I'm Buying if the Nasdaq Enters a Correction
- Feb. 27 was a brutal day for tech stocks.
- 03/02/2025
|
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 11, 2025, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units (“RSUs”) representing 110,681 shares of its common stock to 102 new non-executive employees and one non-qualified stock option award to purchase 22,091 shares of its common stock to one new non-executive employee with a grant date of Febr.
- 02/28/2025
|
Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) (the “Company”) today announced that its Board of Directors (the “Board”) has approved and the Company intends to proceed with the voluntary delisting of its common stock from the Nasdaq Stock Market (“Nasdaq”) and the deregistration of its common stock in order to terminate and suspend the Company's reporting obligations under the Securities and Exchange Act of 1934, as amended (the "Exchange Act"). The Company today.
- 02/28/2025
|
Nasdaq Announces Updated Presentation Schedule for the Morgan Stanley Technology, Media & Telecom Conference
- NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced an update to the timing of its previously announced presentation at the Morgan Stanley Technology, Media & Telecom Conference. Nasdaq CFO Sarah Youngwood will now be presenting at 4:05pm PT (7:05pm ET) on Monday, March 3, 2025. All updated details are included below.
- 02/28/2025
|
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 44,380 shares of common stock and restricted stock units (RSUs) for 22,790 shares of common stock to 5 new employees under Adverum's 2017 Inducement Plan. The Compensation Committee of Adverum's Board of Directors approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/28/2025
|
Why Is Nasdaq (NDAQ) Down 1.8% Since Last Earnings Report?
- Nasdaq (NDAQ) reported earnings 30 days ago. What's next for the stock?
- 02/28/2025
|
HUB Cyber Security Secures Continued Nasdaq Listing, Marking an Important Milestone
- Nasdaq Hearings Panel Grants HUB Cyber Security Continued Listing on Nasdaq Nasdaq Hearings Panel Grants HUB Cyber Security Continued Listing on Nasdaq
- 02/28/2025
|
Safe & Green Holdings Corp. Regains Compliance with Nasdaq Continued Listing Requirements
- MIAMI, FL, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, today announced that it has received a listing decision from The Nasdaq Stock Market LLC (“Nasdaq”) on behalf of the Nasdaq Hearings Panel (the “Panel”), indicating that the Company has evidenced compliance with the minimum equity standard set forth in Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”) and all other applicable criteria for continued listing on The Nasdaq Capital Market. The Company remains subject to a grace period, through June 10, 2025, to regain compliance with Nasdaq's minimum price bid requirement. As a result, the previously disclosed listing matter has been closed, and the Company's securities will remain listed on Nasdaq.
- 02/28/2025
|
The ‘bro bubble' is bursting, says Bank of America strategist. Here are the key levels to watch for the Nasdaq, Palantir and more.
- The so-called ‘bro bubble' — the testosterone-fueled rally in cryptocurrencies and other speculative tech stocks — is popping, and one strategist identifies the key lines in the sand for closely watched assets.
- 02/28/2025
|
BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
- NEW HAVEN, Conn., Feb. 28, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it has received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2).
- 02/28/2025
|
NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market
- BANGKOK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has received a written notice (the “Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) dated February 27, 2025, informing the Company that it has regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”).
- 02/28/2025
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , Feb. 28, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on February 27, 2025, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 125,600 shares of the Company's common stock to four newly hired employees.
- 02/28/2025
|
Lixiang Education Regains Compliance with Nasdaq Requirement on Minimum Market Value of Publicly Held Shares
- LISHUI, China, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lixiang Education Holding Co., Ltd. (the “Company” or NASDAQ: LXEH), a prestigious private education service provider in China, today announced that on February 27, 2025, it received a letter from the Listing Qualification Department of Nasdaq Stock Market LLC (the “Nasdaq”) notifying the Company that it had regained compliance with the minimum market value of publicly held shares (“MVPHS”) as required by The Nasdaq Global Market set forth in Listing Rule 5450(b)(1)(C) (the “Rule”).
- 02/28/2025
|
Nasdaq Tumbles Over 500 Points As Nvidia Plunges Post Q4 Results: Investor Sentiment Declines Further, Greed Index Remains In 'Extreme Fear' Zone
- The CNN Money Fear and Greed index showed further decline in the overall market sentiment, while the index remained in the “Extreme Fear” zone on Thursday.
- 02/28/2025
|
Nasdaq, S&P 500 sell-off as Nvidia sinks 8%, Trump reiterates tariff plans
- To get the latest market news, check out finance.yahoo.com Stocks plummeted on Thursday as tech sold off following Nvidia's (NVDA) latest earnings report while investors took stock of the economy amid President Trump's latest tariff pledges. The S&P 500 (^GSPC) fell more than 1.6%, while the tech-heavy Nasdaq Composite (^IXIC) dropped 2.8%.
- 02/27/2025
|
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on February 24, 2025, the Board of Directors granted a non-qualified stock option award to purchase 56,000 shares of its common stock to two new non-executive employee under the Company's Amended and Restated 2024 Inducement Equity Incentive Plan (the “2024 Inducement Plan”). The stock options were granted as an inducement material to the employee entering into employment with Skye in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/27/2025
|
NewHold Investment Corp III Announces Pricing of $175 Million Initial Public Offering
- New York, New York, Feb. 27, 2025 (GLOBE NEWSWIRE) -- NewHold Investment Corp III (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 17,500,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “NHICU” beginning February 28, 2025. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “NHIC” and “NHICW,” respectively.
- 02/27/2025
|
Delisting of Securities of Adamas One Corp.; Hempacco Co., Inc.; Iris Acquisition Corp; Aura FAT Projects Acquisition Corp.; Newbury Street Acquisition Corporation; Arogo Capital Acquisition Corp.; Compass Digital Acquisition Corp.; Gritstone bio, Inc.; Notable Labs, Ltd.; and Zapata Computing Holdings Inc. from The Nasdaq Stock Market
- NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Nasdaq announced today that it will delist the common stock of Adamas One Corp. Adamas One Corp.'s stock was suspended on September 05, 2024 and has not traded on Nasdaq since that time.
- 02/27/2025
|
Live Updates: Nasdaq Composite Falls After NVDA Earnings
- On the heels of Nvidia's (Nasdaq: NVDA) Q4 earnings beat, technology stocks have turned negative, including a nearly 1% drop in the Nasdaq Composite in a tariff-related sell-off.
- 02/27/2025
|
SUNation Energy Announces $20 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
- RONKONKOMA, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale of 17,391,306 shares of the Company's common stock (or common stock equivalents in lieu thereof) Series A warrants to purchase up to an aggregate 17,391,306 shares of the Company's common stock and Series B warrants to purchase up to an aggregate 17,391,306 shares of the Company's common stock at an effective purchase price of $1.15 per share (or common stock equivalents in lieu thereof) and associated warrants in a registered direct offering priced at-the-market under Nasdaq rules.
- 02/27/2025
|
Nasdaq set to climb as investors mull Nvidia earnings and Trump's tariffs confirmation
- US stocks were tipped to start higher on Thursday, helped by a positive premarket pivot from Nvidia Corp (NASDAQ:NVDA) as investors continued to chew over its overnight earnings release. As a result of the chipmaker's 2.5% premarket gain, futures were indicating the Nasdaq 100 would rise 0.8%, with S&P 500 futures up 0.7% and those for the Dow Jones up 0.3%.
- 02/27/2025
|
Nasdaq, Inc. Announces Early Results of Cash Tender Offers for Up to $218 Million Outstanding Debt Securities
- NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) (“Nasdaq” or the “Company”) announced today the early results of its previously announced offers to purchase for cash up to an aggregate principal amount of $218,053,000 (the “Aggregate Notes Cap”) (reflecting an $18,053,000 increase from the previously announced cap of $200,000,000) of its outstanding Notes, comprised of (i) up to $41,360,000 aggregate principal amount (the “2028 Notes Cap”) of the Company's 5.350% Senior Notes due 2028 (the “2028 Notes”), (ii) up to $57,583,000 aggregate principal amount (the “2034 Notes Cap”) of the Company's 5.550% Senior Notes due 2034 (the “2034 Notes”) and (iii) up to $119,110,000 aggregate principal amount (the “2052 Notes Cap”) of the Company's 3.950% Senior Notes due 2052 (the “2052 Notes”). The 2028 Notes, the 2034 Notes and the 2052 Notes are referred to collectively herein as the “Notes,” such offers to purchase are referred to collectively herein as the “Tender Offers” and each a “Tender Offer,” and the 2028 Notes Cap, the 2034 Notes Cap and the 2052 Notes Cap are referred to collectively herein as the “Series Notes Caps” and each a “Series Notes Cap.” The Tender Offers are being made upon the terms and subject to conditions described in the Offer to Purchase, dated February 10, 2025 (as it may be amended or supplemented from time to time, the “Offer to Purchase”), which sets forth a detailed description of the Tender Offers. The Company refers investors to the Offer to Purchase for the complete terms and conditions of the Tender Offers.
- 02/24/2025
|
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PHILADELPHIA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that Context has granted non-qualified stock option awards to purchase an aggregate of 46,000 shares of its common stock to two new employees as an inducement material for accepting employment with Context.
- 02/24/2025
|
Nasdaq CFO Sarah Youngwood to Present at the Morgan Stanley Technology, Media & Telecom Conference
- NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 02/24/2025
|
Nasdaq Down 100 Points; Domino's Pizza Posts Weak Earnings
- U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 100 points on Monday.
- 02/24/2025
|
S&P 500, Nasdaq extend declines as tech stocks suffer; Palantir falls over 10%, Domino's Pizza slips 3%
- The S&P 500 experienced a slight decline on Monday, as the market was unable to recover from the significant losses incurred on Friday. Major tech companies were particularly affected, with their shares experiencing downward pressure.
- 02/24/2025
|
ZK International Group Co., Ltd. Resolves Nasdaq Bid Price Deficiency and Remains in Compliance with Nasdaq Listing Standards
- WENZHOU, China , Feb. 24, 2025 /PRNewswire/ -- ZK International Group Co., Ltd. (Nasdaq: ZKIN) (" ZK International" or the "Company"), a leading engineering Company focused on high-performance steel products, is pleased to announce that the bid price deficiency concern raised by Nasdaq has been successfully resolved.
- 02/24/2025
|
S&P 500, Nasdaq, Dow Brace for Earnings Storm: Nvidia, Home Depot and Salesforce in Focus
- Earnings week: Nvidia, Salesforce, and Home Depot lead the charge. S&P 500 Index traders brace for potential market volatility and key trading opportunities!
- 02/24/2025
|
Sandisk Celebrates Nasdaq Listing After Completing Separation from Western Digital
- MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation, a global Flash and advanced memory technology innovator, today announced that the company has completed its separation from Western Digital and is now an independent public company set to begin trading today on the Nasdaq Stock Market under the ticker symbol “SNDK.” The company's leadership team with long-time employees and Board members will ring the closing bell at Nasdaq to mark the milestone today. “We are excited to embark on this new.
- 02/24/2025
|
Yoshiharu Intends to Appeal Delisting Notice from Nasdaq
- BUENA PARK, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Yoshiharu Global Co. (NASDAQ: YOSH) ("Yoshiharu" or the "Company"), a restaurant operator specializing in authentic Japanese ramen & rolls, today announced that it has received a notice of delisting from Nasdaq.
- 02/21/2025
|
SaverOne Implements Change in Ratio of Shares to ADSs to Meet Nasdaq Minimum Bid Price Requirement
- Petah Tikvah, Israel, Feb. 21, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), On February 20, 2025, SaverOne 2014 Ltd. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC, notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) which requires listed companies to maintain a minimum bid price of $1.00 per share. Normally, a company would be afforded a 180-calendar day period to demonstrate compliance with the Minimum Bid Price Requirement. However, pursuant to recently enacted Nasdaq regulations, the Company is not eligible for any compliance period) because the Company has effected a reverse stock split over the prior one-year period. The Company's ADSs are subject to delisting from Nasdaq unless the Company requests an appeal of this determination by February 27, 2025.
- 02/21/2025
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , Feb. 21, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on February 20, 2025, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 107,000 shares of its common stock and 53,500 restricted stock units ("RSUs") to twenty-two (22) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/21/2025
|
Nauticus Robotics Regains Compliance with Nasdaq Listing Standards
- HOUSTON , Feb. 20, 2025 /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in autonomous subsea robotics and software, today announced that on February 18, 2025, it received a formal notice from The Nasdaq Capital Market ("Nasdaq") confirming that Nauticus has demonstrated compliance with the equity requirement in Rule 5550(b)(1) (the "Equity Rule"), and is therefore in compliance with Nasdaq's continued listing requirements. John Gibson, CEO and President of Nauticus Robotics, stated, "Pleased to be back in compliance.
- 02/20/2025
|
NewGen Issues Clarification on Press Release Titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” dated February 20, 2025
- BANGKOK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”) today issued a clarification that, in the press release titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” issued on February 20, 2025, the Company did not intend to imply that it has already achieved compliance with the Nasdaq Capital Market's $2.5 million minimum stockholders' equity requirement (the “Equity Rule”). However, during its 1st quarter to date, certain NewGen debtholders converted $2.3 million of debt to equity and the Company has drawn down approximately $4.3 million from its Equity Line of Credit with White Lion Capital. Therefore, the Company believes it has in excess of $2.5 million in stockholders' equity as of this date. The Company is awaiting confirmation from Nasdaq that it has evidenced compliance with the Equity Rule. However, there can be no assurance that Nasdaq will determine that the Company has regained compliance with the Nasdaq continued listing rules.
- 02/20/2025
|
HYZON ANNOUNCES DELISTING FROM NASDAQ AND EXPECTED SEC DEREGISTRATION
- BOLINGBROOK, Ill. , Feb. 20, 2025 /PRNewswire/ -- Hyzon Motors Inc. ("Hyzon" or the "Company"), a U.S.-based, high-performance, hydrogen fuel cell system manufacturer and technology developer focused on providing zero-emission power to decarbonize the most demanding industries, today announced that it has provided notification to The Nasdaq Stock Market, LLC ("Nasdaq") of its intent to delist the Company's Class A common stock, par value $0.0001 per share (the "Common Stock") and its publicly-traded warrants with each whole warrant exercisable for one share of Common Stock at an exercise price of $575.00 per share (the "Warrants"), from the Nasdaq Capital Market.
- 02/20/2025
|
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- DUBLIN, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to five (5) new employees to purchase 173,000 ordinary shares under Avadel's 2021 Inducement Plan. The awards were granted as an inducement material to the employee's acceptance of employment with Avadel in accordance with Nasdaq Listing Rule 5635(c)(4). The options have a ten-year term and vest over four years, with 25% vesting on the one-year anniversary of each new employee's respective start date and 25% vesting on the second, third, and fourth anniversary thereafter. The options are subject to the terms and conditions of Avadel's 2021 Inducement Plan approved by the Board of Directors in November 2021 and the terms and conditions of award agreements covering the grants.
- 02/20/2025
|
Diginex Limited Announces Secondary Listing on the Frankfurt Stock Exchange and Tradegate Exchange and the Engagement of German-based Kirchhoff Consult GmbH to Broaden Investor Base Across Europe
- HONG KONG, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex Limited” or the “Company”) (Nasdaq: DGNX), a Cayman Islands-based impact technology company specializing in environmental, social, and governance (ESG) issues, announced today that its shares currently traded on The Nasdaq Capital Market (“Nasdaq”), are now cross-listed on the Frankfurt Stock Exchange (Open Market) and the Tradegate Exchange under the symbol “I0Q” effective February 20, 2025. We expect this cross-listing to expand the Company's global investor reach, and enhance liquidity and accessibility to European investors while reinforcing its presence in key international financial markets.
- 02/20/2025
|
Millicom (Tigo) reiterates intention to consolidate listing of shares on NASDAQ U.S. by delisting SDRs from Nasdaq Stockholm
- Millicom (Tigo) reiterates intention to consolidate listing of shares on NASDAQ U.S. by delisting SDRs from Nasdaq Stockholm Luxembourg, February 20, 2025 – As previously communicated on November 29, 2024, Millicom International Cellular S.A. (“Millicom”) today reiterated that it intends to file a delisting application with Nasdaq Stockholm on March 3, 2025, which will result in the SDR program being terminated.
- 02/20/2025
|
These Were the 5 Top-Performing Stocks in the Nasdaq-100 in January 2025
- The first full month of 2025 is in the books, and the stock market is off to a decent start. The major indexes -- the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average -- were up 2.7%, 1.6%, and 4.7%, respectively.
- 02/20/2025
|
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
- The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, nutraceuticals, and supplements Aspire has multiple product candidates in key areas of medical needs such as a fast-acting aspirin product for cardiology emergencies and pain management, a proprietary Viagra/Cialis combination product, various bi-hormonal drugs such as testosterone, estrogen, weight loss, anti-seizure, and thyroid drugs. Supplements such as pre-workout and melatonin are already being developed using Aspire's proprietary sublingual delivery system.
- 02/20/2025
|
NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director
- Company Granted Request to Continue its Listing on Nasdaq Appoints Thorain Ko to Lead Business Development Initiatives
- 02/20/2025
|
Sell these overvalued Nasdaq 100 stocks at their top
- The Nasdaq 100 index continues its strong surge this year and is now at its highest record level. It soared to a high of $22,175 on Wednesday, bringing its year-to-date gains to about 4.3%.
- 02/20/2025
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 23,760 restricted stock units of the company's common stock to 10 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of February 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/19/2025
|
iBio to Begin Trading on the Nasdaq Stock Exchange
- SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody therapies, today announced that iBio's common stock has been approved for listing on the Nasdaq Capital Market and iBio will transfer its stock exchange listing to Nasdaq Capital Market from the NYSE American. The Company expects to begin trading as a Nasdaq-listed company on Mar 4, 2025, and will continue to trade under the symbol “IBIO.” The Company's common stock will continue to trade on the NYSE American until the market close on Mar 3, 2025.
- 02/19/2025
|
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
- NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (Nasdaq:PWUP), a Nasdaq Global Market® listed special purpose acquisition company, ("PowerUp"), today announced the completion of their previously announced business combination (the "Business Combination"). The Business Combination was approved by PowerUp Acquisition Corp. stockholders on January 31, 2025, and it closed on February 17, 2025.
- 02/19/2025
|
Sekur Releases Bold 2025 Growth Strategy, Targeting Nasdaq Uplisting and Market Expansion
- MIAMI and TORONTO , Feb. 19, 2025 /PRNewswire/ -- Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA: GDT0) ("Sekur" or the "Company"), a leading Swiss-hosted cybersecurity and privacy communications platform, releases a shareholder update from its CEO, Mr.
- 02/19/2025
|
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
- Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels – today announced that CEO Michael Heltzen will be joined by eXoZymes team members to ring the Nasdaq Stock Market (“Nasdaq”) closing bell on Wednesday, February 19, 2025. This comes following a successful initial public offering of common stock at $8 per share, which closed on November 14, 2024.
- 02/19/2025
|
Lead Real Estate Co., Ltd Announces Receipt of Nasdaq Delisting Determination
- TOKYO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or “the Company”), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, today announced that the Company received a staff determination letter (the “Letter”) on February 12, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company of the determination from the Nasdaq staff (the “Staff”) to delist the Company's securities from The Nasdaq Global Market because the Company has not regained compliance with Nasdaq Listing Rule 5450(b)(1)(C), which requires a market value of publicly held shares of at least $5,000,000. This announcement is made in compliance with Nasdaq Listing Rule 5810(b).
- 02/18/2025
|
The Smartest Nasdaq Exchange-Traded Fund (ETF) to Buy With $2,000 Right Now
- The Nasdaq Composite is one of the U.S. stock market's three major indexes, tracking almost every stock on the Nasdaq stock exchange.
- 02/17/2025
|
UPDATE – GCL and RF Acquisition Corp. Complete Business Combination, GCL to Commence Trading on Nasdaq Under Ticker “GCL” and Announces Bell Ringing to Commemorate Listing
- GCL & RF Acquisition Corp. Complete Business Combination, GCL Commence Trading on Nasdaq Ticker “GCL” & Announces Bell Ringing to Commemorate Listing
- 02/16/2025
|
Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- SAN DIEGO and CALGARY, AB , Feb. 14, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it received a delinquency notification letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on February 13, 2025 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company's ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.
- 02/14/2025
|
Luokung Announces Receipt of Nasdaq Delisting Notice Subject to Hearing
- BEIJING, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Luokung Technology Corp. (NASDAQ: LKCO) (“Luokung” or the “Company”) today announced that on February 11, 2025, it has received a letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”), notifying that the Company is not in compliance with Nasdaq Listing Rule 5550(b), and the Nasdaq staff has determined that the Company did not provide a definitive plan evidencing its ability to achieve near term compliance with the continued listing requirements or sustain such compliance over an extended period of time. As a result, the Nasdaq staff has determined to deny the Company's request for continued listing on The Nasdaq Capital Market (the “Delisting Determination”).
- 02/14/2025
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 371,500 shares of its common stock to eleven newly hired employees, consisting of inducement stock options to.
- 02/14/2025
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 116,725 shares of common stock. Awards were made to nine new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committ.
- 02/14/2025
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on February 6, 2025, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 171,065 shares of common stock and 55,170 restricted stock units (“RSUs”) to eighteen new employees under Acadia's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees.
- 02/14/2025
|
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases, today announced that on February 11, 2025, the company granted inducement awards to nine new employees. The grants were made pursuant to Nurix's 2024 Equity Inducement Plan as an inducement material to the employees' acceptance of employment with Nurix and were approved by the Compensation Committee of Nurix's Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/14/2025
|
Mingzhu Receives Nasdaq Delisting Notice Subject to Hearing Request
- SHENZHEN, China , Feb. 14, 2025 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ ), an elite provider of logistics and transportation services to businesses, today announced that on February 13, 2025, it received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the "Delisting Determination"), because the bid price of the Company's listed securities has closed at less than $1 per share over the previous 30 consecutive business days, and therefore it no longer complies with the Nasdaq Listing Rule 5550(a)(2) (the "Rule"). Normally, a company would be afforded a 180-calendar day period to demonstrate compliance with the Rule.
- 02/14/2025
|
Nasdaq 100 and S&P 500: Tech Sector Strong as Apple and Super Micro Surge
- US indices hold weekly gains as inflation fears ease. Apple soars 6%, boosting tech stocks, while investors focus on Fed policy and trade updates.
- 02/14/2025
|
ConnectM Announces Receipt of Notice from Nasdaq That ConnectM has Regained Compliance with Nasdaq Rule
- MARLBOROUGH, Mass. , Feb. 14, 2025 /PRNewswire/ -- ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) ("ConnectM" or the "Company"), a technology company focused on the electrification economy, had previously announced that on December 6, 2024, it received a notice from the Staff of the Listing Qualifications Department of Nasdaq stating that because the Company had not filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Third Quarter 10-Q"), it no longer complies with Nasdaq Listing Rule 5250(c)(1) (the "Rule") for continued listing, which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.
- 02/14/2025
|
Phoenix Motor Regains Compliance with Nasdaq Listing
- ANAHEIM, CA / ACCESS Newswire / February 14, 2025 / Phoenix Motor Inc. ( NASDAQ:PEV ), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced that it has received confirmation from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires timely filing of periodic financial reports with the Securities and Exchange Commission ("SEC"). On November 20, 2024, Nasdaq Staff notified the Company that it was not in compliance with the Rule due to a delay in filing its periodic financial reports.
- 02/14/2025
|
2 Nasdaq Stocks That Are No-Brainer Buys Now
- The tech-heavy Nasdaq index has been a great place to look for stocks with immense upside. Tech stocks have gone mostly straight up since the start of 2023, and with how much money is flowing into the artificial intelligence (AI) investing space, I don't see this trend subsiding anytime soon.
- 02/14/2025
|
Nasdaq 100: Robinhood and Coinbase Surge on Crypto Boom—Will the Rally Extend on Friday?
- Robinhood, Coinbase, and Roku surge post-earnings, fueling after-hours gains. Will these moves push the S&P 500 and Nasdaq higher on Friday?
- 02/13/2025
|
GCL and RF Acquisition Corp. Complete Business Combination, GCL to Commence Trading on Nasdaq Under Ticker “GCL” and Announces Bell Ringing to Commemorate Listing
- GCL and RF Acquisition Corp. Have Closed the Business Combination on February 13, 2025. GCL's Ordinary Shares and Warrants Will Begin Trading on Nasdaq on February 14, 2025, Under Ticker Symbols “GCL” and “GCLWW,” Respectively.
- 02/13/2025
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on February 8, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 157,750 shares of Class A common stock and restricted stock units (RSUs) for 78,875 shares of Class A common stock to seventeen (17) new employees under the Inducement Plan.
- 02/13/2025
|
ConnectM Announces Receipt of Notice from Nasdaq That ConnectM has Regained Compliance with Nasdaq Rule
- MARLBOROUGH, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) (“ConnectM” or the “Company”), a technology company focused on the electrification economy, had previously announced that on December 6, 2024, it received a notice from the Staff of the Listing Qualifications Department of Nasdaq stating that because the Company had not filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Third Quarter 10-Q”), it no longer complies with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) for continued listing, which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.
- 02/13/2025
|
Nasdaq Surges 150 Points; Cisco Earnings Top Views
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Thursday.
- 02/13/2025
|
LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- PASADENA, CALIF., Feb. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 434,784 shares of the Company's common stock at a purchase price of $2.415 per share. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase up to an aggregate of 434,784 shares of common stock. The warrants have an exercise price of $2.29 per share and are exercisable for five years from the date of issuance.
- 02/13/2025
|
Codere Online Granted Listing Extension by Nasdaq and to Release Q4-24 Earnings on February 20th
- Luxembourg, Grand Duchy of Luxembourg, February 13, 2025 (GLOBE NEWSWIRE) – Codere Online Luxembourg, S.A. (Nasdaq: CDRO / CDROW) (the “Company” or “Codere Online”), a leading online gaming operator in Spain and Latin America, today announced that, by letter received on February 12, 2025, the Nasdaq Hearings Panel (the "Panel") of The Nasdaq Stock Market LLC ("Nasdaq") has determined to grant the Company's request to continue its listing on Nasdaq, subject to the Company filing its annual report on Form 20-F for the year ended December 31, 2023 (the “2023 Annual Report”) on or before May 12, 2025.
- 02/13/2025
|
Banzai Fully Regains Compliance with Nasdaq Continued Listing Requirements
- SEATTLE, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (Nasdaq: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it has received a notification letter from the Hearings Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has demonstrated compliance with the minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1). The Company's securities will therefore continue to be listed and traded on The Nasdaq Capital Market.
- 02/13/2025
|
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that it has sold, in a private placement, an aggregate of 834 newly designated Series B-1 convertible preferred shares (“Series B-1 Preferred Shares”) and 3,468,746 common shares in a private placement priced at-the-market under the rules of the Nasdaq Stock Market. The purchase price per Preferred Share was $10,000 and the purchase price per common share was $1.92. Officers and directors of the Company purchased approximately $1.1 million of the securities sold in the offering.
- 02/13/2025
|
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on February 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 115,100 shares of its common stock to ten new employees, consisting of inducement stock options to purchase an aggregate of 36,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 79,100 shares of its common stock. These inducement stock options and inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/12/2025
|
Nasdaq 100: AppLovin Soars over 15% After Hours, AI Boom Lifts Cisco, Reddit Misses Key Metric
- AppLovin soars 15%, Cisco rises on AI momentum, but Reddit sinks on weak user growth. Nasdaq 100 traders eye Fed policy and tariff risks ahead.
- 02/12/2025
|
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
- DOVER, Del., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Portage Biotech, Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, today announced that on February 11, 2025, it received notification from The Nasdaq Stock Market, LLC (“Nasdaq”) that Nasdaq has accepted Portage's compliance plan and has granted the Company the extension to regain compliance with the continued listing standards on The Nasdaq Capital Market (the “Capital Market”) as set forth in Nasdaq Listing Rule 5550(b)(1) whereby the minimum shareholders' equity is at least $2.5 million or meet either of the alternative continued listing standards for the Capital Market, relating to market value of listed securities of at least $35 million or net income from continued operations of at least $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years.
- 02/12/2025
|
Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings
- U.S. stocks traded mostly lower toward the end of trading, while the Nasdaq Composite edged higher on Wednesday.
- 02/12/2025
|
XTI Aerospace Regains Compliance with Nasdaq Listing Requirements
- ENGLEWOOD, Colo. , Feb. 12, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI Aerospace" or the "Company"), a pioneer in advanced aircraft design, today announced that it has received formal notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
- 02/12/2025
|
Meta achieves historic 16-day rally: a Nasdaq first in decades
- Meta, the social media behemoth behind Facebook and Instagram, is riding the crest of a wave after a historic winning streak that defied broader market trends and AI-related investor anxieties.
- 02/11/2025
|
S&P 500, Nasdaq slip as investors digest Powell testimony, Trump's tariffs
- To get the latest market news, check out finance.yahoo.com US stocks traded mixed on Tuesday as investors assessed more tariff policy shifts from President Donald Trump and looked ahead to upcoming inflation data. Traders also digested the start of Federal Chair Jerome Powell's two-day testimony in Congress.
- 02/11/2025
|
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
- WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing.
- 02/11/2025
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 31, 2025
- NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of January 31, 2025, short interest in 3,109 Nasdaq Global MarketSM securities totaled 12,170,722,591 shares compared with 12,402,417,655 shares in 3,099 Global Market issues reported for the prior settlement date of January 15, 2025. The mid-January short interest represents 2.69 days compared with 2.56 days for the prior reporting period.
- 02/11/2025
|
Nasdaq 100: Nvidia at a Technical Crossroads – Stock Market Awaits Key Signal
- Nvidia tests key resistance near its 50-day moving average. Will earnings fuel a breakout or send the stock lower?
- 02/11/2025
|
Nasdaq 100: Nvidia at Technical Crossroads – Stock Market Awaits Key Signal
- Nvidia tests key resistance near its 50-day moving average. Will earnings fuel a breakout or send the stock lower?
- 02/11/2025
|
Globalstar CEO Paul Jacobs explains why satellite company moved from NYSE to Nasdaq
- Globalstar, a satellite and communications services provider, debuted on the Nasdaq Tuesday morning after delisting from the New York Stock Exchange. CEO Paul Jacobs joined CNBC's Squawk Box to discuss the company's latest investments in satellite connectivity.
- 02/11/2025
|
LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- PASADENA, CALIF., Feb. 11, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 434,784 shares of its common stock at a purchase price of $2.415 per share, in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to an aggregate of 434,784 shares of common stock. The warrants will have an exercise price of $2.29 per share and will be exercisable for five years from the date of issuance. The closing of the offering is expected to occur on or about February 12, 2025, subject to the satisfaction of customary closing conditions.
- 02/11/2025
|
Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve
- CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading genomics and consumer healthcare company, today announced a groundbreaking genomics-based partnership with Humanity Protocol, a decentralized identity verification company. This collaboration leverages Prenetics' advanced genetic testing capabilities to underpin decentralized identity verification.
- 02/11/2025
|
Haoxi Health Technology Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- BEIJING, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that it received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company's Class A ordinary shares, par value US$0.0025 each (the “Ordinary Shares”) to maintain a minimum bid price of $1.00 per share.
- 02/11/2025
|
111, Inc. Regains Compliance with NASDAQ Requirement
- SHANGHAI , Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced today that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") on February 10, 2025, confirming that Nasdaq has determined that for the last ten consecutive business days, from January 24, 2025 to February 7, 2025, the closing bid price of the Company's American Depositary Shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(a)(1).
- 02/11/2025
|
Nasdaq Gains 1% As Nvidia, Broadcom Surge: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
- The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index moved to the “Neutral” zone on Monday.
- 02/11/2025
|
Odysight.ai Announces the Pricing of $21.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
- Odysight.ai common stock to begin trading on Nasdaq Tuesday, February 11, 2025, under the symbol “ODYS” OMER, Israel, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (Nasdaq: ODYS) (“Odysight.ai” or the “Company”), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), today announced the pricing of a public offering of 3,307,692 shares of its common stock at a price to the public of $6.50 per share. The sole book-running manager of the offering will have a 30-day option to purchase up to an additional 496,153 shares of common stock from Odysight.ai at the public offering price, less underwriting discounts and commissions.
- 02/10/2025
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 02/10/2025
|
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 105,100 shares of its common stock and granted an aggregate of 9,950 restricted stock unit (“RSU”) awards to 14 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/10/2025
|
Nasdaq 100: Nvidia and Broadcom Surge Today—Is This the Start of a New Uptrend?
- Stock market rallies as Nvidia, Broadcom, and steel stocks surge. Can momentum continue, or will inflation concerns and Fed policy weigh on US indices?
- 02/10/2025
|
Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Monday.
- 02/10/2025
|
S&P 500 and Nasdaq 100: US Stocks Rise as Traders Look Past Tariff Threat
- S&P 500 and Nasdaq rise despite tariff uncertainty. Traders await Powell's speech and CPI data for insights on inflation, interest rates, and market outlook.
- 02/10/2025
|
Nasdaq, Inc. Announces Cash Tender Offers for Up to $200 Million Outstanding Debt Securities
- NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) (“Nasdaq” or the “Company”) today announced its offers to purchase for cash up to an aggregate principal amount of $200,000,000 (the “Aggregate Notes Cap”) of its outstanding Notes, comprised of (i) up to $40,000,000 aggregate principal amount (the “2028 Notes Cap”) of the Company's 5.350% Senior Notes due 2028 (the “2028 Notes”), (ii) up to $50,000,000 aggregate principal amount (the “2034 Notes Cap”) of the Company's 5.550% Senior Notes due 2034 (the “2034 Notes”) and (iii) up to $110,000,000 aggregate principal amount (the “2052 Notes Cap”) of the Company's 3.950% Senior Notes due 2052 (the “2052 Notes”). The 2028 Notes, the 2034 Notes and the 2052 Notes are referred to collectively herein as the “Notes,” such offers to purchase are referred to collectively herein as the “Tender Offers” and each a “Tender Offer,” and the 2028 Notes Cap, the 2034 Notes Cap and the 2052 Notes Cap are referred to collectively herein as the “Series Notes Caps” and each a “Series Notes Cap.”
- 02/10/2025
|
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- BRAINTREE, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 6,103,289 shares of the Company's common stock at a purchase price of $2.13 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered short-term series I preferred investment options. The short-term series I preferred investment options to purchase up to 12,206,578 shares of common stock have an exercise price of $2.13 per share and will be exercisable for a period of two years beginning on the later of (i) the effective date of the increase of the Company's authorized shares of common stock following stockholder approval and (ii) the effective date of stockholder approval of the issuance of the shares upon exercise of the warrants. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about February 11, 2025, subject to the satisfaction of customary closing conditions.
- 02/10/2025
|
Can a $50,000 Investment in the Nasdaq-100 Today Turn Into $1 Million by the Time You Retire?
- Investors will find many of the best growth stocks in the world on the Nasdaq exchange. An even more exclusive club is in the Nasdaq-100 index, which includes the largest nonfinancial stocks on the exchange.
- 02/09/2025
|
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective February 5, 2025, to three non-executive employees of non-qualified stock option.
- 02/07/2025
|
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to a new employee. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employee entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/07/2025
|
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company's Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 45,000 shares of its common stock under the Company's 2023 Inducement Plan.
- 02/07/2025
|
Brera Holdings Announces Anticipated Receipt of Nasdaq Additional Deficiency Notice
- Dublin, Ireland, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or “the Company”) (Nasdaq: BREA), an Ireland-based, Nasdaq-listed, international holding company focused on expanding its global portfolio of men's and women's sports clubs through a multi-club ownership (“MCO”) approach, today announced that on February 3, 2025, the Company received formal notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company does not satisfy the annual meeting requirement set forth in Nasdaq Listing Rule 5620(a) (the “Annual Meeting Rule”) as the Company did not hold an annual meeting of shareholders within twelve months of the end of the Company's previous fiscal year ended December 31, 2023.
- 02/07/2025
|
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that on February 3, 2025, the Compensation Committee of the Board of Directors of Mersana granted an inducement award, consisting of a restricted stock unit (RSU) award to acquire 20,610 shares of its common stock, to one new employee whose employment commenced in January 2025. The award was granted as an inducement material to the new employee entering employment with Mersana in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/07/2025
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, the Netherlands and MIAMI, Feb. 07, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 138,000 of NewAmsterdam's ordinary shares to four (4) non-executive new hires. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/07/2025
|
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of 1,350 restricted stock units of Atara's common stock to one newly hired employee. This award was approved by the Compensation Committee of Atara's Board of Directors and granted under the Atara.
- 02/07/2025
|
Applovin Emerges As Nasdaq 100's Dark Horse In A Market Fixated On Nvidia, Tesla, Palantir
- In a market obsessed with the usual suspects—Nvidia Corp, Tesla Inc and Palantir Technologies Inc — one stock has been quietly stealing the show: AppLovin Corp. APP.
- 02/07/2025
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on February 3, 2025, the Compensation Committee of Taysha's Board of Directors granted three new employees, in the aggregate, options to purchase 491,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/07/2025
|
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on February 3, 2025, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 164,000 shares of common stock to nine (9) new employees under the Company's 2023 Inducement Option Plan, as amended. The Compensation Committee approved the stock options as an inducement material to such employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/07/2025
|
S&P 500, Nasdaq pop with Amazon set to highlight earnings rush
- To get the latest market news check out finance.yahoo.com US stocks were mixed on Thursday in anticipation of Amazon's (AMZN) quarterly results, as investors assessed the earnings season so far and eyed President Donald Trump's fast-moving policy overhaul. The Dow Jones Industrial Average (^DJI) fell 0.3%.
- 02/07/2025
|
Fusion Fuel Announces Decision by Nasdaq Hearings Panel
- DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), a leading provider of comprehensive energy engineering, advisory, and supply solutions, today announced that the Nasdaq Hearings Panel has found the Company in compliance with Nasdaq Listing Rule 5550(b)(1), requiring minimum stockholders' equity of $2,500,000, and granted the Company's request for an exception to evidence compliance with other applicable criteria for continued listing on The Nasdaq Stock Market LLC.
- 02/06/2025
|
Nasdaq 100: Amazon Stock Drops 4% After Hours Despite Strong Q4 Earnings Beat
- Amazon beats Q4 estimates, but weak Q1 guidance sends shares down 4% after hours. Traders eye AWS growth and retail trends for market direction.
- 02/06/2025
|
Wall Street today: S&P 500 and Nasdaq edge higher, Dow drops amid earnings focus
- The US stock market was little changed on Thursday, with the S&P 500 and Nasdaq Composite holding modest gains while the Dow Jones Industrial Average slipped. Investors assessed a mixed set of corporate earnings and looked ahead to Friday's key jobs report.
- 02/06/2025
|
TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration
- FOXBOROUGH, Mass., Feb. 6, 2025 /PRNewswire/ -- TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the Company has provided notification to The Nasdaq Stock Market, LLC ("Nasdaq") of its intent to voluntarily delist the Company's common stock, par value $0.001 per share (the "Common Stock"), from the Nasdaq Capital Market.
- 02/06/2025
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 163,650 shares of the Company's common stock to seven new employees (the “Inducement Grants”) on January 31, 2025 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/06/2025
|
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent directors serving on the Compensation Committee of the company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 527,750 shares of the company's common stock to 15 new employees (the “Inducem.
- 02/06/2025
|
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- 60 Degrees Pharma closed a $1.075M registered direct offering, raising $2.118M YTD to fund operations. H.C. Wainwright & Co. acted as placement agent.
- 02/06/2025
|
S&P 500, Nasdaq edge higher with Amazon set to highlight earnings rush
- To get the latest market news check out finance.yahoo.com US stocks were mixed on Thursday in anticipation of Amazon's (AMZN) quarterly results, as investors assessed the earnings season so far and eyed President Donald Trump's fast-moving policy overhaul. The Dow Jones Industrial Average (^DJI) fell 0.3%, while the S&P 500 (^GSPC) nudged up around 0.3%.
- 02/06/2025
|
Nasdaq 100: Amazon Earnings Today – Will It Finally Surpass Walmart in Revenue?
- Amazon reports earnings today—will it surpass Walmart in revenue? Key insights on cloud growth, AI spending, and retail sales impact on US stocks.
- 02/06/2025
|
S&P 500 Forecast: Broad Market Edges Higher, But Qualcomm and Arm Weigh on Nasdaq 100
- S&P 500 edges higher as earnings take focus, but Qualcomm and Arm drag Nasdaq 100 lower. Traders eye job data and Fed policy for market direction.
- 02/06/2025
|
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on February 4, 2025 to 15 new employees under Pacira's Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee's entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the Compensation Committee of the Board of Directors (the “Committee”) without stockholder approval.
- 02/06/2025
|
Nasdaq Grants Santech Holdings Limited Extension to File its Annual Report on Form 20-F
- HONG KONG, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Santech Holdings Limited (NASDAQ: STEC) (“Santech” or the “Company”) announced today that The Nasdaq Stock Market LLC (“Nasdaq”) has determined to grant Santech an exception to Listing Rule 5250(c)(1) of Nasdaq's Listing Rules (the “Rules”), giving Santech an extension of the deadline to file its Annual Report on Form 20-F for the fiscal year ended June 30, 2024 (the “Filing”).
- 02/06/2025
|
CERo Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
- SOUTH SAN FRANSCISCO, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, today announced the pricing of its “reasonable best efforts” public offering with participation from a member of the Company's board and a single institutional investor for the purchase and sale of 2,551,020 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,551,020 shares of common stock at a combined purchase price of $1.96 (the “Offering”). The warrants will have an exercise price of $1.96 per share, will be immediately exercisable upon stockholder approval and will expire 5 years from the initial exercise date.
- 02/05/2025
|
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 4, 2025, the Compensation Committee of Puma's Board of Directors approved the grant of inducement restricted stock unit awards covering 7,250 shares of Puma common stock to two new non-executive employees. The awards were granted under Puma's 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awar.
- 02/05/2025
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 62,000 restricted stock units of Arcutis' common stock to eight newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of February 3, 2025, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/05/2025
|
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in January 2025
- January 2025 was a bullish month for many Nasdaq-listed names. But that wasn't the case for all of them.
- 02/05/2025
|
Adia Nutrition Advances Towards OTCQB Uplisting with Third-Party Audit and Provides Roadmap to Listing on Nasdaq Small Cap
- WINTER PARK, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), an innovator nutritional products and medical treatments, has announced that through collaboration with Adia's accountant, Adia has appointed a PCAOB (Public Company Accounting Oversight Board) accounting firm to conduct a comprehensive third-party audit. This strategic move is part of Adia's plan to uplist its shares from the OTC Pink Sheets to the OTCQB Venture Market, aiming to enhance visibility, attract a broader investor base, and reflect the company's commitment to transparency and growth.
- 02/05/2025
|
Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
- GARDEN CITY, N.Y., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced it received a notification from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has been granted an additional 180-day compliance period, or until August 4, 2025 to regain compliance with Nasdaq's minimum bid price rule (Rule 5550(a)(2)). The notification has no immediate effect on the listing of the Company's common stock, and the common stock will continue to trade on the Nasdaq Capital Market under the symbol "XAIR."
- 02/05/2025
|
Nuvini Regains Compliance with Nasdaq Listing Rule 5250(c)(2)
- NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private SaaS B2B companies in Latin America, today announced that it received notice from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) on February 5th, 2025, indicating that the Company has regained compliance with Nasdaq Listing Rules 5250(c)(2).
- 02/05/2025
|
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- 60 Degrees Pharma (SXTP) announces a $1.075M registered direct offering, issuing stock and warrants to fund working capital and corporate initiatives.
- 02/05/2025
|
Nasdaq 100 and S&P 500: Futures Drop as Alphabet, AMD, and Apple Weigh on Markets
- Nasdaq 100 drops as Alphabet and AMD tumble after earnings. Apple faces China scrutiny, adding pressure to US stocks.
- 02/05/2025
|
Nasdaq 100 Slides as China's Apple Probe and Google's Earnings Miss Shake Market Sentiment
- Apple drops 3% as China weighs App Store probe, while Google sinks 9% on weak earnings. Nvidia edges higher, but risks loom.
- 02/05/2025
|
Virtune AB (Publ) launches two new Crypto ETPs on Nasdaq Helsinki
- Helsinki, February 5th, 2025 - Virtune, a Swedish regulated digital asset manager and issuer of crypto exchange-traded products, today announced the listing of Virtune Avalanche ETP and Virtune Staked Cardano ETP on Nasdaq Helsinki. Virtune recently introduced the first five crypto ETPs in Finland on Nasdaq Helsinki, receiving a strong reception in the Finnish market. The previously listed products include Virtune Bitcoin ETP, Virtune Staked Ethereum ETP, Virtune Staked Solana ETP, Virtune XRP ETP, and Virtune Crypto Altcoin Index ETP. To meet the growing demand from Finnish investors, Virtune has now expanded its offering with two additional crypto ETPs on Nasdaq Helsinki. About Virtune Avalanche ETP Virtune Avalanche ETP provides exposure to Avalanche. Like all of Virtune's exchange-traded products, Virtune Avalanche ETP is 100% physically backed and fully collateralized, denominated in EUR for the Finnish investors, available through brokers and banks such as Nordnet.
- 02/05/2025
|
Nasdaq Jumps Over 1% Despite China's Trade Concerns As Palantir, Spotify Surge: Greed Index Remains In 'Fear' Zone
- The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Fear” zone on Tuesday.
- 02/05/2025
|
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on February 3, 2025, the Compensation Committee of Praxis' Board of Directors granted non-qualified stock option awards to purchase an aggregate of 4,050 shares of its common stock and restricted stock unit awards covering an aggregate of 3,038 shares of its common stock to three new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The stock options and restricted stock units were granted as inducements material to the employees' entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/04/2025
|
Veea to Ring the Nasdaq Opening Bell on February 5, 2025
- NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Veea, Inc. (NASDAQ: VEEA), a pioneering technology company specializing in edge computing and AI with smart connectivity solutions, today announced that it will ring the Opening Bell at the Nasdaq MarketSite in Times Square, New York City on Wednesday, February 5, 2025.
- 02/04/2025
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to six new employees to purchase an aggregate of 285,000 shares of the Company's common stock, effective as of February 3, 2025. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/04/2025
|
ReTo Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal
- BEIJING , Feb. 4, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a manufacturer of equipment for production of eco-friendly materials in China, today announced that the Company received a delisting determination notice from The Nasdaq Stock Market LLC ("Nasdaq") on January 29, 2025, notifying the Company that given its Class A shares, par value US$0.10 per share (the "Class A Shares"), had a closing bid price at less than $1 over the previous 30 consecutive business days, the Company is not in compliance with the minimum bid price requirement as set forth in Listing Rule 5550(a)(2). Further, because the Company is not eligible for any compliance period since the Company has effected a reverse stock split over the prior one-year period, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Class A Shares will be scheduled for delisting from Nasdaq at the opening of business on February 7, 2025, unless the Company requests an appeal of such determination to a hearings panel (the "Panel").
- 02/04/2025
|
Nasdaq Index: Alphabet's Earnings Shock—Stock Drops 6% After Hours on Revenue Miss
- Alphabet stock drops 6% after a Q4 revenue miss despite an EPS beat. Traders react to weak cloud growth—what's next for Nasdaq and tech stocks?
- 02/04/2025
|
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 16,500 shares of Astria's common stock on February 3, 2025 under Astria's 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were gra.
- 02/04/2025
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted seven newly-hired employees options to purchase an aggregate of 130,763 shares of Akebia's common stock on January 31, 2025. The options were granted as an inducement material to teach employee entering into employment with Akebia. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/04/2025
|
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the company approved the grant of equity awards to three new employees with a grant date of February 3, 2025, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 2020 Inducement Stock Incentive Plan) and material to the employees' acceptance of employment with the company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/04/2025
|
Carbon Revolution Announces Receipt of Extension from Nasdaq Stock Market
- GEELONG, Australia, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that on January 31, 2025 it received a letter from the Nasdaq Stock Market ("Nasdaq") informing the Company that Nasdaq has granted the Company's request for an exception to Nasdaq's Listing Rule 5250(c)(1) through May 14, 2025. The exception gives the Company until May 14, 2025 to file its Annual Report on Form 20-F for the year ended June 30, 2024. The Company's securities will remain listed and traded on Nasdaq during the exception period. If the Company files the Annual Report by May 14, 2025, the securities will remain listed, so long as the Company remains in compliance with Nasdaq's listing rules.
- 02/04/2025
|
Nasdaq CEO Adena Friedman to Present at the 2025 UBS Financial Services Conference
- NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 02/04/2025
|
Nasdaq Reports January 2025 Volumes
- NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for January 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics .
- 02/04/2025
|
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on February 3, 2025 the Company granted (i) non-qualified stock options to one newly-hired non-executive employee to purchase a total of 35,000 shares of the Company's common stock at an exercise price per share of $1.27, which was the closing price per share of the Company's common stock as reported by NASDAQ on February 3, 2025, the options grant date, and (ii) restricted stock units (RSUs) representing 20,400 shares of its common stock to two newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% vesting in approximately equal monthly installments over the following thirty-six months, subject to the employee being continuously employed by the Company through each vesting date. The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employees being continuously employed by the Company through each vesting date.
- 02/04/2025
|
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on February 1, 2025, it awarded an inducement grant to three new employees under Intellia's 2024 Inducement Plan as a material inducement to employment.
- 02/04/2025
|
Nasdaq Surges Over 1%; Pfizer Earnings Top Estimates
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.
- 02/04/2025
|
NeuroOne® Regains Compliance with Nasdaq Listing Requirements
- EDEN PRAIRIE, Minn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it has regained compliance with the Nasdaq Capital Market's continued listing standard for the minimum share price requirements under Nasdaq Listing Rule 5550(a)(2).
- 02/04/2025
|
mF International Limited Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
- HONG KONG , Feb. 4, 2025 /PRNewswire/ -- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI), a Hong Kong-based experienced financial trading solutions provider, today announced that it has received an extension of 180 calendar days (the "Extension Notice") from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq (the "Bid Price Requirement"), following the expiration of the initial 180 calendar days period to regain compliance on January 28, 2025. As previously announced, the Company received a written notification from Nasdaq dated August 1, 2024, indicating that because the closing bid price of the Company's ordinary shares for the previous 30 consecutive business days was below $1.00 per share, the Company was not in compliance with the Bid Price Requirement, and Nasdaq granted the Company a period of 180 calendar days, or until January 28, 2025, to regain compliance with the Bid Price Requirement.
- 02/04/2025
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted eight newly-hired employees stock options to purchase an aggregate of 22,575 shares, and restricted stock units (RSUs) covering an aggregate of 27,550 shares, of BioCryst common stock. The options and RSUs were granted as of January 31, 2025, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/04/2025
|
Edward and Ludmila Smolyansky Request Lifeway Foods Inc. NASDAQ (LWAY) CEO Julie Smolyansky Immediately Withdraws Her Lawsuit Against Edward Smolyansky. Reiterate and Reaffirm Singular Goal Amid Ongoing Activism Battle
- Summarizes recent filings and next steps, previews upcoming proxy schedule Reaffirms and updates previously stated goal CHICAGO , Feb. 3, 2025 /PRNewswire/ -- Edward and Ludmila Smolyansky ("Founding Shareholders"), who together exercise sole voting control with respect to approximately 28% of the outstanding shares of common stock of Lifeway Foods, Inc. ("Lifeway" or the "Company"), today requested that Lifeway's Board of Directors force its CEO and Chairperson, Julie Smolyansky to immediately withdraw her most recent lawsuit filed in Cook County, IL against the Company's largest individual shareholder Edward Smolyansky. On December 23, 2024, Lifeway's Compensation Committee, led by director Jason Scher, awarded what was described as a $2 million "retention bonus.
- 02/03/2025
|
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that on February 3, 2025, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 35,000 shares of the Company's common stock to one newly hired employee. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/03/2025
|
S&P 500, Nasdaq 100 Close Lower | Closing Bell
- Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Alix Steel, Scarlet Fu, Carol Massar and Tim Stenovec. -------- More on Bloomberg Television and Markets Like this video?
- 02/03/2025
|
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective February 1, 2025, the company granted non-qualified stock options to purchase an aggregate of 83,400 shares of its common stock to four new employees under Xilio Therapeutics' 2022 Inducement Stock Incentive Plan.
- 02/03/2025
|
Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request
- Ji'an, Jiangxi, China, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) on January 29, 2025, notifying the Company that the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the “Delisting Determination”), because the bid price of the Company's listed securities has closed at less than $1 per share over the previous 30 consecutive business days, and therefore no longer complies with the Nasdaq Listing Rule 5550(a)(2) (the “Rule”). Normally, a company would be afforded a 180-calendar day period to demonstrate compliance with the Rule. However, pursuant to the Nasdaq Listing Rule 5810(c)(3)(A)(iv), the Company is not eligible for any compliance period specified in Nasdaq Listing Rule 5810(c)(3)(A) due to the fact that the Company effected a reverse stock split on November 18, 2024, or within the prior one-year period.
- 02/03/2025
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on January 31, 2025, the company granted equity awards to eight new employees, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/03/2025
|
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 130,117 shares of X4's common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by X4's Compensation Committee of the Board of Directors.
- 02/03/2025
|
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on February 3, 2025, the Compensation Committee of the company's Board of Directors granted to 18 new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 117,300 ordinary shares. These awards were made under Bicycle Therapeutics' 2024 Inducement Plan and approved by the Compensation Committee as an inducement material to the employees entering.
- 02/03/2025
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , Feb. 3, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 28,000 restricted stock units (RSUs) to three newly-hired employees.
- 02/03/2025
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 02/03/2025
|
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on January 31, 2025. Two individuals were hired by Adicet in January 2025. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 28,600 shares of Adicet's common stock with an exercise price of $0.89 pe.
- 01/31/2025
|
NioCorp Announces Closing of $5.0 Million Underwritten Offering Priced At-The-Market Under Nasdaq Rules
- CENTENNIAL, CO / ACCESS Newswire / January 31, 2025 / NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:NB) today announced the closing of its previously announced underwritten offering of 2,577,320 common shares, 2,577,320 Series A warrants to purchase up to 2,577,320 common shares (the "Series A Warrants") and 1,288,660 Series B warrants to purchase up to an additional 1,288,660 common shares (the "Series B Warrants") (the "Offering").
- 01/31/2025
|
Nasdaq Jumps Over 150 Points; Apple Posts Upbeat Earnings
- U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 150 points on Friday.
- 01/31/2025
|
Fusion Fuel to Transfer Equity Listing to The Nasdaq Capital Market; Receives Extension to Comply with Bid Price Rule
- DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), a leading provider of comprehensive energy engineering, advisory, and supply solutions, today announced that it was notified by the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Staff has approved the Company's application to transfer its Class A Ordinary Shares and publicly-traded warrants to The Nasdaq Capital Market from The Nasdaq Global Market. This transfer will take effect at the opening of business on February 3, 2025.
- 01/31/2025
|
Nasdaq 100: Tech Stocks Rally as Apple and Chipmakers Lead Market Gains Today
- Nasdaq-100 rises as Apple earnings boost tech stocks. Investors await key PCE inflation data for market direction.
- 01/31/2025
|
Celebrating 40 Years of the Nasdaq-100 Index® (NDX®)
- The combined value of all investment products tracking the NDX® ecosystem globally exceeds $500 billion
- 01/31/2025
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , Jan. 31, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on January 30, 2025, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 62,800 shares of the Company's common stock to two newly hired employees.
- 01/31/2025
|
Nasdaq wavers as shares of Nvidia, Microsoft sink
- To get the latest market news, check out finance.yahoo.com The Nasdaq Composite (^IXIC) struggled to gain on Thursday, dragged by shares of software giant Microsoft (MSFT) and chip maker Nvidia (NVDA). Microsoft fell roughly 6% after the software giant's quarterly results.
- 01/30/2025
|
Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
- HANOVER, Md, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, announces the closing of its previously announced “reasonable best efforts” public offering with participation from the Company's Chief Executive Officer, certain board members, and existing institutional investors of the Company, along with a healthcare focused institutional investor, consisting of 8,050,672 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying Series A warrants to purchase up to 8,050,672 shares of common stock (or pre-funded warrants in lieu thereof) and Series B warrants to purchase up to 4,025,336 shares of common stock at a combined purchase price per share (and accompanying warrants) of $0.615 for the institutional investors and $0.7975 for the Company's Chief Executive Officer and certain board members. The closing occurred on January 29, 2025.
- 01/30/2025
|
Nasdaq 100: Apple Falls 1.6% After Hours as iPhone Sales Miss Raises Concerns
- Apple beats earnings but misses iPhone sales, sending shares down 1.6% after hours. China revenue drops 11%—what's next for AAPL?
- 01/30/2025
|
The Real Good Food Company Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
- CHERRY HILL, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (Nasdaq: RGF) (“Real Good Foods” or the “Company ”), a leading health and wellness frozen and refrigerated foods company, is announcing its intention to voluntarily delist its common stock from the Nasdaq Stock Market, LLC (“Nasdaq”) and subsequently deregister with the Securities and Exchange Commission (“SEC”), following the decision of the Company's Board of Directors on January 27, 2025.
- 01/30/2025
|
60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- WASHINGTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 1,021,549 shares of its common stock at a purchase price of $1.021 per share. In addition, in a concurrent private placement, the Company issued unregistered short-term warrants to purchase up to an aggregate of 2,043,098 shares of common stock.
- 01/30/2025
|
What Makes Nasdaq (NDAQ) a Strong Momentum Stock: Buy Now?
- Does Nasdaq (NDAQ) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 01/30/2025
|
NASDAQ President on crypto and options explosions
- Nasdaq president Nelson Griggs and Strategas head of ETFs Todd Sohn join CNBC's Bob Pisani on "ETF Edge" to discuss the success of crypto ETFs last year and how the momentum can continue into 2025.
- 01/30/2025
|
Nasdaq Moves Lower; Meta Platforms Posts Strong Sales
- U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Thursday.
- 01/30/2025
|
Nasdaq Celebrates AI Company Wins In Home Health and Healthcare in Times Square
- DETROIT, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Amesite, Inc. (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, will be at NASDAQ tomorrow with CEO Dr. Ann Marie Sastry for a media event to include appearing on the NASDAQ Tower in Times Square. NASDAQ is recognizing Amesite's recent progress in its business plan in launching its proprietary AI app, NurseMagic™ , targeting nursing professionals and home health care workers in the healthcare industry.
- 01/30/2025
|
Nasdaq Declines As Nvidia Edges Lower, Fed Leaves Interest Rates Unchanged: Fear & Greed Index In 'Neutral' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Neutral” zone on Wednesday.
- 01/30/2025
|
Nasdaq 100 Forecast: Meta and Tesla Climb After-Hours While Microsoft Drops
- Nasdaq 100 Forecast: Meta and Tesla rally after-hours, while Microsoft slides. Stock futures edge higher—will the gains hold?
- 01/29/2025
|
urban-gro, Inc. Granted Extension by Nasdaq to Regain Compliance
- LAFAYETTE, CO / ACCESS Newswire / January 29, 2025 / urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), an integrated professional services and Design-Build firm offering solutions to the Controlled Environment Agriculture ("CEA") and other commercial sectors, today announced that it has received an exception from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"). This exception extends to February 18, 2025 the deadline for the Company to file its Quarterly Report on Form 10-Q for the fiscal quarters ended June 30, 2024 and September 30, 2024 and to file restatements of the Company's previously issued financial statements relating to annual and quarterly periods during fiscal years ended December 31, 2022 and December 31, 2023 and for the fiscal quarter ended March 31, 2024.
- 01/29/2025
|
Nasdaq 100: Microsoft and Meta Earnings Today—Will AI Investments Pay Off?
- Microsoft and Meta report earnings today, with AI investments and cloud growth in focus. Can these tech giants sustain their stock market momentum?
- 01/29/2025
|
Nasdaq CEO on Chinese AI Companies
- "I'll never underestimate the power of American innovation." Nasdaq CEO Adena Friedman discusses the competition Chinese AI companies pose to US Big Tech
- 01/29/2025
|
NioCorp Announces Pricing of $5.0 Million Underwritten Offering Priced At-The-Market Under Nasdaq Rules
- CENTENNIAL, CO / ACCESS Newswire / January 29, 2025 / NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:NB) today announced the pricing of an underwritten offering of 2,577,320 common shares, 2,577,320 Series A warrants to purchase up to 2,577,320 common shares (the "Series A Warrants") and 1,288,660 Series B warrants to purchase up to an additional 1,288,660 common shares (the "Series B Warrants") (the "Offering").
- 01/29/2025
|
Nasdaq slides, Dow stalls ahead of Fed decision, Big Tech earnings bonanza
- To get the latest market news check out finance.yahoo.com Tech-led stocks were lower on Wednesday morning as the broader mood stayed muted ahead of the first Big Tech earnings and the Federal Reserve's interest rate decision. The tech-heavy Nasdaq Composite (^IXIC) fell more 0.7%, after a bounce-back rally on Tuesday.
- 01/29/2025
|
Nasdaq's Q4 Earnings Surpass Estimates on Higher Revenues
- NDAQ's fourth-quarter results reflect organic growth, higher revenues across three divisions as well as reduced expenses.
- 01/29/2025
|
Nasdaq Down Over 100 Points; Corning Posts Upbeat Earnings
- U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 100 points on Wednesday.
- 01/29/2025
|
Nasdaq, Inc. (NDAQ) Q4 2024 Earnings Call Transcript
- Nasdaq, Inc. (NASDAQ:NDAQ ) Q4 2024 Earnings Conference Call January 29, 2025 8:00 AM ET Company Participants Ato Garrett - SVP and IR Officer Adena Friedman - Chair and CEO Sarah Youngwood - EVP and CFO Conference Call Participants Alexander Blostein - Goldman Sachs Craig Siegenthaler - Bank of America Patrick Moley - Piper Sandler Benjamin Budish - Barclays Michael Cho - JPMorgan Dan Fannon - Jefferies Owen Lau - Oppenheimer Michael Cyprys - Morgan Stanley Jeff Schmitt - William Blair Ashish Sabadra - RBC Alex Kramm - UBS Brian Bedell - Deutsche Bank Operator Good day and thank you for standing by. Welcome to Nasdaq Fourth Quarter and Full Year 2024 Results Conference Call.
- 01/29/2025
|
Nasdaq (NDAQ) Reports Q4 Earnings: What Key Metrics Have to Say
- While the top- and bottom-line numbers for Nasdaq (NDAQ) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 01/29/2025
|
Nasdaq Inc shares fall on earnings but CEO hails 'transformational year'
- Shares in Nasdaq Inc (NASDAQ:NDAQ) fell over 4% in early trading after the New York exchange operator reported its own earnings. "2024 was a transformative year for Nasdaq," said chair and CEO Adena Friedman, with the integration of AxiomSL and Calypso into its Financial Technology division.
- 01/29/2025
|
Nasdaq Tops Q4 EPS, Revenue Expectations
- Nasdaq (NDAQ -3.76%), a leading global technology company and stock exchange operator, reported fourth-quarter 2024 earnings on Wednesday, Jan. 29, that topped analysts' consensus estimates. Adjusted EPS came in at $0.76, surpassing Wall Street expectations of $0.75.
- 01/29/2025
|
Nasdaq (NDAQ) Tops Q4 Earnings Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.72 per share a year ago.
- 01/29/2025
|
Nasdaq CEO Adena Friedman on Q4 results: It's been a transformative year for the company
- Nasdaq CEO and chair Adena Friedman joins 'Squawk Box' to discuss the company's quarterly earnings results, state of the IPO market, impact of AI technology, and more.
- 01/29/2025
|
Nasdaq Announces Quarterly Dividend of $0.24 Per Share
- NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.24 per share on the company's outstanding common stock. The dividend is payable on March 28, 2025 to shareholders of record at the close of business on March 14, 2025. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors.
- 01/29/2025
|
Nasdaq 100: ASML's 9% Surge Lifts Nvidia, AMAT, and Semiconductor Stocks
- ASML shares jump 9% as strong chip orders ease AI spending fears. Traders eye semiconductor stocks as demand for high-end chips remains resilient.
- 01/29/2025
|
Nasdaq Jumps 2% After Nvidia, Other Tech Stocks Bounce Back From DeepSeek Hit: Greed Index Remains In 'Fear' Zone
- The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Fear” zone on Tuesday.
- 01/29/2025
|
DevvStream Discloses Nasdaq Notice and Provides Update
- Calgary, Alberta--(Newsfile Corp. - January 28, 2025) - DevvStream Corp. (NASDAQ: DEVS) ("DevvStream" or the "Company"), a leading carbon credit project co-development and generation firm specializing in technology-based solutions, today announced that it received a notice (the "Notice") on January 22, 2025 from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") because the Company has not yet filed its Form 10-Q for the period ended September 30, 2024 ("Form 10-Q") with the U.S. Securities and Exchange Commission. Following receipt of the Notice, the Company filed the Form 10-Q on January 23, 2025.
- 01/28/2025
|
Nasdaq jumps to chip away at DeepSeek-fueled rout as Nvidia surges nearly 9%
- To get the latest market news, check out finance.yahoo.com The Nasdaq and S&P 500 rebounded on Tuesday, following a steep stock sell-off spurred by Chinese startup DeepSeek and the ripple effect its potentially cheaper AI model could have on Big Tech. Bellwether Nvidia (NVDA) was the standout of the trading day, with shares finishing the day up nearly 9% after it shaved off a record $589 billion from its market cap in the previous session.
- 01/28/2025
|
Blue Hat Announces Receipt of Nasdaq Delisting Notice Subject to Hearing Request
- XIAMEN, China, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), today announced that on January 24, 2025, it has received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), notifying that the Company is not in compliance with Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”), as the Company's securities had a closing bid price of $0.10 or less for ten consecutive trading days from January 8, 2025 through January 23, 2025. The letter indicated that, as a result, the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the “Delisting Determination”).
- 01/28/2025
|
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it has entered into a securities purchase agreement with a single healthcare-focused institutional investor for the purchase and sale of 19,685,040 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 19,685,040 shares of common stock in a registered direct offering (the "Offering") at a combined purchase price of $1.27 per share and accompanying warrant, priced at-the-market under Nasdaq rules. The warrants will have an exercise price of $1.20 per share, will be immediately exercisable upon issuance and will expire 5 years from issuance.
- 01/28/2025
|
S&P500 and Nasdaq: AI Stocks Rally Midday as Nvidia and Cybersecurity Lead the Recovery
- Tech stocks lead Nasdaq 1.5% higher midday after Nvidia's rebound. AI competition looms as traders await key earnings and Fed updates this week.
- 01/28/2025
|
Nasdaq, S&P 500 look to chip away at losses after DeepSeek-inspired tech rout
- To get the latest market news, check out finance.yahoo.com The Nasdaq and S&P 500 rebounded on Tuesday, following a steep stock sell-off spurred by concerns of over-confidence in Big Tech's potential payoff from investments in AI. Investors also assessed a return to a tougher tone on tariffs from President Donald Trump, ahead of the start of a Federal Reserve meeting where the impact of his policies is likely to be discussed.
- 01/28/2025
|
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Tuesday.
- 01/28/2025
|
Fenbo Holdings Limited Receives Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- Hong Kong, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Fenbo Holdings Limited (NASDAQ: FEBO) (the “Company” or “Fenbo”), an established original equipment manufacturer (OEM) for Spectrum Brands, a global home essentials company, producing electrical hair styling products under the “Remington” brand, announced that the Company received a letter on January 16, 2025 (the “Determination Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Determination Letter notified the Company that it is not in compliance with Nasdaq Listing Rule 5620(a) and 5810(c)(2)(G), which requires that Nasdaq-listed companies hold an annual meeting of shareholders within twelve months of their fiscal year end (the “Annual Meeting Requirement”), because the Company did not hold an annual meeting of shareholders within twelve months of its fiscal year end December 31, 2023. The notification received has no immediate effect on the Company's Nasdaq listing. In accordance with Nasdaq rules, the Company has 45 calendar days, or until March 3, 2025 to submit a plan to regain compliance with the Annual Meeting Requirement.
- 01/28/2025
|
Nasdaq 100 Futures: Nvidia Rebound or Renewed Pressure? AI Concerns Loom
- Nvidia, S&P 500, and Nasdaq erase earlier gains as AI fears persist. Investors brace for earnings and Fed signals amid volatile market conditions.
- 01/28/2025
|
Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement
- COPENHAGEN, Denmark, January 28, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, has received notice from the Nasdaq Stock Market LLC (“Nasdaq”) that it has been granted a 180-day extension to comply with Nasdaq's minimum stockholder's equity requirement. Meanwhile, Evaxion has already restored its equity above the Nasdaq minimum requirement.
- 01/28/2025
|
Spectral Capital Submits Application for Uplisting to the Nasdaq Capital Market
- SEATTLE , Jan. 28, 2025 /PRNewswire/ -- Spectral Capital Corporation (OTCQB: FCCN) ("Spectral" or the "Company"), a deep quantum technology platform company, is pleased to announce it has submitted an application to uplist the Company's common shares on the Nasdaq Capital Market® ("Nasdaq"). "A Nasdaq uplist is the next logical step in Spectral's growth journey," stated Sean Michael Brehm, Chairman of Spectral Capital.
- 01/28/2025
|
Nasdaq 100: Nvidia's Plunge Highlights Risk of Concentrated Bets in U.S. Indices
- Nasdaq 100 drops 3% as AI disruption raises fears of overvaluation. Traders reassess portfolios, seeking opportunities beyond megacap tech stocks.
- 01/28/2025
|
Nasdaq Dips 3% As Nvidia, Other Chip Stocks Tumble: Investor Sentiment Declines, Greed Index Moves To 'Fear' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the “Fear” zone on Monday.
- 01/28/2025
|
Euronext to acquire Nasdaq's Nordic power futures business
- Euronext to acquire Nasdaq's Nordic power futures business Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris / New York – 28 January 2025 – Euronext (Euronext: ENX), the leading European capital market infrastructure, and Nasdaq (Nasdaq: NDAQ), a leading transatlantic market operator and global technology company, today announced the signing of a binding agreement under which Euronext will acquire Nasdaq's Nordic power futures business, subject to receipt of applicable regulatory approvals. The agreement entails the transfer of existing open positions in Nasdaq's Nordic power derivatives, currently held in Nasdaq Clearing, to Euronext Clearing, with approval of the members.
- 01/28/2025
|
Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
- HANOVER, MD, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced the pricing of its “reasonable best efforts” public offering with participation from the Company's Chief Executive Officer, certain board members, and existing institutional investors of the Company, along with a healthcare focused institutional investor, consisting of 8,050,672 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying Series A warrants to purchase up to 8,050,672 shares of common stock (or pre-funded warrants in lieu thereof) and Series B warrants to purchase up to 4,025,336 shares of common stock at a combined purchase price per share (and accompanying warrants) of $0.615 for the institutional investors and $0.7975 for the Company's Chief Executive Officer and certain board members.
- 01/27/2025
|
BriaCell Announces Completion of 15:1 Share Consolidation
- PHILADELPHIA and VANCOUVER, British Columbia, Jan. 27, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announces that on January 24, 2025 (the “Effective Date”), the Company completed a share consolidation (the “Consolidation”) of the Company's issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-Consolidation Common Share for every fifteen (15) pre-Consolidation Common Shares. The Consolidation is being implemented to ensure that the Company continues to comply with the listing requirements of The Nasdaq Capital Market (the “Nasdaq”).
- 01/27/2025
|
Intelligent Living Application Group Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- HONG KONG , Jan. 27, 2025 /PRNewswire/ -- Intelligent Living Application Group Inc. (NASDAQ: ILAG) ("Intelligent Living" or the "Company"), a premium lockset manufacturer in Hong Kong, announced today that, on January 23, 2025, the Company received a letter from the Nasdaq Stock Market ("Nasdaq") notifying the Company that, because the closing bid price for the Company's ordinary shares listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company no longer meets the minimum bid price requirement for continued listing on Nasdaq under Nasdaq Marketplace Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share (the "Minimum Bid Price Requirement"). The notification has no immediate effect on the listing of the Company's ordinary shares.
- 01/27/2025
|
Nasdaq Tumbles: NVIDIA, Broadcom and Microsoft Pull the Market Down
- The Nasdaq is currently experiencing a significant pullback.
- 01/27/2025
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 15, 2025
- NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of January 15, 2025, short interest in 3,099 Nasdaq Global MarketSM securities totaled 12,402,417,655 shares compared with 12,137,206,474 shares in 3,085 Global Market issues reported for the prior settlement date of December 31, 2024. The mid-January short interest represents 2.56 days compared with 2.50 days for the prior reporting period.
- 01/27/2025
|
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards
- MOCKSVILLE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it has received formal written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the Nasdaq Minimum Bid Price Requirement for continued listing pursuant to Nasdaq Listing Rule 5550(a)(2).
- 01/27/2025
|
Nasdaq clobbered, S&P 500 tumbles as AI fears rock Nvidia, tech stocks
- To get the latest market news check out finance.yahoo.com The Nasdaq sank on Monday to lead a stock sell-off on Wall Street as a Chinese startup rattled faith in US leadership and profitability in AI, taking a hammer to Nvidia (NVDA) and other Big Tech stocks. The tech-heavy Nasdaq Composite (^IXIC) sank nearly 3.5%, while the S&P 500 (^GSPC) dropped nearly 2%.
- 01/27/2025
|
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
- BERKELEY, Calif. and MAINZ, Germany, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that on January 23, 2025, the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that it has regained compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market set forth in Listing Rule 5550(b)(1).
- 01/27/2025
|
Lichen China Limited Announces Receipt of Notification from Nasdaq
- XIAMEN, China , Jan. 27, 2025 /PRNewswire/ --Lichen China Limited (Nasdaq: LICN ) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has received a written notification (the "Notification Letter") from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on January 23, 2025. The Notification Letter advised the Company that for the last 30 consecutive business days, the minimum closing bid price per share for the Company's ordinary shares was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2).
- 01/27/2025
|
Nasdaq to slump as Nvidia leads Wall Street pummeling on global tech sell-off
- Wall Street looked set to take a beating ahead of Monday's trading as a global technology sector sell-off sparked by China's DeepSeek threatened to weigh. Futures had the Nasdaq off 4.2% ahead of the opening bell, while the Dow Jones and S&P 500 were seen 0.9% and 2.4% lower respectively.
- 01/27/2025
|
Is a Beat in the Cards for Nasdaq This Earnings Season?
- NDAQ's Q4 performance is likely to have been driven by price increases, new sales, higher subscription revenues as well as growth in trading volume.
- 01/24/2025
|
Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements
- NEW YORK , Jan. 24, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) (the "Company" or "Hoth Therapeutics"), a biopharmaceutical company, today announced that it has received notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). The Company received written notification from Nasdaq on January 23, 2025, stating that because the Company's common stock had a closing bid price at or above $1.00 per share for 10 consecutive business days, from January 7, 2025 to January 22, 2025, the Company has regained compliance with Listing Rule 5550(a)(2), and this matter is now closed.
- 01/24/2025
|
Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the closing of its previously announced private placement for the issuance and sale of an aggregate of 2,007,880 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase up to 2,007,880 shares of common stock at a purchase price of $1.27 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrant priced at-the-market under the rules of the Nasdaq Stock Market. The gross proceeds from the offering were approximately $2.55 million, prior to deducting placement agent's fees and other offering expenses payable by the Company.
- 01/23/2025
|
Tuanche Limited announces the receipt of Nasdaq non-compliance notifications regarding the annual meeting and the minimum stockholders' equity requirements
- BEIJING, China, Jan. 23, 2025 (GLOBE NEWSWIRE) -- TuanChe Limited (“TuanChe,” “Company,” “we,” or “our”) (NASDAQ: TC), a leading automotive marketplace platform in China, announced today that on January 16, 2025, it received two notification letters from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”). The letters notified the Company of its non-compliance with the annual meeting requirement and the minimum stockholders' equity requirement, as outlined in the Nasdaq Listing Rules (the “Rules”) for continued listing on the Nasdaq stock exchange.
- 01/23/2025
|
Nuvini Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
- NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq: NVNI) (“Nuvini”) today announces that on January 23, 2025, the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2). As previously disclosed, on July 16, 2024, the Company was notified by Nasdaq that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) because its common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days.
- 01/23/2025
|
Final Trades: Freeport-McMoRan, Clearway Energy and Nasdaq
- The Investment Committee give you their top stocks to watch for the second half.
- 01/23/2025
|
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on January 21, 2025, it granted stock options to purchase an aggregate of 275,000 shares of common stock upon vesting to Delphine Imbert, Ph.D., the Company's newly appointed Chief Technical Officer, as a material inducement to her employment.
- 01/22/2025
|
Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20%
- Shares of Grail, Inc. (GRAL) surged 20% intraday Wednesday, putting the medical technology company above the likes of Arm Holdings (ARM) and Netflix (NFLX) to be the biggest gainer in the Nasdaq 100 index in recent trading.
- 01/22/2025
|
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings
- U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Wednesday.
- 01/22/2025
|
Nasdaq (NDAQ) Earnings Expected to Grow: Should You Buy?
- Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/22/2025
|
Nasdaq 100: Tech Stocks Poised for Gains at Opening Bell on Netflix, AI Optimism
- Nasdaq 100 climbs at the opening bell as Netflix's stellar earnings and AI investments fuel tech stock momentum. Will the rally sustain?
- 01/22/2025
|
Nasdaq and tech gains to drive gains, with Netflix and Oracle set to surge
- US stocks are set to head higher again on Wednesday, led by the tech-powered Nasdaq and with a continued focus on new policy announcements from the White House as well as Netflix after its impressive update overnight. Nasdaq 100 futures were up 0.9%, with S&P 500 futures pointing to gains around 0.5% and those for the Dow Jones 0.3%, with the Russell 2000 called just above flat.
- 01/22/2025
|
Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)
- WEXFORD, Pa. , Jan. 22, 2025 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious diseases, today announced it has regained compliance with Listing Rule 5550(a)(2) (the "Bid Price Rule"), as required by the Nasdaq Hearings Panel's decision of September 17, 2024.
- 01/22/2025
|
Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2,007,880 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase up to 2,007,880 shares of common stock at a purchase price of $1.27 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrant in a private placement priced at-the-market under the rules of the Nasdaq Stock Market. The warrants will have an exercise price of $1.27 per share, will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants and will expire five years from the effective date of stockholder approval.
- 01/22/2025
|
Santech Holdings Limited Announces Change of Auditor and Filing of Compliance Plan with Nasdaq
- HONG KONG, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Change of Auditor On January 22, 2025, Santech Holdings Limited (“the Company”) announced that its Audit Committee has approved the appointment of Audit Alliance LLP (“Audit Alliance”) as the Company's independent registered public accounting firm. The Audit Committee has dismissed Marcum Asia CPAs LLP (“MarcumAsia”) as its independent registered public accounting firm, effective from November 15, 2024.
- 01/22/2025
|
History Says the Nasdaq Will Soar in 2025. 1 Unstoppable Stock Is Surging Right Now.
- The Nasdaq Composite has been on a non-stop thrill ride for more than two years and shows no signs of slowing. A number of factors have contributed to the rally, including waning inflation, falling interest rates, higher corporate earnings, and the advent of artificial intelligence (AI).
- 01/22/2025
|
District to Commence Trading on Nasdaq First North Growth Market in Sweden
- Vancouver, British Columbia--(Newsfile Corp. - January 22, 2025) - District Metals Corp. (TSXV: DMX) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company") is pleased to announce that the Company has received confirmation that its Nasdaq First North Growth Market ("Nasdaq First North") listing application has been approved. As a result, District's depositary receipts (the "DMX SDRs") will begin trading on Nasdaq First North at market open (Sweden local time) on January 23, 2025, under the symbol "DMXSE SDB".
- 01/22/2025
|
Nasdaq Report Identifies Between $25 Billion and $50 Billion in Potential Efficiency Gains in Banks' Risk and Compliance Functions
- The savings, which would come at greater or equal effectiveness, could generate up to $1 trillion in additional lending capacity The savings, which would come at greater or equal effectiveness, could generate up to $1 trillion in additional lending capacity
- 01/22/2025
|
Nasdaq 100: Netflix Adds $40B to Market Cap With Strong 2025 Forecast
- Netflix surges 10% in after-hours trade, adding $40B to market cap. Record 41M new subscribers and strong 2025 revenue guidance fuel investor optimism.
- 01/21/2025
|
HUB Security Announces Receipt of Staff Delisting Notice
- TEL AVIV, Israel, Jan. 21, 2025 (GLOBE NEWSWIRE) -- via IBN – HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or the “Company”), a leading provider of cybersecurity solutions and advanced data fabric, announced receipt of a Staff Delisting Determination (the “Staff Determination”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq”). In accordance with the minimum bid price required for continued listing under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”), the Company was provided until January 13, 2025, to regain compliance with the Minimum Bid Price Requirement, and as of this date the Company has not regained compliance with the requirement. Accordingly, the Staff Determination serves as a basis for delisting of the Company's securities from The Nasdaq Stock Market.
- 01/21/2025
|
Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Raised approximately $12.08 million in gross proceeds since beginning of December 2024 Proceeds intended to be directed for development costs to be incurred in connection with PH-762 clinical activities Marlborough, Massachusetts--(Newsfile Corp. - January 21, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced the closing of its registered direct offering previously announced on January 16, 2024, priced at-the-market under Nasdaq rules, for the purchase and sale of an aggregate of 610,000 shares of its common stock at a purchase price of $3.00 per share. In addition, in a concurrent private placement, the Company issued short-term unregistered warrants to purchase up to an aggregate of 1,220,000 shares of common stock.
- 01/21/2025
|
Nasdaq Jumps 100 Points; Charles Schwab Profit Beats Estimates
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Tuesday.
- 01/21/2025
|
SRIVARU Holding Received Nasdaq Panel Decision on Delisting Notice & Company Appealed
- GRAND CAYMAN, Cayman Islands, Jan. 21, 2025 (GLOBE NEWSWIRE) -- SRIVARU Holding Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), issued a press release on January 21, 2025, announcing that it had received a determination from Nasdaq on January 17, 2025, to delist the Company's shares for failure to regain compliance with the minimum $1.00 bid price per share requirement of Nasdaq's Marketplace Rule 5450(a)(1). The Company's ordinary shares began trading on a reverse share split adjusted basis on Nasdaq as of the open of trading on January 15, 2025, but failed to close with a bid price greater than $1.00.
- 01/21/2025
|
Nasdaq CEO Adena Friedman on investment landscape, crypto regulation and 2025 outlook
- Nasdaq CEO and chair Adena Friedman joins 'Squawk Box' to discuss the latest market trends, expectations for the incoming Trump administration, investment landscape in the U.S., DEI in corporate America, future of crypto, and more.
- 01/21/2025
|
Forafric Announces Nasdaq Compliance Status
- CASABLANCA, MOROCCO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Forafric Global PLC (Nasdaq: AFRI, or the “Company”), a vertically integrated agribusiness serving Africa, today announced that on January 14, 2025, it received written notice from the listing qualifications department of The Nasdaq Stock Market (“Nasdaq”) stating that since the Company has not yet filed a Form 6-K containing an interim balance sheet and income statement as of the end of its second quarter (the “Six Month Report”) by December 31, 2024, the Company was not in compliance with Listing Rule 5250 (c) (2) (the “Rule”).
- 01/21/2025
|
QQA: Unique Nasdaq Exposure With High Income Potential
- Invesco QQQ Income Advantage ETF offers a 10.3% dividend yield, providing income while maintaining exposure to high-quality large-cap companies similar to QQQ. QQA's dynamic option overlay strategy adjusts to market conditions, potentially outperforming in sideways or volatile markets but capping upside potential during bull runs. QQA is too new to gauge long-term resilience or performance in market downturns, and its dividends are classified as ordinary, leading to higher tax burdens.
- 01/21/2025
|
Nasdaq Surges 1.5% Amid Gains In Tesla, Nvidia: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
- The CNN Money Fear and Greed index showed an improvement in overall market sentiment, but the index remained in the “Fear” zone on Friday.
- 01/21/2025
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , Jan. 20, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on January 20, 2025, the Human Capital Management Committee of Avidity's Board of Directors granted a non-qualified stock option award to purchase an aggregate of 10,500 shares of its common stock and 5,250 restricted stock units ("RSUs") to one (1) new non-executive employee under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/20/2025
|
S&P 500, Nasdaq 100, Dow Jones: Will Trump's Policies Boost or Drag US Stock Indices?
- How will Trump's 2025 policy shifts affect US stock indices? Explore the impact of tariffs, tax cuts, and deregulation on the S&P 500, Nasdaq 100, and Dow Jones.
- 01/20/2025
|
Finland welcomes Virtune with the First Five Crypto ETPs listed on Nasdaq Helsinki traded in euro
- Helsinki, January 20th, 2025 – Virtune, the Swedish regulated crypto asset manager, today announced the listing of Finland's first crypto exchange-traded products (ETP) on Nasdaq Helsinki. This makes it easy and secure for Finnish investors to invest in crypto assets through proven and well-established financial instruments in the local currency.
- 01/20/2025
|
Millicom (Tigo) share repurchase activity
- Millicom (Tigo) share repurchase activity Luxembourg, January 20, 2025 - Pursuant to the share repurchase program announced on November 29, 2024, Millicom repurchased 140,587 of its Swedish Depository Receipts (SDRs) and 95,600 of its common shares between January 13, 2025, and January 17, 2025, as detailed in the table below. Exchange Nasdaq Stockholm Nasdaq Stock Market Trade Date Number of SDRs repurchased Average price paid* (SEK) Repurchase amount* (SEK) Number of shares repurchased Average price paid* (USD) Repurchase amount* (USD) 2025-01-13 89 585 266.9617 23 915 764 47 800 23.9970 1 147 057 2025-01-14 51 002 271.9101 13 867 959 47 800 24.5286 1 172 467 * Excluding commissions All purchases were carried out on Nasdaq Stockholm and on the Nasdaq Stock Market by Citigroup Global Markets Limited and Citigroup Global Markets Inc. respectively, on behalf of Millicom.
- 01/20/2025
|
History Says the Nasdaq Could Soar in 2025. Here Is 1 Dirt-Cheap Artificial Intelligence (AI) Semiconductor Stock to Buy Right Now.
- The Nasdaq Composite (^IXIC 1.51%) has been soaring over the last two years, thanks in large part to growing opportunities in the field of artificial intelligence (AI).
- 01/20/2025
|
Is the Nasdaq Headed for a Correction? 3 High-Flying AI Stocks to Buy if Prices Fall.
- It's been a fun couple of years for the technology sector. The arrival of artificial intelligence (AI) has injected growth into various companies and raised long-term expectations, resulting in surging share prices for the top AI stocks and new highs for the tech-heavy Nasdaq Composite index.
- 01/19/2025
|
History Says the Nasdaq Will Soar in 2025: 1 Artificial Intelligence (AI) Growth Stock to Buy Before It Does
- Since ChatGPT was released on Nov. 30, 2022, the S&P 500 (^GSPC 1.00%) and Nasdaq Composite (^IXIC 1.51%) have boasted total returns of 48% and 69%, respectively.
- 01/18/2025
|
SIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders' Equity Deficiency and Annual Meeting Deficiency
- Singapore, Jan. 17, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), an advanced technology solution provider in the emerging property-technology (“PropTech”) space, today announced that it has received letters from the Listing Qualification staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the Company does not meet the minimum stockholders' equity requirement and annual meeting requirement.
- 01/17/2025
|
Jianzhi Education Technology Group Company Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- BEIJING, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a leading provider of digital educational content in China, today announced that the Company has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated January 15, 2025, indicating that for the last 30 consecutive business days, the closing bid price for the Company's American depositary shares (the “ADSs”) was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rules. The Nasdaq notification letter has no current effect on the listing or trading of the Company's ADSs on The Nasdaq Capital Market.
- 01/17/2025
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 7,750 restricted stock units of the company's common stock to eight newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of January 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/17/2025
|
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective January 1, 2025, the company granted a non-qualified stock option to purchase 60,000 shares of its common stock to one new employee under Xilio Therapeutics' 2022 Inducement Stock Incentive Plan.
- 01/17/2025
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 48,000 shares of its common stock to three newly hired employees, consisting of inducement stock options to pu.
- 01/17/2025
|
Nature's Miracle Holding Inc. Addresses Nasdaq Delisting and Steps Forward
- ONTARIO, Calif. , Jan. 17, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, today issued the following statement in response to the delisting notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq"), which indicated that the Nasdaq Hearings Panel has determined to delist the Company's common stock and warrants from Nasdaq due to the Company's failure to comply with minimum shareholder's equity requirement under Nasdaq Listing Rule 5550(b)(1).
- 01/17/2025
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on January 13, 2025, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 23,782 shares of common stock and 13,928 restricted stock units (“RSUs”) to twelve new employees under Acadia's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' e.
- 01/17/2025
|
Wearable Devices Announces Receipt of Nasdaq Notification of Minimum Stockholders' Equity Non-Compliance
- Yokneam Illit, Israel, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), an award-winning pioneer in artificial intelligence (“AI”)-based wearable gesture control technology, today announced that it has received a written notification (the "Notification Letter") from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is no longer in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market, listing Rule 5550(b)(1), due to its failure to maintain a minimum of $2,500,000 in stockholders' equity. In the Company's Report of Foreign Private Issuer on Form 6-K, dated September 23, 2024, the Company reported stockholders' equity of approximately $1,695,000 as of June 30, 2024.
- 01/17/2025
|
Nasdaq Surges Over 300 Points; State Street Earnings Top Views
- U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 1% on Friday.
- 01/17/2025
|
Nasdaq 100: Nvidia, Broadcom Surge as Intel Soars on Takeover Speculation
- Wall St rallies as Intel, Nvidia, and SLB lead gains. Banks surge 6%, while Truist climbs on strong profits.
- 01/17/2025
|
District Publishes Company Description in Connection with Listing on the Nasdaq First North Growth Market in Sweden
- Vancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - District Metals Corp. (TSXV: DMX) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company"). On Thursday December 12, 2024 Nasdaq Stockholm AB approved Districts application for admission to trading the Company's depositary receipts (the "DMX SDRs") on the Nasdaq First North Growth Market ("Nasdaq First North").
- 01/17/2025
|
What's the Better Long-Term Investment: The Nasdaq-100 or the Top S&P 500 Growth Stocks?
- If you're investing in the long term, growth stocks can help you maximize your gains. They can offer superior gains to dividend stocks, which often prioritize making recurring payments over growing their operations at high rates.
- 01/17/2025
|
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to one newly hired employee. The awards were made as inducements material to the individual's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/17/2025
|
Argo Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- LONDON, UNITED KINGDOM / ACCESS Newswire / January 17, 2025 / Argo Blockchain plc (LSE:ARB)(NASDAQ:ARBK), announces today that it has received written notification (the "Notification Letter") from the Nasdaq Stock Market LLC Listing Qualifications Department ("Nasdaq") that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rule 5450(a)(1) since the closing bid price for the Company's American Depositary Shares ("ADS") listed on the Nasdaq Global Select Market was below $1.00 for 30 consecutive business days. In accordance with Listing Rule 5810(c)(3)(A), the Company has until 15 July 2025, to regain compliance with the minimum bid price requirement, during which time the ADSs are expected to continue to trade on the Nasdaq Global Select Market.
- 01/17/2025
|
CarParts.com, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
- TORRANCE, Calif. , Jan. 16, 2025 /PRNewswire/ -- CarParts.com, Inc. (Nasdaq: PRTS), a leading e-commerce provider of automotive parts and accessories, today announced that it has received notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2).
- 01/16/2025
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 145,550 shares of common stock. Awards were made to nine new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committ.
- 01/16/2025
|
Brenmiller Energy Ltd. Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- ROSH HA'AYIN, Israel--(BUSINESS WIRE)---- $BNRG--Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy” or the “Company”) (Nasdaq: BNRG), a leading global provider of thermal energy storage (“TES”) solutions for industrial and utility customers, announced today that it has received a written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires.
- 01/16/2025
|
Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates
- U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 150 points on Thursday.
- 01/16/2025
|
Nasdaq Calypso to Ease Novobanco's Capital Market Operations
- Nasdaq and Novobanco's technology partnership will help the bank use the Calypso platform for its entire capital market operations.
- 01/16/2025
|
Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Marlborough, Massachusetts--(Newsfile Corp. - January 16, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 610,000 shares of its common stock at a purchase price of $3.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue short-term unregistered warrants to purchase up to an aggregate of 1,220,000 shares of common stock.
- 01/16/2025
|
Nasdaq 100: Tesla Falls 3.7% as Tech Slides on Bessent's Tax Cut Warning
- Nasdaq tech stocks tumble as Tesla drops 3.7%. Fed's Waller hints at rate cuts, and Bessent warns of economic risks if 2017 tax cuts are not renewed.
- 01/16/2025
|
Nasdaq Grants Momentus Inc. Continued Listing
- SAN JOSE, Calif.--(BUSINESS WIRE)--Momentus Inc. (NASDAQ: MNTS) (the “Company” or “Momentus”), a U.S. commercial space company, announced today that the Nasdaq Hearings Panel issued a letter granting the Company's request to continue its listing on The Nasdaq Capital Market until April 15, 2025, while the Company executes its plan to regain compliance with the requirements of Nasdaq Listing Rule 5550(b). Additionally, the Nasdaq Hearings Panel confirmed that the Company has regained compliance.
- 01/16/2025
|
Nasdaq, S&P 500 to extend gains after soft core inflation reading
- Wall Street appeared on course for a mixed start on Thursday after Wednesday's rally in the wake of soft core inflation figures for December. Futures had the Nasdaq adding another 0.5% and the S&P 500 rising by 0.3% ahead of the opening bell.
- 01/16/2025
|
Luokung Announces Receipt of Nasdaq Notices Regarding the Periodic Filing
- BEIJING, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Luokung Technology Corp. (NASDAQ: LKCO) (“Luokung” or the “Company”) today announced that on January 9, 2025 (the “First Letter”) and January 13, 2025 (the “Second Letter”), the Company received two letters from the Nasdaq Stock Market LLC (“Nasdaq”).
- 01/15/2025
|
Should You Buy the Dip in Nasdaq ETFs?
- Wall Street wavers due to speculation that the Fed may pause rate cuts amid a strong economy and higher inflation.
- 01/15/2025
|
Nasdaq Surges Over 2%; Goldman Sachs Posts Upbeat Q4 Results
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Wednesday.
- 01/15/2025
|
Rail Vision Regains Compliance with Nasdaq Minimum Bid Price Rule
- Ra'anana, Israel, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related market, today announced that it has received a written notice from Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2). Rail Vision is now in compliance with all applicable listing standards and its ordinary shares will continue to be listed and traded on the Nasdaq Capital Market.
- 01/15/2025
|
TOMI Environmental Solutions Regains Compliance with Nasdaq Minimum Bid Price Requirements
- FREDERICK, Md., Jan. 15, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announced today that as of January 14, 2025, the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) after the closing bid price of the Company's common stock was $1.00 per share or greater for 10 consecutive trading days. Accordingly, the Company's common stock will continue to be listed on The Nasdaq Capital Market and trade under the symbol “TOMZ”.
- 01/15/2025
|
Why I'm Still Choosing To Invest In The Nasdaq-100 With QQQM
- US Tech drives global innovation and growth, with the "Magnificent 7" delivering strong earnings and revenue. Long-term investors risk missing out without Tech exposure. In my view, US Tech justifies its premium with strong profitability, inflation resistance, and competitive moats. QQQM is an efficient, cost-effective way to gain Nasdaq 100 exposure. Over the long term, stocks have shown a consistent upward trajectory, mostly driven by currency debasement, making it in my view unlikely for valuations to revert to historical averages.
- 01/15/2025
|
Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Marlborough, Massachusetts--(Newsfile Corp. - January 15, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 833,335 shares of its common stock at a purchase price of $3.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue short-term unregistered warrants to purchase up to an aggregate of 1,666,670 shares of common stock.
- 01/15/2025
|
2 Nasdaq-100 Stocks That Are No-Brainer Buys in 2025, and 1 to Avoid
- The second year of Wall Street's bull market rally didn't disappoint. Although all three major stock indexes climbed to numerous record-closing highs throughout 2024, it's growth stocks that continued to lead the charge.
- 01/15/2025
|
Novobanco Expands Technology Partnership with Nasdaq Calypso to Simplify its Capital Market Operations
- Portugal's 4 th largest bank expands Nasdaq partnership, adopting Calypso's Front Office and Risk platform
- 01/15/2025
|
Nature's Miracle Holding Inc. Announces Receipt of Delisting Notification from Nasdaq
- ONTARIO, Calif. , Jan. 14, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, today announced that on January 13, 2025, the Company received written notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Nasdaq Hearings Panel has determined to delist the Company's common stock and warrants from Nasdaq due to the Company's failure to comply with minimum shareholder's equity requirement under Nasdaq Listing Rule 5550(b)(1).
- 01/14/2025
|
S&P 500, Nasdaq reverse early gains after PPI inflation data
- To get the latest market news check out finance.yahoo.com US stocks traded mixed after initially rising early Tuesday as investors took in the first of two key inflation reports this week, which showed prices rose less than expected in December. Also in focus was a report that the incoming Trump administration could hike tariffs more gradually to ease inflationary pressures.
- 01/14/2025
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 35,250 shares of Class A common stock and restricted stock units (RSUs) for 17,625 shares of Class A common stock to six new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/14/2025
|
Nasdaq and S&P 500 Slip as Nvidia, Meta Fall; Tesla and Financials Shine
- Producer price data signals softer inflation, lifting Dow. Nasdaq, S&P 500 under pressure as Nvidia and Meta fall.
- 01/14/2025
|
Superior Group of Companies to Commemorate 105 Years by Ringing Nasdaq Closing Bell
- ST. PETERSBURG, Fla., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Michael Benstock, Chairman, President and Chief Executive Officer, will ring the Nasdaq Stock Market Closing Bell on Thursday, January 16, 2025, to commemorate the company's 105-year legacy.
- 01/14/2025
|
Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Marlborough, Massachusetts--(Newsfile Corp. - January 14, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,063,670 shares of its common stock at a purchase price of $3.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue short-term unregistered warrants to purchase up to an aggregate of 2,127,340 shares of common stock.
- 01/14/2025
|
S&P 500, Nasdaq slip as key tech stocks fall; US Steel shares jump, Moderna stock tanks
- US stocks saw a decline on Monday as investors continued to unload key tech shares that have been driving the bull market. The S&P 500 fell by 0.2%, while the Nasdaq Composite dropped 0.8%.
- 01/13/2025
|
Millicom (Tigo) share repurchase activity
- Millicom (Tigo) share repurchase activity Luxembourg, January 13, 2025 - Pursuant to the share repurchase program announced on November 29, 2024, Millicom repurchased 400,821 of its Swedish Depository Receipts (SDRs) and 146,632 of its common shares between January 6, 2025, and January 10, 2025, as detailed in the table below. Exchange Nasdaq Stockholm Nasdaq Stock Market Trade Date Number of SDRs repurchased Average price paid* (SEK) Repurchase amount* (SEK) Number of shares repurchased Average price paid* (USD) Repurchase amount* (USD) 2025-01-06 36 700 24.9620 916 105 2025-01-07 101 821 273.0227 27 799 444 36 700 25.0157 918 076 2025-01-08 100 000 277.3668 27 736 680 36 532 24.7171 902 965 2025-01-09 99 000 275.0214 27 227 119 2025-01-10 100 000 267.0256 26 702 560 36 700 23.9353 878 426 * Excluding commissions All purchases were carried out on Nasdaq Stockholm and on the Nasdaq Stock Market by Citigroup Global Markets Limited and Citigroup Global Markets Inc. respectively, on behalf of Millicom.
- 01/13/2025
|
China Liberal Education Holdings Limited Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency
- BEIJING , Jan. 13, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (NASDAQ: CLEU), a China-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that the Company received a written notification (the "Compliance Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") dated January 10, 2025, informing the Company that it has regained compliance with the Nasdaq Listing Rule 5550(a)(2) ("Minimum Bid Price Requirement") and the matter is closed. As previously announced, the Company received a notification letter from the Nasdaq dated August 21, 2024, indicating its failure to maintain a minimum bid price of US$1.00 per share for 30 consecutive business days under Minimum Bid Price Requirement.
- 01/13/2025
|
Aduro Clean Technologies to Ring the Nasdaq Closing Bell on Friday, January 17th, 2025
- LONDON, Ontario, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the Company will ring the closing bell at the Nasdaq MarketSite in Times Square, New York, on Friday, January 17, 2025.
- 01/13/2025
|
History Says the Nasdaq Will Soar in 2025: 1 Hypergrowth AI Stock to Buy Before It Does
- The Nasdaq Composite (^IXIC -1.63%) has had a monster two-year run. After gaining 43% in 2023, the index put up around 30% gains in 2024, marking one of the best-performing periods in its history.
- 01/12/2025
|
History Says the Nasdaq Will Soar in 2025. My 3 Top AI Stocks to Buy Before It Does.
- Last year was fantastic for the markets in general, but the index that really stood out was the Nasdaq. It climbed 28%, while the S&P 500 rose 23% and the Dow Jones Industrial Average increased 12%.
- 01/11/2025
|
History Says the Nasdaq Could Soar Again in 2025: 1 Artificial Intelligence (AI) Stock-Split Stock to Buy Before That Happens
- Following a solid couple of years in 2023 and 2024, it wouldn't be surprising to see the Nasdaq Composite index fly higher in the new year. It could grow due to several factors, such as strong economic growth in the U.S., controlled inflation, higher consumer spending, and the growing adoption of disruptive technology trends such as artificial intelligence (AI).
- 01/11/2025
|
History Says the Nasdaq Will Soar in 2025. 2 Brilliant Tech Stocks to Buy Before It Does.
- As we roll into a new year, investors are taking stock of the market's performance, and there's much to be thankful for. The Nasdaq Composite (^IXIC -1.63%) led the major indexes higher last year, rising 29% after gaining 43% in 2023.
- 01/11/2025
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 01/10/2025
|
Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 96,100 shares of its common stock to sixteen new non-executive employees and 100,000 to one new executive employee under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/10/2025
|
Delisting of Securities of BIMI International Medical Inc.; The Dixie Group, Inc.; Clover Leaf Capital Corp.; Focus Impact BH3 Acquisition Company; Forza X1, Inc.; Vertex Energy, Inc; Slam Corp.; and HHG Capital Corporation from The Nasdaq Stock Market
- NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of BIMI International Medical Inc. BIMI International Medical Inc.'s stock was suspended on August 22, 2024 and has not traded on Nasdaq since that time.
- 01/10/2025
|
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Craig Swandal, experienced medical device manufacturing executive, joins leadership team Craig Swandal, experienced medical device manufacturing executive, joins leadership team
- 01/10/2025
|
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective January 1, 2025, the company granted a non-qualified stock option to purchase 375,000 shares of its common stock to Caroline Hensley, its newly hired Chief Legal Officer, under Xilio Therapeutics' 2022 Inducement Stock Incentive Plan.
- 01/10/2025
|
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, CA / ACCESSWIRE / January 10, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective January 8, 2025, the Company granted 15,000 restricted stock units (RSUs) to New Employee 1, 15,000 RSUs to New Employee 2, and 45,000 RSUs to New Employee 3. The RSUs for New Employee 1 and New Employee 2 vest over one year starting from each employee's date of hire, and the RSUs for New Employee 3 vest equally over three years, with one-third of the shares vesting each year starting from New Employee 3's date of hire.
- 01/10/2025
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 31, 2024
- NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of December 31, 2024, short interest in 3,085 Nasdaq Global MarketSM securities totaled 12,137,206,474 shares compared with 11,912,589,852 shares in 3,063 Global Market issues reported for the prior settlement date of December 13, 2024. The end-of-December short interest represents 2.50 days compared with 2.65 days for the prior reporting period.
- 01/10/2025
|
3 E Network Technology Group Limited Announces Closing of Nasdaq Initial Public Offering
- Guangzhou, China, Jan. 10, 2025 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3e Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider, today announced the closing of its initial public offering (the “Offering”) of 1,250,000 Class A ordinary shares at a public offering price of US$4.00 per share. The Class A ordinary shares began trading on the Nasdaq Capital Market on January 8, 2025 under the ticker symbol “MASK.”
- 01/10/2025
|
Nasdaq Down Over 2%; Walgreens Posts Upbeat Results
- U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 400 points on Friday.
- 01/10/2025
|
Constellation Energy, A Nasdaq-100 Nuclear Stock, Appears Ripe For Future Gains Following Calpine Deal
- With bullish technical indicators supporting its stock momentum and a transformative acquisition underway, Constellation Energy Corp.‘s CEG stock appears primed for future gains following its $26.6 billion offer for Calpine Corp.
- 01/10/2025
|
EpicQuest Education Regains Compliance with Nasdaq Minimum Bid Price Requirement
- MIDDLETOWN, Ohio , Jan. 10, 2025 /PRNewswire/ -- EpicQuest Education Group International Limited (Nasdaq: EEIQ), ("EpicQuest Education", "EEIQ" or the "Company"), a provider of higher education for domestic and international students in the US, Canada and the UK, today announced that on January 8, 2025, it received a notice from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") indicating that the Company has regained with the minimum bid requirement under Listing Rule 5550(a)(2). The notice indicated that as a result of the closing bid price of the Company's common shares having been at $1.00 per share or greater for 20 consecutive business days, from December 9, 2024, to January 7, 2025, the Company has regained compliance with Nasdaq's minimum bid price requirement and the matter is now closed.
- 01/10/2025
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, the Netherlands and MIAMI, Jan. 09, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 58,000 of NewAmsterdam's ordinary shares to two non-executive new hires and a grant of inducement share options covering 170,800 of NewAmsterdam's ordinary shares to Maryellen McQuade, the Company's new Chief People Officer. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/09/2025
|
Will Nasdaq (NDAQ) Beat Estimates Again in Its Next Earnings Report?
- Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/09/2025
|
These Were the 5 Top-Performing Stocks in the Nasdaq-100 in 2024
- Tech stocks rallied in 2024, with powerhouse artificial intelligence (AI) stocks like Nvidia (NVDA -0.02%) and Palantir Technologies (PLTR -2.52%) bringing up the S&P 500 (^GSPC 0.16%). But it was a good year for the whole market, and the tech-heavy Nasdaq-100 only surpassed it by a hairbreadth -- a 25.9% gain versus 25% for the S&P 500.
- 01/09/2025
|
2 Top Nasdaq Stocks to Buy Before They Skyrocket in 2025
- The Nasdaq Composite index had a solid 2024 with impressive gains of almost 31% during the year. This isn't surprising considering the tech-heavy nature of the index that benefited from the impressive growth reported by several technology companies last year thanks to catalysts such as artificial intelligence (AI).
- 01/09/2025
|
History Says the Nasdaq Could Surge in 2025: 2 Stock-Split AI Stocks to Buy Now, According to Wall Street
- The Nasdaq Composite (^IXIC -0.06%) advanced 29% in 2024, and history says that momentum could spill into 2025. Since its inception in 1971, the Nasdaq has gained over 20% in 20 years.
- 01/09/2025
|
Mint Incorporation Limited Announces Pricing of $7 million Initial Public Offering and Listing on Nasdaq
- Hong Kong, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (Nasdaq: MIMI) (the “Company”), a Hong Kong-based interior design and fit out works provider, today announced the pricing of its initial public offering (the “Offering”) of 1,750,000 Class A ordinary shares (the “Class A Ordinary Shares”), at a price of $4.00 per Class A Ordinary Share (the “Offering Price”).
- 01/08/2025
|
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the issuance and sale of an aggregate of 1,818,183 of the Company's ordinary shares at a purchase price of $2.75 per share. In addition, in a concurrent private placement, the Company issued unregistered short-term warrants to purchase up to 1,818,183 of the Company's ordinary shares. The warrants have a term of three years, are exercisable immediately following the issuance date and have an exercise price of $2.75 per share.
- 01/08/2025
|
Nasdaq Reports December 2024 Volumes and 4Q24 Statistics
- NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for December 2024, as well as quarterly volumes, estimated revenue capture, number of listings, and index statistics for the quarter ended December 31, 2024 on its Investor Relations website.
- 01/08/2025
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , Jan. 8, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on January 6, 2025, the Human Capital Management Committee of Avidity's Board of Directors granted a non-qualified stock option award to purchase an aggregate of 80,000 shares of its common stock and 40,000 restricted stock units ("RSUs") to Charles Calderaro III, under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"), in connection with Mr. Calderaro's hiring and appointment as Avidity's Chief Technical Officer.
- 01/08/2025
|
Stock Market Today: Nasdaq Composite Falls & Quantum Computing Stocks Collapse (RGTI, IONQ, QUBT)
- As of 11:05 a.m. ET, the Nasdaq Composite is still down .27%.
- 01/08/2025
|
S&P 500 and Nasdaq to pull back further as dollar and bond yields rise
- Wall Street stocks have been called lower on Wednesday as pressure from bond markets is set to weigh on equities for another session. Futures for the S&P 500 and Nasdaq 100 pointed to a 0.3% decline, with Dow Jones futures indicating a dip of 0.15%.
- 01/08/2025
|
Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- CRANFORD, N.J. , Jan. 8, 2025 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive agreements for the purchase of an aggregate of 743,496 shares of its common stock and accompanying warrants to purchase up to an aggregate of 743,496 shares of its common stock, at a purchase price of $4.035 per share and accompanying warrant in a registered direct offering priced at-the-market under Nasdaq rules.
- 01/08/2025
|
Foresight Regains Compliance with Nasdaq Minimum Bid Price Rule
- Ness Ziona, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today announced that it has received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) informing Foresight that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), for continued listing on The Nasdaq Capital Market, and the matter of previous non-compliance is now closed.
- 01/08/2025
|
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced that the compensation committee of KalVista's board of directors granted nine newly-hired employees inducement options to purchase an aggregate of 61,000 shares of KalVista common stock on January 2, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock.
- 01/08/2025
|
N2OFF Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
- Neve Yarak, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.\ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a clean tech company engaged in sustainable solutions for the energy and agri-tech industries, announced that on January 7, 2025 the Company received formal notification from the Listing Qualification Department of the Nasdaq Stock Market (“Nasdaq”) that it has been granted an additional 180-day compliance period, or until July 7, 2025, to regain compliance with Nasdaq's minimum $1.00 bid price per share requirement.
- 01/08/2025
|
Mkango Resources to spin-and-spac Songwe project onto Nasdaq
- Mkango Resources Ltd (AIM:MKA, TSX-V:MKA, OTC:MKNGF) primary asset the Songwe Hill Rare Earth project, in Malawi, is to be brought into a SPAC deal that will result in a listing on NASDAQ. The AIM-quoted firm, in a statement, said it had signed a non-binding Letter of Intent (LOI) with Crown PropTech Acquisitions for a proposed business combination.
- 01/08/2025
|
History Says the Nasdaq Could Jump Higher in 2025: 2 Artificial Intelligence (AI) Stocks That Can Bounce Back and Soar 25% to 40%, According to Wall Street
- Technology stocks were in fine form on the stock market in 2024, with the tech-laden Nasdaq Composite (^IXIC -1.89%) index clocking impressive gains of 28.6% last year following an even stronger jump of 43% in 2023.
- 01/08/2025
|
Nasdaq leads stock declines as traders pare rate cut bets, Nvidia plummets after record close
- To get the latest market news check out finance.yahoo.com US stocks reversed early gains to close firmly lower as cautious investors weighed new economic data, while Nvidia (NVDA) retreated from its record close despite the company's big artificial intelligence plans. The benchmark S&P 500 (^GSPC) fell over 1.1%, while the tech-heavy Nasdaq Composite (^IXIC) lost roughly 1.9%.
- 01/07/2025
|
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective January 6, 2025, to three non-executive employees of non-qualified stock option.
- 01/07/2025
|
Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- STATEN ISLAND, N.Y. , Jan. 7, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced the closing of its previously announced registered direct offering of 2,463,058 shares of its common stock at a purchase price of $1.015 per share priced at-the-market under Nasdaq rules.
- 01/07/2025
|
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved the grant of equity awards to one new employee with a grant date of January 2, 2025, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 2020 Inducement Stock Incentive Plan) and material to the employees' acceptance of employment with the company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/07/2025
|
XTI Aerospace, Inc. Announces Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
- ENGLEWOOD, Colo. , Jan. 7, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA), ("XTI" or the "Company"), a pioneer in advanced aircraft design, today announced the pricing of a best-efforts offering of 363,636,364 shares of its common stock priced at-the-market under Nasdaq rules.
- 01/07/2025
|
S&P 500, Nasdaq slip as Treasury yields rise; NVIDIA and Tesla fall, while Getty and Shutterstock shares soar
- Benchmark S&P 500 and the Nasdaq Composite fell on Tuesday as yields on Treasury bills rose, dampening sentiments across the market. At the time of writing, the S&P 500 index was down 0.3%, while the Nasdaq Composite shed 0.7% from the previous close.
- 01/07/2025
|
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025
- SALT LAKE CITY , Jan. 7, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be participating in Nasdaq's Live from MarketSite broadcast at the Silicon Slopes Summit 2025 on January 14, 2025. Live from MarketSite is Nasdaq's flagship broadcast opportunity, showcasing innovative leaders and disruptive companies in their fields.
- 01/07/2025
|
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, announced today that it has entered into a definitive agreement for the issuance and sale of an aggregate of 1,818,183 of the Company's ordinary shares at a purchase price of $2.75 per share in a registered direct offering priced at-the-market under the rules of the Nasdaq Stock Market. In addition, in a concurrent private placement, the Company will issue unregistered short-term warrants to purchase up to 1,818,183 of the Company's ordinary shares. The warrants will have a term of three years, will be exercisable immediately following the issuance date and have an exercise price of $2.75 per share. The closing of the offering is expected to occur on or about January 8, 2025, subject to the satisfaction of customary closing conditions.
- 01/07/2025
|
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MONTREAL and CHARLOTTE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a total of 113,000 options (the “Options”) to purchase the Company's common shares, pursuant to the Company's 2021 Inducement Plan (the “Plan”), previously approved by the Company's Compensation Committee and the Board of Directors, as a material inducement to employment of three new hires.
- 01/07/2025
|
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
- TransCode shares to remain listed on Nasdaq BOSTON , Jan. 7, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from the NASDAQ Stock Market LLC (Nasdaq) that the Company has regained compliance with Listing Rules 5550(a)(2) and 5550(b)(1), the Exchange's minimum bid price and shareholders' equity rules, respectively. The Company has also resolved the violation regarding Listing Rule 5635 (the "Shareholder Approval Rule") by obtaining shareholder ratification of a July 2024 equity transaction.
- 01/07/2025
|
Nasdaq set for flat start as Nvidia overtakes Apple as largest company
- US stocks are set for a flat start on Tuesday, with further gains expected for Nvidia Corp (NASDAQ:NVDA) offset by falls for Apple Inc (NASDAQ:AAPL, ETR:APC) and Tesla Inc (NASDAQ:TSLA). Futures indicated that the Nasdaq 100 is set to open flat, while S&P 500 and Dow Jones futures both pointed to small gains of around 0.1%.
- 01/07/2025
|
Here Are My Top 5 Nasdaq Stock to Buy in 2025
- The Nasdaq Composite (^IXIC 1.24%) has been a great performing index, as it beat the broader S&P 500 (^GSPC 0.55%) in 2024 by rising 28.6% versus the S&P 500's 23.3%. It wouldn't surprise me to see those results again in 2025, but I think a few companies within the Nasdaq Composite can outperform the broader index in 2025.
- 01/07/2025
|
Nasdaq Jumps Over 1% As Nvidia, Micron Surge: Investor Fear Eases, But Greed Index Remains In 'Fear' Zone
- The CNN Money Fear and Greed index showed some easing in the overall fear level, while the index remained in the “Fear” zone on Monday.
- 01/07/2025
|
Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- STATEN ISLAND, N.Y. , Jan. 6, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,463,058 shares of its common stock at a purchase price of $1.015 per share in a registered direct offering priced at-the-market under Nasdaq rules.
- 01/06/2025
|
Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
- SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 39,682,540 shares of its common stock (or common stock equivalents) and warrants to purchase up to an aggregate of 39,682,540 shares of common stock (the “Warrants”), at a combined offering price of $0.252 per share of common stock (or per common stock equivalent) and accompanying Warrant. The Warrants have an exercise price of $0.252 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares of common stock upon exercise of the Warrants (the “Stockholder Approval”).
- 01/06/2025
|
eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- AUSTIN, Texas , Jan. 6, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) ( ehealth.com ), a leading private online health insurance marketplace (the "Company"), today announced that on January 2, 2025, the Compensation Committee of its Board of Directors granted inducement stock unit awards to two new employees covering an aggregate of 13,000 shares of the Company's common stock. Each of these awards was granted under the Company's Amended and Restated 2021 Inducement Plan (the "Inducement Plan") and otherwise will be subject to the terms and conditions of a stock unit agreement under the Inducement Plan.
- 01/06/2025
|
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- DUBLIN, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to twelve (12) new employees to purchase an aggregate of 131,700 ordinary shares under Avadel's 2021 Inducement Plan. The awards were granted as an inducement material to the employee's acceptance of employment with Avadel in accordance with Nasdaq Listing Rule 5635(c)(4). The options have a ten-year term and vest over four years, with 25% vesting on the one-year anniversary of each new employee's respective start date and 25% vesting on the second, third, and fourth anniversary thereafter. The options are subject to the terms and conditions of Avadel's 2021 Inducement Plan approved by the Board of Directors in November 2021 and the terms and conditions of award agreements covering the grants.
- 01/06/2025
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 75,500 restricted stock units of Arcutis' common stock to eight newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of January 2, 2025, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/06/2025
|
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping more than 200 points on Monday.
- 01/06/2025
|
Why T-Mobile Shares Plunged on a Strong Day for the Nasdaq
- Shares of T-Mobile (TMUS -3.99%) fell 4.3% on Monday as of 11:37 a.m. ET, a notable decline even as the Nasdaq Composite (^IXIC 1.53%) was up over 1.8% by that time.
- 01/06/2025
|
The Real Good Food Company Announces Nasdaq Delisting
- CHERRY HILL, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (Nasdaq: RGF) (“Real Good Foods” or the “Company ”), a leading health and wellness frozen and refrigerated foods company, today announced that the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") that it has determined to delist the Company's common stock on Nasdaq. The delisting is a result of the Company's failure to demonstrate compliance with Nasdaq Listing 5250(c)(1) for failure to file periodic financial reports. Trading in the Company's common stock on Nasdaq will be suspended on January 7, 2025. As a result of the foregoing, the Company's common stock is expected to commence trading on the Pink Open Market operated by the OTC Markets Group, Inc. (“OTC”), which is commonly referred to as the “pink sheets,” commencing on January 7, 2025. However, given the Company's situation with regards to the lack of timely filing, trading may ultimately move to OTC's “Expert Market,” where quotes for the Company's common stock will no longer be available for public viewing.
- 01/06/2025
|
Nasdaq 100: Nvidia and Micron Surge as Chip Stocks Drive Market Rebound
- Chip stocks surge as Nvidia, Micron, and AMD lift markets. Tariff relief boosts automakers.
- 01/06/2025
|
Stock Market Today: Nasdaq Composite Up Big as NVIDIA and AI Stocks Rally
- A blog post from Sam Altman, the cofounder and CEO of OpenAI, may be helping drive AI stocks higher today.
- 01/06/2025
|
NeuroSense Regains Compliance with Nasdaq's Minimum Equity Requirement
- NeuroSense in Compliance with all Nasdaq Listing Requirements CAMBRIDGE, Mass. , Jan. 6, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd.
- 01/06/2025
|
Moomoo Launches US Options Paper Trading Challenge, Co-branded with Nasdaq for Joint Promotion
- Win Prizes and Potentially Elevate Your Options Trading Expertise with Moomoo's Pro-Level Trading Platform Risk-Free JERSEY CITY, N.J. , Jan. 6, 2025 /PRNewswire/ -- Moomoo, the intuitive investment and trading platform that offers $0 commission options trading services [1], will launch an Options Paper Trading Challenge ("the Challenge") in the U.S. This presents an outstanding opportunity for U.S. investors to develop, showcase, and refine their trading strategies within a competitive, risk-free, and simulated market environment.
- 01/06/2025
|
SIMPPLE Ltd. Regains Compliance with Nasdaq's Minimum Bid Price Requirement
- Singapore, Jan. 06, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd (Nasdaq: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management sector, today announced that on December 5, 2024 the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that on December 2, 2024, the Company has regained compliance with Nasdaq Capital Market's continued listing standard for the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.
- 01/06/2025
|
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule
- CAESAREA, Israel , Jan. 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it has received a notification letter from Nasdaq Stock Market LLC ("Nasdaq") confirming that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule").
- 01/06/2025
|
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on January 1, 2025, it awarded inducement grants to three new employees under Intellia's 2024 Inducement Plan as a material inducement to employment.
- 01/06/2025
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted 10 newly-hired employees stock options to purchase an aggregate of 52,750 shares, and restricted stock units (RSUs) covering an aggregate of 36,975 shares, of BioCryst common stock. The options and RSUs were granted as of December 31, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/06/2025
|
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
- SAN DIEGO--(BUSINESS WIRE)---- $REVB #GEMINI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of disease, announced today that the Nasdaq Hearings Panel issued a decision letter granting Revelation's request to continue its listing on The Nasdaq Stock Market, subject to its stock trading at or above $1.00 for at least ten consecutive trading days by February 14, 2025.
- 01/06/2025
|
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
- Now that we've shut the door on 2024, it's useful to look back at some of the best -- and, on the flip side, some of the worst -- performers of the year on the stock market. Many outliers were in the tech sector, so it's worth taking a look at the tech-heavy Nasdaq-100 index.
- 01/04/2025
|
2 Nasdaq Artificial Intelligence (AI) Stocks to Buy Before They Soar as Much as 153% in 2025, According to Certain Wall Street Analysts
- The Nasdaq Composite (^IXIC 1.77%) has climbed consistently higher over the past couple of years as technology investors have sought to profit from the economic recovery, the rapid adoption of artificial intelligence (AI), the slowing of inflation, and the ongoing campaign to lower interest rates. After notching gains of 43% in 2023, the index tacked on an additional 29% in 2024.
- 01/04/2025
|
Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Carlsbad, CA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that it had made an equity grant to a new employee under its 2021 Inducement Plan, as amended.
- 01/03/2025
|
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on January 2, 2025, the Compensation Committee of Puma's Board of Directors approved the grant of inducement restricted stock unit awards covering 24,375 shares of Puma common stock to two new non-executive employees. The awards were granted under Puma's 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awar.
- 01/03/2025
|
BriaCell Announces Proposed Effective Date of Share Consolidation
- PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announced today that the Company's board of directors has approved the consolidation (the “Consolidation”) of the Company's issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-Consolidation Common Share for every fifteen (15) pre-Consolidation Common Shares. The Consolidation is being implemented to ensure that the Company continues to comply with the listing requirements of The Nasdaq Capital Market (the “Nasdaq”).
- 01/03/2025
|
Why We Lightened Up On Nasdaq 100 Exposure To End The Year
- With cross currents jostling the markets and a knowledge of history, we were quick to sell. And quick to buy back.
- 01/03/2025
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to three new employees to purchase an aggregate of 26,200 shares of the Company's common stock, effective as of January 2, 2025. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/03/2025
|
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 58,650 shares of Astria's common stock on January 2, 2025 under Astria's 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were gran.
- 01/03/2025
|
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on January 2, 2025, the Compensation Committee of the company's Board of Directors granted to 12 new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 67,300 ordinary shares. These awards were made under Bicycle Therapeutics' 2024 Inducement Plan and approved by the Compensation Committee as an inducement material to the employees entering i.
- 01/03/2025
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on December 31, 2024, the company granted equity awards to one new employee, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to such new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/03/2025
|
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted an equity award, previously approved by the Company's Compensation Committee, as a material inducement to the employment of an individual whose employment commenced on November 4, 2024. The grant totaled the right to purchase 30,000 shares of the Company.
- 01/03/2025
|
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on January 2, 2025 the Company granted (i) non-qualified stock options to two newly-hired non-executive employees to purchase a total of 72,000 shares of the Company's common stock at an exercise price per share of $1.79, which was the closing price per share of the Company's common stock as reported by NASDAQ on January 2, 2025, the options grant date, and (ii) restricted stock units (RSUs) representing 3,200 shares of its common stock to one newly-hired non-executive employee. The grants were approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% vesting in approximately equal monthly installments over the following thirty-six months, subject to the employees being continuously employed by the Company through each vesting date. The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.
- 01/03/2025
|
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
- SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 39,682,540 shares of its common stock (or common stock equivalents) and warrants to purchase up to an aggregate of 39,682,540 shares of common stock (the “Warrants”), at a combined offering price of $0.252 per share of common stock (or per common stock equivalent) and accompanying Warrant in a registered direct offering priced at-the-market under Nasdaq rules. The Warrants will have an exercise price of $0.252 per share, will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares of common stock upon exercise of the Warrants (the “Stockholder Approval”) for a period of five years thereafter.
- 01/03/2025
|
Alset Inc. Announces Closing of $1.5 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
- BETHESDA, MD, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Alset Inc. (NASDAQ: AEI) (the “Company”), a diversified company engaged through its subsidiaries in the development of EHome communities and real estate, financial services, digital transformation technologies, biohealth activities and consumer products with operations in the United States, Singapore, Hong Kong and South Korea, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 1,500,000 shares of common stock at a purchase price of $1.00 per share.
- 01/03/2025
|
Nasdaq Surges Over 1%; Cerence Shares Spike Higher
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite surging more than 1% on Friday.
- 01/03/2025
|
Expion360 Inc. Announces Closing of $2.6 Million Registered Direct Offering and Private Placement Priced at the Market Under Nasdaq Rules
- REDMOND, Ore., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Expion360 Inc. (Nasdaq: XPON) (the “Company”), an industry leader in lithium-ion battery power storage solutions, today announced the closing of its previously announced registered direct offering and concurrent private placement with institutional investors.
- 01/03/2025
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on January 2, 2025, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 311,000 shares of the Company's common stock in connection with their employment. The stock option was granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individual entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/03/2025
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that on January 2, 2025, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 45,000 shares of the Company's common stock to two newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 01/02/2025
|
Nasdaq to Hold Fourth Quarter and Full Year 2024 Investor Conference Call
- NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its fourth quarter and full year 2024 financial results announcement.
- 01/02/2025
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. , Jan. 2, 2025 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to purchase an aggregate of 3,000 shares of Akebia's common stock on December 31, 2024.
- 01/02/2025
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , Jan. 2, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted a stock option to purchase an aggregate of 101,250 shares of Karyopharm's common stock and an aggregate of 108,540 restricted stock units (RSUs) to four newly-hired employees.
- 01/02/2025
|
ScanTech Identification Beam Systems, LLC Closes Business Combination with Mars Acquisition Corp. Shares of the New Public Company, ScanTech AI Systems Inc., Will Begin Trading on Nasdaq
- Business Combination between ScanTech Identification Beam Systems, LLC and Mars Acquisition Corp. closed on January 2, 2025 Trading of common stock of the new public company, ScanTech AI Systems Inc., will commence on Nasdaq on January 3, 2025 under the ticker symbol “STAI” NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (“ScanTech AI”), today announced the successful closing of its previously announced business combination (the “Business Combination”) between ScanTech Identification Beam Systems, LLC (“ScanTech”), a provider of one of the world's most advanced non-intrusive “fixed-gantry” CT screening technologies, and Mars Acquisition Corp. (“Mars”) (Nasdaq: MARX), a special purpose acquisition company. Mars shareholders approved the business combination at a special meeting held on December 12, 2024.
- 01/02/2025
|
Alset Inc. Announces $1.5 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
- BETHESDA, MD, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Alset Inc. (NASDAQ: AEI) (the “Company”), a diversified company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities and consumer products with operations in the United States, Singapore, Hong Kong and South Korea, today announced that it has entered into definitive agreements in a registered direct offering with institutional investors for the purchase and sale of approximately $1.5 million of shares of common stock and pre-funded warrants at a price of $1.00 per share of common stock. The entire transaction has been priced at the market under Nasdaq rules.
- 01/02/2025
|
Expion360 Inc. Announces $2.6 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules
- REDMOND, Ore., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Expion360 Inc. (Nasdaq: XPON) (the “Company”), an industry leader in lithium-ion battery power storage solutions, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of shares of its common stock, par value $0.001 per share (“Common Stock”) and pre-funded warrants to purchase Common Stock (each, a “Pre-Funded Warrant”) in a registered direct offering.
- 01/02/2025
|
Nasdaq Dips Over 100 Points; Unity Software Shares Jump
- U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 100 points on Thursday.
- 01/02/2025
|
Nasdaq Stock Slips Below 50-Day SMA: What Should You Do Now?
- NDAQ is set to grow on the back of its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
- 01/02/2025
|
Nasdaq 100: Bullish Start to 2025 on Tech Optimism; Tesla Slips on Delivery Shortfall
- Nasdaq 100 and S&P 500 futures rise as tech stocks drive optimism into 2025. Tesla dips on delivery shortfall, while Nvidia extends gains.
- 01/02/2025
|
Foxx Development to Celebrate Milestone by Ringing Nasdaq Closing Bell on January 3, 2025
- Irvine, CA, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Foxx Development Holdings Inc. (“Foxx Development” or “Company”) (Nasdaq: FOXX), a leading provider of consumer electronics and integrated Internet-of-Things (IoT) solutions for retail and institutional clients, today announced that it will ring the Nasdaq Closing Bell on Friday, January 3, 2025. This milestone event celebrates the Company's successful transition to a publicly traded entity in September 2024 and highlights its continued momentum in expanding its business operations and market presence.
- 01/02/2025
|
History Says the Nasdaq Will Soar in 2025. My Top 10 Artificial Intelligence (AI) Growth Stocks to Buy Before It Does.
- The Nasdaq Composite has been gaining ground for more than two years now. Its rise was driven by the dawn of artificial intelligence (AI), a U.S. Presidential election, declining inflation, and the beginning of long-awaited interest-rate cuts.
- 01/01/2025
|
Paranovus Entertainment Technology Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- NEW YORK , Dec. 31, 2024 /PRNewswire/ -- Paranovus Entertainment Technology Limited ("PAVS" or the "Company"), (NASDAQ: PAVS) announced today that it received a formal notification from the Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company's Class A ordinary shares ("Ordinary Shares") to maintain a minimum bid price of $1.00 per share. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's Ordinary Shares has been at $1.00 per share or greater for the last 10 consecutive business days from December 13, 2024, to December 30, 2024.
- 12/31/2024
|
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on December 31, 2024. One individual was hired by Adicet in December 2024 and granted new hire non-qualified stock options to purchase 9,000 shares of Adicet's common stock with an exercise price of $0.96 per share, the closing p.
- 12/31/2024
|
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on December 31, 2024 (the “Grant Date”) that were previously approved by the Compensation Committee of its Board of Directors under Sarepta's 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 8 individuals hired by Sarepta in December 2024. The equity awards were approved in accordance with Nasdaq List.
- 12/31/2024
|
Bit Origin Ltd Regains Compliance with Nasdaq Listing Rule 5250(c)(1)
- NEW YORK, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) ("Bit Origin" or the "Company"), an emerging growth company engaged in the crypto mining business with diversified expansion strategies, announced today that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) in connection with the filing of its annual report on Form 20-F for the fiscal year ended June 30, 2024.
- 12/31/2024
|
These are the top 3 Nasdaq-100 performers of 2024
- The tech-heavy Nasdaq-100, which tracks the 100 largest nonfinancial companies in the Nasdaq Composite, is set to wrap up a remarkable 2024 with a 28% gain.
- 12/31/2024
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, , Dec. 31, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/31/2024
|
S&P 500, Nasdaq, Dow slide as strong year nears its close
- To get the latest market news, check out finance.yahoo.com Stocks fell on Monday, with the woes of the three major indexes continuing in the final week of the year as an otherwise strong 2024 comes to a close. The benchmark S&P 500 (^GSPC) slipped more than 1% while the tech-heavy Nasdaq Composite (^IXIC) fell roughly 1.2%.
- 12/30/2024
|
Gaxos.ai Inc. Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Gaxos.ai Inc. raises approximately $9 million in gross proceeds in December 2024 Roseland, NJ, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 1,346,669 shares of its common stock at a purchase price of $3.00 per share. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase up to 1,346,669 shares of common stock.
- 12/30/2024
|
Nasdaq Announces the Closure of its U.S. Markets in Honor of a National Day of Mourning for Former President Jimmy Carter
- NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announces that it will observe the passing of President Jimmy Carter by closing all Nasdaq U.S. equities and options markets on Thursday, January 9, 2025.
- 12/30/2024
|
Polar Power Announces Receipt of Letter from Nasdaq Acknowledging Listing Compliance
- GARDENA, CA, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Polar Power, Inc. (NASDAQ: POLA) (“Polar Power”), a global provider of prime, backup, solar hybrid power, and microgrid solutions, is pleased to announce that it has successfully regained compliance with the minimum bid price requirement set forth by The Nasdaq Stock Market LLC (“Nasdaq”).
- 12/30/2024
|
C3is Inc. Announces Reverse Stock Split
- To be effective January 2, 2025 Aiming to meet the minimum bid price requirement for maintaining listing on Nasdaq ATHENS, Greece, Dec. 30, 2024 (GLOBE NEWSWIRE) -- C3is Inc. (the “Company”) (Nasdaq: CISS) today announced that its board of directors has determined to effect a one-for-two-and-a-half (1-for-2.5) reverse stock split of the Company's common stock, par value $0.01 per share. The reverse stock split will take effect at 11:59 pm Eastern Time on December 31, 2024, and the Company's common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market (“Nasdaq”) as of the opening of trading on January 2, 2025.
- 12/30/2024
|
Garden Stage Limited - Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- Hong Kong, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Garden Stage Limited (NASDAQ: GSIW) (“GSIW” or the “Company”), today announced that it received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on December 24, 2024 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company's ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. The Notice provides that the Company has a period of 180 calendar days from the date of the Notice, or until June 23, 2025, to regain compliance with the minimum bid price requirement.
- 12/30/2024
|
History Says the Nasdaq Will Surge in 2025. 1 Stock-Split Stock to Buy Before It Does.
- The Nasdaq Composite has been in full-on rally mode for a couple of years running now. Several factors have helped propel the tech-centric index higher, including the rebounding economy, advances in artificial intelligence (AI), and recent interest rate cuts courtesy of the Federal Reserve Bank.
- 12/28/2024
|
S&P 500 and Nasdaq 100: Palantir and Microstrategy Slide on Year-End Profit-Taking
- Year-end rebalancing and profit-taking drove Palantir, Microstrategy, and tech stocks lower as rising Treasury yields hit the S&P 500 and Nasdaq 100.
- 12/27/2024
|
Gaxos.ai Inc. Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Roseland, NJ, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,346,669 shares of its common stock at a purchase price of $3.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 1,346,669 shares of common stock. The warrants will have an exercise price of $3.00 per share, will be exercisable upon issuance and expire three years following the date of issuance. The closing of the offering is expected to occur on or about December 30, 2024, subject to the satisfaction of customary closing conditions.
- 12/27/2024
|
FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement
- SHENZHEN, China, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”) today announced that it has received a written notification from The Nasdaq Stock Market LLC (“Nasdaq”) dated December 24, 2024, indicating that the Company is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as the bid price of the Company's Class A ordinary shares had closed below US$1 per share for the last 30 consecutive business days from November 11 through December 23, 2024.
- 12/27/2024
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , Dec. 27, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on December 26, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 31,400 shares of the Company's common stock to a newly hired employee.
- 12/27/2024
|
Meet the Newest Stock in the Nasdaq-100. It's Soared 110,600% Since Its IPO and It's Still a Buy Heading Into 2025, According to Wall Street.
- The Nasdaq Composite is one of the closely watched stock market indexes in the U.S. The wide-ranging tech-focused index tracks the performance of roughly 3,000 stocks listed on the exchange. The Nasdaq-100 is a subsection of that index, tracking the performance of approximately 100 of the largest non-financial companies on the Nasdaq stock exchange.
- 12/27/2024
|
NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Failure to Complete Initial Business Combination
- New York, NY, Dec. 26, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that (i) the Staff has determined that the Company's securities will be delisted from The Nasdaq Stock Market; (ii) trading of the Company's Common Stock, Rights, and Warrants will be suspended at the opening of business on December 27, 2024; and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company's securities from listing on The Nasdaq Stock Market. Pursuant to Nasdaq Listing Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company failed to complete its initial business combination by December 20, 2024, the Company did not comply with IM-5101-2, and its securities are now subject to delisting.
- 12/26/2024
|
Ingles Markets, Incorporated Reports Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K
- ASHEVILLE, N.C.--(BUSINESS WIRE)--Ingles Markets, Incorporated (NASDAQ: IMKTA) (the “Company”), today announced that it received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), stating that because the Company has not yet filed its Annual Report on Form 10-K for the fiscal year ended September 28, 2024 (the “Annual Report”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financ.
- 12/26/2024
|
$10M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- Reno, Nev., Dec. 26, 2024 (GLOBE NEWSWIRE) -- American Battery Technology Company (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, today announced it has entered into securities purchase agreements with two institutional investors for the purchase and sale of 3,773,586 shares of its common stock and warrants to purchase up to an aggregate of 3,773,586 shares of common stock in a registered direct offering. The last closing market price was $2.60 per share and this intraday transaction had at a combined offering price of $2.65 per share and accompanying warrant, priced “at-the-market” under Nasdaq rules. The warrants have an exercise price of $2.80 per share, and will be exercisable immediately from the date of issuance and will expire five years from the initial exercise date.
- 12/26/2024
|
Beyond The Index: Why Nasdaq Is A Fintech Powerhouse
- Nasdaq's Q3 2024 revenue surged 22% YoY, driven by a 26% increase in Index revenue from ETPs, and returned $138 million to shareholders. The Adenza acquisition bolstered Nasdaq's financials, contributing $146 million in Q3 2024 revenue and achieving 80% expense synergy targets, with strong free cash flow projections. Market volatility poses a significant risk; however, upcoming IPOs, deregulation, and new crypto products could catalyze capital market growth in 2025.
- 12/26/2024
|
Meiwu Technology Company Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- Shenzhen, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited (“WNW” or the “Company”), (NASDAQ: WNW) announced today announced that it received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company's ordinary shares, no par value each (the “Ordinary Shares”) to maintain a minimum bid price of $1.00 per share.
- 12/26/2024
|
2 Stocks to Buy Hand Over Fist Before the Nasdaq Soars Higher in 2025
- Technology stocks have been in scintillating form on the market in the past couple of years, which is evident from the 86% gains clocked by the Nasdaq Composite index during this period, and the good news is that the impressive run in tech stocks could continue in 2025 as well.
- 12/26/2024
|
Nasdaq Bets on AI as Nvidia's 2025 Focus Shifts from Infrastructure to Innovation
- 2024's AI boom boosted profits—2025 focuses on implementation. Discover why AI adoption in healthcare, finance, and manufacturing could drive gains.
- 12/26/2024
|
Is the Newest Member of the Nasdaq-100 -- a 764% Gainer Since Its IPO -- a Buy Going Into 2025?
- Outside of megacap technology companies, I'd argue that data analytics specialist Palantir Technologies (PLTR 2.09%) is the hottest name in the artificial intelligence (AI) realm. Palantir marked a lot of milestones this year -- most recently the company's entrance into the Nasdaq-100 index.
- 12/25/2024
|
History Says the Nasdaq Will Soar in 2025. 1 Stock-Split Stock to Buy Before It Does.
- The Nasdaq Composite has repeatedly reached new heights in 2024, notching more than 110 new all-time highs. Its record run has been fueled by a string of encouraging developments.
- 12/25/2024
|
Nasdaq, S&P 500, Dow surge in start to 'Santa Claus' rally ahead of Christmas break
- To get the latest market news check out finance.yahoo.com US stocks rallied in the final, shortened trading session before the Christmas holiday. The benchmark S&P 500 (^GSPC) finished the session up over 1.1%, while the tech-heavy Nasdaq Composite (^IXIC) rose roughly 1.4%.
- 12/24/2024
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 13, 2024
- NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of December 13, 2024, short interest in 3,063 Nasdaq Global MarketSM securities totaled 11,912,589,852 shares compared with 11,857,580,215 shares in 3,065 Global Market issues reported for the prior settlement date of November 29, 2024. The mid-December short interest represents 2.65 days compared with 2.36 days for the prior reporting period.
- 12/24/2024
|
S&P 500 and Nasdaq 100: Tesla and Nvidia Drive Gains as Year-End Rally Builds
- Nasdaq 100 outperforms as Tesla, Amazon, and Nvidia surge. S&P 500 edges up during holiday trade with light volume ahead of Christmas break.
- 12/24/2024
|
Thumzup to Ring the Nasdaq Opening Bell on November 22, 2024
- Los Angeles, CA, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Thumzup Media Corporation ("Thumzup" or the "Company") (Nasdaq: TZUP), a leading provider of innovative social media branding and marketing solutions that allows businesses and brands to pay customers and fans cash through Venmo and PayPal for their posts on social media, is thrilled to announce their upcoming visit to the Nasdaq MarketSite in Times Square on Friday, November 22, 2024 to ring the Opening Bell. In recognition of this milestone, Thumzup's Chair, President, and Chief Executive Officer, Robert Steele, will lead the bell-ringing ceremony.
- 12/24/2024
|
Power Solutions Announces Uplisting to The Nasdaq Stock Market
- Power Solutions International announced today that The Nasdaq Stock Market LLC (“Nasdaq”) has approved its application for uplisting its common stock.
- 12/24/2024
|
Super Micro Stock Beat the Nasdaq for a Day. How a Santa Claus Rally Could Help.
- For investors, the key question is whether management will be able to remove the doubts about the company's finances when it does publish its earnings.
- 12/24/2024
|
History Says the Nasdaq Will Surge in 2025: 1 AI Stock to Buy Before It Does (Hint: It's Not Nvidia)
- The market has gone into overdrive in 2024. Technology stocks especially so.
- 12/24/2024
|
Nasdaq Gains Around 1% As Tesla, Nvidia Rise Ahead Of Christmas: Greed Index Remains In 'Fear' Zone
- The CNN Money Fear and Greed index showed a further easing in the fear level, while the index remained in the “Fear” zone on Monday.
- 12/24/2024
|
Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq
- BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”) is pleased to announce that its previously announced scheme of arrangement in relation to Bionomics Limited's proposed re-domiciliation from Australia to the United States, under which Neuphoria will become the ultimate parent company of Bionomics Limited, has been implemented today, December 23, 2024 New York time (December 24, 2024 Sydney time).
- 12/23/2024
|
Wilhelmina International, Inc. Announces December 27, 2024 as Anticipated Last Day of Trading on the Nasdaq Capital Market
- LONDON, UK / ACCESSWIRE / December 23, 2024 / Wilhelmina International, Inc. (NASDAQ:WHLM) ("Wilhelmina" or the "Company") announced on Friday December 20, 2024 its intention to voluntarily delist its shares of Common Stock from the Nasdaq Capital Markets and to deregister the shares of Common Stock under Section 12(b) of the Securities Exchange Act of 1934. That announcement listed the anticipated last day of trading on the Nasdaq Capital Market as Tuesday, December 31, 2024; however, that date was incorrect.
- 12/23/2024
|
Solid Biosciences Added to the Nasdaq Biotechnology Index
- CHARLESTOWN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it was added to the Nasdaq Biotechnology Index® (Nasdaq: NBI) effective prior to the market open on Monday, December 23, 2024.
- 12/23/2024
|
ETF Prime: Islam on Nasdaq-100 Rebalancing and More
- On this week's episode of ETF Prime, host Nate Geraci was joined by Roxanna Islam, CFA, CAIA, head of sector & industry research at VettaFi. Together, Islam and Geraci examined the recent Nasdaq-100 index rebalance and how it connects to broader ETF trends.
- 12/23/2024
|
Restructuring Complete, Bringing Shareholder Value with New USA-Based CEO Imminent
- NEW YORK, NY / ACCESSWIRE / December 23, 2024 / Nixxy.com is pleased to announce the successful completion of its restructuring process, a pivotal step in enhancing shareholder value and positioning the organization for future growth. The company, threatened with Nasdaq delisting earlier in 2024, has eliminated onerous debt, resulting in increased shareholder equity and value through strategic partnerships with fresh and supportive investor groups, and is now is good standing with Nasdaq, and remains current in its SEC reporting.
- 12/23/2024
|
Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 240,000 shares of its common stock at a purchase price of $2.00 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 240,000 shares of common stock.
- 12/23/2024
|
Nasdaq Index: Tesla, Meta, and Nvidia Rally While MicroStrategy Slides on Bitcoin Exposure
- Tech stocks lift Nasdaq 0.6% while Dow Jones drops 100 points. MicroStrategy falls 5% on Bitcoin volatility.
- 12/23/2024
|
With Recent Volatility for the S&P 500 and Nasdaq, Should You Sell Growth Stocks Before 2025?
- Dec. 18 was a big down day in the stock market with the Nasdaq Composite (^IXIC 1.03%) falling 3.6% and the S&P 500 (^GSPC 1.09%) tumbling 2.9%.
- 12/23/2024
|
Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements
- DALLAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in 2018, that uses multi-spectral imaging and algorithms to predict burn healing potential, is pleased to announce that on December 20, 2024 the Company received a “moot” letter from Nasdaq confirming that the Company has regained compliance with all applicable listing standards for its continued listing on the Nasdaq Capital Market and that a further hearing regarding the Company's compliance is no longer necessary.
- 12/23/2024
|
Ensysce Biosciences Regains Full Compliance with Nasdaq
- SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that on December 20, 2024, it received notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has demonstrated compliance with the minimum bid price requirement in Listing Rule 5550(a)(2). Ensysce had previously regained compliance with the stockholders' equity requirement in Listing Rule 5550(b)(1).
- 12/23/2024
|
History Says the Nasdaq Could See Strong Gains in 2025: Here Are the Top Nasdaq Stocks From Warren Buffett and Bill Ackman Going Into the New Year
- The stock market is so hot that I'm struggling to wrap my mind around the numbers. As of this writing, the Nasdaq Composite Index (^IXIC 1.03%) is up 30% in 2024.
- 12/23/2024
|
History Says the Nasdaq Could Soar in 2025: 2 AI Stocks to Buy Before It Does.
- According to data from CNBC going back to 1980, the Nasdaq and other benchmark indexes have historically risen in the months following a presidential election. This trend has continued in 2024, with the tech-heavy index up by around 10% since Donald Trump's win on Nov. 5.
- 12/22/2024
|
Wilhelmina International, Inc. Announces Voluntary Delisting from the Nasdaq Capital Market
- LONDON, GB / ACCESSWIRE / December 20, 2024 / Wilhelmina International, Inc. (NASDAQ:WHLM) (" Wilhelmina " or the " Company ") today announced that it has formally notified the Nasdaq Stock Market of its intention to voluntarily delist its shares of Common Stock from the Nasdaq Capital Market and to deregister the shares of Common Stock under Section 12(b) of the Securities Exchange Act of 1934 (the " Exchange Act "). The Company filed a Form 25 Notification of Removal of Listing and/or Registration Under Section 12(b) of the Exchange Act, relating to the delisting and deregistration on December 20, 2024, with the delisting of the shares of Common Stock taking effect no earlier than ten days thereafter.
- 12/20/2024
|
JIADE LIMITED Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- Chengdu, China , Dec. 20, 2024 (GLOBE NEWSWIRE) -- JIADE LIMITED (Nasdaq: JDZG) (the “Company”), a company that specializes in providing one-stop comprehensive education supporting services to adult education institutions, today announced that the Company received a letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) on December 17, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.
- 12/20/2024
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , Dec. 20, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on December 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 720,400 shares of its common stock and 276,200 restricted stock units ("RSUs") to thirty-seven (37) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/20/2024
|
Stran & Company Announces Receipt of Nasdaq Staff Delisting Determination
- Quincy, MA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that on December 17, 2024, it received a letter from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), issuing a Staff delisting determination (the “Staff Determination”). The Staff Determination noted that the Staff had notified the Company on June 21, 2024, August 23, 2024 and November 21, 2024 that the Company did not comply with Nasdaq Listing Rule 5250(c)(1) (the “Filing Rule”) because the Company had not filed its Quarterly Reports on Form 10-Q for the periods ended March 31, 2024, June 30, 2024, and September 30, 2024 (the “Forms 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Staff Determination noted that, based on the Staff's review and the materials submitted on August 20, 2024, the Staff granted the Company an exception until December 16, 2024 to regain compliance with the Filing Rule. The Staff Determination stated that the Company had not met the terms of the exception. Specifically, the Company has not filed the Forms 10-Q as required by the Filing Rule. The Staff Determination has no immediate effect and will not immediately result in the suspension of trading or delisting of the Company's common stock.
- 12/20/2024
|
Gaxos.ai Inc. Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Roseland, NJ, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 1,449,277 shares of its common stock at a purchase price of $3.45 per share. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase up to 1,449,277 shares of common stock. The warrants have an exercise price of $3.32 per share, are exercisable upon issuance and expire three years following the date of issuance.
- 12/20/2024
|
S&P 500 & Nasdaq 100 Close Higher | Closing Bell
- Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Alix Steel, Scarlet Fu, Carol Massar and Tim Stenovec. Sign up for the Economics Daily newsletter to discover what's driving the global economy and what it means for policy makers, businesses, investors and you.
- 12/20/2024
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 15,175 restricted stock units of the company's common stock to 15 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of December 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/20/2024
|
Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
- Salt Lake City, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that on December 19, 2024, the Compensation Committee of Recursion's Board of Directors approved the grant of inducement restricted stock unit (RSU) awards covering 7,952,836 shares of its class A common stock in the aggregate to 230 new employees under Recursion's 2024 Inducement Equity Incentive Plan (the “2024 Plan”). Each award was granted as an inducement material to the employee's commencement of employment with a subsidiary of Recursion in connection with Recursion's acquisition of Exscientia plc and pursuant to Nasdaq Listing Rule 5635(c)(4).
- 12/20/2024
|
Renovaro Regains Compliance with NASDAQ Listing Requirement
- LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced that it has received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule, 5550(a)(2). The Company's security will continue to be listed and traded on The Nasdaq Stock Market and this matter is now closed.
- 12/20/2024
|
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping more than 300 points on Friday.
- 12/20/2024
|
S&P 500, Nasdaq-100 are getting an update. Trillions depend on who's in and who's out
- S&P 500, Nasdaq-100 are getting an update. Trillions depend on who's in and who's out
- 12/20/2024
|
Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets
- HAMILTON, BERMUDA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB: CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced that on December 18, 2024 it received notice that the Nasdaq Hearings Panel (the "Panel") had determined to delist the Company's common shares from The Nasdaq Stock Market LLC ("Nasdaq") due to the Company's failure to comply with Rule 5550(a)(2) of Nasdaq's Listing Rules. The Rule requires listed securities to maintain a minimum bid price of $1.00 per share.
- 12/20/2024
|
History Says the Nasdaq Will Soar in 2025. 1 Stock-Split Stock to Buy Before It Does
- The Nasdaq Composite has been on an epic run over the past couple of years, driven higher by the recovering economy, the rapid adoption of artificial intelligence (AI), an undisputed U.S. Presidential election, and two recent interest rate cuts by the Federal Reserve Bank. After the tech-centric index surged 43% in 2023, it's up roughly 34% so far this year (as of this writing).
- 12/20/2024
|
S&P 500, Nasdaq End In Red As Investor Sentiment Declines, Micron Tumbles After Sales Miss: Greed Index In 'Extreme Fear' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index in the “Extreme Fear” zone on Thursday.
- 12/20/2024
|
Primis Financial Corp. Announces Reauthorization of Stock Repurchase Program and Compliance with Nasdaq Listing Rules
- MCLEAN, Va. , Dec. 19, 2024 /PRNewswire/ -- Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company"), today announced that the board of directors of the Company (the "Board") approved a stock repurchase program for up to 740,600 of the outstanding shares of the Company's common stock (the "Stock Repurchase Program").
- 12/19/2024
|
Prestige Wealth Inc. regains compliance with Nasdaq minimum bid price requirement
- HONG KONG, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Prestige Wealth Inc. (NASDAQ: PWM) (“PWM”, or the “Company”), a wealth management and asset management services provider based in Hong Kong, today announced that, on December 18, 2024, it received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on the Nasdaq Capital Market.
- 12/19/2024
|
Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules
- AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, known as engineered toxin bodies, to create novel therapies with potent and differentiated mechanisms of action for cancer, was notified on December 16, 2024 by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) of the Staff's determination pursuant to Nasdaq Listing Rule 5101 that the Company is a “public shell,” and that, in the view of the Staff, the continued listing of the Company's securities was no longer warranted. Further, Nasdaq indicated that the Company's non-compliance with (i) Nasdaq Listing Rule 5250(c)(1) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 and (ii) Nasdaq Listing Rule 5550(a)(2) as a result of its failure to maintain a $1.00 bid price for the required period, each serving as an additional and separate basis for delisting. Trading of the Company's common stock will be suspended at the opening of business on December 26, 2024, and Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission to formally delist the Company's securities from listing and registration, unless the Company timely requests a hearing before a Nasdaq Hearings Panel to appeal Nasdaq's determination and address the deficiencies. The Company does not plan to request a hearing regarding these deficiencies and expects that trading in the Company's common stock on the Nasdaq Stock Market will be suspended upon the opening of business on December 26, 2024.
- 12/19/2024
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 48,000 shares of the Company's common stock to one new employee (the “Inducement Grant”) on December 13, 2024 (the “Grant Date”). The Inducement Grant has been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grant was granted as an inducement material to the individual entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/19/2024
|
Aptose Announces Positive Decision by Nasdaq Hearings Panel
- SAN DIEGO and TORONTO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic malignancies, today announced that the Nasdaq Hearings Panel (“Panel”) has granted the Company's request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Stock Market. On or before March 31, 2025, the Company will be required to demonstrate compliance with NASDAQ Listing Rule 5550(b)(1) requiring the Company to have a minimum of $2.5 million in shareholders' equity (the “Equity Rule”) and NASDAQ Listing Rule 5550(a)(2) requiring the Company to have a minimum bid price of $1.00 (the “Minimum Bid Price Rule”).
- 12/19/2024
|
Phio Pharmaceuticals Announces $1.15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Marlborough, Massachusetts--(Newsfile Corp. - December 19, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 437,192 shares of its common stock at a purchase price of $2.635 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 437,192 shares of common stock.
- 12/19/2024
|
ETF of the Week: iShares Nasdaq Top 30 Stocks ETF (QTOP)
- VettaFi's Head of Research Todd Rosenbluth discussed the iShares Nasdaq Top 30 Stocks ETF (QTOP) on this week's “ETF of the Week” podcast with Chuck Jaffe of “Money Life.” For more news, information, and analysis, visit VettaFi | ETF Trends.
- 12/19/2024
|
Does Warren Buffett Know Something Wall Street Doesn't? The Billionaire Has Been Buying a Nasdaq Stock Split With a Hearty 4.6% Dividend Yield That Analysts Recently Downgraded.
- Berkshire Hathaway Chairman Warren Buffett is a value investor at his core. Value investing involves finding stocks trading below their intrinsic value and buying them at a discount.
- 12/19/2024
|
New Era Helium to Ring Nasdaq Opening Bell, Kicking Off 2025 Trading on January 2, 2025
- MIDLAND, Texas--(BUSINESS WIRE)--New Era Helium, Inc. (NASDAQ:NEHC) (“NEH,” “New Era Helium,” or the “Company”), an exploration and production (E&P) company sourcing helium produced in association with natural gas reserves within the Permian Basin, is excited to announce that Nasdaq has selected New Era Helium to ring the opening bell on January 2, 2025, marking the first trading day of the new year. 2024 has been a landmark year for New Era Helium. The Company successfully completed its bu.
- 12/19/2024
|
MindMed to Be Added to the Nasdaq Biotechnology Index
- NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will be added to the Nasdaq Biotechnology Index (NBI), effective at market open on Monday, December 23, 2024. “2024 has been a transformational year for MindMed. We've successfully executed many important milestones, including raising approximately $250 million.
- 12/19/2024
|
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle's Compensation Committee of its Board of Directors granted restricted stock units (RSUs) as inducement material to new employees.
- 12/19/2024
|
Climb Bio to be Added to the Nasdaq Biotechnology Index
- WELLESLEY HILLS, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) -- December 19, 2024 – Climb Bio, Inc. (Nasdaq: CLYM) today announced that the company will be added to the NASDAQ Biotech Index (Nasdaq: NBI) as part of the annual reconstitution of the 2024 Nasdaq indexes. Climb Bio's inclusion in the Nasdaq Biotechnology Index will be effective prior to market open on Monday, December 23, 2024.
- 12/19/2024
|
History Says the Nasdaq Will Surge in 2025. 1 Stock-Split Stock to Buy Before It Does.
- The U.S. stock market has been on a winning streak in 2024, with the technology-heavy Nasdaq Composite index topping the 20,000 mark. A major part of this rally can be attributed to the rapid adoption of artificial intelligence (AI) across industries and functions.
- 12/19/2024
|
Why Nasdaq-100 Leveraged ETF TQQQ Is Falling
- The ProShares UltraPro QQQ TQQQ, which provides triple-leveraged exposure to the Nasdaq-100 Index, fell some 10.81% to $82.09 Wednesday after the Federal Reserve's December meeting.
- 12/18/2024
|
Spyre Therapeutics Added to the Nasdaq Biotechnology Index
- WALTHAM, Mass. , Dec. 18, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches to target improved efficacy and convenience in the treatment of Inflammatory Bowel Disease ("IBD"), today announced Spyre has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI), effective prior to market open, Monday, December 23, 2024.
- 12/18/2024
|
Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)
- MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced that it is expected to be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the “NBI”). Oruka's addition will become effective prior to market open on Monday, December 23rd, 2024.
- 12/18/2024
|
Super Micro Computer Dropped 70% from Its High and Is Exiting the Nasdaq 100. Could This Beaten-Down Stock Recover in 2025?
- The year 2024 represented the best and worst of times for Super Micro Computer (SMCI 1.08%). The server maker started the year with a bang, reporting triple-digit revenue growth, thanks to demand from artificial intelligence (AI) customers.
- 12/18/2024
|
Better New Nasdaq-100 Buy: Palantir vs. MicroStrategy
- The holidays have come early for a couple of this year's most-watched technology companies. I'm talking about Palantir Technologies (PLTR -1.80%) and MicroStrategy (MSTR -5.41%), software players that have soared more than 300% and 500%, respectively, this year.
- 12/18/2024
|
History Says the Nasdaq May Soar in 2025: 1 Stock-Split AI Stock to Buy Ahead of the New Year
- The Nasdaq Composite (^IXIC -0.32%) has advanced 34% year to date, and history says that momentum may carry into 2025. Since its inception in 1971, the Nasdaq has returned at least 20% in 20 years, and at least 30% in 12 years.
- 12/18/2024
|
HUB Security Announces Receipt of Staff Delisting Notice and Initiation of Appeals Process
- TEL AVIV, Israel, Dec. 17, 2024 (GLOBE NEWSWIRE) -- via IBN – HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or the “Company”), a leading provider of cybersecurity solutions and advanced data fabric, announced receipt of a Staff Delisting Determination (the "Staff Determination") from the Listing Qualifications Department of the Nasdaq Stock Market, LLC ("Nasdaq"). The Company was notified that Nasdaq has determined to delist the Company's securities from the Nasdaq Global Market. As a result, the Company is exercising its right to request an appeal (the “Appeal”) of the Staff Determination before the Nasdaq Hearings Panel (the “Panel”). Such Appeal hearing request will result in a stay of any suspension or delisting action pending the Appeal hearing, and in the meantime, the Company's securities will continue to be fully tradeable and listed on the Nasdaq Global Market
- 12/17/2024
|
Nasdaq Composite Slides as Dow Faces 9-Day Losing Streak | QUBT Soars on NASA Contract
- Let's look at some of the more notable stocks making moves today: Quantum Computing Inc (Nasdaq: QUBT): Up 33% today after it was awarded a contract from NASA.
- 12/17/2024
|
S&P 500 and Nasdaq Futures Slide While Tesla Advances Ahead of Fed Meeting
- Nasdaq and S&P 500 futures decline ahead of the Fed meeting, while Tesla climbs. Traders await economic data and clues on the Fed's policy path.
- 12/17/2024
|
Nasdaq Welcomed 171 IPOs in 2024
- Leading U.S. exchange by number of IPOs and proceeds raised for the sixth consecutive year Featured the largest IPO and switch Over 500 exchange transfers to Nasdaq since 2005 NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today that in 2024, it welcomed 171 initial public offerings (IPOs), raising a total of $22.7 billion. A total of 123 operating companies and 48 SPACs listed on Nasdaq in 2024, representing an 81% win rate of Nasdaq-eligible IPOs in the U.S. market, and extending Nasdaq's leadership to 44 consecutive quarters.
- 12/17/2024
|
Santa Rally or Trump Bump? Nasdaq Soars on Broadcom, Tesla as Dow Slips.
- Broadcom and Tesla soar as tech fuels Nasdaq to new highs, while the Dow stumbles for an 8th day— Early Santa Claus rally or lingering Trump Bump?
- 12/17/2024
|
Should You Buy 3 of the Highest-Paying Dividend Stocks in the Nasdaq?
- If you're in the market for dividend-paying stocks, you're onto a smart investing strategy. That's because shares of healthy and growing dividend-paying companies are likely to rise in value over time, and their dividend payouts will tend to do the same.
- 12/17/2024
|
District Receives Conditional Approval from the Nasdaq First North Growth Market in Sweden
- Vancouver, British Columbia--(Newsfile Corp. - December 17, 2024) - District Metals Corp. (TSXV: DMX) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company") is pleased to announce that the Company has received conditional approval for the listing of its Swedish depository receipts (the "DMX SDRs") on the Nasdaq First North Growth Market ("Nasdaq First North"). Swedish depository receipts are financial instruments issued by a Swedish bank representing shares in a non-Swedish company.
- 12/17/2024
|
Nasdaq 100: Broadcom Shines Amid Nvidia Selloff, Drone Stocks Fly Higher
- Nasdaq 100 hits record high as Broadcom rallies, Nvidia slides into correction, and drone stocks soar on policy buzz and Red Cat's Palantir partnership.
- 12/16/2024
|
Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry
- Super Micro Computer, Inc SMCI stock is trading below its 50-day moving average as it awaits removal from the Nasdaq 100 Index on December 23, 2024, joining the likes of Illumina, Inc ILMN and Moderna, Inc MRNA.
- 12/16/2024
|
Nasdaq soars to record as Tesla, Google, Amazon, Apple hit fresh highs
- To get the latest market news check out finance.yahoo.com The Nasdaq Composite (^IXIC) notched a fresh record high on Monday as most of the Big Tech stocks gained and bitcoin (BTC-USD) hit fresh all-time highs ahead of the Federal Reserve's final policy decision meeting this week. The Nasdaq moved up 1.2%, with shares of Alphabet (GOOGL, GOOG), Tesla (TSLA), Amazon (AMZN), Apple (AAPL), and Broadcom (AVGO) all closing at fresh records.
- 12/16/2024
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on December 4, 2024, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 38,568 shares of common stock and 22,264 restricted stock units (“RSUs”) to thirteen new employees under Acadia's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees'.
- 12/16/2024
|
Super Micro slides 7% after stock is dropped from Nasdaq 100
- Super Micro is exiting the Nasdaq 100 after just five months in the index. The stock fell 7% on Friday and is more than 70% below its high reached in March.
- 12/16/2024
|
Nasdaq Jumps With Bitcoin: MSTR, MARA, COIN Shine on Tech and Crypto Optimism
- MSTR's Nasdaq inclusion, Bitcoin's rise above $106,000, and a tech-heavy Nasdaq rally set the stage for continued upside in Bitcoin-related stocks like Coinbase (COIN), Robinhood (HOOD), and MARA.
- 12/16/2024
|
Nasdaq Composite Builds on Recent Gains as MicroStrategy Joins Nasdaq-100
- The stock market continues rocketing higher, but how does confidence look in other pats of the economy?
- 12/16/2024
|
Premium Catering (Holdings) Limited Receives Nasdaq Deficiency Notice Regarding the Minimum Market Value of Listed Securities Requirement and a Nasdaq Deficiency Notice Regarding Minimum Bid Price
- SINGAPORE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Premium Catering (Holdings) Limited (NASDAQ: PC) disclosed that it had received a notice (the “MLVS Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is currently not in compliance with the minimum market value of listing securities (the “MVLS”) of $35,000,000 for continued listing of the Company's ordinary shares (the “Ordinary Shares”) on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(2) (the “MLVS Requirement”). Nasdaq calculates the MVLS based upon the most recent total shares outstanding multiplied by the closing bid price. The MVLS Notice indicated that the Company has 180 days, or until June 9, 2025 (the “Compliance Deadline”), to regain compliance with the MLVS Requirement by having its MVLS close at $35,000,000 or more for a minimum of ten consecutive business days. If at any time prior to June 9, 2025, the Company's MVLS closes at $35,000,000 or more for a minimum of ten consecutive business days, Nasdaq will provide a written confirmation of compliance and the matter regarding the Company's MLVS will be closed. Receipt of the MVLS Notice does not result in the immediate delisting of the Company's ordinary shares and has no immediate effect on the listing or the trading of the Company's ordinary shares on the The Nasdaq Capital Market under the symbol “PC”.
- 12/16/2024
|
Super Micro Computer Stock Slumps on Nasdaq 100 Removal, Rumored Capital Raise
- Super Micro Computer (SMCI) shares slumped Monday morning as the stock feels the impact of a pair of headlines that came out after the bell Friday, including a potential capital raise and the stock's removal from the Nasdaq 100 Index.
- 12/16/2024
|
SUNation Energy to Ring the Nasdaq Closing Bell on December 16, 2024
- RONKONKOMA, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE) (“SUNation” or the “Company”), a leading provider of sustainable solar energy and backup power to households, businesses, municipalities, and for servicing existing systems, today announced that it will ring the Closing Bell at the Nasdaq MarketSite in Times Square, New York City on Monday, December 16, 2024.
- 12/16/2024
|
Nasdaq, Dow and S&P 500 all seen higher as interest rate call comes into focus
- Wall Street appeared on course for a positive start to the week which will see the Federal Reserve decide whether to cut interest rates further. Futures had the Nasdaq up 0.4% ahead of Monday's open, while the S&P 500 and Dow Jones were seen 0.2% higher each respectively.
- 12/16/2024
|
Want to Invest in the Nasdaq? This ETF Is a Great Option Heading Into the New Year
- When people refer to investing in the Nasdaq, it could mean a few different things.
- 12/15/2024
|
History Says the Nasdaq Will Soar in 2025. Here's the 1 AI Stock to Buy Before It Does.
- The Nasdaq has blasted higher over the past two years, gaining more than 43% last year and now heading for an increase of more than 33% for 2024. This is thanks to the artificial intelligence (AI) boom, as five of the benchmark's most heavily weighted stocks and several others in the top 10 operate in this high-growth area.
- 12/15/2024
|
These Are the 5 Top-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
- Investors have had much to celebrate in 2024. The tech-centric Nasdaq-100, which tracks the performance of the 100 largest nonfinancial companies in the Nasdaq Composite, has gained 28% (as of Dec. 12).
- 12/15/2024
|
The Nasdaq-100 Just Announced Its Latest Addition. The Stock Soared 1,090% Since Early Last Year, and It's Still a Buy Heading Into 2025, According to a Certain Wall Street Analyst.
- The Nasdaq Composite is one of the most widely followed stock indexes in the U.S. The tech-focused index tracks the performance of more than 3,000 stocks listed on its exchange. The Nasdaq-100 is a subset of the index, tracking the performance of approximately 100 of the largest non-financial companies on the Nasdaq stock exchange.
- 12/14/2024
|
History Says the Nasdaq Will Surge in 2025. 2 Stock-Split Stocks to Buy Before It Does
- The Nasdaq Composite (^IXIC 0.12%) has been on a roll for more than two years now, with its gains fueled by improving economic conditions, the dawn of artificial intelligence (AI), an uncontested U.S. election, and recent interest rate cuts by the Federal Reserve Bank. After rising 43% in 2023, the tech-focused index has gained roughly 31% in 2024 (as of this writing).
- 12/14/2024
|
Annual Changes to the Nasdaq-100 Index®
- NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX®), which will become effective prior to market open on Monday, December 23, 2024.
- 12/13/2024
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 208,800 shares of its common stock to twelve newly hired employees, consisting of inducement stock options to.
- 12/13/2024
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 98,000 shares of common stock. Awards were made to six new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committee.
- 12/13/2024
|
Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
- Carlsbad, CA, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, today announced the closing of its previously announced underwritten public offering for gross proceeds of approximately $5 million prior to deducting underwriting commissions and offering expenses. The offering is comprised of (i) 158,000 Class A Units with each unit consisting of (a) one share of common stock and (b) one common warrant to purchase one share of common stock (the “Common Warrants”), and (ii) 3,120,688 Class B Units with each unit consisting of (a) one prefunded common stock purchase warrant to purchase one share of common stock (“Prefunded Warrants”) and (b) one Common Warrant. The price per Class A Unit is $1.525 and the price per Class B Unit is $1.5249 (collectively, the “Offering”).
- 12/13/2024
|
Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)
- DALLAS, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in 2018, that uses multi-spectral imaging and algorithms to predict burn healing potential, today announced today that the Company believes it has regained compliance with Nasdaq Listing Rule 5550(b)(2), which requires listed companies to maintain a minimum market value of listed securities of $35 million.
- 12/13/2024
|
Nasdaq Index: Tech Stocks Retreat, but Broadcom's AI Rally Buoys Sentiment
- Broadcom's $1T market cap fuels Nasdaq strength, but S&P 500 dips 0.2%. Defensive sectors rise as energy and materials lag.
- 12/13/2024
|
Stock Market Today: Nasdaq Composite Soars After Broadcom (AVGO) Earnings
- A key theme to watch in the market this week is ‘breadth.' The S&P 500 recently finished 8 straight days where a majority of stocks finished down.
- 12/13/2024
|
Nasdaq 100: Tech Stocks Rally as Broadcom, Nvidia Lead Semiconductor Gains
- S&P 500 and Nasdaq futures climb as earnings beats and upgrades fuel optimism. Broadcom's AI growth drives tech rally, boosting US market sentiment.
- 12/13/2024
|
Top Wealth Group Holding Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- Hong Kong, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Top Wealth Group Holding Limited (NASDAQ: TWG) (“Top Wealth” or the “Company”), a Hong Kong-based supplier of luxury caviar products, today announced that it received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on December 9, 2024, indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company's ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days.
- 12/13/2024
|
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company's Board of Directors granted a non-qualified stock option to purchase an aggregate of 5,500 shares of the Company's stock (the “Inducement Grant”) to a newly hired employee on December 10, 2024 (the “Grant Date”), in connection with the commencement of employment.
- 12/13/2024
|
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced that it has agreed to grant inducement awards to one newly hired employee. The awards were made as inducements material to the individual's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/13/2024
|
Meet the Newest Stock in the Nasdaq-100. It's Soared 3,250% Since Early Last Year and Is Still a Buy Heading Into 2025, According to Wall Street.
- The Nasdaq Composite is a broad-based tech-centric index that tracks the performance of more than 3,000 stocks listed on the exchange. The Nasdaq-100 is a subset of that index, tracking the performance of roughly 100 of the largest non-financial companies on the Nasdaq stock exchange, spanning a variety of sectors.
- 12/13/2024
|
S&P 500, Nasdaq, Dow slide with rate cuts, sticky inflation in focus
- To get the latest market news check out finance.yahoo.com On a day when President-elect Donald Trump rang the opening bell at the New York Stock Exchange, Wall Street failed to build on a furious rally that had picked up steam after his election win. Fresh inflation data, in focus, helped cast doubt on investor confidence in the path of interest rates ahead.
- 12/12/2024
|
Mountain Lake Acquisition Corp. Announces the Pricing of Upsized $210,000,000 Initial Public Offering
- NEVADA, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Mountain Lake Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 21,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading tomorrow, December 13, 2024, under the ticker symbol “MLACU.” Each unit consists of one Class A ordinary share and one right. Each right entitles the holder thereof to receive one-tenth (1/10) of one Class A ordinary share upon the consummation of an initial business combination. A right holder must hold ten rights to receive one Class A ordinary share at the closing of the initial business combination. Once the securities constituting the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on Nasdaq under the symbols “MLAC” and “MLACR,” respectively. The offering is expected to close on December 16, 2024, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,150,000 units at the initial public offering price to cover over-allotments, if any.
- 12/12/2024
|
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
- BERKELEY, Calif. and MAINZ, Germany, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V.
- 12/12/2024
|
ConnectM Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Company's Quarterly Report
- MARLBOROUGH, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) (“ ConnectM ” or the “ Company ”), a technology company focused on the electrification economy, today announced that on December 6, 2024, it received a notice from the staff of the Listing Qualifications Department of Nasdaq stating that because the Company had not filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “ Filing ”), it no longer complies with Nasdaq Listing Rule 5250(c)(1) for continued listing, which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.
- 12/12/2024
|
Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter
- No impact at this time on the listing of the Company's Ordinary Shares on Nasdaq Company intends to submit to Nasdaq a compliance plan WESTPORT, Conn., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, announced today that it received written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) on December 10, 2024 indicating that the Company was not in compliance with the minimum shareholders' equity requirement for continued listing on The Nasdaq Capital Market (the “Capital Market”) as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Shareholders' Equity Requirement”), because the Company's shareholders' equity of $695,000 as of September 30, 2024, as reported in the Company's Report on Form 6-K containing unaudited condensed consolidated interim financial statements for the three and six months ended September 30, 2024, filed with the United States Securities and Exchange Commission (the “SEC”) on November 26, 2024, was below the required minimum of $2.5 million, and because, as of the date of the Notice (and as of the date of this press release), the Company did not meet either of the alternative continued listing standards for the Capital Market, relating to market value of listed securities of at least $35 million or net income from continuing operations of at least $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years.
- 12/12/2024
|
Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing
- WOBURN, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, celebrated the closing of its business combination with Atlantic Coastal Acquisition Corp II (“ACAB”), a special purpose acquisition company, with a Nasdaq bell ringing ceremony. Abpro also celebrated the consummation of a PIPE offering raising $7 million in gross proceeds and a $2.76 million convertible note financing with YA II PN, LTD (“Yorkville”) to cover expenses in connection with the closing of the business combination.
- 12/12/2024
|
ServiceTitan stock soars 40% on Nasdaq debut
- ServiceTitan made a blockbuster debut on the Nasdaq Stock Exchange on Thursday. Shares opened more than 40% up compared to their initial public offering (IPO) price of $71 and stuck a market cap of $6.3 billion on the cloud-based software company.
- 12/12/2024
|
Software startup ServiceTitan valued at $8.97 bln as shares jump 42% in Nasdaq debut
- Shares of ServiceTitan rose about 42% in their U.S. market debut on Thursday, giving the cloud-based software company a valuation of $8.97 billion.
- 12/12/2024
|
ServiceTitan pops to $101 in cloud software vendor's Nasdaq debut after selling shares at $71
- After raising about $625 million in its IPO, ServiceTitan shares jumped 42% in their Nasdaq debut on Thursday. It's the first notable venture-backed IPO since Rubrik hit the market in April.
- 12/12/2024
|
Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
- Carlsbad, CA, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, today announced the pricing of an underwritten public offering for gross proceeds of approximately $5 million prior to deducting underwriting commissions and offering expenses. The offering is comprised of (i) 158,000 Class A Units with each unit consisting of (a) one share of common stock and (b) one common warrant to purchase one share of common stock (the “Common Warrants”), and (ii) 3,120,688 Class B Units with each unit consisting of (a) one prefunded common stock purchase warrant to purchase one share of common stock (“Prefunded Warrants”) and (b) one Common Warrant. The price per Class A Unit is $1.525 and the price per Class B Unit is $1.5249 (collectively, the “Offering”).
- 12/12/2024
|
ETFs Gaining Momentum as Nasdaq Tops 20000
- The Nasdaq Composite Index crosses the 20,000 mark, powered by a sustained rally in tech stocks.
- 12/12/2024
|
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
- PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq listed companies to maintain an audit committee consisting of three independent directors. This development follows the recent appointment of Mr.
- 12/12/2024
|
Wall Street Poised To Open Lower A Day After Nasdaq's Record Close Above 20,000: Expert Flags 'Deterioration Under The Surface' As 117 S&P 500 Stocks Hit New Monthly Lows
- U.S. stock futures declined on Thursday in premarket hours after hitting fresh highs on Wednesday. The futures of all the four major indices were trading lower.
- 12/12/2024
|
MicroStrategy shares could surge even higher if added to Nasdaq 100 on Friday, crypto analyst says
- MicroStrategy's inclusion on the Nasdaq 100 index largely depends on whether it is classified as a software developer or a financials company
- 12/12/2024
|
Nasdaq Settles Above 20,000 Following Inflation Data, Alphabet Surges After Gemini 2.0 Unveil: Fear & Greed Index Remains In 'Neutral' Zone
- The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the “Neutral” zone on Wednesday.
- 12/12/2024
|
Zacks Industry Outlook Intercontinental Exchange, CME Group, Nasdaq, Cboe Global Markets and MarketAxess
- Intercontinental Exchange, CME Group, Nasdaq, Cboe Global Markets and MarketAxess have been highlighted in this Industry Outlook article.
- 12/12/2024
|
Nasdaq Up Big, Dow Down a Bit, Following CPI, Budget Data
- It's now in the Fed's hands what they want to do about interest rates at their two-day meeting starting next Tuesday.
- 12/11/2024
|
Nasdaq tops 20,000 for first time as Big Tech surges, Tesla hits first record in 3 years
- To get the latest market news, check out finance.yahoo.com Big Tech stocks led the market higher on Wednesday, as investors digested another month of sticky inflation data that met economists' expectations and likely pointed to a Federal Reserve interest rate cut next week. The tech-heavy Nasdaq Composite (^IXIC) jumped about 1.7% amid a feverish rally in the "Magnificent Seven" tech stocks.
- 12/11/2024
|
NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q
- New York, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the period ended September 30, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”).
- 12/11/2024
|
Millicom (Tigo) updates on Interim Dividend and intended SDR delisting from Nasdaq Stockholm
- Millicom (Tigo) updates on Interim Dividend and intended SDR delisting from Nasdaq Stockholm Luxembourg, December 11, 2024 – Millicom International Cellular S.A. (“Millicom” or the “Company”), today announced further details regarding the payment of the Interim Dividend and the intended delisting of SDRs from Nasdaq Stockholm, including removal as from January 13, 2025 of certain fees for conversions of SDRs to Millicom U.S. Shares traded at Nasdaq U.S..
- 12/11/2024
|
ECD Auto Design Announces Receipt of Nasdaq Delisting Notice
- KISSIMMEE, Fla., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (Nasdaq: ECDA) (“ECA Auto Design” or the “Company”), an industry leader in delivering restored, modified and electrified Land Rover Defenders, Jaguars, Ford Mustangs, and Toyota FJs, received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company is delinquent in filing its Form 10-Q for the quarter ended September 30, 2024, the Company no longer complies with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC. The Notice provided that the Company shall have 60 calendar days to submit a plan to regain compliance with the Listing Rule, and if Nasdaq accepts the Company's plan, Nasdaq can grant the Company an exception of up to 180 calendar days from the Filing's due date, or until May 19, 2025, to regain compliance with the Listing Rule.
- 12/11/2024
|
Super Micro Computer Teeters On Edge Of Nasdaq 100: Can xAI, Nvidia Help Stabilize Trajectory?
- Super Micro Computer Inc. SMCI is walking a tightrope this week, with its spot on the Nasdaq 100 Index hanging in the balance.
- 12/11/2024
|
5 Stocks to Watch From the Prospering Securities and Exchanges Industry
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, NDAQ, CBOE and MKTX. However, compliance with regulations remains a challenge.
- 12/11/2024
|
Vivopower Receives Notification of Recompliance with Nasdaq's Minimum Bid Price Rule
- LONDON, Dec. 11, 2024 (GLOBE NEWSWIRE) -- On December 10, 2024, VivoPower International PLC (Nasdaq: VVPR) ("VivoPower" or the "Company") received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company's common stock has maintained a minimum bid closing price of $1.00 per share or greater for 10 consecutive business days. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2).
- 12/11/2024
|
Beamr Featured in Nasdaq Amplify Issuer Spotlight: Strengthening Leadership in the Rapidly Evolving Video Market
- Herzliya Israel, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced that Sharon Carmel, Chief Executive Officer, was recently featured in the Nasdaq Amplify Issuer Spotlight interview series at the Nasdaq MarketSite.
- 12/11/2024
|
Super Micro Stock Falls. CEO Fails to Reassure Market About Nasdaq Future.
- The company was recently granted an extension to file its delayed annual and quarterly reports by Feb. 25
- 12/11/2024
|
History Says the Nasdaq Could Soar in 2025: 1 Trillion-Dollar AI Stock to Buy That's Highly Rated by Wall Street
- The Nasdaq Composite (^IXIC -0.25%) has advanced 32% year to date due in part to enthusiasm about artificial intelligence. That momentum bodes well for 2025 because strength in the index has historically led to more strength.
- 12/11/2024
|
Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on December 10, 2024, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 146,400 shares of its common stock to sixteen new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/10/2024
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 12/10/2024
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 29, 2024
- NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of November 29, 2024, short interest in 3,065 Nasdaq Global MarketSM securities totaled 11,857,580,215 shares compared with 11,973,515,318 shares in 3,070 Global Market issues reported for the prior settlement date of November 15, 2024. The end-of-November short interest represents 2.36 days compared with 2.25 days for the prior reporting period.
- 12/10/2024
|
Atlantic International Corp. Announces Uplisting to the Nasdaq Global Market
- ENGLEWOOD CLIFFS, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Atlantic International Corp. (“Atlantic”), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced that it has received approval to list its common stock on the Nasdaq Global Market (“Nasdaq”) stock exchange. Trading on Nasdaq is expected to commence on Wednesday, December 11, 2024 under the Company's current ticker symbol “ATLN”. Prior to listing on Nasdaq, the Company's shares traded on the OTC Markets. Shareholders are not required to take any action as a result of the uplisting.
- 12/10/2024
|
Nasdaq 100 and S&P500: Meta Rises, Energy Shines Ahead of CPI Report
- Nasdaq 100 slips as Oracle tumbles; Meta rebounds while energy stocks shine. Investors await key CPI data to gauge inflation and Fed rate direction.
- 12/10/2024
|
GreenPro Capital Regains Nasdaq Compliance
- KUALA LUMPUR, MALAYSIA / ACCESSWIRE / December 10, 2024 / Greenpro Capital Corp. (NASDAQ:GRNQ) a multinational financial services company with a current market capitalization of $7.65 million, announced today that is has regained compliance with Nasdaq's Listing Rule 5550(a)(2), which requires a minimum bid of price of $1.00 per share. The news follows a recent communication from the Nasdaq Listings Qualifications Staff confirming the company's adherence to the rule.
- 12/10/2024
|
S&P 500, Nasdaq Retreat From Record Highs As Nvidia Declines Over Chinese Antitrust Concerns: Fear & Greed Index Remains In 'Neutral' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Neutral” zone on Monday.
- 12/10/2024
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on December 3, 2024, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 171,750 shares of Class A common stock and restricted stock units (RSUs) for 86,625 shares of Class A common stock to seventeen new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/09/2024
|
S&P 500, Nasdaq pull back from records as Nvidia tumbles
- To get the latest market news, check out finance.yahoo.com US stocks pulled back on Monday as Nvidia (NVDA) shares slipped amid a Chinese antitrust probe and investors prepared for this week's consumer inflation report. The Dow Jones Industrial Average (^DJI) edged down 0.5%, coming off a losing week for the blue-chip index.
- 12/09/2024
|
Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- WEST CHESTER, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Verrica's Compensation Committee granted David Zawitz, Verrica's new Chief Operating Officer, a nonqualified stock option to purchase 950,000 shares of its common stock under the Company's Inducement Plan, effective December 9, 2024. The stock option was granted as a material inducement to Mr. Zawitz's employment with Verrica in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/09/2024
|
iRobot Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass. , Dec. 9, 2024 /PRNewswire/ -- iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced that it granted an equity award as a material inducement to the employment of the company's newly-hired Senior Vice President and Chief Human Resources Officer, Jules Connelly.
- 12/09/2024
|
Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
- PRINCETON, NJ, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet") (NASDAQ:SONN), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that it has entered into a definitive agreement with institutional investors for the purchase and sale of an aggregate of 1,085,325 shares of its common stock (or common stock equivalents in lieu thereof) (the “Registered Direct Shares”) and warrants to purchase up to an aggregate of 1,085,325 shares of common stock (the “Registered Direct Warrants”), in a registered direct offering. Each share of common stock (or pre-funded warrant in lieu thereof) is being sold in the registered direct offering together with one common warrant at a combined offering price of $2.23, priced at-the-market under the rules of the Nasdaq Stock Market. The Registered Direct Warrants will have an exercise price of $2.10 per share, are immediately exercisable and will expire five years from the date of issuance. The Company has also entered into a definitive agreement with an existing investor, in a concurrent private placement, for the purchase and sale of an aggregate of 673,000 shares of its common stock (or common stock equivalents in lieu thereof) (the “PIPE Shares”) and warrants to purchase up to an aggregate of 673,000 shares of common stock (the “PIPE Warrants”). Each share of common stock (or pre-funded warrant in lieu thereof) is being sold in the private placement offering together with one common warrant at a combined offering price of $2.23, priced at-the-market under the rules of the Nasdaq Stock Market. The PIPE Warrants will have an exercise price of $2.10 per share, are immediately exercisable and will expire five years from the date of issuance.
- 12/09/2024
|
S&P 500 and Nasdaq Outlook as CPI and Fed Meeting Shape Year-End Moves
- Tech stocks tumble as Nvidia faces antitrust scrutiny and AMD is downgraded. Energy stocks rise while CPI data looms, shaping the Fed's next move.
- 12/09/2024
|
Watch These Super Micro Price Levels as Stock Jumps After Nasdaq Filing Extension
- Super Micro Computer (SMCI) shares traded higher in early trading on Monday after the embattled server maker said late Friday that it had received an extension until February from the Nasdaq to file its delayed annual report.
- 12/09/2024
|
Nasdaq 100: Nvidia's 2% Slide Adds Pressure Ahead of CPI and Fed Decision
- Nasdaq and S&P 500 dip as Nvidia falls 2% on China antitrust probe. Traders await inflation data ahead of Fed's potential rate cut decision next week.
- 12/09/2024
|
Super Micro Computer Stock Soars on Nasdaq Listing Extension
- Shares of Super Micro Computer, or Supermicro (SMCI), jumped in premarket trading Monday after the troubled server maker announced that it won't face a possible delisting by the Nasdaq for a couple of months.
- 12/09/2024
|
S&P 500, Nasdaq Hit Record Close As November Jobs Data Beats Expectations: Fear & Greed Index In 'Neutral' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index in the “Neutral” zone on Friday.
- 12/09/2024
|
2 Nasdaq Stocks to Buy Before They Soar as Much as 115% in 2025, According to Certain Wall Street Analysts
- The Nasdaq Composite is a tech-centric index that tracks the performance of more than 3,000 stocks listed on the exchange. Just this week, the Nasdaq, the S&P 500, and the Dow Jones Industrial Average all climbed to record heights, the latest in a long line of all-time highs hit this year.
- 12/08/2024
|
History Says the Nasdaq Will Surge in 2025. 1 Stock-Split Stock to Buy Before It Does.
- The Nasdaq Composite has been on fire over the past couple of years, driven higher by the advent of artificial intelligence (AI), improving economic conditions, an uncontested election, and the Federal Reserve Bank's recent moves to cut interest rates. After returning 43% in 2023, the tech-centric index is up roughly 30% in 2024.
- 12/07/2024
|
Nasdaq Staff Determination Letter
- NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Nasdaq Staff Determination Letter.
- 12/06/2024
|
Super Micro Wins Key Nasdaq Extension. The Stock Is Soaring.
- Super Micro said late Friday that the Nasdaq granted its request for an extension for submitting key filings. SMCI stock jumped late, continuing a big rebound.
- 12/06/2024
|
Super Micro gets Nasdaq listing extension, says it can file financials by February
- Super Micro said on Friday that it had received an extension from Nasdaq that pushes off a potential delisting until at least February. The server maker has been facing the potential of being delisted because it has yet to file audited year-end financials.
- 12/06/2024
|
Nasdaq, S&P 500 pop to strong weekly gains after jobs report boosts Fed rate cut odds
- US stocks mostly rose on Friday as investors digested the last monthly jobs report of the year, a crucial test of the prospects for interest rate cuts in December and beyond. The Dow Jones Industrial Average (^DJI) lost about 0.3%, while the S&P 500 (^GSPC) rose roughly 0.3%.
- 12/06/2024
|
Super Micro Computer Inc. Announces Receipt of Extension from Nasdaq Stock Market
- SAN JOSE, Calif.--(BUSINESS WIRE)--Super Micro Computer, Inc. (NASDAQ:SMCI) (“SMCI” or the “Company”), a Total IT Solution Provider for AI, Cloud, Storage and 5G/Edge, today announced that on December 6, 2024, it received a letter from the Nasdaq Stock Market ("Nasdaq") informing the Company that Nasdaq has granted the Company's request for an exception to Nasdaq's Listing Rule 5250(c)(1) through February 25, 2025. The exception gives the Company until February 25, 2025 to file its Annual Repor.
- 12/06/2024
|
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company's Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 9,450 shares of its common stock under the Company's 2023 Inducement Plan.
- 12/06/2024
|
Presidio Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule
- SAN DIEGO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (“Presidio” or the “Company”) (NASDAQ: SQFT; SQFTP; SQFTW), an internally managed, diversified real estate investment trust (“REIT”), today announced that the Company has been granted an additional 180-day period from Nasdaq's Listing Qualification Department, through June 2, 2025, to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The Company's common stock continues to trade on the Nasdaq Capital Market under the symbol “SQFT.
- 12/06/2024
|
Dynamix Corporation Announces the Separate Trading of its Class A ordinary shares and Warrants Commencing December 9, 2024
- Houston, TX, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Dynamix Corporation (the “Company”) today announced that commencing December 9, 2024, holders of the units sold in the Company's initial public offering may elect to separately trade the Class A ordinary shares and warrants included in the units. Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the ticker symbol “DYNX” and “DYNXW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “DYNXU.” No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Odyssey Transfer and Trust Company, the Company's transfer agent, in order to separate the units into Class A ordinary shares and warrants.
- 12/06/2024
|
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on December 4, 2024, the Compensation Committee of Adverum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 68,640 shares of common stock and restricted stock units (RSUs) for 34,920 shares of common stock to 13 new employees under Adverum's 2017 Inducement Plan. The Compensation Committee of Adverum's Board of Directors approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/06/2024
|
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved the grant of equity awards to four new employees with a grant date of December 2, 2024, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 2020 Inducement Stock Incentive Plan) and material to the employees' acceptance of employment with the company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/06/2024
|
BloomZ Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- TOKYO, JAPAN / ACCESSWIRE / December 6, 2024 / BloomZ Inc. (NASDAQ:BLMZ) ("BloomZ" or the "Company"), a Cayman Islands holding company with an operating subsidiary, Kabushiki Kaisha BloomZ, in Japan, and a Japanese audio production, and voice actor and VTuber management company, today announced that it has received a deficiency letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Capital Market ("Nasdaq") on December 2, 2024, indicating that the Company was not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule") for continued listing on Nasdaq. The Minimum Bid Price Rule requires listed securities to maintain a minimum bid price of US $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet this requirement exists if the deficiency continues for a period of 30 consecutive business days.
- 12/06/2024
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, The Netherlands and MIAMI, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 79,000 of NewAmsterdam's ordinary shares to two non-executive new hires. The share options were granted as an inducement material to the employees'acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/06/2024
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 44,000 restricted stock units of Arcutis' common stock to six newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of December 2, 2024, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/06/2024
|
F/m Investments Announces Listing Exchange Change for US Credit Series ETFs to Nasdaq
- WASHINGTON--(BUSINESS WIRE)--F/m Investments (“F/m”), a $16 billion multi-boutique investment firm and innovative provider of exchange-traded funds (ETFs), today announced that effective December 19, 2024, it will transfer the stock exchange listing for the F/m US Credit Series ETFs (ZTWO, ZTRE, ZTEN) from NYSE Arca, Inc. to The Nasdaq Stock Market LLC ("Nasdaq"). Shareholders in the funds will not be required to take any action as a result of this change. F/m expects these ETFs will begin trad.
- 12/06/2024
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on December 2, 2024, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 152,000 shares of the Company's common stock in connection with their employment. The stock option was granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individual entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/06/2024
|
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 35 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of Jelmyto® (mitomycin) for pyelocalyceal solution, UroGen's first approved product, and the c.
- 12/06/2024
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , Dec. 6, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on December 2, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 170,000 shares of the Company's common stock to a newly hired employee.
- 12/06/2024
|
Jeffs' Brands Regains Compliance with Nasdaq Minimum Bid Price Rule
- Tel Aviv, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs' Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that it has received a written notice from Nasdaq Stock Market LLC (“Nasdaq”), indicating that the Company has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.
- 12/06/2024
|
Nasdaq CFO Sarah Youngwood to Present at the Goldman Sachs U.S. Financial Services Conference
- NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 12/05/2024
|
Final Trades: Nasdaq, the IBIT and the IAU
- The Investment Committee give you their top stocks to watch for the second half.
- 12/05/2024
|
Nasdaq 100 and Crypto Stocks: Bitcoin's Rally Boosts Market Sentiment
- US stocks hold steady as Bitcoin soars past $100K, lifting crypto equities. Retail and tech stocks lead premarket moves.
- 12/05/2024
|
Sol Strategies Applies For Listing on Nasdaq Exchange
- Toronto, Ontario--(Newsfile Corp. - December 5, 2024) - Sol Strategies Inc. (CSE: HODL) (OTC Pink: CYFRF) ("Sol Strategies" or the "Company"), a publicly traded Canadian company actively investing in, supporting, and providing infrastructure for the Solana blockchain and ecosystem, today submitted its application for listing on the Nasdaq Stock Market ("Nasdaq"). This marks a critical milestone in the Company's strategic plan to enhance institutional investor access and expand its market presence.
- 12/05/2024
|
Santech Holdings Limited Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
- HONG KONG, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Santech Holdings Limited (NASDAQ: STEC) (“Santech” or the “Company”) announced today that it has received an extension of the period to regain compliance with The Nasdaq Stock Market Inc.'s (the "Nasdaq") the minimum bid price requirement (the “Minimum Bid Price Requirement”).
- 12/05/2024
|
Nasdaq, Dow, S&P 500 hit records as tech surges, Fed Chair says economy in 'remarkably good shape'
- To get the latest market news check out finance.yahoo.com A tech rally boosted US stocks on Wednesday, with all three major indexes hitting new record closes, as investors digested Federal Reserve Chair Jerome Powell's comments that US economy is in "remarkably good shape." The Dow Jones Industrial Average (^DJI) climbed about 0.7%, or over 300 points, to close above 45,000 for the first time ever.
- 12/04/2024
|
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced the grant of an inducement award to a November new hire, as required under Nasdaq Listing Rule 5635(c)(4).
- 12/04/2024
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted five newly-hired employees stock options to purchase an aggregate of 17,400 shares, and restricted stock units (RSUs) covering an aggregate of 12,150 shares, of BioCryst common stock. The options and RSUs were granted as of November 29, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/04/2024
|
Coinbase to Participate in 51st Nasdaq London Investor Conference
- Remote-First-Company/MIAMI--(BUSINESS WIRE)--Coinbase Global, Inc. announced today that Alesia Haas, Chief Financial Officer, will participate in a fireside chat at the 51st Nasdaq London Investor Conference on Wednesday, December 11, 2024 at 1:30pm GMT / 8:30 am ET. A live webcast and replay of the virtual session will be available on Coinbase's Investor Relations website at https://investor.coinbase.com. Disclosure Information In addition to filings with the Securities and Exchange Commission.
- 12/04/2024
|
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent directors serving on the Compensation Committee of the company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 391,500 shares of the company's common stock to 10 new employees (the “Inducem.
- 12/04/2024
|
Nasdaq, S&P 500 hover near record highs as tech leads gains
- To get the latest market news check out finance.yahoo.com The S&P 500 (^GSPC) and tech-heavy Nasdaq Composite (^IXIC) touched intraday record highs on Wednesday as markets edged higher, buoyed by tech stocks. The S&P 500 Tech sector (XLK) outperformed, jumping about 1.3%.
- 12/04/2024
|
FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance
- New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the “Company”) (NASDAQ: FTII), today announced that it received an expected deficiency notification letter from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) on November 27, 2024 (the “Notice”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Q3 10-Q”), as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the “SEC”) on November 15, 2024. The Staff also noted that this serves as an additional basis for delisting the Company's securities from Nasdaq and since the Company is already before a Hearings Panel for its failure to comply with the Market Value of Listed Securities requirement of Nasdaq Listing Rule 5420(a)(2) (the “Market Value of Listed Shares Rule”), the Company has until December 4, 2024 to request a stay of the sustention, pending a Hearings Panel decision. In addition, the Staff noted that based on the Company disclosure that 1,564,549 shares were tendered for redemption following the special meeting on November 18, 2024, the Company no longer complies with the minimum 1,100,000 publicly held shares requirement set forth in Listing Rule 5450(b)(2)(B) (the “Publicly Held Shares Rule”).
- 12/04/2024
|
5 Stocks Driving Nasdaq ETF to New Highs in 2024
- Nasdaq achieves its 34th record closing high of the year. Here are the five best stocks of QQQ this year.
- 12/04/2024
|
Nasdaq and S&P 500 hit record highs on Salesforce, Marvell gains
- US equity benchmarks rose on Wednesday led by gains in technology shares such as Salesforce and Marvell Technology. At the time of writing, the Dow Jones Industrial Average was up 0.6%, while the S&P 500 gained 0.3%.
- 12/04/2024
|
Cognizant to Present at the Nasdaq Investor Conference
- TEANECK, N.J. , Dec. 4, 2024 /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading provider of information technology, consulting, and business process services, today announced a presentation at the following investor conference: Nasdaq Investor Conference Presenter: Ravi Kumar S, Chief Executive Officer Date: Wednesday, December 11, 2024 Time: 1:00PM UK / 8:00AM EST A live audio webcast of the presentation will be available at Cognizant's website: http://investors.cognizant.com A replay of the webcast will remain available on the company's website for 90 days.
- 12/04/2024
|
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted five newly-hired employees inducement options to purchase an aggregate of 36,000 shares of KalVista common stock on December 2, 2024 as inducements material to each employee entering into employment with KalVista. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4). The options have.
- 12/04/2024
|
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective December 1, 2024, the company granted non-qualified stock options to purchase 8,400 shares of its common stock to one new employee under Xilio Therapeutics' 2022 Inducement Stock Incentive Plan.
- 12/03/2024
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to two new employees to purchase an aggregate of 60,000 shares of the Company's common stock, effective as of December 2, 2024. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/03/2024
|
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass and DUBLIN, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that on December 2, the Company granted to four newly hired employees (i) non-statutory stock options to purchase an aggregate of 26,300 ordinary shares of the Company and (ii) restricted stock units with respect to an aggregate of 13,200 ordinary shares of the Company, pursuant to the Company's 2024 Inducement Stock Option and Incentive Plan, each as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/03/2024
|
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 32,500 shares of Astria's common stock on December 2, 2024 under Astria's 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were gra.
- 12/03/2024
|
SPS Commerce to Present at the Nasdaq 51st Investor Conference
- MINNEAPOLIS, Dec. 03, 2024 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that management will present at the Nasdaq 51st Investor Conference on Tuesday, December 10, 2024, at 3:00 PM GMT.
- 12/03/2024
|
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on December 2, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 396,824 shares of X4's common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by X4's Compensation Committee of the Board of Directors.
- 12/03/2024
|
Qurate Retail, Inc. Transfers Equity Listing to the Nasdaq Capital Market
- ENGLEWOOD, Colo.--(BUSINESS WIRE)--Qurate Retail, Inc. Transfers Equity Listing to the Nasdaq Capital Market.
- 12/03/2024
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. , Dec. 3, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted nine newly-hired employees options to purchase an aggregate of 121,000 shares of Akebia's common stock on November 29, 2024.
- 12/03/2024
|
EA to Present at the Nasdaq 51st Investor Conference
- REDWOOD CITY, Calif.--(BUSINESS WIRE)--Electronic Arts Inc. (NASDAQ: EA) today announced that Stuart Canfield, CFO, will present at the Nasdaq 51st Investor Conference on Tuesday, December 10, in London, England. During the course of this event, EA may disclose material developments affecting its business and/or financial performance. Listeners may access the event via live audio webcast at http://ir.ea.com. Tuesday, December 10, 2024 Presentation at 8:30 AM GMT / 3:30 AM EST Duration: 30 Minut.
- 12/03/2024
|
Sprouts Farmers Market to Present at the Nasdaq 51st Annual Investor Conference
- PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, Inc. (Nasdaq: SFM), one of the largest and fastest-growing specialty retailers of fresh, natural and organic food in the United States, today announced the company's participation in the Nasdaq 51st Annual Investor Conference in London. Jack Sinclair, chief executive officer, and Curtis Valentine, chief financial officer, are scheduled to conduct a fireside chat discussion at 9:30 a.m. Eastern Daylight Time/2:30 p.m. Greenwich Mean Time on Decem.
- 12/03/2024
|
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on December 2, 2024 the Company granted restricted stock units (RSUs) representing 18,600 shares of its common stock to one newly-hired non-executive employee. The grant was approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.
- 12/03/2024
|
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on December 1, 2024, it awarded an inducement grant to one new employee under Intellia's 2024 Inducement Plan as a material inducement to employment.
- 12/03/2024
|
New Calamos ETFs Offer S&P 500 & Nasdaq-100 Exposure
- Calamos Investments expanded its lineup of Structured Protection ETFs with the launch of two new funds, providing exposure to S&P 500 and Nasdaq-100 with 100% downside protection over one year: Calamos S&P 500® Structured Alt Protection ETF™ — December (CPSD) has an upside cap rate of 8.
- 12/03/2024
|
AgriFORCE Announces Reverse Stock Split for Nasdaq Compliance
- VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI), an intellectual property focused agtech company, today announced the Company's Board of Directors has approved a reverse stock split of the Company's issued and outstanding common shares whereby every one hundred (100) shares of its outstanding common shares will automatically be combined into one (1) common share. The reverse split was approved by the Company's shareholders on November 25, 2024 and will be effective as of the commencement of trading on December 5, 2024. The reverse stock split is being implemented for the purpose of complying with the closing bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
- 12/03/2024
|
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON--(BUSINESS WIRE)--Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that, effective December 2, 2024, the Compensation Committee of Tango Therapeutics' Board of Directors granted a non-qualified stock option to purchase 187,500 shares of its common stock and 31,250 restricted stock units (RSUs) to a new employee under Tango Therapeutics' 2023 Inducement.
- 12/03/2024
|
Billionaires Are Piling Into This Nasdaq Stock-Split Company Down 52% and Yielding a Healthy 4% Dividend
- In case you missed it, institutional funds recently disclosed their latest equity holdings for the third quarter of the year in their 13F forms filed with the Securities and Exchange Commission (SEC).
- 12/03/2024
|
Nasdaq Study Shows Firms Turning to AI and Data Scientists to Enhance Regulatory Compliance
- 35% of respondents identified advanced technologies and AI as the main influences on their near-term compliance efforts
- 12/03/2024
|
S&P, Nasdaq Settle At Record Highs As Tesla, SMCI Surge: Fear Index Remains In 'Greed' Zone
- The CNN Money Fear and Greed index showed some decline in the overall market sentiment, while the index remained in the “Greed” zone on Monday.
- 12/03/2024
|
Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq
- Jupiter, Florida, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a pipeline targeting neuroinflammation with its unique resveratrol platform product, JOTROL™, today announced the pricing of its initial public offering (the “Offering”) of 2,750,000 shares of common stock at a price of $4.00 per share.
- 12/02/2024
|
Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements
- AUSTIN, Texas, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, known as engineered toxin bodies, to create novel therapies with potent and differentiated mechanisms of action for cancer, announced that it has received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on November 25, 2024. The notice indicated that MTEM is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Form 10-Q”), as described more fully in MTEM's Form 12b-25 Notification of Late Filing (the “Form 12b-25”) filed with the Securities and Exchange Commission (the “SEC”) on November 15, 2024. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC. MTEM has until January 24, 2025 to submit a plan of compliance with respect to the notice.
- 12/02/2024
|
S&P 500 and Nasdaq notch record closes
- Scott Chronert, Citi head of U.S. equity strategy, and Adam Crisafulli, Vital Knowledge founder, joins 'Closing Bell Overtime' to talk the days record market action.
- 12/02/2024
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that on December 2, 2024, the Compensation Committee of Zentalis' Board of Directors granted the following equity awards: non-qualified stock options to purchase an aggregate of 3,028,800 shares of the Company's common stock to Julie Eastland, who joined the Company as Chief Executive Officer and President, non-qualified stock options to purchase an aggregate of 712,650 shares of the Company's common stock to Dr. Ingmar Bruns, who joined the Company as Chief Medical Officer, and non-qualified stock options to purchase an aggregate of 753,660 shares of the Company's common stock to five newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 12/02/2024
|
Cadence's Anirudh Devgan to Present at Nasdaq Investor Conference
- SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence's Anirudh Devgan to Present at Nasdaq Investor Conference.
- 12/02/2024
|
Nasdaq touches intraday record, Apple at record highs
- To get the latest market news check out finance.yahoo.com Tech stocks helped lift the Nasdaq Composite (^IXIC) to record intraday highs on Monday morning. Shares of Apple (AAPL) rose 1% to touch a new record.
- 12/02/2024
|
Nasdaq Reports November 2024 Volumes
- NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for November 2024 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics .
- 12/02/2024
|
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on December 2, 2024, the Compensation Committee of the company's Board of Directors granted to thirteen new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 62,400 ordinary shares. These awards were made under Bicycle Therapeutics' 2024 Inducement Plan and approved by the Compensation Committee as an inducement material to the employees ent.
- 12/02/2024
|
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and development of oral covalent small molecules to treat and improve the lives of patients with diabetes, obesity, and genetically defined cancers, today announced that on December 2, 2024, the compensation committee of Biomea's board of directors granted one new employee non-qualified stock options to purchase an aggregate of 30,000 shares of the Company's common stock. The shares underlying the employee's stock options will vest 1/16 on a quarterly basis over four years, subject to the employee's continued employment with the Company on such vesting dates. The above-described award was made under Biomea's 2023 Inducement Equity Plan (the “Plan”).
- 12/02/2024
|
Nasdaq Stock Surges 43% YTD: What Should Be Investors' Approach Now?
- NDAQ is set to grow on an increasing on-trading revenue base, impressive organic growth and investment in proprietary data supported by a solid capital position.
- 12/02/2024
|
Nasdaq hits record high as Intel, Tesla and Super Micro Computers surge; investors eye Trump tariff, Fed policy
- The Nasdaq Composite index rose to a record high on Monday, boosted by gains in Intel, Super Micro Computers and Tesla. At the time of writing, the Nasdaq Composite index was nearly 1% higher, while the S&P 500 index rose 0.2%.
- 12/02/2024
|
Nasdaq Gains Over 100 Points; Li Auto Delivers 48,740 Vehicles In November
- U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday.
- 12/02/2024
|
Nasdaq 100: Tesla's Gains and Intel's Shake-Up Shape Premarket Trends
- Nasdaq 100 rises on Tesla upgrades, while Intel CEO exit adds tech sector intrigue. Dow and S&P 500 pause as economic data and retail trends take focus.
- 12/02/2024
|
Nasdaq Stockholm Streamlines Dual Listing Process for US-Listed Companies to access European markets
- STOCKHOLM, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today an update to the Nasdaq Stockholm Main Market rulebook, effective from 1 January 2025. This update will streamline the listing review process for companies seeking to list on Nasdaq Stockholm simultaneously with or within 12 months of a listing on the U.S. exchanges, including the Nasdaq Stock Exchange and the New York Stock Exchange.
- 12/02/2024
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , Dec. 2, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 4,800 restricted stock units (RSUs) to two newly-hired employees.
- 12/02/2024
|
Meet the Newest Stock in the Nasdaq. It's Soared 918% Since Last Year, and It's Still a Buy Right Now, According to Certain Wall Street Analysts.
- The Nasdaq Composite is a comprehensive technology-focused index that tracks the performance of more than 3,000 stocks listed on the exchange. Earlier this month, the index hit (another) all-time high, marking the 27th so far this year.
- 12/01/2024
|
Notice of Delisting and Re-Compliance of Nasdaq Listing Rule
- HONG KONG, Nov. 30, 2024 (GLOBE NEWSWIRE) -- On November 21, 2024, Primega Group Holdings Limited (Nasdaq: PGHL) (the “Company”), was notified by Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has not paid a sum of certain fees as required under Nasdaq Listing Rule 5900 Series (“Delisting Notice”). Nasdaq Listing Rule 5250(f) states that “the Company is required to pay all applicable fees as described in the Rule 5900 Series.
- 11/30/2024
|
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on November 29, 2024. One individual was hired by Adicet in November 2024 and granted new hire non-qualified stock options to purchase 6,000 shares of Adicet's common stock with an exercise price of $1.13 per share, the closing p.
- 11/29/2024
|
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced the grant of an inducement option award to its newly appointed interim chief development officer, Daniel Baker, M.D. The grant was approved by a majority of the independent directors of the Company as inducement material to Dr. Baker entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) (“the Inducement Award”).
- 11/29/2024
|
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on November 29, 2024 (the “Grant Date”) that were previously approved by the Compensation Committee of its Board of Directors under Sarepta's 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 14 individuals hired by Sarepta in November 2024. The equity awards were approved in accordance with Nasdaq Lis.
- 11/29/2024
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on November 29, 2024, the company granted equity awards to one new employee, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to such new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/29/2024
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 49,800 shares of the Company's common stock to four new employees (the “Inducement Grants”) on November 25, 2024 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/29/2024
|
Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan
- SEATTLE, WA / ACCESSWIRE / November 29, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-37 (the "Reverse Stock Split"). The Reverse Stock Split is expected to become effective on December [3], 2024 at 5:01 p.m.
- 11/29/2024
|
Jianzhi Receives Good News from Nasdaq
- BEIJING, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a leading provider of digital educational content in China, today announced that it has received a written notification letter (the “Compliance Notice”) from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated November 27, 2024, informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).
- 11/29/2024
|
Millicom (Tigo) intends to consolidate listing of shares on NASDAQ U.S. by delisting SDRs from Nasdaq Stockholm and resumes shareholder remuneration
- Millicom (Tigo) intends to consolidate listing of shares on NASDAQ U.S. by delisting SDRs from Nasdaq Stockholm and resumes shareholder remuneration
- 11/29/2024
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , Nov. 29, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on November 27, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 33,300 shares of the Company's common stock to a newly hired employee.
- 11/29/2024
|
S&P 500, Nasdaq slide after key Fed inflation gauge shows faltering progress
- To get the latest market news check out finance.yahoo.com US stocks dipped Wednesday as investors digested fresh data that showed inflation made little progress toward the Fed's 2% target in October. After clinching record highs on Tuesday, the S&P 500 (^GSPC) fell about 0.4%, while the Dow Jones Industrial Average (^DJI) was off about 0.3%.
- 11/27/2024
|
Nvidia leads Nasdaq lower
- To get the latest market news check out finance.yahoo.com Nvidia (NVDA) stock slipped more than 3% on Wednesday, weighing on the Nasdaq 100 (^NDX). Shares in the AI chip giant are off about 9% in the past five days as investors have digested the company's latest quarterly earnings release.
- 11/27/2024
|
Primis Financial Corp. Receives Nasdaq Notice Regarding Delayed 10-Q Filing
- MCLEAN, Va. , Nov. 27, 2024 /PRNewswire/ -- Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") announced today that, as expected, it received a notice (the "Additional Notice") from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the "Q2 Form 10-Q") and Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Q3 Form 10-Q", and together with the Q2 Form 10-Q, the "Form 10-Qs").
- 11/27/2024
|
Primech Holdings Receives NASDAQ Minimum Bid Price Requirement Extension
- SINGAPORE, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Primech Holdings Limited (Nasdaq: PMEC), an established technology-driven facility services provider in the public and private sectors operating mainly in Singapore, announced that it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is eligible for an additional 180 calendar day period, or until May 12, 2025, to regain compliance with the Nasdaq's minimum $1 bid price per share requirement.
- 11/27/2024
|
Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq
- RESEARCH TRIANGLE PARK, N.C. , Nov. 27, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
- 11/27/2024
|
Digital Ally, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
- Lenexa, KS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on November 25, 2024, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Quarterly Report”). The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”). This notification has no immediate effect on the listing of the Company's securities on Nasdaq.
- 11/27/2024
|
urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- LAFAYETTE, CO / ACCESSWIRE / November 27, 2024 / urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), an integrated professional services and Design-Build firm offering solutions to the Controlled Environment Agriculture ("CEA") and other commercial sectors, today announced that the Company received a notice (the "Notice) from The Nasdaq Stock Market LLC ("Nasdaq") on September 21, 2024, stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024 (the "Form 10-Q"), the Company continues to not be in compliance with Nasdaq listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. This notification has no immediate effect on the listing of the Company's common stock on the Nasdaq Capital Market.
- 11/27/2024
|
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
- NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on November 22, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq's continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (“Rule 5250”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Q3 Form 10-Q”) in a timely manner.
- 11/27/2024
|
Nasdaq Down Over 100 Points; HP Shares Plunge
- U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday.
- 11/27/2024
|
S&P 500 and Nasdaq extend losses as markets assess US PCE data; HP, Dell slide while Urban Outfitters surges
- The S&P 500 and the Nasdaq Composite extended losses on Wednesday as investors digested an in-line inflation report. The personal consumption expenditure index (PCE) rose in October but was above the US Federal Reserve's preferred inflation target.
- 11/27/2024
|
Pony.ai Lists on Nasdaq
- NEW YORK--(BUSINESS WIRE)--NASDAQ MarketSite – Pony.ai, a global leader in autonomous driving technology, today listed on the Nasdaq Global Select Market (NASDAQ: PONY) and celebrated its initial public offering by ringing the Nasdaq opening bell. The IPO marks a significant milestone in Pony.ai's journey toward global leadership in the large-scale commercialization and mass production of autonomous vehicles. The IPO offered 20 million American Depository Shares (ADSs) priced at $13.00 per shar.
- 11/27/2024
|
China robotaxi startup Pony AI to get $4.5B valuation in Nasdaq IPO
- Pony AI Inc, a Chinese robotaxi company with some of its operations in Silicon Valley, California, has priced its initial public offer on New York's Nasdaq, giving it a potential debut market cap of just over US$4.5 billion. The Guangzhou-based startup said it could raise US$452.4 million from the IPO and private placements with various "strategic third-party investors".
- 11/27/2024
|
Pony AI stock price: Chinese autonomous car company's Nasdaq IPO will be closely watched today
- Pony AI is having its initial public offering today. The firm, which is based in Silicon Valley but also has a headquarters in Guangzhou, China, makes autonomous mobility tech that can turn cars into self-driving vehicles.
- 11/27/2024
|
Pony AI set for Nasdaq debut at $4.55B valuation
- Chinese autonomous driving technology company Pony AI will start trading on the Nasdaq on Wednesday at an offering price of $13 per share, the higher end of its expected range.
- 11/27/2024
|
Jet.AI Formally Regains Compliance with Nasdaq Stockholders' Equity Requirement and Minimum Bid Price Requirement
- LAS VEGAS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation and artificial intelligence company, announced it has officially received notice from the Nasdaq Stock Market LLC (“Nasdaq”) confirming it has regained compliance with both the $2.5 million minimum stockholders' equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”) and the minimum bid price requirement as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as required by the Nasdaq Hearing Panel's (“Panel”) decision dated August 14, 2024. No further deficiencies remain outstanding.
- 11/27/2024
|
Lottery.com Inc. Receives Expected Notice from The NASDAQ Stock Market LLC Pertaining to its Form 10-Q of September 30, 2024
- FORT WORTH, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- On November 20, 2024, Lottery.com Inc. (NASDAQ: LTRY; LTRYW) (“Lottery.com” or “the Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed the Form 10-Q for the period ended September 30, 2024 with the SEC, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires timely filing of all required periodic financial reports with the SEC.
- 11/26/2024
|
Nasdaq jumps as Nvidia surges before earnings, Wall Street shrugs off Russia-Ukraine tensions
- To get the latest market news, check out finance.yahoo.com US stocks closed mixed on Tuesday as Wall Street largely shrugged off fears over a nuclear escalation to the Russia-Ukraine war, while Nvidia (NVDA) provided a solid boost for the tech-heavy Nasdaq. The Dow Jones Industrial Average (^DJI) closed down about 0.3% but still recovered from earlier session lows.
- 11/26/2024
|
NKGen Biotech Receives Notifications From Nasdaq Related to Delayed Quarterly Report and Decision of the Nasdaq Hearings Panel
- SANTA ANA, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced it received a notice (the “Notice”) on November 20, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) because it had not timely filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) on or before November 19, 2024, the extended period provided for the filing under Rule 12b-25(b) of the Securities Exchange Act of 1934, as amended. The delay is in part due to the additional time required for valuation and review of various derivative securities as the Company has taken on more reporting responsibility internally. The Notice from Nasdaq has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Global Market.
- 11/26/2024
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 15, 2024
- NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of November 15, 2024, short interest in 3,070 Nasdaq Global MarketSM securities totaled 11,973,515,318 shares compared with 12,172,949,545 shares in 3,083 Global Market issues reported for the prior settlement date of October 31, 2024. The mid-November short interest represents 2.25 days compared with 3.02 days for the prior reporting period.
- 11/26/2024
|
S&P, Nasdaq climb while Dow dips amid Trump tariff concerns; Amgen, Kohl's shares tumble
- The S&P 500 and Nasdaq Composite rose on Tuesday, while Dow Jones slipped as investors assessed the threat of new tariffs from President-elect Donald Trump. The S&P 500 index rose 0.2%, while the Nasdaq Composite climbed more than 0.5%.
- 11/26/2024
|
Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results
- U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 100 points on Tuesday.
- 11/26/2024
|
Rigetti Computing Announces Pricing of $100 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
- BERKELEY, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced that it has entered into securities purchase agreements with two institutional investors for the purchase and sale of 50,000,000 shares of the Company's common stock, par value $0.0001 per share, at a purchase price of $2.00 per share, pursuant to a registered direct offering priced at-the-market under Nasdaq rules, resulting in gross proceeds of approximately $100 million, before deducting placement agent commissions and other offering expenses.
- 11/26/2024
|
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
- The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although it's not a part of the U.S. stock market's big three indexes ( S&P 500 , Nasdaq Composite, and Dow Jones), the Nasdaq-100 has grown in popularity over the years because of its concentration of tech stocks (almost 60%), many of which have seen their valuations skyrocket in recent years.
- 11/26/2024
|
Here's why Nasdaq 100 index ETF like QQQ could drop soon
- The Nasdaq 100 index jumped to a record high this year, helped by the ongoing artificial intelligence wave and the Federal Reserve interest rate cuts. It soared to a high of $21,185 this month, bringing the year-to-date gains to 22.50%.
- 11/26/2024
|
The Real Good Food Company Receives Anticipated Additional Delinquency Notice from Nasdaq
- CHERRY HILL, N.J., Nov. 25, 2024 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (Nasdaq: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen and refrigerated foods company, announced today that, on November 20, 2024, the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company that the Company's failure to timely file its Form 10-Q with the Securities and Exchange Commission (the “SEC”), for the period ended September 30, 2024, serves as an additional basis for the delisting of the Company's securities from Nasdaq, per Nasdaq Listing Rule 5250(c)(1). The Company previously presented its plan to file all delinquent periodic reports with the SEC, including the Form 10-Q for the period ended September 30, 2024, and requested an extension to do so at a hearing before the Nasdaq Hearings Panel (the “Panel”). The Panel has not yet issued its decision following the hearing.
- 11/25/2024
|
Flux Power Receives Non-Compliance Letter from Nasdaq
- VISTA, Calif.--(BUSINESS WIRE)--Flux Power Receives Non-Compliance Letter from Nasdaq.
- 11/25/2024
|
noco-noco Inc to Appeal Nasdaq Delisting Determination
- Singapore, Nov. 25, 2024 (GLOBE NEWSWIRE) -- SINGAPORE, November 25, 2024 — noco-noco Inc. (“noco-noco” or the “Company”), a next-generation battery technology innovator, today announced that, on November 22, 2024 Singapore Time, it has received a determination letter from The Nasdaq Stock Market's Hearings Panel (the “Panel”) notifying the Company of its decision to delist noco-noco's securities due to non-compliance with Nasdaq's continued listing requirements. The Panel determined that the Company's securities will be suspended from trading on Nasdaq at the open of business on November 25, 2024. The Company intends to appeal the Panel's decision to the Nasdaq Listing and Hearing Review Council (the “Listing Council”) within the applicable 15-day appeal period. While the initiation of the appeal will not automatically stay the suspension, the Company is taking concrete measures to regain compliance with Nasdaq's listing requirements. Impact on Operations The delisting notice will have no material impact on the Company's operations, and noco-noco will continue to focus on driving performance growth and operational efficiency. The Company remains committed to creating value for shareholders and strengthening its position as a leader in next-generation energy storage technology.
- 11/25/2024
|
Santech Holdings Limited Received Notification of Deficiency from Nasdaq Related to Not Timely Filing of Annual Report on Form 20-F
- HONG KONG, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Santech Holdings Limited (NASDAQ: STEC) (“Santech” or the “Company”) announced today that it received a notice of non-compliance from Nasdaq Stock Market LLC (“Nasdaq”) on November 21, 2024 stating that, as a result of not having timely filed its annual report on Form 20-F for the year ended June 30, 2024, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission. This notice has no immediate effect on the listing or trading of the Company's American depositary shares on the Nasdaq.
- 11/25/2024
|
Got $10,000? This Unique Nasdaq ETF Could Turn It Into About $1,000 of Income Each Year.
- Got $10,000? This Unique Nasdaq ETF Could Turn It Into About $1,000 of Income Each Year.
- 11/23/2024
|
Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
- NEWPORT BEACH, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Elevai Labs Inc. (NASDAQ: ELAB) (Elevai" or the "Company") announced today it will implement a 1-for-200 reverse stock split (“Reverse Stock Split”) of its common stock, which will be effective at midnight on November 27, 2024.
- 11/22/2024
|
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”).
- 11/22/2024
|
Stran & Company Receives Additional Notification of Deficiency From Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
- Quincy, MA, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Form 10-Q") in a timely fashion. The Notification Letter advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1).
- 11/22/2024
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on November 18, 2024, the Compensation Committee of Vera's Board of Directors granted inducement awards consisting of a non-qualified stock option to purchase 108,000 shares of Class A common stock and restricted stock units (RSUs) for 53,000 shares of Class A common stock to Jason S. Carter, Vera's new Chief Legal Officer, under Vera's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employee's employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/22/2024
|
Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq
- GEELONG, Australia, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that the Company has received a notification letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company's delay in filing its Annual Report on Form 20-F for the fiscal year ended June 30, 2024 (the “Annual Report”). The Letter has no immediate effect on the listing or trading of the Company's ordinary shares or warrants on Nasdaq. The Letter stated that, under Nasdaq rules, the Company has until 60 calendar days after receipt of the Letter, which is January 21, 2025, to submit a plan to regain compliance, and that if a plan is submitted and accepted, Nasdaq could grant the Company an exception of up to 180 calendar days from the filing's due date, or until May 14, 2025, to regain compliance. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel. The Company continues to work diligently to file its Annual Report as promptly as practical to regain compliance with Nasdaq Listing Rule 5250(c)(1).
- 11/22/2024
|
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
- ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it has regained compliance with the minimum bid price requirement set forth by The Nasdaq Stock Market LLC (“Nasdaq”). On November 21, 2024, the Company received notification from the Nasdaq Listing Qualifications Department confirming its compliance with Listing Rule 5550(a)(2), thereby meeting Nasdaq's maintenance requirements for listi.
- 11/22/2024
|
Phoenix Motor Inc. Announces Receipt of Nasdaq Delisting Notice
- ANAHEIM, CA / ACCESSWIRE / November 21, 2024 / Phoenix Motor Inc. (NASDAQ:PEV) (the "Company") today announced that it received a delinquency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024 (the "Form 10-Q"). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC").
- 11/21/2024
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 227,600 shares of common stock. Awards were made to 15 new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committee.
- 11/21/2024
|
Thumzup to Ring the Nasdaq Opening Bell on November 22, 2024
- Los Angeles, CA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Thumzup Media Corporation ("Thumzup" or the "Company") (Nasdaq: TZUP), a leading provider of innovative social media branding and marketing solutions that allows businesses and brands to pay customers and fans cash through Venmo and PayPal for their posts on social media, is thrilled to announce their upcoming visit to the Nasdaq MarketSite in Times Square on Friday, November 22, 2024 to ring the Opening Bell. In recognition of this milestone, Thumzup's Chair, President, and Chief Executive Officer, Robert Steele, will lead the bell-ringing ceremony.
- 11/21/2024
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , Nov. 21, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on November 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 117,000 shares of its common stock and 58,500 restricted stock units ("RSUs") to twelve (12) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/21/2024
|
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
- U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining by more than 500 points on Thursday.
- 11/21/2024
|
Iterum Therapeutics Regains Full Nasdaq Compliance
- Iterum will Continue to be Listed and Traded on the Nasdaq Stock Market Iterum will Continue to be Listed and Traded on the Nasdaq Stock Market
- 11/21/2024
|
Nasdaq, Wall Street to drop as Nvidia slides after earnings
- Wall Street faced a negative start on Thursday in the wake of Nvidia Corp's earnings, which saw the chip-making giant slip almost 3% in pre-market trading. Futures had the Nasdaq down 0.4% ahead of the opening bell, while the S&P 500 and Dow Jones were seen 0.3% and 0.2% lower respectively.
- 11/21/2024
|
Meet the Newest AI Stock in the Nasdaq-100. It Soared 2,140% in 2 Years and Is Still a Buy, According to a Wall Street Analyst.
- Meet the Newest AI Stock in the Nasdaq-100. It Soared 2,140% in 2 Years and Is Still a Buy, According to a Wall Street Analyst.
- 11/21/2024
|
Nasdaq Traders Brace for Volatility as Nvidia's Q4 Guidance Signals Supply Constraints
- Nvidia Q3 revenue surged 94%, but cautious Q4 guidance and supply concerns sent shares lower. How will this impact AI chips and major market indices?
- 11/20/2024
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 20,820 restricted stock units of the company's common stock to 13 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of November 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/20/2024
|
Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on November 17, 2024, the Compensation Committee of Adverum's Board of Directors granted an inducement award consisting of non-qualified stock options to purchase 55,000 shares of common stock to a new employee under Adverum's 2017 Inducement Plan. The Compensation Committee of Adverum's Board of Directors approved the award as an inducement material to the new employee's employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/20/2024
|
QQA: Nasdaq 100 Exposure With A 10% Yield
- The Invesco QQQ Income Advantage ETF combines Nasdaq-100 growth with an options overlay to generate income and protect against market drops. QQA's tech-heavy focus offers high growth potential but also poses risks due to sector concentration and U.S. market exposure. QQA's 10.27% SEC 30-day yield and waived 0.29% management fee until Dec. 31, 2024, make it attractive for income-focused investors.
- 11/20/2024
|
Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views
- U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling by more than 100 points on Wednesday.
- 11/20/2024
|
Nasdaq and S&P500: AI Spending Concerns Pressure Tech Stocks Ahead of Nvidia Earnings
- S&P 500 drops 0.95% as Nvidia's AI demand faces scrutiny. Retail struggles deepen with Target's 20% plunge and retail ETFs falling 1.5%.
- 11/20/2024
|
Nasdaq and S&P 500: Can Nvidia's Results Reignite Tech Stock Momentum?
- Nasdaq 100 awaits Nvidia's earnings report, a potential game-changer for AI-driven demand and stock market sentiment into year-end.
- 11/20/2024
|
Bitcoin hits fresh record high after Nasdaq lists options on BlackRock's spot bitcoin ETF
- CNBC's MacKenzie Sigalos reports on bitcoin hitting a new all-time high as the first options on spot bitcoin ETFs go live on the Nasdaq.
- 11/20/2024
|
Nvidia Earnings: Will a $292B Market Cap Swing Reshape AI, the S&P 500, Nasdaq, and Dow?
- Will Nvidia's earnings surprise again? See how its results could shift $292B in value, drive AI stocks, and impact the Dow, Nasdaq, and S&P 500.
- 11/20/2024
|
Nasdaq Gains 1% Ahead Of Nvidia Earnings: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone
- The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Neutral” zone on Tuesday.
- 11/20/2024
|
S&P 500, Nasdaq climb as Tesla jumps, Nvidia earnings loom
- To get the latest market news check out finance.yahoo.com US stocks were mixed on Monday as Tesla (TSLA) shares resumed a post-election rally and investors looked ahead to Nvidia (NVDA) earnings to test the health of the AI trade. The Dow Jones Industrial Average (^DJI) fell 0.2%, while the S&P 500 (^GSPC) was up 0.4%.
- 11/19/2024
|
Nano Labs Regains Compliance with Nasdaq Minimum Bid Price Requirement
- HANGZHOU, China, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading fabless integrated circuit design company and product solution provider in China, today announced that it received a notification letter (the “Notification Letter on Compliance”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (“Nasdaq”) on November 18, 2024, indicating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5450(a)(1) of the Nasdaq Listing Rules.
- 11/19/2024
|
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
- Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the inflammatory response in patients with chronic inflammatory diseases, today announced the implementation of an At-The-Market program (“ATM Program”) allowing the Company to issue and sell, including with unsolicited investors who have expressed an interest, ordinary shares in the form of American Depositary Shares (“ADS”), each ADS representing one ordinary share, nominal value €0.01 per share, of the Company, with aggregate gross sales proceeds of up to $150,000,000 (subject to French regulatory limits and within the limits of the investors' requests expressed in the context of the program), from time to time, pursuant to the terms of an equity distribution agreement with Piper Sandler & Co. (“Piper Sandler”), acting as sales agent. The timing of any issuances in the form of ADSs will depend on a variety of factors.
- 11/19/2024
|
Noodles Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BROOMFIELD, Colo., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Noodles & Company (NASDAQ: NDLS) (the “Company”) today announced that its Board of Directors (the “Board”) granted an equity award to Steve Kennedy as an equity inducement award outside of the Company's 2023 Stock Incentive Plan and material to Mr. Kennedy's acceptance of employment with the company. The equity award was approved by the Board, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/19/2024
|
5 Non-Tech Nasdaq Composite High Flyers to Buy for More Gains Ahead
- These five stocks have provided 50% returns year to date. Despite the rally, their favorable Zacks Rank indicates more room to run.
- 11/19/2024
|
Super Micro Computer stock keeps going up after 11th-hour bid to avoid Nasdaq delisting
- Shares of Super Micro Computer are set to see their second day of double-digit gains on Tuesday after the storage tech giant announced that it has submitted a list-minute bid to regain compliance with the Nasdaq stock exchange.
- 11/19/2024
|
Final Trades: Nasdaq, D.R. Horton, Crowdstrike, and the IJR
- The Investment Committee give you their top stocks to watch for the second half.
- 11/19/2024
|
Super Micro shares soar 30% after company names new auditor to help keep Nasdaq listing
- Super Micro shares popped on Tuesday after the company named BDO as its independent auditor. The stock, which has cratered since peaking in March, has gained more than 50% over the last two trading days.
- 11/19/2024
|
Nasdaq Gains 100 Points; Lowe's Earnings Beat Views
- U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining by around 100 points on Tuesday.
- 11/19/2024
|
Super Micro Computer surges on auditor appointment, Nasdaq compliance update
- Super Micro Computer Inc (NASDAQ:SMCI) shares rallied on Tuesday on the news the IT firm has appointed BDO as its new auditor and filed a compliance plan with the Nasdaq. The company's stock has slumped since the resignation of its previous auditor Ernst & Young in October, citing concerns about governance transparency and internal controls over financial reporting.
- 11/19/2024
|
Live Markets Today: Nasdaq Composite and S&P 500 Deep in the Red | SMCI, WMT
- Here are a couple of stocks making the biggest moves in premarket trading: Super Micro Computer: Up 25% in premarket trading after announcing it is engaging with a new auditor in its quest to avoid delisting by the Nasdaq.
- 11/19/2024
|
Wall Street, Nasdaq to dip but Walmart to rally following strong results
- The Nasdaq 100 is tipped to open essentially flat when trading commences this Tuesday, following a buoyant Monday that saw the tech index surge by 145 points. Futures contracts suggest a sharp downturn for the Dow Jones Industrial Average though.
- 11/19/2024
|
J-Long Group Limited Announces Receipt of NASDAQ Determination Letter
- Hong Kong, Nov. 19, 2024 (GLOBE NEWSWIRE) -- J-Long Group Limited (Nasdaq: JL), a Hong Kong based and established distributor of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pulls and drawcords, today announced receipt of a letter (the “Determination Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Determination Letter indicated that, as previously notified by Nasdaq on May 13, 2024, the bid price of the Company's listed security had closed at less than $1 per share over the previous 30 consecutive business days and, as a result, did not comply with Listing Rule 5550(a)(2) (the “Rule”). In accordance with the Rule, the Company was provided 180 calendar days, or until November 11, 2024, to regain compliance with the Rule
- 11/19/2024
|
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
- The superficial logic holds water, but there's always more to the story.
- 11/19/2024
|
Nasdaq Gains Over 100 Points As Tesla Surges: Investor Sentiment Declines, Fear & Greed Index Remains In 'Neutral' Zone
- The CNN Money Fear and Greed index showed a further decline in the overall market sentiment, while the index remained in the “Neutral” zone on Monday.
- 11/19/2024
|
Super Micro hires new auditor to maintain Nasdaq listing; shares pop
- Super Micro said on Monday that it hired BDO as its independent auditor. The stock, which as cratered since peaking in March, rose 16% in extended trading, continuing its rally from earlier in the day.
- 11/18/2024
|
Supermicro Announces Appointment of BDO USA as Independent Auditor and Filing of Compliance Plan with Nasdaq
- SAN JOSE, Calif.--(BUSINESS WIRE)--Super Micro Computer, Inc. (Nasdaq: SMCI), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, announced today that the Audit Committee of its Board of Directors has engaged BDO USA, P.C. (“BDO”) as its independent auditor, effective immediately. BDO is a member firm of BDO International, one of the world's top five accounting firms network with over 115,000 professionals across its global network and a recognized leader in audit and assurance. “.
- 11/18/2024
|
S&P 500 & Nasdaq 100 Close Higher | Closing Bell
- Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Alix Steel, Scarlet Fu, Carol Massar and Tim Stenovec. Sign up for the Economics Daily newsletter to discover what's driving the global economy and what it means for policy makers, businesses, investors and you.
- 11/18/2024
|
Codere Online Receives Delisting Notice from Nasdaq and Submits Appeal
- Luxembourg, Grand Duchy of Luxembourg, November 18, 2024 – (GLOBE NEWSWIRE) Codere Online Luxembourg, S.A. (“Codere Online” or the “Company”) (Nasdaq: CDRO / CDROW), today announced that, on November 12, 2024, it received a staff determination letter (the "Letter"), from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company of the determination from the Nasdaq Staff (the "Staff") to delist the Company's securities from The Nasdaq Stock Market, given the Company had not filed its Form 20-F for the year ended December 31, 2023 (the “Form 20-F”) in accordance with continued Listing Rule 5250(c)(1) (the “Public Reports Rule”). As previously reported, the Company's delay in filing its Form 20-F is due to the fact that the finalization of the audit of our financial statements for the three years ended December 31, 2023 has taken longer than expected following the engagement of our new independent registered public accounting firm in March 2024.
- 11/18/2024
|
SRIVARU Holding Completes the Interim Audit and Advances Plan to Comply with Nasdaq Listing Standards
- GRAND CAYMAN, Cayman Islands, Nov. 18, 2024 (GLOBE NEWSWIRE) -- SRIVARU Holding Limited (Nasdaq: SVMH, SVMHW) (“SRIVARU” or the “Company”), a manufacturer of premium electric motorcycles, today announced progress in its efforts to gain compliance with Nasdaq listing standards. On September 18, 2024, the Company received a letter from the Office of the General Counsel of The Nasdaq Stock Market LLC (“Nasdaq”) confirming the Nasdaq Hearing Panel's (the “Panel”) decision to grant SRIVARU's request for continued listing on Nasdaq. This decision allowed the Company additional time to execute its compliance plan (the “Plan”), subject to the condition that SRIVARU demonstrate compliance with certain requirements for continued listing by November 14, 2024. The Panel would then evaluate the Company's progress and consider its request for additional time to complete the Plan.
- 11/18/2024
|
Nasdaq, S&P 500 rise ahead of key earnings; Tesla, Oklo stocks jump as Spirit Airlines halts trading
- Wall Street's main indexes rose on Monday as investors waited for major market-moving earnings results. Investors were waiting for the earnings results of AI-chip leader NVIDIA on Monday after last week's sharp losses.
- 11/18/2024
|
Nasdaq 100 Forecast: Tesla Gains, Nvidia's AI Chips Face Scrutiny
- Nasdaq 100 gains as Tesla rallies; US stocks mixed with Dow lower. Fed's rate stance and Nvidia's AI chip challenges shape market trends today.
- 11/18/2024
|
Caravelle International Group Regains Compliance with Nasdaq Minimum Bid Price Requirement
- HONG KONG , Nov. 18, 2024 /PRNewswire/ -- Caravelle International Group (NASDAQ: HTCO), a global ocean technology company, today announced that it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules. The Company had previously announced on July 31, 2024, that it was notified by Nasdaq on July 26, 2024 that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), as the closing bid price of the Company's ordinary shares had been below $1.00 per share for more than 30 consecutive business days.
- 11/18/2024
|
Nasdaq 100: Tesla Rallies, Nvidia Stumbles; Market Awaits Earnings Results
- Tesla's 8% surge lifts Nasdaq futures, while Nvidia faces chip issues. Traders watch Fed signals and key earnings for market direction.
- 11/18/2024
|
Sharps Regains Nasdaq Listing Compliance
- NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that on November 13, 2024, the Company was notified by the Nasdaq Stock Market (“Nasdaq”) that the Company had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Stock Market, as set forth in Nasdaq Listing Rule 5550(a)(2) as of November 5, 2024.
- 11/18/2024
|
Nasdaq 100 Infighting Makes QQQM, QQQ Risky Bets (Technical Analysis)
- Technical analysis, especially chart reading, is crucial for understanding market trends and assessing probabilities and possibilities, surpassing traditional fundamental analysis in today's market. My late father's teachings on investing planted the seeds for my career, emphasizing the importance of listening to the market's story through charts. With algorithmic trading, hedge funds, and indexation dominating, classic fundamental analysis has less impact, making charting increasingly reliable and essential.
- 11/18/2024
|
MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
- Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced Prenetics' acquisition of Europa, one of the largest sports nutrition distributors in the U.S. IM8 is now available at www.IM8health.com , shipping to 31 countries (David Beckham pictured with The Beckham Stack) CHARLOTTE, N.C., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, in partnership with David Beckham, today announced the official launch of IM8.
- 11/18/2024
|
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
- Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced Prenetics' acquisition of Europa, one of the largest sports nutrition distributors in the U.S. IM8 is now available at www.IM8health.com , shipping to 31 countries CHARLOTTE, N.C., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, in partnership with David Beckham, today announced the official launch of IM8.
- 11/18/2024
|
International Petroleum Corporation Announces Completion of Annual Normal Course Issuer Bid
- TORONTO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC has completed the current normal course issuer bid / share repurchase program (NCIB), purchasing for cancellation 8,342,119 IPC common shares between December 2023 and November 2024, representing approximately 6.5% of the total outstanding common shares at the commencement of the NCIB. As previously announced, the IPC Board of Directors has approved, subject to acceptance by the Toronto Stock Exchange (TSX), the renewal of IPC's NCIB for a further twelve months from December 2024 to December 2025. IPC expects that the 2024/2025 NCIB will permit IPC to purchase on the TSX and/or Nasdaq Stockholm, and cancel up to a further approximately 7.5 million common shares, representing approximately 6.2% of the total outstanding common shares (10% of IPC's "public float" under applicable TSX rules).
- 11/18/2024
|
District Applies to List on the Nasdaq First North Growth Market in Sweden
- Vancouver, British Columbia--(Newsfile Corp. - November 18, 2024) - District Metals Corp. (TSXV: DMX) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company") is excited to announce that it has initiated the process of applying for a secondary listing of its shares on the Nasdaq First North Growth Market in Sweden ("Nasdaq First North"). The Company's objective is to complete the listing and start trading on the Nasdaq before the end of 2024.
- 11/18/2024
|
Nasdaq Futures Up Sunday Night: NVIDIA Earnings & Trump Cabinet In Focus
- Earnings season is almost over, but there are a few key earnings to watch this week that aren't NVIDIA.
- 11/17/2024
|
Medicus Pharma makes debut on Nasdaq raising $4M to advance skin cancer trial - ICYMI
- Medicus Pharma (TSX-V:MDCX, NASDAQ:MDCX) CEO and chairman Raza Bokhari joined Proactive to discuss the company's recent listing on the Nasdaq, a key milestone for the biotechnology firm. Following their initial public offering (IPO) on the Nasdaq, Medicus Pharma (TSX-V:MDCX, NASDAQ:MDCX) raised $4 million to fund its ongoing Phase 2 proof-of-concept trial for a promising noninvasive treatment for basal cell carcinoma, the most common form of skin cancer.
- 11/16/2024
|
Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration
- WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq and OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has notified The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to file its own Form 25 (Notification of Removal of Listing) with the U.S. Securities and Exchange Commission (the “SEC”) to complete the previously-disclosed process to delist the Company's common stock, par value $0.001 per share (the “Common Stock”), from the Nasdaq Global Market in advance of Nasdaq's anticipated filing of a Form 25 with the SEC.
- 11/15/2024
|
Luna Innovations Receives Additional Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- ROANOKE, Va.--(BUSINESS WIRE)--Luna Innovations Incorporated (Nasdaq: LUNA) (the “Company”), a global leader in advanced fiber optic-based technology, today announced that it has received a written notice (the “Notice”) on November 14, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the quarter ended September 30, 2024 (the “Q3 2024 Form 10-Q”) and because the Company remains delinque.
- 11/15/2024
|
LuxUrban Hotels Inc. Announces Reverse Stock Split and Nasdaq Compliance Approval
- MIAMI, Nov. 15, 2024 (GLOBE NEWSWIRE) -- LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today announced that it will effectuate a one-for-seventy (1:70) reverse stock split of its common stock. This reverse stock split was approved by stockholders at the special meeting held on November 12, 2024, and will be effective at the opening of trading on November 20, 2024.
- 11/15/2024
|
LuxUrban Hotels Inc. Announces Reverse Stock Split and Nasdaq Compliance Approval
- Miami, Florida, November 15, 2024 – PRISM MediaWire – LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today announced that it will effectuate a one-for-seventy (1:70) reverse stock split of its common stock.
- 11/15/2024
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 100,500 shares of its common stock to four newly hired employees, consisting of inducement stock options to pu.
- 11/15/2024
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on November 8, 2024, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 70,571 shares of common stock and 40,731 restricted stock units (“RSUs”) to twenty-three new employees under Acadia's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employ.
- 11/15/2024
|
Super Micro faces deadline to keep Nasdaq listing after 85% plunge in stock
- Super Micro is facing a key Monday deadline that could kick off the Nasdaq's delisting process if the server company fails to provide a viable compliance plan. The one-time AI darling is reeling after a stretch of bad news and has lost 85% of its value since the stock peaked in March.
- 11/15/2024
|
Nasdaq Tumbles Over 200 Points; Alibaba Posts Upbeat Sales
- U.S. stocks traded lower this morning, with the Nasdaq Composite falling by more than 200 points on Friday.
- 11/15/2024
|
S&P 500 and Nasdaq Composite: Weekly Losses Loom Amid Fed Caution
- Dow and Nasdaq slide as postelection rally fades. Fed remarks on inflation temper rate cut hopes, dragging US indices into negative territory this week.
- 11/15/2024
|
Live Market Updates: Nasdaq Composite Slides & Warren Buffett's Newest Buy
- Here's a rundown of economic data points released this morning. US Retail Sales Came in at a .4% growth versus October, which was slightly ahead of expectations of a .3% jump.
- 11/15/2024
|
authID Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Denver, Nov. 15, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of secure biometric identity verification and authentication solutions, today announced that the Company granted an option as an inducement to a new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/15/2024
|
Will Super Micro Computer stock be delisted from the Nasdaq? Critical deadline looms amid accounting scandal
- Investors in Super Micro Computer (Nasdaq: SMCI) may be wondering this week if there is any bottom.
- 11/14/2024
|
These Are the 6 Top-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
- Which stocks are leading the Nasdaq-100 higher in 2024? This diverse bunch of leaders is taking the market by storm.
- 11/14/2024
|
Live Market Updates: Nasdaq Drops & Disney Surges
- Let's take a look at the performance of some of the market's biggest stocks today: Winners NVIDIA: Up 1.14% Charles Schwab: Up 3.59% General Motors: Up 2.59% Losers Alphabet: Down 1.13% Eli Lilly: Down 1.84$ Tesla: Down 3.65% Shortly after 10 a.m.
- 11/14/2024
|
Thumzup Accelerates Expansion Across the Greater Los Angeles Area Following Nasdaq Listing
- Los Angeles, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Thumzup Media Corporation ("Thumzup" or the "Company") (Nasdaq: TZUP), a leading provider of innovative social media branding and marketing solutions which allow businesses and brands to pay customers and fans cash through Venmo and PayPal for their posts on social media, is thrilled to announce an ambitious expansion plan aimed at significantly growing its presence throughout the greater Los Angeles region. The Company, which has been primarily focused on the west side of Los Angeles, is aggressively expanding into new areas. Following the Company's successful Nasdaq listing and $8.2 million dollar underwritten offering, Thumzup is leveraging new resources to accelerate growth and connect more businesses with local communities through its innovative user-generated advertising approach.
- 11/14/2024
|
Mercurity Fintech CEO Highlights Strategic Vision Following Participation in Nasdaq Small-Cap Forum
- New York, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Mercurity Fintech Holding Inc. (“Mercurity Fintech,” “the Company,” “we,” “us,” “our company,” or “MFH”) (Nasdaq: MFH), a digital fintech group, today announced that its CEO, Shi Qiu, recently participated in the 4th Annual Nasdaq Small-Cap Forum. This virtual event brought together leaders from across the financial landscape to share insights on the most topical issues faced by small-cap companies in 2025.
- 11/14/2024
|
Nasdaq heading lower but Russell 2000 higher, Disney set to jump, Tapestry climbs
- US stocks are set for a mixed but mostly higher open on Thursday, as the dollar adds to its post-election gains. Futures for the main Wall Street indexes are modestly higher, led by the Russell 2000, up 0.4% as the Trumpian rally in small-caps continues.
- 11/14/2024
|
AirNet Resolves Nasdaq Minimum Market Value of Publicly Held Shares Deficiency
- BEIJING , Nov. 14, 2024 /PRNewswire/ -- AirNet Technology Inc., formerly known as AirMedia Group Inc. ("AirNet" or the "Company") (Nasdaq: ANTE), today announced that it received a written notice from the Listing Qualifications Staff of Nasdaq (the "Staff") on November 12, 2024, notifying the Company that it has regained compliance with the minimum market value of publicly held shares ("MVPHS") requirement under Nasdaq Listing Rule 5550(a)(5). The Company was previously notified by the Staff on September 18, 2024 that it was not in compliance with the MVPHS requirement due to its failure to maintain a minimum MVPHS of US$1.0 million for a period of 30 consecutive business days.
- 11/14/2024
|
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 22, 2024, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units (“RSUs”) representing 233,603 shares of its common stock to 123 new non-executive employees and non-qualified stock option awards to purchase an aggregate of 50,349 shares of its common stock to three new non-executive employees with a gra.
- 11/13/2024
|
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that on November 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 24,400 shares of its common stock. These inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/13/2024
|
Telix ADSs Commence Trading on Nasdaq
- MELBOURNE, Australia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) announces that its American Depository Shares (ADSs) have commenced trading on the Nasdaq Global Select Market (Nasdaq) under the ticker symbol ‘TLX'.
- 11/13/2024
|
Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing
- Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology
- 11/13/2024
|
Horizon Space Acquisition I Corp. Announces Transfer to Nasdaq Capital Market
- NEW YORK, NY / ACCESSWIRE / November 13, 2024 / Horizon Space Acquisition I Corp. (the "Company") (Nasdaq:HSPO), a special purpose acquisition company, today announced that the Nasdaq Stock Market LLC has approved the Company's application to list its ordinary shares, units, warrants and rights on the Nasdaq Capital Market. The Company's ordinary shares, units, warrants and rights are expected to commence trading on the Nasdaq Capital Market at the opening of business on November 14, 2024.
- 11/13/2024
|
SaverOne Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Petah Tikvah, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company that develops and sells advanced transportation safety solutions (he “Company”), today announced that on November 12, 2024, it received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on the Nasdaq Capital Market.
- 11/13/2024
|
Kaixin Holdings Announces Receipt of Nasdaq Letter Regarding Regaining Compliance with Minimum Bid Price Requirement
- HANGZHOU, China, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Kaixin Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) today announced the receipt of a notification letter dated November 12, 2024 from the Hearing Panel of the Nasdaq Stock Market (the “Hearing Panel”), notifying Kaixin that the Company has regained compliance with the minimum bid price requirement in Listing Rule 5550(a)(2) (the “Bid Price Rule”), as required by the Hearing Panel's decision dated September 12, 2024.
- 11/13/2024
|
Fusion Fuel Receives Staff Determination Notice from Nasdaq, Submits Appeal Request
- DUBLIN, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (“Fusion Fuel” or the “Company”) today announced that the Company received a letter (the “Staff Determination Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”). The Staff Determination Notice noted that on May 8, 2024, the Staff had notified the Company that it did not comply with the minimum $10,000,000 stockholders' equity requirement for continued listing set forth in Nasdaq Listing Rule 5450(b)(1)(A), since the Company's Form 20-F for the fiscal year ended December 31, 2023, reported stockholders' equity of $3,022,125. The Staff Determination Notice also noted that the Company did not meet the continued listing requirements under the alternative standards for continued listing.
- 11/12/2024
|
LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
- MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) (“LifeWallet,” or the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced that it will affect a reverse stock split of its Class A common stock at a reverse stock split ratio of 1-for-25, effective at 11:59 P.M. on November 15, 2024, in order to regain compliance with the minimum $1.00 bid price per share requirement of Nasdaq's Marketplace Rule 5450(a)(1).
- 11/12/2024
|
BioHarvest shares rise in Nasdaq debut
- BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) began trading on the Nasdaq Global Market on Tuesday under the ticker symbol "BHST." Shares of the company gained nearly 5% in early morning trading, reaching US$6 just after the opening bell.
- 11/12/2024
|
BioHarvest Sciences Begins Trading on the Nasdaq Global Market
- Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 12, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Company's shares will begin trading on the Nasdaq Global Market ("Nasdaq") at the opening of the U.S. market today under the new ticker symbol "BHST". The Company's common shares will continue to trade on the Canadian Securities Exchange ("CSE").
- 11/12/2024
|
Mustang Bio Receives Positive Listing Determination from Nasdaq
- WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company's request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders' equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.
- 11/12/2024
|
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- FARMINGTON HILLS, Mich., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other ophthalmological disorders (the “Company”), today announced that the independent members of its Board of Directors approved an equity award under the Company's 2021 Inducement Plan, as amended, as a material inducement to Dr. Benjamin Yerxa, Ph.D., the Company's newly appointed President, in connection with his employment with the Company, effective November 7, 2024. The equity award was approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of any equity awards that are not made under a stockholder approved equity plan.
- 11/12/2024
|
Tech stocks hold back Nasdaq as Nvidia, Apple, Meta lag
- To get the latest market news check out finance.yahoo.com Tech stocks lagged on Monday, holding the Nasdaq Composite (^IXIC) back from the rest of the market euphoria. With the exception of (TSLA) gaining for a fifth straight session, the rest of the "Magnificent Seven" stocks were under pressure.
- 11/11/2024
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Brisbane, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on November 4, 2024, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 54,050 shares of Class A common stock and restricted stock units (RSUs) for 27,025 shares of Class A common stock to seven new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/11/2024
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2024
- NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of October 31, 2024, short interest in 3,083 Nasdaq Global MarketSM securities totaled 12,172,949,545 shares compared with 12,303,886,017 shares in 3,089 Global Market issues reported for the prior settlement date of October 15, 2024. The mid-October short interest represents 3.02 days compared with 3.26 days for the prior reporting period.
- 11/11/2024
|
Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted non-qualified stock option awards to purchase an aggregate of 99,500 shares of its common stock to eleven new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/11/2024
|
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective November 8, 2024, to two new non-executive employees of non-qualified stock opti.
- 11/11/2024
|
Live Markets Today: Nasdaq Composite Down, Dow Hits 44,000, and Tesla Rallies | TSLA, MSTR, CRM, NVDA
- As we head into the afternoon on Monday, indexes are mixed. Small cap and value stocks are rallying while tech stocks are under more pressure.
- 11/11/2024
|
Nasdaq Moves Lower; Canaan Shares Surge
- U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 50 points on Monday.
- 11/11/2024
|
Banzai Regains Compliance with Nasdaq Minimum Market Value of Publicly Held Shares Requirement
- SEATTLE, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum market value of publicly held shares (“MVPHS”) requirement under Nasdaq Listing Rule 5550(a)(5) (the "Rule") for continued listing.
- 11/11/2024
|
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
- First and only NMPA-approved treatment for patients with CIDP in China Second VYVGART Hytrulo indication approved in China November 11, 2024 – 7:30am ET Amsterdam, the Netherlands— argenx SE (Euronext & Nasdaq: ARGX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced that China's National Medical Products Administration (NMPA) approved the supplemental Biologics License Application (sBLA) for VYVGART Hytrulo 1,000mg (5.6ml)/vial [efgartigimod alfa injection (subcutaneous injection)] for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP). VYVGART Hytrulo is approved for CIDP as a once weekly 30-to-90 second subcutaneous injection.
- 11/11/2024
|
2 Nasdaq Stocks Up 510% and 910% in 2 Years to Buy Now, According to Wall Street
- Nvidia and Meta Platforms led the Nasdaq-100 higher over the last two years.
- 11/11/2024
|
JPMorgan Nasdaq Equity Premium Income ETF: Good for Income, but It Comes With Risks
- It sounds too good to be true: a growth oriented ETF investment that also offers a 9% dividend yield. Here's what you need to know about JEPQ.
- 11/09/2024
|
AppLovin Corporation to Join the Nasdaq-100 Index® Beginning November 18, 2024
- NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that AppLovin Corporation (Nasdaq: APP), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®) and the Nasdaq-100 Equal Weighted™ Index (Nasdaq: NDXE™) prior to market open on Monday, November 18, 2024. AppLovin Corporation will replace Dollar Tree, Inc. (Nasdaq: DLTR) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index.
- 11/08/2024
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 11/08/2024
|
MacKenzie Realty Capital, Inc. Announces Listing on Nasdaq
- ORINDA, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- MacKenzie Realty Capital, Inc. (“MacKenzie” or the “Company”) is pleased to announce that the Company has received approval to list its common stock on the Capital Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “MKZR”. Trading on Nasdaq is expected to commence with the open of trading on Monday, November 11th. Shareholders are not required to take any action as a result of the uplisting. Trading on Nasdaq will enhance the visibility and accessibility of MacKenzie to U.S. investors.
- 11/08/2024
|
InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules
- Vancouver, British Columbia--(Newsfile Corp. - November 8, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced, pursuant to a directors' resolution, InMed will be consolidating all of its issued and outstanding share capital on the basis of one (1) post‐consolidation share for each twenty (20) pre‐consolidation common shares, no par value, of the Company (the "Common Shares") in order to regain compliance with all of Nasdaq's continued listing requirements (the "Consolidation"). The Consolidation will result in the number of issued and outstanding Common Shares being reduced from 14,361,550 to approximately 718,078 Common Shares on a non-diluted basis, and each shareholder will hold the same percentage of Common Shares outstanding immediately after the Consolidation as such shareholder held immediately prior to the Consolidation.
- 11/08/2024
|
Vision Marine Technologies Inc. Regains Compliance with Nasdaq Listing Requirements
- MONTREAL, QC / ACCESSWIRE / November 7, 2024 / Vision Marine Technologies Inc. (the "Company") (NASDAQ:VMAR) a pioneer in electric marine propulsion, is pleased to announce that the Company received a compliance notice (the "Notice") from the Nasdaq Hearing Panel (the "Panel") informing the Company that it has regained compliance with the bid price requirement under Nasdaq Listing Rule 5550(a)(2). This compliance fulfils the requirements outlined by the Panel in its decision dated October 3, 2024.
- 11/07/2024
|
Nvni Group Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq: NVNI) (“Nuvini”) received a notification letter on November 1, 2024, from Nasdaq's Listing Qualifications Department, indicating the Company's minimum bid price per share had been below $1.00 for 30 consecutive business days, failing to meet Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The notification has no immediate effect on the Company's Nasdaq listing, and shares continue to trade under “NVNI”.
- 11/07/2024
|
BioHarvest Sciences shares to list on Nasdaq next week
- BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) said it has received approval from the Nasdaq Stock Market LLC for the listing of its common shares on the Nasdaq Global Market. The company confirmed that it expects to begin trading on the Nasdaq under the ticker symbol “BHST” on Tuesday, November 12.
- 11/07/2024
|
S&P 500, Nasdaq hit record close after Fed announces 25bps rate cut
- David Zervos, Jefferies chief market strategist, and Stephanie Link, Hightower chief investment strategist and portfolio manager, joins 'Closing Bell Overtime' to talk the day's market action.
- 11/07/2024
|
Nasdaq Surges 1%; Hershey Posts Downbeat Q3 Results
- U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 1% on Thursday.
- 11/07/2024
|
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
- IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day compliance period from the Nasdaq Stock Market LLC ("Nasdaq") to meet the minimum $1.00 per share bid price requirement for continued listing on the Nasdaq Capital Market. This extension allows Biomerica until May 5, 2025, to regain compliance.
- 11/07/2024
|
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market
- Common Shares to Begin Trading on Nasdaq on Tuesday, November 12, 2024 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Nasdaq Stock Market LLC has approved the listing of the Company's common shares on the Nasdaq Global Market ("Nasdaq"). The Company expects to begin trading on the Nasdaq on Tuesday, November 12th, 2024, under the new symbol "BHST".
- 11/07/2024
|
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
- DUBLIN, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that on November 6, 2024, it received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum market value of publicly held shares (“MVPHS”) requirement under Nasdaq Listing Rule 5450(b)(2)(C) (the “MVPHS Requirement”).
- 11/07/2024
|
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
- SAN DIEGO, CA / ACCESSWIRE / November 7, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that it has received notice from The Nasdaq Stock Market ("Nasdaq") as described in a decision dated November 5, 2024, that the Company may continue its listing on The Nasdaq Capital Market tier with an extension to November 14, 2024, to demonstrate compliance with the equity requirement in Listing Rule 5550(b)(1) as of September 30, 2024, with filing of its Form 10-Q. Additionally, the Company received an extension toDecember 19, 2024, to evidence compliance with the Minimum Bid Price in Listing Rule 5550(a)(2), all other applicable requirements and the Company's satisfaction of certain other interim conditions.
- 11/07/2024
|
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
- embecta will be joined by diabetes advocacy groups to ring the Nasdaq Closing Bell today in recognition of National Diabetes Awareness Month in November.
- 11/07/2024
|
Super Micro Computer Stock Dives on Sustained Risk of Nasdaq Delisting
- Super Micro Computer (SMCI) shares fell 20% Wednesday after the company inflamed concerns it could be delisted after it didn't fully clarify when it would file its delayed annual report for 2024, a necessity for the company to comply with Nasdaq rules.
- 11/06/2024
|
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 500 points on Wednesday.
- 11/06/2024
|
Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
- PRINCETON, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing innovative targeted immunotherapeutic drugs, today announced the pricing of an underwritten public offering of 1,111,111 shares of common stock (or pre-funded warrants to purchase shares of common stock in lieu of shares of common stock) and common warrants to purchase up to an aggregate of 2,222,222 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) is being sold together with one common warrant at a combined offering price of $4.50, priced at-the-market under the rules of the Nasdaq Stock Market, for total gross proceeds of approximately $5.0 million, before underwriting discounts and commissions and offering expenses payable by Sonnet. Each common warrant is exercisable for two shares of common stock at an exercise price of $4.50 per share for a period of five years from the date of issuance. The offering is expected to close on or about November 7, 2024, subject to the satisfaction or waiver of customary closing conditions.
- 11/06/2024
|
Live Markets Today: Russell 2000 Up 6%, Nasdaq Jumps After Trump Victory | TSLA, DJT, RIVN
- Stock market indexes are jumping massive amounts in premarket trading in reaction to last night's election.
- 11/06/2024
|
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
- Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.
- 11/06/2024
|
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on November 4, 2024, the Compensation Committee of Puma's Board of Directors approved the grant of an inducement restricted stock unit award covering 5,625 shares of Puma common stock to one new non-executive employee. The award was granted under Puma's 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity award.
- 11/05/2024
|
Nasdaq Executives to Present at Upcoming Investor Conferences
- NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in November with webcasts available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 11/05/2024
|
HeartCore Regains Compliance with Nasdaq Listing Requirements
- NEW YORK and TOKYO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, announced today that it has received written notice from the Nasdaq Stock Market LLC that the Company demonstrated compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) and that the Company is therefore in compliance with the Nasdaq Capital Market's listing requirements. As a result, the Company's securities will continue to be listed and traded on The Nasdaq Stock Market.
- 11/05/2024
|
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on November 1, 2024 it awarded inducement grants to ten new employees under Intellia's 2024 Inducement Plan as a material inducement to employment.
- 11/05/2024
|
Nasdaq 100 and S&P 500: Markets Brace for Election Volatility and Fed Rate Cut
- U.S. stocks rise as tight presidential race unfolds; markets brace for volatility with election results and Fed rate decision on the horizon.
- 11/05/2024
|
InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules
- Vancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the decision by the Nasdaq Listing Qualifications Panel (the "Panel") to grant an exception until December 2, 2024, to implement a share consolidation to satisfy the Nasdaq Listing Rules. As previously reported by InMed on its current report on Form 8-K, on September 17, 2024, the Listing Qualifications Department (the "Nasdaq Staff") of the Nasdaq Stock Market ("Nasdaq") issued a determination to the Company, which was communicated through a delisting notice (the "Delisting Notice"), indicating that the Company did not satisfy the minimum $1.00 bid price per share requirement for the continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule") by September 16, 2024.
- 11/05/2024
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., Nov. 05, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted five newly-hired employees stock options to purchase an aggregate of 18,200 shares, and restricted stock units (RSUs) covering an aggregate of 12,750 shares, of BioCryst common stock. The options and RSUs were granted as of October 31, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/05/2024
|
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance
- BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from The Nasdaq Stock Market LLC (Nasdaq) that the Nasdaq Hearings Panel before which TransCode appeared on October 1, 2024, has determined to grant TransCode's request to continue its listing on The Nasdaq Stock Market subject to certain conditions to regain compliance. The Panel has also issued a Public Reprimand Letter in accordance with Listing Rule 5815(c)(1)(D).
- 11/05/2024
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to one new employee to purchase an aggregate of 2,500 shares of the Company's common stock, effective as of November 1, 2024. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan, with a grant date of November 1, 2024, as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/04/2024
|
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass and DUBLIN, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that on November 1, the Company granted to five newly hired employees (i) non-statutory stock options to purchase an aggregate of 23,500 ordinary shares of the Company and (ii) restricted stock units with respect to an aggregate of 12,500 ordinary shares of the Company, pursuant to the Company's 2024 Inducement Stock Option and Incentive Plan, each as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/04/2024
|
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on November 1, 2024 the Company granted restricted stock units (RSUs) representing 20,000 shares of its common stock to one newly-hired non-executive employee. The grant was approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.
- 11/04/2024
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 50,000 restricted stock units of Arcutis' common stock as well as options to purchase an aggregate of 50,000 shares of Arcutis' common stock to five newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of November 1, 2024, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/04/2024
|
3-Stock Lunch: Trump Media, KBW Bank & First Trust Nasdaq Cybersecurity
- Jay Woods, Freedom Capital Markets chief global strategist, joins 'Power Lunch' to discuss stock plays for three stocks.
- 11/04/2024
|
S&P 500 and Nasdaq 100: Market Holds Steady as U.S. Election and Fed Decision Loom
- With a close U.S. election and Fed rate cuts likely, stock market sentiment hangs in the balance. Key decisions could sway year-end trading trends.
- 11/04/2024
|
Nasdaq, Dow Jones and S&P 500 Forecast – US Stocks Wait for Elections and Fed
- The US Indices are currently treading water, as we wait for the overall direction to be determined via elections night, and of course the Fed decision on Thursday. At this point, the markets are simply “killing time.
- 11/04/2024
|
Banzai Announces Listing Transfer to Nasdaq Capital Market Pursuant to Nasdaq Compliance Plan
- SEATTLE, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, announces that it has received approval from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") to transfer their listing to the Nasdaq Capital Market. The Company's securities were transferred from the Nasdaq Global Market to the Nasdaq Capital Market at the opening of business on October 31, 2024.
- 11/04/2024
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that on November 1, 2024, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 79,500 shares of the Company's common stock and 21,000 restricted stock units to three newly hired employees. The stock options and restricted stock units were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/01/2024
|
DevvStream Provides Update on Previously Announced Business Combination and Nasdaq Listing
- DevvStream's business combination with Focus Impact Acquisition Corp. and uplisting to the Nasdaq continues to progress towards completion Vancouver, British Columbia--(Newsfile Corp. - November 1, 2024) - DevvStream Holdings Inc. (CBOE: DESG) (OTCQB: DSTRF) (FSE: CQ0) ("DevvStream" or the "Company"), a leading carbon credit project co-development and generation firm specializing in technology-based solutions, today announced a progress update regarding its previously announced business combination (the "Business Combination") with Focus Impact Acquisition Corp (NASDAQ: FIAC). On September 13, 2023, DevvStream and Focus Impact Acquisition Corp. announced that they had entered into a definitive Business Combination Agreement (the "Business Combination Agreement") for a Business Combination that is expected to result in DevvStream being the first publicly traded carbon streaming company on a major U.S. stock exchange.
- 11/01/2024
|
APX Acquisition Corp. I Announces Nasdaq Delisting Notification for Warrants and Units
- NASHVILLE, Tenn. , Nov. 1, 2024 /PRNewswire/ -- As previously announced, on September 4, 2024, APX Acquisition Corp. I (NASDAQ: APXI ) (the "Company"), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that since the Company's aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C) (the "Rule"), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the "Notice").
- 11/01/2024
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, The Netherlands and MIAMI, Nov. 01, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 97,600 of NewAmsterdam's ordinary shares to two non-executive new hires. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/01/2024
|
Nasdaq, S&P 500 rebound as Amazon surges, market shrugs off jobs data
- US stocks staged a comeback on Friday as investors digested a big miss in the monthly jobs report and welcomed Amazon (AMZN) and Intel (INTC) earnings. The tech-heavy Nasdaq Composite (^IXIC) gained 0.8%, while the S&P 500 (^GSPC) rose 0.4%, both coming off a steep sell-off fueled by worries about Big Tech's artificial intelligence spending.
- 11/01/2024
|
Lilium N.V. Receives Notice of Delisting from Nasdaq
- MUNICH, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (Nasdaq: LILM) (the “Company” or “Lilium”), a leading electric aircraft manufacturer and pioneer in Regional Air Mobility (RAM), on Tuesday, October 29, 2024, announced in a Form 6-K filed with the Securities and Exchange Commission that the Company received a written notice from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) on October 28, 2024, following the applications of Lilium GmbH and Lilium eAircraft GmbH, the principal operating wholly-owned German subsidiaries of Lilium (the “Subsidiaries”), for insolvency in the local court of Weilheim in Germany and self-administration proceedings pursuant to Section 270(a) of the German Insolvency Code, notifying the Company that, in accordance with Nasdaq Listing Rule 5101, the trading of the Company's Class A ordinary shares and warrants will be suspended at the opening of business on November 6, 2024, and a Form 25 Notification of Delisting will be filed with the U.S. Securities Exchange Commission (the “SEC”) to delist the Company's securities from the Nasdaq Global Select Market (“Nasdaq”).
- 11/01/2024
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on November 1, 2024, the Compensation Committee of Taysha's Board of Directors granted three new employees, in the aggregate, options to purchase 157,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/01/2024
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON , Nov. 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on October 31, 2024, the company granted equity awards to six new employees, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/01/2024
|
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on October 31, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 271,764 shares of X4's common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by X4's Compensation Committee of the Board of Directors.
- 11/01/2024
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. , Nov. 1, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted three newly-hired employees options to purchase an aggregate of 20,000 shares of Akebia's common stock on October 31, 2024.
- 11/01/2024
|
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on November 1, 2024, the Compensation Committee of the company's Board of Directors granted to twelve new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 56,700 ordinary shares. These awards were made under Bicycle Therapeutics' 2024 Inducement Plan and approved by the Compensation Committee as an inducement material to the employees enter.
- 11/01/2024
|
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and development of oral covalent small molecules to treat and improve the lives of patients with diabetes, obesity, and genetically defined cancers, today announced that on November 1, 2024, the compensation committee of Biomea's board of directors granted one new employee non-qualified stock options to purchase an aggregate of 6,500 shares of the Company's common stock. The shares underlying the employee's stock options will vest 1/16 on a quarterly basis over four years, subject to the employee's continued employment with the Company on such vesting dates. The above-described award was made under Biomea's 2023 Inducement Equity Plan (the “Plan”).
- 11/01/2024
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , Nov. 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 10,500 restricted stock units (RSUs) to three newly-hired employees.
- 11/01/2024
|
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Ji'an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on October 25, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.
- 11/01/2024
|
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday.
- 11/01/2024
|
Nasdaq, S&P 500 rebound amid Amazon cheer, jobs report
- US stocks jumped and were set for a comeback on Friday as investors digested a big miss in the monthly jobs report and welcomed Amazon (AMZN) and Intel (INTC) earnings. The tech-heavy Nasdaq Composite (^IXIC) surged 1.2%, while the S&P 500 (^GSPC) rose about 1%, both coming off a steep sell-off fueled by worries about Big Tech's artificial intelligence spending.
- 11/01/2024
|
PS International Group Ltd. Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- Hong Kong, Nov. 01, 2024 (GLOBE NEWSWIRE) -- PS International Group Ltd. (NASDAQ: PSIG) (“PSIG” or the “Company”), a long-established global logistics service provider headquartered in Hong Kong specialized in cross-border air freight services, today announced that it received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on October 30, 2024 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company's ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. The Notice provides that the Company has a period of 180 calendar days from the date of the Notice, or until April 28, 2025, to regain compliance with the minimum bid price requirement.
- 11/01/2024
|
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
- HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market (“Nasdaq”) on October 31, 2024, notifying the Company that it has regained compliance with Nasdaq's minimum bid price requirement under Nasdaq Rule 5550(a)(2).
- 11/01/2024
|
S&P 500 and Nasdaq 100: Tech Stocks Lift Futures Ahead of Key Jobs Report
- Nasdaq 100 futures rise on Amazon, Intel gains; traders await key U.S. jobs data for insights into tech stock momentum.
- 11/01/2024
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 11/01/2024
|
SOBRsafe Regains Compliance with Nasdaq Listing Requirements
- DENVER, CO / ACCESSWIRE / October 31, 2024 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), provider of next-generation transdermal alcohol detection solutions, today announced that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), the public float requirement under Nasdaq Listing Rule 5550(a)(4) and the stockholders' equity requirement (the "Equity Rule") under Nasdaq Listing Rule 5550(b)(1), as required by the Nasdaq Hearings Panel decision dated August 2024. Accordingly, the Company's common stock will continue to be listed and trade on The Nasdaq Capital Market under the symbol "SOBR".
- 10/31/2024
|
Nasdaq leads sell-off after Microsoft, Meta earnings prompt Big Tech slide
- To get the latest market news check out finance.yahoo.com The Nasdaq led a tumble in US stocks on Thursday after Meta (META) and Microsoft (MSFT) earnings sparked worries about prospects for Big Techs amid rising artificial intelligence costs. The tech-heavy Nasdaq Composite (^IXIC) sank 2.7%, while the S&P 500 (^GSPC) fell nearly 1.9%, as both indexes ended the month slightly in the red.
- 10/31/2024
|
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on October 31, 2024. Three individuals were hired by Adicet in October 2024. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 59,800 shares of Adicet's common stock with an exercise price of $1.28.
- 10/31/2024
|
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
- SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-marker under Nasdaq rules for the purchase and sale of an aggregate of 9,881,113 shares of its common stock and Series C warrants to purchase up to an aggregate of 9,881,113 shares of common stock and short-term Series D warrants to purchase up to an aggregate of 9,881,113 shares of common stock (collectively, the “Warrants”) at a combined offering price of $0.3039 per share of common stock and accompanying Warrants. The Warrants have an exercise price of $0.3039 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares of common stock upon exercise of the Warrants (the “Stockholder Approval”). The Series C warrants expire five years following the date of the Stockholder Approval and the short-term Series D warrants expire eighteen months following the date of Stockholder Approval.
- 10/31/2024
|
Trident Rings the Nasdaq Opening Bell Following Successful U.S. Listing
- Company Rings Opening Bell to Celebrate Completion of Initial Public Offering and Begins Journey as a Public Company; Shares trade under “TDTH” Ticker Company Rings Opening Bell to Celebrate Completion of Initial Public Offering and Begins Journey as a Public Company; Shares trade under “TDTH” Ticker
- 10/31/2024
|
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
- U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping around 500 points on Thursday.
- 10/31/2024
|
Nasdaq Index Under Pressure as Microsoft, Meta Earnings Disappoint Investors
- Nasdaq falls as Microsoft, Meta miss earnings targets; Fed's stable inflation data adds to market uncertainty ahead of next rate decision.
- 10/31/2024
|
Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results
- U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday.
- 10/31/2024
|
Nasdaq, Dow Jones and S&P 500 Forecast – US Indices Continue to See Hesitation
- The US Indices have pulled back a bit in the early hours of Thursday, as we await the Non-Farm Payroll results to get an idea where the stock markets might go running to.
- 10/31/2024
|
23andMe Regains Compliance With Nasdaq Listing Requirements
- SUNNYVALE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and preventive health company, today announced that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the majority independent board and various board committee requirements under Nasdaq Listing Rule 5605. Accordingly, the Company's Class A common stock will continue to be listed on The Nasdaq Capital Market and trade under the symbol “ME”.
- 10/30/2024
|
S&P500 and Nasdaq Index: Cloud Gains Lift Alphabet, but AMD Drags on Market
- Alphabet leads tech as Nasdaq hits highs, while AMD and Super Micro slump on earnings misses. Mixed signals keep investors cautious on US stock outlook.
- 10/30/2024
|
Nasdaq, Dow Jones and S&P 500 Forecast – US Indices Continues to Churn
- The US indices continue to see a lot of noisy behavior, but at this point in time, it looks like we are waiting to see what happens in the Non-Farm Payroll numbers on Friday, and of course the US Presidential elections Tuesday of next week.
- 10/30/2024
|
BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
- NEW YORK , Oct. 30, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced that on October 29, 2024, the Company received written notice from The Nasdaq Stock Market stating that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Accordingly, the Company's common stock will continue to trade on The Nasdaq Capital Market, subject to the Company's compliance with Nasdaq's continued listing requirements.
- 10/30/2024
|
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
- GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced the pricing of its "reasonable best efforts" public offering with a health-care focused institutional investor for the purchase and sale of up to 2,950,820 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,950,820 shares of common stock at a combined offering price of $1.525 per share and accompanying warrant, priced at-the-market under Nasdaq rules (the “Offering”). The Company expects to receive aggregate gross proceeds of approximately $4.5 million, before deducting placement agent fees and other offering expenses, and assuming no exercise of the warrants. The warrants will have an exercise price of $1.40 per share, will be exercisable immediately and will expire five years from the issuance date.
- 10/29/2024
|
Terrifier 3's Art the Clown to Ring Nasdaq Closing Bell as Cineverse Celebrates Halloween - and the Killer Box Office Success of its Hit Indie Slasher Film
- NEW YORK , Oct. 29, 2024 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), an innovative streaming entertainment and technology company, will visit the Nasdaq MarketSite in Times Square on October 31, 2024. To celebrate the recent box office success of independent slasher hit movie, Terrifier 3— distributed by Cineverse — the company has asked the film's iconic character Art the Clown to ring the Closing Bell.
- 10/29/2024
|
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
- GAITHERSBURG, Md., Oct. 29, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has received a written notice (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") dated October 21, 2024, informing the Company that it has regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
- 10/29/2024
|
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 745,342 shares of the Company's common stock at an offering price of $4.025 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 745,342 shares of common stock. The warrants have an exercise price of $3.90 per share, will be exercisable upon issuance, and will expire five years following issuance. The closing of the offering is expected to occur on or about October 29, 2024, subject to the satisfaction of customary closing conditions.
- 10/29/2024
|
Thumzup Media Corp Lists Shares on Nasdaq and Prices Upsized Public Offering of Shares of Common Stock to $7,125,000
- Los Angeles, CA., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Thumzup Media Corporation ("Thumzup" or the "Company") (OTCQB: TZUP) (Nasdaq: TZUP), a leading provider of innovative social media branding and marketing solutions which allow businesses and brands to pay customers and fans cash through Venmo and PayPal for their posts on social media, is pleased to announce the pricing of an underwritten public offering of 1,425,000 shares of common stock, at a price of $5.00 per share (the “Shares”). In addition, the Company has granted the underwriters a 45-day over-allotment option to purchase up to an additional 213,750 Shares, less underwriting discounts and commissions. Closing is expected to occur on October 30, 2024.
- 10/29/2024
|
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst
- It has been a rotten year for Apellis Pharmaceuticals stock, but better times could be ahead.
- 10/29/2024
|
Gelteq Limited Prices US$5.2 Million Initial Public Offering
- Company anticipates commencement of trading on Nasdaq effective October 29, 2024 under the symbol “GELS” Company anticipates commencement of trading on Nasdaq effective October 29, 2024 under the symbol “GELS”
- 10/28/2024
|
Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”
- Raanana, Israel, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (the "Company" or "PLRZ"), a development stage biotech company specializing in the development of innovative medical device hydrogels, today announced the pricing of its underwritten initial public offering of 958,903 units at a combined public offering price of $4.38 per unit, with each unit each consisting of one ordinary share and three warrants to purchase one ordinary share per warrant, with an initial exercise price of $4.38 per share. Aggregate gross proceeds are expected to be $4.2 million, prior to deducting underwriting discounts and offering expenses.
- 10/28/2024
|
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase 345,600 shares of the Company's common stock to one new employee (the “Inducement Grant”), with the grant made on October 28, 2024 (the “Grant Date”). The Inducement Grant was granted as a material inducement to this individual entering into employment with C4T in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/28/2024
|
Fate Of Nasdaq 100 Depends On Just Five Earnings This Week, Oil Falls On Israel Attack On Iran
- To gain an edge, this is what you need to know today.
- 10/28/2024
|
Delisting of Kindred Group plc
- SLIEMA, Malta , Oct. 28, 2024 /PRNewswire/ -- Nasdaq Stockholm has approved Kindred Group plc's ("Kindred" or the "Company") request for delisting of the Swedish Depository Receipts (the "SDRs") in Kindred from Nasdaq Stockholm. The last day of trading in the SDRs will be on 11 November 2024.
- 10/28/2024
|
S&P 500 and Nasdaq 100: Microsoft, Meta Earnings in Focus as Fed Data Looms
- Big Tech earnings and key Fed data could boost S&P 500 Index, with Alphabet and Microsoft reports set to impact AI investment trends.
- 10/28/2024
|
Nasdaq Hits All-Time Closing High: 4 Tech Stocks With Growth Potential
- Tech stocks like GOOGL, AVGO, NFLX and PANW are poised to benefit from the ongoing Nasdaq rally.
- 10/28/2024
|
Wearable Devices Regains Compliance with Nasdaq Minimum Bid Price Rule
- YOKNEAM ILLIT, ISRAEL, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (“AI")-powered touchless sensing wearables, today announced that it has received a written notice from Nasdaq Stock Market LLC (“Nasdaq”), indicating that the Company has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.
- 10/28/2024
|
Nasdaq to Join the American Bankers Association's Partner Network as a Premier Partner
- NEW YORK--(BUSINESS WIRE)--Nasdaq Verafin® and Nasdaq Governance Solutions to join the American Bankers Association's Partner Network as Premier Partners.
- 10/28/2024
|
The pros and cons for investors of nonstop trading as NYSE looks to go 22 hours a day
- The Big Board announced on Friday that it was seeking approval to expand trading on its electronic Arca platform from 16 hours a day to 22 hours a day.
- 10/28/2024
|
Nasdaq Surges To Fresh Highs As Nvidia, Meta And Amazon Surge: Fear Index Remains In 'Greed' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Greed” zone on Friday.
- 10/28/2024
|
Andretti Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 28, 2024
- New York, NY, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Andretti Acquisition Corp. II (Nasdaq: POLEU) (the “Company”) announced today that, commencing October 28, 2024, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “POLE” and “POLEW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “POLEU.”
- 10/25/2024
|
SIMPPLE LTD. Announces Receipt of Nasdaq Staff Determination Letter
- Singapore, Oct. 25, 2024 (GLOBE NEWSWIRE) -- SIMPPLE LTD. (Nasdaq: SPPL) (the “Company” or “SIMPPLE”), an advanced technology solution provider in the emerging property-technology (“PropTech”) space, today announced that on April 26, 2024, the Company received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from March 14, 2024 to April 25, 2024, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2) (the “Rule”), to maintain a minimum bid price of $1 per share. The Company was provided 180 calendar days, or until October 23, 2024, to regain compliance.
- 10/25/2024
|
U-BX Technology Ltd. Announced Receipt of Notification Letter from Nasdaq
- BEIJING, Oct. 25, 2024 (GLOBE NEWSWIRE) -- U-BX Technology Ltd. (the "Company" or "U-BX") (NASDAQ:UBXG), a leading company providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers, today announced that it has received written notifications (the "Notification Letters") from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on Oct. 21, 2024. The Notification Letters advised the Company that for the last 31 consecutive business days, the minimum closing bid price per share for the Company's ordinary shares was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2). The Notification Letters also advised the Company that for the last 30 consecutive business days, the minimum Market Value of Listed Securities (MVLS) of the Company was below the $35 million requirement for continued listing under Nasdaq Listing Rule 5550(b)(2).
- 10/25/2024
|
Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that the Board of Directors of Firefly granted 557,885 restricted shares (the “Shares”) as an inducement grant to David Johnson, the Company's Executive Chairman, pursuant to that certain Employment Agreement (the “Agreement”), by and between the Company and Mr. Johnson. The Shares were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and are subject to the terms and conditions of the Agreement and the Company's 2024 Long-Term Incentive Plan.
- 10/25/2024
|
Luokung Announces Receipt of Nasdaq Notices Regarding Periodic Filing Compliance and Stockholders' Equity Deficiency
- BEIJING, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Luokung Technology Corp. (NASDAQ: LKCO) (“Luokung” or the “Company”), a leading spatial-temporal intelligent big data services company and provider of interactive location-based services (“LBS”) and high-definition maps (“HD Maps”) in China, today announced that on October 23, 2024, the Company received two letters from the Nasdaq Stock Market LLC (“Nasdaq”).
- 10/25/2024
|
S&P 500, Nasdaq rise sharply ending 3-day losing streak; Viking Therapeutics surge, while Capri's shares slump
- US benchmark equity averages rose on Friday as the market ended a three-day losing streak. At the time of writing, the Dow Jones Industrial Average was up 0.3%, while S&P 500 rose 0.8% from the previous close.
- 10/25/2024
|
Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut
- Septerna's shares rose about 31% in their market debut on Friday, giving the Goldman Sachs-backed biotech firm a valuation of $970 million.
- 10/25/2024
|
Chinese self-driving startup WeRide's shares open flat in Nasdaq debut
- Chinese self-driving startup WeRide's shares opened flat in their Nasdaq debut on Friday.
- 10/25/2024
|
Nasdaq Surges Over 200 Points; AutoNation Posts Downbeat Earnings
- U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 200 points on Friday.
- 10/25/2024
|
Nasdaq Hits All-Time High—First Since July As Tesla Stock Leads Tech Rally
- The Nasdaq Composite jumped to an all-time high Friday, a first for the tech-heavy stock index in more than three months as the group shook off tailwinds such as rising bond yields and enjoyed a boost from Tesla's share price.
- 10/25/2024
|
Nasdaq: Once Again Reports A Solid Quarter Of Organic Solutions Revenue Growth
- Nasdaq's 3Q24 earnings exceeded expectations with non-GAAP revenue of $1.18bn (+26% Y/Y) and adjusted EPS of $0.74, beating consensus estimates. Strong organic growth across Nasdaq's business lines, particularly in Index, and effective integration of Adenza highlight robust operational performance. Despite solid results, I maintain a HOLD rating due to limited upside potential, with Nasdaq's shares offering less than 10% upside, in my view.
- 10/25/2024
|
Nasdaq 100: Robust Tesla Earnings, Sales Forecast Set Stage For Rally
- The Nasdaq 100, after reaching record highs, has recently experienced a pullback as analysts revise their earnings expectations.
- 10/25/2024
|
DevvStream to Voluntarily Halt Trading in Anticipation of Expected Nasdaq Listing
- Company shares listed on Cboe Canada will no longer be tradeable as of Friday, October 25, 2024 at 5:00 PM Eastern Company expects to close its Business Combination with Focus Impact on October 30, 2024 and begin trading on the Nasdaq Exchange the following day Vancouver, British Columbia--(Newsfile Corp. - October 25, 2024) - DevvStream Holdings Inc. (CBOE: DESG) (OTCQB: DSTRF) (FSE: CQ0) ("DevvStream" or the "Company"), a leading carbon credit project co-development and generation firm specializing in technology-based solutions, today announced that the Company has elected to halt trading of its stock on Cboe Canada on October 25, 2024 at 5:00 PM Eastern, in anticipation of the closure of its business combination (the "Business Combination") with Focus Impact Acquisition Corp. (NASDAQ: FIAC). On September 13, 2023, DevvStream and Focus Impact Acquisition Corp. announced that they had entered into a definitive Business Combination Agreement (the "Business Combination Agreement") for a Business Combination that is expected to result in DevvStream being the first publicly traded carbon streaming company on a major U.S. stock exchange.
- 10/25/2024
|
Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq
- RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
- 10/24/2024
|
Aeries Technology Regains Compliance with Nasdaq Listing Standards
- NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Aeries Technology (Nasdaq: AERT) (the “Company”), a global professional services and consulting partner for businesses in transformation mode and their stakeholders, today announced that it has received written notice from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC informing the Company that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) regarding periodic reporting.
- 10/24/2024
|
Jeffs' Brands Receives NASDAQ Minimum Bid Price Requirement Extension
- No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares Tel Aviv, Israel, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs' Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, announced today that on October 23, 2024, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is eligible for an additional 180 calendar day period, or until April 21, 2025, to regain compliance with the Nasdaq's minimum $1 bid price per share requirement. The Company was first notified by Nasdaq of its failure to maintain a minimum bid price of $1 per share for 30 consecutive trading days under Nasdaq Listing Rule 5550(a)(2) on April 25, 2024, and was given until October 22, 2024 to regain compliance.
- 10/24/2024
|
S&P 500 and Nasdaq Composite climb, Dow slips; Tesla soars on strong earnings, Boeing drops
- US benchmark equity averages were mixed on Thursday, but S&P 500 index rose slightly led by gains in Tesla and others. At the time of writing, the S&P 500 index was slightly higher by 0.1%, while the Nasdaq Composite was up 0.6%.
- 10/24/2024
|
Nasdaq Tops Q3 Earnings Estimates, Tweaks Expense Guidance
- NDAQ's third-quarter results reflect broad-based growth across three divisions and another quarter of double-digit Solutions growth.
- 10/24/2024
|
Nasdaq Edges Higher; Honeywell Shares Fall After Q3 Results
- U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 0.3% on Thursday.
- 10/24/2024
|
Nasdaq (NDAQ) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
- Although the revenue and EPS for Nasdaq (NDAQ) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 10/24/2024
|
Nasdaq, Inc. (NDAQ) Q3 2024 Earnings Call Transcript
- Nasdaq, Inc. (NASDAQ:NDAQ ) Q3 2024 Earnings Conference Call October 24, 2024 8:00 AM ET Company Participants Ato Garrett - Senior Vice President and Investor Relations Officer Adena Friedman - Chair and Chief Executive Officer Sarah Youngwood - Executive Vice President and Chief Financial Officer Conference Call Participants Owen Lau - Oppenheimer Craig Siegenthaler - Bank of America Michael Cyprys - Morgan Stanley Patrick Moley - Piper Sandler Kyle Voigt - KBW Michael Cho - JPMorgan Daniel Fannon - Jefferies Alexander Blostein - Goldman Sachs Benjamin Budish - Barclays William Katz - TD Cowen Simon Clinch - Redburn Atlantic Brian Bedell - Deutsche Bank Operator Good day and thank you for standing by. Welcome to Nasdaq Third Quarter 2024 Results Conference Call.
- 10/24/2024
|
S&P 500 and Nasdaq 100: Futures Rebound as Tesla Powers Tech Stocks Higher
- S&P 500 futures rise as Tesla's 14% surge leads tech stocks higher, while Dow struggles with IBM and Boeing declines. Read more for key market insights.
- 10/24/2024
|
Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule
- BERKELEY HEIGHTS, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative cancer medicines, today announced that it received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an extension until December 24, 2024, to regain compliance with Nasdaq's minimum stockholders equity requirement under Nasdaq Listing Rule 5550(b)(1) (the "Equity Standard Rule").
- 10/24/2024
|
Nasdaq (NDAQ) Tops Q3 Earnings Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.71 per share a year ago.
- 10/24/2024
|
Safe and Green Development Corporation Regains Compliance with Nasdaq Listing Standards
- MIAMI , Oct. 24, 2024 /PRNewswire/ -- Safe and Green Development Corporation (Nasdaq: SGD) ("the Company") today is pleased to announce that it has received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). "We are pleased to have regained compliance with Nasdaq's listing standards, which reflects our commitment to enhancing shareholder value and ensuring the long-term growth of the Company," said David Villarreal, Chief Executive Officer of Safe and Green Development Corporation.
- 10/24/2024
|
Nasdaq, S&P 500 seen bouncing back in mixed start on Wall Street
- Wall Street was set for a mixed start on Thursday as the S&P 500 looked on course to break a three-day losing streak. Futures had the S&P 500 up 0.4% ahead of the open, while the Nasdaq was seen jumping 0.8%, on the back of gains for tech stocks after Tesla Inc (NASDAQ:TSLA)'s earnings on Wednesday evening.
- 10/24/2024
|
Nasdaq Futures Rise; Tesla Jumps on Strong Earnings
- U.S. stock futures were mixed, with Tesla's surprisingly good results bolstering futures for the tech-focused Nasdaq-100. S&P 500 futures also rose, while contracts tied to the Dow edged lower.
- 10/24/2024
|
Nasdaq Announces Quarterly Dividend of $0.24 Per Share
- NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.24 per share on the company's outstanding common stock. The dividend is payable on December 20, 2024 to shareholders of record at the close of business on December 6, 2024. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors.
- 10/24/2024
|
Nasdaq Reports Third Quarter 2024 Results; Fourth Consecutive Quarter of Double-Digit Solutions Revenue Growth
- NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the third quarter of 2024.
- 10/24/2024
|
S&W Seed Company Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)
- LONGMONT, Colo. , Oct. 23, 2024 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW) announced that, on October 17, 2024, the Company received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market (Nasdaq), advising the Company that its failure to timely file its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the Form 10-K) with the Securities and Exchange Commission (the SEC) is in contravention of Nasdaq Listing Rule 5250(c)(1) (the Filing Requirement), and could serve as an additional deficiency and basis for the delisting of the Company's securities from Nasdaq.
- 10/23/2024
|
DT Cloud Acquisition Corporation Announces Entering into a Business Combination Agreement with Maius Pharmaceutical
- New York, New York, Oct. 23, 2024 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (“DT Cloud” or the “SPAC”), a publicly-traded special purpose acquisition company, and Maius Pharmaceutical Co., Ltd. (“Maius” or the “Company”), a biopharmaceutical R&D company, announced that they had entered into a definitive business combination agreement (the “Business Combination Agreement”) for the merger transactions (the “Business Combination,” and the transactions in connection with the Business Combination collectively, the “Transaction”). As contemplated in the Business Combination Agreement, upon closing of the Transaction, Maius will become a wholly-owned subsidiary of Maius Pharmaceutical Group Co., Ltd., a newly formed holding company (“Pubco”), the securities of which will be listed on The Nasdaq Stock Market LLC (“Nasdaq”).
- 10/23/2024
|
Delisting of Securities of Minim, Inc. from The Nasdaq Stock Market
- NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Minim, Inc. Minim, Inc.'s securities were suspended on July 24, 2024, and have not traded on Nasdaq since that time.
- 10/23/2024
|
If I Could Invest $1,000 In Any Nasdaq ETF, It Would Be This One
- The Nasdaq Composite provides broad exposure to stocks, but a more concentrated approach has been the better long-term option.
- 10/23/2024
|
A2Z Fully Compliant with Nasdaq Listing Requirements; Warrant Extension
- TEL AVIV, ISRAEL / ACCESSWIRE / October 23, 2024 / A2Z Cust2Mate Solutions Corp. ("A2Z" or the "Company") (NASDAQ:AZ)(FRA - WKN: A3CSQ), a global leader in innovative technology solutions, today announced that it has received formal notice from the Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). As previously disclosed, the Company received a written notice from Nasdaq on April 24, 2024, notifying the Company that it had failed to meet the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Capital Market.
- 10/23/2024
|
Beat the Nasdaq With This Cash-Gushing Dividend Stock
- The company is performing well despite recently losing its biggest growth driver.
- 10/23/2024
|
Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter
- PROVIDENCE, Rhode Island, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on October 16, 2024, it received a Staff Determination Letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that on April 18, 2024, May 22, 2024, and August 19, 2024, Staff notified the Company that it did not comply with Nasdaq's filing requirements set forth in Listing Rule 5250(c)(1) (the “Rule”) because it had not filed its Form 10-K for the year ended December 31, 2024 (the “Form 10-K”), and its Forms 10-Q for the periods ended March 31, 2024 and June 30, 2024 (the “Forms 10-Q”), respectively. Based on its review and the materials submitted on June 17, 2024 and August 27, 2024, Staff granted the Company an exception until October 14, 2024, to regain compliance with the Rule. Upon further review, Staff determined that the Company did not meet the terms of the exception. Specifically, the Company has not filed the either its Form 10-K or Forms 10-Q as required by the Rule. The Company will appeal Staff's determination to a Hearings Panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series.
- 10/22/2024
|
DevvStream Provides Update on Proposed Business Combination and Nasdaq Listing
- DevvStream's business combination with Focus Impact Acquisition Corp. and uplisting to the Nasdaq continues to progress towards completion. Vancouver, British Columbia--(Newsfile Corp. - October 22, 2024) - DevvStream Holdings Inc. (CBOE: DESG) (OTCQB: DSTRF) (FSE: CQ0) ("DevvStream" or the "Company"), a leading carbon credit project co-development and generation firm specializing in technology-based solutions, today announced a progress update regarding its previously announced business combination (the "Business Combination") with Focus Impact Acquisition Corp. (Nasdaq: FIAC).
- 10/22/2024
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , Oct. 21, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on October 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 421,600 shares of its common stock and 210,800 restricted stock units ("RSUs") to thirty-four (34) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/21/2024
|
Stay Ahead of the Game With Nasdaq (NDAQ) Q3 Earnings: Wall Street's Insights on Key Metrics
- Beyond analysts' top -and-bottom-line estimates for Nasdaq (NDAQ), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
- 10/21/2024
|
Snail Games Regains Compliance with Nasdaq Minimum Bid Price Requirement
- CULVER CITY, Calif. , Oct. 21, 2024 /PRNewswire/ -- Snail, Inc. (Nasdaq: SNAL) ("Snail Games" or the "Company"), a leading global independent developer and publisher of interactive digital entertainment, announced today that the Company received written notice from the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market.
- 10/21/2024
|
Finch Announces Delisting from Nasdaq and SEC Deregistration
- BOSTON, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Nasdaq: FNCH) (“Finch” or the “Company”), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced that it has provided notification to The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to delist the Company's common stock, par value $0.001 per share (the “Common Stock”), from the Nasdaq Global Select Market. Finch expects to file a Form 25 (Notification of Removal from Listing) with the Securities and Exchange Commission (the “SEC”) and Nasdaq relating to the delisting of its Common Stock on or about October 31, 2024.
- 10/21/2024
|
Nasdaq Confirms VEON's Full Compliance Following its 2023 20-F Filing
- Amsterdam and Dubai, 21 October 2024: VEON Ltd. (Nasdaq: VEON; Euronext Amsterdam: VEON), a global digital operator (“VEON” or the “Company”), today announces that, following the filing of the Company's Form 20-F for the period ended December 31, 2023 (“2023 20-F”) on October 17, 2024, it has received confirmation from the Nasdaq Stock Market ("Nasdaq") that VEON is now compliant with the Nasdaq listing requirements.
- 10/21/2024
|
Village Farms International Provides Update on Nasdaq Listing
- VANCOUVER, British Columbia and ORLANDO, Fla., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) has received notification from The Nasdaq Stock Market LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirement (NASDAQ Listing Rule) as the bid price for the Company's common shares closed below US $1.00 (the “Minimum Bid Requirement”) from September 6, 2024 to October 17, 2024 (the “Notification”).
- 10/18/2024
|
Wytec Announces Its Uplisting Preparation to the Nasdaq Capital Markets in Conjunction With Completing Its AI Gunshot Detection Technology
- SAN ANTONIO, Texas, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Wytec (OTCQB:WYTC) has announced today, plans to uplist to the Nasdaq Capital Markets to accelerate their Pilot Smart Sensor Project to be demonstrated in detecting active threats such as gunshots within America's Independent School Districts (ISD's) and cities. Wytec's AI based sensor technology is patent protected and has produced a better than 90% gunshot detection accuracy on over 400,000 live samples and simulated environments.
- 10/18/2024
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 22,405 restricted stock units of the company's common stock to six newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of October 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/18/2024
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 23,500 shares of its common stock to two newly hired employees, consisting of inducement stock options to purc.
- 10/18/2024
|
Nasdaq Resumes Trading in Nebius Group N.V.
- NEW YORK, Oct. 18, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume in Nebius Group N.V. (Nasdaq: NBIS) at 9:00 a.m. Eastern Time on October 21, 2024. Trading in the company's stock was halted on February 28, 2022 at 6:38 a.m. Eastern Time under its former name and symbol, Yandex N.V. (Nasdaq:YNDX).
- 10/18/2024
|
Flux Power Receives Non-Compliance Letter from Nasdaq
- VISTA, Calif.--(BUSINESS WIRE)--Flux Power Receives Non-Compliance Letter from Nasdaq.
- 10/18/2024
|
Nasdaq Index Today: Netflix Rally Leads Gains as Dow Falters on AmEx Slump
- Nasdaq rallies as Netflix jumps 11% on strong earnings, while AmEx drags down Dow. Will tech stocks keep leading the market's bullish momentum?
- 10/18/2024
|
Live Market Updates: Nasdaq Composite Up | NFLX & ISRG Crush Earnings
- Major indexes faded late in Thursday's trading, with the Nasdaq Composite finishing up just .036%.
- 10/18/2024
|
Nasdaq Futures Rise as Netflix Soars 4% on Earnings, Dow and S&P 500 Eye 6-Week Streak
- U.S. stocks on track for weekly gains, with the Dow and S&P 500 set to hit their longest 2024 streak. Netflix jumps 4% on strong Q3 earnings.
- 10/18/2024
|
Nebius to resume Nasdaq trading after severing ties with Russia and Yandex
- Nebius, the company formerly known as Yandex that's now focused on cloud infrastructure for AI uses (aka “AI compute”), is to begin trading on the public markets once again — more than two years after the Nasdaq halted trading due to economic sanctions imposed in the wake of Russia's Ukraine invasion in 2022.
- 10/18/2024
|
Telix Files Form 20-F Registration Statement for Nasdaq ADS
- MELBOURNE, Australia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registration Statement) with the United States (U.S.) Securities and Exchange Commission (SEC) relating to a proposed listing of American Depository Shares (ADS), representing the Company's ordinary shares, on the Nasdaq Stock Market (Nasdaq).
- 10/17/2024
|
Nasdaq Turns to AI to Improve Bank and Insurance Risk Assessment
- Nasdaq has introduced technology to calculate investment portfolio risk using machine learning. The new functionality, announced Thursday (Oct. 17), will be woven into Nasdaq's Calypso platform, used by banks, insurers and other financial institutions to do things like access capital markets, manage risk and adhere to regulatory reporting obligations.
- 10/17/2024
|
Fresh2 Group Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
- New York, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) (“Fresh2” or the “Company”), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on October 16, 2024, it received a Staff Determination Letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company did not comply with Nasdaq's filing requirements as set forth in Listing Rule 5250(c)(1). The letter is a result of the Company's failure to file its Form 10-K for the year ended December 31, 2023, and its Forms 10-Q for the periods ended March 31, and June 30, 2024, within the required deadlines.
- 10/17/2024
|
Nasdaq (NDAQ) Expected to Beat Earnings Estimates: Should You Buy?
- Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/17/2024
|
Sky Quarry to Ring the Nasdaq Closing Bell on Friday, October 25, 2024
- WOODS CROSS, Utah, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Sky Quarry Inc. (NASDAQ: SKYQ) ("Sky Quarry" or the "Company"), an integrated energy solutions company committed to revolutionizing the waste asphalt shingle recycling industry, today announced the Company will ring the closing bell at the Nasdaq MarketSite in Times Square, New York on Friday, October 25, 2024. “We are honored to ring the closing bell to celebrate our recent listing on the Nasdaq Exchange ,” said David Sealock, Chief Executive Officer, Co-Founder, and Chairman of Sky Quarry.
- 10/17/2024
|
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
- PRINCETON, NJ, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that it received notice on October 16, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company regained compliance with the bid price requirement in Listing Rule 5550(a)(2) (the “Bid Price Rule”) for continued listing on the Nasdaq Capital Market.
- 10/17/2024
|
Nasdaq poised to jump as chip maker TSMC inspires gains in Nvidia, AMD
- Nasdaq-listed tech stocks are poised to drive a positive open on Wall Street on Thursday, following encouraging reports from the semiconductor industry. Futures for the Nasdaq 100 were up almost 0.9%, while those for the broader S&P 500 rose 0.45% and Dow Jones futures inched up 0.1%.
- 10/17/2024
|
Nasdaq Composite Today: TSM Leads Another AI Stock Frenzy (TSM, NVDA, AVGO)
- Shortly before 8 a.m. ET markets are looking up across the board on Thursday.
- 10/17/2024
|
Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement
- LISHUI, China, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Lixiang Education Holding Co., Ltd. (the “Company” or NASDAQ: LXEH), a prestigious private education service provider in China, today announced that on October 14, 2024, it received a letter from the Listing Qualification Department of Nasdaq Stock Market LLC (the “Nasdaq”) notifying the Company that “for the last 10 consecutive business days, from September 30 to October 11, 2024, the closing bid price of the Company's American Depositary Shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(a)(1), and this matter is now closed.”
- 10/17/2024
|
Nasdaq Integrates AI to Simplify and Accelerate Bank and Insurance Risk Calculations
- Market volatility and regulatory requirements are driving increasingly complex and computationally intensive risk calculations
- 10/17/2024
|
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- YARDLEY, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the company has granted a non-qualified stock option awards to purchase an aggregate of 185,000 shares of its common stock to eight new employees as an inducement material for accepting employment with OptiNose. The stock option awards were granted outside of the OptiNose, Inc. 2010 Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/16/2024
|
Direct Digital Holdings Regains Nasdaq Compliance
- HOUSTON , Oct. 16, 2024 /PRNewswire/ -- Direct Digital Holdings, Inc. (Nasdaq: DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP"), Orange 142, LLC ("Orange 142") and Huddled Masses LLC ("Huddled Masses"), announced today that it received written notice from the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC informing the Company that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) regarding periodic reporting. The regaining of compliance is a result of yesterday's filings of Direct Digital Holdings' Form 10-K for the full-year ended December 31, 2023, as well as its Form 10-Q for the first quarter ended March 31, 2024 and its Form 10-Q for the second quarter ended June 30, 2024.
- 10/16/2024
|
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- WATERTOWN, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company utilizing its Acrivon Predictive Precision Proteomics (AP3) platform for the discovery, design, and development of drug candidates through a mechanistic match to patients whose disease is predicted sensitive to the specific treatment, today announced that the company approved a grant of equity awards under its 2023 Inducement Plan to certain employees. The equity awards were granted in the form of stock options and have a grant date of October 15, 2024.
- 10/16/2024
|
Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- KELOWNA, BC / ACCESSWIRE / October 16, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 1,633,987 shares of common stock at a purchase price of $3.06 per share. In a concurrent private placement, the Company issued unregistered warrants to purchase up to 4,551,019 shares of common stock at an exercise price of $3.06 per share.
- 10/16/2024
|
Wrap Technologies, Inc. Regains Nasdaq Listing Requirements Compliance
- TEMPE, Ariz., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (the “Company”), a global leader in innovative public safety solutions, announced today that it received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) regarding periodic reporting.
- 10/16/2024
|
Wednesday Market News: Nasdaq Composite and S&P Futures Up Slightly (J
- As of 8 a.m. ET, indexes are slightly in the green in premarket trading.
- 10/16/2024
|
Versus Systems Enters Agreements with ASPIS Cyber Technologies for Nasdaq Compliance Plan and to Strengthen Compliance and Technology Offerings
- VANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Versus Systems, Inc. (NASDAQ: VS) (the “Company”) announced today the execution of two significant agreements with Aspis Cyber Technologies, Inc. (“ASPIS”), a cloud-based mobile endpoint cybersecurity technology firm.
- 10/16/2024
|
authID Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Denver, Oct. 15, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of secure identity verification and authentication solutions, today announced that the Compensation Committee of the Company approved the grant of options as an inducement to new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/15/2024
|
Nasdaq leads stock declines as Nvidia, chip stocks sell off
- To get the latest market news check out finance.yahoo.com US stocks closed lower on Tuesday as investors reacted to downbeat earnings from ASML Holding (ASML) that dropped a day earlier than expected, sending chipmaker stocks lower across the board. Shares of the leading semiconductor supplier sank more than 15% after its earnings, released in an apparent error, showed a disappointing sales outlook for 2025.
- 10/15/2024
|
Ribbon Communications Announces Inducement Equity Grants to John Townsend Under Nasdaq Listing Rule 5635(c)(4)
- PLANO, Texas , Oct. 15, 2024 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications technology and IP optical networking solutions to many of the world's largest service providers, enterprises, and critical infrastructure operators to modernize and protect their networks, today announced that, in connection with his appointment as Chief Financial Officer, the Board of Directors has awarded John Townsend, as inducement awards, sign-on equity grants consisting of one time-based vesting grant of restricted share units ("RSUs") and two performance-based vesting grants of restricted share units ("PSUs"). Subject to Mr.
- 10/15/2024
|
Biodexa Announces Successful Appeal of Nasdaq Delisting
- Exhibit 99.1 October 15, 2024 Biodexa Announces Successful Appeal of Nasdaq Delisting Biodexa Pharmaceuticals PLC. (the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announced today that a Nasdaq Hearings Panel (the “Panel”) has granted the Company's request for an extension of time to demonstrate compliance with the $1.00 minimum bid price requirement for continued listing on Nasdaq Stock Market LLC (“Nasdaq”) set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).
- 10/15/2024
|
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
- U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 150 points on Tuesday.
- 10/15/2024
|
Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market
- NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that on October 14, 2024, Seelos Therapeutics, Inc. (the "Company") received notice that the Nasdaq Hearings Panel (the "Panel") had determined to delist the Company's common stock from The Nasdaq Stock Market LLC ("Nasdaq") due to the Company's failure to comply with the minimum stockholder's equity requirement under Nasdaq Listing Rule 5550(b)(1) (the "Equity Standard Rule"). As previously disclosed, the Panel had provided the Company until October 11, 2024, to regain compliance with the Equity Standard Rule.
- 10/15/2024
|
Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has entered into a definitive agreement for the purchase and sale of 1,633,987 shares of common stock at a purchase price of $3.06 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company will issue unregistered warrants to purchase up to 4,551,019 shares of common stock at an exercise price of $3.06 per share.
- 10/15/2024
|
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
- Wall Street mood has become circumspect as traders gear up to receive a slew of earnings reports this week amid the market's record run. The Nasdaq Composite has been a laggard among the major averages and it remains to be seen if the early sentiment reverses and tech stocks could finish the session with a flourish.
- 10/15/2024
|
Nasdaq-100 Income ETF QQQI Crosses $500 Million
- Launched at the end of January, the NEOS Nasdaq 100 High Income ETF (QQQI) recently crossed $500 million in AUM. The fund remains a consistent performer within its category, offering high income and tax efficiency within the Nasdaq-100 Index.
- 10/14/2024
|
Stock Market Today: Nasdaq Composite Rises As NVIDIA & AI Stocks Soar
- At market open, key indexes are generally showing green. Shortly after 9:30 a.m.
- 10/14/2024
|
Sharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective Date
- NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it will effect a one-for-22 reverse stock split (the "reverse split") of its common stock, par value $0.0001 per share (the "Common Stock"), that will become effective on October 15, 2024 at 11:59 PM Eastern Time, before the opening of trading on The Nasdaq Capital Market ("Nasdaq"). Sharps has requested that its Common Stock begin trading on October 16, 2024, on a post-reverse split basis on the Nasdaq under the existing symbol "STSS".
- 10/14/2024
|
CeriBell IPO: Stock price will be closely watched today as the AI brain-monitoring headband maker debuts on the Nasdaq
- CeriBell, a neurodiagnostic startup known for its brain-monitoring headband that can detect seizure activity, is making its market debut on Friday in an IPO that is expected to generate $180.3 million in proceeds. Here's what to know about the medtech company and its initial public offering:
- 10/11/2024
|
eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- AUSTIN, Texas, Oct. 11, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace (the "Company"), today announced that on October 9, 2024, the Compensation Committee of its Board of Directors granted inducement stock unit awards to two new employees covering an aggregate of 24,000 shares of the Company's common stock. Each of these awards was granted under the Company's Amended and Restated 2021 Inducement Plan (the "Inducement Plan") and otherwise will be subject to the terms and conditions of a stock unit agreement under the Inducement Plan.
- 10/11/2024
|
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/11/2024
|
X3 Holdings Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price Requirement
- SINGAPORE , Oct. 11, 2024 /PRNewswire/ -- X3 Holdings Co., Ltd. (Nasdaq: XTKG) (the "Company" or "XTKG"), a global provider of digital solutions and technology services spanning diverse industries, today announced that it has received an extension of 180 calendar days from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the "Bid Price Requirement").
- 10/11/2024
|
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, CA / ACCESSWIRE / October 11, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective October 7, 2024, the Company granted 80,000 restricted stock units (RSUs) to New Employee 1 and 15,000 RSUs to each of four other new employees ("New Employees 2-5"). The RSUs for New Employee 1 vest equally over three years, with one-third of the shares vesting each year starting from New Employee 1's date of hire.
- 10/11/2024
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 265,000 shares of the Company's common stock to two new employees (the “Inducement Grants”) on October 10, 2024 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/11/2024
|
Upstream Bio valued at $1.1 bln as shares jump in Nasdaq debut
- Shares of Upstream Bio opened 26.5% above the initial public offering price in their Nasdaq debut on Friday, valuing the drug developer at $1.05 billion.
- 10/11/2024
|
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company's Board of Directors granted non-qualified stock options to purchase an aggregate of 95,000 shares of the Company's stock (the “Inducement Grants”) to newly hired employees on October 8, 2024 (the “Grant Date”), in connection with the commencement of employment. Included in the aggregate number is the grant of an option to purchase 75,000 shares to Dr. Hardean Achneck, in connection with the commencement of his role as Chief Medical Officer.
- 10/11/2024
|
FangDD Regains Compliance with Nasdaq Minimum Bid Price Requirement
- SHENZHEN, China, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (“FangDD” or the “Company”) (Nasdaq: DUO) today announced that the Company received a notification letter (the “Compliance Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), dated October 10, 2024, indicating that the Company regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).
- 10/11/2024
|
Nano Labs Resolves Nasdaq Minimum Market Value of Publicly Held Shares Deficiency
- HANGZHOU, China, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading fabless integrated circuit design company and product solution provider in China, announced today that it received a written notice from the Listing Qualifications Staff of Nasdaq on October 10, 2024, notifying the Company that it has regained compliance with the minimum market value of publicly held shares (“MVPHS”) requirement under Nasdaq Listing Rule 5450(b)(2)(C) (the “Rule”).
- 10/11/2024
|
U.S. Energy Corp. Regains Full Compliance with Nasdaq Listing Standards
- HOUSTON, Oct. 11, 2024 (GLOBE NEWSWIRE) -- U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”) a growth-focused company engaged in the operation and development of high-quality producing energy assets, today announced that on October 10, 2024, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that Nasdaq has determined that the Company has regained compliance with the minimum bid price rule and that the Company is in compliance with all applicable listing standards. Accordingly, the matter is now closed.
- 10/11/2024
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 10/10/2024
|
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- HOUSTON, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it has closed its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of an aggregate of 4,597,702 shares of its common stock (or common stock equivalents in lieu thereof), series A warrants to purchase up to 6,407,657 shares of common stock and short-term series B warrants to purchase up to 6,407,657 shares of common stock at a purchase price of $0.87 per share of common stock (or per common stock equivalent in lieu thereof) and accompanying warrants in a private placement. The series A warrants and short-term series B warrants have an exercise price of $1.00 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants (the “Stockholder Approval Date”). The series A warrants will expire five years from the Stockholder Approval Date and the short-term series B warrants will expire twenty-four months from the Stockholder Approval Date.
- 10/10/2024
|
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted non-qualified stock option awards to purchase an aggregate of 258,800 shares of its common stock to twenty-seven new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/10/2024
|
Delisting of Securities of Gamer Pakistan Inc.; Biotricity, Inc.; Zalatoris II Acquisition Corp.; Warrantee Inc.; Spectaire Holdings, Inc.; Centogene N.V.; DZS Inc.; Corner Growth Acquisition Corp. 2; Collective Audience, Inc.; Grom Social Enterprises Inc.; Fintech Ecosystem Development Corp.; Edgio, Inc.; Kineta, Inc.; BurgerFi International Inc.; A SPAC II Acquisition Corp.; and African Agriculture Holdings Inc. from The Nasdaq Stock Market
- NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Gamer Pakistan Inc. Gamer Pakistan Inc.'s securities were suspended on August 5, 2024, and have not traded on Nasdaq since that time.
- 10/10/2024
|
Nasdaq Rises to 5th in RiskTech100 Global Ranking Following Launch of Financial Technology Division
- Announcement comes ahead of the first anniversary of Nasdaq's acquisition of Adenza Nasdaq also wins two awards for its financial crime management and regulatory reporting technology NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced it has jumped to 5th place in Chartis' annual RiskTech100® global ranking and has won two awards for its financial crime management and regulatory reporting technology. The news comes less than a year after Nasdaq's acquisition of Adenza and the establishment of its Financial Technology division.
- 10/10/2024
|
Edible Garden Regains Compliance with Nasdaq Continued Listing Requirements
- BELVIDERE, NJ, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that it received notice from The Nasdaq Stock Market on October 9, 2024, indicating that Edible Garden had regained compliance with the minimum stockholders' equity requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(1).
- 10/10/2024
|
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
- You might be surprised by who tops this list.
- 10/10/2024
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date September 30, 2024
- NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of September 30, 2024, short interest in 3,067 Nasdaq Global MarketSM securities totaled 12,246,444,747 shares compared with 12,241,625,467 shares in 3,057 Global Market issues reported for the prior settlement date of September 13, 2024. The mid-September short interest represents 2.94 days compared with 3.06 days for the prior reporting period.
- 10/09/2024
|
Primis Financial Corp. Provides Progress Report on Filings and Compliance with Nasdaq Listing Requirements
- MCLEAN, Va. , Oct. 9, 2024 /PRNewswire/ -- Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") today provided an update on its delinquent filings and process for regaining compliance with Nasdaq listing requirements.
- 10/09/2024
|
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced that it has agreed to grant inducement awards to its newly appointed Chief Legal Officer, Todd D.C. Anderman. The awards were made as inducements material to Mr. Anderman's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/09/2024
|
Nasdaq 100 Forecast: Alphabet Falls on DOJ News, Tech Stocks Under Pressure
- Tech stocks drag U.S. indices lower as Alphabet falls on DOJ action. Investors await Fed minutes for clues on future rate hikes and market direction.
- 10/09/2024
|
Alternus Clean Energy announces reverse stock split to meet Nasdaq requirements
- Alternus Clean Energy Inc (NASDAQ:ALCE, OTC:ACLEW) announced that it will be implementing a 1-for-25 reverse stock split as part of its efforts to regain compliance with the $1 minimum bid price requirement for the Nasdaq Capital Market. It is expected the company's stock will start trading on a post-split basis at the opening of the market on October 11 under its existing ticker symbol “ALCE.
- 10/09/2024
|
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
- PALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180"), is pleased to announce that it has received confirmation from Nasdaq that the Company has officially regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders' equity of $2,500,000. With this important achievement, the Company can now fully focus on developing its newly announced iGaming business, while also continuing to advance its legacy biotechnology programs.
- 10/09/2024
|
Alternus Clean Energy, Inc. Announces 1-for-25 Reverse Stock Split as Part of Nasdaq Compliance Plan
- Fort Mill, South Carolina--(Newsfile Corp. - October 9, 2024) - Alternus Clean Energy Inc. (NASDAQ: ALCE) ("Alternus"), a leading utility-scale transatlantic, clean energy independent power producer (IPP), today announced that it will effect a 1-for-25 reverse stock split of its common stock. The reverse stock split will become effective at 12:01 a.m.
- 10/09/2024
|
Baird Medical Lists in the U.S. on the Nasdaq Exchange
- Company Rings Opening Bell to Celebrate Closure of Business Combination and Begins Journey as a Public Company; Shares trade under "BDMD" Ticker FORT MILL, S.C. , Oct. 9, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd.
- 10/09/2024
|
Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day
- SOUTH SAN FRANCISCO, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development of groundbreaking therapies for psychiatric disorders based on nose-to-brain neurocircuitry, and The Goldie Hawn Foundation's MindUP, a neuroscience-based preventative mental health program for youth, along with children from New York City schools utilizing MindUP, will join together in New York City on Oc.
- 10/09/2024
|
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 4,597,702 shares of its common stock (or common stock equivalents in lieu thereof), series A warrants to purchase up to 6,407,657 shares of common stock and short-term series B warrants to purchase up to 6,407,657 shares of common stock at a purchase price of $0.87 per share of common stock (or per common stock equivalent in lieu thereof) and accompanying warrants in a private placement priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants will have an exercise price of $1.00 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants (the “Stockholder Approval Date”). The series A warrants will expire five years from the Stockholder Approval Date and the short-term series B warrants will expire twenty-four months from the Stockholder Approval Date. The closing of the offering is expected to occur on or about October 10, 2024, subject to the satisfaction of customary closing conditions.
- 10/08/2024
|
Chinese Tech Stocks Slump as Nasdaq's Golden Dragon Index Dips
- On Tuesday, major Chinese stocks experienced significant declines, leading to a 6.85% drop in the Nasdaq Golden Dragon China Index (HXC). Among those showing gains, Taiwan Semiconductor Manufacturing (TSM) rose by 0.86%, WSP Global (WSP) increased by 1.08%, and RLX Technology (RLX) edged up by 0.53%.
- 10/08/2024
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on October 3, 2024, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 111,631 shares of common stock and 30,484 restricted stock units (“RSUs”) to thirteen new employees under Acadia's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees'.
- 10/08/2024
|
Nasdaq Resumes Trading in BAIYU Holdings, Inc.
- NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume in BAIYU Holdings, Inc. (Nasdaq: BYU) at 9:00 a.m. Eastern Time on October 9, 2024. Trading in the company's stock was halted on September 5, 2024 at 7:50 p.m. Eastern Time.
- 10/08/2024
|
Nasdaq Surges Over 1%; DocuSign Shares Spike Higher
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 1% on Tuesday.
- 10/08/2024
|
Inno Holdings Inc. Announces 1-for-10 Reverse Stock Split
- BROOKSHIRE, TX / ACCESSWIRE / October 8, 2024 / Inno Holdings Inc. ("Inno" or the "Company") (Nasdaq Capital Market:INHD), an innovative building-technology company with a mission to transform the construction industry with our proprietary cold-formed steel-framing technology and other building innovations, today announced that the Company's board of directors (the "Board") approved a reverse stock split (the "Reverse Stock Split") of Inno's common stock, no par value (the "Common Stock"), at a ratio of 1-for-10 (the "Reverse Stock Split Ratio"). The Reverse Stock Split is expected to become effective immediately after the close of trading on the Nasdaq Capital Market (the "Nasdaq") on October 9, 2024 (the "Effective Time"), and Inno's Common Stock is expected to begin trading on the Nasdaq on a split-adjusted basis at the opening of trading on October 10, 2024, under the existing ticker symbol "INHD".
- 10/08/2024
|
Nasdaq Golden Dragon Index Sees Largest Drop Since March 2023 as Chinese Stocks Decline
- The Nasdaq Golden Dragon China Index took a significant hit, dropping 5.4% in its initial trading phase, marking its steepest decline since March 2023. This downturn affected numerous popular Chinese stocks.
- 10/08/2024
|
Nasdaq 100 and S&P 500: Tech Stocks Lead Today's Rebound Amid Volatile Oil Prices
- Tech stocks lead market recovery after Monday's dip, while oil prices fall. Find out how rising bond yields and geopolitical risks impact US indices today.
- 10/08/2024
|
22nd Century Regains Compliance with Nasdaq Stockholders' Equity Requirement
- Mocksville, North Carolina--(Newsfile Corp. - October 8, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it has received formal written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the minimum stockholders' equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule"). This confirmation follows the Company's successful efforts to improve its balance sheet and liquidity by completing new equity offerings, while reducing outstanding liabilities and debt through various forms of settlement with creditors.
- 10/08/2024
|
Nasdaq Launches PureStream in Europe – A new tool for trajectory trading
- STOCKHOLM, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the planned launch of PureStream, a new volume-based trajectory trading solution giving clients access to EU shares on Nasdaq Europe*. PureStream is already available in the US and Canada and is expected to launch on Nasdaq Europe in Q1 2025, pending regulatory approval.
- 10/08/2024
|
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective October 4, 2024, to five new non-executive employees of non-qualified stock opti.
- 10/07/2024
|
Nasdaq Reports September 2024 Volumes and 3Q24 Statistics
- NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for September 2024, as well as quarterly volumes, estimated revenue capture, number of listings, and index statistics for the quarter ended September 30, 2024, on its Investor Relations website.
- 10/07/2024
|
Luna Innovations Announces Receipt of Nasdaq Staff Determination Letter
- ROANOKE, Va,--(BUSINESS WIRE)--Luna Innovations Incorporated (Nasdaq: LUNA) (the “Company”), a global leader in advanced fiber optic-based technology, today announced that on October 1, 2024, it received a staff determination letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to the Company's failure to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companie.
- 10/07/2024
|
Nasdaq: Tailwinds In IPO Activity And Software Company Acquisitions
- Nasdaq's diversified business model, with strong segments in Capital Access Platforms, Financial Technology, and Market Services, ensures stable revenue and hedges against downturns. The IPO market is expected to rebound, potentially adding $200 million to Nasdaq's revenue and $1.2 billion in value. Recent acquisitions like Verafin and Adenza enhance Nasdaq's regulatory tech and financial crime management, boosting recurring revenue and growth prospects.
- 10/07/2024
|
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
- ATLANTA and VANCOUVER, British Columbia, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (NASDAQ: VIRI) (the “Company”), and Wex Pharmaceuticals, Inc. (“WEX”), a wholly owned subsidiary of CK Life Sciences Int'l., (Holdings) Inc. (“CKLS”), today announced that Virios has entered into a definitive share exchange agreement with Sealbond Limited, an indirect parent of Wex, pursuant to which the companies will combine in an all-stock transaction (the “Combination”).
- 10/07/2024
|
Meihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
- YANGZHOU, China , Oct. 7, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that on October 3, 2024, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement").
- 10/07/2024
|
Strong Performance by Nasdaq Golden Dragon China Index and Related ETFs
- During China's "Golden Week" holiday, overseas Chinese stocks and funds experienced notable gains. The Nasdaq Golden Dragon China Index increased by 3.1%, reaching its highest level since February 2, 2023, with a weekly gain of 11.9%.
- 10/06/2024
|
You'll Never Guess the Best-Performing Stock in the Nasdaq-100 Last Quarter. Is It Still a Buy?
- Hint: It wasn't Nvidia.
- 10/05/2024
|
Is It Time to Buy September's Worst-Performing Nasdaq Stocks?
- September is typically a bad month for stocks, but the Nasdaq still gained.
- 10/05/2024
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 100,000 of NewAmsterdam's ordinary shares to one non-executive new hire. The share options were granted as an inducement material to the employee's acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/04/2024
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 249,550 shares of common stock. Awards were made to ten new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committe.
- 10/04/2024
|
Urgently Notified By Nasdaq Of Non-Compliance With Nasdaq Minimum Bid Price Requirement
- Intends to Cure the Deficiency and Return to Compliance with Nasdaq Standard Intends to Cure the Deficiency and Return to Compliance with Nasdaq Standard
- 10/04/2024
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on October 2, 2024, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 125,000 shares of Class A common stock and restricted stock units (RSUs) for 62,500 shares of Class A common stock to seven new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/04/2024
|
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a grant date of October 1, 2024, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 2020 Inducement Stock Incentive Plan) and material to the employees' acceptance of employment with the company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/04/2024
|
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Compensation Committee of the Company's Board of Directors approved the grant of inducement awards of 242,500 restricted stock units (RSUs). This includes the previously disclosed 100,000 RSUs granted to the Company's CFO, James Sterling, with a grant date of September 30, 2024 and 142,500 RSUs granted to 19 other employees, with a grant date of October 1, 2024 (collectively, the “Inducement Grants”).
- 10/04/2024
|
Altamira Therapeutics Provides Update on Nasdaq Listing
- Hamilton, Bermuda, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO) today announced that it received on September 30, 2024, a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that it no longer complied with Rule 5550(a)(2) of Nasdaq's Listing Rules, which requires listed securities to maintain a minimum bid price of $1.00 per share, because the bid price of the Company's listed securities has closed at less than $1.00 per share over the previous 30 consecutive business days, from August 16, 2024 through September 27, 2024. The letter stated that the Company is not eligible for any cure period due to the fact that the Company effectuated one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one. The Company intends to appeal this determination to a hearing panel (the “Panel”). The hearing request will result in a stay of any suspension or delisting action pending the hearing. There can be no assurance that the Panel will grant the Company's request for continued listing or that any extension will be granted by the Panel.
- 10/04/2024
|
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on October 1, 2024, Anika granted non-statutory stock options (“Options”) covering an aggregate of 6,350 shares of common stock at a per share exercise price of $24.27, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation.
- 10/04/2024
|
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of 3,500 restricted stock units of Atara's common stock to one newly hired employee. This award was approved by the Compensation Committee of Atara's Board of Directors and granted under the Atara.
- 10/04/2024
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 95,000 restricted stock units of Arcutis' common stock as well as options to purchase an aggregate of 38,000 shares of Arcutis' common stock to 11 newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of October 1, 2024, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/04/2024
|
Nasdaq Gains Over 100 Points; Beneficient Shares Spike Higher
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Friday.
- 10/04/2024
|
China's BingEx opens flat in Nasdaq debut
- China's BingEx notched a valuation of $1.17 billion in its Nasdaq debut on Friday, after shares of the courier delivery firm traded in line with its initial public offering price.
- 10/04/2024
|
Vision Marine Technologies Granted Extension for Continued Listing on the Nasdaq Stock Market
- Vision Marine Announces Reverse Stock Split to Regain Nasdaq Compliance MONTREAL, QC / ACCESSWIRE / October 4, 2024 / Vision Marine Technologies Inc. (the "Company") (NASDAQ:VMAR), a pioneer in electric marine propulsion, today announced that it has received an extension from the Nasdaq Hearings Panel to continue its listing on the Nasdaq Capital Market. This extension allows the Company additional time to regain compliance with Nasdaq's continued listing requirements, subject to meeting specific compliance criteria within designated timeframes.
- 10/04/2024
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on October 1, 2024, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 501,600 shares of the Company's common stock in connection with their employment. The stock option was granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individual entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/04/2024
|
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on October 1, 2024 it awarded inducement grants to nine new employees under Intellia's 2024 Inducement Plan as a material inducement to employment.
- 10/03/2024
|
Nasdaq Moves Lower; Levi Strauss Shares Slide
- U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday.
- 10/03/2024
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted 21 newly-hired employees stock options to purchase an aggregate of 71,175 shares, and restricted stock units (RSUs) covering an aggregate of 50,025 shares, of BioCryst common stock. The options and RSUs were granted as of September 30, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/03/2024
|
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
- Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories IRVINE, Calif., Oct. 02, 2024 – Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with new and existing investors, including Bio-Rad Laboratories, Inc.
- 10/02/2024
|
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
- Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories
- 10/02/2024
|
Innventure LLC and Learn CW Investment Corporation Announce Closing of Business Combination
- Innventure Common Stock Expected to Begin Trading on October 3, 2024, on the Nasdaq Global Market Under Ticker Symbol “INV” Innventure Common Stock Expected to Begin Trading on October 3, 2024, on the Nasdaq Global Market Under Ticker Symbol “INV”
- 10/02/2024
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers, today announced that the Company granted stock options to three new employees to purchase an aggregate of 118,800 shares of the Company's common stock, effective as of October 1, 2024. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan, with a grant date of October 1, 2024, as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/02/2024
|
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass. and DUBLIN, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that on October 1, the Company granted to three newly hired employees (i) non-statutory stock options to purchase an aggregate of 28,525 ordinary shares of the Company and (ii) restricted stock units with respect to an aggregate of 14,975 ordinary shares of the Company, pursuant to the Company's 2024 Inducement Stock Option and Incentive Plan, each as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/02/2024
|
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CHARLESTOWN, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 51,338 restricted stock units (“RSUs”) to three newly hired employees.
- 10/02/2024
|
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective October 1, 2024, the Compensation Committee of the Board of Directors granted non-qualified stock options to purchase an aggregate of 101,000 shares of its common stock to three new employees under Xilio Therapeutics' 2022 Inducement Stock Incentive Plan.
- 10/02/2024
|
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 52,000 shares of Astria's common stock on October 1, 2024 under Astria's 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were gran.
- 10/02/2024
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on September 30, 2024, the company granted equity awards to five new employees, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/02/2024
|
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on October 1, 2024 the Company granted restricted stock units (RSUs) representing 16,400 shares of its common stock to two newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.
- 10/02/2024
|
Nasdaq Trading Near 52-Week High: How Should You Play the Stock?
- NDAQ is poised to gain from impressive organic growth, strategic buyouts to capitalize on growing market opportunities and effective capital deployment.
- 10/02/2024
|
Banzai Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
- SEATTLE, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Hearings Panel has granted the Company's request to continue its listing on The Nasdaq Stock Market, subject to the Company meeting certain conditions, including filing on or before October 7, 2024, an application for listing on The Nasdaq Capital Market, and demonstrating compliance on or before January 31, 2025 with Listing Rules 5550(a)(2), 5550(a)(5) and 5550(b)(1). The Company is in violation of the bid price requirement of Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Rule”) and the market value of listed securities (“MVLS”) requirement in Listing Rule 5450(b)(2)(A) (the “MVLS Rule”).
- 10/02/2024
|
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted six newly-hired employees inducement options to purchase an aggregate of 31,000 shares of KalVista common stock on October 1, 2024 as inducements material to each employee entering into employment with KalVista. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an.
- 10/02/2024
|
Nasdaq Ends 1.5% Lower As Tesla, Nvidia, And Apple Fall: Investor Optimism Declines, Fear Index Remains In 'Greed' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Greed” zone on Tuesday.
- 10/02/2024
|
Mitek Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Mitek Systems, Inc. (NASDAQ: MITK), a global leader in digital identity verification, mobile capture, and fraud management solutions, announced today it granted equity awards as a material inducement to the employment of the company's newly-hired Chief Executive Officer, Edward H. West. The overarching philosophy in the design of Mr. West's compensation package was an emphasis on equity-based compensation directly tied to building stockholder value in lieu of signifi.
- 10/01/2024
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. , Oct. 1, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to purchase an aggregate of 111,600 shares of Akebia's common stock on September 30, 2024.
- 10/01/2024
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , Oct. 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 17,000 restricted stock units (RSUs) to three newly-hired employees.
- 10/01/2024
|
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Oct. 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on September 30, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 744,468 shares of X4's common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by X4's Compensation Committee of the Board of Directors.
- 10/01/2024
|
Nasdaq Drops Today While One Large Stock Gains
- As of the middle of the trading today, the Nasdaq Composite (^IXIC) is down 2.1% on news from the Middle East escalating, which is causing an oil price spike, combined with the port workers strike.
- 10/01/2024
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 10/01/2024
|
Sagimet Biosciences to Present at the H.C. Wainwright 8th Annual MASH Virtual Conference and Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN MATEO, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced that management will participate in a virtual fireside chat at the H.C. Wainwright 8th Annual MASH Virtual Conference at 2:30 PM ET on Monday, October 7, 2024.
- 10/01/2024
|
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on September 30, 2024. Four individuals were hired by Adicet in September 2024. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 33,600 shares of Adicet's common stock with an exercise price of $1.
- 09/30/2024
|
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on September 30, 2024 it granted stock options to purchase an aggregate of 120,000 shares of common stock upon vesting to Gary Palmer, M.D., the Company's newly appointed Senior Vice President of Medical Affairs as a material inducement to his employment.
- 09/30/2024
|
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on September 30, 2024 (the “Grant Date”) that were previously approved by the Compensation Committee of its Board of Directors under Sarepta's 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 28 individuals hired by Sarepta in September 2024. The equity awards were approved in accordance with Nasdaq L.
- 09/30/2024
|
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- WATERTOWN, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase 146,880 shares of the Company's common stock to one new employee (the “Inducement Grant”), with the grant made on September 30, 2024 (the “Grant Date”). The Inducement Grant was granted as a material inducement to this individual entering into employment with C4T in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/30/2024
|
S&P 500 ETF Titans Drive $691B In 2024 Inflows: Nasdaq, Bitcoin ETFs Close Behind
- The U.S. exchange-traded fund (ETF) market has reached a monumental milestone, surpassing $10 trillion in assets.
- 09/30/2024
|
111, Inc. Announces Receipt of Notification from Nasdaq
- SHANGHAI , Sept. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced it has received a notification letter dated September 26, 2024 (the "Notice") from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), indicating that for the last 30 consecutive business days, the closing bid price of the Company's American depositary shares (the "ADSs") was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5450(a)(1).
- 09/27/2024
|
Ensysce Biosciences Receives Notice from Nasdaq
- SAN DIEGO, CA / ACCESSWIRE / September 27, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, has received notice from the listing qualifications department staff of The Nasdaq Stock Market ("Nasdaq") stating that the Company has not regained compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price for the Company's common stock has remained below $1.00 per share through the initial 180-day compliance period ended September 23, 2024. The Company is not eligible for a second 180-day period because it does not comply with the minimum stockholders' equity requirement for initial listing on The Nasdaq Capital Market.
- 09/27/2024
|
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DELRAY BEACH, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), today announced that on September 27, 2024, PetMeds granted two equity awards previously approved by its Board of Directors to two newly hired executives as a material inducement to employment.
- 09/27/2024
|
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
- – Financing strengthens balance sheet and is expected to provide sufficient cash runway through June 2026 – – Retiring $17.5 million in Avenue Capital debt, aided by $11.5 million in new debt from insider-led group; eliminates $12 million in scheduled debt payments through June 2026 – – Avenue Capital, current insiders, and select group of healthcare-focused investment funds participated in the equity offering – GARDEN CITY, N.Y., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients, today announced that it has entered into a securities purchase agreement with certain institutional and accredited investors, as well as Company insiders.
- 09/27/2024
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , Sept. 27, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on September 26, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 140,000 shares of the Company's common stock to a newly hired employee.
- 09/27/2024
|
Banzai Announces Closing of $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- SEATTLE, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced the closing of its previously announced private placement priced at-the-market under the rules of the Nasdaq Stock Market for the issuance and sale of an aggregate of 1,176,471 shares of Class A common stock (or pre-funded warrant in lieu thereof), accompanying Series A warrants to purchase up to 1,176,471 shares of Class A common stock and accompanying short-term Series B warrants to purchase up to 1,176,471 shares of Class A common stock at a purchase price of $4.25 per share (or per pre-funded warrant in lieu thereof).
- 09/26/2024
|
Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer indications, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 1,219,513 shares of its common stock (or pre-funded warrants in lieu thereof), accompanying Series A warrants to purchase up to 1,219,513 shares of common stock and accompanying short-term Series B warrants to purchase up to 1,219,513 shares of common stock at a purchase price of $4.10 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants in a private placement priced at-the-market under the rules of the Nasdaq Stock Market. The Series A and the short-term Series B warrants will have an exercise price of $3.85 per share and will be exercisable immediately upon issuance. The Series A warrants will expire five years from the issuance date and the short-term Series B warrants will expire 18 months from the issuance date. The closing of the offering is expected to occur on or about September 30, 2024, subject to the satisfaction of customary closing conditions.
- 09/26/2024
|
Voyager Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about September 30, 2024
- BROOKLYN, N.Y., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Voyager Acquisition Corp. (Nasdaq: VACHU) (the “Company”) announced that holders of the units sold in the Company's initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the exercise by the underwriters of their overallotment option, completed on August 12, 2024 (the “Offering”) may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about September 30, 2024. Any units not separated will continue to trade on The Nasdaq Global Market under the symbol “VACHU”, and each of the Class A ordinary shares and warrants will separately trade on The Nasdaq Global Market under the symbols “VACH” and “VACHW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into Class A ordinary shares and warrants.
- 09/26/2024
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on September 23, 2024, the Board of Directors granted Catherine Owen Adams, Acadia's new Chief Executive Officer, a one-time sign-on equity award of (i) 353,261 options to purchase shares of Acadia's common stock with an exercise price of $16.29 per share, Acadia's closing trading price on September 23, 2024, which vest 25% on the first anniversary of grant and in equal monthly installments over the thre.
- 09/26/2024
|
Foxx Development Closes Business Combination with Acri Capital Acquisition Corporation and Will Begin Trading on Nasdaq
- Business Combination between Foxx Development Inc. and Acri Capital Acquisition Corporation closed on September 26, 2024 Trading of common stock and warrants of the new public company, Foxx Development Holdings Inc., commence on Nasdaq on September 27, 2024 under the ticker symbols "FOXX" and "FOXXW" Austin, TX, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Foxx Development Holdings Inc. (Nasdaq: FOXX), a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients, today announced the successful closing of the previously announced business combination (“the Business Combination”) between Foxx Development Inc. (“Foxx”) and Acri Capital Acquisition Corporation (“Acri”), a publicly traded special purpose acquisition company.
- 09/26/2024
|
Nasdaq Q3 Preview: Improving IPO Activity Could Start In H1 FY25
- Nasdaq's Solutions business continues to show double-digit growth, driven by strong ARR and increasing SaaS revenue, supporting a 'Strong Buy' rating with a fair value of $95 per share. The acquisition of Adenza is expected to significantly boost Nasdaq's software revenue mix and contribute to the sustained growth of the Solutions business. With the Fed entering an interest rate cut cycle, I anticipate a recovery in Nasdaq's Listing business in FY25, further enhancing overall growth.
- 09/26/2024
|
BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq
- BioAge Labs is having its initial public offering today. The drug developer's signature product, Azelaprag, isn't yet on sale, but it is undergoing clinical trials in hopes it will one day be.
- 09/26/2024
|
Nasdaq set to lead Wall Street higher as Micron fuels AI stocks
- Wall Street was set for a bright start on Thursday, with the Nasdaq expected to jump at the open following well-received earnings from Micron Technology Inc (NASDAQ:MU). Futures had the Nasdaq adding 1.5% ahead of the bell, while the Dow Jones and S&P 500 were seen 0.4% and 0.8% higher respectively.
- 09/26/2024
|
Nasdaq Expands Presence in Latin America With New Agreement
- Nasdaq extends agreement with Nubank to provide AxiomSL regulatory reporting solution to the later and expands presence in Latin America.
- 09/25/2024
|
HeartCore's Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange
- Company anticipates Q3 2024 revenue to be between $19 million-$23 million and net profit to be between $4 million-$8 million Company anticipates Q3 2024 revenue to be between $19 million-$23 million and net profit to be between $4 million-$8 million
- 09/25/2024
|
Big Tree Cloud Holdings Limited Resolves Nasdaq Minimum Market Value of Publicly Held Shares Deficiency and Regains Compliance with Nasdaq Listing Requirements
- SHENZHEN, China , Sept. 25, 2024 /PRNewswire/ -- Big Tree Cloud Holdings Limited ("Big Tree Cloud" or the "Company") (NASDAQ: DSY) (NASDAQ: DSYWW), a company devoted to the development, production, and sales of personal care products and other consumer goods in China, today announced that it has received a written notice from the Listing Qualifications Staff of Nasdaq On September 23, 2024, notifying the Company that it has regained compliance with the minimum market value of publicly held shares ("MVPHS") requirement under Nasdaq Listing Rule 5450(b)(2)(C) (the "Rule").
- 09/25/2024
|
District Provides Notice to Shareholders who Seek to Transfer Shares in Preparation for Nasdaq First North Growth Listing
- Vancouver, British Columbia--(Newsfile Corp. - September 25, 2024) - District Metals Corp. (TSXV: DMX) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company") is pleased to provide notice to shareholders who would like to transfer their common shares in the Company from the TSX Venture Exchange ("TSXV") to Swedish depository receipts ("SDRs"), financial instrument issued by a Swedish bank representing shares in a non-Swedish company. The Company is currently in the process of preparing for a potential secondary listing on the Nasdaq First North Growth Market ("Nasdaq First North") in Sweden.
- 09/25/2024
|
Banzai Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- SEATTLE, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 1,176,471 shares of Class A common stock (or pre-funded warrant in lieu thereof), accompanying Series A warrants to purchase up to 1,176,471 shares of Class A common stock and accompanying short-term Series B warrants to purchase up to 1,176,471 shares of Class A common stock at a purchase price of $4.25 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants in a private placement priced at-the-market under the rules of the Nasdaq Stock Market. The Series A and the short-term Series B warrants will have an exercise price of $4.00 per share and will be exercisable immediately upon issuance. The Series A warrants will expire five years from the issuance date and the short-term Series B warrants will expire 18 months from the issuance date. The closing of the offering is expected to occur on or about September 26, 2024, subject to the satisfaction of customary closing conditions.
- 09/24/2024
|
Nasdaq Leads Another Stock Market Advance; TSMC Scores Breakout As Nvidia Awakes From Slumber
- The Nasdaq reversed higher above the 18,000 level in the stock market Tuesday, helped by strength in Taiwan Semiconductor and Nvidia.
- 09/24/2024
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date September 13, 2024
- NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of September 13, 2024, short interest in 3,057 Nasdaq Global MarketSM securities totaled 12,241,625,467 shares compared with 12,296,040,928 shares in 3,037 Global Market issues reported for the prior settlement date of August 30, 2024. The mid-September short interest represents 3.06 days compared with 3.38 days for the prior reporting period.
- 09/24/2024
|
BlackRock's Mitchnick on ETF Custody, Nasdaq Listing IBIT Options, Crypto-Stock Correlation
- BlackRock Head of Digital Assets Robbie Mitchnick discusses crypto ETF custody, SEC approving Nasdaq to list IBIT options, crypto-stock correlation and Ether ETFs. He speaks with Sonali Basak and Mike Regan on "Bloomberg Crypto.
- 09/24/2024
|
Nasdaq Surges 100 Points; Thor Industries Earnings Top Views
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Tuesday.
- 09/24/2024
|
Nasdaq to Hold Third Quarter 2024 Investor Conference Call
- NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its third quarter 2024 financial results announcement.
- 09/23/2024
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , Sept. 23, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on September 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 212,000 shares of its common stock and 106,000 restricted stock units ("RSUs") to twenty-one (21) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan").
- 09/23/2024
|
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now
- Corbus Pharmaceuticals Holdings, Inc. CRBP received reaffirmed buy ratings from both H.C. Wainwright and Oppenheimer this week, with analysts citing the company's diversified pipeline as a key driver for future growth, despite a sharp stock decline after Novo Nordisk‘s NVO mid-stage data on its obesity drug.
- 09/23/2024
|
Nasdaq Extends Partnership With Nubank to Grow Latam Banking Presence
- Nasdaq wants to expand its digital bank FinTech presence in Latin America. The tech company agreed to provide its AxiomSL regulatory reporting tool to Nubank, the region's digital banking giant, according to a Monday (Sept.
- 09/23/2024
|
Alternus Clean Energy outlines plan to regain Nasdaq compliance
- Alternus Clean Energy Inc (NASDAQ:ALCE, OTC:ACLEW) announced that it has received a delisting notice from the Nasdaq Stock Market for not meeting the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2). In response, the company plans to appeal the decision and file the necessary appeal within the seven-day window allowed under Nasdaq rules.
- 09/23/2024
|
Nasdaq Expands Digital Bank FinTech Presence in Latin America
- Expanded partnership with Nubank reflects rapid growth of banking and payment services in Latin America Over half of Nasdaq's Latin American banking clients have expanded their technology partnership in the last 12 months Nasdaq's financial technology solutions simplify regulatory compliance and reduce time to market across multiple jurisdictions NEW YORK and SAO PAULO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Nasdaq today announced it has expanded its digital bank financial technology presence in Latin America, having agreed to provide its AxiomSL regulatory reporting solution to Nubank, a leading digital bank with over 100 million customers across Brazil, Mexico, and Colombia.
- 09/23/2024
|
Bull Market Buys: 2 Nasdaq Stocks to Own for the Long Run
- Consumer spending habits have shifted, but essentials like healthcare and key staples remain resilient categories. Intuitive Surgical benefits from market leadership in its niche, a wide moat, and a clever business model.
- 09/21/2024
|
This Metric Says Buy the Dip on These Nasdaq Stocks
- The insatiable demand for data center chips could fuel excellent results for Advanced Micro Devices. Google saw double-digit percentage growth in advertising revenue following the launch of its Gemini AI model.
- 09/21/2024
|
Mobile-health Network Solutions Delinquency Notification Letter From Nasdaq
- SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received a notice dated September 18, 2024, from the Listings Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share of its Class A ordinary shares (“Class A Ordinary Shares”) was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Nasdaq notification letter does not result in the immediate delisting of the Company's Class A Ordinary Shares, and the shares will continue to trade uninterrupted under the symbol “MNDR.”
- 09/20/2024
|
Super Micro Computer, Inc. Announces Receipt of Non-Compliance Letter from Nasdaq
- SAN JOSE, Calif.--(BUSINESS WIRE)--Super Micro Computer, Inc. (NASDAQ:SMCI) (“SMCI” or the “Company”), a Total IT Solution Provider for AI, Cloud, Storage and 5G/Edge, today announced that the Company received a notification letter from Nasdaq stating that the Company is not in compliance with Nasdaq listing rule 5250(c)(1), which requires timely filing of reports with the U.S. Securities and Exchange Commission. The September 17, 2024 letter was sent as a result of the Company's delay in filin.
- 09/20/2024
|
AirNet Announces Receipt of Deficiency Letters from Nasdaq
- BEIJING , Sept. 20, 2024 /PRNewswire/ -- AirNet Technology Inc., formerly known as AirMedia Group Inc. ("AirNet" or the "Company") (Nasdaq: ANTE), today announced that it received two deficiency letters (the "Deficiency Letters") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq") both dated on September 18, 2024 indicating that (1) the Company is no longer in compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules as the Company's closing bid price per American depositary share ("ADS"), each representing one ordinary share of the Company, has been below $1.00 for a period of 30 consecutive business days, and (2) the Company is no longer in compliance with Rule 5550(a)(5) of the Nasdaq Listing Rules for continued listing due to its failure to maintain a minimum Market Value of Publicly Held Shares ("MVPHS") of US$1.0 million for a period of 30 consecutive business days.
- 09/20/2024
|
Smart for Life Provides Update Following Nasdaq Delisting Due to Audit Delays; Reports Plans to Reapply to Nasdaq Upon Full Compliance
- MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today provided an update following its delisting from Nasdaq, which was primarily due to delays in the completion of its audit. The Company's common stock continues to be quoted on the OTC Markets, and the ticker symbol “SMFL” remains unchanged. Management believes this move to the OTC Markets is temporary and the Company plans to reapply for listing as soon as it is fully compliant with the listing requirements.
- 09/20/2024
|
Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company's Board of Directors granted two employees nonqualified stock options to purchase an aggregate of 79,500 shares of its common stock under the Company's 2023 Inducement Plan.
- 09/20/2024
|
InMed Receives NASDAQ Delisting Notice, and Confirms it has Filed an Appeal and Obtained a Panel Hearing Date
- Vancouver, British Columbia--(Newsfile Corp. - September 20, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced that it has timely requested a hearing (the "Hearing") before the Nasdaq Listing Qualifications Panel (the "Panel") to appeal (the "Appeal") the determination by the Listing Qualifications Department (the "Nasdaq Staff") of The Nasdaq Stock Market LLC ("Nasdaq"), and present its plan to regain and sustain compliance with Nasdaq's minimum bid price requirement of at least $1.00 for the continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule"). Nasdaq has notified the Company via electronic mail that the Hearing has been scheduled for October 31, 2024.
- 09/20/2024
|
Maxeon Receives Nasdaq Notification and is Proceeding with Approved Reverse Stock Split
- SINGAPORE , Sept. 20, 2024 /PRNewswire/ -- Maxeon Solar Technologies, Ltd.
- 09/20/2024
|
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted three equity awards, previously approved by the Company's Compensation Committee, as a material inducement to the employment of three individuals whose employment commenced in August 2024. The grants totaled the right to purchase an aggregate of 46,000 s.
- 09/20/2024
|
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody-drug conjugates (ADCs), today announced that on September 16, 2024, the Compensation Committee of Sutro's Board of Directors granted 60,000 restricted stock units (RSUs) of Sutro common stock to a new employee. The grant was made as an inducement material to the employee's acceptance of employment with Sutro and was approved by the Compensation Committee of Sutro's Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/20/2024
|
Alternus Clean Energy Receives Nasdaq Delisting Notice; Intends to Appeal and Regain Compliance Within Timeframes Allowed
- Fort Mill, South Carolina--(Newsfile Corp. - September 20, 2024) - Alternus Clean Energy Inc. (NASDAQ: ALCE) ("Alternus", "The Company") received a Delisting Notice from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") informing the Company that Nasdaq has determined the Company had not regained compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In response, Alternus plans to appeal the decision under Nasdaq rules and intends to file such appeal within the 7-day period allowed.
- 09/20/2024
|
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
- New York, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Longevity Biomedical, Inc. (“Longevity” or “Longevity Biomedical”), a biopharmaceutical company focused on advancing new technologies across therapeutics, health monitoring, and digital health solutions to increase human health span, and FutureTech II Acquisition Corp. (“FutureTech”) (NASDAQ: FTII), a publicly traded special purpose acquisition company (“SPAC”), announced today that they have entered into a definitive business combination agreement (the “BCA”) on September 16, 2024. Upon the closing of the transaction pursuant to the BCA, the combined company (the “Combined Company”) will operate as Longevity Biomedical, Inc. and is expected to list on Nasdaq under the ticker symbol “LBIO.”
- 09/20/2024
|
BioHarvest Sciences reshuffles board amid Nasdaq listing efforts
- BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) has announced the resignation of David Ryan as a director of the company. The company highlighted that Ryan will remain a key member of its management team, continuing to serve as vice president of investor relations.
- 09/20/2024
|
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
- CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company received a notice from Nasdaq indicating that the Nasdaq Hearings Panel (“Panel”) has granted an extension for the continued listing of the Company, subject to the Company evidencing compliance with all applicable criteria for continued listing on The Nasdaq Capital Market by November 19, 2024. The Company is diligently working to fulfill the requirements set forth by the Panel to ensure the Company's continued listing on Nasdaq.
- 09/20/2024
|
Nasdaq to dip as Apple iPhone 16 store launch kicks off
- US tech stocks are expected to open lower this Friday, with the Nasdaq 100 down 0.13% to 19,809 in pre-market trades. Apple Inc (NASDAQ:AAPL, ETR:APC), the largest of the Nasdaq constituents, is expected to open 0.2% lower on the same day that the new iPhone 16 hits shelves.
- 09/20/2024
|
M3-Brigade Acquisition V Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 23, 2024
- NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- M3-Brigade Acquisition V Corp. (the “Company”) announced that, commencing on September 23, 2024, holders of the units sold in the Company's initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the exercise by the underwriters of their overallotment option, completed on August 2, 2024 may elect to separately trade the Class A ordinary shares and warrants included in the units. Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “MBAV” and “MBAVW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “MBAVU.” No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of the units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into the Class A ordinary shares and warrants.
- 09/20/2024
|
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, gene insertion, and gene excision, today announced that, on September 18, 2024, the Compensation Committee of Precision's Board of Directors approved the grant of inducement awards to new employees under the Precision BioSciences, Inc. 2021 Em.
- 09/20/2024
|
Cayson Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
- NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cayson Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The Company's units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, September 20, 2024, under the ticker symbol “CAPNU.” Each unit consists of one ordinary share and one right entitling its holder to receive one tenth of one ordinary share upon the Company's completion of an initial business combination, subject to adjustment. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “CAPN” and “CAPNR,” respectively.
- 09/19/2024
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 15,000 shares of the Company's common stock to one new employee (the “Inducement Grant”) on September 13, 2024 (the “Grant Date”). The Inducement Grant has been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grant was granted as an inducement material to the individual entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/19/2024
|
authID Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Denver, Sept. 19, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of biometric identity verification and authentication solutions, today announced the grant of non-qualified options to purchase 25,000 shares of common stock to one new employee (the “Option”). The Option grant date is September 9, 2024, the exercise price is $7.99 per share and the Option vests in equal amounts monthly over a period of three years, subject to continued employment. The term of the Option is ten years. The Option was granted as an inducement to this employee entering into employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/19/2024
|
23andMe faces Nasdaq delisting after its entire board resigns
- CNBC's Deidre Bosa joins 'The Exchange' to report on the latest drama in 23andMe.
- 09/19/2024
|
23andMe faces Nasdaq delisting
- CNBC's Deidre Bosa joins 'Money Movers' to discuss the latest updates on 23andMe's, following the exodus of several independent board members.
- 09/19/2024
|
SRIVARU Holding Limited Secures Nasdaq Panel Approval for Continued Listing Amid Compliance Efforts
- GRAND CAYMAN, Cayman Islands, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SRIVARU Holding Limited (Nasdaq: SVMH, SVMHW) ("SRIVARU" or the "Company"), a leading innovator in the electric motorcycle market, today announced that it has received a favorable decision from the Nasdaq Hearings Panel (the “Panel”). The Panel's decision grants the Company's request for continued listing on Nasdaq, which we believe will provide SRIVARU the necessary time to implement its plan to regain compliance with Nasdaq's listing requirements.
- 09/19/2024
|
Agape ATP Corporation Regains Compliance with Nasdaq's Minimum Bid Price Rule
- KUALA LUMPUR, MALAYSIA / ACCESSWIRE / September 19, 2024 / AGAPE ATP Corporation ("ATPC" or the Company) , is pleased to announce that it has regained compliance with the $1 minimum bid price requirement under the continued listing requirements of the Nasdaq Stock Market LLC ("Nasdaq") and that the matter is now closed. On September 17, 2024, the Company received a written notification from Nasdaq's Listing Qualifications Department confirming that the closing bid price of the Company's ordinary shares has been $1.00 per share or greater for 10 consecutive trading days, from August 30, 2024 to September 16, 2024.
- 09/19/2024
|
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
- BOULDER, CO / ACCESSWIRE / September 19, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it received a formal determination letter from Nasdaq notifying Sonoma that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market and the matter is now closed. As previously reported, On September 22, 2023, Sonoma received a letter from Nasdaq indicating that it did not comply with the $1.00 minimum closing bid price requirement for its common stock for continued listing on the Nasdaq Capital Market.
- 09/19/2024
|
Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
- WEXFORD, Pa. , Sept. 19, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, announced today that it has received a notification letter from the Nasdaq Hearings Panel (the "Panel") granting its request for continued listing on The Nasdaq Stock Market ("Nasdaq") through January 15, 2025, subject to the Company demonstrating compliance with Nasdaq Listing Rule 5550(a)(2).
- 09/19/2024
|
Argentina's BYMA to Adopt Nasdaq's Clearing Platform
- BYMA to base its entire post-trade ecosystem on Nasdaq technology Argentinian exchange group to adopt Nasdaq's real-time clearing platform, expanding the companies' existing Central Securities Depository partnership The clearing platform will enhance capacity and connectivity whilst reducing operational complexity NEW YORK and BUENOS AIRES, Argentina, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) and BYMA, Argentina's leading stock exchange group, today announced a significant expansion of their technology partnership that will see BYMA base its entire post-trade ecosystem on Nasdaq technology.
- 09/19/2024
|
BloomZ Receives Nasdaq Notification Regarding Minimum Market Value of Listed Securities
- TOKYO, JAPAN / ACCESSWIRE / September 18, 2024 / BloomZ Inc. ("BloomZ" or the "Company"), a Japanese audio production and voice actor management company, announced today that, on September 12, 2024, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC advising the Company that it is not in compliance with the minimum market value of listed securities ("Minimum Market Value of Listed Securities Requirement") set forth in Nasdaq Listing Rules for continued listing on The Nasdaq Capital Market ("Nasdaq"). Nasdaq Listing Rule 5550(b)(2) requires companies to maintain a minimum market value of listed securities of $35 million.
- 09/18/2024
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 62,555 restricted stock units of the company's common stock to 16 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of September 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/18/2024
|
Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance
- NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (the “Company”) (NASDAQ: MCAG), today announced that it received an expected deficiency notification letter from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) on September 13, 2024 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file (i) its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Q1 10-Q”), as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the “SEC”) on April 2, 2024 and (ii) its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Q2 10-Q”), as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the SEC on August 14, 2024.
- 09/18/2024
|
The Real Good Food Company Receives Nasdaq Notice Regarding Potential Delisting
- CHERRY HILL, N.J., Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (Nasdaq: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen and refrigerated foods company, announced that on September 12, 2024, it received a notification from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that Nasdaq has initiated a process that could result in the delisting of the Company's securities from Nasdaq due to the Company's failure to comply with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to file in a timely manner all required periodic financial reports with the Securities and Exchange Commission (the “SEC”).
- 09/18/2024
|
Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
- SEATTLE, WA / ACCESSWIRE / September 18, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced the closing of its previously announced offering of (i) 9,090,910 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 18,181,820 shares of its common stock (the "Common Warrants") at a purchase price of $0.33 per share and associated Common Warrant in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock is being offered together with two Common Warrants, each to purchase one share of common stock.
- 09/18/2024
|
Delisting of Securities of OceanTech Acquisitions I Corp.; OCA Acquisition Corp.; Assure Holdings Corp.; Selina Hospitality PLC; Maquia Capital Acquisition Corporation; ToughBuilt Industries, Inc.; SunPower Corporation; Meta Materials Inc.; Talis Biomedical Corporation; and Holdco Nuvo Group D.G Ltd. from The Nasdaq Stock Market
- NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, units, and warrants of OceanTech Acquisitions I Corp. OceanTech Acquisitions I Corp.'s securities were suspended on January 24, 2024, and have not traded on Nasdaq since that time.
- 09/18/2024
|
Zacks Industry Outlook Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess
- Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess have been highlighted in this Industry Outlook article.
- 09/18/2024
|
XCharge, Asia Green Fund's Portfolio, Successfully Listed on Nasdaq
- BEIJING , Sept. 14, 2024 /PRNewswire/ -- XCHG Limited (XCHARGE) (NASDAQ: XCH) announced the pricing of its initial public offering.
- 09/17/2024
|
SBC Medical Group Holdings and Pono Capital Two Announce Completion of Business Combination and Schedule to Begin Trading on the Nasdaq
- TOKYO & HONOLULU--(BUSINESS WIRE)-- #InvestorRelations--SBC Medical Group Holdings and Pono Capital Two Announce Completion of Business Combination and Schedule to Begin Trading on the Nasdaq.
- 09/17/2024
|
Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- Dermata raises approximately $7.8 million in gross proceeds since May 2024 - expected to fund its operations into the second quarter of 2025 SAN DIEGO, CA / ACCESSWIRE / September 17, 2024 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the closing of its previously announced private placement for the issuance and sale of an aggregate of 1,912,569 shares of common stock (or pre-funded warrant in lieu thereof) and accompanying series A warrants to purchase up to 1,912,569 shares of common stock and short-term series B warrants to purchase up to 1,912,569 shares of common stock at a purchase price of $1.83 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying series warrants priced at-the-market under the rules of the Nasdaq Stock Market. The gross proceeds from the offering were approximately $3.5 million, prior to deducting placement agent's fees and other offering expenses payable by the Company.
- 09/17/2024
|
The Board of Directors in Sivers Semiconductors resolves on a directed share issue to the CEO and proposes an incentive program for the Group's employees
- NEW YORK, Sept. 17, 2024 /PRNewswire/ --The Board of Directors of Sivers Semiconductors AB (publ) ("Sivers Semiconductors" or the "Company") (Nasdaq Stockholm: SIVE) has resolved, subject to approval by the Extraordinary General Meeting on 11 October 2024, to carry out a directed new share issue of 1,524,584 ordinary shares corresponding to approximately 6.9 million SEK to the Company's CEO Vickram Vathulya (the "Directed Issue"). The Board of Directors has also proposed that the Extraordinary General Meeting resolve on an incentive program comprising a maximum of 7,500,000 employee stock options. Notice of the Extraordinary General Meeting will be published through a separate press release. The Directed Issue Vickram Vathulya, who took office as CEO of Sivers on 19 August 2024, has expressed interest in increasing his commitment to the Company through a larger investment where the invested amount is added to the Company. The Board has assessed that the Directed Issue to Vickram Vathulya increases his motivation and commitment to the Company, while the issue proceeds will strengthen the Company's working capital. The Board has therefore resolved, subject to approval by an extraordinary general meeting on 11 October 2024, to carry out the Directed Issue comprising 1,524,584 ordinary shares, corresponding to approximately 6.9 million SEK. Deviating from shareholders' preferential rights, the new ordinary shares may only be subscribed for by Vickram Vathulya. The subscription price in the Directed Issue is 4.536 SEK per ordinary share. The subscription price has been determined through agreement between the Board of Directors and Vickram Vathulya and corresponds to the closing price of the ordinary share on Nasdaq Stockholm on 17 September 2024. The Board of Directors' assessment is that the subscription price in the Directed Issue is carried out on market terms. Through the Directed Issue, the number of shares in the Company will increase by a maximum of 1,524,584 shares, from 235,884,460 shares to 237,409,044 shares, and the share capital will increase by a maximum of 762,292 SEK, from 117,942,230 SEK to 118,704,522 SEK. The total dilution effect through the Directed Issue amounts to approximately 0.6 percent. Incentive Program In addition to the Directed Issue, the Board has proposed, as previously communicated, that the Extraordinary General Meeting resolves on an incentive stock option program intended for the Group's employees ("P09"). The Board of Directors proposes that P09 shall consist of a maximum of 7,500,000 new stock options (the "Stock Options") entitling to purchase of the same number of shares in the Company, corresponding to approximately 3.8 per cent of the share capital and votes in the Company after dilution. In total, the proposed P09 and the previous outstanding incentive programs corresponds to a dilution of not more than approximately 6.3 per cent of the share capital and votes of the Company after dilution. The final number of Stock Options that the participants in Europe are eligible to exercise depends on the degree of fulfilment in respect of the performance conditions for the Group. Stock Options granted to participants in the US shall not be subject to performance conditions. The performance condition for P09 is based on the average growth of the Group's net sales for the financial years 2024, 2025 and 2026 with 2023 actual as the calculation base. The Stock Options shall be granted to the participants free of charge and may not be transferred or pledged. The Stock Options are vested after three years from the date of grant of the Stock Options, i.e. the participant must remain employed within the Group for three years in order for all Stock Options to vest. The CEO is proposed to be allocated 2,000,000 Employee Stock Options within P09. However, Stock Options granted to the CEO will be conditional upon purchase or subscription of at least 2 million ordinary shares in the Company, however limited to USD 1 million. As of 13 September 2024, the CEO has purchased 475,416 ordinary shares on Nasdaq Stockholm and these shares will be included in the minimum investment for the CEO as referred to above. Each Stock Option entitles the employee to acquire one share of Sivers Semiconductors during the period commencing on the third anniversary of date of grant and ending on the fifth anniversary of the date of grant at a price corresponding to 130 percent of the average volume-weighted share price for the Company's share on Nasdaq Stockholm for the date of granting the Stock Options to the participant. To implement the P09 in a cost-effective and flexible manner, the Board of Directors proposes that the obligations of the Company to deliver shares under the Stock Options are secured by an authorisation for the Board of Directors to resolve upon issue, repurchase and transfer of shares of series C which thereafter can be converted into ordinary shares. For more information, please refer to the notice of the Extraordinary General Meeting which will be published through a separate press release. Advisers Setterwalls Advokatbyrå AB acts as legal adviser to the Company. For more information, please contact: Dr. Bami Bastani, Chairman of the Board of DirectorsTel: +1 908 87 28 370E-mail: [email protected] Sivers Semiconductors AB (SIVE.ST) is a leader in SATCOM, 5G, 6G, Photonics, and Silicon Photonics that drives innovation in global communications and sensor technology. Our business units, Photonics and Wireless, supply cutting-edge, integrated chips and modules critical for high-performance gigabit wireless and optical networks. Catering to a broad spectrum of industries from telecommunication to aerospace, we fulfill the increasing demand for computational speed and AI application performance, replacing electric with optical connections for a more sustainable world. Our wireless solutions are forging paths in advanced SATCOM/5G/6G systems, while our photonics expertise is revolutionizing custom semiconductor photonic devices for optical networks and optical sensing, making us a trusted partner to Fortune 100 companies as well as emerging unicorns. With innovation at our core, Sivers Semiconductors is committed to delivering bespoke, high-performance solutions for a better-connected and safer world. Discover our passion for perfection at www.sivers-semiconductors.com. This information was brought to you by Cision http://news.cision.com https://news.cision.com/sivers-semiconductors/r/the-board-of-directors-in-sivers-semiconductors-resolves-on-a-directed-share-issue-to-the-ceo-and-pr,c4038258 The following files are available for download:
- 09/17/2024
|
5 Securities and Exchanges Stocks to Watch Amid Market Volatility
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, NDAQ, CBOE and MKTX. However, compliance with regulations remains a challenge.
- 09/17/2024
|
Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
- LOS GATOS, CA / ACCESSWIRE / September 17, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced the closing of its previously announced "reasonable best efforts" public offering with a single health-care focused institutional investor for the purchase and sale of 1,222,850 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 1,222,850 shares of common stock at a combined offering price of $3.68 per share and accompanying warrant, priced at-the-market under Nasdaq rules (the "Offering"). The Company received aggregate gross proceeds of approximately $4.5 million, before deducting placement agent fees and other offering expenses.
- 09/17/2024
|
Nasdaq 100: Markets Rally as Microsoft Dividend Boost and Fed Outlook Fuel Optimism
- Microsoft boosts its dividend by 10.7% and announces a $60B buyback as Intel surges 7% on new plans and $3B funding from the Chips Act. Read the full analysis
- 09/17/2024
|
Polestar's stock rises as it maintains Nasdaq listing requirements
- Polestar Automotive Holding's stock was up about 1.7% in premarket trading on Tuesday after the electric-vehicle maker said it has satisfied requirements to remain on the Nasdaq.
- 09/17/2024
|
Nasdaq, Marvell Technology And 2 Other Stocks Executives Are Selling
- The Nasdaq 100 closed lower by around 0.5% during Monday's session. Investors, meanwhile, focused on some notable insider trades.
- 09/17/2024
|
Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- SAN DIEGO, CA / ACCESSWIRE / September 16, 2024 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 1,912,569 shares of common stock (or pre-funded warrant in lieu thereof) and accompanying series A warrants to purchase up to 1,912,569 shares of common stock and short-term series B warrants to purchase up to 1,912,569 shares of common stock at a purchase price of $1.83 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying series warrants in a private placement priced at-the-market under the rules of the Nasdaq Stock Market. The series A warrants and series B warrants will have an exercise price of $1.58 per share and will be exercisable immediately upon issuance.
- 09/16/2024
|
Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
- SEATTLE, WA / ACCESSWIRE / September 16, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that it has entered into securities purchase agreements with certain healthcare-focused and institutional investors to purchase (i) 9,090,910 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 18,181,820 shares of its common stock (the "Common Warrants") at a purchase price of $0.33 per share and associated Common Warrant in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock is being offered together with two Common Warrants, each to purchase one share of common stock.
- 09/16/2024
|
5 Stocks Fueling Nasdaq ETF's Best Week in 2024
- The Nasdaq Composite Index has outperformed last week on looming rate cuts. We have highlighted five best-performing stocks of QQQ that led the way higher.
- 09/16/2024
|
Nasdaq Index: Chip Stocks Slump, Intel Rises Amid Uncertainty in US Indices
- Chip stocks slide as Fed rate cut looms. Intel shines with a $3.5B federal grant.
- 09/16/2024
|
Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
- STOCKHOLM , Sept. 16, 2024 /PRNewswire/ -- Nasdaq Stockholm has decided that Calliditas Therapeutics AB (publ) will be delisted from Nasdaq Stockholm.
- 09/16/2024
|
Intelligent Living Application Group Inc. Regains Compliance with Nasdaq's Minimum Bid Price Rule
- HONG KONG, Sept. 16, 2024 /PRNewswire/ -- Intelligent Living Application Group Inc. (NASDAQ: ILAG) ("Intelligent Living" or the "Company"), a premium lockset manufacturer in Hong Kong, announced today that it has regained compliance with the $1 minimum bid price requirement under the continued listing requirements of the Nasdaq Stock Market LLC ("Nasdaq").
- 09/16/2024
|
Veea Inc. and Plum Acquisition Corp. I Announce Closing of Business Combination
- The combined company will begin trading on the Nasdaq Capital Market under the ticker symbols “VEEA” for its common stock and “VEEAW” for its publicly traded warrants The combined company will begin trading on the Nasdaq Capital Market under the ticker symbols “VEEA” for its common stock and “VEEAW” for its publicly traded warrants
- 09/16/2024
|
ECD Regains Compliance with Nasdaq Continued Listing Requirement
- KISSIMMEE, Fla., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (Nasdaq:ECDA) (“ECD” or the “Company”), an industry leader in delivering restored, modified and electrified Land Rover Defenders, Jaguars, and other classic and collectible automobiles announced today that it received a letter from The Nasdaq Stock Market ("Nasdaq") stating that Nasdaq has approved ECD's application to list its shares of common stock for trading on the Nasdaq Capital Market effective September 13, 2024.
- 09/16/2024
|
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
- High dividend yields often signal financial struggles rather than lucrative opportunities. The "dogs of the Dow" strategy may not work well with Nasdaq's top-yielding dividend stocks.
- 09/16/2024
|
S&P 500, Nasdaq Record Best Week Of Year As Alphabet, Super Micro Surge: Fear & Greed Index Moves To 'Neutral' Zone
- The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index moved to the “Neutral” zone on Friday.
- 09/16/2024
|
Leveraged Exposure To The Nasdaq 100 Via TQQQ: Is It Worth The Risk?
- TQQQ offers triple the daily returns of the Nasdaq 100, suitable for short-term trading but risky for long-term holding due to volatility decay. Leveraged ETFs like TQQQ face high volatility and daily rebalancing effects, making them inappropriate for buy-and-hold investors. TQQQ's 0.88% expense ratio is fair for its speculative nature but adds to the long-term underperformance risk.
- 09/14/2024
|
Moolec Received NASDAQ Bid Price Letter
- LUXEMBOURG / ACCESSWIRE / September 13, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today that it received a letter (the "Nasdaq Bid Price Letter") from Nasdaq notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company's ordinary shares has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The Nasdaq Bid Price Letter has no immediate effect on the listing of the Company's common stock, and its common stock will continue to trade on The Nasdaq Capital Market under the symbol "MLEC".
- 09/13/2024
|
Nasdaq Correction: 1 No-Brainer Stock to Buy On This Dip
- Alphabet is down 20% from highs set earlier this year. The narrative that the company is losing in AI is misguided.
- 09/13/2024
|
NorthView Acquisition Corporation Announces Exception Granted by Nasdaq to Permit to The Company to Regain Compliance with Listing Rules
- New York, NY, Sept. 13, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an exception to regain compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). Pursuant to the terms of the exception, the Company must file its Quarterly Reports on Form 10-Q for the periods ending March 31, 2024 and June 30, 2024 on or prior to October 14, 2024. If the Company does not satisfy the terms of the exception, the Staff will provide written notification that the Company's securities will be delisted. At such time, the Company could appeal the Staff's determination to a Hearings Panel.
- 09/13/2024
|
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to three new employees. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/13/2024
|
MBX Biosciences shares surge 44% in blockbuster Nasdaq debut
- Shares of MBX Biosciences , which is developing therapies that target endocrine and metabolic disorders, including diabetes and obesity, rose nearly 44% in their Nasdaq debut on Friday, underscoring investors' focus on weight-loss drugs.
- 09/13/2024
|
Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- - New CFO Brings Multiple Years of Experience from Biotech Companies - As Part of the New Hire, the Company Issues Inducement Grants
- 09/13/2024
|
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company's Board of Directors granted a non-qualified stock option to purchase an aggregate of 3,500 shares of the Company's stock (the “Inducement Grant”) to a newly hired employee on September 10, 2024 (the “Grant Date”), in connection with the commencement of employment.
- 09/13/2024
|
New Nasdaq-100 Dividend Payer: Is This the Perfect Dividend Growth Stock?
- Alphabet began to pay a dividend this spring. The payout equates to a low yield now, but the tech giant has plenty of room to grow its dividend.
- 09/13/2024
|
This Dividend Stock Is Outperforming the S&P 500, Nasdaq, and Dow Jones This Year -- Is It a Buy?
- AT&T has been able to focus on its core telecom business after dropping its media ambitions. The telecom giant offers an ultra-high dividend yield while maintaining a good payout ratio.
- 09/13/2024
|
Tenon Medical, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
- LOS GATOS, CA / ACCESSWIRE / September 12, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced the pricing of its "reasonable best efforts" public offering with a single health-care focused institutional investor for the purchase and sale of up to 1,222,850 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 1,222,850 shares of common stock at a combined offering price of $3.68 per share and accompanying warrant, priced at-the-market under Nasdaq rules (the "Offering"). The Company expects to receive aggregate gross proceeds of approximately $4.5 million, before deducting placement agent fees and other offering expenses, and assuming no exercise of the warrants.
- 09/12/2024
|
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that on September 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 33,500 shares of its common stock. These inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan (“2018 Plan”), but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/12/2024
|
Nasdaq Index Today: Nvidia Powers Tech Rally as Upcoming Fed Meeting Sparks Rate Cut Hopes
- Nasdaq and S&P 500 rally as inflation eases and Nvidia leads tech gains. Investors now focus on the Fed's upcoming interest rate decision.
- 09/12/2024
|
Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders' Meeting
- NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: STSS and STSSW) (“Sharps Technology” or the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, announced today that the Company has secured approval from The Nasdaq Stock Market (“Nasdaq” or the “Exchange”) to maintain its listing, subject to conditions outlined below.
- 09/12/2024
|
These 3 Dividend Stocks Are Beating the S&P 500 and Nasdaq Composite in 2024, and They Could Still Have More Room to Run
- American Electric Power can put a jolt in investors' passive income streams with its high-yield dividend. The growth transformation of the heating, ventilation, and air-conditioning company Carrier Global is almost complete.
- 09/12/2024
|
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
- CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has received written notice from the Nasdaq Listing Qualifications Department stating that the Company has regained compliance with the filing requirement in Nasdaq Listing Rule 5250(c), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, and that the Company has also cured the deficiency under Nasdaq Listing Rule 5620(a), which requires listed companies to hold an annual meeting of stockholders during each fiscal year. With the Company in compliance with Nasdaq Listing Rule 5250(c), and having cured its deficiency under Nasdaq Listing Rule 5620(a), Nasdaq has ceased any action to delist the Company's common stock.
- 09/12/2024
|
Nasdaq Jumps Over 2% Amid Nvidia Surge: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone
- The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, but the index remained in the “Fear” zone on Wednesday.
- 09/12/2024
|
Nasdaq, S&P 500 surge as Nvidia leads bounce back from post-CPI sell-off
- US stocks reversed early losses to close higher on Wednesday as investors digested an inflation report that showed consumer price increases ticked lower in August. The benchmark S&P 500 (^GSPC) rose more than 1%, while the tech-heavy Nasdaq Composite (^IXIC) led the charge, rising almost than 2.2%.
- 09/11/2024
|
Blue Hat Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- XIAMEN, China, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), today announced that on September 6, 2024, it has received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement from July 25, 2024 through September 5, 2024, as set forth in Nasdaq Listing Rules 5550(a)(2), which require that the closing bid price for the Company's ordinary shares listed on Nasdaq be maintained at a minimum of US$1.00 and failure to meet it for 30 consecutive business days constitutes a compliance deficiency.
- 09/11/2024
|
SigmaTron International, Inc. Regains Compliance with Nasdaq Listing Rule 5250(c)(1)
- ELK GROVE VILLAGE, Ill., Sept. 11, 2024 (GLOBE NEWSWIRE) -- SigmaTron International, Inc. (NASDAQ: SGMA), an electronic manufacturing services company (the “Company”), announced today that on September 10, 2024, it received notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) by filing with the Securities and Exchange Commission (“SEC”) its Form 10-K for the annual period ended April 30, 2024, on September 3, 2024 (as amended on September 6, 2024, the “Form 10-K”).
- 09/11/2024
|
Meiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
- Shenzhen, China, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited (“WNW” or the “Company”), (NASDAQ: WNW) announced today that on September 10, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).
- 09/11/2024
|
VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
- BOCA RATON, Fla.--(BUSINESS WIRE)--VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on September 6, 2024, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024 (the “Form 10-Q”), the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securiti.
- 09/11/2024
|
Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date August 30, 2024
- NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of August 30, 2024, short interest in 3,037 Nasdaq Global MarketSM securities totaled 12,296,040,928 shares compared with 12,277,781,936 shares in 3,037 Global Market issues reported for the prior settlement date of August 15, 2024. The end of August short interest represent 3.38 days average daily Nasdaq Global Market share volume for the reporting period, compared with 2.62 days for the prior reporting period.
- 09/11/2024
|
bleuacacia receives notice of deficiency from Nasdaq
- NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- bleuacacia ltd (NASDAQ: BLEU) announced today that on September 6, 2024, it received a notice (the “Notice”) from the Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company no longer complies with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the U.S. Securities and Exchange Commission (the “SEC”). As previously disclosed in the Notification of Late Filing on Form 12b-25 filed by the Company with the SEC on August 15, 2024 (the “Form 12b-25”), the Company is delayed in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”) due to the reasons described in the Form 12b-25.
- 09/11/2024
|
Arm Holdings Stock Is Top Performer as Nasdaq 100 Makes a Comeback
- Morgan Stanley analyst Lee Simpson rates the chip stock at Overweight with a $175 price target,
- 09/11/2024
|
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)
- Boston (September 11, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that the Company is taking a decisive step toward regaining compliance with Nasdaq's listing requirements, as outlined by the Nasdaq Hearings Panel during a meeting on August 15, 2024.
- 09/11/2024
|
History Says the Nasdaq Will Soar: 2 Growth Stocks With 26% and 38% Upside to Buy Now, According to Wall Street
- The Nasdaq Composite entered a correction in August, but the index tends to rebound sharply during the year following its first close in correction territory. Amazon is gaining market share in e-commerce, digital advertising, and cloud computing, and the stock trades at a discount to its historical PEG ratio.
- 09/11/2024
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 09/10/2024
|
Aeries Technology Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
- NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (“Aeries Technology” or “the Company”) (Nasdaq: AERT), a global professional services and technology consulting partner, today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on September 5, 2024 (the “Notice”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Fiscal 2025 First Quarter Form 10-Q”) as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the "SEC") on August 15, 2024, and for remaining delinquent in filing its Annual Report on Form 10-K for the year ended March 31, 2024 (the “Fiscal 2024 Form 10-K”). The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.
- 09/10/2024
|
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted non-qualified stock option awards to purchase an aggregate of 120,200 shares of its common stock to fifteen new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/10/2024
|
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
- SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (“Telesis” or the “Company”), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis technology in their own lab, announced today that it has notified the Nasdaq Stock Market LLC (“Nasdaq”) of its decision to delist the Company's shares of common stock, par value $0.001 per share (the “Common Stock”) and deregister the Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
- 09/10/2024
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on September 5, 2024, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 21,750 shares of Class A common stock and restricted stock units (RSUs) for 9,875 shares of Class A common stock to two new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/10/2024
|
iRobot Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass. , Sept. 10, 2024 /PRNewswire/ -- iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced that it granted equity awards as a material inducement to the employment of the company's newly-hired President and Chief Operating Officer, Jeff Engel.
- 09/10/2024
|
Xiao-I Corporation Regains Compliance with Nasdaq Listing Rules
- SHANGHAI , Sept. 10, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading artificial intelligence company, today announced that on September 9, 2024 it received a written notice from The Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company regained compliance with the minimum bid price requirement, as set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Market.
- 09/10/2024
|
Buy These 5 Nasdaq Stocks With Double-Digit Returns in the Past Month
- Five recently thriving Nasdaq Composite-listed stocks are: AFRM, ACGL, COO, ERIE, WDAY.
- 09/10/2024
|
Sunrise Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- ZIBO, China, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced that the Company has received a formal notification from the Nasdaq Capital Market, LLC (“Nasdaq”), dated September 9, 2024, notifying the Company that it has regained compliance with the minimum bid price requirement as set forth under NASDAQ Listing Rule 5550(a)(2) for continued listing on Nasdaq.
- 09/10/2024
|
Nasdaq to show resilience despite Apple drag
- A tepid reaction to Apple Inc (NASDAQ:AAPL, ETR:APC)'s iPhone 16 debut is expected to cause a 0.7% fall on the world's most valuable company's share price when US markets open today. That will not be enough to drag the Nasdaq 100 into the red though- futures contracts have the tech-led index staying flat at 40,834.
- 09/10/2024
|
Nasdaq, S&P 500 Futures Slip As Traders Eye Presidential Debate, Oracle Rallies Over 8%: Economist Points This Shift In Broader Market Trend Amid Flurry Of Weak Data
- The market sentiment seems to fluctuate as the index futures dipped slightly, indicating a lower opening on Tuesday. The CBOE Volatility, aka VIX, rose slightly but held around the 20 level.
- 09/10/2024
|
Mountain & Co. I Acquisition Corp. Announces Receipt of Nasdaq Delisting Determination - Intention to Appeal
- NEW YORK , Sept. 9, 2024 /PRNewswire/ -- Mountain & Co. I Acquisition Corp. (the "Company") announces that on September 3, 2024, the Company received a letter (the "Letter") from the NASDAQ Stock Market ("Nasdaq") notifying the Company that Nasdaq Listing Qualifications Staff ("Staff") have determined to deny the Company's request for continued listing on The Nasdaq Stock Market.
- 09/09/2024
|
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September 3, 2024, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,500 shares of common stock at a per share exercise price of $25.15, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation.
- 09/09/2024
|
Vine Hill Capital Investment Corp. Announces Closing of $200,000,000 Initial Public Offering
- Fort Lauderdale, Florida, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Vine Hill Capital Investment Corp. (the “Company”), a special purpose acquisition company, today announced the closing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units began trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “VCICU” on September 6, 2024. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be traded on Nasdaq under the symbols “VCIC” and “VCICW,” respectively. The Company has granted the underwriters a 45-day option to purchase on a pro rata basis up to 3,000,000 units at the initial public offering price to cover over-allotments, if any.
- 09/09/2024
|
Should You Buy the 4 "Magnificent Seven" Stocks That Underperformed the S&P 500 and Nasdaq Composite in 2024?
- After big gains in 2023, many of the "Magnificent Seven" stocks have cooled off in 2024. Alphabet, Amazon, Microsoft, and Tesla all lag the major indexes through the end of August.
- 09/09/2024
|
2 Nasdaq Stocks to Buy Before They Soar as Much as 141%, According to Select Wall Street Analysts
- Despite the index notching a number of new all-time highs this year, many Wall Street analysts believe there's still upside ahead for the Nasdaq. Economic headwinds have weighed on Sirius XM, representing a compelling opportunity for savvy investors.
- 09/08/2024
|
Embrace Change Acquisition Corp. Receives Additional Staff Determination Notice from Nasdaq Related to Delayed Quarterly Report
- SAN DIEGO, Sept. 07, 2024 (GLOBE NEWSWIRE) -- Embrace Change Acquisition Corp. (Nasdaq: EMCG, EMCGW, EMCGU, EMCGR) ("Embrace Change" or the "Company"), announced today that on September 5, 2024, it received an additional staff determination notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is delinquent in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the "Form 10-Q") and that this matter serves as an additional basis for delisting the Company's securities from The Nasdaq Stock Market. The failure to timely file the 10-Q is a violation of Nasdaq Listing Rule 5250(c)(1).
- 09/07/2024
|
Is It Time to Buy August's Worst-Performing Nasdaq Stocks?
- Super Micro Computer tumbled on a weak earnings report, a short-seller attack, and a delay in its 10-K filing. Moderna plunged as it slashed its guidance for the year.
- 09/07/2024
|
Eastside Distilling Announces Closing of $0.4 Million Registered Direct Offering, Priced at a Premium to Market Under Nasdaq Rules
- PORTLAND, Ore. , Sept. 6, 2024 /PRNewswire/ -- Eastside Distilling, Inc. (Nasdaq: EAST) ("Eastside" or the "Company"), a consumer-focused beverage company that builds craft inspired experiential brands and high-quality artisan products around premium spirits, digital can printing, co-packing and mobile filling, announced today the closing of its previously announced registered direct offering for the sale and issuance of 442,042 shares of the Company's common stock (or pre-funded warrants in lieu thereof) to a single institutional investor at a purchase price of $1.00 per share or $0.9999 per pre-funded warrant.
- 09/06/2024
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, the Netherlands and MIAMI, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 111,000 of NewAmsterdam's ordinary shares to three non-executive new hires. The share options were granted as an inducement material to the employees acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/06/2024
|
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CHASKA, Minn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore has granted a restricted stock unit (“RSU”) award with respect to 262,500 shares of its common stock and a performance stock unit (“PSU”) award for up to 750,000 shares of its common stock to Ryan D. Lake, Lifecore's newly hired chief financial officer. The RSU award and PSU award were granted September 3, 2024, pursuant to the Company's previously announced employment agreement with Mr. Lake, and as a material inducement to Mr. Lake joining Lifecore as chief financial officer.
- 09/06/2024
|
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM Mass., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a grant date of September 3, 2024, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 2020 Inducement Stock Incentive Plan) and material to the employees' acceptance of employment with the company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/06/2024
|
Foresight Receives Nasdaq Notification Regarding Minimum Bid Requirements
- Ness Ziona, Israel, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, announced today that on September 3, 2024, the Company received a written notice (the “Notice”) from the Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the Company's closing bid price for its American Depositary Shares (“ADSs”) was below $1.00 per share for the last 30 consecutive business days.
- 09/06/2024
|
Preparing To Bet Against Nasdaq With The PSQ ETF
- With a P/E ratio of 41 for the Nasdaq composite it is hard to build a bull case going forward, while odds of a correction being triggered are arguably rising. The PSQ inverse ETF offers investors a mechanism to bet against the Nasdaq composite, which is a short-term investment opportunity, where timing is of the essence. Headlines such as rate cuts may push the Nasdaq composite back toward all-time highs in coming months, which is where I see a good entry point for this inverse ETF.
- 09/06/2024
|
Nasdaq Down Over 400 Points; Braze Shares Tumble After Q2 Results
- U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 400 points on Friday.
- 09/06/2024
|
Nasdaq Halts BAIYU Holdings, Inc.
- NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted on September 5, 2024 in BAIYU Holdings, Inc. (Nasdaq: BYU) at 19:50:00 Eastern Time for information requested from the company at a last sale price of $1.02.
- 09/06/2024
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on September 3, 2024, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 311,000 shares of the Company's common stock in connection with their employment. The stock option was granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individual entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/06/2024
|
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on September 4, 2024, the compensation committee of BridgeBio's board of directors approved equity grants to 123 new employees in restricted stock units for an aggregate of 359,926 shares of the Company's common stock. One-fourth of the shares underlying each employee's restricted stock units will vest on August 16, 2025, with one-twelfth of the remaining shares underlying each such employee's restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee's continued employment with the Company or one of its subsidiaries on such vesting dates. All of the above-described awards were made under BridgeBio's Amended and Restated 2019 Inducement Equity Plan (the “Plan”).
- 09/06/2024
|
Nasdaq Announces New Leadership and Structure for Financial Crime Management Technology
- Appoints 13-year Nasdaq Verafin Veteran, Stephanie Champion, as New Head of Nasdaq Verafin Nasdaq Chief Strategy Officer, Jeremy Skule, to Take on Expanded Role as Executive Chair of Nasdaq's Financial Crime Management Technology Business NEW YORK and ST. JOHN'S, Newfoundland, Sept.
- 09/06/2024
|
Nasdaq Implements AxiomSL Revenue Recognition Change
- NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today announced that it has implemented a change to the accounting treatment of the revenues associated with AxiomSL on-premises subscription contracts.
- 09/06/2024
|
Forget the Nasdaq -- Buy This Magnificent ETF Instead
- The Nasdaq Composite Index has trounced the S&P 500 during the past decade. But one ETF has beaten the Nasdaq in that time period.
- 09/06/2024
|
Faraday Future Regains Compliance with All Nasdaq Continued Listing Criteria
- LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (“FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company today announced that it received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company regained compliance with the bid price requirement in Nasdaq Listing Rule 5550(a)(2) and the periodic filing requirement in Listing Rule 5250(c)(1). The Company is now in compliance with all.
- 09/05/2024
|
Vine Hill Capital Investment Corp. Announces Pricing of $200 Million Initial Public Offering
- Fort Lauderdale, Florida, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Vine Hill Capital Investment Corp. (the “Company”), a special purpose acquisition company, today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to be listed for trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “VCICU” beginning September 6, 2024. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on Nasdaq under the symbols ‘‘VCIC” and ‘‘VCICW,'' respectively. The offering is expected to close on September 9, 2024, subject to customary closing conditions.
- 09/05/2024
|
Nasdaq to Hold Teach-In Regarding AxiomSL Revenue Recognition Change
- NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) has scheduled a teach-in to discuss a change to the accounting treatment of the revenues associated with AxiomSL on-premises subscription contracts. This change was previously referenced during Nasdaq's second quarter earnings announcement and the financial impacts of the change are consistent with what was communicated at that time.
- 09/05/2024
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 37,000 restricted stock units of Arcutis' common stock to three newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of September 3, 2024, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/05/2024
|
Eastside Distilling Announces $0.4 Million Registered Direct Offering, Priced at a Premium to Market Under Nasdaq Rules
- PORTLAND, Ore., Sept. 5, 2024 /PRNewswire/ -- Eastside Distilling, Inc. (Nasdaq: EAST) ("Eastside"), a consumer-focused beverage company that builds craft inspired experiential brands and high-quality artisan products around premium spirits, digital can printing, co-packing and mobile filling, announced today the pricing of a registered direct offering for the sale and issuance of 442,042 shares of the Company's common stock (or pre-funded warrants in lieu thereof) to a single institutional investor at a unit purchase price of $1.00.
- 09/05/2024
|
Nasdaq Stock Rallies 42.5% in a Year: More Room for Upside?
- NDAQ stock gains from impressive organic growth, strategic buyouts to capitalize on growing market opportunities and effective capital deployment.
- 09/05/2024
|
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on September 3, 2024, the Compensation Committee of Adverum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 12,660 shares of common stock and restricted stock units (RSUs) for 6,330 shares of common stock to 3 new employees under Adverum's 2017 Inducement Plan. The Compensation Committee of Adverum's Board of Directors approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/05/2024
|
RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
- TEL AVIV, Israel and RALEIGH, N.C. , Sept. 5, 2024 /PRNewswire/ -- RedHill Biopharma Ltd.
- 09/05/2024
|
S&P 500, Nasdaq Fall For 2nd Straight Session Amid Nvidia Decline: Fear & Greed Index In 'Neutral' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index in the “Neutral” zone on Wednesday.
- 09/05/2024
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers, today announced that the Company granted stock options to five new employees to purchase an aggregate of 130,600 shares of the Company's common stock, effective as of September 3, 2024. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan, with a grant date of September 3, 2024, as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/04/2024
|
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass. and DUBLIN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that on September 3, the Company granted to one newly hired employee (i) non-statutory stock options to purchase an aggregate of 21,500 ordinary shares of the Company and (ii) restricted stock units with respect to an aggregate of 11,500 ordinary shares of the Company, pursuant to the Company's 2024 Inducement Stock Option and Incentive Plan, each as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/04/2024
|
Nasdaq Executives to Present at Upcoming Investor Conferences
- NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in September with webcasts available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 09/04/2024
|
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 180,000 shares of Astria's common stock on September 3, 2024 under Astria's 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were g.
- 09/04/2024
|
Delisting of Securities of Liberty Resources Acquisition Corp.; Achari Ventures Holdings Corp. I; PetVivo Holdings, Inc.; Galera Therapeutics, Inc.; Clean Energy Special Situations Corp.; Capitalworks Emerging Markets Acquisition Corp.; AERWINS Technologies Inc.; Biolase, Inc.; Global Gas Corporation; Corner Growth Acquisition Corp.; Lucy Scientific Discovery Inc.; Chicken Soup for the Soul Entertainment, Inc.; Ideanomics, Inc.; NexImmune, Inc.; Shapeways Holdings, Inc.; QIWI plc;
- ASLAN Pharmaceuticals Limited; Conn's, Inc.; 2U, Inc.; International Media Acquisition Corp.; Presto Automation, Inc.; and VBI Vaccines, Inc.; from The Nasdaq Stock Market ASLAN Pharmaceuticals Limited; Conn's, Inc.; 2U, Inc.; International Media Acquisition Corp.; Presto Automation, Inc.; and VBI Vaccines, Inc.; from The Nasdaq Stock Market
- 09/04/2024
|
Nasdaq Reports August 2024 Volumes
- NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for August 2024 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics .
- 09/04/2024
|
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CHARLESTOWN, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 42,082 restricted stock units (“RSUs”) to three newly hired employees.
- 09/04/2024
|
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- 60 Degrees Pharmaceuticals raises $4M through private placement for working capital, commercialization, and R&D, with H.C. Wainwright as placement agent.
- 09/04/2024
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted nine newly-hired employees stock options to purchase an aggregate of 28,400 shares, and restricted stock units (RSUs) covering an aggregate of 20,025 shares, of BioCryst common stock. The options and RSUs were granted as of August 30, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/04/2024
|
Laser Photonics Regains Compliance With Nasdaq Listing Requirements
- ORLANDO, Fla.--(BUSINESS WIRE)--Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global industrial developer of laser systems for cleaning and other material processing applications, announced today that the Company received a letter from Nasdaq stating that the Company was now in compliance with Listing Rule 5250(c)(1). About Laser Photonics Corporation Laser Photonics is a vertically integrated manufacturer and R&D Center of Excellence for industrial laser technologies and syst.
- 09/03/2024
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that on September 3, 2024, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 16,000 shares of the Company's common stock to 2 newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/03/2024
|
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that it awarded inducement grants to five new employees under Intellia's 2024 Inducement Plan as a material inducement to employment.
- 09/03/2024
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. , Sept. 3, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to purchase an aggregate of 4,000 shares of Akebia's common stock on August 30, 2024.
- 09/03/2024
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , Sept. 3, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 22,050 restricted stock units (RSUs) to five newly-hired employees.
- 09/03/2024
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on August 30, 2024, the company granted equity awards to two new employees, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/03/2024
|
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on August 30, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 230,588 shares of X4's common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by X4's Compensation Committee of the Board of Directors.
- 09/03/2024
|
Trump Media stock slides under $18, a new low since it began publicly trading
- Trump Media, the parent company of Truth Social owned by Donald Trump, fell to a new public trading low since it debuted on the Nasdaq stock exchange in March. The DJT dip followed a broader market decline, with the Nasdaq, Dow Jones Industrial Average and S&P 500 all trading lower Tuesday.
- 09/03/2024
|
Time To Exchange Nasdaq Stock After Its 23% Gains This Year?
- NASDAQ stock (NASDAQ: NDAQ) has gained 23% YTD as compared to a 17% rise in the S&P500 index. In sharp contrast, Nasdaq's peer CME Group (NASDAQ: CME) is up 5% YTD.
- 09/03/2024
|
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
- Highlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of approximately $316 million. Industry-Leading Platform: Aspire is focused on developing a pipeline of products utilizing its novel delivery mechanisms to enhance the efficacy of “do no harm” FDA approved drugs, nutraceuticals and supplements.
- 09/03/2024
|
OTC Markets Group Announces Incorporation of EDGAR® Online Financial Data onto Nasdaq Data Link®
- NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for over 12,000 U.S. and global securities, today announced that EDGAR Online's (EOL) SEC and OTC financials data set is now available on Nasdaq Data Link ®, Nasdaq's cloud-based data distribution platform. The integration of EDGAR Online's financial data into Nasdaq Data Link® provides subscribers with access to the most comprehensive financials data for all SEC and OTC reporting issuers.
- 09/03/2024
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 09/02/2024
|
History Says the Nasdaq Will Soar: 2 Growth Stocks to Buy Now, According to Wall Street
- The Nasdaq entered a correction in early August, but the index usually recovers quickly. Alphabet is the largest digital advertiser and the third-largest public cloud in the world.
- 08/31/2024
|
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on August 30, 2024. Three individuals were hired by Adicet in August 2024. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 30,600 shares of Adicet's common stock with an exercise price of $1.46 pe.
- 08/30/2024
|
Aquaron Acquisition Corp. Announces Receipt of Delisting Notification from Nasdaq
- NEW YORK , Aug. 30, 2024 /PRNewswire/ -- Aquaron Acquisition Corp. (NASDAQ: AQU, the "Company"), a special purpose acquisition company, announced today that it received a written notice (the "Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, because the Company has not regained compliance with Listing Rule 5550(a)(3) (the "Minimum Public Holders Rule"), which requires the Company to have at least 300 public holders for continued listing on Nasdaq, trading of the Company's common stock will be suspended at the opening of business on September 4, 2024 and a Form 25-NSE will be filed with the Securities and Exchange Commission (the "SEC"), which will remove the Company's securities (including the units, common stock, and rights) from listing and registration on Nasdaq, unless the Company requests a hearing to appeal this determination by 4:00 p.m. Eastern Time on September 4, 2024.
- 08/30/2024
|
BurgerFi Receives Nasdaq Deficiency Notices
- FORT LAUDERDALE, Fla., Aug. 30, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi” or the “Company”), owner of the high-quality, casual dining pizza brand Anthony's Coal Fired Pizza & Wings (“Anthony's”) and one of the nation's leading fast-casual “better burger” dining concepts through the BurgerFi brand, has received deficiency notices from Nasdaq Stock Market LLC (“Nasdaq”) related to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended July 1, 2024 (“Q2 Form 10-Q”) and the composition of Board committees arising from the resignation of directors.
- 08/30/2024
|
NeuroSense Therapeutics Announces Receipt of Nasdaq Minimum Bid Price Notification
- CAMBRIDGE, Mass. , Aug. 30, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd.
- 08/30/2024
|
Receipt of Nasdaq Delisting Determination - Plans to Appeal
- August 30, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Receipt of Nasdaq Delisting Determination Plans to Appeal Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announced today that on August 27, 2024, it received a Staff Determination letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of the Staff's determination to delist the Company's securities from The Nasdaq Capital Market because the Company's securities have had a closing bid price below $1.00 for 30 consecutive business days, which triggers a notice of delisting pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Rule”). Normally, a company would be afforded a 180-calendar day period to demonstrate compliance with the Rule.
- 08/30/2024
|
Nasdaq Jumps Over 100 Points; Dell Posts Upbeat Results
- U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining over 100 points on Friday.
- 08/30/2024
|
With Increased Volatility YOY Exchange Volumes Are Up Nicely In Q3 2024 To Date
- Volatility metrics show an increase, with the VIX averaging 17.0 in 3QTD, up from previous quarters, indicating a more volatile market environment. CME Group exhibits the strongest performance in 3Q24TD, suggesting significant upside to transaction revenues, making it a recommended buy. Cboe also shows strong transaction revenue potential due to increased index options and futures volumes, benefiting from the current volatile market.
- 08/30/2024
|
Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q
- New York, NY, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the “Company”) announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-Q for the period ended June 30, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC").
- 08/30/2024
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , Aug. 30, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on August 29, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 34,000 shares of the Company's common stock to a newly hired employee.
- 08/30/2024
|
Forget the Nasdaq -- Buy This Magnificent ETF Instead
- The Fidelity MSCI Information Technology Index ETF is often overlooked, but it combines stellar performance with low fees. The fund has outperformed both the Nasdaq Composite and the S&P 500 over the last 10 years.
- 08/30/2024
|
CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed
- NEW YORK, USA and SEOUL, Korea, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V, a Delaware corporation formed as a special purpose acquisition company (“Mountain Crest V”), with its common stock publicly traded on The Nasdaq Stock Market under the trading symbol “MCAG” and CUBEBIO Co., Ltd., a corporation (“chusik hoesa”) organized under the laws of Korea (“CUBEBIO”), which has an innovative technology that diagnoses cancer at an early stage using urine, today announced that the parties entered into a definitive business combination agreement, dated August 29, 2024 (the “BCA”) for a proposed business combination transaction through which CUBEBIO plans to become a public company with its securities listed on The Nasdaq Stock Market. Mountain Crest V is the fifth vehicle in the Mountain Crest family of SPACs, the management of which has successfully completed four prior SPAC business combinations.
- 08/29/2024
|
Stran & Company Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
- Quincy, MA, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the "Form 10-Q") in a timely fashion. The Notification Letter advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1).
- 08/29/2024
|
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
- The combined company will operate as “Oruka Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “ORKA” effective Tuesday, September 3, 2024 The combined company will operate as “Oruka Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “ORKA” effective Tuesday, September 3, 2024
- 08/29/2024
|
HUB Receives Nasdaq Notification Regarding Total Assets and Total Revenue Non-compliance
- TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- via IBN – HUB Cyber Security Ltd (Nasdaq: HUBC), a developer of cybersecurity solutions and services (the “Company”), was notified on August 23, 2024, by the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is no longer in compliance with Nasdaq Listing Rule 5450(b)(3) (the “Total Assets and Total Revenue Requirement”) because the Company's total assets and total revenue for the most recently completed fiscal year and two of the last three most recently completed fiscal years were each below the minimum $50 million threshold for continued listing on The Nasdaq Global Market.
- 08/29/2024
|
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- LEXINGTON, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agreement with a newly hired employee that, among other things, provides for the grant to such employee of a non-qualified stock option and restricted stock units as an inducement material to such employee's entering into employment with Voyager. The inducement awards were approved by the Compensation Committee of Voyager's Board of Directors in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). The option award became effective on August 28, 2024, and the restricted stock unit award is scheduled to become effective on October 1, 2024.
- 08/29/2024
|
Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Thursday.
- 08/29/2024
|
JE Cleantech Holdings Limited Announces Regaining of Compliance with the Bid Price Requirement to Continue Listing on Nasdaq
- SINGAPORE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- JE Cleantech Holdings Limited (Nasdaq: JCSE), a precision cleaning and cleantech equipment manufacturer, announced that on August 27, 2024, it received a letter (the “Compliance Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Compliance Letter informed the Company that it had regained compliance with Nasdaq's bid price requirement (the “Bid Price Requirement”) in Listing Rule 5550(a)(2), as required by the Hearing Panel's (the “Panel”) decision dated July 15, 2024.
- 08/29/2024
|
Rezolve AI Confirms Market Leadership Ambitions in Conversational Commerce Following Nasdaq Listing and Key Partnerships with ChatWerk and ePages
- NEW YORK, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Rezolve AI (NASDAQ: RZLV) is excited to announce its rapid progress towards achieving its goal of becoming a global leader in Conversational Commerce, following its successful NASDAQ listing and recently announced strategic partnerships with industry leaders such as ChatWerk and ePages. These milestones underline Rezolve's significant potential in the AI-powered eCommerce space, driven by its proprietary foundational Large Language Model (LLM), brainpowa.
- 08/29/2024
|
Tembo E-LV, a subsidiary of Nasdaq-listed VivoPower International PLC (“VVPR”) executes a definitive Business Combination Agreement with CCTS for a combined enterprise value of US$904 million
- Independent third-party fairness opinion was obtained and satisfactorily completed Pro forma fully diluted combined enterprise value assumes no public trust redemptions
- 08/29/2024
|
Nasdaq 100 Forecast: Nvidia, Salesforce Boost Tech Stocks as Wall Street Rebounds
- Tech earnings spark stock futures rebound; Nvidia stabilizes, while the market awaits critical economic data today.
- 08/29/2024
|
Scinai Regains Full Compliance with Nasdaq Listing Requirements
- JERUSALEM , Aug. 29, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that on August 27, 2024, it received formal notification (the "Notification") from the Listing Qualification Department (the "Staff") of the Nasdaq Stock Market ("Nasdaq") that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Rule") that requires listed companies to maintain stockholders' equity of at least $2.5 million.
- 08/29/2024
|
So-Young Announces Receipt of Minimum Bid Price Notice from Nasdaq
- BEIJING , Aug. 29, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced it has received a notification letter dated August 28, 2024 (the "Notice") from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), indicating that for the last 30 consecutive business days, the closing bid price of the Company's American depositary shares (the "ADSs") was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5450(a)(1). The Notice has no current effect on the listing or trading of the Company's ADSs on Nasdaq.
- 08/29/2024
|
Nasdaq Tumbles Over 1% As Super Micro And Other Chip Stocks Decline: Fear & Greed Index Remains In 'Neutral' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index in the “Neutral” zone on Wednesday.
- 08/29/2024
|
Perception Capital Corp. III received written notice from Nasdaq related to delayed filing of quarterly report on Form 10-Q
- MINNEAPOLIS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Perception Capital Corp. III (Nasdaq: PFTA) (the “Company”), a special purpose acquisition company, today announced that it received written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on August 26, 2024 (the “Notice”) indicating that the Company is delinquent in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”), which may serve as an additional basis for the delisting of the Company's securities from Nasdaq. As a result, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”). The Company previously filed a Form 12b-25 with the SEC on August 15, 2024, disclosing that it was unable to file the Form 10-Q within the prescribed time period without unreasonable effort or expense. Under Nasdaq rules, a company that receives a delist determination for delinquency, can request an appeal to a Nasdaq Hearings Panel (the “Hearings Panel”). A request for a hearing regarding a delinquent filing will stay the suspension of the Company's securities for a period of 15 days from the date of the request. Since the Company is already before a Hearings Panel for its failure to achieve a business combination in 36 months, the Notice provided that the Company has until September 3, 2024 to request a stay of the suspension, pending a Hearing Panels decision.
- 08/28/2024
|
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements
- WASHINGTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that on August 26, 2024 it received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. The Company had been notified by Nasdaq on February 27, 2024 that it was not in compliance with the Minimum Bid Price Requirement because its common stock had failed to maintain a minimum bid price of $1.00 for 30 consecutive business days.
- 08/28/2024
|
Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results
- U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Wednesday.
- 08/28/2024
|
Nasdaq 100: Nvidia Earnings Key to Sustaining Tech Rally in Volatile Market
- Nvidia's stock, up 159% in 2024, faces a major test today with earnings that could shift the tech market. Watch closely for AI demand updates.
- 08/28/2024
|
Nasdaq 100 and S&P500: Nvidia's AI Guidance Today to Test Market Sentiment
- S&P 500 futures rise as Nvidia's earnings loom, with analysts expecting strong results. Market sentiment hinges on AI demand and tech stock guidance.
- 08/28/2024
|
Nasdaq, Wall Street set for cautious start ahead of Nvidia earnings
- Futures had the Nasdaq, Dow Jones and S&P 500 just off the mark ahead of Wednesday's opening bell and much-anticipated results for Nvidia Corp later. Nvidia is due to report after the market closes on Wednesday, with expectations “sky-high” for its latest in a string of earnings beats, according to Swissquote Bank analyst Ipek Ozkardeskaya.
- 08/28/2024
|
Nasdaq, S&P 500 Futures Flatline As Traders Await Earnings Report From AI Barometer Nvidia: Fund Manager Says Market Could Hold Up Until Presidential Election
- Sentiment on Wall Street could be guarded until Nvidia Corp's NVDA earnings are in the rearview mirror. The index futures are barely holding up early Wednesday.
- 08/28/2024
|
Black Spade Acquisition II Co Announces Pricing Of $150 Million Initial Public Offering
- HONG KONG--(BUSINESS WIRE)--Black Spade Acquisition II Co (the “Company”), a special purpose acquisition company (“SPAC”) sponsored by an affiliate of Black Spade Capital Limited, announced today the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units are expected to be listed for trading on The Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “BSIIU” on August 28, 2024. Each unit consists of one Class A ordinary share and one-third of o.
- 08/27/2024
|
Stock Market Bides Time, Nasdaq Holds Support As Nvidia Earnings Loom Large
- Small caps lagged in the stock market Tuesday, but the Nasdaq composite reversed higher and closed above its 50-day moving average.
- 08/27/2024
|
Adamas One Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- SCOTTSDALE, Ariz., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for industrial uses, today reports that, as previously disclosed, the Company had a hearing scheduled for May 30, 2024 before a Nasdaq Hearings Panel (the “Panel”) regarding its plan to regain compliance with: (1) Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”); (2) Nasdaq Listing Rule 5250(f) (the “Fees Rule”); and (3) Nasdaq Listing Rule 5250(c)(1) (the “Filings Rule”). On June 07, 2024, the Company received a decision letter from the Panel of the Nasdaq Stock Market (“Nasdaq”). The Panel granted the Company's request for continued listing on The Nasdaq Capital Market, subject to the following: 1) on or before July 29, 2024, the Company shall cure its filing delinquencies and demonstrate compliance with the Filings Rule; and 2) on or before August 30, 2024, the Company shall have demonstrated compliance with the Minimum Bid Price Rule, by evidencing a closing bid price of $1 or more per share for a minimum of ten consecutive trading sessions.
- 08/27/2024
|
Primis Financial Corp. Announces Notification of Delinquency with Nasdaq
- MCLEAN, Va. , Aug. 27, 2024 /PRNewswire/ -- On August 21, 2024, Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") received an expected delinquency notification letter (the "Letter") from Nasdaq's Listing Qualifications Department which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 ("Second Quarter 10-Q") and its continued delay in filing its Annual Report on Form 10-K for the year ended December 31, 2023 ("Annual Report") and Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 ("First Quarter 10-Q").
- 08/27/2024
|
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
- WOODCLIFF LAKE, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company” or “Eagle”) today announced that it received a notice (the “Notice”) on August 21, 2024, from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that pursuant to Nasdaq Listing Rule 5810(d)(2), the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Q2 2024 Form 10-Q”) serves as an additional and separate basis for delisting.
- 08/27/2024
|
Direct Digital Holdings Announces Receipt of Anticipated Additional Delinquency Notice
- HOUSTON , Aug. 27, 2024 /PRNewswire/ -- Today, Direct Digital Holdings, Inc. (the "Company") reported that the Company received an additional delinquency notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on August 21, 2024, which indicated that, as a result of the delay in the Company's filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the "Q2 Form 10-Q") by the applicable due date, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the "SEC"). The additional delinquency could serve as an additional basis for the delisting of the Company's securities from Nasdaq.
- 08/27/2024
|
Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
- WILMETTE, Ill., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced that it received notice from The Nasdaq Stock Market LLC (Nasdaq) that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) as a result of the closing bid price of the Company's common stock being $1.00 per share or greater for 10 consecutive trading sessions. The Company is now compliant with the minimum bid price listing standard for continued Nasdaq listing.
- 08/27/2024
|
Can These 3 Nasdaq 100 Laggards Rebound in September?
- Investors have been on a roller coaster ride for the past four years and the stock market may be heading into another big loop higher.
- 08/27/2024
|
Nasdaq and CF Benchmarks to Drive Development and Adoption of Digital Asset with New Index Options
- Nasdaq® Bitcoin Index Options (XBTX) will track CME CF Bitcoin Real-Time Index, providing added transparency, accessibility and reliability to cryptocurrency ecosystem Nasdaq® Bitcoin Index Options (XBTX) will track CME CF Bitcoin Real-Time Index, providing added transparency, accessibility and reliability to cryptocurrency ecosystem
- 08/27/2024
|
Laser Photonics Received NASDAQ Compliance Letters Related to Late Filing of the June 30, 2024 10-Q
- ORLANDO, FL / ACCESSWIRE / August 27, 2024 / Laser Photonics Corporation (LPC) (NASDAQ:LASE), a leading global industrial developer of CleanTech Laser Systems for laser cleaning and other applications, today announced that on August 20, 2024, it received a notice from Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC ("Nasdaq") stating that since the Company has not yet filed its Form 10-Q for the quarter ended June 30, 2024 (the "Filing"), and it no longer complies with Nasdaq's Listing Rules (the "Rules"), specifically Listing Rule 5250(c)(1), for continued listing. Under the Rules, the Company has 60 calendar days to submit a plan to regain compliance, and if Nasdaq accepts the Company's plan, Nasdaq can grant an exception of up to 180 calendar days from the Filing's due date, or until February 17, 2025, to regain compliance.
- 08/27/2024
|
Nasdaq, Wall Street seen lower as NVIDIA earnings remain in focus
- Wall Street looked set for a poor start on Tuesday morning as NVIDIA's latest update on Wednesday remained front and centre of investors' minds. This follows a negative session for both the Nasdaq and S&P 500 on Monday, with futures showing each 0.1% lower ahead of Tuesday's bell.
- 08/27/2024
|
LuxUrban Hotels Inc. Receives Nasdaq Listing Deficiency Notice
- MIAMI, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LuxUrban Hotels Inc. (NASDAQ: LUXH) today announced it has received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 20, 2024 indicating that the Company is not currently in compliance with Nasdaq's Listing Rules (“the Listing Rules”) due to the Company's not timely filing its Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (“SEC”). The Notice does not immediately affect the listing or trading of the Company's securities. According to Listing Rule 5250(c)(1), the Company was required to file Form 10-Q by August 14, 2024 (the “Due Date”). The Company previously reported its inability to file Form 10-Q by the Due Date on a Form 12b-25 that the Company filed with the SEC on August 14, 2024.
- 08/26/2024
|
Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)
- GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today reports that it received formal notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Q2 Quarterly Report”).
- 08/26/2024
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date August 15, 2024
- NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of August 15, 2024, short interest in 3,037 Nasdaq Global MarketSM securities totaled 12,277,781,936 shares compared with 11,985,723,964 shares in 3,043 Global Market issues reported for the prior settlement date of July 31, 2024. The mid-August short interest represents 2.62 days compared with 2.90 days for the prior reporting period.
- 08/26/2024
|
noco-noco Inc Announces Grant of Temporary Exception to remain listed on Nasdaq
- Singapore, Aug. 26, 2024 (GLOBE NEWSWIRE) -- noco-noco Inc (the "Company”) received a hearing decision letter (the “Decision Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Decision Letter gave the Company an exception period until October 30, 2024 to regain compliance with Listing Rule 5550(a)(2) (the “Bid Price Rule”) and Listing Rule 5550(b)(2) (the “MVLS Rule”) or any of the alternatives outlined in Listing Rule 5550(b).
- 08/26/2024
|
Capital Clean Energy Carriers Corp. Announces Completion of Corporate Conversion, Change of Name, Corporate Logo and Nasdaq Ticker
- ATHENS, Greece, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Capital Clean Energy Carriers Corp. (“CCEC”, “we” or “us”) (NASDAQ: CCEC), an international owner of ocean-going vessels, announces today completion of our conversion from a Marshall Islands limited partnership named “Capital Product Partners L.P.” to a Marshall Islands corporation (the “Conversion”) and our adoption of a new corporate identity with a change in name to “Capital Clean Energy Carriers Corp.” and Nasdaq stock market ticker to “CCEC” (the “Name Change”).
- 08/26/2024
|
This ETF Has Outperformed the S&P 500 and Nasdaq So Far in 2024. You Might Be Surprised What It Holds (Hint: Not The "Magnificent Seven").
- Exchange-traded funds (ETF) provide investors with exposure to broad investment themes without requiring ownership in a specific stock or asset. Spot Bitcoin ETFs are a good way to invest in crypto without directly purchasing Bitcoin itself.
- 08/25/2024
|
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
- These Nasdaq stocks offer ultra-high forward dividend yields of between 18% and 33%. All three stocks are down year to date, with two experiencing major declines.
- 08/25/2024
|
ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements
- VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutics company, announced today that the Company received written notification (the "Notification Letter") from the Nasdaq Global Market LLC ("Nasdaq") on August 19, 2024, indicating that the Company is not in compliance with the minimum bid price requirement set forth in the Nasdaq Rule 5450(a)(1) based on the closing bid price of the Company's common shares.
- 08/23/2024
|
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on August 22, 2024, the Board of Directors granted a non-qualified stock option award to purchase 40,000 shares of its common stock to one new non-executive employee under the Company's 2024 Inducement Equity Incentive Plan (the “2024 Inducement Plan”). The stock options were granted as an inducement material to the employee entering into employment with Skye in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/23/2024
|
Pioneer Receives Notification of Delinquency from Nasdaq
- FORT LEE, N.J.--(BUSINESS WIRE)--Pioneer Power Solutions, Inc. (Nasdaq: PPSI) (“Pioneer” or the “Company”), a leader in the design, manufacture, service and integration of electrical power systems, distributed energy resources, power generation equipment and mobile electric vehicle (“EV”) charging solutions, today announced that on August 21, 2024, the Company received a delinquency notification letter (the “10-Q Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Na.
- 08/23/2024
|
B. Riley Financial Announces Notification of Delinquency with Nasdaq
- LOS ANGELES , Aug. 23, 2024 /PRNewswire/ -- B. Riley Financial, Inc. (Nasdaq: RILY) (the "Company") announced it received an expected delinquency notification letter from Nasdaq on August 21, 2024, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Quarterly Report on Form 10-Q for the period ended June 30, 2024.
- 08/23/2024
|
Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq
- FLORHAM PARK, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the Company had received an expected delinquency notification letter (the “Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) on August 20, 2024. The Notice indicated that the Company is not in compliance with the periodic financial report filing requirement set forth in Nasdaq Listing Rule 5250(c)(1) as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Second Quarter 10-Q”), by the applicable due date.
- 08/23/2024
|
Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q
- BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) advising that, because the Company failed to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 (the “Form 10-Q”), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”). Nasdaq has informed the Company that it has until October 21, 2024, to submit a plan to regain compliance with the Rule. If Nasdaq approves the Company's plan, it has the discretion to grant the Company an extension of up to 180 calendar days from the due date of the Form 10-Q (or until February 17, 2025) to regain compliance.
- 08/23/2024
|
urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- LAFAYETTE, CO / ACCESSWIRE / August 23, 2024 / urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), an integrated professional services and Design-Build firm offering solutions to the Controlled Environment Agriculture ("CEA") and other commercial sectors, today announced that the Company received a notice (the "Notice) from The Nasdaq Stock Market LLC ("Nasdaq") on August 20, 2024, stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 (the "Form 10-Q"), the Company is no longer in compliance with Nasdaq listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. This notification has no immediate effect on the listing of the Company's common stock on the Nasdaq Capital Market.
- 08/23/2024
|
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company's Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 60,000 shares of its common stock under the Company's 2023 Inducement Plan.
- 08/23/2024
|
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”).
- 08/23/2024
|
China Liberal Education Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- BEIJING , Aug. 23, 2024 /PRNewswire/ -- China Liberal Education Holdings Limited (Nasdaq: CLEU) ("China Liberal", the "Company", "we", "our", or "us"), a China-based company that provides smart campus solutions and other educational services, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on August 21, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.
- 08/23/2024
|
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/23/2024
|
Sotherly Hotels Inc. Receives Notification of Deficiency From Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
- WILLIAMSBURG, Va., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO) (the “Company”) today announced that it has received a notice (“Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the "Form 10-Q") in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1).
- 08/23/2024
|
Nasdaq Surges Over 1%; Workday Shares Climb After Q2 Earnings
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 1% on Friday.
- 08/23/2024
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , Aug. 23, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on August 19, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 150,000 shares of the Company's common stock to a newly hired employee.
- 08/23/2024
|
NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report
- SANTA ANA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced it received a standard notice (the “Notice”) on August 20, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) because it had not timely filed its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) on or before August 19, 2024, the extended period provided for the filing under Rule 12b-25(b) of the Securities Exchange Act of 1934, as amended. The delay is in part due to the recent change in the Company's independent registered public accounting firm and its valuation firm. The Notice indicated that the Company has 60 calendar days, or until October 21, 2024, to submit a plan to regain compliance and that Nasdaq can grant an exception of up to 180 calendar days from the Form 10-Q due date, or until February 18, 2025, to regain compliance. The Notice from Nasdaq has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Global Market.
- 08/22/2024
|
Gulf Resources Announces Receipt of Nasdaq Non-Compliance Notice
- SHOUGUANG, China, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Gulf Resources, Inc. (NASDAQ: GURE) (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that on August 20, 2024, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2024, with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC. The Notice indicates that as a result of this additional delinquency, the Company must submit an update to its original plan to regain compliance with respect to the filing requirements. The Company has until September 4, 2024 to submit such update to Nasdaq.
- 08/22/2024
|
Fresh2 Group Ltd. Announces Receipt of an Additional Delinquency Compliance Alert Notice from Nasdaq
- New York, NY, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) (“Fresh2” or the “Company”), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on August 19 , 2024, it received an additional delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising they have not received the Company's Form 10-Q for the period ended June 30, 2024, it does not comply with the Listing Rules 5250(c)(1) (the “Rules”), which requires the timely filing of all required periodic reports with the SEC.
- 08/22/2024
|
Kaixin Holdings Announces Receipt of Nasdaq Delisting Determination and Submission of Appeal
- HANGZHOU, China, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kaixin Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN), a leading new energy vehicle manufacturer and sales platform in China, today announced that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) dated August 19, 2024, indicating that the Company was not in compliance with Nasdaq Listing Rule 5810(c)(3)(A)(iii), as the Company's securities had a closing bid price of $0.10 or less for ten consecutive trading days (the “Letter”). The Letter indicated that, as a result, the Nasdaq staff has determined to delist the Company's securities from The Nasdaq Capital Market (the “Delisting Determination”).
- 08/22/2024
|
Nasdaq Down Over 200 Points; Williams-Sonoma Shares Tumble After Q2 Results
- U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Thursday.
- 08/22/2024
|
Yunhong Green CTI Ltd. Receives Non-Compliance Notification from Nasdaq Related to its Inability to file its 10-Q for the Period Ended June 30, 2024
- Prior Auditor Suspended from Practicing, Requiring Additional Work to be Performed Prior to issuing 2024 Filings
- 08/22/2024
|
Nasdaq Sell-Off: 2 Unstoppable Growth Stocks to Buy Right Now
- Macroeconomic concerns have caused a dip in the tech-rich Nasdaq Composite. As a result, now is an excellent time to add to your portfolio with some of tech's most reliable growth stocks.
- 08/22/2024
|
Alpine 4 Holdings, Inc. Announces Receipt of Nasdaq Staff Determination Letter
- PHOENIX, AZ / ACCESSWIRE / August 21, 2024 / Alpine 4 Holdings, Inc. (NASDAQ:ALPP) (the "Company"), announced today that on August 16, 2024, the Company received an Additional Staff Determination letter (the "August 16 Letter") from The Nasdaq Stock Market ("Nasdaq") informing the Company that because the Company is delinquent in filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the "Q2 Quarterly Report"), such delinquency would serve as an additional basis for delisting the Company's securities from Nasdaq. The Staff Determination was issued because the Company did not file its Q2 Quarterly Report in a timely manner.
- 08/21/2024
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 37,975 restricted stock units of the company's common stock to 12 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of August 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/21/2024
|
Phoenix Motor Inc. Announces Receipt of Nasdaq Listing Delinquency Letter
- ANAHEIM, CA / ACCESSWIRE / August 21, 2024 / Phoenix Motor Inc. (NASDAQ:PEV) (the "Company") today announced that it received a delinquency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC ("Nasdaq") on August 16, 2024 due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024. Previously, on May 22, 2024, the Company received a delinquency notification from Nasdaq that the Company no longer complied with the Listing Rule as it had not yet filed its Form 10-Q for the quarterly period ended March 31, 2024 (the "Initial Delinquent Filing").
- 08/21/2024
|
SigmaTron International, Inc. Receives Nasdaq Notice Regarding Late Form 10-K Filing
- ELK GROVE VILLAGE, Ill., Aug. 21, 2024 (GLOBE NEWSWIRE) -- SigmaTron International, Inc. (the “Company”) announced today that on August 16, 2024, it received a delinquency notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the continued listing requirements under Nasdaq Listing Rule 5250(c)(1) because the Company did not timely file its Form 10-K for the fiscal year ended April 30, 2024 (the “Form 10-K”). The notification letter has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market.
- 08/21/2024
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , Aug. 21, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on August 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 52,100 shares of its common stock and 26,050 restricted stock units ("RSUs") to seven (7) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/21/2024
|
Nasdaq Gains 0.5%; TJX Earnings Top Estimates
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.5% on Wednesday.
- 08/21/2024
|
2 Recent Artificial Intelligence (AI) Stock-Split Stocks to Buy During the Nasdaq Sell-Off
- Nvidia and Broadcom have recently split their stocks, but only a sell-off makes them cheaper. Nvidia looks like a deal, but buying lower would give investors some cushion just in case.
- 08/21/2024
|
Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules
- CUPERTINO, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced the pricing of an underwritten offering of 4,761,905 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and investor warrants to purchase up to 4,761,905 shares of common stock. The combined offering price of each share of common stock and accompanying warrant sold in the offering (including the pricing for the warrant repricing described below) will be equal to $1.05, priced at-the-market under the Nasdaq rules. The combined offering price of each pre-funded warrant and accompanying warrant sold in the offering will be equal to $1.0499. The warrants have an exercise price of $0.7964 per share, will be immediately exercisable and will expire five years following the date of issuance. The pre-funded warrants have an exercise price of $0.0001 per share, will be immediately exercisable and may be exercised at any time after their original issuance. The offering is expected to close on or about August 22, 2024, subject to customary closing conditions.
- 08/21/2024
|
This Is the Only Stock I Added to During the Recent Nasdaq Sell-Off -- and It Remains Jaw-Droppingly Cheap
- Stock market corrections are usually an opportune time for long-term investors to scoop up amazing companies at a discounted price. However, the stock market remains historically pricey, which has made investors selective about where they'll put their cash to work.
- 08/21/2024
|
Mesa Air Group Discloses Notice from Nasdaq
- PHOENIX, AZ / ACCESSWIRE / August 20, 2024 / Mesa Air Group, Inc. (NASDAQ:MESA) ("Mesa" or the "Company") today announced that it received a notice ("Notice") on August 16, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the "Form 10-Q") with the Securities and Exchange Commission. The filing delay is not the result of a forthcoming restatement of the Company's financial statements or any disagreement with the Company's auditors.
- 08/20/2024
|
TOYO Co., Ltd to Ring the Nasdaq Closing Bell on Thursday, August 22, 2024
- TOKYO , Aug. 20, 2024 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) ("TOYO" or the "Company"), a solar solution company, today announced the Company will ring the closing bell at the Nasdaq MarketSite in Times Square, New York on Thursday August 22, 2024. "We are excited and honored to ring the bell to commemorate our recent listing," said Mr.
- 08/20/2024
|
Final Trades: Nasdaq, TJX Companies, UnitedHealth and Salesforce
- The Investment Committee give you their top stocks to watch for the second half.
- 08/20/2024
|
Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
- U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday.
- 08/20/2024
|
Vision Marine Technologies Announces Reverse Stock Split, Warrant Exchange and Receives Nasdaq Staff Determination Letter Regarding Non-Compliance with Minimum Bid Price Requirement
- MONTREAL, QC / ACCESSWIRE / August 20, 2024 / Vision Marine Technologies, Inc. (NASDAQ:VMAR) ("Vision Marine" or the "Company"), a pioneer in electric marine propulsion, today announced that its Board of Directors (the "Board") has approved a 15-for-1 reverse stock split of the Company's common shares. The reverse stock split is expected to become effective when the market opens on August 22, 2024 (the "Effective Date").
- 08/20/2024
|
Middlefield Banc Corp. to Celebrate 10th Anniversary of Nasdaq Listing
- Middlefield to Ring the Nasdaq Stock Market Opening Bell on Tuesday, August 27, 2024 Middlefield to Ring the Nasdaq Stock Market Opening Bell on Tuesday, August 27, 2024
- 08/20/2024
|
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced, as required by Nasdaq Stock Market rules, the grant of inducement awards to six new employees.
- 08/19/2024
|
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 150 points on Monday.
- 08/19/2024
|
Calamos Announces Upside Cap Ranges for Upcoming Structured Protection ETFs Providing Exposure to S&P 500 and Nasdaq-100 with 100% Downside Protection Over One Year
- The Calamos S&P 500® Structured Alt Protection ETF™ – September (CPST) has an estimated upside cap range of 7.39% - 8.57% over the one-year outcome period following its launch on September 3, 2024. The Calamos Nasdaq-100® Structured Alt Protection ETF™ – September (CPNS) has an estimated upside cap range of 7.82% - 9.18% over the one-year outcome period following its launch on September 3, 2024.
- 08/19/2024
|
Metalpha Receives Notification of Deficiency from The Nasdaq Stock Market LLC
- HONG KONG , Aug. 19, 2024 /PRNewswire/ -- Metalpha Technology Holding Limited (Nasdaq: MATH) (the " Company " or " Metalpha "), a global digital asset-focused wealth management company, today announced that on August 1 5 , 202 4 it has received a written notice from The Nasdaq Stock Market LLC (the " Nasdaq ") which states that, as a result of not having timely filed its annual report on Form 20-F for the fiscal year ended March 31, 202 4 (the " 202 4 Form 20-F "), Metalpha is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (the " SEC "). This notice has no immediate effect on the listing or trading of Metalpha's ordinary shares on the Nasdaq Capital Market.
- 08/19/2024
|
Down 98%, Here's Why You'll Regret Buying the Dip on This Nasdaq Stock
- This business was once a darling on Wall Street, as consumer demand was red-hot. Following the pandemic, revenue started declining, with rising net losses.
- 08/19/2024
|
Nasdaq Sell-Off: 1 Unstoppable Stock Down 39% to Buy on the Dip, According to Wall Street
- After a smooth first half of 2024, the stock market is undergoing volatility. That could be a buying opportunity, and Datadog is one stock to consider, especially for its growing artificial intelligence (AI) business.
- 08/19/2024
|
2 Nasdaq Stocks to Buy Before They Soar as Much as 102%, According to Select Wall Street Analysts
- Despite the recent Nasdaq correction, many on Wall Street believe the rally will continue. CrowdStrike Holdings suffered a very public shellacking for starting a global IT meltdown, but many believe this is a buying opportunity.
- 08/18/2024
|
Viomi Technology Co., Ltd Regains Compliance with Nasdaq's Minimum Bid Price Requirement
- GUANGZHOU, China , Aug. 17, 2024 /PRNewswire/ -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced that it has received a written notification letter (the "Compliance Notice") from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") dated August 16, 2024, informing the Company that it has regained compliance with the Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement"). As previously announced, on March 26, 2024, Viomi received a notification letter from Nasdaq indicating that the Company was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company's American Depositary Shares (the "ADSs") was below US$1.00 per ADS for 30 consecutive business days.
- 08/17/2024
|
Arogo Capital Acquisition Corp. Announces Receipt of Nasdaq Delisting Notice
- MIAMI BEACH, FL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Arogo Capital Acquisition Corp. (“Arogo” or the “Company”) (Nasdaq: AOGO/AOGOU/AOGOW), a special purpose acquisition company, today announced that it received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 12, 2024, notifying the Company that, based on the market value of publicly held shares for the previous 30 consecutive business days, the Company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(C), which requires the Company's listed securities to maintain a minimum market value of publicly held shares of $15,000,000 (the "MVPHS Rule"). The notice has no immediate effect on the listing of the Company's securities on Nasdaq. The Company intends to monitor the market value of the Company's listed securities and may, if appropriate, consider available options to regain compliance with the MVPHS Rule.
- 08/16/2024
|
Powerfleet Announces Receipt of Expected Delinquency Notification Letters from Nasdaq Relating to Non-Compliance with Nasdaq Listing Rule 5250(c)(1)
- Submitted response to previously announced SEC comment letter involving non-cash accounting issue; targeting to resolve matter within the month of August WOODCLIFF LAKE, N.J. , Aug. 16, 2024 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: AIOT) today announced that on August 8 and August 15, 2024, the Company received, as expected, written notices from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it did not timely file its Transition Report on Form 10-KT for the transition period ended March 31, 2024 (the "Form 10-KT") and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the "Form 10-Q"), as required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5250(c)(1).
- 08/16/2024
|
ECD Automotive Design Announces Nasdaq Delisting Notification
- KISSIMMEE, Fla., Aug. 16, 2024 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (“ECD” or the “Company”) (NASDAQ: ECDA), an industry leader in delivering restored, modified and electrified Land Rover Defenders, Jaguars, and other classic and collectible automobiles, today announced that the Company received a delisting notice from The Nasdaq Stock Market LLC (“Nasdaq”).
- 08/16/2024
|
CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PRINCETON, N.J., Aug. 16, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today announced that it granted inducement equity awards on August 14, 2024 (the “Grant Date”) to its newly-hired Chief Financial Officer, Peter J. Mariani.
- 08/16/2024
|
Can Stocks Hold Strong Weekly Gains?
- In what continues to be a remarkable turnaround, stocks further added to this week's gains on Thursday. The S&P 500 closed higher by 1.6% while the Nasdaq Composite gained 2.34%. The Russell 2000 and Dow Jones Industrial Average were higher by 2.6% and 1.4%, respectively. For the week, the Nasdaq is higher by 5% while the S&P is up 3.5%. For the month, the S&P is now in positive territory with the Nasdaq flat. It's an amazing turnaround from where we were just eleven days ago.
- 08/16/2024
|
Rezolve AI Limited Closes Business Combination with Armada Acquisition Corp. I; Announces Date for Commencement of Trading on the Nasdaq; Launching one of the first pure play Ai companies with its own foundation Large Language Model - brainpowa
- Rezolve AI Limited Closes Business Combination with Armada Acquisition Corp. I; Launching one of the first pure play Ai companies with own LLM on Nasdaq
- 08/15/2024
|
Lead Real Estate Co., Ltd Receives Notification Regarding Non-Compliance of Nasdaq Global Market Minimum Market Value of Publicly Held Shares Requirement
- TOKYO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd. (Nasdaq: LRE) (“LRE” or the “Company”), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, today announced that the Company received a written notification (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 12, 2024, notifying the Company that it is not in compliance with the minimum market value of publicly held shares ("MVPHS") requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq Global Market.
- 08/15/2024
|
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1, 2024, Anika granted non-statutory stock options (“Options”) covering an aggregate of 8,850 shares of common stock at a per share exercise price of $26.29, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to two newly hired non-executive employees. The grants were made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, were approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), were made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation.
- 08/15/2024
|
Collective Audience to Transition to OTC Markets Following Delisting from Nasdaq Global Market
- Company Received Notice of Delisting Yesterday from Nasdaq without Traditionally Granted Grace Period as it Pursues Potential Appeal to Continue Trading on Nasdaq NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Collective Audience, Inc. (Nasdaq:CAUD), a leading innovator of audience-based performance advertising and media, announced its common stock will be suspended from trading on the Nasdaq Global Market effective upon the open of trading on Friday, August 16, 2024 following a Nasdaq Hearings Panel determination to delist the company's shares. The company is currently arranging for its stock to begin trading temporarily on the OTC Markets' Pink Open Market at the opening of the markets on Friday, August 16, 2024, while it pursues a request for reconsideration and contemplates filing an appeal to the Nasdaq Listing and Hearing Review Council.
- 08/15/2024
|
TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b)
- EDINBURGH, Scotland , Aug. 15, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that the Company has regained compliance with the Nasdaq Stock Market Listing Rule 5550(b) which will maintain the listing of the Company's American depositary shares on the Nasdaq Global Select Market. On May 24, 2024, the Company received written notification from the listing qualifications staff of the Nasdaq Stock Market, LLC ("Nasdaq") indicating that the Company was not in compliance with the Minimum Stockholders' Equity Requirement, as of March 31, 2024.
- 08/15/2024
|
Nasdaq Jumps Over 2%; Walmart Earnings Top Views
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Thursday.
- 08/15/2024
|
ZK International Achieves Nasdaq Compliance and Provides Update on Bid Price Compliance Plan
- WENZHOU, China , Aug. 15, 2024 /PRNewswire/ -- ZK International Group Co., Ltd. ( Nasdaq: ZKIN ) ("ZKIN", "ZK International" or the "Company"), a leading manufacturer and supplier of patented high-performance stainless steel and carbon steel pipe products, is pleased to announce two important updates regarding its Nasdaq listing status.
- 08/15/2024
|
Golden Heaven Group Holdings Ltd. Announces Receipt of Nasdaq Delisting Determination and Plans to Appeal
- NANPING, China, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Golden Heaven Group Holdings Ltd. ("Golden Heaven" or the "Company") (Nasdaq: GDHG), an amusement park operator in China, today announced the Company received a staff determination letter (the “Letter”), on August 9, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to the Company's failure to regain compliance with the minimum bid price of $1.00 per share requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Requirement"), Nasdaq has determined (the “Determination”) that the Company's securities will be scheduled for delisting from Nasdaq unless the Company requests an appeal of such Determination to a Hearings Panel (the "Panel").
- 08/14/2024
|
3 Nasdaq Stocks to Buy on the Dip: August 2024
- Nasdaq stocks are effectively navigating a rollercoaster market with resilience. Despite a recent flurry of challenges for the tech space, Nasdaq stocks have outperformed the S&P 500 in the past two months.
- 08/14/2024
|
3 Nasdaq Stocks Poised for a Comeback After Last Week's Market Meltdown
- Earlier this month, the CBOE Volatility Index or VIX shot higher, indicating extreme pessimism among investors. While not a directional index per say, the VIX measures anticipated market movement.
- 08/14/2024
|
Benson Hill Announces Listing Transfer to The Nasdaq Stock Market LLC
- ST. LOUIS--(BUSINESS WIRE)---- $BHIL #BHIL--Benson Hill will transfer its stock exchange listing to The Nasdaq Stock Market LLC from the New York Stock Exchange.
- 08/13/2024
|
UTime Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets, announced today that it received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company's ordinary shares to maintain a minimum bid price of $1.00 per share.
- 08/13/2024
|
Nasdaq Sell-Off: Buy the Dip on This "Magnificent Seven" Stock Before It Takes Off
- Meta Platforms' shares are down along with other big tech stocks recently. However, this means very little for the company's long-term prospects.
- 08/13/2024
|
Nasdaq, S&P 500 Futures Waver As Home Depot Sags And PPI Report Awaited: Analyst Says 'Insufficient Technical Evidence' That Bottom Has Been Set
- Wall Street is priming for a positive start on Tuesday, as the market resiliently holds onto optimism regarding receiving benign inflation data, which will likely seal the fate of a rate cut. The producer price inflation data due ahead of the market opening is likely to show further easing in pricing pressure at the wholesale level, potentially serving as a harbinger of tame consumer price inflation data.
- 08/13/2024
|
3 Underrated Nasdaq 100 Stocks to Turn $10,000 Into $50,000 by 2029
- Finding underrated Nasdaq 100 stocks to buy in 2024 will not be a walk in the park. Although the index recently experienced a small dip, many of the companies are still extremely expensive.
- 08/13/2024
|
SOBRsafe Provides Q2 2024 Quarterly Update
- DENVER, CO / ACCESSWIRE / August 12, 2024 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), provider of next-generation transdermal alcohol detection solutions, today provided a comprehensive update on the status of its Nasdaq listing, financial positioning and sales progress: Nasdaq Listing The Nasdaq Hearings Panel has granted SOBRsafe an exception period continuing the listing of its common stock on The Nasdaq Stock Market. SOBRsafe has until October 23, 2024 to execute its plan to regain compliance with Nasdaq's $1.00 minimum bid price per share requirement, and to demonstrate long-term compliance with the required minimum of $2.5 million in stockholders' equity.
- 08/12/2024
|
Jianzhi Education Technology Group Company Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- BEIJING, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a leading provider of digital educational content in China, today announced that the Company has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated August 7, 2024, indicating that for the last 30 consecutive business days, the closing bid price for the Company's American depositary shares (the “ADSs”) was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rules. The Nasdaq notification letter has no current effect on the listing or trading of the Company's securities on the Nasdaq Global Select Market.
- 08/12/2024
|
Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on August 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted non-qualified stock option awards to purchase an aggregate of 103,900 shares of its common stock to fifteen new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/12/2024
|
Should You Buy the 3 Worst Nasdaq 100 Stocks Since the Tech Sector Selloff?
- The tech sector selloff that began in July gave investors the jitters. The best tech stocks were in freefall after carrying the Nasdaq 100 to new heights.
- 08/12/2024
|
Nasdaq 100: Nvidia Surge Lifts Tech Stocks as Investors Brace for Inflation Data
- Stocks mixed as markets brace for key inflation data this week. Nvidia boosts Nasdaq, while small caps falter.
- 08/12/2024
|
3 Bullish Tech Stocks That Are Ignoring the Nasdaq Selloff
- The tech-heavy Nasdaq Composite index has officially entered into correction territory, having fallen more than 10% from its record high set just a few weeks ago in July. Many high-flying tech stocks that saw massive rallies over the past two years have been hit the hardest in the recent market rout.
- 08/11/2024
|
Nasdaq Sell-Off: 3 Smart Stocks to Buy Right Now
- Global-e has a growing, niche e-commerce business. Roku's accounts and streaming hours continue to increase.
- 08/11/2024
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 08/09/2024
|
Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2024
- NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of July 31, 2024, short interest in 3,043 Nasdaq Global MarketSM securities totaled 11,985,723,964 shares compared with 12,309,469,231 shares in 3,044 Global Market issues reported for the prior settlement date of July 15, 2024. The end of July short interest represent 2.90 days average daily Nasdaq Global Market share volume for the reporting period, compared with 2.95 days for the prior reporting period.
- 08/09/2024
|
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to four new employees. Fulcrum granted stock options to purchase shares of the company's common stock pursuant to the company's 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/09/2024
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 19,800 shares of the Company's common stock to two new employees and 350,000 shares of the Company's common stock to the newly-hired Chief Operating Officer, Francis Sarena (the “Inducement Grants”) on August 5, 2024 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/09/2024
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on August 6, 2024, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 33,000 shares of Class A common stock and restricted stock units (RSUs) for 16,500 shares of Class A common stock to three new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/09/2024
|
Nasdaq and S&P 500 to slip lower as markets calm; Expedia and Paramount surge
- 8.33am: Wall Street to edge lower US stocks are on track to open slightly lower later today, in what could be a slightly more relaxed day of trading compared to earlier this week. However, it might not be calm for long if Terry Sandven at U.S. Bank Wealth Management is correct.
- 08/09/2024
|
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced that it has agreed to grant inducement awards to four newly hired employees. The awards were made as inducements material to each individual's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/09/2024
|
Nasdaq Stock Market Sell-Off: 3 Stocks to Put on Your Buy List
- Alphabet is growing rapidly, but priced in line with the broad market. Taiwan Semiconductor Manufacturing is seeing revenue growth accelerate and its competitive advantages remain impressive.
- 08/09/2024
|
The 3 Best Nasdaq Stocks to Buy in August 2024
- The Nasdaq 100 has more than doubled over the past five years. It's filled with the top 100 non-financial Nasdaq stocks based on market cap.
- 08/09/2024
|
Nasdaq Sell-Off: 5 Unstoppable Stocks to Buy That Can Protect Your Principal and Grow Your Wealth in an Unpredictable Market
- The Nasdaq Composite shed almost 1,400 points in a three-day stretch, which decisively pushed this growth-oriented index into correction territory. Heightened volatility on Wall Street is no reason for long-term investors to retreat to the sideline.
- 08/09/2024
|
Nasdaq Market Correction: 2 Brilliant Artificial Intelligence (AI) Stocks to Buy on the Dip
- The Nasdaq Composite has declined 13% from its record high, but history says the index could rebound sharply during the next 12 months. Alphabet has a strong presence in digital advertising and cloud computing and is using artificial intelligence to create new monetization opportunities.
- 08/09/2024
|
Final Trades: Qualcomm, Seagate and the Nasdaq
- The Investment Committee give you their top stocks to watch for the second half.
- 08/08/2024
|
JPMorgan Asset Management Launches Fundamental Data Science ETF Suite on Nasdaq
- Funds leverage advanced data insights NEW YORK , Aug. 8, 2024 /PRNewswire/ -- J.P. Morgan Asset Management (JPMAM) today announced the launch of the JPMorgan Fundamental Data Science (FDS) Suite on the Nasdaq Stock Exchange.
- 08/08/2024
|
Nasdaq and S&P 500 to open flat as recession fears grow; Eli Lilly rallies
- 8.30am: Wall Street to open flat US markets are set to open flat today, with stocks struggling to stabilise as recession fears were renewed and carry trades continued to unwind. The Dow Jones is shifting slightly lower in premarket futures, predicted to open 46 points lower at 38,864.
- 08/08/2024
|
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on August 6, 2024, the compensation committee of BridgeBio's board of directors approved equity grants to 17 new employees in restricted stock units for an aggregate of 71,859 shares of the Company's common stock. One-fourth of the shares underlying each employee's restricted stock units will vest on August 16, 2025, with one-twelfth of the remaining shares underlying each such employee's restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee's continued employment with the Company or one of its subsidiaries on such vesting dates. All of the above-described awards were made under BridgeBio's Amended and Restated 2019 Inducement Equity Plan (the “Plan”).
- 08/08/2024
|
Nasdaq Correction: My Top "Magnificent Seven" Stock to Buy in August
- Microsoft's valuation reached a more attractive level. It is slowing the pace of buybacks to reinvest in the business.
- 08/08/2024
|
The Nasdaq Is in Turmoil: 3 High-Yield Dividend Stocks That Make for Screaming Buys During This Historic Sell-Off
- The Nasdaq Composite has firmly entered correction territory, with the index logging its eighth-largest nominal-point decline (576 points) in its storied history on Monday, Aug. 5. Few investment strategies have delivered with more consistency for long-term investors than buying and holding high-quality dividend stocks.
- 08/08/2024
|
CENTOGENE Receives Delisting Notice From Nasdaq
- CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it received a notice from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel has determined to delist CENTOGENE'S common stock from Nasdaq. The notice indicates that CENTOGENE (the “Company”) remains noncompliant with Nasdaq Listing Rule 5450(b)(2)(C), which requires a minimum USD 15 million market value of publicly held shares.
- 08/07/2024
|
Fusion Fuel Green Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
- Ordinary shares will continue to trade on the Nasdaq Global Market, and the Company's listing on such exchange is not affected by the receipt of the Notice Ordinary shares will continue to trade on the Nasdaq Global Market, and the Company's listing on such exchange is not affected by the receipt of the Notice
- 08/07/2024
|
Nasdaq Jumps 250 Points; Disney Earnings Beat Estimates
- U.S. stocks traded higher this morning, with the Dow Jones index gaining around 1% on Wednesday.
- 08/07/2024
|
Is It Time to Buy July's Worst-Performing Nasdaq Stocks?
- DexCom signaled slower growth in the second half of 2024 but looks ready to perform in the long run. Helen of Troy doesn't look great after a weak earnings report with unclear long-term growth prospects.
- 08/07/2024
|
1 No-Brainer Artificial Intelligence (AI) Stock to Buy Following the Nasdaq's Recent Drop
- Alphabet stock has pulled back of late despite the company posting better-than-expected results last month. AI has started boosting Alphabet's growth, a trend that's likely to continue.
- 08/07/2024
|
Nasdaq Market Correction: 1 "Magnificent Seven" Stock to Buy Now, and Another to Avoid
- The Nasdaq Composite recently entered correction territory, meaning the index has fallen more than 10% from its record high. Amazon has a strong presence in e-commerce, digital advertising, and cloud computing, and shares look inexpensive at their current valuation.
- 08/07/2024
|
The Nasdaq Is Plunging: 3 No-Brainer Hypergrowth Stocks to Buy Right Now to Take Advantage of This Sell-Off
- Monday's 576-point decline was the Nasdaq Composite's eighth-largest nominal-point drop in its storied history. Although a full-blown bear market is possible, the Nasdaq sell-off has unearthed some plain-as-day deals among growth stocks.
- 08/07/2024
|
Aeries Technology Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
- NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a global professional services and technology consulting partner, today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on July 31, 2024 ( the “Notice”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Annual Report on Form 10-K for the year ended March 31, 2024 (the “Fiscal 2024 Form 10-K”) as described more fully in the Company's Form 12b-25 Notification of Late Filing (the “Form 12b-25”) filed with the Securities and Exchange Commission (the "SEC") on July 1, 2024. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.
- 08/06/2024
|
mF International Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- HONG KONG, Aug. 06, 2024 (GLOBE NEWSWIRE) -- mF International Limited (the “Company” or “mF International”) (Nasdaq: MFI), a Hong Kong-based experienced financial trading solution provider, today announced that the Company received a written notification letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) on August 1, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon the receipt of a deficiency notification.
- 08/06/2024
|
Third Coast Celebrates its 1,000th day as a Nasdaq listed company by Ringing the Nasdaq Closing Bell
- Completed successful IPO on November 12, 2021 Expanded community banking offices from 11 in 2021 to 18 today HOUSTON , Aug. 6, 2024 /PRNewswire/ -- Third Coast Bancshares, Inc. (NASDAQ: TCBX) (the "Company," "Third Coast," "we," "us," or "our"), the bank holding company for Third Coast Bank operating primarily in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, today announced that its Chairman and Chief Executive Officer, Bart Caraway, and other members of the Third Coast management team will ring the closing bell at the Nasdaq MarketSite in Times Square, New York on Tuesday, August 6, 2024. "Today we celebrate another milestone for our Company," said Mr.
- 08/06/2024
|
Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements
- DUBLIN, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, obtained an extension to demonstrate compliance with a continued listing requirement of The Nasdaq Global Select Market.
- 08/06/2024
|
Nasdaq Grants NWTN Extension to File its Annual Report on Form 20-F
- DUBAI, United Arab Emirates, Aug. 06, 2024 (GLOBE NEWSWIRE) -- NWTN Inc. (Nasdaq: NWTN), an eco-conscious mobility technology company bringing passenger-centric green premium mobility solutions to the world (“NWTN”), today announced that the Nasdaq Stock Market LLC (“Nasdaq”) has determined to grant NWTN an exception to Listing Rule 5250(c)(1) (the “Rule”), giving NWTN an extension of the deadline to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 (the “2023 20-F”).
- 08/06/2024
|
3 Nasdaq Stocks to Sell in August Before They Crash & Burn
- The stock market has enjoyed a nice rally for most of 2024 after a strong recovery in 2023. However, equities are showing some weakness, with many tech companies in the middle of corrections.
- 08/06/2024
|
Grindrod Shipping Holdings Ltd. Announces Voluntary Delisting from Nasdaq Global Select Market
- SINGAPORE, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Grindrod Shipping Holdings Ltd. (NASDAQ: GRIN) (JSE: GSH) (“Grindrod Shipping” or “Company”), a global provider of maritime transportation services predominantly in the drybulk sector, today announced its intention to voluntarily delist its ordinary shares from the NASDAQ Global Select Market (“Nasdaq”), in connection with its proposed Selective Capital Reduction pursuant to Section 78G of the Companies Act of 1967 of Singapore (the “Selective Capital Reduction”).
- 08/06/2024
|
International Media Acquisition Corp. Announces Receipt of Nasdaq Delisting Notice
- NEW YORK, NY / ACCESSWIRE / August 5, 2024 / International Media Acquisition Corp. (the "Company" or "IMAQ") (NASDAQ:IMAQ) today announced that it received a delisting notification letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on July 30, 2024. The delisting determination arises from the Company's failure to complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement.
- 08/05/2024
|
YY Group Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- SINGAPORE, Aug. 05, 2024 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”, “YYGH”, or the “Company”), a data and technology-driven provider of hotel and hospitality staffing and commercial cleaning and janitorial services, today announces that it has received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Capital Market (“Nasdaq”) on August 1, 2024, notifying the Company that it was not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon the receipt of a deficiency notification.
- 08/05/2024
|
Nasdaq Reports July 2024 Volumes
- NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for July 2024 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics .
- 08/05/2024
|
Inverse ETFs Spike as Nasdaq Enters Correction
- The tech-heavy Nasdaq Composite Index entered correction territory (down 10% from its early July record high) after a softer-than-expected jobs data report spurred worries over a slowing U.S. economy.
- 08/05/2024
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , Aug. 5, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on August 1, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted a non-qualified stock option award to purchase an aggregate of 160,000 shares of its common stock and 25,000 restricted stock units ("RSUs") to John B. Moriarty, Jr., under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"), in connection with Mr.
- 08/05/2024
|
Top Wealth Group Holding Limited Announces Receipt of Nasdaq Notification Letter Regarding
- Minimum Bid Price Deficiency Hong Kong, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Top Wealth Group Holding Limited (NASDAQ: TWG) (“Top Wealth” or the “Company”), a Hong Kong-based supplier of luxury caviar products, today announced that it received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on July 30, 2024 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company's ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.
- 08/05/2024
|
Nasdaq Market Correction: 3 No-Brainer Stocks to Buy on the Pullback
- The Nasdaq Composite Index slipped into a correction last week. Three Nasdaq stocks have especially strong growth prospects.
- 08/05/2024
|
CNBC Daily Open: Nasdaq in correction territory; Berkshire's cash holdings reach record high
- Nasdaq in correction territory as U.S. stocks plunge. Berkshire's cash holdings hit a record high of $276.9 billion
- 08/04/2024
|
Meet the 5.4%-Yielding Dividend Stock That Is Crushing the S&P 500 and Nasdaq Composite in 2024
- Kinder Morgan is at a five-year high, and it still has more potential ahead. Results have been good, and the balance sheet is in excellent shape.
- 08/04/2024
|
History Says the Nasdaq Could Soar: 3 Warren Buffett Stocks to Buy Now
- A century's worth of market history suggests investors could be looking at several more years of strong returns. Buffett's favorite stock of all time continues to look like a solid long-term investment.
- 08/04/2024
|
2 Nasdaq Stocks to Buy Before They Soar as Much as 226% According to Select Wall Street Analysts
- Despite the index hitting multiple all-time highs this year, many veteran Wall Street analysts believe the rally has legs. Nvidia is an early beneficiary of the AI revolution and is poised to climb even higher.
- 08/04/2024
|
Maquia Capital Acquisition Corporation Plans to Trade OTC After Delist from Nasdaq
- Miami, Florida, Aug. 02, 2024 (GLOBE NEWSWIRE) -- On May 7, 2024, Maquia Capital Acquisition Corporation (“Maquia” or the “Company”) received a notice from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) that Maquia was not in compliance with Nasdaq Listing Rule IM-5101-2 requiring a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement triggering the issuance of a Staff Delisting Determination under Rule 5810 to delist the Company's securities. Because the Company was unable to complete a business combination by the end of the 36-month period, the Company was not in compliance. In conformity with the Listing Rules, the Company filed an appeal on May 13, 2024. A hearing on this matter was held by the Nasdaq Hearings Panel (“Panel”) on June 20, 2024.
- 08/02/2024
|
Nasdaq Enters Correction As Jobs Report Fuels Massive Stock Selloff
- All three major indexes fell Friday, as stocks declined following a report indicating the U.S. economy added fewer jobs than expected last month, kindling concerns of a recession.
- 08/02/2024
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers, today announced that the Company granted stock options to two new employees to purchase an aggregate of 11,800 shares of the Company's common stock, effective as of August 1, 2024. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan, with a grant date of August 1, 2024, as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/02/2024
|
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass. and DUBLIN, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that on August 1, the Company granted to one newly hired employee (i) non-statutory stock options to purchase an aggregate of 13,000 ordinary shares of the Company and (ii) restricted stock units with respect to an aggregate of 7,000 ordinary shares of the Company, pursuant to the Company's 2024 Inducement Stock Option and Incentive Plan, each as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/02/2024
|
JIADE LIMITED Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- Chengdu, China, Aug. 02, 2024 (GLOBE NEWSWIRE) -- JIADE LIMITED (Nasdaq: JDZG) (the “Company”), a company that specializes in providing one-stop comprehensive education supporting services to adult education institutions, today announced that the Company received a letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) on July 31, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.
- 08/02/2024
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on July 31, 2024, the company granted equity awards to five new employees, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/02/2024
|
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of July 31, 2024, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 1,250 shares of Vor Bio's common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 1,875 shares of Vor Bio's common stock to one newly hired employee. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).
- 08/02/2024
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, The Netherlands and MIAMI, Aug. 02, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 59,200 of NewAmsterdam's ordinary shares to one non-executive new hire. The share options were granted as an inducement material to the employee's acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/02/2024
|
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on August 1, 2024 the Company granted restricted stock units (RSUs) representing 34,200 shares of its common stock to four newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.
- 08/02/2024
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 38,000 restricted stock units of Arcutis' common stock to four newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of August 1, 2024, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/02/2024
|
Q3's Rising Stars: 3 Nasdaq Stocks for Your Must-Watch List
- The growth and tech-heavy Nasdaq 100 index is in something of a significant correction at the moment. After hitting new all-time highs early in July, the benchmark Invesco QQQ ETF (NASDAQ: QQQ ) has already pulled back close to 10% from its recent peak.
- 08/02/2024
|
The 3 Best Stocks to Buy Doing Successful Secondary Offerings in 2024
- The IPO (initial public offering) market has gotten stronger in 2024, according to the Q2 2024 quarterly review from IPO specialist Renaissance Capital. That has resulted in a more buoyant market for secondary offerings.
- 08/02/2024
|
Nasdaq Tumbles Over 3% After Jobs Report Sparks Recession Fears
- Stocks across several industries fell Friday, after the Labor Department reported the U.S. economy added fewer jobs than expected last month, stoking fears of a possible recession.
- 08/02/2024
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on August 1, 2024, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 356,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/02/2024
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., Aug. 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted nine newly-hired employees stock options to purchase an aggregate of 40,350 shares, and restricted stock units (RSUs) covering an aggregate of 28,200 shares, of BioCryst common stock. The options and RSUs were granted as of July 31, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/02/2024
|
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted eleven newly-hired employees inducement options to purchase an aggregate of 90,000 shares of KalVista common stock on August 1, 2024 as inducements material to each employee entering into employment with KalVista. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4). The options have.
- 08/02/2024
|
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for 12,300 shares of G1's common stock and 6,150 restricted stock units (RSUs) to five hired employees under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Amended and Restated 2021 Plan”).
- 08/01/2024
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that on August 1, 2024, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 282,500 shares of the Company's common stock to 11 newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/01/2024
|
Nasdaq 100 Heavyweights Report: Apple Shines, Intel Stumbles, Snap and Amazon Miss Targets
- Tech giants report mixed Q2. Apple shines, Snap and Amazon miss targets, Intel restructures.
- 08/01/2024
|
Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
- PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc.
- 08/01/2024
|
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, Aug. 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on July 31, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 708,236 shares of X4's common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by X4's Compensation Committee of the Board of Directors.
- 08/01/2024
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. , Aug. 1, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted three newly-hired employees options to purchase an aggregate of 47,000 shares of Akebia's common stock on July 31, 2024.
- 08/01/2024
|
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC) today announced that on August 1, 2024, the Compensation Committee of the company's Board of Directors granted to seven new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 71,200 ordinary shares. These awards were made under Bicycle Therapeutics' 2024 Inducement Plan and approved by the Compensation Committee as an inducement material to the employees entering.
- 08/01/2024
|
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and development of covalent small molecules to treat patients with metabolic diseases and genetically defined cancers, today announced that on August 1, 2024, the compensation committee of Biomea's board of directors granted one new employee non-qualified stock options to purchase an aggregate of 7,500 shares of the Company's common stock. The shares underlying the employee's stock options will vest 1/16 on a quarterly basis over four years, subject to the employee's continued employment with the Company on such vesting dates. The above-described award was made under Biomea's 2023 Inducement Equity Plan (the “Plan”).
- 08/01/2024
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , Aug. 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 14,000 restricted stock units (RSUs) to four newly-hired employees.
- 08/01/2024
|
Here's Why Nasdaq (NDAQ) is a Great Momentum Stock to Buy
- Does Nasdaq (NDAQ) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 08/01/2024
|
Innovative Eyewear Inc. Regains Compliance with Nasdaq Listing Requirements
- Miami, Florida--(Newsfile Corp. - August 1, 2024) - Innovative Eyewear Inc. (NASDAQ: LUCY) (NASDAQ: LUCYW) ("Innovative Eyewear" or "the Company") the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced that the Company received formal notice (the "Notice") from the Nasdaq Office of General Counsel of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule"). To regain compliance with the Bid Price Rule, the Company's Common Stock was required to maintain a minimum closing bid price of $1.00 or more for at least ten consecutive business days.
- 08/01/2024
|
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
- U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 1% on Thursday.
- 08/01/2024
|
3 Nasdaq Stocks to Sell Before the Next Market Crash: Q3 Edition
- Nasdaq is one of the world's most active stock exchanges. The exchange takes pride in only allowing companies that meet its stringent requirements, including an aggregate earning of $11 million over the last three years and no net loss.
- 08/01/2024
|
Nasdaq expected to continue rally, led by Meta
- Whatsapp and Instagram owner Meta Platforms is expected to lead a continuation of the big tech rally on Thursday, the first day of August. S&P 500 and Nasdaq 100 futures both were up 0.4% ahead of the open, with Dow Jones futures rising 0.1% and those for the small- and mid-cap Russell 2000 rising 0.2%.
- 08/01/2024
|
Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
- PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc.
- 08/01/2024
|
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 08/01/2024
|
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
- PRINCETON, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces that it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement of $1.00 per share.
- 08/01/2024
|
Nasdaq Settles Higher As Nvidia Records Best Session Since February: Fear & Greed Index Now In 'Neutral' Zone As Investor Sentiment Improves
- The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Neutral” zone on Wednesday.
- 08/01/2024
|
Jianzhi Education Technology Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
- BEIJING, July 31, 2024 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a leading provider of digital educational content in China, today announced it has received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) Listing Qualifications Department on July 26, 2024, notifying the Company is not in compliance with the minimum market value requirement set forth in Nasdaq Listing Rules for continued listing on the Nasdaq Global Select Market. Nasdaq Listing Rule 5450(b)(1)(C) requires companies to maintain a minimum market value of publicly held shares of at least US$5 million, and Listing Rule 5810(c)(3)(D) provides that a failure to meet the market value requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the market value of the Company for the 30 consecutive business days from June 12, 2024 to July 26, 2024, the Company no longer meets the minimum market value requirement.
- 07/31/2024
|
Bitvavo Adopts Nasdaq Market Surveillance to Enhance Integrity of its Digital Asset Exchange
- Bitvavo will use Nasdaq Market Surveillance to detect and investigate suspected market abuse Enhanced capability marks a major milestone in the development of the Bitvavo platform Supports early compliance with market surveillance requirements under the EU's incoming Markets in Crypto Assets Regulation (MiCA) AMSTERDAM and LONDON, July 31, 2024 (GLOBE NEWSWIRE) -- Bitvavo, the largest cryptocurrency Euro spot exchange globally, and Nasdaq (Nasdaq: NDAQ) today announced an agreement that will see the digital asset exchange use Nasdaq's Market Surveillance technology across its platform. With this agreement, Bitvavo is seeking to further enhance the trust, transparency, and integrity of its marketplace by enabling its compliance framework to keep pace with the rapid growth and development of the business.
- 07/31/2024
|
Nasdaq Tumbles As Microsoft, Nvidia And Other Tech Stocks Decline: Greed Index Moves To 'Fear' Zone
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the “Fear” zone on Tuesday.
- 07/31/2024
|
Faraday Future Regains Compliance with Nasdaq Timely Reporting Requirements
- LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (“FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company today provided a business update, highlighting significant strategic developments and operational progress, including regaining compliance with Nasdaq timely reporting requirements. Overview Financial Update – First Quarter 2024 China-U.S. Automotive Bridge Strategy Fundraising and Expense Initiatives Inve.
- 07/30/2024
|
Petco Health + Wellness Company, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , July 30, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced that it has granted inducement equity awards on July 29, 2024 to its newly-hired Chief Executive Officer, Joel D. Anderson, as a material inducement to the employment of Mr.
- 07/30/2024
|
The Top 3 Nasdaq Stocks to Buy Now: Summer 2024
- The Nasdaq Composite has been a solid benchmark for many years. It's up by 16% year-to-date and has logged a 114% gain over the past five years.
- 07/30/2024
|
Stock Market Today: Nasdaq Slumps Ahead of Microsoft Earnings
- The S&P 500 also closed lower Tuesday, while the Dow Jones Industrial Average managed a win.
- 07/30/2024
|
Nvidia and Other Chip Stocks Drag S&P 500, Nasdaq Lower Tuesday—Here's Why
- Nvidia (NVDA), AMD (AMD), Qualcomm (QCOM) and other chip stocks lost ground in intraday trading Tuesday, dragging the tech sector and major indexes down with them.
- 07/30/2024
|
Nasdaq, S&P Futures Rise As Microsoft, AMD Earnings Take Spotlight: Will Fed Provide 'Turbo Boost' For Market? Analyst Weighs In
- Wall Street is likely to tenaciously hold onto the slender optimism ahead of a slew of earnings from notable companies and the Federal Reserve's two-day rate-setting meeting that gets underway on Tuesday. Traders appear to be overlooking some negative tech earnings released late Monday as they factor in better performances by their mega-cap counterparts.
- 07/30/2024
|
Centurion Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about August 1, 2024
- NEW YORK, July 29, 2024 (GLOBE NEWSWIRE) -- Centurion Acquisition Corp. (Nasdaq: ALFUU) (the “Company”) announced that holders of the units sold in the Company's initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the exercise by the underwriters of their overallotment option, completed on June 12, 2024 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about August 1, 2024. Any units not separated will continue to trade on The Nasdaq Global Market under the symbol “ALFUU,” and each of the Class A ordinary shares and warrants will separately trade on The Nasdaq Global Market under the symbols “ALF” and “ALFUW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into Class A ordinary shares and warrants.
- 07/29/2024
|
3 Stocks to Buy Amid the Big Tech Tumble
- The rotation out of technology stocks continues, with the Nasdaq Composite index down 2% in the past month versus a 12% gain in the Russell 2000 index comprised of small-cap stocks. However, the decline in the Nasdaq does not reflect the huge selloff that's taken place in many individual technology stocks in recent weeks.
- 07/29/2024
|
Nasdaq Announces Pricing of Secondary Offering of Nasdaq Common Stock
- NEW YORK, July 29, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) (the “Company” or “Nasdaq”) today announced the pricing of the previously announced secondary public offering by Argus Seller, LP (the “Selling Stockholder”), an affiliate of certain funds managed by Thoma Bravo, L.P., of 41,604,207 shares of Nasdaq's common stock at a price to the public of $65.30 per share. The offering is expected to close on July 30, 2024, subject to customary closing conditions. Nasdaq is not selling any shares of its common stock in the offering and will not receive any proceeds from the sale of the shares by the Selling Stockholder in the offering.
- 07/29/2024
|
Asset Entities Inc. Regains Compliance with Nasdaq
- DALLAS, July 29, 2024 (GLOBE NEWSWIRE) -- Asset Entities Inc. (“Asset Entities” or “the Company”) (NASDAQ: ASST), a provider of digital marketing and content delivery services across Discord and other social media platforms, and a Ternary Payment Platform company, today announced that the Company received formal notice (the “Notice”) from the Nasdaq Office of General Counsel of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”).
- 07/29/2024
|
1 Nasdaq ETF to Buy With $1,000 and Hold Forever
- The Nasdaq-100 comprises the largest 100 non-financial companies on the Nasdaq exchange. The "Magnificent Seven" accounts for close to 43% of the index as well as the ETF tracking it.
- 07/29/2024
|
3 Nasdaq Stocks to Buy on the Dip: July 2024
- While most Nasdaq stocks continue to trade near all-time high levels, some of the names have dipped in recent days due to a general market pullback, potentially making them good buys at their current levels. In fact, some Nasdaq stocks failed to keep up with the overall market rally of the past year in the first place, making the recent dip in stock prices an extra-attractive opportunity.
- 07/29/2024
|
Why I Loaded Up on This Ultra-High-Yielding ETF After the Nasdaq's Recent Slump
- JPMorgan Nasdaq Equity Premium Income ETF supplies a generous stream of passive income. The ETF also provides equity market upside to the Nasdaq-100.
- 07/29/2024
|
Follow the Money: 3 Stocks That Will Gain from Wall Street's Boom
- The Wall Street Journal reported on July 16 that the investment banking revenue of multiple Wall Street banks rose by double-digit percentage levels last quarter. As a result of increased economic stability in the U.S., the firm's corporate clients utilized more banking services, including deal advisory and debt offerings.
- 07/27/2024
|
SRIVARU Holding Limited Announces Receipt of Nasdaq Delisting Notification and Plans to Appeal
- GRAND CAYMAN, Cayman Islands, July 26, 2024 (GLOBE NEWSWIRE) -- SRIVARU Holding Limited (Nasdaq: SVMH, SVMHW) (“SRIVARU” or the “Company”), a manufacturer of premium electric motorcycles today announced that on July 24, 2025, the Company received a staff determination letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of the determination of the Nasdaq staff (the “Staff”) that because the Company had not regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the “Rule”), the Company's ordinary shares are now subject to delisting from the Nasdaq Global Market. In addition, the Staff advised that the Company's warrants are subject to delisting pursuant to Listing Rule 5455(a). Unless the Company requests an appeal of this determination, the Company's ordinary shares and warrants would be scheduled for delisting from The Nasdaq Global Market at the opening of business on August 2, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company's securities from listing and registration on The Nasdaq Stock Market.
- 07/26/2024
|
Prestige Wealth Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- HONG KONG, July 26, 2024 (GLOBE NEWSWIRE) -- Prestige Wealth Inc. (NASDAQ: PWM) (“PWM”, or the “Company”), a wealth management and asset management services provider based in Hong Kong, today announced that, on July 23, 2024, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that based on the closing bid price of the Class A ordinary shares of the Company for the last 33 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.
- 07/26/2024
|
Nasdaq Announces Launch of Secondary Offering of Nasdaq Common Stock
- NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) (the “Company” or “Nasdaq”) today announced a secondary public offering of 41,604,207 shares of its common stock currently held by Argus Seller, LP (the “Selling Stockholder”), an affiliate of certain funds managed by Thoma Bravo, L.P. Nasdaq is not selling any shares of its common stock and will not receive any proceeds from the sale of the shares by the Selling Stockholder in the offering.
- 07/26/2024
|
Rail Vision Receives Nasdaq Notification Regarding Minimum Bid Requirements
- Ra'anana, Israel, July 26, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (the “Company”) (Nasdaq: RVSN), a technology company at the forefront of revolutionizing railway safety and the data-related market, announced today that on July 22, 2024, the Company received a written notice from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the Company's closing bid price for its Ordinary Shares was below $1.00 per share for the last 30 consecutive business days.
- 07/26/2024
|
What Makes Nasdaq (NDAQ) a New Buy Stock
- Nasdaq (NDAQ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 07/26/2024
|
QDTE: Weekly Variable Distributions On Nasdaq 100, 10% Yield
- Roundhill N-100 0DTE Covered Call Strategy ETF seeks income from the Nasdaq 100 index via selling synthetic covered call options. QDTE pays variable weekly distributions, offering a trailing 10% yield, and has outperformed a similar ETF. Investors recouped 10% of their investment so far, but tax implications and risks should be considered before investing.
- 07/26/2024
|
Motorsport Games Announces $1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- MIAMI, July 26, 2024 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or the “Company”), today announced that it has entered into definitive agreements for the sale and issuance of 460,830 shares of Class A common stock (or pre-funded warrants in lieu thereof) of the Company at an offering price of $2.17 per share (or per pre-funded warrant in lieu thereof), in a registered direct offering priced at-the-market under the Nasdaq rules. In a concurrent private placement, Motorsport Games will issue unregistered Series A warrants to purchase up to 460,830 shares of Class A common stock and unregistered Series B warrants to purchase up to 460,830 shares of Class A common stock, each will be exercisable on the effective date of stockholder approval of the issuance of the shares upon exercise of the unregistered common warrants (the “Stockholder Approval”), at an exercise price of $2.17 per share. The Series A warrants will expire five and one-half years following the Stockholder Approval and the Series B will expire 18 months following the Stockholder Approval. The closing of the offering is expected to occur on or about July 29, 2024, subject to the satisfaction of customary closing conditions.
- 07/26/2024
|
Webuy Receives Extension to Regain Compliance with Nasdaq's Minimum Bid Requirements
- Singapore, July 26, 2024 (GLOBE NEWSWIRE) -- Webuy Global Ltd. (Nasdaq: WBUY) (“Webuy” or the “Company”), a Southeast Asian community e-commerce retailer, today announced that, following the receipt of a written notice from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq”) on January 26, 2024 regarding the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) for continued listing on the Nasdaq Capital Market, it received written notification from Nasdaq, providing an additional 180 calendar days, or until January 21, 2025, to regain compliance with the minimum bid price of U.S. $1.00, as required by Nasdaq Listing Rule.
- 07/26/2024
|
United Community Banks, Inc. Announces Transfer of Listing of Common Stock and Depositary Shares to NYSE
- GREENVILLE, S.C., July 26, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NASDAQ: UCBI; UCBIO) (the “Company” or “United”) announced today that the Company will transfer the listing of its common stock and its Depositary Shares (each representing 1/1000th interest in a share of Series I Non-Cumulative Preferred Stock) from the Nasdaq Stock Market LLC (“Nasdaq”) to the New York Stock Exchange (“NYSE”). The Company expects to commence trading as a NYSE-listed company upon market open on August 6, 2024. United's common stock and depositary shares will trade under new ticker symbols, “UCB” and “UCB PRI”, respectively, after the transfer. The Company's common stock and depositary shares will continue to trade on Nasdaq until the close of the market on August 5, 2024.
- 07/26/2024
|
The REIT Way To Invest
- Stocks, especially the tech-heavy Nasdaq, plummeted on Wednesday with the Dow dropping 1.25%, S&P 500 falling 2.31%, and Nasdaq cratering 3.64%. Tech stocks took a hit after lackluster Alphabet and Tesla earnings, leading to worries about Big Tech's fading power to fuel gains. Magnificent 7 tech stocks lost over $750 billion in market cap, with Nvidia, Broadcom, and Arm experiencing significant drops.
- 07/26/2024
|
Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
- TEL AVIV, Israel, July 26, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab) a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that it has received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
- 07/26/2024
|
Get Your Money Out of These 3 Nasdaq Stocks by the End of July
- Nasdaq-listed stocks have sustained a prolonged rally in recent months, reflecting investor optimism and robust market sentiment. However, in recent days, we have seen a notable pullback in several overvalued stocks, with investors increasingly favoring value over high flyers.
- 07/26/2024
|
Meet the New Nasdaq 100 and S&P 500 Artificial Intelligence Stock That Topped Nvidia in the First Half
- This artificial intelligence (AI) leader rose 188% in the first half, outperforming AI chip leader Nvidia. This company recently reported its first $3 billion quarter.
- 07/26/2024
|
Tims China Receives Nasdaq Notice; Files 6-K
- SHANGHAI and NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- On July 19, 2024, TH International Limited, (Nasdaq:THCH), the exclusive operator of Tim Hortons coffee shops in China (“Tims China” or the “Company”) , received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company's ordinary shares, par value $0.00000939586994067732 per share (the “ordinary shares”), fail to comply with the $1.00 minimum bid price requirement for continued listing on Nasdaq in accordance with Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the ordinary shares for the 30 consecutive business days prior to the date of the Notice.
- 07/25/2024
|
S&P 500, Nasdaq Extend Losses After GDP, Inflation Data; Nvidia Stock Enters Bear Market
- The S&P 500 and Nasdaq extended their losses Thursday after GDP and inflation data. Nvidia stock entered bear market territory.
- 07/25/2024
|
Why Nasdaq Stock Surged Today
- Nasdaq's recent acquisition of Adenza has given the company a whole new look. Despite still integrating this acquisition, the early results appear to be promising.
- 07/25/2024
|
Nasdaq (NDAQ) Tops on Q2 Earnings on Solid Solutions Revenues
- Nasdaq's (NDAQ) second-quarter results reflect broad-based growth across three divisions and another quarter of double-digit Solutions growth.
- 07/25/2024
|
Nasdaq (NDAQ) Reports Q2 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Nasdaq (NDAQ) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 07/25/2024
|
Nasdaq (NDAQ) Tops Q2 Earnings and Revenue Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.71 per share a year ago.
- 07/25/2024
|
Purple Biotech Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price Rule
- REHOVOT, Israel, July 25, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class oncology therapies that overcome tumor immune evasion and drug resistance, today announced that on July 24, 2024, it received an extension of 180 calendar days from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the “Bid Price Requirement”). As a result of the extension, the Company has until January 21, 2025, to regain compliance with the Bid Price Requirement. To regain compliance, the closing bid price of the Company's American Depositary Share (“ADSs”) must be at least $1.00 for at least 10 consecutive business days (with such compliance period extendable at the discretion of Nasdaq) prior to January 21, 2025. Nasdaq would then provide a written confirmation of compliance and the matter will be closed.
- 07/25/2024
|
As the Nasdaq 100 index sinks, is it time to buy SQQQ ETF?
- The Nasdaq 100 index suffered a harsh reversal on Wednesday as the market reacted to the mixed earnings by Tesla and Alphabet. It slipped by more than 505 points, its worst single-day drop since 2022.
- 07/25/2024
|
Nasdaq Announces Quarterly Dividend of $0.24 Per Share
- NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.24 per share on the company's outstanding common stock. The dividend is payable on September 27, 2024 to shareholders of record at the close of business on September 13, 2024. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors.
- 07/25/2024
|
Forget the Nasdaq -- Buy This Magnificent ETF Instead
- There's more than one way to capture potential upside in the stock market. The Vanguard S&P 500 Growth ETF has outperformed the S&P 500 over the long term.
- 07/25/2024
|
Nasdaq, S&P 500 Record Worst Session Since 2022 Amid Tesla, Alphabet Selloff: Investor Optimism Decreases Further
- The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the “Neutral” zone on Wednesday.
- 07/25/2024
|
Tech Rout Erases Almost $1 Trillion From Nasdaq Composite
- The Nasdaq Composite on Wednesday suffered its worst day since October 2022 after disappointing earnings reports from Tesla (TSLA) and Alphabet (GOOGL) shook Wall Street's confidence in the stocks that were, until recently, its brightest stars.
- 07/24/2024
|
Nasdaq Pummeled As Stock Market Outlook Gets This Downgrade; Alphabet Triggers Sell Rule
- Year to date, the Nasdaq's gain has shrunk to 16.3%.
- 07/24/2024
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 15, 2024
- NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of July 15, 2024, short interest in 3,044 Nasdaq Global MarketSM securities totaled 12,309,469,231 shares compared with 12,156,830,526 shares in 3,052 Global Market issues reported for the prior settlement date of June 28, 2024. The mid-July short interest represents 2.95 days compared with 3.37 days for the prior reporting period.
- 07/24/2024
|
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., July 24, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that it awarded inducement grants on July 22, 2024 to its Executive Vice President and Chief Financial Officer, Edward Dulac, under Intellia's 2024 Inducement Plan as a material inducement to employment.
- 07/24/2024
|
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings
- U.S. stocks traded lower this morning, with the Dow Jones dipping around 400 points on Wednesday.
- 07/24/2024
|
TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today
- BALTIMORE--(BUSINESS WIRE)---- $MYMD--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (formerly MyMD Pharmaceuticals, Inc.) (the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases and autoimmune and inflammatory conditions, today announced that its common stock, listed on the Nasdaq Capital Market, begins trading under the new ticker symbol, “TNFA,” effective before the market open today, July 24, 2024. The new trading symbol “TNFA” replaces t.
- 07/24/2024
|
The Secret's Out - 3 Fantastic Dividend Growth Stocks You Need To Know
- Stocks outperform cash, but most wealth comes from a few standout companies. More than half of individual stocks lose money long-term, highlighting the need for careful selection. Investors can build wealth with stocks offering essential products and steady growth. Success doesn't require high-risk choices but finding solid, reliable performers. The article explores three promising stocks flying under the radar, each excelling in critical industries. These picks demonstrate how strategic investments can yield impressive returns.
- 07/24/2024
|
Nasdaq tech stocks to lead Wall Street retreat after Tesla and Alphabet underwhelm
- Nasdaq-listed tech stocks are expected to march at the head of a Wall Street retreat on Wednesday, led by Tesla after its underwhelming earnings report overnight. Nasdaq 100 futures have dropped 1.05%, while S&P 500 futures are 0.7% lower, down 0.4% for the Dow Jones and 0.5% for the Russell 2000.
- 07/24/2024
|
It's Trump vs. Harris. Brokerage Stocks Are One Way to Profit.
- Investors can prepare for a wave of stock market volatility heading into the November election by using a risk-reversal strategy with Nasdaq stock.
- 07/24/2024
|
Nasdaq 100: Tesla Stumbles While Alphabet Steady in Q2 Earnings Analysis
- Tesla's Q2 earnings miss estimates, while Alphabet's steady performance boosts confidence. Discover the tech giants' contrasting fortunes in our detailed analysis.
- 07/23/2024
|
Paranovus Entertainment Technology Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq
- NEW YORK , July 23, 2024 /PRNewswire/ -- Paranovus Entertainment Technology Limited ("PAVS" or the "Company"), (NASDAQ: PAVS) announced today that the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") on July 17, 2024, notifying the Company that the minimum bid price per share for its Class A ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company's Class A ordinary shares on Nasdaq.
- 07/23/2024
|
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- LEXINGTON, Mass., July 23, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agreement with Eric Hall, Ph.D., M.B.A. that, among other things, provides for the grant to Dr. Hall of a non-qualified stock option and restricted stock units as an inducement material to Dr. Hall's entering into employment with Voyager. The inducement awards were approved by the Compensation Committee of Voyager's Board of Directors in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). The option award became effective on July 22, 2024, and the restricted stock unit award is scheduled to become effective on October 1, 2024.
- 07/23/2024
|
Should You Buy the 3 Best Nasdaq 100 Stocks So Far in 2024?
- Artificial intelligence has been the primary force behind the gains made by the Nasdaq exchange in 2024. While the S&P 500 had risen 16% by July 4, and the Dow Jones Industrial Average was only 4% higher, the Nasdaq 100 soared 20% for the year.
- 07/23/2024
|
The 7 Most Undervalued Stocks in the Nasdaq-100 You Must Not Ignore
- The Nasdaq 100 is a list of the 100 most valuable companies traded on the Nasdaq index as measured by market capitalization. The Nasdaq index is generally associated with the technology sector.
- 07/23/2024
|
4 Solid Tech Stocks to Buy as S&P 500, Nasdaq Resume Rally
- Stocks like Amazon.com, Inc. (AMZN), Netflix, Inc. (NFLX), QUALCOMM Incorporated (QCOM) and Apple, Inc. (AAPL) are likely to benefit from the rebound in tech rally.
- 07/23/2024
|
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq's Periodic Filing Requirement
- BEIJING, July 23, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced that the Company received a written notification from the Nasdaq Stock Market LLC ("Nasdaq") on July 18, 2024, informing the Company that it has regained compliance with Nasdaq's periodic filing requirement set forth under Listing Rule 5250(c)(1), because the Company had filed its annual report on Form 20-F for the period ended October 31, 2023 on July 17, 2024.
- 07/23/2024
|
Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- SARASOTA, FL, July 22, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 763,638 shares of common stock at a purchase price of $2.75 per share. In a concurrent private placement, the Company issued unregistered warrants to purchase up to 763,638 shares of common stock at an exercise price of $2.75 per share that are immediately exercisable upon issuance and will expire five years following the date of issuance.
- 07/22/2024
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , July 22, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on July 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 128,200 shares of its common stock and 22,100 restricted stock units ("RSUs") to six (6) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/22/2024
|
HUB Receives Nasdaq Notification Regarding Minimum Bid Price Requirement
- TEL AVIV, Israel, July 22, 2024 (GLOBE NEWSWIRE) -- via IBN – HUB Security Ltd (Nasdaq: HUBC), a developer of cybersecurity solutions and services (“HUB” or the “Company”), received a notification from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5450(a)(1), because for the past 30 consecutive business days preceding the date of the notification (“Notice”), the bid price per share of the Company's ordinary shares, no par value (“Ordinary Shares”) had closed below the $1.00 per share minimum bid price required for continued listing on Nasdaq (the “Minimum Bid Price Requirement”).
- 07/22/2024
|
Is a Beat in the Offing for Nasdaq (NDAQ) in Q2 Earnings?
- Nasdaq's (NDAQ) second-quarter performance is likely to have been driven by organic revenue growth and strong Market Platforms businesses, data and listing service revenues, and Adenza contributions.
- 07/22/2024
|
Nvidia Stock Rises Monday, Helping Fuel S&P 500 and Nasdaq Gains—Here's Why
- Nvidia (NVDA) shares climbed in intraday trading Monday as chip stocks rebounded from losses during last week's sell-off, helping boost the S&P 500 and Nasdaq.
- 07/22/2024
|
Nasdaq 100: Alphabet and Tesla Earnings Critical as Tech Sector Faces High Expectations
- Alphabet's AI and cloud strides in focus as Q2 revenue expected to rise 12.9% to $84.2B. Will these advancements reignite investor enthusiasm?
- 07/22/2024
|
Connexa Regains Full Nasdaq Compliance
- Windsor Mills, MD, July 22, 2024 (GLOBE NEWSWIRE) -- Connexa Sports Technologies Inc. (Nasdaq: YYAI), the owner of Slinger Bag and Gameface AI, announces receipt of Nasdaq confirmation that the Hearing Panel, convened for July 24, 2024, to review Connexa's bid price compliance has been canceled and the delisting determination withdrawn.
- 07/22/2024
|
3 Nasdaq Stocks to Buy Now: Q3 Edition
- The Nasdaq Composite lists thousands of publicly-traded stocks in various industries. The index has more than doubled over the past five years and looks like it will continue to march higher.
- 07/21/2024
|
If You Can Only Buy One Nasdaq Stock in July, It Better Be One of These 3 Names
- In the dynamic investing world, selecting standout stocks from the bustling Nasdaq can be a game-changer. As the market navigates through mid-year economic indicators and corporate earnings reports, some Nasdaq-listed companies show promising resilience and potential for significant growth.
- 07/20/2024
|
Aptose Announces Receipt of Deficiency Notice from Nasdaq
- SAN DIEGO and TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, today announced that it has received a deficiency letter (the "Deficiency Letter") from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, for the last thirty (30) consecutive business days, the closing bid price for the Company's common shares have been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
- 07/19/2024
|
NextTrip, Inc. Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements
- SUNRISE, FL / ACCESSWIRE / July 19, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, received a notice (the "Notice") from the listing qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") on July 17, 2024 stating the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended May 31, 2024. Additionally, the Company has not yet filed its Annual Report on Form 10-K for the fiscal year ended February 29, 2024.
- 07/19/2024
|
Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Deficiency Letter
- NEW YORK, NY / ACCESSWIRE / July 19, 2024 / Healthcare AI Acquisition Corp. (NASDAQ:HAIA) (the "Company"), a special purpose acquisition company, announced today that it received a notification letter from The Nasdaq Stock Market ("Nasdaq") that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the "Form 10-Q"). Under the Nasdaq Listing Rules, the Company now has 60 calendar days to submit a plan to regain compliance and if the plan is accepted, Nasdaq may grant an exception of up to 180 calendar days from the Form 10-Q's due date, or until December 12, 2024, to regain compliance.
- 07/19/2024
|
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification
- CAESAREA, Israel , July 19, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it has received a written notice (the "Notice") from Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.
- 07/19/2024
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., July 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 19,875 restricted stock units of the company's common stock to 14 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of July 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/19/2024
|
SGI Enhanced Nasdaq-100 ETF, QXQ, NAV Restated
- BOUNTIFUL, Utah , July 19, 2024 /PRNewswire/ -- Summit Global Investments announces that the previously disclosed net asset value (NAV) per share of the SGI Enhanced Nasdaq-100 ETF [Ticker: QXQ], contained an error of greater than 1%. The NAV error occurred on 7/3/2024 and the NAV is being restated as of 7/19/2024.
- 07/19/2024
|
5 Non-Tech Nasdaq Stocks to Buy Amid Index's Recent Bloodbath
- We have narrowed our search to five Nasdaq Composite-listed non-tech stocks. These are: COST, ISRG, IBKR, TXRH, FSLR.
- 07/19/2024
|
Up 19% Year to Date, Can Gold Outperform the S&P 500 and Nasdaq Composite by the End of 2024?
- Gold has put up impressive five-year returns. The investment thesis in gold is far different than shares in a company.
- 07/19/2024
|
Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- SARASOTA, FL, July 19, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that it has entered into definitive agreements for the purchase and sale of 763,638 shares of common stock at a purchase price of $2.75 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company will issue unregistered warrants to purchase up to 763,638 shares of common stock at an exercise price of $2.75 per share that will be immediately exercisable upon issuance and will expire five years following the date of issuance. The closing of the offering is expected to occur on or about July 22, 2024, subject to the satisfaction of customary closing conditions.
- 07/19/2024
|
Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
- SAN DIEGO, July 19, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, announced that it was notified by the Nasdaq Office of General Counsel that the Company regained compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2) as a result of the closing bid price of the Company's common stock being $1.00 per share or greater for 10 consecutive trading sessions and that the matter is closed.
- 07/19/2024
|
S&P 500, Nasdaq Extend Losses As Two Magnificent Seven Stocks Break Key Levels
- The S&P 500 and Nasdaq composite extended losses Thursday, as Magnificent Seven stocks Amazon and Google broke below key levels.
- 07/18/2024
|
Nasdaq 100: Netflix Beats Q2 Earnings, Falls on Weak Guidance – Tech Stocks Waver
- Netflix Q2 earnings beat expectations, but stock falls on weak Q3 guidance. Tech sector wavers as streaming giant's mixed results impact Nasdaq 100.
- 07/18/2024
|
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that it has agreed to grant inducement awards to its newly appointed Senior Vice President, Chief of Staff, Chad Clatterbaugh. The awards were made as inducements material to Mr. Clatterbaugh's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/18/2024
|
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
- U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Thursday.
- 07/18/2024
|
Nasdaq (NDAQ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/18/2024
|
Tough Time Ahead of Nasdaq & Semiconductor ETFs?
- Tech stocks have surged immensely in the past year. However, with "Trump Trade" starting and the Biden administration considering stricter measures on companies supplying advanced chip technology to China, tech ETFs may suffer.
- 07/18/2024
|
valantic FSA sign with Nasdaq to develop Web UI for Fixed Income Markets
- London / Stockholm, July 18, 2024 (GLOBE NEWSWIRE) -- valantic FSA today announced it has agreed with Nasdaq (Nasdaq: NDAQ) to develop Nasdaq Rates Trader, a new web-based user interface for Nasdaq's Nordic and Baltic fixed income markets.
- 07/18/2024
|
Nasdaq, S&P 500 Futures Plunge After Trump's Comments And ASML's Weak Forecast Deepens Tech Sell-Off: AI Narrative May Be Priced In, Says Analyst
- Sentiment will likely reverse course, with the index futures trading notably lower early Wednesday. The recent run-up ideally should render the mood cautious, and the caution may intensify as the first AI-levered chip company from across the Atlantic reported second-quarter results that were not viewed positively by the Street.
- 07/17/2024
|
MingZhu Logistics Regains Compliance with Nasdaq Minimum Bid Price Requirement
- SHENZHEN, China , July 17, 2024 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ), an elite provider of logistics and transportation services to businesses, today announced that on July 16, 2024, it received notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming the Company has cured the bid price deficiency, and that the Company has regained compliance with Listing Rule 5550(a)(2). Accordingly, this matter is now closed and the Company's ordinary shares will continue to trade uninterrupted on Nasdaq under the ticker "YGMZ".
- 07/17/2024
|
Buy Alert: 3 Dividend Stocks That Have Outperformed the Nasdaq in 2024
- The Nasdaq Composite has been off to a strong start this year. Powered by the Magnificent Seven stocks, the index is up by 24% year-to-date (YTD).
- 07/17/2024
|
Delisting of Securities of CONX Corp.; Priveterra Acquisition Corp. II; Yield10 Bioscience, Inc.; Aesthetic Medical International Holdings Group Ltd.; Breeze Holdings Acquisition Corp.; Quadro Acquisition One Corp.; DermTech, Inc.; TRACON Pharmaceuticals, Inc.; eFFECTOR Therapeutics, Inc.; Dynatronics Corporation; and Canna-Global Acquisition Corp. from The Nasdaq Stock Market
- NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, units, and warrants of CONX Corp. CONX Corp.'s securities were suspended on May 6, 2024, and have not traded on Nasdaq since that time.
- 07/16/2024
|
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
- U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index surging more than 650 points on Tuesday.
- 07/16/2024
|
JE Cleantech Holdings Limited Announces Grant of Temporary Exception to remain listed on Nasdaq
- SINGAPORE, July 16, 2024 (GLOBE NEWSWIRE) -- JE Cleantech Holdings Limited (Nasdaq: JCSE), a precision cleaning and cleantech equipment manufacturer, announced that on July 15, 2024, it received a letter (the “Exception Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Exception Letter gave the Company a temporary exception to regain compliance with The Nasdaq Stock Market LLC's (“Nasdaq” or the “Exchange”) Listing Rule 5550(a)(2) (the “Bid Price Rule”).
- 07/16/2024
|
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on July 1, 2024, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,500 shares of common stock at a per share exercise price of $25.85, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation.
- 07/16/2024
|
3 Dividend Stocks That Have Outperformed the S&P 500 and Nasdaq Composite Over the Last 5 Years
- Deere's valuation can remain low even if earnings fall. You don't have to buy high-technology stocks to massively outperform the market.
- 07/16/2024
|
Meet the Newest Artificial Intelligence (AI) Stock in the Nasdaq-100. Buy It Before Nvidia Stock, According to Wall Street.
- Super Micro Computer's median price target implies 16% upside, while Nvidia's median price target implies 4% upside. Supermicro is a leader in artificial intelligence (AI) servers, and it's quickly gaining share due to engineering expertise and its unique approach to product development.
- 07/16/2024
|
argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
- First and only NMPA-approved subcutaneous injectable FcRn blocker for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in Phase 3 ADAPT-SC study July 16, 2024 6:30am CET Amsterdam, the Netherlands— argenx SE (Euronext & Nasdaq: ARGX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced that China's National Medical Products Administration (NMPA) approved the Biologics License Application (BLA) on July 16, 2024 for efgartigimod alfa injection (subcutaneous injection) (efgartigimod SC), 1,000mg (5.6ml)/vial indicated as an add on to standard therapy for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. “The NMPA approval for efgartigimod SC is yet another key milestone on our journey to expand into new patient populations around the world with our transformative medicine.
- 07/16/2024
|
Super Micro CEO Charles Liang: We are excited to be a part of the Nasdaq 100
- Super Micro Computer CEO Charles Liang joins 'Mad Money' host Jim Cramer to talk growth, plans to join the Nasdaq 100 and company outlook.
- 07/15/2024
|
3 Best Dividend Stocks to Buy from the Nasdaq 100
- The entire goal of investing is generating wealth over time via capital appreciation and dividends. For income investors, dividend stocks that provide consistent and stable dividends over time (preferably with growth) are among the most sought-after assets in the market.
- 07/15/2024
|
Supermicro to replace Walgreens in Nasdaq 100: ‘SMCI is an adjacency to NVDA'
- Super Micro Computer Inc (NASDAQ: SMCI) will replace Walgreens Boots Alliance Inc (NASDAQ: WBA) in the Nasdaq 100 on July 22nd, as per a press release on Monday. The Nasdaq 100 is an index comprising the largest 100 nonfinancial companies in the Nasdaq Composite.
- 07/15/2024
|
Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement
- SAN DIEGO, July 15, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it received formal notice from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market.
- 07/15/2024
|
Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite rising more than 200 points on Monday.
- 07/15/2024
|
Super Micro Computer Stock Rises on Nasdaq-100 Addition
- Super Micro Computer (SMCI) has been tapped to join the Nasdaq-100 Index and the Nasdaq-100 Equal Weighted Index starting July 22, the exchange announced Friday.
- 07/15/2024
|
The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
- As good as the S&P 500 is performing in 2024, the Nasdaq 100 is doing even better. The tech-oriented index is up 23% this year, compared to an 19% gain by the benchmark index.
- 07/15/2024
|
Nasdaq Index, Dow Jones, S&P 500 News: Apple Surges on AI Potential, Indian Market Growth
- The S&P 500 and Apple, Inc. show bullish short-term outlooks, propelled by robust earnings forecasts and potential election impacts.
- 07/15/2024
|
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal
- SAN MATEO, Calif. and SINGAPORE, July 15, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN” or the “Company”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that on July 9, 2024, the Company was notified by the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") that, based upon the Company's non-compliance with the $1.00 bid price and $2.5 million stockholders' equity requirements for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rules 5550(a)(2) and 5550(b)(1), respectively, the Staff had determined to delist the Company's securities from Nasdaq. Upon consideration by the Company's board of directors, the Company has determined not to request a hearing before the Nasdaq Hearings Panel.
- 07/15/2024
|
Is It Time to Buy 2024's Worst-Performing Nasdaq Stocks?
- Markets in general continue to rise. Yet some stocks have gone in the bargain bin.
- 07/14/2024
|
Super Micro to Join the Nasdaq 100. Walgreens Gets the Boot.
- The change reflects the sharp decline in Walgreens' market value this year and the surge in Super Micro's stock price.
- 07/13/2024
|
Super Micro Computer Inc. to Join the Nasdaq-100 Index® Beginning July 22, 2024
- NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Super Micro Computer Inc. (Nasdaq: SMCI), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®) and the Nasdaq-100 Equal Weighted™ Index (Nasdaq: NDXE™) prior to market open on Monday, July 22, 2024. Super Micro Computer Inc. will replace Walgreens Boots Alliance Inc. (Nasdaq: WBA) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted Index.
- 07/12/2024
|
Nano Labs Announces Receipt of Deficiency Letters from Nasdaq
- HANGZHOU, China , July 12, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider in China, today announced that it received a notification letter dated July 11, 2024 (the "Deficiency Letter") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq") notifying that the Company is no longer in compliance with the Nasdaq Listing Rule 5450(b)(2)(C) for continued listing due to its failure to maintain a minimum of Market Value of Publicly Held Shares ("MVPHS") of US$15.0 million. The Deficiency Letter does not result in the immediate delisting of the Company's Class A ordinary shares on the Nasdaq Global Market.
- 07/12/2024
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards on July 10, 2024, covering an aggregate of 285,000 shares of its common stock to two newly hired employees, consisting of inducement st.
- 07/12/2024
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, July 12, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 125,000 shares of the Company's common stock to six new employees (the “Inducement Grants”) on July 9, 2024 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/12/2024
|
Nasdaq Surges 1%; JPMorgan Posts Upbeat Earnings
- U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Friday.
- 07/12/2024
|
Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule
- CHENGDU, China , July 12, 2024 /PRNewswire/ -- Qilian International Holding Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced that on July 10, 2024, NASDAQ notified the Company that it has determined that for the 10 consecutive business days, from June 21, 2024 to July 9, 2024, the closing bid price of the Company's Class A ordinary shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and NASDAQ has closed this matter.
- 07/12/2024
|
Icon Energy Corp. Announces Listing on Nasdaq and Pricing of $5.0 Million Initial Public Offering
- ATHENS, Greece, July 12, 2024 (GLOBE NEWSWIRE) -- Icon Energy Corp . (“Icon Energy” or the “Company”) (Nasdaq: ICON), an international shipping company that provides worldwide seaborne transportation services for dry bulk cargoes, announced today the pricing of its initial public offering (the “Offering”) of 1,250,000 shares of the Company's common stock, par value $0.001 per share (the “Common Stock”), at an offering price of $4.00 per share, for gross proceeds of approximately $5,000,000, before deducting underwriting discounts and offering expenses. In addition, Icon Energy has granted the underwriters a 45-day option to purchase up to an additional 187,500 shares of Common Stock to cover over-allotments at the initial public offering price, less the underwriting discount.
- 07/12/2024
|
Nasdaq, S&P 500 Sell Off Despite Cool CPI Data; Magnificent Seven Tumble
- The S&P 500 and Nasdaq sold off despite cooler-than-expected CPI data. The Magnificent Seven stocks suffered heavy losses Thursday.
- 07/11/2024
|
Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q
- New York, NY, July 11, 2024 (GLOBE NEWSWIRE) -- Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the “Company”) announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-Q for the period ended March 30, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC").
- 07/11/2024
|
SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- DENVER, July 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) announces that it has closed its previously announced registered offering for the issuance and sale of an aggregate of 947,868 shares of its common stock at a purchase price of $10.55 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, SeaStar Medical has issued in a concurrent private placement unregistered warrants to purchase up to 947,868 shares of common stock. The warrants have an exercise price of $10.55 per share, are immediately exercisable and will expire five years following the issuance date.
- 07/11/2024
|
Eos Energy Announces Compliance with Nasdaq Continued Listing Criteria
- EDISON, N.J., July 11, 2024 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), a leading provider of safe, scalable, efficient, and sustainable zinc-based long duration energy storage systems, today announced that it received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company regained compliance with the minimum continued listing criteria set forth in Nasdaq Listing Rule 5550(a)(2) as of July 9, 2024, based on the closing bid price of the Company's common stock being at or above $1.00 per share for the 10 consecutive business days from June 24, 2024 to July 8, 2024.
- 07/11/2024
|
Nasdaq 100, Dow Jones, S&P 500 News: Nvidia and Microsoft Tumble as Sector Rotation Begins
- The S&P 500 and Nasdaq 100 Index may face continued pressure as investors reassess valuations in light of changing interest rate expectations.
- 07/11/2024
|
Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales
- U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 points on Thursday.
- 07/11/2024
|
Nasdaq to open lower, Delta Airlines hits a spot of turbulence
- US stocks are expected to come off from yesterday's record highs when markets open today. The Nasdaq 100 flew to an all-time high following Federal Reserve chair Jerome Powell's optimistic comments about near-term interest rate cuts.
- 07/11/2024
|
China Natural Resources Receives Nasdaq Notification Regarding Minimum Bid Requirements
- HONG KONG , July 11, 2024 /PRNewswire/ -- On July 5, 2024, China Natural Resources, Inc. (NASDAQ: CHNR) (the "Company") received a letter from the Listing Qualifications Department of The Nasdaq Capital Market ("Nasdaq") notifying the Company that it is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company's common shares was below the minimum of $1.00 per share for a period of 30 consecutive business days. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.
- 07/11/2024
|
Rectitude Celebrates Completion of Initial Public Offering with Nasdaq Bell Ringing Ceremony
- SINGAPORE, July 11, 2024 (GLOBE NEWSWIRE) -- Rectitude Holdings Ltd. (Nasdaq: RECT; the “Company” or “Rectitude”), a Singapore-based provider of safety equipment and related industrial products, today announced that its management team participated in a Nasdaq Bell Ringing Ceremony at Capella Singapore. Nasdaq investor relations and IPO director for Asean, Hiren Krishnani, attended the ceremony. The bell ringing ceremony highlights the Company's successful initial public offering and listing on Nasdaq. The Company began trading on Nasdaq on June 21, 2024 under the ticker symbol “RECT”.
- 07/11/2024
|
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted non-qualified stock option awards to purchase an aggregate of 137,900 shares of its common stock to eighteen new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/10/2024
|
MMTEC, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- HONG KONG , July 10, 2024 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on July 8, 2024, the Company received a notification letter (the "Notification Letter") from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") regarding a failure to meet Nasdaq's minimum bid price requirements. The Notification Letter advised that for the last 30 consecutive business the minimum closing bid price per share for the Company's common stock was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").
- 07/10/2024
|
S&P 500 and Nasdaq notch record closes as Apple hits 7th straight record close
- Barbara Doran, BD8 Capital Partners CIO, and Paul Hickey, Bespoke Investment Group co-founder, talk the day's record market action.
- 07/10/2024
|
Announcement of receipt of notice from Nasdaq regarding minimum bid price requirement
- GOTHENBURG, Sweden--(BUSINESS WIRE)--Polestar (Nasdaq: PSNY) has received notice from the Nasdaq Stock Market LLC that the Company is not currently in compliance with the $1.00 minimum bid price requirement, as set forth in Nasdaq Listing Rule 5450(a)(1). The Notice indicated that, consistent with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 days, or until 2 January 2025, to regain compliance, by having the closing bid price of the Company's ADSs meet or exceed $1.00 per ADS for at le.
- 07/10/2024
|
Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date June 28, 2024
- NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of June 28, 2024, short interest in 3,052 Nasdaq Global MarketSM securities totaled 12,156,830,526 shares compared with 12,415,199,809 shares in 3,063 Global Market issues reported for the prior settlement date of June 14, 2024. The end of June short interest represent 3.37 days average daily Nasdaq Global Market share volume for the reporting period, compared with 3.44 days for the prior reporting period.
- 07/10/2024
|
Nasdaq Gains 1%; LegalZoom Shares Slide
- U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Wednesday.
- 07/10/2024
|
Nasdaq Surges 100 Points; Manchester United Shares Rise After Q3 Results
- U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Wednesday.
- 07/10/2024
|
Nasdaq Index, Dow Jones, S&P 500 News: TSMC Surges On Strong Q2 Results, Boosting Tech Sector
- Nasdaq 100 climbs on bullish tech sentiment. TSMC gains 2% after strong earnings, Tesla up 1% on analyst upgrade, driving index higher.
- 07/10/2024
|
Tevogen Bio's R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With Nasdaq's Kristina Ayanian
- WARREN, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Dr. Neal Flomenberg and Dr. Lori Grosso of Tevogen Bio Holding Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, discussed the promise of T cell therapy and Tevogen's mission to make it mainstream on Nasdaq's broadcast, Live From MarketSite with Kristina Ayanian.
- 07/10/2024
|
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- EMERYVILLE, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world's most potent vaccines, today announced that the Compensation Committee of the company's Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 39,000 shares of its common stock with an exercise price of $0.57, which is equal to the closing price of Gritstone's common stock on July 3, 2024, the date of the grant. These stock options are part of an inducement material to the new employees becoming an employee of Gritstone, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/10/2024
|
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of July 1, 2024, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 3,000 shares of Vor Bio's common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 4,500 shares of Vor Bio's common stock to three newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).
- 07/09/2024
|
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- LEXINGTON, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agreement with Nathan Jorgensen, Ph.D., M.B.A. that, among other things, provides for the grant to Dr. Jorgensen of a non-qualified stock option and restricted stock units as an inducement material to Dr. Jorgensen's entering into employment with Voyager. The inducement awards were approved by the Compensation Committee of Voyager's Board of Directors in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). The option award became effective on July 8, 2024, and the restricted stock unit award is scheduled to become effective on October 1, 2024.
- 07/09/2024
|
Final Trades: Nasdaq, Energy Transfer, Hilton Worldwide and Ventas
- The Investment Committee give you their top stocks to watch.
- 07/09/2024
|
Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”
- CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, announced today that it has signed a merger agreement with ReShape Lifesciences (Nasdaq: RSLS).
- 07/09/2024
|
Nasdaq 100, Dow Jones, S&P 500 News: Powell, NVIDIA Fuel Rally as Market Hits Record Highs
- S&P 500 and Nasdaq maintain bullish trend, fueled by AI-driven tech leaders like NVIDIA, despite concerns over market concentration and valuations.
- 07/09/2024
|
NCI Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- HONG KONG, July 09, 2024 (GLOBE NEWSWIRE) -- Neo-Concept International Group Holdings Limited (Nasdaq: NCI) (the “Company”), announced that, on July 8, 2024, the Company received a letter from the Listing Qualifications staff of The Nasdaq Stock Market ("Nasdaq") notifying the Company that based on the closing bid price of the Company for the period from May 21, 2024 to July 5, 2024, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.
- 07/09/2024
|
Nasdaq and S&P 500 notch record closes as Apple, Amazon, Meta hit record highs
- Ryan Detrick, Carson Group chief market strategist, and Nicole Webb, Wealth Enhancement Group SVP, join 'Closing Bell Overtime' to talk the day's record market action.
- 07/08/2024
|
Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- $10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants $10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants
- 07/08/2024
|
Nasdaq Reports June 2024 Volumes and 2Q24 Statistics
- NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for June 2024, as well as quarterly volumes, estimated revenue capture, number of listings, and index statistics for the quarter ended June 30, 2024 on its investor relations website.
- 07/08/2024
|
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”, the “Company” ), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that it has agreed to grant inducement awards to (i) its newly appointed Director, Statistical Programming, Yong Rao, and (ii) three other newly hired employees. The awards were made as inducements material to each individual's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/08/2024
|
Nasdaq Index, Dow Jones, S&P 500 News: Morphic Holding Shares Surge Over 75%; Alibaba Group Stumbles
- Nasdaq flat, but Alibaba shares dip 1.17% pre-market as AI progress showcased at Shanghai conference.
- 07/08/2024
|
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif., July 05, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on July 2, 2024, the compensation committee of BridgeBio's board of directors approved equity grants to 25 new employees in restricted stock units for an aggregate of 123,070 shares of the Company's common stock. One-fourth of the shares underlying each employee's restricted stock units will vest on August 16, 2025, with one-twelfth of the remaining shares underlying each such employee's restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee's continued employment with the Company or one of its subsidiaries on such vesting dates. All of the above-described awards were made under BridgeBio's Amended and Restated 2019 Inducement Equity Plan (the “Plan”).
- 07/05/2024
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., July 05, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on July 1, 2024, the Compensation Committee of Vera's Board of Directors granted inducement awards consisting of a non-qualified stock option to purchase 160,000 shares of Class A common stock to David Johnson, Vera's new Chief Operating Officer, under Vera's 2024 Inducement Plan. Vera also announced that on July 2, 2024, the Compensation Committee granted additional inducement awards consisting of a non-qualified stock option to purchase 139,100 shares of Class A common stock and restricted stock units (RSUs) for 61,925 shares of Class A common stock to ten new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/05/2024
|
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of 2,200 restricted stock units of Atara's common stock to one newly hired employee. This award was approved by the Compensation Committee of Atara's Board of Directors and granted under the Atara.
- 07/05/2024
|
Nasdaq Surges Over 100 Points; Sharps Technology Shares Spike Higher
- U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Friday.
- 07/05/2024
|
AGBA Group, one of Nasdaq's top 10 best-performing stocks for 2024, further cements strategic partnership with Yorkville
- LOS ANGELES, July 05, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or the “Company” or the “Group”), entered into an Amended and Restated Standby Equity Purchase Agreement ("A&R SEPA") with YA II PN, LTD, a Cayman Islands exempt limited partnership ("Yorkville"), and Triller.
- 07/05/2024
|
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- $10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants $10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants
- 07/05/2024
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, July 05, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on July 3, 2024, the Compensation Committee of Taysha's Board of Directors granted four new employees, in the aggregate, options to purchase 484,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/05/2024
|
VS Media Holdings Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Requirement
- HONG KONG, July 05, 2024 (GLOBE NEWSWIRE) -- VS Media Holdings Limited (NASDAQ: VSME , the "Company"), a leader in managing a global network of digital creators, today announced the receipt of formal notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
- 07/05/2024
|
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on July 1, 2024, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 128,700 shares of common stock to eight (8) new employees under the Company's 2023 Inducement Option Plan. The Compensation Committee approved the stock options as an inducement material to such employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/05/2024
|
Nasdaq Underdogs: 3 Beaten-Down Stocks Primed for a July Comeback
- As hot as the S&P 500 has been, the Nasdaq 100 is performing even better. The tech-heavy index is up 19% year-to-date (YTD) and 83% higher since the beginning of 2023.
- 07/05/2024
|
UK-based IT firm Noventiq scraps SPAC deal to list on Nasdaq
- July 4 (Reuters) - London-headquartered information technology firm Noventiq and special purpose acquisition company Corner Growth Acquisition have mutually agreed to terminate their blank-check deal, the companies said on Thursday.
- 07/04/2024
|
History Says the Nasdaq Will Soar: 2 Remarkable Growth Stocks to Buy Now for the Bull Market
- The Nasdaq Composite has advanced 76% so far during this bull market, but the index has returned an average of 215% during bull markets since 1990. Alphabet reported accelerating revenue and earnings growth in the first quarter, and its Google Cloud platform has gained market share over the past year.
- 07/04/2024
|
eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- AUSTIN, Texas , July 3, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace (the "Company"), today announced that on July 1, 2024, the Compensation Committee of its Board of Directors granted inducement stock unit awards to two new employees covering an aggregate of 15,000 shares of the Company's common stock. Each of these awards was granted under the Company's Amended and Restated 2021 Inducement Plan (the "Inducement Plan") and otherwise will be subject to the terms and conditions of a stock unit agreement under the Inducement Plan.
- 07/03/2024
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 330,000 shares of common stock. Awards were made to six new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committe.
- 07/03/2024
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, The Netherlands and MIAMI, July 03, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 195,000 of NewAmsterdam's ordinary shares to three non-executive new hires. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/03/2024
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 325,000 restricted stock units of Arcutis' common stock as well as options to purchase an aggregate of 55,000 shares of Arcutis' common stock to 43 newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of July 1, 2024, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/03/2024
|
ToughBuilt Industries, Inc. Announces Receipt of Nasdaq Staff Determination Letter and Hearing Request
- IRVINE, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- ToughBuilt Industries, Inc. (Nasdaq: TBLT) ("ToughBuilt" or the "Company"), today announced its receipt of a Staff Determination letter from the Nasdaq Listing Qualifications department on June 28, 2024. The letter outlines the Staff's determination that the Company's securities are subject to delisting from The Nasdaq Stock Market due to non-compliance with Nasdaq's majority independent board and independent committee requirements, as well as the Company's failure to timely file its Form 10-K for the year ended December 31, 2023, and the Form 10-Q for the period ended March 31, 2024.
- 07/03/2024
|
Stock Market Today: S&P 500, Nasdaq End at Record Highs Ahead of July 4th
- Wednesday's abbreviated session was jam-packed with news, including labor market updates and Southwest Airlines' "poison pill."
- 07/03/2024
|
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., July 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that on May 28, 2024, the Compensation Committee of Spero's Board of Directors approved the grant of an aggregate of 227,500 restricted stock unit awards (RSUs) to new employees under the Spero Therapeutics, Inc. 2019 Inducement Equity Incentive Plan, as amended (2019 Inducement Plan). The RSUs are being granted as an inducement material to each of the new employees becoming an employee of Spero in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/03/2024
|
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that the Compensation Committee of its Board of Directors granted Corrina Pavetto, a new employee, a non-qualified stock option award and restricted stock units (RSUs) for an aggregate of 10,275 shares of its common stock, pursuant to the Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan, with a grant date of June 28, 2024. The stock option has an exercise price of $11.94 per share, which is equal to the closing price of Cidara's common stock on the grant date. The shares subject to the option will vest over four years, with 25% of the shares vesting on the one-year anniversary of the vesting commencement date and the balance of the shares vesting in a series of 36 successive equal monthly installments thereafter. All RSUs vest in four equal annual installments, with 1/4 vesting on each of the first, second, third and fourth anniversaries of the Quarterly Vesting Date that occurs during the calendar quarter that includes the Date of Grant. Quarterly Vesting Date means March 10, June 10, September 10 or December 10. The awards are subject to the award holder's continuous service through each vesting date and to the terms and conditions of Cidara's 2020 Inducement Incentive Plan and its standard forms of grant agreements thereunder.
- 07/03/2024
|
Nasdaq 100, Dow Jones, S&P 500 News: Tesla's Winning Streak Propels Market Sentiment Higher
- As Nasdaq and S&P 500 traders look ahead to Friday's crucial June jobs report, the markets appears poised for potential gains.
- 07/03/2024
|
With Nasdaq Up 22%, Why The IPO Market Remains Tepid
- Investors can't seem to get enough of technology stocks. That demand has propelled the Nasdaq up 22% so far in 2024.
- 07/03/2024
|
Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
- JERUSALEM , July 3, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) (the "Company"), a biotechnology company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that it has received notice from the Nasdaq Hearings Panel (the "Hearings Panel") of The Nasdaq Stock Market LLC ("Nasdaq") that the Hearings Panel has determined to grant the Company's request to continue its listing on The Nasdaq Stock Market, subject to the Company meeting certain conditions, including filing on or before August 14, 2024, a public disclosure demonstrating compliance with the Equity Requirement (defined below).
- 07/03/2024
|
The Nasdaq is Up 20% Halfway Through 2024. Here's What History Says Could Happen in the Second Half.
- In 8 of the last 10 years, the Nasdaq has climbed higher in the back half of the year. Seven companies account for more than half of the Nasdaq Composite's weight.
- 07/03/2024
|
Nasdaq, S&P 500 Futures Flat Ahead Of Jobs, Services Sector Data; Tesla Rises: Analyst Sees Further Gains For US Stocks
- Trading in the index futures reflects cautious optimism among traders following the market's record run. Wednesday's session is abbreviated, with the stock market closing at 1 p.m.
- 07/03/2024
|
These 5 Artificial Intelligence (AI) Stocks Make Up 35.9% of the Entire Nasdaq-100 Index
- The Nasdaq-100 index is home to the 100 largest companies listed on the Nasdaq stock exchange, excluding those from the financial sector. A handful of technology companies have surged in value recently, and they have a growing influence over the performance of the Nasdaq-100.
- 07/03/2024
|
Nasdaq Leads Another Stock Market Gain, Closes Above 18,000; Reddit Surges Out Of Base
- Buyers dictated the action again in the stock market Tuesday as the Nasdaq composite and S&P 500 marked all-time closing highs.
- 07/02/2024
|
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology granted an inducement award to one new employee, who was hired in June 2024.
- 07/02/2024
|
Farmer Brothers Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Farmer Brothers issued inducement awards under the Farmer Bros. Co. 2020 Inducement Incentive Plan to newly appointed Chief Financial Officer Vance Fisher.
- 07/02/2024
|
S&P 500 and Nasdaq notch record closes as Microsoft, Apple and Amazon hit record highs
- Courtney Garcia, Payne Capital Management senior wealth advisor, and Adam Crisafulli, Vital Knowledge founder, join 'Closing Bell Overtime' to talk the day's record market action.
- 07/02/2024
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, July 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers, today announced that the Company granted stock options to two new employees to purchase an aggregate of 44,400 shares of the Company's common stock, effective as of July 1, 2024. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan, with a grant date of July 1, 2024, as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/02/2024
|
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass. and DUBLIN, July 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that on July 1, the Company granted to four newly hired employees (i) non-statutory stock options to purchase an aggregate of 15,470 ordinary shares of the Company and (ii) restricted stock units with respect to an aggregate of 8,330 ordinary shares of the Company, pursuant to the Company's 2024 Inducement Stock Option and Incentive Plan, each as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/02/2024
|
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on July 1, 2024 the Company granted restricted stock units (RSUs) representing 28,200 shares of its common stock to three newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.
- 07/02/2024
|
Nasdaq 100, Dow Jones, S&P 500 News: Powell Cautious as Tesla Leads Consumer Discretionary Sector Higher
- The mixed signals from the Fed and strong job market data suggest a cautiously bullish outlook for the S&P 500 Index in the near term.
- 07/02/2024
|
5 Stocks That Powered Nasdaq ETF in the First Half
- The Nasdaq Composite Index outperformed in the first half of 2024, gaining about 18%. We have highlighted the five best-performing stocks of QQQ this year that led the way higher in the portfolio.
- 07/02/2024
|
Forget the Nasdaq -- Buy This Magnificent ETF Instead
- The VanEck Semiconductor ETF tracks 25 large-cap stocks across the semiconductor ecosystem. Over the last 10 years, a $10,000 initial investment in this fund has grown in value to over $118,000.
- 07/02/2024
|
180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
- PALO ALTO, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Hearings Panel has determined to grant the Company's request to continue its listing on The Nasdaq Stock Market, subject to the Company meeting certain conditions, including filing on or before July 31, 2024, a public disclosure describing the transactions undertaken by the Company to achieve compliance with Nasdaq's continued listing rules and demonstrate long-term compliance with the Equity Rule (defined below) and providing an indication of its equity following those transactions.
- 07/02/2024
|
3 Nasdaq Stocks to Sell in July Before They Crash & Burn
- When deciding which stocks to invest in, understanding which exchanges they are listed on can make a big difference in long-term performance and perception. For most U.S.-based investors, the two exchanges they hear about the most are the New York Stock Exchange (NYSE) and the Nasdaq.
- 07/02/2024
|
Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional investor for the issuance and sale of an aggregate of 5,853,659 shares of its common stock (or common stock equivalents in lieu thereof) at a purchase price of $2.05 per share of common stock (or per common stock equivalent in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, Checkpoint will issue and sell unregistered warrants to purchase up to 5,853,659 shares of common stock. The warrants will have an exercise price of $2.05 per share, will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrant and will expire five years following the issuance date.
- 07/02/2024
|
TOYO Co., Ltd Announces Consummation of Business Combination and Debut on Nasdaq
- Ordinary Shares of TOYO Co., Ltd to Trade on Nasdaq under the Ticker Symbol "TOYO" NEW YORK , July 2, 2024 /PRNewswire/ -- TOYO Co., Ltd ("TOYO" or the "Company"), a solar solution company, and Blue World Acquisition Corporation ("Blue World") (NASDAQ: BWAQ) today announced the completion of the previously announced business combination (the "Business Combination") between Vietnam Sunergy Cell Company Limited, a wholly-owned subsidiary of TOYO, and Blue World. The listed company following the Business Combination is TOYO Co., Ltd.
- 07/02/2024
|
Nasdaq Welcomes 66 IPOs in the First Half of 2024
- Featured the largest U.S. company IPO and switch Nasdaq IPO Pulse Index signals positive outlook for remainder of 2024 NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today that in the first half of 2024, it welcomed 66 initial public offerings (IPOs), raising a total of $8.7 billion. A total of 53 operating companies and 13 SPACs listed on Nasdaq during the first six months of 2024, representing a 71% win rate of Nasdaq-eligible operating company IPOs in the U.S. market, and extending Nasdaq's leadership to 42 consecutive quarters.
- 07/02/2024
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., July 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted five newly-hired employees stock options to purchase an aggregate of 46,850 shares, and restricted stock units (RSUs) covering an aggregate of 19,435 shares, of BioCryst common stock. The options and RSUs were granted as of June 28, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/02/2024
|
Nasdaq Closes At Record High Led By Microsoft And Apple: Fear & Greed Index In 'Neutral' Zone
- The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Neutral” zone on Monday.
- 07/02/2024
|
RF Acquisition Corp II Announces the Separate Trading of its Ordinary Shares and Rights Commencing July 5, 2024
- GRAND CAYMAN, Cayman Islands, July 01, 2024 (GLOBE NEWSWIRE) -- RF Acquisition Corp II (NASDAQ: RFAIU) (the “Company”) announced that, commencing July 5, 2024, holders of the 11,500,000 units sold in the Company's initial public offering may elect to separately trade the ordinary shares and rights included in the units. Any units not separated will continue to trade on The Nasdaq Global Market (the “Nasdaq”) under the symbol “RFAIU,” and the separated ordinary shares and rights are expected to trade on the Nasdaq under the symbols “RFAI” and “RFAIR,” respectively. Unitholders will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into ordinary shares and rights.
- 07/01/2024
|
The first JAPAN IR Event 2024 was held at Nasdaq's U.S. headquarters
- Four Nasdaq-listed Japanese Companies Gather to Showcase the Appeal of Japanese Companies to the World Four Nasdaq-listed Japanese Companies Gather to Showcase the Appeal of Japanese Companies to the World
- 07/01/2024
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that on July 1, 2024, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 40,875 shares of the Company's common stock to five newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/01/2024
|
Aetherium Receives Nasdaq Notice and Provides Update on Compliance Plans
- GREENWICH, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- Aetherium Acquisition Corp. (Nasdaq: GMFI) (the “Company”) previously announced on Form 8-K that The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company on June 18, 2024, that the Nasdaq Hearings Panel (the “Panel”) is seeking to suspend trading of the Company's securities because the Company did not regain compliance with the (i) total holder requirement under Listing Rule 5450(a)(2) and (ii) the minimum market value of listed securities (“MVLS”) requirement under Listing Rule 5450(b)(2)(A).
- 07/01/2024
|
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 11,847 restricted stock units (“RSUs”) to one newly hired employee.
- 07/01/2024
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, July 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that on June 28, 2024, the company granted equity awards to one new employee, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to such new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 07/01/2024
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. , July 1, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted five newly-hired employees options to purchase an aggregate of 517,000 shares of Akebia's common stock on June 28, 2024, including an option to purchase 500,000 shares to Erik Ostrowski, Akebia's newly hired Chief Financial Officer and Chief Business Officer.
- 07/01/2024
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , July 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 8,800 restricted stock units (RSUs) to three newly-hired employees.
- 07/01/2024
|
TOYO Co., Ltd Announces Consummation of Business Combination and Debut on Nasdaq
- Ordinary Shares of TOYO Co., Ltd to Trade on Nasdaq under the Ticker Symbol “TOYO” NEW YORK, NY, July 01, 2024 (GLOBE NEWSWIRE) -- TOYO Co., Ltd (“TOYO” or the “Company”), a solar solution company, and Blue World Acquisition Corporation (“Blue World”) (NASDAQ: BWAQ) today announced the completion of the previously announced business combination (the “Business Combination”) between Vietnam Sunergy Cell Company Limited, a wholly-owned subsidiary of TOYO, and Blue World. The listed company following the Business Combination is TOYO Co., Ltd.
- 07/01/2024
|
The 3 Best Nasdaq Stocks to Buy in July 2024
- When you it comes to targeting ideas in specific exchanges, the Nasdaq offers a compelling argument. As a technology-centric arena, the best Nasdaq stocks tend to be young or young at heart.
- 07/01/2024
|
The 3 Smartest Nasdaq Stocks to Buy With $500 Right Now
- The Nasdaq has more than 2,500 companies in its exchange. While the Nasdaq has performed well, investors enjoyed higher returns with the Nasdaq 100.
- 07/01/2024
|
Nasdaq 100, Dow Jones, S&P 500 News: Crypto Surge Lifts Coinbase, Microstrategy
- Traders should stay alert to sector shifts, economic data impacts, and the ongoing influence of AI-related enthusiasm on Nasdaq 100 stocks.
- 07/01/2024
|
Bull Market Buys: 2 Nasdaq Stocks to Own for the Long Run
- These two companies are profitable and positioned as leaders in their respective industries. Intuitive Surgical boasts a recurring revenue model that lends predictability to its business.
- 07/01/2024
|
Nasdaq Announces the Board of Directors of its U.S. Exchanges
- NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today announced the election of all nominated directors to the boards of the U.S. exchanges operated by the company, which include The Nasdaq Stock Market LLC, Nasdaq PHLX LLC, Nasdaq BX, Inc., Nasdaq ISE, LLC, Nasdaq MRX, LLC, and Nasdaq GEMX, LLC:
- 07/01/2024
|
American Resources Corporation's American Metals LLC Executes Business Combination Agreement with Nasdaq-Listed AI Transportation Acquisition Corp
- ~ The proposed transaction represents a total equity value of USD 170 million for the combined company on a pro forma basis ~ ~ American Metals LLC, a cutting-edge recycler of metals for the electrified economy, operates within the U.S. coal country, surrounded by an abundance of copper, aluminum and metal reserves from former thermal coal mines ~ ~ Leveraging its successful track record, American Metals LLC seeks to expand its preprocessing of both end-of-life magnets, lithium-ion batteries and ferrous metals to ensure a domestic supply chain for copper, aluminum, steel, plastic as well as rare earth and battery elements ~ NEW YORK, NY / FISHERS, IN / ACCESSWIRE / July 1, 2024 / American Resources Corporation's (NASDAQ:AREC) ("American Resources") wholly-owned subsidiary, American Metals LLC ("American Metals"), and AI Transportation Acquisition Corp (Nasdaq: AITR), a publicly-listed special purpose acquisition company ("AITR"), today announced that American Metals and AITR have executed a definitive business combination agreement (the "Business Combination Agreement") for a proposed business combination (the "Business Combination") in a transaction valued at $170,000,000. Pursuant to the Business Combination Agreement, each of AITR and American Metals will become wholly-owned subsidiaries of a newly formed Delaware corporation, Electrified Materials Corporation ("Pubco"), which will serve as the parent company of AITR and American Metals following the consummation of the Business Combination.
- 07/01/2024
|
SU Group to Ring Nasdaq Closing Bell on Tuesday, July 2, 2024
- HONG KONG , July 1, 2024 /PRNewswire/ -- SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"), an integrated security-related engineering services company in Hong Kong, today announced that it will be ringing the Nasdaq closing bell on Tuesday, July 2, 2024. This significant event marks a milestone for the Company following its successful initial public offering in January 2024, and its continued business expansion.
- 07/01/2024
|
2 Stocks That Could Crush the Nasdaq Over the Next Five Years
- Carnival benefits from a growing travel market and is focused on maximizing earnings growth to benefit shareholders. Uber has a great opportunity to expand margins from advertising, which could send the stock sharply higher over the next five years.
- 07/01/2024
|
Got $1,000? Here's 1 Unique ETF to Cash In on the Nasdaq.
- The Nasdaq-100 index has delivered high returns over the years. The index is more volatile, and the ETFs tracking it don't supply much income.
- 07/01/2024
|
Record Notional Value of Shares Traded on the Nasdaq Closing Cross During the 2024 Russell US Indexes Reconstitution
- Nasdaq Closing Cross continues to play an integral and innovative role in capital markets Global growth in trading volumes demands increasingly scalable and flexible technology architecture NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today announced the Nasdaq Closing Cross had a record day as it was used to rebalance Nasdaq-listed securities in the entire family of Russell US Indexes, part of global index provider FTSE Russell, during its annual reconstitution. This year marks the 40th anniversary of the Russell 3000® Index and the 21st year that the Closing Cross has been used to calculate the Russell Reconstitution.
- 06/28/2024
|
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis Oncology's Compensation Committee of the Board of Directors granted restricted stock units with respect to an aggregate of 89,530 shares of Pyxis Oncology's common stock and stock options to purchase an aggregate of 111,913 shares of Pyxis Oncology's common stock to five newly hired employees. The awards were granted under the Pyxis Oncology, Inc. 2022 Inducement Plan with a grant date of June 28, 2024, as an inducement material to the new employee entering employment with Pyxis Oncology, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/28/2024
|
EpicQuest Education Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- MIDDLETOWN, Ohio , June 28, 2024 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ: EEIQ), ("EpicQuest Education", "EEIQ" or the "Company"), a provider of higher education for domestic and international students in the US, Canada and the UK, announced that it received a delinquency notification letter (the "Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on June 24, 2024 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company's common shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.
- 06/28/2024
|
Biopharma firm Alumis' shares fall nearly 16% in Nasdaq debut
- Shares of biopharmaceutical firm Alumis opened nearly 16% below their initial public offering (IPO) price in their debut on the Nasdaq on Friday.
- 06/28/2024
|
Here's Why You Should Retain Nasdaq (NDAQ) in Your Portfolio
- Nasdaq (NDAQ) appears well poised on impressive organic growth, ramping up of on-trading revenue base, strategic buyouts to capitalize on market opportunities and effective capital deployment.
- 06/28/2024
|
Nasdaq Halts Canna-Global Acquisition Corp
- NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that the trading halt status in Canna-Global Acquisition Corp (Nasdaq: CNGL, CNGLU and CNGLW) was changed to “additional information requested” from the company. Trading in the company's stock had been halted on June 27, 2024 at 16:45:36 Eastern Time for "news dissemination” at a last sale price of $10.45 (Nasdaq: CNGL), $10.99 (Nasdaq: CNGLU), and $0.0105 (Nasdaq: CNGLW).
- 06/28/2024
|
Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules
- SEATTLE, WA / ACCESSWIRE / June 28, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that it has entered into securities purchase agreements with certain healthcare-focused and institutional investors to purchase (i) 5,339,806 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 10,679,612 shares of its common stock (the "Common Warrants") at a purchase price of $0.515 per share and associated Common Warrant in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock is being offered together with two Common Warrants, each to purchase one share of common stock.
- 06/28/2024
|
Buy 5 Nasdaq Composite Laggards of 1H Set to Rebound in 2H
- We have narrowed our search to five Nasdaq Composite listed laggards of year to date. These are: BSY, CHKP, DDOG, ZS, OKTA.
- 06/28/2024
|
Massimo Group to Ring the Nasdaq Closing Bell on Monday, July 15, 2024
- GARLAND, Texas , June 28, 2024 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo"), a manufacturer and distributor of powersports vehicles and pontoon boats, today announced the Company will ring the closing bell at the Nasdaq MarketSite in Times Square, New York on Monday, July 15, 2024. "We are excited and honored to ring the bell to commemorate our recent listing," said David Shan, Founder, Chairman & CEO of Massimo.
- 06/28/2024
|
Asset Entities Inc. Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price
- DALLAS, June 28, 2024 (GLOBE NEWSWIRE) -- Asset Entities Inc. (“Asset Entities” or the “Company”) (NASDAQ: ASST), a provider of digital marketing and content delivery services across Discord and other social media platforms, and a Ternary Payment Platform company, today announced a 1-for-5 reverse stock split (the “Reverse Stock Split”) of its class A common stock, $0.0001 par value per share (the “Class A Common Stock”), and its class B common stock, $0.0001 par value per share (the “Class B Common Stock” and together with the Class A Common Stock, the “common stock”).
- 06/28/2024
|
3 Stocks That Should Have Replaced Sirius XM Holdings in the Nasdaq 100 (Rather Than ARM)
- When I first thought of the idea for this article, Sirius XM Holdings (NASDAQ: SIRI ) was still a part of the Nasdaq 100, a collection of 100 of the largest non-financial stocks listed on Nasdaq. However, there was speculation certain companies were Nasdaq 100 stock candidates to replace the satellite radio business.
- 06/28/2024
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif. , June 28, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on June 27, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 92,000 shares of the Company's common stock to two newly hired employees.
- 06/28/2024
|
Super Micro Could Soon Replace Walgreen in Nasdaq 100 Index
- Walgreen was bounced from the Dow Jones Industrial Average in February and its stock fell to its lowest level Thursday since 1997.
- 06/27/2024
|
Yoshiharu Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- BUENA PARK, CA / ACCESSWIRE / June 27, 2024 / Yoshiharu Global Co. (NASDAQ:YOSH) ("Yoshiharu" or the "Company"), a California-based restaurant operator specializing in authentic Japanese ramen, has received a notification letter from the Nasdaq Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on June 21, 2024, notifying the Company that because it has not yet filed its Form 10-Q for the quarter ended March 31, 2024 (the "Filing"), Nasdaq has determined that the Company has failed to comply with the filing requirement set forth in Listing Rule 5250(c)(1). Under applicable Nasdaq rules, the Company has up to 60 calendar days to submit a plan to regain compliance.
- 06/27/2024
|
Faraday Future Receives Approval for Continued Listing from the Nasdaq Hearings Panel Subject to Certain Compliance Deadlines
- LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that the Company was notified on June 26, 2024 by The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel has granted the Company's request for continued listing on Nasdaq subject to the Company's compliance with the periodic reporting requirement by July 31, 2024, and the minimum bi.
- 06/27/2024
|
Webtoon's Nasdaq debut sees shares jump 14%
- Shares of online comics platform Webtoon Entertainment surged as much as 14.3% above their initial public offering price in their Nasdaq debut on Thursday.
- 06/27/2024
|
Webtoon IPO: Stock price will be closely watched today as comics platform debuts on Nasdaq
- The latest tech company to go public is Los Angeles-based Webtoon Entertainment, a platform for content creators who make and sell digital comic books and manga. Here's what you need to about Webtoon and its initial public offering.
- 06/27/2024
|
The Nasdaq Just Notched Another All-Time High, and Cathie Wood Thinks This Artificial Intelligence (AI) Stock Could Soar Another 1,300%
- Cathie Wood recently revised her price target for Tesla stock, calling for a huge increase from current trading levels. Wood's thesis relies heavily on a successful launch of Tesla's Robotaxi initiative.
- 06/27/2024
|
US Stocks Settle Higher As Investor Sentiment Improves: Nasdaq On Course To Gain 19% In First-Half Of 2024 Following Nvidia Surge
- The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Fear” zone on Wednesday.
- 06/27/2024
|
Conn's, Inc. Announces Receipt of Delinquency Notification Letter from Nasdaq
- THE WOODLANDS, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- Conn's, Inc. (NASDAQ: CONN) (“Conn's” or the “Company”), a specialty retailer of home goods, including furniture and mattresses, appliances, and consumer electronics, today announced that on June 20, 2024, it received a delinquency notification letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because of the Company's delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended April 30, 2024 (the “Form 10-Q”) by the applicable due date required by the U.S. Securities and Exchange Commission (the "SEC"). The Notice has no immediate effect on the listing or trading of the Company's common stock on The Nasdaq Global Select Market.
- 06/26/2024
|
Delisting of Securities of PHP Ventures Acquisition Corp.; Green Giant Inc.; RMG Acquisition Corp. III; Biophytis SA; OMNIQ Corp.; AIB Acquisition Corporation; Goal Acquisitions Corp.; Applied UV, Inc.; Cue Health Inc.; Twelve Seas Investment Company II; CalAmp Corp.; and ThermoGenesis Holdings, Inc.; from The Nasdaq Stock Market
- NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, rights, warrants, and units of PHP Ventures Acquisition Corp. PHP Ventures Acquisition Corp.'s securities were suspended on April 19, 2024, and have not traded on Nasdaq since that time.
- 06/26/2024
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date June 14, 2024
- NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of June 14, 2024, short interest in 3,063 Nasdaq Global MarketSM securities totaled 12,415,199,809 shares compared with 11,833,288,492 shares in 3,059 Global Market issues reported for the prior settlement date of May 31, 2024. The mid-June short interest represents 3.44 days compared with 3.54 days for the prior reporting period.
- 06/26/2024
|
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
- CHATHAM, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company, today announced that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. On June 26, 2024, Tonix received a letter from The Nasdaq Stock Market LLC stating that because Tonix's shares had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, Tonix's stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2), and the matter is now closed.
- 06/26/2024
|
You've Been Warned! 3 Nasdaq Stocks to Buy Now or Regret Forever.
- Investors can benefit from looking deeper into the holdings of top-performing indices and ETFs. While the Nasdaq Composite has plenty of exciting companies available, investors may want to narrow their focus toward the Nasdaq 100.
- 06/26/2024
|
Nasdaq 100, Dow Jones, S&P 500 News: Modest Gains for Tech Stocks as FedEx and Whirlpool Surge
- The Nasdaq sees modest gains as Nvidia edges up, continuing its recovery after a significant selloff that erased $430 billion from its market value.
- 06/26/2024
|
ZK International Group Co., Ltd. Granted Extension to File Form 20-F by Nasdaq
- WENZHOU, China , June 26, 2024 /PRNewswire/ -- ZK International Group Co., Ltd. (Nasdaq: ZKIN) (the "Company") announces that Nasdaq has granted the Company an additional extension to file its Form 20-F for the fiscal year ended September 30, 2023.
- 06/26/2024
|
Nasdaq and Dow Jones set for mixed session as Nvidia continues to rise
- Dow Jones and S&P 500 seen lower Nasdaq expected to rise Nvidia up 2% 8.36am: Wall Street set for another mixed session Wall Street stocks are set for a mixed opening, with the S&P 500 and Dow Jones expected to tick lower, while the Nasdaq is predicted to continue on from yesterday's gains. Yesterday saw US investor fears reduced after Nvidia, which had suffered three consecutive days of falls, lifted more than 6.5%.
- 06/26/2024
|
Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement
- JAGX's securities continue to be listed and traded on Nasdaq Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024 SAN FRANCISCO, CA / ACCESSWIRE / June 26, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that on June 25, 2024 the Company received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") that Jaguar has regained compliance with Nasdaq's minimum bid price requirement. "We are very happy that Jaguar has regained compliance with Nasdaq.
- 06/26/2024
|
Nasdaq, S&P 500 Set To Open Higher On Nvidia Prop, FedEx Earnings, But Traders Could Move To Sidelines Ahead Of Key Data: Analyst Says Underweighting Techs 'Contrarian Bet'
- Futures trading reflects the same trend seen on Tuesday, with the Nasdaq and S&P 500 futures firming up in early trading, while the Dow futures slipped. Notwithstanding the tech strength, the underlying sentiment is likely to be one of caution ahead of some key market-moving economic catalysts scheduled for the next two sessions.
- 06/26/2024
|
Investing $1,000 Into Each of These Top ETFs Would Incur a Mere $12 Annual Fee, and They Have All Beaten the S&P 500 and Nasdaq Composite So Far in 2024
- The Vanguard Russell 1000 Growth ETF provides exposure to hundreds of growth-oriented stocks. The Roundhill Generative AI & Technology ETF provides exposure to the powerful generative AI trend.
- 06/26/2024
|
3 Nasdaq Stocks to Buy on the Dip: June 2024
- For growth-oriented opportunities, many investors turn to Nasdaq-listed enterprises for good reason. Generally, they're younger and thus offer significant upside potential compared to your average New York Stock Exchange-listed blue chips.
- 06/26/2024
|
Nasdaq Announces Termination of Previously Announced Agreement with EEX
- NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today announced the termination of its transaction agreement with the European Energy Exchange (EEX), previously announced on June 20, 2023, under which EEX had agreed to acquire Nasdaq's Nordic power trading and clearing business.
- 06/26/2024
|
Embrace Change Acquisition Corp. Receives Delisting Notice from Nasdaq and Plans to Request Hearing
- SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- Embrace Change Acquisition Corp. (the "Company") (NASDAQ: EMCG), a special purpose acquisition company, today announced that on June 24, 2024, it received a Staff Delisting Determination (the "Staff Determination") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company of its noncompliance with Nasdaq's continued listing requirements and that unless appealed and their determination reversed, the Company's securities will be delisted from Nasdaq.
- 06/25/2024
|
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare's Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare's new Chief Executive Officer and member of the Board, effective June 24, 2024. The awards were granted as an inducement material to Mr. Coop's commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/25/2024
|
Nasdaq Leads Mixed Session As Nvidia Powers Chip Rally; FedEx, Rivian Soar Late
- The Nasdaq composite was the clear winner in the stock market Tuesday, helped by big gains for Nvidia and Arm Holdings.
- 06/25/2024
|
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants are expected to provide cash runway to complete the Phase 1 Part 3 clinical trial CAMBRIDGE, Mass. , June 25, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) (NeuroBo), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced the closing of its previously announced sale in a private placement of 4,325,701 shares of its common stock (or pre-funded warrants in lieu thereof), at a purchase price of $3.93 per share (or per pre-funded warrant in lieu thereof).
- 06/25/2024
|
Stock Market Today: S&P 500, Nasdaq Snap Losing Streaks
- Nvidia regained $197 billion in market value thanks to Tuesday's buy-the-dip session.
- 06/25/2024
|
Nasdaq to Hold Second Quarter 2024 Investor Conference Call
- NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Second Quarter 2024 financial results announcement.
- 06/25/2024
|
Treasure Hunt: 3 Nasdaq Stocks Wall Street Hasn't Discovered Yet
- When looking for stocks with high yields, business development companies (BDCs) and mortgage real estate investment trusts (REITs) stand out as potential options. These sectors often have high dividend yields.
- 06/25/2024
|
Grail's shares fall in Nasdaq debut after spin-off from Illumina
- Shares of Grail fell as much as 11.7% in their market debut on Tuesday after being spun out of gene-sequencing company Illumina.
- 06/25/2024
|
Nasdaq and Dow Jones poised for mixed start as Nvidia looks to bounce back
- Nasdaq to open higher after worst session since April Nvidia up 2.5% in premarket 8.41am: Wall Street mixed ahead of open US stocks are mixed in premarket trading, with the Nasdaq looking to rise at the open following its worst session since April. Tech giant Nvidia saw its shares drop more than 6% yesterday, pushing the Nasdaq lower and marking its worst daily drop since April 19.
- 06/25/2024
|
Nasdaq Index, Dow Jones, S&P 500 News: Nvidia Rebounds 3% as Tech Sector Eyes Recovery
- S&P 500 Index traders anticipate sector rotation continuation, with value stocks potentially outperforming growth in near-term market conditions.
- 06/25/2024
|
Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements
- ZURICH, SWITZERLAND / ACCESSWIRE / June 25, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a leading Swiss biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, announced today that it received notice from the Nasdaq Hearings Panel ("Panel") of The Nasdaq Stock Market ("Nasdaq") that it has granted the Company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market, as discussed more fully below.
- 06/25/2024
|
Nasdaq, S&P 500 Futures Firm Up As Nvidia Poised To Lead Tech Rebound: Expert Says 'A Major Gaffe By One Of The Candidates' In Presidential Debate Could Alter Market Trajectory
- The U.S. stocks could be primed for another mixed session on Tuesday, with techs looking poised for a bounce back from the previous session's losses. Nvidia Corp. NVDA could lead from the front, with the stock climbing over 2% in the premarket.
- 06/25/2024
|
3 Nasaq Stocks That Could Make Your Grandchildren Rich
- While the Nasdaq composite has delivered a total return of about 20% this year, there are certain Nasdaq stocks for long-term growth that industry analysts consider primed for future success. Let's go through some of these three Nasdaq stocks revolutionizing their respective industries, and how experts gauge their long-term performance.
- 06/25/2024
|
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
- The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Fear” zone on Monday.
- 06/25/2024
|
Faraday Future Announces Plans for Regaining Compliance With Nasdaq's Listing Standards
- LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (“FF”, “Faraday Future”, or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that its Board of Directors (the “Board”) has approved a proposal, among other proposals, to be submitted to stockholders for approval at the upcoming annual meeting of stockholders, to authorize the Board to effect a reverse stock split of the Company's common stock (“Commo.
- 06/24/2024
|
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced, as required by Nasdaq Stock Market rules, the grant of inducement awards to eight new employees.
- 06/24/2024
|
Protara Therapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the grant of inducement non-qualified stock options to purchase an aggregate of 118,400 shares of common stock to Lisa Schlesinger, Protara's newly appointed Vice President, Head of New Product Development and Market Access.
- 06/24/2024
|
Stran & Company Receives Nasdaq Notice Related to Late Filing of its Form 10-Q
- Quincy, MA, June 24, 2024 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that it received a written notification, dated June 21, 2024 (the “Notification Letter”), from The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is not in compliance with the periodic financial report filing requirement set forth in Nasdaq Listing Rule 5250(c)(1) for continued listing on The Nasdaq Capital Market tier of Nasdaq since the Company has not yet filed its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 (the “Form 10-Q”).
- 06/24/2024
|
Nasdaq to dip as Nvidia retreat continues, but Dow Jones seen rising
- Wall Street is heading for a mixed start, futures markets are indicating, with a 2% premarket falls for Nvidia weighing on expectations for the Nasdaq. Nasdaq 100 futures are down 0.1%, while those for the S&P 500 are flat and the Dow Jones and Russell 2000 are both pointing to a 0.3% gain.
- 06/24/2024
|
Nasdaq, Dow Jones, S&P 500 News: Futures Inch Higher; Nvidia's Decline Sparks Caution
- S&P 500's strong performance suggests potential gains, though tech stocks like Nvidia may face increased volatility.
- 06/24/2024
|
NeuroBo Pharmaceuticals Announces up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants are expected to provide cash runway to complete the Phase 1 Part 3 clinical trial CAMBRIDGE, Mass. , June 24, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) (NeuroBo), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that it has entered into definitive agreements for the issuance and sale in a private placement of 4,325,701 shares of its common stock (or pre-funded warrants in lieu thereof), at a purchase price of $3.93 per share (or per pre-funded warrant in lieu thereof).
- 06/24/2024
|
Nasdaq Futures Slip As Nvidia Sell-Off Continues, S&P 500 Futures Hold Up: Analyst Says 'Valuations Will Go Parabolic And It Will Be A Perfect Time To Sell'
- The U.S. market is on track to open Monday's session on a firmer note after retreating from its record high in the final two sessions of last week. Potential clues on the near-term rate outlook from Federal Reserve officials' speeches could potentially move stocks.
- 06/24/2024
|
eFFECTOR Therapeutics Announces it will Wind Down Operations as it Seeks Strategic Alternatives and Expects to be Delisted from Nasdaq
- SOLANA BEACH, Calif. and REDWOOD CITY, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) today announced that the Company has terminated its employees and will wind down it operations, including seeking potential strategic alternatives for the Company's development programs. This decision was made at a special meeting of the board of directors. Further, as previously disclosed, the Company's securities do not presently meet the continued listing requirements of the Nasdaq Stock Market and its securities would be subject to delisting if the Company fails to regain compliance during the required compliance period. The Company plans to voluntarily request a delisting of its securities and expects its securities to be delisted in the near term.
- 06/24/2024
|
3 Nasdaq Stocks to Buy Before They Soar as Much as 97% According to Select Wall Street Analysts
- Despite the composite hitting multiple all-time highs in 2024, many on Wall Street believe the rally will continue. Nvidia and Super Micro Computer are early winners in the AI revolution and are poised for additional gains.
- 06/23/2024
|
2 Magnificent Growth Stocks That Have Outperformed the Nasdaq in 2024 and Can Keep Soaring
- The streaming and fast-casual restaurant industries are booming, high-growth spaces. Netflix is seeing wide success with its ad-based tier, while profits and cash are flowing in.
- 06/23/2024
|
Nasdaq-100 Income ETF QQQI Surpasses $250 Million
- Investors do not lack choices when it comes to income strategies, but one recently launched tech-focused income fund continues to draw interest. Launched earlier this year, the NEOS Nasdaq 100 High Income ETF (QQQI) passed $250 million in AUM this month.
- 06/21/2024
|
NextTrip, Inc Receives Nasdaq Notification Regarding Late 10K Filing and Continued Listing Requirements
- SUNRISE, FL / ACCESSWIRE / June 21, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip", "we," "our," or the "Company"), a travel technology company, has received a notice (the "Notice") from the listing qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the delinquency in the timely filing of the Company's annual report on Form 10-K for the fiscal year ended February 29, 2024 (the "10-K"), the Company is out of compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the "SEC"). In accordance with Nasdaq's listing rules, the Company has 60 calendar days after the date of the Notice to submit a plan to regain compliance with respect to the delinquent 10-K filing.
- 06/21/2024
|
NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal
- CAMBRIDGE, Mass. , June 21, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd.
- 06/21/2024
|
Thunder Power Holdings, Inc. Announces Consummation of Business Combination and Commencement of Trading on Nasdaq
- Wilmington, Delaware, June 21, 2024 (GLOBE NEWSWIRE) -- Thunder Power Holdings, Inc. (Nasdaq: AIEV), a developer of premium passenger EVs positioned to earn market share based on competitive design, quality, comfort, range, and price, today announced the successful closing of the business combination (the “Business Combination”) between Thunder Power Holdings Limited (“TPHL”) and Feutune Light Acquisition Corporation (“FLFV”), a publicly traded special purpose acquisition company. The Business Combination was approved at a special meeting of FLFV stockholders on June 17, 2024. Upon consummation of the Business Combination, the combined company changed its name to “Thunder Power Holdings, Inc.” (“Thunder Power Holdings”). The shares of common stock of Thunder Power Holdings are expected to commence trading on the Nasdaq Global Market on June 24, 2024, under the new ticker symbol “AIEV.”
- 06/21/2024
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , June 21, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on June 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 173,300 shares of its common stock and 86,650 restricted stock units ("RSUs") to fourteen (14) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/21/2024
|
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- WORCESTER, Mass., June 21, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules, for the issuance and sale of an aggregate of 6,130,000 of its shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $0.41 per share (or common stock equivalent in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, Mustang also issued unregistered warrants to purchase up to an aggregate of 6,130,000 shares of its common stock. The unregistered warrants have an exercise price of $0.41 per share, are exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the warrants and will expire five years from the date of stockholder approval.
- 06/21/2024
|
Nasdaq Moves Lower; FactSet Research Posts Upbeat Earnings
- U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Friday.
- 06/21/2024
|
3 Nasdaq Stocks to Buy Now: June 2024
- The summer stock market presents a myriad of opportunities for investors looking for Nasdaq stocks to buy now. The Nasdaq-100 has been on a spectacular rally, leaving the Dow Jones Industrial Average behind.
- 06/21/2024
|
Nasdaq ETFs Set for Further Growth in 2024
- The expansion of AI applications holds the promise of ushering in fresh growth opportunities.
- 06/21/2024
|
Nasdaq 100, Dow Jones, S&P 500 News: Triple Witching Adds Volatility; Nvidia Drops in Market Rebalancing
- Given the current market developments, S&P 500 Index and Nasdaq-100 Index traders should prepare for heightened volatility in the short term.
- 06/21/2024
|
3 Nasdaq Stocks to Sell in June Before They Crash & Burn
- The Nasdaq index is driving the stock market to record heights, having risen 20% through the year's first half. The index is being powered higher by a select number of mega-cap technology stocks that are outperforming such as Nvidia (NASDAQ: NVDA ) and Microsoft (NASDAQ: MSFT ).
- 06/21/2024
|
YY Group to Ring the Nasdaq Stock Market Opening Bell
- SINGAPORE, June 21, 2024 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”, “YYGH”, or the “Company”), a data and technology-driven provider of hotel and hospitality staffing and commercial cleaning and janitorial services, is pleased to announce that Mike Fu, YY Group's CEO and Chairman, will ring the Nasdaq Stock Market Opening Bell on Monday, June 24, 2024.
- 06/21/2024
|
Nasdaq and S&P 500 to slide at the open as Nvidia continues to tumble
- Nvidia slide 2% in premarket Wall Street to open lower 8.40am: Wall Street to open lower US stocks are on track to open slightly lower this morning, with Nvidia, "the market's major bellwether", having dropped another 2% ahead of the opening bell. The S&P 500 is forecast to open around 8 points lower at 5,534, while the Dow Jones is predicted to start trading 53 points down at 39,513.
- 06/21/2024
|
2 Growth Stocks That Could Outperform the Nasdaq Over the Next Five Years
- Growth in data center spending is a long-term tailwind for Nvidia. Datadog is well positioned in the growing cloud computing industry.
- 06/21/2024
|
Actelis Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- FREMONT, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has received a written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities, including the Company's ordinary shares, to maintain a minimum bid price of $1.00 per share.
- 06/20/2024
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 45,525 restricted stock units of the company's common stock to 26 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of June 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/20/2024
|
Oportun Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SAN CARLOS, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven fintech, today announced that on June 14, 2024, it granted a total of 142,478 restricted stock units to 39 new employees who joined Oportun in 2024.
- 06/20/2024
|
Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- WORCESTER, Mass., June 20, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 6,130,000 of its shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $0.41 per share (or common stock equivalent in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, Mustang has also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 6,130,000 shares of its common stock. The offering is expected to close on or about June 21, 2024, subject to the satisfaction of customary closing conditions.
- 06/20/2024
|
JE Cleantech Holdings Limited Announces Receipt of NASDAQ Determination Letter
- SINGAPORE, June 20, 2024 (GLOBE NEWSWIRE) -- JE Cleantech Holdings Limited (Nasdaq: JCSE), a manufacturer of a broad range of cleaning systems, announced that on June 17, 2024, it received a letter (the “Determination Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Determination Letter indicated that, as previously notified by Nasdaq on December 14, 2023, the bid price of the Company's listed security had closed at less than $1 per share over the previous 30 consecutive business days and, as a result, did not comply with Listing Rule 5550(a)(2) (the “Rule”). In accordance with the Rule, the Company was provided 180 calendar days, or until June 11, 2024, to regain compliance with the Rule
- 06/20/2024
|
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle Biosciences reports inducement grants under Nasdaq Listing Rule 5635(c)(4).
- 06/20/2024
|
United Hydrogen Group Inc., a Comprehensive Hydrogen Solution Company in China, Announces Execution of Business Combination Agreement with Aimei Health Technology Co., Ltd to Become a Publicly Traded Company on Nasdaq
- Shanghai, China, June 20, 2024 (GLOBE NEWSWIRE) -- United Hydrogen Group Inc. (“United Hydrogen” or the “Company”), a comprehensive hydrogen solution company, and Aimei Health Technology Co., Ltd (“AFJK”) (Nasdaq: AFJK, AFJKU, AFJKR), a Cayman Islands special purpose acquisition company, announced that they entered into a definitive business combination agreement (the “Business Combination Agreement”) for a business combination (the “Business Combination”). Upon the consummation of the Business Combination, United Hydrogen will operate through a publicly-traded holding company listed on the Nasdaq Stock Market.
- 06/20/2024
|
History Says the Nasdaq Could Soar: 2 AI Stocks to Buy Hand Over Fist
- The Nasdaq has risen sharply over the last year, but the average duration of bull markets is almost five years. Alphabet and Meta Platforms are seeing early gains in implementing AI throughout their businesses.
- 06/20/2024
|
Nasdaq Stockholm fined by Swedish regulator over insider trading failings
- The Nasdaq Stockholm has been fined SEK 100 million (US$9.6 million) by Sweden's financial supervisory authority Finansinspektionen for failing to detect and report suspected insider trading. Finansinspektionen said on Wednesday it had investigated four major company events in 2021 and 2022 and two other cases of the trading of financial instruments in 2022 and 2023.
- 06/19/2024
|
The Nasdaq Is Soaring, but These 3 Stocks Are Near Their 52-Week Lows
- Intel's stock has plunged 40% this year amid concerns about its profitability. Cisco's declining sales numbers have kept investors away from what should be a promising artificial intelligence stock.
- 06/19/2024
|
Nasdaq Stockholm fined $9.6 million over insider trading monitoring failures
- Nasdaq Stockholm, Nasdaq Inc's stock exchange in Sweden, has been fined 100 million Swedish kronor ($9.6 million) by the country's financial watchdog, the Financial Supervisory Authority (Finansinspektionen), over deficiencies in monitoring insider trading violations. The regulatory body found flaws in how Nasdaq Stockholm conducted its trade monitoring during significant company events in 2021 and 2022.
- 06/19/2024
|
Hashdex Waives Fee for Hashdex Nasdaq Crypto Index Europe ETP
- Innovative ETP Tracks Universal Crypto Benchmark, Offering Investors Broad Exposure to the Digital Asset Class Zurich / Rio de Janeiro, June 19 , 2024 – Hashdex , a leading global crypto-focused asset manager, today announced it is offering a complete fee waiver for the Hashdex Nasdaq Crypto Index Europe ETP (HASH), which is available on the SIX Swiss Exchange under the ticker symbol SIX: HASH SW, the Deutsche Börse Xetra under HDX1 GY, the Euronext Paris under HASH FP, and the Euronext Amsterdam under HASH NA. The sponsor fee for the Nasdaq Crypto Index Europe ETP will be waived until the ETP has reached $1 billion in net asset value.
- 06/19/2024
|
Life360 Makes Nasdaq Debut, Poised For Profitability In Growing Niche
- Life360 began trading on Nasdaq recently after operating for over a decade and being listed on the Australian Securities Exchange. Despite not being profitable yet, investors are optimistic about its transition to profitability and growth within the family safety niche. With strong margins and revenue growth, Life360 aims to reach profitability in 2025 and has a bullish outlook for its future earnings.
- 06/19/2024
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 96,700 shares of its common stock to 5 newly hired employees, consisting of inducement stock options to purcha.
- 06/18/2024
|
Nasdaq 100, Dow Jones, S&P 500 News: Chipmakers Drive Market Higher; Broadcom Hits Record
- Given the mixed retail sales data and the ongoing strength in key technology stocks, the S&P 500 and Nasdaq 100 Index outlook remains optimistic.
- 06/18/2024
|
Better Passive Income Vehicle: AT&T vs. JPMorgan Nasdaq Equity Premium Income ETF
- Equities are an easy way to generate passive income. Still, stocks and exchange-traded funds with above-average yields can come with unique risk profiles.
- 06/18/2024
|
Time to Pounce: 2 Beaten-Down, High-Yield Nasdaq-100 Stocks That Are Begging to Be Bought Right Now
- Dividend stocks have lapped non-payers in the return column over the last 50 years. A top-tier consumer-facing business with a nearly 3% yield, strong brand loyalty, and a lengthy track record of innovation, can make its patient investors richer.
- 06/18/2024
|
Greenwave Technology Solutions Regains Full Compliance with Nasdaq Listing Standards
- CHESAPEAKE, Va. , June 18, 2024 /PRNewswire/ -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (Nasdaq: GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today announced that on June 17, 2024, the Company received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has evidenced compliance for continued listing on The Nasdaq Capital Market.
- 06/18/2024
|
Fresh Closing Highs for S&P, Nasdaq; Lennar Beats in Q2
- Month over month, Retail Sales are expected to tick up 20 basis points (bps) from the flat 0.0% read in April.
- 06/17/2024
|
Wall Street Favorites: 3 Nasdaq Stocks With Strong Buy Ratings for June 2024
- Analysts love certain stocks. Driven by strong financial results and other catalysts, analysts favor certain stocks and continuously raise their ratings and price targets on the company's shares.
- 06/17/2024
|
Nasdaq (NDAQ) and IDX Strengthen Technology Partnership
- Nasdaq's (NDAQ) partnership expansion with IDX is expected to promote efficiency in capital markets and increase transaction capacity.
- 06/17/2024
|
Nasdaq/Tech/A.I. Leading Markets Again
- The tech-heavy bull run is perhaps looking a little long in the tooth (horn?), with the Nasdaq notching yet another all-time closing high Friday.
- 06/17/2024
|
5 Top Tech Stocks to Win Big With Nasdaq on a Roll
- Invest in Byrna Technologies (BYRN), CareCloud (CCLD), American Superconductor (AMSC), Alphabet (GOOGL) and NVIDIA (NVDA), which are poised to make the most of the Nasdaq's upward movement banking on rate cut hopefulness.
- 06/17/2024
|
Nasdaq Index, Dow Jones, S&P 500 News: Futures Stable; TSMC and TDK Announce Key Technology Updates
- The AI sector's continued strength and potential breakthroughs in technology like TDK's batteries offer bullish signals for the Nasdaq-100 Index.
- 06/17/2024
|
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
- - Significant YoY improvement in operating performance - - Ends Q1-2024 with $16.4 million cash, cash equivalents, and marketable securities - MELVILLE, N.Y., June 17, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc.
- 06/17/2024
|
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market Infrastructure
- Technology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products and services
- 06/17/2024
|
$5,000 in This Vanguard ETF Incurs a Mere $4 Annual Fee, and It Has Beaten the S&P 500 and Nasdaq Composite in 2024
- The Russell 1000 Growth ETF tilts toward tech and consumer discretionary stocks. Vanguard has many different low-cost growth ETFs to choose from these days.
- 06/16/2024
|
Tempus IPO: Stock price watched today as AI health-tech company starts Nasdaq trading
- Nothing is hotter in tech right now than artificial intelligence. No wonder then that many AI companies see 2024 as the year to go public.
- 06/16/2024
|
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, June 14, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 25,500 shares of the Company's common stock to two new employees (the “Inducement Grants”) on June 10, 2024 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company's 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/14/2024
|
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 06/14/2024
|
Tempus AI Surges in Nasdaq Debut Following IPO
- Shares of healthcare technology firm Tempus AI surged Friday as they began trading on the Nasdaq.
- 06/14/2024
|
Arm Holdings To Join the Nasdaq-100 Index
- Arm Holdings (ARM) could get a boost after the Nasdaq announced that the British semiconductor and software design company would be added to the Nasdaq-100 Index.
- 06/14/2024
|
Tempus AI shares soar in Nasdaq debut
- SoftBank Group-backed Tempus AI shares surged over 15% after its Nasdaq debut Friday, valuing the AI-driven genetic testing company at around $6.6 billion. The stock opened at $40 per share and rose to trade around $42.30 by midday, compared to the initial public offering (IPO) price of $37.
- 06/14/2024
|
Tempus AI shares jump 8% in Nasdaq debut
- Shares of SoftBank Group-backed Tempus AI rose 8.1% in their debut on the Nasdaq on Friday, giving the artificial intelligence-based genetic testing company a valuation of $6.6 billion.
- 06/14/2024
|
Super Micro Could Be Next to Join Nasdaq 100. Walgreens Could Be Dropped.
- On Thursday evening, the index added Arm Holdings, the U.K. chip maker, and dropped Sirius XM Holdings in a move that Barron's had predicted could happen.
- 06/14/2024
|
Nasdaq Index, Dow Jones, S&P 500 News: Futures Dip in Premarket; Adobe Surges
- The S&P 500's 21x earnings valuation suggests a potentially overextended market, but excluding top performers shows a more reasonable valuation.
- 06/14/2024
|
Arm Holdings promoted into Nasdaq 100
- Arm Holdings PLC's (NASDAQ:ARM) elevation to ‘tech royalty' was confirmed yesterday with the UK-based but US-listed chip designer being added to the Nasdaq 100 and a clutch of other indices. The British semiconductor and software design will replace Sirius XM in the Nasdaq-100 Index and the Nasdaq-100 Equal Weighted Index.
- 06/14/2024
|
Arm Holdings to Replace Sirius XM in Nasdaq 100 Index
- The change, which comes as Sirius' market value falls below 0.1% of the index's capitalization, will take place before the start of trading on June 24.
- 06/13/2024
|
Arm Holdings plc to Join the Nasdaq-100 Index® Beginning June 24, 2024
- NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Arm Holdings plc (Nasdaq: ARM), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®), the Nasdaq-100 Equal Weighted™ Index (Nasdaq: NDXE™), the Nasdaq-100 Tech Sector™ Index (Nasdaq: NDXT™), the Nasdaq-100 Technology Sector Market-Cap Weighted™ Index (Nasdaq: NDXTMC™), and the Nasdaq-100 Technology Sector Adjusted Market-Cap Weighted™ Index (Nasdaq: NDXT10™) prior to market open on Monday, June 24, 2024. Arm Holdings plc will replace Sirius XM Holdings Inc. (Nasdaq: SIRI) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index. Sirius XM will also be removed from the Nasdaq-100 Ex-Tech Sector™ Index (Nasdaq: NDXX™), the Nasdaq-100 ESG Index (Nasdaq: NDXESG™), the Nasdaq-100 Sustainable ESG Select Index (Nasdaq: NDXSES™), and the Nasdaq-100 Target 25 Index® (Nasdaq: NDXT25™) on the same date.
- 06/13/2024
|
Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
- NEW YORK, June 13, 2024 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) (the "Company"), a special purpose acquisition company, announced that it had previously received written notification (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on June 3, 2024 that, because the Company had not yet filed its Quarterly Report on Form 10-Q for the three month period ended March 31, 2024 (the "10-Q") with the Securities and Exchange Commission (the "SEC"), the Company was not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1). The Notice has no immediate effect on the listing of the Company's securities on Nasdaq.
- 06/13/2024
|
Nasdaq 100, Dow Jones, S&P 500 News: Mixed After Positive PPI Data; Broadcom Shares Surge
- Given the encouraging inflation data and the Fed's cautious optimism, the S&P 500 is likely to maintain its upward momentum in the near term.
- 06/13/2024
|
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
- TORONTO , June 13, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced the Company received a letter from the Listing Qualifications Staff (the "Staff') of the Nasdaq Stock Market LLC ("Nasdaq") on June 12, 2024, which stated that the Company has regained compliance with Listing Rule 5550(a)(2). On June 14, 2023, Staff notified the Company that its common shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market.
- 06/13/2024
|
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- EMERYVILLE, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world's most potent vaccines, today announced that the Compensation Committee of the company's Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 6,850 shares of its common stock with an exercise price of $0.75, which is equal to the closing price of Gritstone's common stock on June 7, 2024, the date of the grant. These stock options are part of an inducement material to the new employees becoming an employee of Gritstone, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/13/2024
|
Is It Time to Buy May's Worst-Performing Nasdaq Stocks?
- Software businesses like MongDB were a drag on the market in May. Medical testing company Exact Sciences also took a sharp turn lower.
- 06/13/2024
|
Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, CA and TAICANG, China, June 12, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect or the Company), a U.S.-headquartered, global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, announced today that the Board of Directors (Board), including all of the independent directors of the Board, granted to Barry Quart, Pharm.D., the Company's newly-appointed Chief Executive Officer, and David Szekeres, the Company's newly-appointed President, non-qualified stock option awards to purchase an aggregate of 2,658,734 ordinary shares and 1,772,489 ordinary shares, respectively, under the Connect Biopharma Holdings Limited 2024 Employment Inducement Incentive Award Plan (the Inducement Plan). The options were granted effective June 12, 2024 and have an exercise price of $1.77 per share (the closing price of Connect's ordinary shares on the grant date). The options vest over a period of four years, with 25% vesting on June 12, 2025 and the remaining shares vesting in equal monthly installments thereafter, subject to each executive's continued employment or service. The awards were granted as inducements material to Dr. Quart and Mr. Szekeres entering into employment with Connect in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/12/2024
|
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on June 10, 2024, it granted stock options to purchase an aggregate of 120,000 shares of common stock upon vesting to Chohee Yun, M.D., the Company's newly appointed Senior Vice President of Clinical Development as a material inducement to her employment.
- 06/12/2024
|
Sirius XM Could Be Dropped From the Nasdaq 100 at Coming Rebalancing
- The shares appear to meet the criteria to be removed from the index.
- 06/12/2024
|
SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement
- Salt Lake City, Utah., June 12, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (SINTX) (www.sintx.com) (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and related technologies, today announced that on June 11, 2024, the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has evidenced compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Accordingly, the previously announced listing matter has been closed.
- 06/12/2024
|
S&P 500, Nasdaq Hit Record Highs As Apple Shares Surge: Fear And Greed Index Shows Progress Amid Improving Market Sentiment
- The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index remained in the “Neutral” zone on Tuesday.
- 06/12/2024
|
Nasdaq: Texas Stock Exchange Announcement Likely Not Cause For Major Concern
- TXSE Group plans to launch the Texas Stock Exchange as a challenger to established exchanges like Nasdaq and Cboe. Previous upstart exchanges have struggled to gain significant market share, with only a combined 6% of U.S. equity share volume. The impact on Nasdaq's revenue and earnings from TXSE's launch is likely manageable, but the effect on listings and other capital access platforms remains uncertain.
- 06/12/2024
|
S&P, Nasdaq Notch New Closing Highs Ahead of CPI, Fed
- While Apple (AAPL) helped the Nasdaq and S&P higher, the Dow and Russell 2000 were lower for the session.
- 06/11/2024
|
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, June 11, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that on June 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to three new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 10,500 shares of its common stock. These inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan (“2018 Plan”), but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/11/2024
|
Capture More Nasdaq-100 Upside With Income ETF QQQI
- Covered-call strategies gained popularity for their attractive income potential, but at a cost to upside capture. The NEOS Nasdaq 100 High Income ETF (QQQI) is changing the game, offering better upside capture alongside tax efficient, high income.
- 06/11/2024
|
Mountain & Co. I Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- NEW YORK , June 11, 2024 /PRNewswire/ -- Mountain & Co. I Acquisition Corp. (the "Company") today announced that, on June 5, 2024, it received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the period ended March 31, 2024 (the "Form 10-Q"), the Company was no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the "Periodic Filing Rule"). The Notice states that the Company has 60 calendar days from the date of the Notice to submit a plan to regain compliance with the Periodic Filing Rule.
- 06/11/2024
|
Nasdaq Executives to Present at Upcoming Investor Conferences
- NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in June with webcasts available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 06/11/2024
|
Stock Market Today: Nasdaq Hits New High as Apple Stock Soars
- Apple stock was one of the biggest gainers Tuesday as analysts were encouraged by the tech giant's new AI offerings.
- 06/11/2024
|
Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 31, 2024
- NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of May 31, 2024, short interest in 3,059 Nasdaq Global MarketSM securities totaled 11,833,288,492 shares compared with 11,646,612,058 shares in 3,063 Global Market issues reported for the prior settlement date of May 15, 2024. The end of May short interest represent 3.54 days average daily Nasdaq Global Market share volume for the reporting period, compared with 3.15 days for the prior reporting period.
- 06/11/2024
|
Nasdaq Announces Results from 2024 Annual Meeting of Shareholders
- All 12 Nominated Directors Elected Kathryn A. Koch Joins the Board of Directors as a Newly Elected Independent Director Nasdaq Board Re-elects Adena T.
- 06/11/2024
|
Origin Materials Regains Compliance with Nasdaq Listing Requirements
- WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Origin Materials (“Origin”) (NASDAQ: ORGN, ORGNW), the world's leading carbon negative materials company with a mission to enable the world's transition to sustainable materials, today announced that on June 11, 2024 it received written notice from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) stating that the Company regained compliance with the Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5550(a)(2). T.
- 06/11/2024
|
iRobot Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass. , June 11, 2024 /PRNewswire/ -- iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced that it granted equity awards on June 7, 2024 as a material inducement to the employment of the company's newly-hired Chief Executive Officer, Gary S.
- 06/11/2024
|
Nasdaq Surges 100 Points; CoreCivic Shares Plummet
- U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 100 points on Tuesday.
- 06/11/2024
|
The 3 Most Undervalued Nasdaq 100 Stocks to Buy: Summer 2024
- After last year's monstrous 53% gains the Nasdaq 100 is at it again in 2024. Year-to-date (YTD) the popular index is up another 13%.
- 06/11/2024
|
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- 06/10/2024
|
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted non-qualified stock option awards to purchase an aggregate of 158,000 shares of its common stock to nine new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/10/2024
|
3 No-Brainer Nasdaq Stocks to Buy in June
- 24/7 Insights The Nasdaq is up a stunning 14.5% this year after a massive 43% gain in 2023.
- 06/10/2024
|
Nasdaq and S&P 500 to open lower amid political uncertainty; Apple AI event later today
- US stocks set to open down Apple to unveil AI strategy at conference today Interest rate decision this week 8.35am: Wall Street to open lower In the US, stocks are set to open lower as the markets react to the growing uncertainty in Europe and digest last week's jobs data, which may lead to some hawkish comments from the Fed at its interest rate meeting later this week. Futures for the Dow Jones are implying it will open at 38,827, down 41 points, while the S&P 500 is expected to open 5 points lower at 5,353.
- 06/10/2024
|
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that on June 6, 2024, the compensation committee of BridgeBio's board of directors approved equity grants to 18 new employees in restricted stock units for an aggregate of 90,591 shares of the Company's common stock. One-fourth of the shares underlying each employee's restricted stock units will vest on May 16, 2025, with one-twelfth of the remaining shares underlying each such employee's restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee's continued employment with the Company or one of its subsidiaries on such vesting dates. All of the above-described awards were made under BridgeBio's Amended and Restated 2019 Inducement Equity Plan (the “Plan”).
- 06/10/2024
|
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
- BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from the NASDAQ Stock Market LLC (Nasdaq) that the Company has regained compliance with all applicable Nasdaq listing standards. As a result, the Company's stock will remain listed and traded on the Nasdaq Stock Market.
- 06/10/2024
|
$1,000 in This Vanguard ETF Incurs a Mere $1 Annual Fee, and It Has Beaten the S&P 500 and Nasdaq Composite in 2024
- The Vanguard S&P 500 Growth ETF has some distinguishing characteristics. Nearly three-quarters of the fund is concentrated in just three sectors.
- 06/09/2024
|
2 Top Artificial Intelligence (AI) Stocks to Buy Before the Nasdaq Soars Higher
- Nvidia's latest guidance makes it clear that the semiconductor bellwether is set to deliver more upside. Qualcomm's growth is accelerating due to the adoption of AI-enabled smartphones and personal computers.
- 06/08/2024
|
Waystar IPO: Stock price will be closely watched today as the healthcare software company debuts on Nasdaq
- The name may conjure up memories of HBO's Succession (in which the fictional company at the center of the action is called “Waystar Royco”), but this Waystar is very much real—and it's hitting the public exchanges on Friday.
- 06/08/2024
|
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 6, 2024, the Compensation Committee of Puma's Board of Directors approved the grant of an inducement restricted stock unit award covering 3,500 shares of Puma common stock to one new non-executive employee. The award was granted under Puma's 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards to.
- 06/07/2024
|
NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Annual Report on Form 10-Q
- New York, NY, June 07, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the period ended March 31, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”).
- 06/07/2024
|
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective June 5, 2024, to one new non-executive employee of non-qualified stock option aw.
- 06/07/2024
|
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, CA / ACCESSWIRE / June 7, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective June 4, 2024, the Company granted 1,111 restricted stock units (RSUs) to one new employee. These RSUs vest over one year starting from this new employee's date of hire.
- 06/07/2024
|
Papaya Growth Opportunity Corp. I Receives Expected Notice from Nasdaq Regarding Delayed Quarterly Filing
- Oakland, CA, June 07, 2024 (GLOBE NEWSWIRE) -- Papaya Growth Opportunity Corp. I (NASDAQ: PPYA) (the "Company") announced today that it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Form 10-Q") with the Securities and Exchange Commission ("SEC"). The Notice has no immediate effect on the listing or trading of the Company's securities on Nasdaq. The Company is working diligently to finalize the financial statements and to file the Form 10-Q as soon as practicable.
- 06/07/2024
|
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on June 4, 2024, the Compensation Committee of Vera's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 31,250 shares of Class A common stock and restricted stock units (RSUs) for 14,500 shares of Class A common stock to five new employees under Vera's 2024 Inducement Plan (the Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/07/2024
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NAARDEN, the Netherlands and MIAMI, June 07, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 90,000 of NewAmsterdam's ordinary shares to five non-executive new hires. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/07/2024
|
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3, 2024, Anika granted: (i) non-statutory stock options (“Options”) covering 96,525 shares of common stock at a per share exercise price of $29.35, which equaled 110% of the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, and (ii) restricted stock units (“RSUs”) covering 38,520 shares of common stock, to Stephen Griffin, the Company's recently appointed Executive Vice President, Chief Financial Officer and Treasurer. The grants were made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, were approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), were made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation.
- 06/07/2024
|
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of 9,700 restricted stock units of Atara's common stock to one newly hired employee. This award was approved by the Compensation Committee of Atara's Board of Directors and granted under the Atara.
- 06/07/2024
|
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass, June 07, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics company, today announced that on June 5, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an aggregate of 6,188 shares of its common stock to one new employee, consisting of stock options to purchase 4,125 shares of common stock and restricted stock units (“RSUs”) covering 2,063 shares of its common stock.
- 06/07/2024
|
Waystar shares slip in Nasdaq debut after digital health company priced IPO in middle of range
- Health-care payments company Waystar began trading on the Nasdaq Friday. The stock opened at $21 per share, after the company priced its IPO at $21.50.
- 06/07/2024
|
Waystar shares fall 2% in underwhelming Nasdaq debut
- Shares of Waystar fell 2.3% below their initial public offering price in their Nasdaq Global Select Market debut on Friday, giving the healthcare payments company a valuation of $3.50 billion.
- 06/07/2024
|
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
- WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today its common stock will uplist and commence trading on the Nasdaq Global Market, effective June 14, 2024, and will continue under the ticker symbol “IRMD.
- 06/07/2024
|
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- DALLAS, June 07, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 3, 2024, the Compensation Committee of Taysha's Board of Directors granted three new employees, in the aggregate, options to purchase 360,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/07/2024
|
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) and an option (“Option”) to 15 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of Jelmyto® (mitomycin) for pyelocalyceal solution, UroGen's first ap.
- 06/07/2024
|
These 3 Nasdaq-100 Stocks Are Trading at Dirt Cheap Multiples
- The Nasdaq's largest non-financial stocks can be found in the Nasdaq-100 index. Comcast, Kraft Heinz, and Sirius XM are all in the index and trade at discounted prices.
- 06/07/2024
|
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on June 3, 2024, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 152,500 shares of common stock to eight (8) new employees under the Company's 2023 Inducement Option Plan. The Compensation Committee approved the stock options as an inducement material to such employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/07/2024
|
2 Soaring Nasdaq Stocks I'd Buy Now With No Hesitation
- Nvidia continues to be one of the major beneficiaries of the explosive growth in the AI market. Meta Platforms uses advanced AI technologies to improve digital ad targeting and performance on its social media platforms.
- 06/07/2024
|
Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement
- JERUSALEM , June 7, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) (the "Company"), a biotechnology company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that on June 5, 2024, it received formal notification from the Listing Qualification Department (the "Staff") of the Nasdaq Stock Market ("Nasdaq") that the Company has regained compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule").
- 06/07/2024
|
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BRISBANE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company's Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 14,000 shares of its common stock under the Company's 2023 Inducement Plan.
- 06/07/2024
|
Solidion Technology Announces Receipt of Expected Delinquency Notification Letter From Nasdaq Relating to Non-Compliance with Listing Rule 5250(c)(1)
- Dallas, TX, June 06, 2024 (GLOBE NEWSWIRE) -- On May 31, 2024, Solidion Technology, Inc. (the “Company”) received an expected delinquency notification letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Form 10-Q”) by the applicable due date, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”).
- 06/06/2024
|
S&P 500, Nasdaq Reverse From New Highs, As Does Nvidia
- The S&P 500 and Nasdaq reversed from record highs Thursday ahead of the Labor Department's May jobs report.
- 06/06/2024
|
Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- SARASOTA, FL, June 06, 2024 (GLOBE NEWSWIRE) -- SARASOTA, FL, June 6, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 917,432 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $2.18 per share (or per common stock equivalent in lieu thereof). In a concurrent private placement, the Company issued unregistered warrants to purchase up to 917,432 shares of common stock at an exercise price of $2.06 per share that are immediately exercisable upon issuance and will expire five years following the date of issuance.
- 06/06/2024
|
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent directors serving on the Compensation Committee of the company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 450,000 shares of the company's common stock to.
- 06/06/2024
|
10 Upcoming Dividend Increases
- This article features ten companies with a history of raising their dividends, including two well-known insurance companies. The average dividend increase among the featured companies is 7.7%, with a median increase of 7.6%. My investment strategy involves buying companies that consistently increase their dividends and outperform a benchmark.
- 06/06/2024
|
Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win
- The S&P 500 achieves its 25th record high this year, and the Nasdaq touched another record on tech surge. This has fueled a rally in the leveraged space.
- 06/06/2024
|
ETFs for Leveraging the Surge in Nasdaq and S&P 500
- The S&P 500 and the Nasdaq keep surging higher. Both indexes hit an all-time high yesterday, mainly on strength in NVIDIA.
- 06/06/2024
|
Venus Concept Regains Compliance with Nasdaq's Minimum Equity Requirement
- TORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that on June 4, 2024, it was notified by the Nasdaq Stock Market LLC (“Nasdaq”) that the Company had regained compliance with the stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) (“Minimum Equity Requirement”). Pursuant to Nasdaq Listing Rule 5815(d)(4)(B), the Company will be subject to a mandatory panel monitor through June 4, 2025.
- 06/06/2024
|
Nasdaq Index, Dow Jones, S&P 500 News: Nvidia Leads Tech Rally Ahead of NFP Report
- The recent surge in the S&P 500 and Nasdaq stock indices, powered by Nvidia and strong earnings reports, sets a bullish tone for the market.
- 06/06/2024
|
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it has closed its previously announced private placement for the issuance and sale of an aggregate of 1,809,955 shares of its common stock (or common stock equivalents in lieu thereof), series A warrants to purchase up to 1,809,955 shares of common stock and short-term series B warrants to purchase up to 1,809,955 shares of common stock at a purchase price of $2.21 per share of common stock (or per common stock equivalent in lieu thereof) and accompanying warrants priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants have an exercise price of $2.00 per share and are exercisable immediately upon issuance. The series A warrants expire five years from the date of issuance and the short-term series B warrants expire twenty-four months from the date of issuance.
- 06/05/2024
|
Yotta Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Annual Report on Form 10-Q
- NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Yotta Acquisition Corporation. (Nasdaq: YOTA) (the “Company”) announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the period ended March 31, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). This notification has no immediate effect on the listing of the Company's shares on Nasdaq. Subsequent to the receipt of the Notice, the Company filed the Form 10-Q on May 31, 2024.
- 06/05/2024
|
Brooge Energy Ltd. Announces Receipt of Nasdaq Non-Compliance Letter
- NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Brooge Energy Ltd, (“Brooge Energy” or the “Company”) is a Cayman Islands-based infrastructure provider, which is engaged in Clean Petroleum Products and Biofuels and Crude Oil storage and related services. The Company conducts the business and operations through its subsidiary Brooge Petroleum and Gas Investment Company FZE (BPGIC), which is strategically located outside the Strait of Hormuz at the Port of Fujairah in the Emirate of Fujairah in the UAE. The Company announced today that it has received a letter from The Nasdaq Stock Market dated May 23, 2024 (the “Notice”), stating that the Company is not in compliance with Listing Rule 5250(c)(1). The Company is not in compliance as it has not yet filed its Form 20-F for the period ended December 31, 2023 (the “Filing”).
- 06/05/2024
|
Project Energy Reimagined Acquisition Corp. Receives Expected Notice from Nasdaq Regarding Delayed Quarterly Report
- Menlo Park, California, June 05, 2024 (GLOBE NEWSWIRE) -- Project Energy Reimagined Acquisition Corp. (Nasdaq: PEGR) (the “Company”) today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) due to a delay in filing its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company's securities on the Nasdaq Global Market.
- 06/05/2024
|
BurTech Acquisition Corp. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
- NEW YORK--(BUSINESS WIRE)--BurTech Acquisition Corp. (the “Company”) (NASDAQ: BRKH) today announced that it received a notice (“Notice”) on June 3, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “10-Q”) with the Securities and Exchange Comm.
- 06/05/2024
|
PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- New York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that, on June 3, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that the Company was not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (“SEC”).
- 06/05/2024
|
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WESTLAKE VILLAGE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 57,500 restricted stock units of Arcutis' common stock to six newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of June 3, 2024, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/05/2024
|
APX Acquisition Corp. I Reports 10-K Delinquency Notice
- NASHVILLE, Tenn. , June 5, 2024 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI ) ("Company"), a publicly traded special purpose acquisition company, today announced that it received a deficiency letter (the "Letter") on May 30, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq").
- 06/05/2024
|
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
- Walgreens has lost some 70% of its value, and the stock now yields 6.5%. Kraft Heinz has experienced a similar slump, and its shares offer a 4.6% yield.
- 06/05/2024
|
Nasdaq Grants Extension to Knightscope Until October 4, 2024
- MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $KSCP #SecurityRobot--Nasdaq Grants Extension to Knightscope.
- 06/05/2024
|
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., June 05, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for 4,650 shares of G1's common stock and 2,400 restricted stock units (RSUs) to one hired employee under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Amended and Restated 2021 Plan”).
- 06/05/2024
|
3 Stocks Billionaires Are Buying in the Wake of the Nasdaq Bull Market
- The Nasdaq has surged 60% off previous lows, but these skilled investors see opportunistic values in the market. Billionaires Daniel Loeb, Chase Coleman, and David Tepper see more upside in shares of Amazon, Take-Two, and JD.com.
- 06/05/2024
|
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on June 3, 2024, the Compensation Committee of Praxis' Board of Directors granted non-qualified stock option awards to purchase an aggregate of 300 shares of its common stock and restricted stock unit awards covering an aggregate of 225 shares of its common stock to one new non-executive employee under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the “2024 Inducement Plan”). The stock options and restricted stock units were granted as inducements material to the employee's entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/04/2024
|
Vision Sensing Acquisition Corp. Announces Receipt of a Deficiency Notice from Nasdaq for Failure to Timely File its 1st Quarter 2024 Form 10-Q and Announces the Filing of the Form 10-Q
- Vision Sensing Acquisition Corp. Announces Deficiency Notice from Nasdaq for Failure to Timely File 1st Quarter 2024 Form 10-Q and Announces Filing of 10-Q
- 06/04/2024
|
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- ATLANTA, June 04, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better vision longer, today announced that, pursuant to Nasdaq Listing Rule 5635(c)(4) and in connection with the appointments of five non-executive employees, the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) approved, on May 22, 2024 (the “Grant Date”), inducement awards consisting of stock options under the Alimera Sciences, Inc. 2024 Equity Inducement Plan to persons who were not previously employees or who rejoined the Company following a bona fide period of non-employment, as an inducement material to each such new or re-hired employee's employment (collectively, the “Inducement Awards”).
- 06/04/2024
|
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers, today announced that the Company granted stock options to four new employees to purchase an aggregate of 51,600 shares of the Company's common stock, effective as of June 3, 2024. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan, with a grant date of June 3, 2024, as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/04/2024
|
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- HINGHAM, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 1,566,669 shares of the Company's common stock at a purchase price of $1.50 per share of common stock . In addition, in a concurrent private placement, the Company has issued unregistered series F preferred investment options. The series F preferred investment options to purchase up to 3,133,338 shares of common stock have an exercise price of $1.50 per share and are immediately exercisable following issuance for a period of two years thereafter.
- 06/04/2024
|
MultiSensor AI Announces Compliance With Nasdaq Continued Listing Criteria
- HOUSTON, TX / ACCESSWIRE / June 4, 2024 / MultiSensor AI Holdings, Inc. (Nasdaq:MSAI, MSAIW), a pioneer in AI-powered industrial condition-based maintenance and process control solutions, today announced that it received written notification from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has demonstrated compliance with the Nasdaq continued listing criteria. Accordingly, the Company will be removed from the list of companies published by Nasdaq that are noncompliant with its continued listing standards.
- 06/04/2024
|
Graphjet Technology Receives Notification of Delinquency from Nasdaq
- Kuala Lumpur, June 04, 2024 (GLOBE NEWSWIRE) -- Graphjet Technology, a Cayman Islands exempt company (“Graphjet” or the “Company”) (Nasdaq: GTI), today announced that on May 30, 2024, the Company received a delinquency notification letter (the “10-Q Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of the Company's failure to have timely filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Quarterly Report”), with the Securities and Exchange Commission. The Company is working diligently with its independent registered public accounting firm to complete the Form 10-Q. The 10-Q Notice has no immediate effect on the listing of the Company's ordinary shares on the Nasdaq Global Market.
- 06/04/2024
|
HeartSciences Regains Compliance with Nasdaq Listing Requirements
- Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that on June 3, 2024, the Company received formal notice from the Listing Qualifications Staff of the Nasdaq Stock Market LLC indicating that HeartSciences has regained compliance with bid price requirement as set forth in Listing Rule 5550(a)(2), and that the Company is therefore in compliance with the Nasdaq Capital Market's listing requirements and the scheduled hearing has now been cancelled.
- 06/04/2024
|
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 40,000 shares of Astria's common stock on June 3, 2024 under Astria's 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were grant.
- 06/04/2024
|
Nasdaq May 2024 Volumes
- NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for May 2024 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics.
- 06/04/2024
|
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BEDFORD, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that it has agreed to grant inducement awards to (i) its newly appointed Chief Medical Officer, Nadia K. Waheed, MD, MPH, and (ii) six other newly hired employees. The awards were made as inducements material to each individual's acceptance of employment with Ocular under Ocular's 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/04/2024
|
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of June 1, 2024, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 1,000 shares of Vor Bio's common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 1,500 shares of Vor Bio's common stock to one newly hired employee. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).
- 06/04/2024
|
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, June 04, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that on June 1, 2024 the Company granted (i) a non-qualified stock option to one newly-hired employee to purchase a total of 65,000 shares of the Company's common stock at an exercise price per share of $3.68, which was the closing price per share of the Company's common stock as reported by NASDAQ on May 31, 2024, the last date preceding the grant effective date for which a closing price was reported, and (ii) restricted stock units (RSUs) representing 14,500 shares of its common stock to three newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The option will vest over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% percent vesting in approximately equal monthly installments over the following thirty-six months, subject to the employee being continuously employed by the Company through each vesting date. The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.
- 06/04/2024
|
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- WALTHAM, Mass. and DUBLIN, June 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that on June 3, the Company granted to two newly hired employees (i) non-statutory stock options to purchase an aggregate of 7,995 ordinary shares of the Company and (ii) restricted stock units with respect to an aggregate of 4,305 ordinary shares of the Company, pursuant to the Company's 2024 Inducement Stock Option and Incentive Plan, each as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/04/2024
|
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CHARLESTOWN, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 30,949 restricted stock units (“RSUs”) to four newly hired employees.
- 06/04/2024
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- RESEARCH TRIANGLE PARK, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted 10 newly-hired employees stock options to purchase an aggregate of 74,875 shares, and restricted stock units (RSUs) covering an aggregate of 39,050 shares, of BioCryst common stock. The options and RSUs were granted as of May 31, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/04/2024
|
The 3 Most Undervalued Nasdaq 100 Stocks to Buy in June 2024
- The Nasdaq 100 represents one of the more realistic economic aggregates to keep an eye on because it's there you'll find undervalued Nasdaq stocks. Unlike the Dow Jones Industrial Average, the Nasdaq 100 has triple the company data from which to extrapolate predictions while maintaining a tighter focus on quality and company value.
- 06/04/2024
|
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted one newly-hired employee inducement options to purchase an aggregate of 7,000 shares of KalVista common stock on June 3, 2024 as inducement material to such employee entering into employment with KalVista. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exerc.
- 06/04/2024
|
Calamos Rolls Out Nasdaq-100® Structured Alt Protection ETF™ – June (CPNJ)
- Calamos Investments has unveiled its new fund within the growing line of its Structured Protection ETFs. The Calamos Nasdaq-100® Structured Alt Protection ETF™ – June (CPNJ) is the second fund in the series to launch.
- 06/03/2024
|
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEW YORK & SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that on June 3, 2024, the Compensation Committee of Zentalis' Board of Directors granted non-qualified stock options to purchase an aggregate of 20,000 shares of the Company's common stock to two newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual's entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/03/2024
|
Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Zapata Computing Holdings Inc. (“Zapata AI” or the “Company”) (Nasdaq: ZPTA), the Industrial Generative AI company, today announced that the Compensation Committee of Zapata AI's Board of Directors has approved an inducement grant of a nonstatutory stock option to Derron Blakely to purchase 300,000 shares of Zapata AI's common stock with an exercise price of $0.841 per share, the closing price of Zapata AI's common stock on June 3, 2024. As previously announced, Mr. Blakely will serve as Zapata AI's General Counsel, effective today. The option will vest as to 25% of the underlying shares on the first anniversary of the date of grant and the remaining 75% of the underlying shares will vest in 36 substantially equal monthly increments thereafter, subject to Mr. Blakely's continued employment on each vesting date. The option is subject to the terms and conditions of Zapata AI's 2024 Equity and Incentive Plan and the respective terms and conditions of the nonstatutory stock option agreement covering the award, but was granted outside of the 2024 Equity and Incentive Plan.
- 06/03/2024
|
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- SAN DIEGO and TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 3,855,000 of its common shares (or common share equivalents in lieu thereof) at a purchase price of $1.15 per share (or per common share equivalent in lieu thereof). Additionally, in a concurrent private placement, Aptose has issued unregistered series A warrants to purchase up to 3,855,000 common shares and series B warrants to purchase up to 3,855,000 common shares, each at an exercise price of $1.15 per share.
- 06/03/2024
|
Nasdaq Chair & CEO Adena Friedman to Present at the Piper Sandler Global Exchange & Trading Conference
- NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 06/03/2024
|
Cadence's John Wall to Present at Nasdaq Conference
- SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence's John Wall to Present at Nasdaq Conference.
- 06/03/2024
|
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass. , June 3, 2024 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 4 newly-hired employees options to purchase an aggregate of 76,000 shares of Akebia's common stock on May 31, 2024, as inducements material to such employee entering into employment with Akebia.
- 06/03/2024
|
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and development of covalent small molecules to treat patients with genetically defined cancers and metabolic diseases, today announced that on June 1, 2024, the compensation committee of Biomea's board of directors granted one new employee non-qualified stock options to purchase an aggregate of 25,000 shares of the Company's common stock. The shares underlying the employee's stock options will vest 1/16 on a quarterly basis over four years, subject to the employee's continued employment with the Company on such vesting dates.
- 06/03/2024
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NEWTON, Mass. , June 3, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 9,500 restricted stock units (RSUs) to three newly-hired employees.
- 06/03/2024
|
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that on May 28, 2024, the Compensation Committee of Spero's Board of Directors approved the grant of 116,667 restricted stock unit awards (RSUs) to a new employee under the Spero Therapeutics, Inc. 2019 Inducement Equity Incentive Plan, as amended (2019 Inducement Plan). The RSUs are being granted as an inducement material to the new employee becoming an employee of Spero in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/03/2024
|
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on May 31, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 166,353 shares of X4's common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by X4's Compensation Committee of the Board of Directors.
- 06/03/2024
|
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- HINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of the Company's common stock at a purchase price of $1.50 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered series F preferred investment options. The series F preferred investment options to purchase up to 3,133,338 shares of common stock have an exercise price of $1.50 per share and are immediately exercisable following issuance for a period of two years thereafter. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about June 4, 2024, subject to the satisfaction of customary closing conditions.
- 06/03/2024
|
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
- ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced that it has agreed to issue and sell to an institutional accredited investor an aggregate of 225,000 registered pre-funded warrants to purchase shares of common stock and unregistered warrants to purchase up to an aggregate of 112,500 shares of common stock. The pre-funded warrants were sold at a purchase price of $6.43 minus $0.001 per pre-funded warrant, and are exercisable immediately at an exercise price of $0.001 per share. Each share of common stock is being sold together with one-half of one warrant at a combined effective offering price of $6.4925 per share and related warrant. The warrants will be immediately exercisable after the date of issuance at a price of $6.43 per share and will expire five years after issuance.
- 06/03/2024
|
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives an Extension on Compliance with Nasdaq Filing Requirement
- BEIJING, June 03, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on May 29, 2024, informing the Company that it has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). According to the Notification Letter, as of May 28, 2024, the Company has maintained a closing bid price of $1.00 per share or greater for ten consecutive business days.
- 06/03/2024
|
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
- SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the Company will be changing its ticker symbol from “LIFE” to “ATYR.” Effective at the market open on June 5, 2024, the Company's common stock will trade on the Nasdaq Capital Market under the new symbol “ATYR.
- 06/03/2024
|
Nasdaq expected to lead gains on Wall Street, Nvidia and GameStop seen rising
- US stock markets are set for a mixed open on Monday, the first trading day in June, after a strong finish to last month. Tech stocks are likely to remain the key driver, with Nasdaq 100 futures pointing to a 0.4% gain, while S&P 500 futures are up 0.12%.
- 06/03/2024
|
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CLEVELAND, June 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- 06/03/2024
|
High-Flying Picks: 3 Nasdaq Stocks to Buy Amid the Record-Breaking Rally
- With the Nasdaq keeping up its record of reaching new heights in May, investors are wondering which stocks to buy amidst the record-breaking environment. The artificial intelligence (AI) rally continues, with Nvidia (NASDAQ: NVDA ) posting new records.
- 06/03/2024
|
Worried About a Stock Market Correction With the S&P 500 and Nasdaq Composite at an All-Time High? 2 ETFs and 1 Dividend King to Buy Now
- These two ETFs distribute monthly payouts and have high yields. Covered calls provide consistent income in a challenging market period.
- 06/02/2024
|
1 Ultra-High-Yielding ETF I Can't Wait to Buy More of in June
- JPMorgan Nasdaq Equity Premium ETF offers a high-yielding payout and equity upside potential. It generates income by writing call options on the Nasdaq-100.
- 06/02/2024
|
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
- COPENHAGEN, Denmark, and MAINZ, Germany, June 1, 2024 — Genmab A/S (Nasdaq: GMAB, “Genmab”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced initial data from the ongoing Phase 2 trial ( NCT05117242 ) evaluating acasunlimab (DuoBody-PD-L1x4-1BB), an investigational bispecific antibody also known as GEN1046/BNT311, as monotherapy and in combination with pembrolizumab in patients with PD-L(1)-positive metastatic non-small cell lung cancer (“mNSCLC”) who had disease progression following one or more prior lines of anti-PD(L)1-containing treatment. The results showed a 12-month overall survival (“OS”) rate of 69%, a median overall survival (“mOS”) of 17.5 months, and a 30% overall response rate (“ORR”) (confirmed ORR 17%) at the time of data cut-off in patients treated with the combination of acasunlimab and pembrolizumab every six weeks. The findings were presented at the 2024 American Society of Clinical Oncology (“ASCO”) Annual Meeting held in Chicago, IL from May 31-June 4, 2024.
- 06/01/2024
|
$10,000 in This High-Yield Vanguard ETF Incurs a Mere $10 Annual Fee, and It Has Beaten the S&P 500 and Nasdaq Composite in 2024
- Utilities have been one of the best-performing sectors so far this year. The Vanguard Utilities ETF is a low-cost way to get exposure to the sector while earning a 3.3% yield.
- 06/01/2024
|
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on May 31, 2024 (the “Grant Date”) that were previously approved by the Compensation Committee of its Board of Directors under Sarepta's 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 9 individuals hired by Sarepta in May 2024. The equity awards were approved in accordance with Nasdaq Listing Rule 5.
- 05/31/2024
|
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on May 31, 2024. Two individuals were hired by Adicet in May 2024. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 44,800 shares of Adicet's common stock with an exercise price of $1.45 per share,.
- 05/31/2024
|
Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc.; NextPlay Technologies, Inc.; Relativity Acquisition Corp.; iSun, Inc.; Ace Global Business Acquisition Limited; and Marpai, Inc. from The Nasdaq Stock Market
- NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of RiskOn International, Inc. RiskOn International, Inc.'s securities were suspended on February 28, 2024, and have not traded on Nasdaq since that time.
- 05/31/2024
|
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BOSTON, May 31, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that on May 31, 2024, the company granted equity awards to four new employees, pursuant to the company's 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/31/2024
|
Correction Collection: 3 Value Stocks to Buy When the Nasdaq Nosedives
- Is this the beginning of the end? After a tremendous run higher over the last year and a half, the Nasdaq exchange is pulling back from recent highs.
- 05/31/2024
|
Astra Space Inc. Receives and Subsequently Cures Deficiency Notice from Nasdaq Due to Late 10-Q Filing
- ALAMEDA, Calif.--(BUSINESS WIRE)---- $ASTR #adastra--Astra Space, Inc. (“Astra”) announced that on May 22, 2024, it received a deficiency notice from Nasdaq indicating that, because Astra did not timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 with the Securities and Exchange Commission (the “SEC”), Astra was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the SEC. As previo.
- 05/31/2024
|
The Real Good Food Company Receives Nasdaq Notice Regarding Filing Requirements
- CHERRY HILL, N.J., May 31, 2024 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (NASDAQ: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen and refrigerated foods company, announced that on May 17, 2024, it received a notification from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company no longer satisfies Nasdaq Listing Rule 5250(c)(1) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Quarterly Report”) with the Securities and Exchange Commission.
- 05/31/2024
|
This Vanguard ETF Just Hit an All-Time High as It Continues to Outperform the S&P 500 and the Nasdaq Composite Over the Last 3 Years
- The tech sector is up nearly threefold over the last five years. There's a lot more to this group than just semiconductor and software stocks.
- 05/31/2024
|
Maxeon Solar Technologies Regains Compliance with Nasdaq Listing Rule 5250(c)(1)
- SINGAPORE , May 31, 2024 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) (the "Company"), a global leader in solar innovation and channels, announced that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") in connection with the filing of its 2023 Annual Report on Form 20-F (the "Annual Report").
- 05/31/2024
|
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- SAN DIEGO and TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, today announced that it has entered into a definitive agreement for the issuance and sale of 3,855,000 of its common shares (or common share equivalents in lieu thereof) at a purchase price of $1.15 per share (or per common share equivalent in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. Additionally, in a concurrent private placement, Aptose has agreed to issue unregistered series A warrants to purchase up to 3,855,000 common shares and series B warrants to purchase up to 3,855,000 common shares, each at an exercise price of $1.15 per share.
- 05/31/2024
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO , May 31, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on May 30, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 49,000 shares of the Company's common stock to two newly hired employees. The stock options were granted under the IDEAYA Biosciences, Inc. 2023 Employment Inducement Incentive Award Plan (2023 Inducement Plan) as an inducement material to such individuals' entering into employment with IDEAYA in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/31/2024
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 200,000 shares of common stock. An award was made to one new employee of the Company. The award was granted as an inducement material to the new employee becoming an employee of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and has been approved by the Company's Compensation Committee.
- 05/30/2024
|
Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing Requirements
- NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Collective Audience, Inc. (NASDAQ-GM: CAUD) has received an additional notification from the listing qualifications department of The Nasdaq Stock Market. Similar to the previous notifications announced on April 25, the new notification has no immediate effect on the continued listing of the company's common stock on the Nasdaq Global Market.
- 05/30/2024
|
Pioneer Receives Notification of Delinquency from Nasdaq
- FORT LEE, N.J.--(BUSINESS WIRE)--Pioneer Power Solutions, Inc. (Nasdaq: PPSI) (“Pioneer” or the “Company”), a leader in the design, manufacture, service and integration of electrical power systems, distributed energy resources, power generation equipment and mobile electric vehicle (“EV”) charging solutions, today announced that on May 24, 2024, the Company received a delinquency notification letter (the “10-Q Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasd.
- 05/30/2024
|
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
- CARLSBAD, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), announced today that on May 23, 2024, it received written notice (the “Delist Notice”) from The Nasdaq Stock Market (“Nasdaq”) indicating the Company's continued non-compliance with the minimum bid price requirement, pursuant to Listing Rule 5550(b)(2).
- 05/30/2024
|
Should You Retain Nasdaq (NDAQ) Stock in Your Portfolio?
- Nasdaq (NDAQ) is poised to grow on the back of its impressive organic growth, ramping up of on-trading revenue base and strategic buyouts to capitalize on growing market opportunities.
- 05/30/2024
|
History Says the Nasdaq Will Soar in 2024: Here Are My Top 5 Software Growth Stocks to Buy Right Now
- The excitement surrounding artificial intelligence (AI) has ignited tech stocks to reach new highs. Applications in enterprise software, fintech, cybersecurity, and workplace automation represent compelling long-term opportunities.
- 05/30/2024
|
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- PROVIDENCE, Rhode Island, May 30, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on May 22, 2024, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”).
- 05/30/2024
|
3 Nasdaq Stocks to Dump as They Near Peak Performance
- The Nasdaq hit a new record high again on Tuesday. It has investors wondering which Nasdaq stocks to sell to lock in profits before the upside runs its course.
- 05/30/2024
|
Forget the Nasdaq -- Buy This Magnificent ETF Instead
- The Invesco QQQ Trust and its underlying Nasdaq-100 index are cap-weighted, meaning they're not very well balanced right now. The Invesco S&P 500 Equal Weight ETF is always highly diversified as measured by market cap and sector breakdown.
- 05/30/2024
|
Twelve Seas Investment Company II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-Q
- New York, NY, May 29, 2024 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company II (NASDAQ): TWLV) (the “Company”) today announced that it has received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 (the “Form 10-Q”); consequently, the Company is not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). The Notice advised this matter serves as an additional basis for delisting the Company's securities from Nasdaq.
- 05/29/2024
|
Broadway Financial Corporation Announces Notification from Nasdaq Regarding Late Filing of Form 10-Q
- LOS ANGELES--(BUSINESS WIRE)--Broadway Financial Corporation (“Broadway”, “we”, or the “Company”) (Nasdaq Stock Market: BYFC), parent company of City First Bank, National Association, announced today it received a letter from the Nasdaq Stock Market LLC (“Nasdaq”), dated May 22, 2024, informing the Company that it no longer complies with Nasdaq Listing Rule 5250(c)(1) (“Rule 5250(c)(1)”) because Broadway had not filed its Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”) by the ti.
- 05/29/2024
|
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 1,898,734 shares of the Company's common stock and warrants to purchase up to 1,898,734 shares of common stock at a combined offering price of $1.58 per share of common stock and accompanying warrant priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $1.455 per share, are immediately exercisable and will expire five years following the date of issuance.
- 05/29/2024
|
Innovative Eyewear, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- MIAMI , May 29, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY; LUCYW), the developer and seller of smart eyewear, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the issuance and sale of 5,263,161 shares of its common stock at a purchase price per share of $0.475. Additionally, in a concurrent private placement, Innovative Eyewear has also issued unregistered warrants to purchase up to 5,263,161 shares of common stock at an exercise price of $0.475 per share.
- 05/29/2024
|
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- TAMPA, FL, May 29, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on May 23, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ending March 31, 2024 (the “Form 10-Q”), the Company is not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
- 05/29/2024
|
Clean Energy Special Situations Corp. Receives Notice from Nasdaq Regarding Suspension of Trading of Securities
- New York, New York, May 29, 2024 (GLOBE NEWSWIRE) -- Clean Energy Special Situations Corp. (the “Company”) announced that, on May 23, 2024, it received a notification letter (the “Notification Letter”) from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq's continued listing standards (the “Rules”), because the Company had not filed its Form 10-Q for the period ended March 31, 2024 (the “Q1 10-Q”). The May 2024 Notification Letter noted that this delinquency serves as an additional basis for delisting the Company's securities from Nasdaq.
- 05/29/2024
|
Nasdaq (NDAQ) & FIA Tech to Enhance Post Trade Infrastructure
- Nasdaq (NDAQ) and FIA Tech forge a partnership deal to reduce complexity and increase the reliability of post-trade infrastructure, leading to efficiency.
- 05/29/2024
|
Sotherly Hotels Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
- WILLIAMSBURG, Va., May 29, 2024 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO) (the “Company”) today announced that it has received a notice (“Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Form 10-Q") in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1).
- 05/29/2024
|
Greenwave Announces Reverse Stock Split to Regain Nasdaq Compliance
- Common stock will begin trading on reverse split-adjusted basis on June 3, 2024 CHESAPEAKE, Va. , May 29, 2024 /PRNewswire/ -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (Nasdaq: GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the "Common Stock") at a ratio of 1 post-reverse split share for every 150 pre-reverse split shares.
- 05/29/2024
|
5 Top-Ranked Stocks Powering Nasdaq's Rally to the 17,000 Mark
- The Nasdaq closed above the 17,000 mark for the first time, buoyed by solid corporate earnings, an AI boom and rate-cut bets. We have highlighted five stocks that more than doubled this year and have a top Zacks Rank.
- 05/29/2024
|
Nasdaq Tops 17K: 5 Best-Performing Stocks in ETF YTD
- The Nasdaq Composite Index topped the 17,000 level for the first time. We have highlighted five best-performing stocks of QQQ this year that led the way higher in the portfolio.
- 05/29/2024
|
Faraday Future Plans to Share Details of its "US-China Automotive Industry Bridge Strategy" in the Next Month or Two and has Received a Grant from Nasdaq for an Extended Stay of Suspension
- LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (“FF”, “Faraday Future”, or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that it will share the details of the "US-China Automotive Industry Bridge Strategy" in the next month or two. This will include a phase 1 strategy of its "FF Automotive Industry Bridge Strategy.” During the earnings call held yesterday for its financial results for its four.
- 05/29/2024
|
This Nasdaq-100 Growth Stock Just Hit a New 52-Week Low. Here's Why It's Worth Buying Now
- Weak consumer-discretionary spending continues to be a challenge in an otherwise strong market. Consumers are bogged down by high outstanding credit card balances and relatively unaffordable homes.
- 05/29/2024
|
'Own Nvidia, don't trade it', Jim Cramer doubles down on advice after company pushes Nasdaq higher
- 'Mad Money' host Jim Cramer looks at Nvidia's recent climb and where the stock came from.
- 05/28/2024
|
Nasdaq Hits New Closing High; BOX, CAVA Report Q1
- Economic data is also lightening up, along with earnings season, but not quite over.
- 05/28/2024
|
Stock Market Ends Mixed As 10-Year Yield Jumps; Nasdaq Hits All-Time High, Buoyed By Nvidia
- Nvidia continued its post-earnings rally in the stock market Tuesday, helping the Nasdaq score an all-time closing high.
- 05/28/2024
|
Assure Holdings Receives Notification of Delinquency from Nasdaq
- DENVER, May 28, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that as a result of the delinquency in the timely filing of the Company's quarterly report on Form 10-Q for the period ended March 31, 2024 (the “10-Q”), the Company is out of compliance with Nasdaq Listing Rules (Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission) and that the Nasdaq Hearings Panel (the “Panel”) will consider this matter as an additional deficiency, under Listing Rule 5810(d), in their decision regarding the Company's continued listing on The Nasdaq Capital Market. Nasdaq's extension notice has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market.
- 05/28/2024
|
Faraday Future Receives Anticipated Letter from Nasdaq Regarding Form 10-Q
- LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global shared intelligent electric mobility ecosystem company, today announced that on May 21, 2024, it received written notice from The Nasdaq Stock Market (“Nasdaq”) indicating that the Company's failure to timely file the Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”) could serve as an additional basis for the delis.
- 05/28/2024
|
Nvidia Shares Help Lift Nasdaq
- A jump in bond yields weighed on the broader market.
- 05/28/2024
|
Jianzhi Education Technology Receives Nasdaq Notification of Minimum Stockholders' Equity Non-Compliance
- BEIJING, May 28, 2024 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a leading provider of digital educational content in China, today announced it has received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) Listing Qualifications Department on May 22, 2024, notifying the Company no longer complies with the Nasdaq Listing Rule 5450(b)(1)(A) that requires companies listed on the Nasdaq Global Select Market to maintain a minimum of $10,000,000 in stockholders' equity for continued listing, and the Company's Form 20-F for the year ended December 31, 2023 reported stockholders' equity of ($2,425,096). In accordance with the Rules, the Company has 45 calendar days, or until July 8, 2024, to submit a plan to regain compliance. If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance.
- 05/28/2024
|
Staffing 360 Solutions Receives Nasdaq Notification Related to Non-Timely Filing of 2024 First Quarter Form 10-Q
- NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. ( Nasdaq: STAF ) (“Staffing 360” or the “Company”), a company executing a buy-integrate-build strategy through the acquisition of staffing organizations in the United States, today reported that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirements of Nasdaq Listing Rule 5250(c)(1) as a result of not having timely filed its Quarterly Report on Form 10-Q with the Securities and Exchange Commission (“SEC”) for the period ended March 30, 2024.
- 05/28/2024
|
Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- VANCOUVER, British Columbia--(BUSINESS WIRE)--Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the “Panel”) regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the “Stockholders' Equity Rule”). On May 21, 2.
- 05/28/2024
|
Innovative Eyewear, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- MIAMI , May 28, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY; LUCYW), the developer and seller of smart eyewear, today announced that it has entered into a definitive agreement for the issuance and sale of 5,263,161 shares of its common stock at a purchase price per share of $0.475 in a registered direct offering priced at-the-market under Nasdaq rules. Additionally, in a concurrent private placement, Innovative Eyewear has also agreed to issue unregistered warrants to purchase up to 5,263,161 shares of common stock at an exercise price of $0.475 per share.
- 05/28/2024
|
EEX offers remedies to address EU concerns on Nasdaq deal
- The European Energy Exchange (EEX) has offered remedies in a bid to address EU antitrust concerns about its bid for Nasdaq's European power trading and clearing business, according to an update on the European Commission website on Tuesday.
- 05/28/2024
|
4 Solid Stocks to Gain From Nasdaq's New Milestone
- Stocks like NVIDIA Corporation, Alphabet Inc. (GOOGL), Netflix, Inc. (NFLX) and Palo Alto Networks, Inc. (PANW) are likely to benefit from the ongoing tech rally.
- 05/28/2024
|
3 Sorry Nasdaq Stocks to Sell in May While You Still Can
- The Nasdaq Composite‘s rally has yet to abate, but there are still Nasdaq stocks to sell. The tech-heavy index has risen over 11% and is likely to edge upwards.
- 05/28/2024
|
NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Value of Listed Securities
- BANGKOK, May 28, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on May 24, 2024, the Company received two letters from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is currently not in compliance with certain requirements under the relevant Nasdaq Listing Rules.
- 05/28/2024
|
Nasdaq to lead gains ahead of consumer confidence data, GameStop surges
- US markets are heading for a mixed start as they reopen after the Memorial Day holiday, with meme stock followers no doubt excited to see GameStop rocketing higher again. On a wider view, tech stocks seem to be expected to drive gains, with Nasdaq 100 futures pointing to a 0.2% increase, with S&P 500 futures up 0.1%, while Dow Jones futures are down 0.1%.
- 05/28/2024
|
Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- CUPERTINO, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that it has entered into a definitive agreement for the sale and issuance of 1,898,734 shares of the Company's common stock and warrants to purchase up to 1,898,734 shares of common stock at a combined offering price of $1.58 per share of common stock and accompanying warrant in a registered direct offering priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $1.455 per share, will be immediately exercisable and will expire five years following the date of issuance. The closing of the offering is expected to occur on or about May 29, 2024, subject to the satisfaction of customary closing conditions.
- 05/28/2024
|
If You Can Only Buy One Nasdaq Stock in May, It Better Be One of These 3 Names
- Operating over 29 markets and centered in New York, the Nasdaq was the world's first automated stock exchange. With 2,500 companies+ on the Nasdaq and heavy exposure to the technology industry, it is no wonder that many companies in many investors' portfolios are brimming with companies trading on this exchange.
- 05/28/2024
|
History Says the Nasdaq Could Soar: 2 Top Growth Stocks to Buy Now for the Bull Market
- The Nasdaq Composite has returned an average of 215% during bull markets since 1990. Alphabet outperformed the Nasdaq over the last five years, and strength in advertising and cloud computing could keep its stock ahead of the index during the next five years.
- 05/28/2024
|
Nasdaq and FIA Tech Partner to Reduce Complexity and Increase Resiliency of Post Trade Infrastructure
- Nasdaq and FIA Tech will catapult efficient data sharing across the global post-trade industry Nasdaq and FIA Tech will catapult efficient data sharing across the global post-trade industry
- 05/28/2024
|
What's in the Cards for Nasdaq ETFs?
- The tech-heavy Nasdaq Composite Index hit a record high in the last trading session, marking a five-week win streak. Solid corporate earnings and rate cut bets have been driving the stocks higher.
- 05/27/2024
|
3 Tech Superstars Destined for Stratospheric Returns
- The technology-laden Nasdaq Composite Index is at an all-time high, as corporate earnings come in stronger-than-expected and U.S. Federal Reserve Chair Jerome Powell reassures markets that further interest rate hikes are unlikely. The Nasdaq is approaching the 17,000 level after another blockbuster earnings report from Nvidia (NASDAQ: NVDA ).
- 05/27/2024
|
Top 5 Nasdaq Composite Laggards of 2024 Likely to Gather Pace
- Five Nasdaq Composite listed laggards of year to date with strong potential for the rest of 2024 are: DDOG, PANW, ROP, INTU, BSY.
- 05/27/2024
|
Want to Retire Comfortably With at Least $1.5 Million? Here's How Much You Should Invest Today.
- Rising inflation means that you'll probably need more than just $1 million by the time you retire to live comfortably. Targeting a growth-oriented fund can help you achieve better returns than just trying to track the S&P 500.
- 05/27/2024
|
Aquaron Acquisition Corp. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-Q
- NEW YORK , May 27, 2024 /PRNewswire/ -- Aquaron Acquisition Corp. (NASDAQ: AQU, the " Company "), a special purpose acquisition company, announced today that on May 22, the Company received a written notice (the "Notice") from the Listing Qualifications staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it currently does not satisfy Listing Rule 5250(c)(1), as a result of not having timely filed with the U.S. Securities and Exchange Commission (the "Commission") its Form 10-Q for the period ended March 31, 2024 (the "Form 10-Q"). The Notice is a notification of deficiency, not of imminent delisting, and has no immediate effect on the listing or trading of the Company's securities on the Nasdaq Capital Market.
- 05/27/2024
|
Nvidia powers the Nasdaq to a fresh record high and its fifth straight positive week
- Nvidia powers the Nasdaq to a fresh record high, and its fifth straight positive week but the Dow tails off, closing down more than 2 percent for the week. Chinese industrial profits bounce back to growth in April, providing a boost to policymakers as they try to reignite the world's second largest economy.
- 05/27/2024
|
3 No-Brainer Dividend Stocks That Have Outperformed The S&P 500 and Nasdaq Composite Over the Last 3 Years
- WM is an expensive stock for all the right reasons. ExxonMobil is an oil supermajor that's a must-watch for income investors looking for dividends from the oil patch.
- 05/26/2024
|
Forget the Nasdaq 100, Buy This ETF Instead
- Investing in a specific sector carries higher risks. The fund has taken calculated risks when opportunities arise.
- 05/26/2024
|
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
- MELVILLE, N.Y., May 24, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ), a clinical stage company focused on stem cell-based therapies, today announced that it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Form 10-Q") with the Securities and Exchange Commission (the "SEC"), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires the timely filing of all required periodic reports with the SEC.
- 05/24/2024
|
Adamas One Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- SCOTTSDALE, Ariz., May 24, 2024 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for industrial uses, today reports that it has a hearing scheduled for May 30, 2024 before a Nasdaq Hearings Panel (the “Panel”) regarding its plan to regain compliance with (1) Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”); (2) Nasdaq Listing Rule 5250(f) (the “Fees Rule”); and (3) Nasdaq Listing Rule 5250(c)(1) (the “Filings Rule”).
- 05/24/2024
|
Binah Capital Group, Inc. Announces Receipt of Nasdaq Non-Compliance Notice
- NEW YORK , May 24, 2024 /PRNewswire/ -- Binah Capital Group, Inc. (the "Company") today announced that it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Form 10-Q"), with the Securities and Exchange Commission (the "SEC"), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires the timely filing of all required periodic reports with the SEC. The Notice states that the Company has until July 21, 2024, to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules.
- 05/24/2024
|
Snow Lake Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Winnipeg, Manitoba--(Newsfile Corp. - May 24, 2024) - Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) ("Snow Lake" or the "Company") announces that on May 24, 2024, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common shares ("Shares") has been below US $1.00 per share for 30 consecutive business days.
- 05/24/2024
|
Urban One, Inc. Receives Additional Delinquency Notification from Nasdaq
- SILVER SPRING, Md. , May 24, 2024 /PRNewswire/ -- Today, Urban One, Inc. (the "Company") reported that on May 23, 2024, the Company received a second letter (the "Second Nasdaq Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it was further non-compliant with Nasdaq Listing Rule 5250(c)(1) (the "Periodic Filing Rule") as a result of not having timely filed its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the "2024 Q1 Form 10-Q") with the United States Securities and Exchange Commission ("SEC").
- 05/24/2024
|
Maquia Capital Acquisition Corporation
- Miami, Florida, May 24, 2024 (GLOBE NEWSWIRE) -- On May 22, 2024, Maquia Capital Acquisition Corporation (“Maquia” or the “Company”), received a notice from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) (the “Notice”) that Maquia was delinquent in the filing of its periodic Form 10Q Report with the Securities and Exchange Commission (the “SEC”) for the period ending March 31, 2024 and that Nasdaq has initiated a process which could result in the delisting of the Company's securities from Nasdaq Stock Market as a result of the Company not being in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to file in a timely manner all required periodic financial reports with the SEC. The Company intends to timely appeal the Notice and request a hearing in accordance with NASDAQ Listing Rule 5815(a)(1)(B). A request for a hearing regarding a delinquent filing will stay the suspension of the Company's securities for a period of 15 days from the date of the request. The Company is working diligently to file the delinquent periodic report as soon as possible to regain full compliance with the Listing Rule. There can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be successful in implementing its plan to regain compliance with the Rule, by filing the Report with the Commission
- 05/24/2024
|
Nano Labs Announces Receipt of Deficiency Letters from Nasdaq
- HANGZHOU, China , May 24, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider in China, today announced that it received two notification letters dated May 24, 2024 (the "Deficiency Letters") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq") notifying that the Company is no longer in compliance with the Nasdaq continued listing criteria, including (1) the Nasdaq Listing Rule 5450(b)(2)(A) due to its failure to maintain a minimum of $50 million in market value of listed securities; (2) the Nasdaq Listing Rule 5450(a)(1) due to its failure to maintain a minimum bid price of US$1 per share. Nasdaq also determined that the Company does not meet the alternatives of total assets and total revenue for continued listing.
- 05/24/2024
|
ToughBuilt Industries Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- IRVINE, Calif., May 24, 2024 (GLOBE NEWSWIRE) -- ToughBuilt Industries, Inc. (NASDAQ: TBLT) (the “Company”) today announced that it has received a written notice (the “Notice”) on May 22, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the quarter ended March 31, 2024 (the “Form 10-Q”) and because the Company remains delinquent in filing its Form 10-K for the year ended December 31, 2023 (the "Form 10-K"), it is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC").
- 05/24/2024
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 15, 2024
- NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of May 15, 2024, short interest in 3,063 Nasdaq Global MarketSM securities totaled 11,646,612,058 shares compared with 11,683,381,571 shares in 3,072 Global Market issues reported for the prior settlement date of April 30, 2024. The mid-May short interest represents 3.15 days compared with 3.29 days for the prior reporting period.
- 05/24/2024
|
MARPAI ANNOUNCES WITHDRAWAL FROM NASDAQ HEARINGS PROCESS AND WILL TRANSITION TRADING TO THE OTCQX MARKET
- Move reduces cost and burdens of Nasdaq listing TAMPA, Fla. , May 24, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced it has informed The Nasdaq Stock Market LLC of its intention to withdraw from the Nasdaq hearings process and transition the listing of its Class A common shares, par value $0.0001 per share (the "Shares"), from The Nasdaq Capital Market ("Nasdaq") and have the Shares quoted on the OTCQX Market ("OTCQX").
- 05/24/2024
|
Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance
- JERUSALEM , May 24, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (the "Company") (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced the receipt of an additional Nasdaq Staff determination letter regarding noncompliance with the minimum shareholders' equity required for continued listing and a hearing with the Nasdaq Hearings Panel (the "Hearings Panel") to present a plan for the Company to regain compliance (the "Plan").
- 05/24/2024
|
Direct Digital Holdings Announces Receipt of Expected Delinquency Notification Letter From Nasdaq Relating to Non-Compliance with Listing Rule 5250(c)(1)
- HOUSTON , May 24, 2024 /PRNewswire/ -- Today, Direct Digital Holdings, Inc. (the "Company") reported that the Company received an expected delinquency notification letter (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") on May 21, 2024, which indicated that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Form 10-Q") by the applicable due date, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the "SEC"). As previously disclosed by press release on April 23, 2024, the Company received a delinquency notification letter from Nasdaq on April 17, 2024 due to the Company's non-compliance with the Rule as a result of the Company's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2023 (the "Form 10-K").
- 05/24/2024
|
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, May 24, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the Compensation Committee of aTyr's Board of Directors has granted two employees nonstatutory stock options to purchase an aggregate of 9,400 shares of aTyr's common stock, each with an exercise price of $1.86 per share, which is equal to the closing price of aTyr's common stock on the Nasdaq Capital Market on May 22, 2024, the effective date of the grants. These stock awards were granted as an inducement material to the new employees entering into employment with aTyr in accordance with Nasdaq Listing Rule 5635(c)(4) and were made pursuant to the aTyr Pharma, Inc. 2022 Inducement Plan.
- 05/24/2024
|
Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
- MIAMI, May 24, 2024 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (Nasdaq: WRAP) (“Wrap” or the “Company”), the makers of BolaWrap and the innovative public safety solutions platform powered by artificial intelligence (“AI”), virtual reality and data, today reports that it has received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirements of Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of not having timely filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2024 (the “Form 10-Q”), with the Securities and Exchange Commission (“SEC”). As previously disclosed, on April 18, 2024, the Company received a notice from Nasdaq notifying the Company that as it has not yet filed its Annual Report on Form 10-K (the “Form 10‑K”) for the year ended December 31, 2023, the Company is not in compliance with the Listing Rule.
- 05/24/2024
|
Wall Street to recover, Nasdaq, Nvidia to open higher on Friday
- Futures contracts are pointing to a bullish start to Friday for the US markets, with the Nasdaq 100 tipped to open 54 points above yesterday's close. The broader S&P 500 index is set to open 15 points higher at 5,283, while the Dow Jones Industrial Average, which had its worst trading session of the year yesterday, is expected to add 41 points.
- 05/24/2024
|
3 Nasdaq Stocks to Buy Now: May 2024
- Technology stocks have been one of the major industries that have led the stock market on this bull run over the last year. The Nasdaq is one of the three major indices.
- 05/24/2024
|
The Nasdaq 100 Vault: 3 Stellar Stocks to Lock Up Now
- The Nasdaq 100 keeps hitting new all-time highs. No longer just a handful of stocks are driving the index higher, this is a broad-based rally.
- 05/23/2024
|
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
- New York, NY, May 23, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) (“ Fresh2 ” or the “ Company ”), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on May 23, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) advising the Company that due to its failure to timely file its Form 10-Q for the period ended March 31, 2024, with the Securities and Exchange Commission (the “ SEC ”), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended December 31, 2023, it is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”), which requires the timely filing of all required periodic reports with the SEC.
- 05/23/2024
|
Selina Receives Nasdaq Notice and Provides Update on Nasdaq Hearings Panel
- NEW YORK--(BUSINESS WIRE)---- $SLNA #SLNA--Selina Hospitality PLC ("Selina" or the “Company”; NASDAQ: SLNA), a global lifestyle and experiential hospitality company catering to millennial and Gen Z travelers, announces today that it has received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) dated May 20, 2024. This notice informs the Company of its delinquency in filing its Form 20-F for the year ended December 31, 2023 (“2023 20-F”) in accordance with Nasdaq listing requirements (the “Reporting Obligat.
- 05/23/2024
|
Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement
- SYDNEY , May 23, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) (Kazia or the company) received a letter on May 22, 2024 from Nasdaq notifying the Company that, while the Company has not regained compliance with the Minimum Bid Price Requirement, Nasdaq has determined that the Company is eligible for an additional 180 calendar day period, or until November 18, 2024 (the "Second Compliance Period"), to regain compliance with the Minimum Bid Price Requirement. As previously disclosed, on November 20, 2023, Kazia Therapeutics Limited (the "Company") received a deficiency notification from the Listing Qualifications Staff of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it was not in compliance with the minimum bid price requirement as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
- 05/23/2024
|
Final Trades: Nasdaq, Archer-Daniels-Midland & COPX
- The Investment Committee shares their top stocks to watch for the second half.
- 05/23/2024
|
Nvidia Earnings Surge Pulls Up Nasdaq, Chip ETFs, and Others in AI Ecosystem
- After reporting better-than-expected earnings and meeting the increasingly high bar set for investors' artificial intelligence (AI) darling, Nvidia (NVDA) shares popped, pulling up the Nasdaq 100, exposed semiconductor exchange-traded funds (ETFs), and other companies in its AI ecosystem. Shares of Nvidia were up over 10% at $1,044.88 in early trading Thursday as of 10:30 a.m.
- 05/23/2024
|
Recon Technology Regains Nasdaq Compliance; Hearing Moot
- BEIJING , May 23, 2024 /PRNewswire/ -- Recon Technology, Ltd. (NASDAQ: RCON) ("Recon" or the "Company") announced today that on May 22, 2024, it had received a letter dated May 22, 2024 (the "Compliance Letter") from the Listing Qualifications Hearings Department of Nasdaq notifying the Company that (i) the Company's bid price deficiency had been cured and (ii) the Company was in compliance with all applicable listing standards.
- 05/23/2024
|
This Obscure Nasdaq Listing From A Faraway Land Has Outperformed The S&P 500 Over The Last Two Years. Is It Worth The Risk?
- When one thinks of emerging market stocks, few consider that faraway Central Asian nation, Kazakhstan, the place billionaire Timur Turlov calls home. But this year, a Kazakh e-commerce platform called Kaspi.Kz KSPI made its debut on the Nasdaq at $95.97 a share on January 19.
- 05/23/2024
|
Nasdaq to lead gains as Wall Street mood lifted by Nvidia
- Nvidia is set to lead US stock indices higher on Thursday, after publishing impressive earnings overnight that have helped to lift tech stocks as well as the broader market. The chipmaker was trading up 6.9% premarket, while Nasdaq 100 futures were up 1.16% and S&P 500 futures were pointing to a 0.74% gain.
- 05/23/2024
|
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
- Momentum trading is one of my favorite strategies. Legendary trader Mark Minervini, who won the U.S. investing championship in 1997 and 2021, used momentum trading strategies to win.
- 05/23/2024
|
$10,000 Invested in This Vanguard ETF Incurs a Mere $7 Annual Fee, and It Has Outperformed the S&P 500 and the Nasdaq Composite So Far This Year
- The Vanguard Mega Cap ETF has a slightly higher fee than the Vanguard S&P 500 ETF. The fund has higher weightings in the growth pockets of the market than the S&P 500.
- 05/23/2024
|
Tritium Will Not Appeal Nasdaq Delisting Determination
- BRISBANE, Australia, May 22, 2024 (GLOBE NEWSWIRE) -- Tritium DCFC Limited¹ (OTC: DCFCQ) (“Tritium” or the “Company”), a global developer and manufacturer of direct current (“DC”) fast chargers for electric vehicles, previously reported, on April 18, 2024, that the Company and three of its Australian subsidiaries, Tritium Pty Ltd², Tritium Holdings Pty Ltd³ and Tritium Nominee Pty Ltd⁴ (together with the Company, the “Companies”) (i) were insolvent or likely to become insolvent, (ii) a voluntary administrator should be appointed under the Australian Corporations Act 2001 (the “Act”), and (iii) to appoint Peter James Gothard, James Douglas Dampney and William Martin Colwell of KPMG as joint and several administrators (together, the “Administrators”) pursuant to section 436A of the Act. Separately, on 19 April 2024, Shaun Fraser, Matthew Hutton, Kathy Sozou and Jamie Harris of McGrath Nicol were appointed Receivers and Managers of the Companies (excluding Tritium Nominee Pty Ltd.
- 05/22/2024
|
Primis Financial Corp. Announces Notification of Delinquency with Nasdaq
- MCLEAN, Va. , May 22, 2024 /PRNewswire/ -- On May 16, 2024, Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") received an expected delinquency notification letter (the "Letter") from Nasdaq's Listing Qualifications Department which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 ("Quarterly Report") and its continued delay in filing its Annual Report on Form 10-K for the year ended December 31, 2023 ("Annual Report").
- 05/22/2024
|
Brera Holdings Receives Nasdaq Notice Related to Late Filing of its Form 20-F
- DUBLIN, Ireland and MILAN, Italy, May 22, 2024 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings,” “Brera” or the “Company”) (Nasdaq: BREA) today announced that it received a written notification, dated May 16, 2024 (the “Notification Letter”), from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the periodic financial report filing requirement set forth in Nasdaq Listing Rule 5250(c)(1) for continued listing on The Nasdaq Capital Market tier of Nasdaq since the Company had not yet filed its Annual Report on Form 20-F for the year ended December 31, 2023 (the “Form 20-F”).
- 05/22/2024
|
Gulf Resources Announces Receipt of Nasdaq Non-Compliance Notice
- SHOUGUANG, China, May 22, 2024 (GLOBE NEWSWIRE) -- Gulf Resources, Inc. (NASDAQ: GURE) (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Form 10-Q”), with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC.
- 05/22/2024
|
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CHASKA, Minn., May 22, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization, today announced that Lifecore has granted a restricted stock unit (“RSU”) award with respect to 525,000 shares of its common stock and a performance stock unit (“PSU”) award for up to 1,500,000 shares of its common stock to Paul Josephs, Lifecore's newly hired President and Chief Executive Officer. The RSU award and PSU award were granted May 20, 2024 pursuant to the Company's previously-announced offer letter with Mr. Josephs, and as a material inducement to Mr. Josephs joining Lifecore as President and Chief Executive Officer.
- 05/22/2024
|
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
- LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) on May 21, 2024 informing the Company that it has regained compliance with the market value of listed securities (“MVLS”) requirement, as set forth in Nasdaq Listing Rule 5550(b)(2) (the “Rule”) for continued listing on the Nasdaq Capital Market.
- 05/22/2024
|
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
- WOODCLIFF LAKE, N.J., May 22, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company” or “Eagle”) today announced that it received a notice (the “Notice”) on May 20, 2024, from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it has initiated a process to delist the Company's securities from Nasdaq because the Company had not filed its Form 10-Q for the quarter ended September 30, 2023 (the “Q3 2023 Form 10-Q”) and its Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”) by May 13, 2024. The Notice further advises the Company that, pursuant to Nasdaq Listing Rule 5810(d)(2), the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Q1 2024 Form 10-Q”) serves as an additional and separate basis for delisting.
- 05/22/2024
|
Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel
- ATLANTA--(BUSINESS WIRE)---- $ABBV #Alzamend--Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel.
- 05/22/2024
|
iClick Interactive Asia Group Limited Receives NASDAQ Deficiency Notice For Failure to Timely File Form 20-F
- HONG KONG , May 22, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced that it received a notice (the "Notice") from the Nasdaq Stock Market LLC ("Nasdaq") dated May 17, 2024 stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because the Company did not timely file its annual report for the year ended December 31, 2023 on Form 20-F (the "Annual Report") with the Securities and Exchange Commission (the "SEC"). The Notice indicates that, according to the Nasdaq Listing Rules for continued listing, the Company has 60 calendar days from the date of the Notice to submit to Nasdaq a plan to regain compliance.
- 05/22/2024
|
Calamos Plans Launch of Nasdaq-100® Structured Alt Protection ETF™- June (CPNJ)
- Calamos Plans Launch of Nasdaq-100® Structured Alt Protection ETF™- June (CPNJ), 9.83% – 10.33%Upside Cap Range with 100% Downside Protection Over One Year CPNJ targets an attractive upside cap range near historical return averages for the Nasdaq- 100 Index while mitigating volatility and eliminating risk of loss concerns.
- 05/21/2024
|
Luna Innovations Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
- ROANOKE, Va.--(BUSINESS WIRE)--Luna Innovations Incorporated (NASDAQ: LUNA) (the “Company”), a global leader in advanced fiber optic-based technology, today announced that it has received a written notice (the “Notice”) on May 17, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the quarter ended March 31, 2024 (the “Form 10-Q”) and because the Company remains delinquent in filing its.
- 05/21/2024
|
Maxeon Solar Technologies Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Filing and Rescheduling of Release of Financial Results for Fourth Quarter, Fiscal Year 2023 and First Quarter 2024
- SINGAPORE , May 21, 2024 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) (the "Company"), a global leader in solar innovation and channels, announced that on May 17, 2024, it received a notice of non-compliance (the "Notice") from the Nasdaq Global Select Market ("Nasdaq") stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) ("Listing Rule") because the Company did not timely file its annual report for the fiscal year ended December 31, 2023 on Form 20-F (the "Annual Report") with the Securities and Exchange Commission (the "SEC").
- 05/21/2024
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO , May 21, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on May 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 150,500 shares of its common stock and 33,250 restricted stock units ("RSUs") to seven (7) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/21/2024
|
3 Silicon Valley Tech Stocks to Buy as Nasdaq Edges Higher
- Invest in NVIDIA (NVDA), Alphabet (GOOGL) and Seagate Technology (STX) which are poised to make the most of the Nasdaq's upward movement banking on rate cut hopefulness.
- 05/21/2024
|
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- BRISBANE, CALIFORNIA, May 21, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), today announced that it has entered into a definitive securities purchase agreements for the purchase and sale of 740,000 shares of the Company's common stock at a purchase price of $4.35 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company will issue warrants to purchase up to 740,000 shares of common stock. The warrants have an exercise price of $4.35 per share, will be exercisable immediately and will have a term of five years following the date of issuance. The closing of the offering is expected to occur on or about May 23, 2024, subject to the satisfaction of customary closing conditions.
- 05/21/2024
|
3 Growth Stocks That Could Continue Outperforming the Nasdaq-100
- Alphabet is finding new ways to grow. Deere is still on track to deliver excellent results amid a cyclical slowdown.
- 05/21/2024
|
Roma Green Finance Limited Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
- Ordinary shares will continue to trade on the Nasdaq Capital Market, and the Company's listing on such exchange is not affected by the receipt of the Notice
- 05/21/2024
|
American Oncology Network Announces Voluntary Delisting From Nasdaq
- FORT MYERS, Fla., May 21, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market ("Nasdaq"). The Company's decision to delist its securities from Nasdaq was recommended to the Board of Directors (the "Board") of the Company by a Special Committee (the "Special Committee") of the Board comprised solely of independent directors.
- 05/21/2024
|
Nvidia leads Nasdaq to fresh record high
- The Nasdaq hits a new high on the back of a stellar Nvidia performance, with investors predicting an out-sized impact from the chip titan's earnings. JP Morgan CEO Jamie Dimon suggests he will quite the post within the next five years.
- 05/21/2024
|
Tech Lifts Nasdaq to Record; JPMorgan Tumbles, Drags Dow Below 40K
- U.S. stocks were mixed on Monday, with tech stocks climbing and the Dow retreating from 40,000, a milestone it reached last week as investors increased bets cooling inflation could prompt cuts in interest rates by the Federal Reserve this year. The Nasdaq Composite advanced 0.7% Monday, while the S&P 500 inched up 0.1% and the Dow Jones Industrial Average slipped 0.5%. The Dow and S&P 500 were weighed down by shares of JPMorgan Chase (JPM), which slid more than 4% after CEO Jamie Dimon hinted he was preparing to retire after nearly 20 years at the helm of America's largest bank. Artificial intelligence (AI) darling Nvidia (NVDA) is set to report earnings after markets close on Wednesday, in what could be a highlight of this week's events. The chipmaker is expected to post yet another quarter of rapid earnings and revenue growth amid surging AI demand. The week is light on economic data. The Federal Reserve will dominate the economic calendar, with officials speaking throughout the week and the minutes of the central bank's May meeting slated to be released on Wednesday. Metals prices held near record highs Monday, with gold (GOLD) and copper hitting new records, while silver (SILVER) continued to increase after it climbed to an 11-year high above the closely watched psychological $30 mark. Investors have piled into metals this year in pursuit of gold and silver's safety and copper's industrial applications. Treasury yields and the dollar climbed on Monday. Cryptocurrencies also advanced. Stock Indexes Wrap: Semiconductor, AI Stock Send Nasdaq Higher; JPMorgan Weighs on Dow 2 hr 43 min ago The Dow Microsoft (MSFT) gained 1.2% after the tech giant unveiled a new line of personal computers equipped with AI chips and the company’s CoPilot AI software. Tech stocks followed Microsoft higher, with Intel (INTC) gaining 0.9% and Apple (AAPL) rising 0.6%. JPMorgan Chase (JPM) fell 4.5% after CEO Jamie Dimon hinted that the company had begun to prepare for his retirement. That overshadowed the firm’s raising its full-year net interest income forecast to $91 billion from $90 billion. The S&P 500 Norwegian Cruise Line Holdings (NCLH) jumped 7.6% after it raised its current-quarter earnings outlook for the second time this month, citing strong demand. Competitors Carnival Corp (CCL) and Royal Caribbean (RCL) gained 7.3% and 4.1%, respectively. Electronics manufacturer Jabil (JBL) added 5.3% after announcing several leadership changes, including a new CEO and CFO. Applied Materials (AMAT) rose 3.7% as several firms raised their price targets on the stock following last week’s earnings report. Peers Lam Research (LRCX) and KLA Corp (KLA) each advanced about 3.3%. Nvidia (NVDA) gained 2.5% ahead of its quarterly earnings report after markets close on Wednesday. Johnson Controls (JCI) added 2.3% after Bloomberg reported activist investor Elliott Investment Management had taken an approximately $1 billion stake in the company. Discount retailers slipped after advancing last week following better-than-expected earnings from Walmart (WMT). Dollar Tree (DLTR) slid 3.3% Monday, while TJX Companies (TJX) fell 2.4%. Target (TGT) shed 2.1% after cutting prices on thousands of items in a bid to draw in cost-conscious consumers. Lowe’s (LOW) slipped 0.8% ahead of its earnings report before the opening bell on Tuesday. The Nasdaq 100 Chip stocks advanced, led by Marvell Technology (MRVL), up 3.6%, and Micron (MU), up 3%. Palo Alto Networks (PANW) ticked up 1.9% before reporting earnings after markets closed. Tesla (TSLA) shed 1.5% after Chinese rival Li Auto (LI) reported earnings well below analysts’ estimates, a sign the electric vehicle price war in the world’s largest auto market has taken a toll on carmakers’ profits. What You Need To Know Ahead of Palo Alto Networks' Earnings Report Monday 3 hr 32 min ago Palo Alto Networks (PANW) is set to report earnings for its fiscal third quarter after the bell on Monday, with investors likely watching sales amid concerns about reduced customer spending. The cybersecurity company could also provide updates on its "platformization" strategy in its efforts to become a "one-stop shop" for cybersecurity. Analysts project Palo Alto Networks' revenue to be $1.97 billion for the third quarter of 2024, down from the previous quarter but up from $1.72 billion in the same period in 2023, according to estimates compiled by Visible Alpha. Net income is expected to be $143.3 million, a significant drop from the second quarter but up from $107.8 million in the third quarter of fiscal 2023. Analysts anticipate diluted earnings per share (EPS) of 40 cents, compared with 31 cents in the same period a year earlier. Read more about what to expect from Palo Alto Networks' earnings report. -Naomi Buchanan Gold Price Reaches Record High Amid Expectations of Fed Rate Cuts 4 hr 19 min ago The spot price of gold reached a record high above $2,450 per ounce early Monday morning, before sliding to $2,435.28 in the afternoon as markets continued to digest economic data from last week that raised hopes the Federal Reserve could move to cut interest rates, though Fed officials cautioned they may need more data on inflation before cutting rates. Scheduled comments this week from several Fed officials could impact the price of gold in the days to come. Purchases by China's central bank could help sustain gold's rise in price, with the World Gold Council (WGC) recently reporting China's central bank was one of the top buyers of gold in the first quarter compared to other central banks. TradingView Concerns about geopolitical risks in the Middle East and Eastern Europe could also impact the price of gold, raising demand for traditional "safe haven" assets. The death of Iranian President Ebrahim Raisi and worries about his death's implications in the Middle East was another factor that drove the price of gold higher Monday, The Wall Street Journal reported. -Aaron McDade Hims & Hers Soars on Release of Wegovy Challenger 5 hr 23 min ago Shares of Hims & Hers Health (HIMS) surged on Monday after the online pharmacy said it was jumping on the weight-loss bandwagon. The company said in a press release Monday that it would begin offering GLP-1 injections similar to Novo Nordisk’s (NVO) Wegovy and Eli Lilly’s (LLY) Zepbound. Injections, the company said, would start at $199/month, more than 85% less than Wegovy’s $1,350 monthly price tag. Hims & Hers said its partnership with a US manufacturer of generic drugs would enable patients to access Wegovy and Ozempic’s active ingredient “without navigating the shortages and costs that are currently limiting access to the branded medications.” The popularity of GLP-1s has turbocharged Novo Nordisk and Eli Lilly's sales in the last year and propelled them into the ranks of the world’s most valuable companies. Novo Nordisk, shares of which have risen more than 50% in the past year, had a market capitalization of about $584 billion Monday afternoon, making it larger than Tesla (TSLA). Eli Lilly’s market cap of more than $740 billion ranked it eighth among the S&P 500’s largest companies. Its shares have risen more than 75% in the last 12 months. Hims & Hers shares were up about 30% Monday afternoon, bringing their year-to-date return to 112%. Li Auto Sinks on Q1 Profit Slump 6 hr 25 min ago American depositary receipts (ADRs) of Li Auto (LI) tumbled in intraday trading Monday after the Chinese electric vehicle manufacturer posted a 36% year-over-year drop in first-quarter net income as it lowered car prices. The company said its profit attributable to shareholders was 592.6 million yuan ($82.0 million), versus CNY929.7 million in the same period last year, and well below analysts’ forecasts of CNY1.63 billion. Revenue was up, however, by 36% at CNY25.63 billion, including a 32% jump in vehicle sales to CNY24.3 billion. “The increase in revenue from vehicle sales over the first quarter of 2023 was mainly attributable to the increase in vehicle deliveries, partially offset by the lower average selling price due to different product mix and pricing strategy changes between two quarters,” the company said in a press release. Li Auto ADRs were down more than 12% early in the afternoon on Monday. -Fatima Attarwala Norwegian Cruise Lines Leads S&P 500 on Raised Guidance 7 hr 22 min ago Norwegian Cruise Line Holdings (NCLH) was the best-performing stock in the S&P 500 Monday morning after the Miami-based cruise operator raised its full-year guidance amid strong demand. Norwegian on Monday raised its adjusted earnings per share forecast to $1.42 from $1.32. The company also upped its net yield forecast to 7.2% from 6.4%, as well as its forecast for adjusted earnings before interest, taxes, depreciation and amortization (EBITDA), which was raised to $2.3 billion from $2.25 billion. Monday's update is the second such increase to Norwegian’s earnings guidance this year. The company raised its outlook for all three of the metrics above when it reported first-quarter earnings at the beginning of the month. “We have continued to see strong demand and record bookings,” said chief financial officer Mark Kempa in a press release. Shares of Norwegian were up more than 7% Monday morning. Competitors Royal Caribbean (RCL) and Carnival (CCL) each traded more than 5% higher. Johnson Controls Stock Rises As Elliott Reportedly Takes $1 Billion-Plus Stake 8 hr 37 min ago Shares in Johnson Controls International (JCI) moved higher in early trading Monday after Bloomberg reported late Sunday that activist investor Elliott Investment Management has taken a significant stake in the industrial conglomerate. According to people familiar with the matter, the New York-based hedge fund has built a position in the company valued at over $1 billion, though the intentions for taking the stake couldn’t be immediately learned, the report said. Source: TradingView.com. Since bottoming out in late October last year, the Johnson Controls share price has trended mostly higher, with the 50-day moving average (MA) crossing above the 200-day MA in March to form a bullish golden cross buy signal. More recently, investors promptly stepped in to buy the dip below the 50-day MA, suggesting underlying strength in the stock. Following the news that Elliott has taken a significant stake in the company, it’s worth keeping an eye on a key area of chart resistance around $70 that has been in play since early last year. A convincing close above this technically important area could lead to a retest of the stock’s all-time high (ATH) at $81.77 set in December 2021. Johnson Controls shares were up 2.9% Monday morning, bringing their year-to-date return to 23%. -Timothy Smith Stock Futures Tick Up 9 hr 54 min ago Futures contracts connected to the Dow Jones Industrial Average were effectively flat Monday morning. S&P 500 futures rose 0.1%. Nasdaq 100 futures were up about 0.2%.
- 05/20/2024
|
The stock market will inflate another 20% before the bubble bursts, research firm says
- Investors on the lookout for signs of a bubble should expect the stock market to be pumped up by another 20% before correcting, Capital Economics researchers said. The research firm pointed to the latest run-up in stocks, with the S&P 500 and Dow Jones Industrial Average recently notching fresh records and major indexes headed for new all-time highs as the week kicked off on Monday. But investors trying to push the bull market higher should know that there's only so much more the market can gain. According to John Higgins, Capital Economics' chief market economist, stocks look like they're in a late-stage bubble, meaning equities are in for a steep rally before the bubble eventually bursts. "There's always the temptation to sort of chase the market higher, but I'm not convinced that you should be doing that at this stage. The … story that we've been telling a year or so ago appears to be coming true," Higgins said in a recent podcast. "What is that story? I think that it's a simple one really that involves a bubble inflating in the stock market," he said, pointing to the excitement for big tech. Wall Street's enthusiasm for AI mirrors the hype around internet stocks in the 90s, Higgins noted, which should be an omen for the market. The Nasdaq Composite lost 77% peak-to-trough in the early 2000s, with the overall market seeing $5 trillion in value wiped out by 2002. It's "impossible" to predict when the bubble will finally burst, how deep stocks will fall, or what will trigger the correction, Higgins noted. But one could come as soon as the end of next year, he suggested, as that would lengthen the pandemic bull market to about 5 years, the lifespan of the dot-com bubble. He predicted the S&P 500 could notch 6,500 by the end of 2025. That implies another 22% run-up in stocks before the bubble begins to deflate. "Bubbles tend to inflate the most in their final stages as the excitement sort of reaches fever-pitch," Higgins warned. Other market commentators have warned stocks look to be in a bubble, with stock prices blowing past a series of record highs in 2024. More extreme forecasters have predicted that stocks could crash as much as 65% as the hype for AI rapidly unwinds. Read the original article on Business Insider
- 05/20/2024
|
Palo Alto Networks reports 15% growth in Q3 revenue: stock is still losing
- Palo Alto Networks Inc (NASDAQ: PANW) is trading down in extended hours on Monday even though it came in ahead of Street estimates for its third financial quarter. Palo Alto Networks stock down in muted guidance Investors are concerned because $PANW issued somewhat of a muted guidance for the future. The cybersecurity company forecasts its revenue to fall between $2.15 billion and $2.17 billion on up to $1.42 of per-share earnings. That was only in line with analysts at $2.16 billion and $1.41 a share, respectively. Still, Nikesh Arora – the chief executive of Palo Alto Networks said in a press release today: We are pleased with enthusiastic response to platformization … a long-term strategy that addresses the increasing sophistication and volume of threats, and the need for AI-infused security outcomes. The Nasdaq-listed firm ended its Q3 with $11.3 billion in remaining performance obligation – up 23% year-over-year. Palo Alto Networks stock is now up close to 15% versus its year-to-date low. Palo Alto Networks Q3 earnings snapshot Earned $279 million versus the year-ago $108 million Per-share earnings also climbed from 35 cents to 86 cents Adjusted EPS printed $1.32 at as per the earnings report Revenue jumped 15% year-over-year to $2.0 billion Consensus was $1.25 a share on $1.97 billion in revenue $PANW saw its adjusted operating margin sit at 26% – up 200 basis points in Q3. According to Dipak Golechha – the chief financial officer of Palo Alto Networks: We have remained disciplined in our execution while investing in go-to-market and innovation … and look forward to executing against our strategic goals and financial targets as we close out the year. Last month, the multinational based out of Santa Clara, California partnered with Google on AI-enabled cybersecurity as Invezz reported here. Watch here: https://www.youtube.com/embed/TGSJKqDQU50?feature=oembed The post Palo Alto Networks reports 15% growth in Q3 revenue: stock is still losing appeared first on Invezz
- 05/20/2024
|
Broadway Financial Corporation Announces Notification from Nasdaq Regarding Late Filing of Form 10-Q and Form 10-K
- LOS ANGELES--(BUSINESS WIRE)--Broadway Financial Corporation (“Broadway,” “we,” or the “Company”) (Nasdaq Stock Market: BYFC), parent company of City First Bank, National Association, announced today it received a Staff Delisting Determination letter (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on May 14, 2024 notifying the Company that Nasdaq has initiated a process which could result in the delisting of the Company's securiti.
- 05/20/2024
|
Techs Lead Nasdaq To New High As Stock Market's Pool Of Breakouts Grows
- Excluding tech, the S&P 500 would have fallen.
- 05/20/2024
|
Market Today: JPMorgan's Share Repurchase Halt, Dell-Nvidia Collaboration, and Tesla's Upcoming
- The Nasdaq Composite (+0.7%) logged another record closing high, supported by gains in mega caps and semiconductor-related names. The S&P 500 (+0.2%) and Russell 2000 (+0.3%) also closed with gains, while the Dow Jones Industrial Average (-0.5%) fell nearly 200 points. Market breadth favored advancers by a slim margin at both the NYSE and the Nasdaq. The overall upside bias was driven by carryover momentum following last week's solid gains and strength in mega caps and chipmakers. Market rates settled slightly higher, acting as a limiting factor for equities. The 10-yr note yield settled two basis points higher at 4.44%, and the 2-yr note yield rose two basis points to 4.84%. There was no US economic data of note today and none is expected tomorrow. Key releases this week include: JPMorgan Chase (JPM, Financial) shares dipped 1.5% after CEO Jamie Dimon announced that the bank will not repurchase a significant amount of stock at current prices. Dimon expressed a cautious outlook on the economy, citing geopolitical tensions and persistent inflation as key concerns. Dell Technologies (DELL, Financial) revealed its partnership with Nvidia (NVDA, Financial) to integrate the latest Blackwell GPUs into its servers, addressing the rising demand for AI capabilities. Dell's new PowerEdge XE9680L server, featuring eight Nvidia Blackwell Tensor Core GPUs, is designed to support AI workloads more efficiently. Tesla (TSLA, Financial) is set to hold its annual shareholder meeting in Austin, Texas, on June 13. The agenda includes voting on CEO Elon Musk's compensation package and the formal ratification of the company's re-incorporation in Texas. The board has shown strong support for Musk's compensation plan. Microsoft (MSFT, Financial) introduced what CEO Satya Nadella called the "fastest, most AI-ready PC ever built," featuring chips from Qualcomm (QCOM, Financial), AMD (AMD, Financial), and Intel (INTC, Financial). The new Copilot Plus PCs are expected to sell 50 million units this year, with manufacturing partners including Acer, Asus, Dell (DELL, Financial), HP (HPQ), Lenovo, and Samsung. Zoom Video (ZM, Financial) shares fell over 2% after reporting mixed first-quarter results and guidance. The company posted an adjusted $1.35 per share on $1.14 billion in sales, but its enterprise customer count and future earnings guidance fell short of expectations. Palo Alto Networks (PANW, Financial) reported strong Q3 results, with non-GAAP EPS of $1.32 beating estimates and revenue growing 15.1% year-over-year to $1.98 billion. The company provided a positive outlook for Q4 and 2024, with expected revenue growth and increased billings. Hims & Hers Health (HIMS, Financial) surged ~31% after announcing it will offer compounded versions of Novo Nordisk's (NVO) semaglutide at a lower cost. The company plans to provide injectable and oral versions of the drug, commonly known as Ozempic and Rybelsus, respectively. Faraday Future Intelligent Electric (FFIE, Financial) experienced an 85% gain amid high trading volume, despite the absence of fundamental news. The stock's volatility is attributed to a high short interest, with the company set to release its Q4 earnings report on May 28. Kroger (KR, Financial) drivers at a Romulus, Michigan fulfillment site voted to join the Teamsters Union, aiming for higher wages and better working conditions. This marks the first unionization effort at a Kroger fulfillment center, though many of its stores are already unionized. Sprout Social (SPT, Financial) gained 6.3% following reports that its founders are in talks with private equity firms to take the company private. The board has formed a committee to evaluate the potential deal, with Morgan Stanley as its advisor. Instacart (CART, Financial) shares fell after CFO Emily Reuter indicated that the company does not expect to exceed its gross transaction value guidance. Despite a strong Q1 performance, Q2 is expected to be less favorable due to seasonal factors and the impact of a new partnership with Uber (UBER). Rio Tinto (RIO, Financial) declared force majeure on alumina cargoes from its Queensland refineries due to gas shortages. The impact is limited to third-party sales, with Rio's own aluminum operations remaining unaffected.
- 05/20/2024
|
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- SAN MATEO, Calif. , May 20, 2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted inducement awards consisting of a non-statutory time-based stock option to purchase 185,000 shares of common stock and a time-based restricted stock unit award for 32,000 shares of common stock on May 20, 2024 to Dr. Shakil Aslam in connection with his appointment as the Chief Development Officer of Talphera in May 2024.
- 05/20/2024
|
Transamerica Announces New Collaboration With First Trust
- First Trust Equity Edge Index added to Transamerica Structured Index Advantage Annuity's index lineup BALTIMORE, May 20, 2024 /PRNewswire/ -- Today Transamerica announced a new collaboration with FT Indexing Solutions LLC ("First Trust") that adds the First Trust Equity Edge Index™ to the popular and innovative Transamerica Structured Index Advantage® Annuity. The new equity index option, Equity First Trust Edge (Nasdaq: FTEQUEDGE), is exclusively available through Transamerica's registered index-linked annuity. The index provides additional exposure to U.S. equities that exhibit high quality and value, consistent with a balanced investment approach. "We are excited to work with an experienced manager like First Trust to offer customers and distribution partners access to an index that helps address key retirement challenges facing Americans today," said Liza Tyler, Transamerica's head of annuity solutions. "First Trust Equity Edge provides investors with access to growth potential with limits to downside risk, which is consistent with Transamerica's mission to help people make the most of what's important to them." Adding the index enhances Transamerica Structured Index Advantage Annuity's ability to help investors seeking growth through a diverse range of indexes as well as protection buffers to limit downside market risk. The annuity is a cost-effective solution that reinforces Transamerica's commitment to helping everyday Americans who are saving to live their best lives in retirement. Transamerica's Structured Index Advantage Annuity already has been extremely popular with customers, surpassing $1 billion in sales in its first two years. "We believe that partnering with First Trust will accelerate our growth momentum with its talented distribution force," said Jonathan Cressman, vice president and managing director for annuities wholesale distribution for Transamerica. First Trust is a leading exchange traded funds provider with access to a large network of financial advisors. With $200 billion in assets under management, First Trust will provide exposure to 300 wholesalers and 87,000 financial advisors who can partner directly with Transamerica wholesalers in distributing the custom index. The First Trust Equity Edge Index stands out for its unique blend of U.S. equities that demonstrate high quality and value. This innovative approach, which combines two equally weighted methodologies, is sourced from the Value Line Dividend Index™, a benchmark of the highest-yielding stocks in the Value Line universe, and the Nasdaq U.S. Rising Dividend Achievers™ Index, which tracks companies with a history of increasing dividends. This ensures that clients have access to a mix of investments to navigate various market conditions. About TransamericaWith a history that dates back more than 100 years, Transamerica is a leading provider of life insurance, retirement, and investment solutions, serving millions of customers throughout the United States. Transamerica's dedicated professionals focus on helping people live their best lives through saving, investing, and protecting their loved ones. Transamerica is dedicated to building America's leading middle market life insurance and retirement company, with unique access to the large and growing middle market consumer via World Financial Group and US retirement recordkeeping. Transamerica provides a broad range of quality individual life insurance policies, workplace supplemental insurance benefits, workplace retirement plans, individual retirement accounts, and investment products including mutual funds, annuities, stable value solutions, as well as investment management services. In 2023, Transamerica fulfilled its promises to customers, paying more than $47 billion in insurance, retirement, and annuity claims and benefits, including return of annuity premiums paid by the customer. Transamerica's head office is in Baltimore, Maryland, with other major operations in Cedar Rapids, Iowa, and Denver, Colorado. Transamerica is part of the Aegon group of companies. Each Aegon company is solely responsible for its own financial conditions and contractual obligations. Based in the Netherlands, Aegon is an international financial services holding company. For more information, visit www.transamerica.com. Annuities issued in all states except New York by Transamerica Life Insurance Company, Cedar Rapids, Iowa. Annuities are underwritten and distributed by Transamerica Capital, Inc., 1801 California St., Suite 5200, Denver, CO 80202, FINRA member. References to Transamerica may pertain to one or all of these companies. Registered Index-Linked Annuities are long-term, tax-deferred vehicles designed for retirement purposes and are not for everyone. They are subject to possible loss of principal and earnings due to market fluctuation, investment risks as a result of fees and charges under the policy including surrender charges, other transaction charges, and periodic charges. A current prospectus for this product should either precede or accompany this material. Before investing, consider the investment objectives, risks, charges and expenses carefully before investing. Go to transamerica.com for prospectuses containing this and other information. Please read carefully. Withdrawals of taxable amounts are subject to ordinary income tax and may be subject to a 10% additional federal tax if withdrawn before age 59½. You cannot directly invest in an index and the annuity does not participate directly in any stock or equity investments. Stock dividends on the index are not included as a component of the Index Value. All guarantees, including optional benefits, are based on the claims-paying ability of the issuing insurance company. The policy may be referred to as a variable annuity, or modified guaranteed annuity in some states. Not available in Missouri, New York or Oregon. All policies, riders, and forms may vary by state and may not be available in all states. TPVA1400-0720, TRIA1000-R0821 TPVA14FL-0720 (SC), TPVA14OR-0720 (SC), TRIA10OR-R0821 The First Trust Equity Edge Index (FTIS Index) is a product of FT Indexing Solutions LLC (FTIS) and is administered and calculated by Bloomberg Index Service Limited and its affiliates (collectively, BISL). FIRST TRUST® and FIRST TRUST EQUITY EDGE INDEX™ are trademarks of First Trust Portfolios L.P. (collectively, with FTIS and its respective affiliates, First Trust). The foregoing index and trademarks have been licensed for use for certain purposes by Bloomberg, Transamerica Life Insurance Company (TLIC), Money Services, Inc., and Transamerica Capital, Inc., (Transamerica) in connection with the FTIS Index and the Transamerica Structured Index Advantage Annuity. The Nasdaq U.S. Rising Dividend Achievers™ INDEX (Nasdaq Index) is a product of Nasdaq, Inc., (which, with its affiliates, is referred to as the Nasdaq). NASDAQ® and NASDAQ U.S. RISING DIVIDEND ACHIEVERS™ are trademarks of Nasdaq. The foregoing index and trademarks have been licensed for use for certain purposes by FTIS and Transamerica in connection with the FTIS Index and Transamerica Structured Index Advantage Annuity. The Value Line Dividend Index (Value Line Index) is a product of Value Line, Inc., (Value Line). VALUE LINE® and VALUE LINE DIVIDEND INDEX™ are trademarks of Value Line. The foregoing index and trademarks have been licensed for use for certain purposes by FTIS and Transamerica in connection with the FTIS Index and Transamerica Structured Index Advantage Annuity. The FTIS Index is not sponsored, endorsed, recommended, sold, or promoted by Value Line and Value Line makes no representation regarding the advisability of investing in the FTIS Index. BLOOMBERG® is a trademark and service mark of Bloomberg Finance L.P. Bloomberg Finance L.P., BISL, and their affiliates (Bloomberg) are not affiliated with First Trust. Bloomberg's relationship to First Trust is only (1) in the licensing of the FIRST TRUST® and FIRST TRUST EQUITY EDGE INDEX™ trademarks and (2) to act as the administrator and calculation agent of the FTIS Index. Bloomberg does not guarantee the timeliness, accurateness, or completeness of the FTIS Index or any data or information relating thereto and shall have no liability in connection with the FTIS Index or any data or information relating thereto. Transamerica Structured Index Advantage Annuity is not issued, sponsored, endorsed, sold, recommended, or promoted by First Trust, Bloomberg, Nasdaq, Value Line, or their respective affiliates (collectively, the Companies). The Companies do not make any representation regarding the advisability of investing in Transamerica Structured Index Advantage Annuity or products based on the FTIS Index, Nasdaq Index, or Value Line Index, do not make any warranties or bear any liability with respect to such products, and do not make any warranties or bear any liability with respect to Transamerica Structured Index Advantage® Annuity or another party's index. Media inquiries: Email: [email protected] Hank Williams(319) 355-7789 Erin Yang(303) 383-5295
- 05/20/2024
|
Dow Jones Futures: AI Stock Palo Alto Plunges On Earnings; Nvidia Earnings, Fed Minutes Loom
- Dow Jones futures, along with S&P 500 futures and Nasdaq 100 futures, were little changed ahead of Tuesday's stock market open. Artificial intelligence stock Palo Alto Networks (PANW) plunged on earnings late Monday. And, later this week, Nvidia (NVDA) earnings and minutes from the Federal Reserve's latest policy meeting are due out. Key earnings movers late Monday include Palo Alto Networks and Zoom Video Communications (ZM). Cybersecurity leader Palo Alto plunged more than 9% in extended trading, while Zoom stock cut losses to less than 1%. The coming week sees Wednesday's release of Federal Reserve minutes for May. Investors will look for further clues into the thoughts of Fed Chair Jerome Powell and other central bankers on the future path of interest rates. Other economic reports due in the coming week include existing-home sales on Wednesday, new-home sales Thursday and S&P flash U.S. Purchasing Managers' Index data for both manufacturing and services, which come Thursday. Check Out IBD's New Exposure Levels To Help You Stay In Step With The Market Trend On Monday, the Dow Jones Industrial Average moved down 0.5% and the S&P 500 rose 0.1%. The tech-heavy Nasdaq composite climbed 0.7%. Robinhood Markets (HOOD), PDD (PDD), Taiwan Semiconductor Manufacturing (TSM), Trade Desk (TTD) and Tradeweb Markets (TW) — plus Dow Jones components JPMorgan Chase (JPM) and Merck (MRK) — are among the best companies to watch on the stock market today. And Dow Jones tech icons Apple (AAPL) and Microsoft (MSFT) ended higher in today's stock market, with Apple and Microsoft up 0.6% and 1.2%, respectively. Microsoft and Trade Desk are featured in this Stocks Near A Buy Zone column. Find The Best Stocks To Buy And Watch With IBD Stock Screener And IBD Screen Of The Day Ahead of Tuesday's opening bell, Dow Jones futures, along with S&P 500 futures and tech-heavy Nasdaq 100 futures, were little changed vs. fair value. Remember that overnight action in Dow Jones futures and elsewhere doesn't necessarily translate into actual trading in the next regular stock market session. On Monday, the 10-year U.S. Treasury yield ticked higher to 4.44%. And oil prices fell, as West Texas intermediate futures settled around $79.20 a barrel. Get Real-Time Buy And Sell Alerts On Stock Market Leaders With IBD Leaderboard Now is an important time to read IBD's The Big Picture column amid the ongoing stock market rally. Following Monday's action, be sure to check out today's The Big Picture for an updated exposure level. On Monday's IBD Live show, the IBD Live team discussed current trading conditions and continued to survey prospects for a new power trend in the market. An essential resource for daily breakouts is IBD MarketSurge's "Breaking Out Today" list. It shows MarketSurge Growth 250 stocks that are breaking out past buy points. Notably, Abercrombie & Fitch (ANF) broke out past a consolidation's 140.28 buy point. Meanwhile, the MarketSurge "Near Pivot" list shows stocks nearing buy points in bases. To find more stock ideas, check IBD Stock Lists like IBD 50, Big Cap 20 and Stocks Near A Buy Zone. These features identify bullish patterns and buy points and are available to check every day. JPMorgan gave up its flat base's 200.94 entry during Monday's decline of 4.5%. Meanwhile, drug giant Merck is building a flat base that has a 133.10 entry. 4 Top Growth Stocks To Watch In The Stock Market Action Outside the Dow Jones index, Temu-parent PDD is in buy range past a cup-with-handle's 142.32 buy point, according to IBD MarketSurge. Robinhood Markets rallied 3.7% Monday, breaking out past a 20.55 buy point in a cup base. Chipmaker Taiwan Semiconductor is in buy range above a 148.43 buy point in a double-bottom base in the wake of strong recent gains. Trade Desk climbed 2.9% Monday, closing further above a 94 entry in a consolidation. And Tradeweb is squarely in its buy range past a flat base's 108.04 buy point, despite a 1.8% drop Friday. Learn How To Time The Market With IBD's ETF Market Strategy These are four stocks in or near buy zones in today's stock market. Join IBD experts as they analyze leading stocks in the current stock market action on IBD Live Among Dow Jones stocks in the Magnificent Seven, Apple stock added 0.6% Monday, closing at its highest level since late January. Shares forming the right side of a new base that has a 199.62 entry. Microsoft shares climbed 1.2% Monday, moving closer to a flat base's 430.82 buy point. The software leader is expected to announce new initiatives in the artificial intelligence space at its Build 2024 event, which kicks off on Tuesday. The Dow Jones component will be looking to maintain its momentum in the AI space following Google-parent Alphabet's (GOOGL) recent I/O developer conference. Be sure to follow Scott Lehtonen on X/Twitter at @IBD_SLehtonen for more on growth stocks and the Dow Jones Industrial Average. YOU MAY ALSO LIKE: Top Growth Stocks To Buy And Watch Learn How To Time The Market With IBD's ETF Market Strategy Find The Best Long-Term Investments With IBD Long-Term Leaders Check Out IBD's New Exposure Levels To Help You Stay In Step With The Market Trend Spot Buy Points And Sell Signals With MarketSurge Pattern Recognition
- 05/20/2024
|
Nasdaq Scores Record Close as Tech Stocks Soar
- Nasdaq Scores Record Close as Tech Stocks Soar Gold futures also hit a new record high Jake Scott Deputy Editor May 20, 2024 at 4:26 PM VIX|SPX|IXIC|DJIA The Dow sidestepped the broader-market bounce today with a triple-digit loss The Nasdaq held onto its midday triple-digit lead, closing at a new record high thanks to a resurgent tech sector. The S&P 500 logged a modest win of its own -- and closed two-hundredths of a point (0.02) from a record close -- while the Dow lagged the broader market with a 196-point loss. Against this backdrop, Wall Street's "fear gauge," the Cboe Volatility Index (VIX) turned in only its second win of the month. Continue reading for more on today's market, including: Snowflake stock brushed off a pre-earnings bear note. How options traders are playing Apple stock. Plus, MU upgraded; bull notes for Wall Street newbie ; and Elliott's new stake. 5 Things to Know Today Microsoft announced new PCs that use Qualcomm's (QCOM) artificial intelligence (AI) chips. (CNBC) The meme-stock rally is taking a breather. (MarketWatch) Micron stock gets yet another bull note. Bullish coverage boosted Rubrik stock. EIlliot builds stake in electrical stock. There were no earnings of note today. Gold Futures Bounce to Record High Oil futures dipped Monday, reversing intraday gains amid fears of potential risks to global crude supplies after Iranian President Ebrahim Raisi died in a helicopter crash. In addition, the health of Saudi Arabia King Salman also has investors on edge. After trading as high as $80.60, June-dated West Texas Intermediate (WTI) crude lost 26 cents, or 0.3%, at $79.80 a barrel on the day. Gold futures jumped to record high today, sent skyward by a conflux of positive catalysts, including potential U.S. interest rate cuts and stimulus measures in China. At last glance, June-dated gold was up $18.40 or 0.8%, to finish the day at $2,435.80. Follow @Schaeffers (function () { var po = document.createElement('script'); po.type = 'text/javascript'; po.async = true; po.src = 'https://apis.google.com/js/platform.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(po, s); })();
- 05/20/2024
|
Nisun International Receives Notification of Deficiency from Nasdaq Related to Not Timely Filing of Annual Report on Form 20-F
- SHANGHAI , May 20, 2024 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd (Nasdaq: NISN) (the "Company") announced today that it received a notice of non-compliance from Nasdaq Stock Market LLC ("Nasdaq") on May 17, 2024 stating that, as a result of not having timely filed its annual report on Form 20-F for the year ended December 31, 2023, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission. This notice has no immediate effect on the listing or trading of the Company's Class A common shares on Nasdaq.
- 05/20/2024
|
SaverOne Announces Receipt of Nasdaq Minimum Bid Price Notification
- Petah Tikvah, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company engaged in disruptive transportation safety solutions, received a notice letter May 17, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company's American Depositary Shares (the “Shares”), for the last 31 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2).
- 05/20/2024
|
ZW Data Action Announces Receipt of Nasdaq Non-Compliance Notice
- BEIJING, China, May 20, 2024 (GLOBE NEWSWIRE) -- ZW Data Action Technologies Inc. (NASDAQ: CNET) (“ZW Data Action” or the “Company”), an integrated online advertising, precision marketing, data analytics and other value-added services provider serving enterprise clients, today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on May 17, 2024 notifying the Company that due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Form 10-Q”), with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC.
- 05/20/2024
|
“NASDAQ JAPAN IR EVENT” to Be Held at Nasdaq MarketSite on June 20, 2024
- NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (“MEDIROM”, the “Company”), today announced it will participate in a “NASDAQ JAPAN IR EVENT” to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience.
- 05/20/2024
|
Raytech Holding: Making Nasdaq Debut as It Pioneers Personal Care Electrical Appliances in a Booming Market
- Hong Kong, May 20, 2024 (GLOBE NEWSWIRE) -- In the dynamic world of personal grooming, Raytech Holding (Nasdaq: RAY) emerges as a shining star, dedicated to enhancing consumer lifestyles through its innovative range of personal care electrical appliances. Since its inception in 2013, this Hong Kong-based company has garnered over 10 years of industry experience, positioning itself as a leading player in the market.
- 05/20/2024
|
Lead Real Estate Co., Ltd. to Participate in Nasdaq Japan IR Event on June 20, 2024
- TOKYO, May 20, 2024 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd. (Nasdaq: LRE), a Japanese real estate developer of luxury residential properties including single-family homes and condominiums across Tokyo, Kanagawa prefecture, and Sapporo, today announced it will participate in the NASDAQ JAPAN IR EVENT on June 20, 2024, at the Nasdaq MarketSite headquarters in New York City.
- 05/20/2024
|
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- SOUTH SAN FRANCISCO, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools”) (Nasdaq:LAB) today announced that the Human Capital Committee of its Board of Directors, which is composed entirely of independent directors, granted an equity award effective as of May 20, 2024, under the Standard BioTools Inc. 2022 Inducement Equity Incentive Plan (Plan).
- 05/20/2024
|
Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
- Boston (May 20, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it has received formal written notice from The Nasdaq Stock Market, LLC's Office of General Counsel (“Nasdaq”) that the Company has regained compliance with the minimum stockholders' equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”).
- 05/20/2024
|
Up 7% YTD, What To Expect From NASDAQ Stock?
- NASDAQ stock (NASDAQ NASDAQ : NDAQ) has gained 7% YTD as compared to an 11% rise in the S&P500 index. Further, at its current price of $62 per share, it is almost 7% below its fair value of $67 – Trefis' estimate for NASDAQ's valuation.
- 05/20/2024
|
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
- SHENZHEN, China, May 20, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it has received a determination letter of the Hearings Panel (the “Panel”) of The Nasdaq Capital Market (“Nasdaq”) dated May 17, 2024, notifying the Company that the Panel determined to delist the Company's securities from Nasdaq, due to the failure to satisfy the continued listing conditions as previously disclosed. As a result, the Company expects that its securities will be suspended from trading at the open of business on May 21, 2024 and delisted from Nasdaq after the completion of Nasdaq's filing of a Form 25 Notification of Delisting with the Securities and Exchange Commission after all appeal periods have expired. The Company does not intend to file an appeal of the determination.
- 05/20/2024
|
The 3 Most Undervalued Nasdaq 100 Stocks to Buy in May 2024
- The Nasdaq 100 presents a compelling investment opportunity for several reasons. Firstly, it features a roster of top global brands, encompassing influential companies that dominate various sectors like technology and consumer discretionary, making their products and services integral to our daily lives.
- 05/19/2024
|
WM Technology, Inc. Announces Notification of Delinquency with Nasdaq
- IRVINE, Calif.--(BUSINESS WIRE)--WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS), announced it received an expected delinquency notification letter from Nasdaq's Listing Qualifications Department on May 14, 2024 which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (“Quarterly Report”) and its c.
- 05/17/2024
|
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
- Achilles ADSs will continue to trade on the Nasdaq Global Select Market at this time, and the Company's operations are not affected by the receipt of the Notice Achilles ADSs will continue to trade on the Nasdaq Global Select Market at this time, and the Company's operations are not affected by the receipt of the Notice
- 05/17/2024
|
Primech Holdings Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- SINGAPORE, May 17, 2024 (GLOBE NEWSWIRE) -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, today announces that it received a delinquency notification letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on May 14, 2024 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company's ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. The Notice provides that the Company has a period of 180 calendar days from the date of the Notice, or until November 11, 2024, to regain compliance with the minimum bid price requirement.
- 05/17/2024
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NOVATO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 17,180 restricted stock units of the company's common stock to ten newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of May 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/17/2024
|
Swedish EV maker Polestar gets Nasdaq notice on potential de-listing
- Swedish electric vehicle firm Polestar said on Friday it received a deficiency notice from the Nasdaq stock exchange for not filing its annual report on Form 20-F with the U.S. securities regulator for the fiscal year ended Dec 31.
- 05/17/2024
|
Polestar Acknowledges Receipt of Deficiency Notice From Nasdaq
- GOTHENBURG, Sweden--(BUSINESS WIRE)--Polestar (Nasdaq: PSNY) announces that, as a consequence of not having filed its Annual Report on Form 20-F for the fiscal year ended 31 December 2023, the Company has received a deficiency notice from The Nasdaq Stock Market, LLC confirming that it is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the U.S. Securities and Exchange Commission. The Notice has no immediate impa.
- 05/17/2024
|
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 102,150 shares of its common stock to six newly hired employees, consisting of inducement stock options to pur.
- 05/17/2024
|
Mesa Air Group Discloses Notice from Nasdaq
- PHOENIX, May 17, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today announced that it received a notice (“Notice”) on May 16, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission. The filing delay is not the result of a forthcoming restatement of the Company's financial statements or any disagreement with the Company's auditors.
- 05/17/2024
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on May 15, 2024, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 57,252 shares of common stock and 33,675 restricted stock units (“RSUs”) to twenty-two new employees under Acadia's 2023 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' e.
- 05/17/2024
|
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
- DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation Committee of Forte's Board of Directors approved the grant of equity awards to purchase a total of 70,000 shares of common stock to new non-exec.
- 05/17/2024
|
T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- LEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has closed its previously announced private placement for the purchase and sale of an aggregate of 2,025,317 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 2,025,317 shares of common stock and short-term series B warrants to purchase up to 2,025,317 shares of common stock at a purchase price of $3.95 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrants priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants have an exercise price of $3.70 per share and are exercisable immediately upon issuance. The series A warrants will expire five and one-half years from the date of issuance and the short-term series B warrants will expire eighteen months from the date of issuance.
- 05/17/2024
|
Alpine 4 Holdings, Inc. Announces Receipt of Nasdaq Staff Determination Letter
- PHOENIX, AZ / ACCESSWIRE / May 17, 2024 / Alpine 4 Holdings, Inc (NASDAQ:ALPP) (the "Company"), announced today that on May 14, 2024, it received a Staff Delisting Determination letter (the "Staff Determination") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that Nasdaq has initiated a process which could result in the delisting of the Company's securities from Nasdaq as a result of the Company's not being in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Staff Determination has no immediate effect and will not immediately result in the suspension of trading or delisting of the Company's securities.
- 05/17/2024
|
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
- SAN DIEGO, CA / ACCESSWIRE / May 17, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 516,336 shares of the Company's common stock, having exercise prices of $9.7665 and $32.40 per share, issued by Dermata in November 2023 (with respect to 462,945 warrants) and May 2023 (with respect to 53,391 warrants), at a reduced exercise price of $5.16 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to effective registration statements on Form S-3 (File No.
- 05/17/2024
|
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on April 22, 2024, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units (“RSUs”) representing 215,601 shares of its common stock to 94 new non-executive employees and non-qualified stock option awards to purchase an aggregate of 98,076 shares of its common stock to three new non-executive employees with a grant.
- 05/17/2024
|
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that, on May 13, 2024, the Compensation Committee of Precision's Board of Directors approved the grant of inducement awards to new employees under the Precision BioSciences, Inc. 2021 Employment Inducem.
- 05/17/2024
|
Wall Street Favorites: 3 Nasdaq Stocks With Strong Buy Ratings for May 2024
- The Nasdaq Composite index is at an all-time high after April's inflation rate came in weaker than expected and U.S. Federal Reserve Chair Jerome Powell reassured markets that further interest rate hikes are unlikely. The Nasdaq is now hovering near 16,700, a pretty high level.
- 05/17/2024
|
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
- NEW YORK , May 16, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 380,968 shares of common stock and pre-funded warrants to purchase up to 81,239 shares of common stock at a price of $2.46 per share (or $2.459 per pre-funded warrant) in a registered direct offering priced at-the-market under Nasdaq rules, resulting in total gross proceeds of approximately $1.1 million, before deducting the placement agent's fees and other estimated offering expenses. The Company also agreed to issue to the investors unregistered warrants to purchase up to 924,414 shares of common stock in a concurrent private placement.
- 05/16/2024
|
RF Acquisition Corp II Announces Pricing of $100 Million Initial Public Offering
- GRAND CAYMAN, Cayman Islands, May 16, 2024 (GLOBE NEWSWIRE) -- RF Acquisition Corp II (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “RFAIU” beginning on May 17, 2024. Each unit consists of one ordinary share, par value $0.0001 per share, of the Company (“ordinary share”), and one right to receive one-twentieth of one ordinary share. After the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “RFAI” and “RFAIR,” respectively. The offering is expected to close on May 21, 2024, subject to customary closing conditions.
- 05/16/2024
|
Society Pass Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- SINGAPORE, May 16, 2024 (GLOBE NEWSWIRE) -- Society Pass Inc. (NASDAQ: SOPA) (“SoPa” or the “Company”), a leading e-commerce ecosystem in Southeast Asia (“SEA”), announced a formal notification from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Listing Rule 5550(a)(2), which requires the Company's common stock to maintain a minimum bid price of $1.00 per share.
- 05/16/2024
|
Assure Announces it will Remain Listed on the Nasdaq Capital Market Pursuant to Nasdaq Panel Decision
- DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today it received a written notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that it has granted the Company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market (the “Panel Decision”). The Hearings Panel granted the Company an extension until July 22, 2024, by which date the Company will be required to demonstrate compliance with all applicable initial listing requirements for the Nasdaq Capital Market in relation to its completion of its previously announced transaction with Danam Health Inc.
- 05/16/2024
|
Nasdaq and S&P 500 to open at record highs; Walmart soars on earnings beat
- US stocks to open flat S&P 500 and Nasdaq at record highs Walmart rallies on earnings beat 8.30am: Wall Street to hold at record highs US stocks are expected to open flat on Thursday, coming off a strong Wednesday which saw both the Nasdaq and S&P 500 reach record highs as inflation data came in lighter than expected. Now, futures for both indexes are indicating they will open higher, with the S&P 500 at 5,335 and the Nasdaq at 18,709.
- 05/16/2024
|
J-Long Group Limited Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
- Ordinary shares will continue to trade on the Nasdaq Global Market, and the Company's listing on such exchange is not affected by the receipt of the Notice
- 05/16/2024
|
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 51,500 shares of its common stock to five new employees, consisting of inducement stock options to purchase an aggregate of 25,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 26,500 shares of its common stock. These inducement stock options and inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan (“2018 Plan”), but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4).
- 05/15/2024
|
Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock Market
- NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.'s securities were suspended on March 18, 2024, and have not traded on Nasdaq since that time.
- 05/15/2024
|
7 Cheap Nasdaq Stocks to Buy Now: May 2024
- The Nasdaq stock exchange lists numerous corporations, and some of them present attractive long-term buying opportunities. While trades can make some money by correctly timing their buy and sell points, time in the market often beats timing the market.
- 05/15/2024
|
Tech Stock Ready For A Bounce
- The shares of global technology company Nasdaq (NDAQ) have been choppy the past few months, with firm support at the $58 level. Today's 1.7% rise has NDAQ adding to its 5.8% year-to-date gain, and its recent pullback has it closing in on a historically bullish trendline.
- 05/15/2024
|
4 Top Stocks to Tap Nasdaq's New All-Time High
- Stocks like Netflix, Inc. (NFLX), Alphabet Inc. (GOOGL), NVIDIA Corporation (NVDA) and Super Micro Computer, Inc. (SMCI) are expected to benefit from the ongoing Nasdaq rally.
- 05/15/2024
|
Nasdaq Closes at New Record High; CPI on Deck
- Considering the challenges with PPI this morning, this demonstrates a bullish sentiment remaining in the market.
- 05/14/2024
|
3 Unshakeable Nasdaq Stocks Built to Thrive in Market Extremes
- The tech sector continues to set new highs, having investors wonder which Nasdaq stocks to buy next. Supported by substantial tailwinds, the Nasdaq 100 is heavily weighted towards the booming Artificial Intelligence ( AI ) sector.
- 05/14/2024
|
3 Companies to Watch as Nasdaq Warms Up to Cannabis Listings
- Many investors and analysts have been bullish on the prospects of the U.S. cannabis industry since its legalization in several states. However, despite being legal in 40 out of 50 U.S. states for medical use and 24 out of 50 for recreational, the drug is still not federally legal.
- 05/14/2024
|
2 Magnificent Growth Stocks to Add to Your Buy Basket in the New Nasdaq Bull Market
- Surgical robotics and media streaming represent two rapidly growing and evolving industries. Intuitive Surgical just garnered a new regulatory approval, and profits are soaring.
- 05/14/2024
|
3 Stock Gems Hiding in the Nasdaq
- With the technology benchmark Nasdaq index encountering some choppy weather since April, speculators may want to consider undervalued Nasdaq stocks. Granted, it's always risky betting on enterprises that haven't caught other people's attention.
- 05/13/2024
|
2 Nasdaq Stocks That Could Crush Nvidia and Deliver Bigger Gains, Thanks to Artificial Intelligence (AI)
- Super Micro Computer's outstanding growth seems sustainable thanks to the fast-growing market it serves, which could lead to impressive long-term stock upside. Meta Platforms is integrating AI across its social media properties, and its focus on monetizing its AI offerings should allow it to maintain healthy growth levels in the future.
- 05/11/2024
|
3 Thrilling Growth Stocks to Grab for the Next Nasdaq Bull Run
- Bull runs can lead to outsized gains for patient investors. Some stocks perform better than others, leaving the rest of the market in dust.
- 05/09/2024
|
3 Vanguard ETFs That Have Outperformed the S&P 500 and Nasdaq Composite Over the Last Year
- Megacap growth stocks have been leading the broader market indexes higher. It stands to reason that funds with high exposure to these names are doing quite well.
- 05/09/2024
|
3 No-Brainer Nasdaq-100 Stocks to Buy in May
- Warren Buffett's favorite stock is worth picking up. Adobe is committed to enhancing its suite of products with AI features.
- 05/09/2024
|
Nasdaq and S&P 500 to open lower, Uber tumbles on suprise loss, Reddit rallies on optimistic outlook
- US stocks to open lower Uber tumbles on surprise loss Reddit (NYSE:RDDT) optimism sends shares higher 8.36am: Wall Street set to open lower US stocks are poised to open lower today, looking to break the long winning streak which started in December last year. All three indexes are looking to open down, with Nasdaq futures implying a drop of 85 points, the Dow Jones looking at a 46-point fall and an 18-point slip for the S&P 500.
- 05/08/2024
|
The 3 Best Nasdaq Stocks to Buy in May 2024
- While conventional wisdom calls for selling securities, these best Nasdaq stocks may require a complete rethink. With the possibility that the Federal Reserve might get its soft landing after all, risk-on sentiment has returned on Wall Street.
- 05/07/2024
|
3 Nasdaq Stocks to Sell in May Before They Crash & Burn
- Markets seem to have their mojo back to start the month of May. After suffering a downturn in April, equities are once again rallying on news of strong corporate earnings.
- 05/07/2024
|
3 Nasdaq Darlings With Hidden Upside Potential
- As the stock market starts to pick up where it left off before running into April turbulence, value investors should be willing to give undervalued Nasdaq stocks a look. Some are cheaper after the latest round of earnings season, which was met with mixed results across the board.
- 05/07/2024
|
The 3 Best Stocks to Buy to Survive the Coming Nasdaq 100 Crash
- The Nasdaq 100 has been on a tear. The tech-heavy index is up 37% over the past 12 months compared to a 26% gain by the S&P 500 and a 17% rise in the Dow Jones Industrial Average.
- 05/07/2024
|
Coinbase (Nasdaq: COIN) and Block Inc. (NYSE: SQ) stock prices are up, but is the crypto party over?
- This morning, stock prices for cryptocurrency exchange platform company Coinbase Global Inc are up almost 9% in pre-market trading. Meanwhile, cryptocurrency-focused financial services company Block Inc (which allows clients to transact and invest in stocks using Bitcoin) has enjoyed a similar surge in price.
- 05/03/2024
|
SBUX, NDAQ, REXR: Inflation is Going to Progress Downward
- The reversion to the mean suggests that now is a good time to lean on value stocks, notes Burns McKinney. He talks about how despite recent stubbornness, inflation is continuing to progress downward.
- 04/30/2024
|
Nasdaq: Operating Leverage Embedded Given Revenue Mix; Multiple Expansion Is Warranted
- Following the acquisition of Adenza in 2023, Nasdaq's operating margins are set for significant expansion. Deleveraging likely to occur ahead of schedule, which could lead to increased capital return. Business mix changes and more rapid deleveraging warrant multiple expansion.
- 04/26/2024
|
Nasdaq's (NDAQ) Q1 Earnings Miss, Revenues Top, Dividend Raised
- Nasdaq's (NDAQ) first-quarter results reflect lower Market Services net revenues and higher expenses. Listings, too, dropped in the reported quarter.
- 04/25/2024
|
Nasdaq (NDAQ) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
- Although the revenue and EPS for Nasdaq (NDAQ) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 04/25/2024
|
Nasdaq (NDAQ) Misses Q1 Earnings Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.63 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.69 per share a year ago.
- 04/25/2024
|
Nasdaq (NDAQ) Set to Report Q1 Earnings: What to Expect
- Nasdaq's (NDAQ) first-quarter performance is likely to have been driven by organic revenue growth, and strong Market Platforms businesses, data and listing service revenues and Adenza contributions.
- 04/22/2024
|
Here's Why You Should Stay Invested in Nasdaq (NDAQ) Stock
- Organic growth, ramping up of on-trading revenue base, strategic buyouts and effective capital deployment poise Nasdaq (NDAQ) for growth.
- 04/10/2024
|
Will Nasdaq (NDAQ) Beat Estimates Again in Its Next Earnings Report?
- Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/10/2024
|
Three-Stock Lunch: Boeing, Nasdaq & Molson Coors
- Malcolm Ethridge, CIC Wealth EVP, joins 'Power Lunch' to discuss plays for three stocks: Boeing, Nasdaq and Molson Coors.
- 04/09/2024
|
5 Securities and Exchanges Stocks to Gain From Trading Volatility
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, COIN, NDAQ, and CBOE. However, compliance with regulations remains a challenge.
- 04/04/2024
|
Final Trades: GXO Logistics, Thermo Fisher & Nasdaq
- The Investment Committee gives you their top stocks to watch for the second half.
- 04/03/2024
|
Nasdaq to Hold First Quarter 2024 Investor Conference Call
- NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its First Quarter 2024 financial results announcement.
- 03/25/2024
|
Why Nasdaq Stock Sank on Wednesday
- A top investor has initiated a secondary stock sale. It will continue to hold in excess of 10% of the U.S. exchange operator, however.
- 03/20/2024
|
Nasdaq's stock drops after $1.6 billion offering from stock-exchange parent
- Nasdaq Inc.'s common stock was down by 4.2% in premarket trading on Wednesday after the parent of the Nasdaq stock exchange said it priced a stock offering from one of its largest shareholders, Borse Dubai.
- 03/20/2024
|
Dubai exchange to sell one-third of stake in Nasdaq
- Nasdaq Inc (NASDAQ:NDAQ)'s largest shareholder Borse Dubai is to sell around one-third of its stake in the US stock exchange operator, worth US$1.6 billion. Set to see Borse Dubai lose its spot as Nasdaq's top shareholder, the UAE-based sovereign wealth fund will sell 27 million shares at US$59 each.
- 03/20/2024
|
Nasdaq Stock Drops After Announcement of Secondary Offering—Key Levels to Watch
- Shares in stock exchange operator and market technology company Nasdaq (NDAQ) fell in extended trading Tuesday after the company announced that minority shareholder Borse Dubai plans to commence a secondary offering of its stock.
- 03/19/2024
|
Nasdaq hit with two-hour technical glitch
- Nasdaq Inc (NASDAQ:NDAQ) has announced that a technical glitch which affected connectivity for over two hours was resolved on Monday morning. The exchange, which lists shares in some of the US' largest technology firms, had started facing issues at around 4.55 am Eastern Time.
- 03/18/2024
|
Nasdaq: 8%-11% Of Solutions Growth Target Is Impressive
- Nasdaq has set a target of 8%-11% revenue growth for its Solutions business in the medium term. The acquisition of Adenza has been a milestone for Nasdaq, leading to strong cross-selling results and expanding their client base. Nasdaq's operating margin is expected to increase due to disciplined cost management and potential synergies, with a fair value of $75 per share.
- 03/12/2024
|
Here's Why You Should Hold Nasdaq (NDAQ) Stock Right Now
- Nasdaq (NDAQ) is poised to grow on the back of impressive organic growth, ramping up of on-trading revenue base and strategic buyouts to capitalize on growing market opportunities.
- 03/11/2024
|
Nasdaq Chief Financial Officer Sarah Youngwood to Present at the BofA Securities 2024 Information and Business Services Conference
- NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 03/06/2024
|
Nasdaq Chief Financial Officer Sarah Youngwood to Present at the Morgan Stanley Technology, Media & Telecom Conference
- NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm. Who: Sarah Youngwood, Executive Vice President and CFO, Nasdaq What: Morgan Stanley Technology, Media & Telecom Conference When: Thursday, March 7, 2024 8:45 AM PT (11:45 AM ET) Where: Ms.
- 03/01/2024
|
Why Is Nasdaq (NDAQ) Down 1.6% Since Last Earnings Report?
- Nasdaq (NDAQ) reported earnings 30 days ago. What's next for the stock?
- 03/01/2024
|
Appeals court will rehear challenge to Nasdaq board diversity rule, putting mandate at risk
- The Nasdaq rule, which was approved by the SEC, mandates disclosure of women, minorities and LGBTQ+ board members of companies listed on the stock exchange.
- 02/20/2024
|
Nasdaq (NDAQ) Expands Its Risk Platform in Asia With KKPS
- Nasdaq (NDAQ) secures its first client, Kiatnakin Phatra Securities, to adopt its risk solution in Asia.
- 02/13/2024
|
1 Magnificent S&P 500 Dividend Stock Returning 1,280% Since 2002 to Buy Right Now
- Nasdaq's recent $10.5 billion Adenza acquisition more than doubled its debt load. By buying Adenza, the company expanded its capacities to help patrol and regulate the financial markets.
- 02/13/2024
|
Nasdaq's (NDAQ) Q4 Earnings & Revenues Top Estimates, Rise Y/Y
- Nasdaqs (NDAQ) fourth quarter results reflect organic growth and solid results in the Solutions segment.
- 01/31/2024
|
Compared to Estimates, Nasdaq (NDAQ) Q4 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Nasdaq (NDAQ) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 01/31/2024
|
Nasdaq (NDAQ) Q4 Earnings and Revenues Beat Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.64 per share a year ago.
- 01/31/2024
|
Will Nasdaq (NDAQ) Retain Its Earnings Surprise Streak in 4Q?
- Nasdaq's (NDAQ) fourth-quarter performance is likely to reflect organic revenue growth, strong performance at Market Platforms businesses, data and listing service revenues, and Adenza contributions.
- 01/26/2024
|
What Analyst Projections for Key Metrics Reveal About Nasdaq (NDAQ) Q4 Earnings
- Beyond analysts' top -and-bottom-line estimates for Nasdaq (NDAQ), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
- 01/26/2024
|
Nasdaq (NDAQ) Reports Next Week: Wall Street Expects Earnings Growth
- Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/24/2024
|
This Cannabis Giant Only Generates 35% of Its Revenue From Its Marijuana Products. Here's Where the Rest Comes From.
- Tilray Brands is a leading cannabis producer in Canada. The federal ban on marijuana in the U.S. has effectively forced the company to look to other ways to expand its operations.
- 01/24/2024
|
Will Nasdaq (NDAQ) Beat Estimates Again in Its Next Earnings Report?
- Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/23/2024
|
Nasdaq (NDAQ) Leverages AI to Enhance Anti-Fin Crime Offerings
- Nasdaq (NDAQ) makes heavy investments in technology to enhance its offerings related to anti-fin crime protection.
- 01/11/2024
|
Investors Shouldn't Get Their Hopes Up for Marijuana Legalization in 2024: Here's Why
- President Biden pardon of marijuana convictions has investors bullish on the prospects of marijuana legalization. But the process of legalization is by no means simple.
- 01/10/2024
|
Nasdaq Set to Beat NYSE in IPO Race for Fifth Year in a Row
- U.K. chip designer Arm, which raised $5.2 billion in the year's biggest IPO, was among the companies to debut on Nasdaq.
- 12/26/2023
|
Here's Why You Should Stay Invested in Nasdaq (NDAQ) Stock
- An impressive organic growth, ramping up of on-trading revenue base, strategic buyouts to capitalize on growing market opportunities and effective capital deployment poise Nasdaq (NDAQ) for growth.
- 12/22/2023
|
Nasdaq to Hold Fourth Quarter 2023 Investor Conference Call
- NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Fourth Quarter 2023 financial results announcement.
- 12/21/2023
|
Nasdaq Looks to Carbon Markets for Abandoned Crypto Tech
- Nasdaq co-President Tal Cohen explains the company's plans to deploy technology developed for a curtailed custodian business for cryptocurrencies in the US to expand in other nascent markets, including carbon capture. --------
- 12/13/2023
|
Nasdaq: Becoming A Software And Technology Company With Solutions Business
- Nasdaq's Solutions Business, which includes data analytics and software, is driving recurring revenue growth and is expected to contribute 77% of the group's revenue. The acquisition of Adenza is expected to accelerate Nasdaq's transformation into a software and technology company, with potential for substantial revenue synergy. Growth drivers within the Solutions Business include anti-financial crime solutions, marketplace technology, workflow and insights, and Nasdaq index.
- 11/22/2023
|
2 stocks that under-promised and over-delivered on their earnings
- Companies that underpromise and over-deliver are a joy for shareholders and analysts alike. Like underdogs, these mighty yet soft-spoken companies surprise with actions, not words.
- 11/20/2023
|
5 Stocks You Can Confidently Invest $500 in Right Now
- Sea and Coupang seek to extend their leadership positions in their respective geographies. Pool and Snap-on might not seem exciting, but their total returns are.
- 10/31/2023
|
Nasdaq Chair & CEO Adena Friedman to Present at the J.P. Morgan Ultimate Services Investor Conference
- NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm.
- 10/30/2023
|
Nasdaq stock trades higher on earnings beat
- Nasdaq, Inc. (NDAQ) shares are trading in the green after the company reported earnings that topped analyst estimates. The company saw revenue grow about 5 percent amid recent IPO debuts, such as Arm Holdings (ARM) and Instacart (CART).
- 10/18/2023
|
5 Securities and Exchanges to Gain From Increased Trading
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CME, ICE, CBOE, NDAQ and COIN. However, compliance with regulations remains a challenge.
- 10/18/2023
|
Nasdaq's (NDAQ) Q3 Earnings Top, Expense View Tightened
- Nasdaq's (NDAQ) Q3 results reflect organic growth and solid performance of the Solutions segment.
- 10/18/2023
|
Nasdaq (NDAQ) Surpasses Q3 Earnings and Revenue Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.68 per share a year ago.
- 10/18/2023
|
Nasdaq supported by rising demand for anti-financial crime solutions
- Nasdaq Inc reported a solid jump in third quarter revenue, drievn by demand for anti-financial crime products, and a marked improvement in free cash flow. The financial services company said third quarter net revenues increased 6% to $940 million from the year prior with Solutions Businesses revenue up 9%, with organic growth of 8%.
- 10/18/2023
|
Is a Beat in Store for Nasdaq (NDAQ) This Earnings Season?
- Nasdaq's (NDAQ) third-quarter performance is likely to have been aided by solid organic revenue growth, strong performance at Market Platforms businesses, data and listing services revenues and contributions from the Adenza acquisition.
- 10/16/2023
|
Is a Surprise Coming for Nasdaq (NDAQ) This Earnings Season?
- Nasdaq (NDAQ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 10/16/2023
|
Why Nasdaq (NDAQ) is Poised to Beat Earnings Estimates Again
- Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/12/2023
|
Here's Why You Should Stay Invested in Nasdaq (NDAQ) Stock Now
- Improving organic growth, focus on ramping up the on-trading revenue base, buyouts to capitalize on growing market opportunities and effective capital deployment poise Nasdaq (NDAQ) for growth.
- 09/29/2023
|
DBOEY vs. NDAQ: Which Stock Should Value Investors Buy Now?
- Investors with an interest in Securities and Exchanges stocks have likely encountered both Deutsche Boerse AG (DBOEY) and Nasdaq (NDAQ). But which of these two stocks offers value investors a better bang for their buck right now?
- 09/28/2023
|
Nasdaq to Hold Third Quarter 2023 Investor Conference Call
- NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Third Quarter 2023 financial results announcement.
- 09/26/2023
|
Cannabis Stocks Are Red-Hot Right Now and This Could Send Them Even Higher
- Shares of Canopy Growth and Aurora Cannabis have more than doubled in just a few weeks. The U.S. government potentially rescheduling marijuana has gotten investors extremely bullish on pot stocks.
- 09/20/2023
|
5 NYSE-Listed Emerging Market Stocks For Income Investors
- Emerging markets have much to offer investors in 2023 and 2024, including globe-leading growth. The emerging markets are expected to more than double their developed counterparts in 2024, and many pay dividends along with the diversification.
- 09/20/2023
|
Nasdaq Exchange Gets Permission for First-Ever AI-Powered Order Type
- Artificial intelligence is coming to orders at the Nasdaq.
- 09/08/2023
|
It's Not Just BlackRock. Exchanges Like Nasdaq Are Pushing into Crypto, Too.
- Traditional exchanges have opportunities in crypto beyond listing Bitcoin ETFs, including selling market data and tokenizing other assets.
- 09/08/2023
|
SEC set to approve proposal to shift audit funding costs to brokers, investors
- The Securities and Exchange Commission was on track Wednesday to approve a new proposal for funding the Consolidated Audit Trail, a database that tracks all trades, orders and quotes in the U.S. equity market.
- 09/06/2023
|
Top-Tier Financial Dividend Growth With Nasdaq
- Nasdaq Inc. is a strong technology proxy with a competitive dividend yield, low payout ratio, and high dividend growth. The company's transformation into a leading technology provider for the financial system has been successful, with investments in cloud computing, AI innovation, and strategic acquisitions. Nasdaq's focus on market modernization, ESG trends, and anti-financial crime initiatives enhances its cross-selling potential and presents an attractive opportunity for long-term investors.
- 08/31/2023
|
Bull Market and Beyond: 2 Cheap Growth Stocks to Own for the Long Run
- Nasdaq just made a big splash with an acquisition that should boost its long-term prospects. American Express is seeing booming growth in two key areas.
- 08/27/2023
|
Why Is Nasdaq (NDAQ) Up 4.2% Since Last Earnings Report?
- Nasdaq (NDAQ) reported earnings 30 days ago. What's next for the stock?
- 08/18/2023
|
Nasdaq: Adenza Worries Are Not Taken Away
- Nasdaq's +$10 billion deal for Adenza caused a $3 billion decline in shares due to near-term dilution and increased debt. Nasdaq's Q2 earnings release confirmed the soundness of the strategic deal but highlighted the painful near-term dilution and higher leverage. The Adenza acquisition is expected to be accretive in year two, but the added debt and dilution make me cautious with a desired entry target in the mid-forties.
- 08/14/2023
|
5 Stocks to Watch From the Prospering Securities and Exchanges Industry
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CME, ICE, CBOE, NDAQ, and COIN. However, compliance with regulations remains a challenge.
- 07/28/2023
|
Looking for a Bounce Back? These 3 Stocks Near 52-Week Lows May Deliver Soon.
- If you're looking for stocks to rebound, the relatively strong performance of the S&P 500 in 2023 is up nearly 19% year-to-date, so you won't be able to find as many options as you once could. A quick screen of the index's stocks shows 25 at a new high and just two at a new low.
- 07/24/2023
|
Nasdaq Chair & CEO Adena Friedman to Present at the Oppenheimer 26th Annual Technology, Internet & Communications Conference
- NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 07/24/2023
|
Nasdaq Pauses Plans for Crypto-Custodian Business
- Adena Friedman, Nasdaq President and CEO, discusses moving markets to the cloud, its purchase of Adenza and why it's pausing plans to launch a crypto-custodian business. She speaks with David Westin on "Wall Street Week Daily.
- 07/19/2023
|
The 7 Most Undervalued Nasdaq Stocks to Buy Now: July 2023
- The Nasdaq is known for its high-flying growth stocks, and with good reason. But there's more to the index than just those aggressive names.
- 07/19/2023
|
Nasdaq halts plans to launch crypto custody service due to regulatory uncertainty
- (Kitco News) - Nasdaq announced that it is halting its plans to launch a crypto custody service due to the uncertain regulatory conditions in the U.S., remains dedicated to digital assets.
- 07/19/2023
|
Nasdaq (NDAQ) Beats on Q2 Earnings, Tightens Expense View
- Nasdaq (NDAQ) Q2 results reflect organic growth and solid results at the Solutions segment.
- 07/19/2023
|
Nasdaq, Inc. (NDAQ) Q2 2023 Earnings Call Transcript
- Nasdaq, Inc. (NASDAQ:NDAQ ) Q2 2023 Earnings Call Transcript July 19, 2023 8:00 AM ET Company Participants Ato Garrett - Senior Vice President, Investor Relations Adena Friedman - Chair & Chief Executive Officer Ann Dennison - Chief Financial Officer Conference Call Participants Owen Lau - Oppenheimer Patrick Moley - Piper Sandler Michael Cyprys - Morgan Stanley Alex Kramm - UBS Kyle Voigt - KBW Michael Cho - JPMorgan Brian Bedell - Deutsche Bank Operator Good day and thank you for standing by. Welcome to the Nasdaq Second Quarter 2023 Results Conference Call.
- 07/19/2023
|
Nasdaq (NDAQ) Tops Q2 Earnings and Revenue Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.69 per share a year ago.
- 07/19/2023
|
Nasdaq reports 2Q earnings beat on rising demand for anti-financial crime solutions
- NASDAQ OMX Group, Inc. (NASDAQ:NDAQ) has reported second-quarter earnings that beat expectations as rising demand for software to tackle financial crime compensated for a flat performance from trading services. The stock exchange operator reported a 4% year-over-year increase in net revenues to $925 million for the three months to June 30, 2023.
- 07/19/2023
|
What's in Store for Nasdaq (NDAQ) This Earnings Season?
- Nasdaq's (NDAQ) second-quarter performance is likely to have been driven by solid organic revenue growth, strong performance at corporate solutions and analytics businesses and higher market technology revenues.
- 07/17/2023
|
Bitcoin slips after SEC reportedly calls ETF filings inadequate, but still heads for a winning month
- Bitcoin slipped after the SEC reportedly called recent spot bitcoin ETF filings inadequate.
- 06/30/2023
|
Nasdaq to Hold Second Quarter 2023 Investor Conference Call
- NEW YORK, June 26, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Second Quarter 2023 financial results announcement.
- 06/26/2023
|
Here's Why Should You Stay Invested in Nasdaq (NDAQ) Stock
- Improving organic growth, focus on ramping up the on-trading revenue base, buyouts to capitalize on growing market opportunities, effective capital deployment poise Nasdaq (NDAQ) for growth.
- 06/26/2023
|
How To Build A Dividend Portfolio With $25,000 Among June's Top 30 Stocks
- A dividend income-oriented investment portfolio can provide you with an excellent source of extra income via dividend payments. I will show you how you could build an investment portfolio with my top 10 high dividend yield, dividend growth, and growth companies for the month of June. This portfolio provides you with a Weighted Average Dividend Yield [TTM] of 3.58% and has shown a Weighted Average Dividend Growth Rate [CAGR] of 11.05%.
- 06/24/2023
|
Nasdaq to sell debt worth $5 bln to fund Adenza deal
- Nasdaq said on Thursday it aims to sell debt worth $5.07 billion to fund its purchase of Thoma Bravo-owned software company Adenza.
- 06/22/2023
|
Nasdaq expects expanded markets to justify $10.5 bln Adenza merger price tag
- Nasdaq's eye-popping $10.5 billion bet on the little known financial software company Adenza will help the exchange operator vastly expand the market for its products, from risk management and regulatory software to anti-financial crime technology.
- 06/22/2023
|
Is Nasdaq a Buy, Sell, or Hold After Its $10.5 Billion Adenza Acquisition?
- Nasdaq is paying for Adenza with $5.75 billion in cash and $4.75 billion in stock. The purchase will bolster its ambitions to serve the financial markets.
- 06/21/2023
|
Why Nasdaq Stock Fell 9.6% This Week
- Nasdaq made the most expensive acquisition in its history, buying software company Adenza. Some analysts and investors thought it paid too much, thus the sell-off.
- 06/16/2023
|
Nasdaq CEO Adena Friedman Pursues a Black Belt in Dealmaking
- She agreed to the largest deal in the company's history; ‘I tend to take a competitive approach to life'
- 06/15/2023
|
Why Nasdaq Stock Was Falling Today
- Nasdaq is buying Thoma Bravo's Adenza for $10.5 billion. Investors seemed to think the company was overpaying or it was a poor strategic move.
- 06/12/2023
|
Nasdaq to buy Thoma Bravo-owned software firm Adenza for $10.5 billion
- Nasdaq said it would buy Thoma Bravo-owned software firm Adenza for $10.5 billion. This would be the exchange operator's biggest acquisition as it pushes to be more tech-focused.
- 06/12/2023
|
Nasdaq Buys Adenza From Thoma Bravo in Its Biggest Purchase Ever
- Nasdaq agreed to buy software firm Adenza for $10.5 billion, expanding Nasdaq's reach into fintech.
- 06/12/2023
|
Markets Gain Amid Anticipation of a Fed Rate Hike Pause
- U.S. equities were up at midday on Monday, June 12, 2023 amid optimism the Fed will pause its rate hike cycle.
- 06/12/2023
|
All Eyes Set on June FOMC Meeting
- All Eyes Set on June FOMC Meeting.
- 06/12/2023
|
3 Dividend Stocks That Should Pay You the Rest of Your Life
- Visa's "everyone is a partner" approach to its peers could create new growth avenues. FactSet's high customer retention and subscription model make it a strong compounder for the long haul.
- 06/12/2023
|
Big Week With a Slew of Key Economic Data and Fed's FOMC
- U.S. stock futures are trading higher to start a crucial week for the global financial markets.
- 06/12/2023
|
Nasdaq just announced a $10.5 billion deal to scoop up a behind-the-scenes tech provider for Wall Street
- Nasdaq announced plans to acquire Adenza from PE firm Thoma Bravo. It's a cash-and-stock deal valued at $10.5 billion.
- 06/12/2023
|
Nasdaq to acquire financial services software company Adenza for $10.5B
- Nasdaq announced on Monday that it is spending $10.5 billion in cash and stock to acquire Adenza, a company that develops risk-management and related regulatory software for the financial services market, from Thoma Bravo. The deal will extend Nasdaq's serviceable addressable market (SAM) to $34 billion, $10 billion more than what it is today, the company stated in a press release.
- 06/12/2023
|
Nasdaq CEO Adena Friedman on Adenza deal: Brings more capabilities to each of our clients
- Adena Friedman, Nasdaq chair and CEO, joins 'Squawk Box' to discuss the exchange operator's deal to acquire financial services software and technology company Adenza from private equity firm Thoma Bravo for $10.5 billion, and more.
- 06/12/2023
|
Nasdaq Pays $10.5 Billion for Risk Management Firm Adenza
- Nasdaq is acquiring risk management and compliance software maker Adenza for $10.5 billion. The deal, announced Monday (June 12), is apparently Nasdaq's largest ever, and will see the exchange operator pay Adenza's owner — investment firm Thoma Bravo — $5.75 billion in cash and 85.6 million shares of Nasdaq common stock.
- 06/12/2023
|
Nasdaq Stock Tumbles After $10.5 Billion Buyout
- The shares of Nasdaq Inc (NASDAQ:NDAQ) are 8% lower premarket, after the stock exchange operator announced a $10.5 billion deal to buy software investment firm Adenza.
- 06/12/2023
|
15 Upcoming Dividend Increases, Including A Dividend King
- Companies with a track record of increasing dividends tend to perform better than those without, indicating strong business performance and commitment to rewarding shareholders. The article provides a list of stocks raising their dividends in the next week, sorted by ex-dividend day and streak, with data sourced from the U.S. Dividend Champions spreadsheet and NASDAQ. The list includes companies with a minimum of five years of consistent dividend growth, and it is important for investors to consider historical returns and perform due diligence before investing.
- 06/08/2023
|
Nasdaq Chair & CEO Adena Friedman to Present at the Piper Sandler Global Exchange & FinTech Conference
- NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 06/06/2023
|
Here's Why Celsius Stock Surged 31% in May and Is Now at an All-Time High
- Celsius is reporting record numbers and far exceeding expectations. Wall Street keeps adjusting its financial models upward in response to the company's results.
- 06/05/2023
|
How To Allocate $15,000 Among My Top 10 Dividend Growth Companies For June 2023
- In today's article, I will demonstrate how you could allocate $15,000 among two dividend-paying ETFs and my top 10 dividend growth companies for June 2023. This investment portfolio offers you a Weighted Average Dividend Yield [TTM] of 3.12% and a broad diversification over Sectors and Industries. The selected picks have also shown a Weighted Average Dividend Growth Rate [CAGR] of 11.67% over the past 5 years.
- 06/03/2023
|
My Top 10 Dividend Growth Stocks To Invest In For June 2023
- I will introduce you to 10 dividend growth companies that I believe could be excellent choices for dividend growth investors right now. The 10 selected picks have shown an Average Dividend Growth Rate [CAGR] of 15.48% over the past 5 years. Furthermore, the companies provide investors with an Average Dividend Yield [FWD] of 2.17%.
- 05/30/2023
|
Here's Why Hold is an Apt Strategy for Nasdaq (NDAQ) Stock
- Improving organic growth, focus on ramping up the on-trading revenue base, buyouts to capitalize on growing market opportunities, effective capital deployment poise Nasdaq (NDAQ) for growth.
- 05/26/2023
|
DBOEY or NDAQ: Which Is the Better Value Stock Right Now?
- Investors interested in Securities and Exchanges stocks are likely familiar with Deutsche Boerse AG (DBOEY) and Nasdaq (NDAQ). But which of these two companies is the best option for those looking for undervalued stocks?
- 05/26/2023
|
Why Is Nasdaq (NDAQ) Down 2.3% Since Last Earnings Report?
- Nasdaq (NDAQ) reported earnings 30 days ago. What's next for the stock?
- 05/19/2023
|
Up 27% In 2023, Is It Safe to Invest In the Nasdaq Right Now?
- The Nasdaq 100 has outperformed the S&P 500 so far in 2023. The tech-heavy index tanked nearly 33% in 2022.
- 05/18/2023
|
Why Absolute Software Stock Zoomed 33% Today
- The cybersecurity specialist is being bought out by a strategic investor. That party is paying a premium of over 30% for the privilege.
- 05/11/2023
|
5 Securities and Exchanges to Gain From Increased Volatility
- A compelling and diversified product portfolio helps drive revenues of Zacks Securities and Exchanges industry players.
- 05/09/2023
|
This Top Fund Manager Buys Growth Stocks Without Paying Too Much
- Daniel Morris, manager of top mutual fund Manor Growth Fund (MNRGX), admits he has a conservative streak. The post This Top Fund Manager Buys Growth Stocks Without Paying Too Much appeared first on Investor's Business Daily.
- 05/05/2023
|
Watch These 5 Stocks That Recently Hiked Their Dividend
- At this stage, dividend-paying stocks should be in demand as investors try to safeguard their portfolios. Five of them are: TRV, NDAQ, SON, DFS and COST.
- 04/25/2023
|
AI: ‘We're trying to be really intelligent about capacity management,' Nasdaq EVP says
- Nasdaq EVP and Division President Tal Cohen and Nasdaq Capital Access Platforms President Nelson Griggs join Yahoo Finance Live to discuss recent leadership changes, restructuring into three divisions, AI's impact, and the outlook for markets.
- 04/21/2023
|
Nasdaq (NDAQ) Q1 Earnings Top Estimates, Revenues Increase Y/Y
- Nasdaq's (NDAQ) first-quarter 2023 results reflect organic growth and solid segmental performance.
- 04/19/2023
|
Nasdaq beats Q1 estimates, stock trades higher
- Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the rise in Nasdaq shares.
- 04/19/2023
|
Nasdaq (NDAQ) Q1 Earnings and Revenues Surpass Estimates
- Nasdaq (NDAQ) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.66 per share a year ago.
- 04/19/2023
|
Why Earnings Season Could Be Great for Nasdaq (NDAQ)
- Nasdaq (NDAQ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/17/2023
|
5 U.S. Giants Set to Beat on Q1 Earnings Next Week
- We have narrowed our search to five U.S. corporate bigwigs that are set to report first-quarter 2023 earnings results next week. These are: BK, TSLA, DFS, STT and NDAQ.
- 04/14/2023
|
Here's Why Hold is an Apt Strategy for Nasdaq (NDAQ) Stock Now
- Accelerating organic growth, focus on ramping up the on-trading revenue base, strategic buyouts to capitalize on growing market opportunities, effective capital deployment poise Nasdaq (NDAQ) for growth.
- 04/12/2023
|
Here's Why Hold Strategy is Appropriate for Nasdaq (NDAQ)
- Nasdaq's (NDAQ) focus on well-performing Market Technology and Investment Intelligence segments, technology expansion as well as favorable growth estimates bodes well.
- 04/12/2023
|
Nasdaq Plans to Launch a Crypto Custody Platform This Year: Report
- Nasdaq Inc., the company behind the giant namesake stock market exchange, is seeking to launch its digital asset custody platform in Q2 2023, Bloomberg reported Friday.
- 03/24/2023
|
Nasdaq to start offering crypto custody services by end of H1
- Despite widespread regulatory uncertainty and suspicion of cryptocurrencies in some countries, the global stock exchange operator Nasdaq plans to begin offering custody services for digital assets by the end of June 2023, demonstrating an increased institutional interest in the crypto industry.
- 03/24/2023
|
Nasdaq: A Future Dividend Aristocrat
- Nasdaq has shifted its focus to areas where it sees more opportunities for future growth. Investors could get a nice return on FCF and dividend increases.
- 03/23/2023
|
Here's Why Should You Stay Invested in Nasdaq (NDAQ) Stock
- Accelerating organic growth, focus on ramping up the on-trading revenue base, strategic buyouts to capitalize on growing market opportunities and effective capital deployment poise Nasdaq (NDAQ) well for growth.
- 03/13/2023
|
Nasdaq: Time To Trade Again
- Nasdaq has been a steady and boring value creator. Macro headwinds have limited earnings growth in 2022, but growth was reported nonetheless.
- 03/05/2023
|
2 Top Fintech Stocks to Buy in March
- These two stocks are long-term growers that are good buys right now.
- 03/02/2023
|
5 Stocks to Watch From the Prospering Securities and Exchanges Industry
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CME, CBOE, NDAQ, MKTX and COIN. However, compliance with regulations remains a challenge.
- 02/15/2023
|
Nasdaq to Present at the Credit Suisse 24th Annual Financial Services Forum
- NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 02/03/2023
|
History Suggests the Nasdaq Could Soar In 2023 -- 1 Stock-Split Stock Wall Street Says to Buy Hand Over Fist
- This cybersecurity juggernaut has made all the right moves in preparation for a new wave of growth.
- 02/02/2023
|
The Bear Takes a Bite Out of Nasdaq Shares
- Results disappointed, but the company is taking steps to diversify the business.
- 01/28/2023
|
Nasdaq's (NDAQ) Q4 Earnings Miss, Revenues Increase Y/Y
- Nasdaq's (NDAQ) Q4 results reflect solid performance in both Solutions Businesses and Trading Services segments.
- 01/25/2023
|
Nasdaq, Inc. (NDAQ) Q4 2022 Earnings Call Transcript
- Nasdaq, Inc. (NASDAQ:NDAQ ) Q4 2022 Results Conference Call January 25, 2023 8:00 AM ET Company Participants Neil Stratton - IR Adena Friedman - CEO Ann Dennison - CFO Conference Call Participants Richard Repetto - Piper Sandler Michael Cyprys - Morgan Stanley Alexander Kramm - UBS Owen Lau - Oppenheimer & Co. Craig Siegenthaler - Bank of America Dan Fannon - Jefferies Brian Bedell - Deutsche Bank Gautam Sawant - Credit Suisse Alexander Blostein - Goldman Sachs Kyle Voigt - KBW Operator Good day, and thank you for standing by. Welcome to the Nasdaq Fourth Quarter 2022 Results Conference Call.
- 01/25/2023
|
Nasdaq (NDAQ) Lags Q4 Earnings and Revenue Estimates
- Nasdaq (NDAQ) delivered earnings and revenue surprises of -1.54% and 0.01%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 01/25/2023
|
Nasdaq CEO: We have about 200 companies on file to go public
- Adena Friedman, Nasdaq chair and CEO, joins 'Squawk Box' to discuss the company's quarterly earnings results, what will bring public listings back and more.
- 01/25/2023
|
Nasdaq Stock Likely To Edge Past The Street Expectations In Q4
- The exchange reported mixed results in the last quarter, with the net revenues (total revenues minus transaction-based expenses) marginally missing expectations, despite increasing 6% y-o-y to $890 million.
- 01/24/2023
|
These 3 Stock Exchanges Stand to Benefit From SEC Trading Reforms
- New rules proposed by the SEC could be the most significant change to the market in more than a decade.
- 01/22/2023
|
Why Nasdaq (NDAQ) Could Beat Earnings Estimates Again
- Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/20/2023
|
Will Nasdaq (NDAQ) Keep Its Beat Streak Alive in Q4 Earnings?
- Solid organic revenue growth, strong performance at index and analytics businesses and contributions from the acquisition of Verafin are likely to have aided Nasdaq's (NDAQ) fourth-quarter performance.
- 01/20/2023
|
Nasdaq Stock Boasts Multiple Support Layers
- Nasdaq Inc (NASDAQ:NDAQ) has layers of technical support in place on the charts.
- 01/17/2023
|
My 6-Figure Market-Beating Dividend Growth Portfolio
- As requested by many, I decided to dedicate an article to my personal dividend growth portfolio, consisting of more than 90% of my net worth. I start by explaining my strategy and approach, followed by a discussion of the benefits that come with dividend (growth) investment strategies.
- 01/12/2023
|
History Suggests the Nasdaq Could Soar in 2023, and Here's the Stock to Buy If It Does
- The Nasdaq-100 index has a habit of roaring back to life in the year following a loss.
- 01/11/2023
|
Watch CNBC's full interview with Nasdaq Chair and CEO Adena Friedman
- Adena Friedman, chairman and CEO of the NASDAQ, joins 'TechCheck' to discuss her outlook for the markets heading into 2023.
- 01/06/2023
|
Should You Retain Nasdaq (NDAQ) Stock in Your Portfolio?
- Nasdaq's (NDAQ) focus on strategic buyouts, technology expansion as well as increased demand for Verafin's fraud and anti-money laundering solutions bodes well.
- 01/06/2023
|
Cathie Wood Stays Firm On Tesla With $4M Buy Even As Stock Slips Below Key Level — Also Loads Up On These 2 Crypto Stocks - Tesla (NASDAQ:TSLA)
- Cathie Wood-led ARK Investment Management continued buying Tesla Inc TSLA stock as it slipped below the $150 mark on the downside on Monday.
- 12/20/2022
|
7 Nasdaq Stocks to Buy and Hold Forever
- The Nasdaq stocks are known as high-flying growth plays, not necessarily buy-and-hold candidates. Electric vehicles, biotechnology, social networking stocks, cloud software companies and the like.
- 12/06/2022
|
Nasdaq's Tal Cohen on why the exchange is putting options trading in the cloud
- Tal Cohen, Nasdaq executive vice president, joins CNBC's "Fast Money" to discuss moving options trading to the cloud.
- 12/05/2022
|
4 Top Dividend Payers of the S&P 500
- If you want to invest in solid companies with a dividend that has room to grow, these are the stocks for you.
- 12/04/2022
|
Here's Why Hold is an Apt Strategy for Nasdaq (NDAQ) Now
- Nasdaq's (NDAQ) focuses on strategic buyouts and aims to generate revenues from high growth Market Technology and Investment Intelligence segments bodes well.
- 12/02/2022
|
Nasdaq to Hold Fourth Quarter 2022 Investor Conference Call
- NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Fourth Quarter 2022 financial results announcement.
- 11/23/2022
|
5 Securities and Exchanges Stocks to Gain From Increased Trading
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
- 11/22/2022
|
Why Is Nasdaq (NDAQ) Up 14.1% Since Last Earnings Report?
- Nasdaq (NDAQ) reported earnings 30 days ago. What's next for the stock?
- 11/18/2022
|
Utility And Home Products Stocks In Buy Zones Near New Highs
- Global power stock broke out of a cup base, hitting a buy point. Products stock reaches a new high on relative strength line.
- 11/11/2022
|
Nasdaq to Present at the 2022 J.P. Morgan Ultimate Services Investor Conference
- NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm .
- 11/10/2022
|
Looking for Passive Income? 2 Dividend Payers I'm Buying Hand Over Fist
- With critical operations supporting steady growth, these tech stocks are great long-term passive income generators.
- 11/02/2022
|
Nasdaq, Inc. (NDAQ) Q3 2022 Earnings Call Transcript
- Nasdaq, Inc. (NASDAQ:NDAQ ) Q3 2022 Results Conference Call October 19, 2022 8:00 AM ET Company Participants Ed Ditmire - Investor Relations Adena Friedman - Chief Executive Officer Ann Dennison - Chief Financial Officer John Zecca - Chief Legal Risk and Regulatory Officer Conference Call Participants Richard Repetto - Piper Sandler Gautam Sawant - Credit Suisse Brian Bedell - Deutsche Bank Craig Siegenthaler - Bank of America Michael Cho - JPMorgan Dan Fannon - Jefferies Alex Blostein - Goldman Sachs Owen Lau - Oppenheimer Andrew Bond - Rosenblatt Securities Operator Good day and thank you for standing by. Welcome to Nasdaq's Third Quarter 2022 Quarterly Update Conference Call.
- 10/19/2022
|
IPO market is not really in the context of concern right now, says Nasdaq CEO Adena Friedman
- Nasdaq CEO Adena Friedman joins CNBC's 'Squawk Box' to discuss the company's quarterly earnings results, the current market trading environment, and more.
- 10/19/2022
|
Nasdaq shares rise after adjusted earnings beat expectations
- Nasdaq Inc. NDAQ, +0.81% shares advanced by 1.4% in premarket trades Wednesday after the equities marketplace's third-quarter adjusted earnings and revenue beat analyst estimates amid organic growth across its business. Nasdaq's third-quarter profit rose to $294 million, or 59 cents a share, from $288 million, or 56 cents a share, in the year-ago quarter.
- 10/19/2022
|
Choppy markets likely to boost profit for U.S. exchange operators
- Heightened market volatility could prove to be a boon for U.S. exchange operators as higher trading volumes during their third quarter help offset a hit from fewer stock listings so far this year.
- 10/18/2022
|
What To Expect From Nasdaq Stock In Q3?
- We expect Nasdaq to beat the consensus estimates for revenues and earnings.
- 10/18/2022
|
Nasdaq (NDAQ) to Report Q3 Earnings: What's in the Offing?
- Solid organic revenue growth, strong performance at index and analytics businesses and contributions from the acquisition of Verafin are likely to have aided Nasdaq's third-quarter performance.
- 10/14/2022
|
Nasdaq Makes First Major Push Into Crypto
- Nasdaq Inc. is making its first major push into crypto, as the second-largest stock exchange prepares to capitalize on increasing appetite for digital currencies among big-money investors. Tal Cohen, the company's executive vice president and head of North American markets, is on "Bloomberg Crypto.
- 10/04/2022
|
Nasdaq (NDAQ) Organizes Business Operation in Three Units
- Nasdaq (NDAQ) is set to arrange its business units into three divisions, Market Platforms, Capital Access Platforms, and Anti-Financial Crime, as part of a strategic move to ramp up growth.
- 09/29/2022
|
Nasdaq to Hold Third Quarter 2022 Investor Conference Call
- NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Third Quarter 2022 financial results announcement.
- 09/22/2022
|
Nasdaq is preparing to launch a crypto custody solution for institutions
- (Kitco News) - Nasdaq is looking to establish a 40-person digital asset unit by year's end that offers a crypto custody solution for institutional investors.
- 09/20/2022
|
Nasdaq to provide crypto custody for institutional investors
- Nasdaq Inc., owner of the second largest stock exchange, is looking to provide crypto custody service to institutional investors, in its first major push into the rather nascent industry, despite a price downturn for the asset.
- 09/20/2022
|
Nasdaq Pushes Into Crypto With New Custodial Service
- Nasdaq unveils a new digital asset business in a bid to advance institutional investor participation in the cryptocurrency space.
- 09/20/2022
|
Nasdaq CFO Ann Dennison to Present at Barclays Global Financial Services Conference
- NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm.
- 09/12/2022
|
Nasdaq Board-Diversity Rule Takes Center Stage in Court Battle
- Two conservative groups argue the exchange's diversity targets for listed companies amount to an illegal racial and gender quota.
- 08/29/2022
|
5 Securities and Exchanges to Gain From Increased Volatility
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
- 08/24/2022
|
Nasdaq: When Quality Means Outperformance
- In this article, I start by assessing why "quality" stocks are in a good position to deliver long-term outperformance. Nasdaq stands for quality thanks to a strong business model, increasing margins, and the ability to generate high free cash flow in an industry with high entry barriers.
- 08/23/2022
|
Here's Why Should You Hold Nasdaq (NDAQ) Stock in Portfolio
- Accelerating organic growth, focus on ramping up on-trading revenue base, strategic buyouts to capitalize on growing markets opportunities, effective capital deployment well poise Nasdaq (NDAQ) for growth.
- 08/23/2022
|
Stock Market Rebound: 4 Incredible Growth Stocks to Buy and Hold Forever
- These four growth stocks could be perfect for your portfolio.
- 08/20/2022
|
Why Is Nasdaq (NDAQ) Up 10.4% Since Last Earnings Report?
- Nasdaq (NDAQ) reported earnings 30 days ago. What's next for the stock?
- 08/19/2022
|
Generate Passive Income as This Dividend Payer Eyes a Stock Split
- The growing SaaS business offers promise for investors, plus a rising dividend.
- 08/03/2022
|
7 Nasdaq Stocks to Buy and Hold Forever
- The Nasdaq has a reputation for being the home of aggressive hypergrowth companies — firms that can go up five- or tenfold in a year and sometimes crash just as quickly. Most investors probably wouldn't imagine creating a buy-and-hold forever portfolio filled with Nasdaq stocks.
- 08/02/2022
|
Why Nasdaq's Stock Price Rocketed 18.6% in July
- The financial stock surged on strong earnings, among other factors
- 08/02/2022
|
3 Fintech Stocks That Could Beat the Market Over the Next 5 Years
- These may not be the fastest-growing names, but they have the right ingredients to produce excellent returns.
- 07/27/2022
|
Nasdaq, Inc. (NDAQ) CEO Adena Friedman on Q2 2022 Results - Earnings Call Transcript
- Nasdaq, Inc. (NASDAQ:NDAQ ) Q2 2022 Earnings Conference Call July 20, 2022 8:00 AM ET Company Participants Ed Ditmire - Investor Relations Adena Friedman - Chief Executive Officer Ann Dennison - Chief Financial Officer John Zecca - Chief Legal Risk and Regulatory Officer Conference Call Participants Rich Repetto - Piper Sandler Alex Kramm - UBS Brian Bedell - Deutsche Bank Alexander Blostein - Goldman Sachs Daniel Fannon - Jefferies Craig Siegenthaler - Bank of America Kyle Voigt - KBW Michael Cyprys - Morgan Stanley Gautam Sawant - Credit Suisse Owen Lau - Oppenheimer Operator Good day and thank you for standing by. Welcome to the Nasdaq Second Quarter 2022 Results Call.
- 07/20/2022
|
Nasdaq (NDAQ) Beats on Q2 Earnings, Tightens Expense View
- Nasdaq (NDAQ) Q2 earnings reflect solid performance of both segments.
- 07/20/2022
|
Nasdaq (NDAQ) Q2 Earnings and Revenues Surpass Estimates
- Nasdaq (NDAQ) delivered earnings and revenue surprises of 8.38% and 1.06%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 07/20/2022
|
Nasdaq (NDAQ) Earnings Expected to Grow: Should You Buy?
- Nasdaq (NDAQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/13/2022
|
The Nasdaq is an electronic stock exchange where some of the fastest-growing, most innovative companies trade
- Nasdaq is the world's largest electronic stock exchange. Its indexes, the Nasdaq Composite and Nasdaq 100, play an important role in the stock market.
- 07/07/2022
|
Trading Volume Is Falling — And These Exchange Stocks Are Getting Hit
- As financial markets have weakened in 2022, trading volumes have fallen across all asset classes, according to a new report by Bank of America analyst Craig Siegenthaler. Siegenthaler said Friday that these declining volumes are weighing on exchange stocks, such as CME Group Inc (NYSE: CME),.
- 07/01/2022
|
Nasdaq Inc.: A Dividend Grower You'll Love
- In this article, I start by explaining why owning dividend growth stocks is so important. Then, we look into Nasdaq's business model, which provides high earnings and free cash flow growth used to boost what has become a decent dividend yield.
- 06/30/2022
|
Buy the Dip: 3 Stocks to Buy Today and Hold for the Next 3 Years
- Here are three stocks you can scoop up today and hold for another three years to wait for a good outcome.
- 06/22/2022
|
Nasdaq to Hold Second Quarter 2022 Investor Conference Call
- NEW YORK, June 17, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Second Quarter 2022 financial results announcement.
- 06/17/2022
|
Is the Options Market Predicting a Spike in Nasdaq (NDAQ) Stock?
- Investors need to pay close attention to Nasdaq (NDAQ) stock based on the movements in the options market lately.
- 06/15/2022
|
Trading exchange execs ask if tough times are ahead as market-altering rules loom
- Exchange executives are wondering if tough times are ahead as SEC Chair Gary Gensler speaks at a key conference.
- 06/08/2022
|
Nasdaq Executives to Present at Upcoming Investor Conferences
- NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in June with webcasts available at Nasdaq's Investor Relations Website: ir.nasdaq.com/events.cfm.
- 05/25/2022
|
Here's Why You Should Stay Invested in Nasdaq (NDAQ) Stock
- Accelerating organic growth, focus on ramping up on-trading revenue base, strategic buyouts to capitalize on growing markets opportunities, effective capital deployment well poise Nasdaq (NDAQ) for growth.
- 05/25/2022
|
This Beaten-Down Growth Stock Keeps Gaining Market Share: Should You Buy It?
- Market sell-offs can create great opportunities to buy stocks like this at cheaper prices today.
- 05/25/2022
|
Nasdaq Is a FCF Powerhouse Raising Its Dividend In the Middle of a Crash
- Nasdaq stock could move at least 6.6% higher based on its powerful FCF and its growing dividend and free cash flow. The post Nasdaq Is a FCF Powerhouse Raising Its Dividend In the Middle of a Crash appeared first on InvestorPlace.
- 05/13/2022
|
Nasdaq Inc.: Good Historical Growth, But Can It Continue?
- Many investors don't realize you can actually buy stock in the Nasdaq Stock Exchange through publicly traded Nasdaq Inc. ( NDAQ , Financial). Revenues from various exchanges produce less than half of this company's total income; the rest comes from other business lines, including listing services, analytics and various market technology applications.
- 05/09/2022
|
Nasdaq Stock is a Buy the (Deep) Dip Opportunity
- Electronic U.S. stock market exchange operator Nasdaq (NASDAQ: NDAQ) stock has been collapsing with the benchmark indices as it has fallen (-22%) year-to-date.
- 05/08/2022
|
These 2 Critical Numbers Have Me Buying More Nasdaq Stock
- Nasdaq's ongoing SaaS transformation is progressing beautifully -- and I'm ready to buy.
- 04/30/2022
|
5 Securities and Exchanges in Focus Despite Industry Headwinds
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
- 04/21/2022
|
Nasdaq: One Of My Favorite Dividend Stocks
- Nasdaq, Inc. offers investors a great mix between "growth" and "value", which I believe is key when it comes to long-term outperformance. Dividend growth is set to remain high as free cash flow is high and overall growth rates remain satisfying.
- 04/20/2022
|
Nasdaq (NDAQ) Beats on Q1 Earnings, Tweaks Expense View
- Nasdaq's (NDAQ) Q1 performance reflect solid results at the Solutions segment.
- 04/20/2022
|
When Is the Nasdaq Stock Split Date? What Will Happen to NDAQ Stock?
- Shares of NDAQ stock are in the spotlight after the company reported Q1 earnings. Nasdaq also announced a 3-for-1 stock split.
- 04/20/2022
|
Nasdaq, Inc. (NDAQ) CEO Adena Friedman on Q1 2022 Results - Earnings Call Transcript
- Nasdaq, Inc. (NASDAQ:NDAQ ) Q1 2022 Earnings Conference Call April 20, 2022 8:00 AM ET Company Participants Edward Ditmire - VP, IR Adena Friedman - President, CEO & Director Ann Dennison - EVP & CFO Conference Call Participants Richard Repetto - Piper Sandler & Co. Craig Siegenthaler - Bank of America Merrill Lynch Owen Lau - Oppenheimer Alexander Kramm - UBS Daniel Fannon - Jefferies Alexander Blostein - Goldman Sachs Group Brian Bedell - Deutsche Bank Michael Cyprys - Morgan Stanley Kyle Voigt - KBW Gautam Sawant - Crédit Suisse Operator Good day, and thank you for standing by. Welcome to the Nasdaq First Quarter 2022 Results Conference Call.
- 04/20/2022
|
Nasdaq (NDAQ) Surpasses Q1 Earnings Estimates
- Nasdaq (NDAQ) delivered earnings and revenue surprises of 2.07% and 0.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 04/20/2022
|
Nasdaq CEO Adena Friedman breaks down earnings, 3-for-1 stock split
- Nasdaq CEO Adena Friedman joins CNBC's 'Squawk Box' to discuss the company's first-quarter earnings report and its newly announced 3-for-1 stock split.
- 04/20/2022
|
Nasdaq Announced Stock Split, Delivered Mixed Earnings
- Revenue missed estimated but profit was better than expected.
- 04/20/2022
|
Is a Beat in Store for Nasdaq (NDAQ) This Earnings Season?
- Growth across the segments and contributions from the acquisition of Verafin are likely to have aided performance in the to-be-reported quarter for Nasdaq (NDAQ).
- 04/18/2022
|
Should You Buy Nasdaq (NDAQ) Ahead of Earnings?
- Nasdaq (NDAQ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/18/2022
|
Why Nasdaq (NDAQ) is Poised to Beat Earnings Estimates Again
- Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/14/2022
|
3 Dividend-Paying Tech Stocks to Buy in April
- Despite having a slow start to 2022, these dividend-paying businesses make for excellent long-term holdings.
- 04/14/2022
|
Nasdaq (NDAQ) Expected to Beat Earnings Estimates: Should You Buy?
- Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/13/2022
|
What Is a Tech-Ish Stock? 7 Tech Stocks That Get to Play in 2 Sectors
- Tech stocks have been expensive, at least until recently. However, looking for tech-ish stocks in related industries can turn up bargains.
- 04/01/2022
|
Here's Why Hold is an Apt Strategy for Nasdaq (NDAQ) Now
- Nasdaq's (NDAQ) focus on repositioning its business and aims to generate revenues from high growth Market Technology and Investment Intelligence segments bodes well.
- 03/21/2022
|
Nasdaq to Hold First Quarter 2022 Investor Conference Call
- NEW YORK, March 17, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its First Quarter 2022 financial results announcement.
- 03/17/2022
|
Nasdaq: High Quality Dividend Growth In Tech
- Nasdaq: High Quality Dividend Growth In Tech
- 02/16/2022
|
A Peloton Bailout Could Start a Big Nasdaq Stock Trend
- Earnings reports are also helping the Nasdaq Composite Monday morning.
- 02/07/2022
|
Nasdaq's (NDAQ) CEO Adena Friedman on Q4 2021 Results - Earnings Call Transcript
- Nasdaq's (NDAQ) CEO Adena Friedman on Q4 2021 Results - Earnings Call Transcript
- 01/26/2022
|
Nasdaq's (NDAQ) Q4 Earnings and Revenues Surpass Estimates
- Nasdaq's (NDAQ) Q4 results reflect growth in Market Services, Corporate Platforms, Investment Intelligence and Market Technology segments.
- 01/26/2022
|
Nasdaq (NDAQ) Beats Q4 Earnings and Revenue Estimates
- Nasdaq (NDAQ) delivered earnings and revenue surprises of 8.43% and 2.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 01/26/2022
|
NASDAQ Stock To Miss The Street Expectations In Q4?
- NASDAQ is scheduled to report its fiscal Q4 2021 results on Wednesday, January 26, 2022. We expect NASDAQ to miss the consensus estimates for revenues and earnings.
- 01/25/2022
|
What's in the Cards for Nasdaq (NDAQ) This Earnings Season?
- Nasdaq's (NDAQ) fourth-quarter performance is likely to have benefited from higher organic growth and contributions from the acquisition of Verafin.
- 01/21/2022
|
This Nasdaq Stock Is Up 22,660% Since the 1980s -- But Are Its Best Times Behind It?
- In a little-watched corner of the market, a company has started to pull back from decades of strong gains.
- 01/12/2022
|
NASDAQ Stock Has Limited Upside
- NASDAQ stock has gained 47% since the end of 2020, and at its current price of $195 per share, it is almost 9% below its fair value of $215 – Trefis' estimate for NASDAQ's valuation. While the exchange outperformed the street expectations in the third-quarter 2021 results, its stock has lost 2%.
- 01/10/2022
|
Can Nasdaq (NDAQ) Keep the Earnings Surprise Streak Alive?
- Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/07/2022
|
Bed Bath & Beyond Disappoints, but This Nasdaq Stock Took the Biggest Hit Thursday
- Here's one reason why the market could fall yet again.
- 01/06/2022
|
Investing in This ETF Right Now Could Make You a Millionaire Retiree
- Not all indexes are highly diversified, but that's not a bad thing.
- 01/01/2022
|
Nasdaq (NDAQ) Rallies 60% YTD: More Room for Upside Left?
- Accelerating organic growth, focus on ramping up on-trading revenue base, strategic buyouts to capitalize on growing markets opportunities, effective capital deployment and upbeat guidance continue to drive Nasdaq (NDAQ).
- 12/23/2021
|
JD.com Is Falling, But an M&A Bid Is Lifting This Small Nasdaq Stock Thursday
- Find out why the stock market could see more gains.
- 12/23/2021
|
The Nasdaq has a Weight Problem
- We have discussed extensively that technology-related stocks have led the S&P 500. In fact, technology-related stocks make up nearly 45% of the market index's weighting, causing the index to be substantially out of balance.
- 12/22/2021
|
5 Securities and Exchanges Industry Stocks to Benefit From Increased Trading
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CBOE, CME, ICE, NDAQ and OTCM. However, compliance with regulations remains a challenge.
- 12/17/2021
|
Nasdaq falls nearly 2% as US stocks battered by Omicron volatility
- The disappointing November jobs report added to the uncertainty as investors try to chart the path of Fed policy.
- 12/03/2021
|
Nasdaq, AWS Collaborate: What You Need To Know
- Nasdaq Inc (NASDAQ: NDAQ) and Amazon.com Inc's (NASDAQ: AMZN) Amazon Web Services Inc forged a multi-year collaboration to build the next generation of cloud-enabled infrastructure for the world's capital markets. Nasdaq aims to migrate its North American markets to AWS starting 2022 in a phased approach, beginning with Nasdaq MRX, a U.S. options market.
- 11/30/2021
|
Here Are Monday's 2 Must-Watch Nasdaq Stock Winners
- Stock markets are trying to rebound after a steep drop last Friday.
- 11/29/2021
|
NASDAQ Stock Is Trading Close To Its Fair Value
- NASDAQ stock (NASDAQ: NDAQ) has gained 56% YTD, and at its current price of $208 per share, it is almost 3% below its fair value of $215 – Trefis' estimate for NASDAQ's valuation. The company recently released its third-quarter results, with revenues and earnings surpassing the consensus estimates.
- 11/24/2021
|
Got $5,000? 3 Top Dividend Stocks to Buy Right Now
- These S&P 500 stocks offer great long-term dividend growth potential to investors.
- 11/20/2021
|
Wall Street Is Missing Out on This Surprising SaaS Story
- Investors should be paying close attention to this company's ongoing software-as-a-service transformation.
- 11/19/2021
|
Rivian Plunges, but This Under-the-Radar Nasdaq Stock Is Soaring
- Find out what took two stocks listed on the Nasdaq in different directions on Thursday.
- 11/18/2021
|
The 2021 Stock Market Is Quietly Breaking a Record in This Specific Category
- When money is this easy to come by, it's important to watch out for companies that are coming public but aren't good investment opportunities.
- 11/10/2021
|
Continued Economic Improvement Ahead?
- In October, the markets bounced back strongly from September's weakness. Commonwealth CIO Brad McMillan weighs the prospects for November.
- 11/09/2021
|
Nasdaq Reports Strong Q3 Earnings on Trading and Software Revenues
- The stock exchange operator is executing on its strategic repositioning, but its expenses are growing faster than revenue.
- 10/27/2021
|
Nasdaq stock outlook as Q3 results edge expectations
- On Wednesday, Nasdaq Inc. (NASDAQ:NDAQ) shares advanced after announcing its most recent quarterly results. The company reported its fiscal Q3 revenue and earnings before markets opened edging consensus Street estimates.
- 10/20/2021
|
Nasdaq, Inc. (NDAQ) CEO Adena Friedman on Q3 2021 Results - Earnings Call Transcript
- Nasdaq, Inc. (NDAQ) CEO Adena Friedman on Q3 2021 Results - Earnings Call Transcript
- 10/20/2021
|
Nasdaq (NDAQ) Beats on Q3 Earnings, Tightens Expense View
- Nasdaq (NDAQ) Q3 results reflect consistent long-term growth in the Anti Financial Crime, Index and Analytics offerings, the benefits of the materially-expanded listed issuer base, and robust performance of the marketplace and connectivity platforms.
- 10/20/2021
|
Nasdaq profit beats on robust demand for investment products
- Nasdaq Inc on Wednesday reported a third-quarter profit that topped Wall Street estimates, helped by strong demand for its investment-related products and a jump in the number of initial public offerings.
- 10/20/2021
|
Dividends Make These Two Exchanges Lifelong Holds
- S&P Global and Nasdaq demonstrate the immense power of buy-and-hold dividend-growth investing.
- 10/20/2021
|
Preview: Nasdaq's Earnings
- Nasdaq (NASDAQ: NDAQ ) is set to give its latest quarterly earnings report on Wednesday, 2021-10-20. Here's what investors need to know before the announcement.
- 10/19/2021
|
Nasdaq (NDAQ) to Report Q3 Earnings: What's in the Offing?
- Nasdaq's (NDAQ) third-quarter performance is likely to benefit from organic revenue growth and accretion from strategic acquisitions.
- 10/15/2021
|
Alpine 4 Holdings says it has been approved by The Nasdaq Stock Market; names new chief financial officer
- Alpine 4 Holdings, Inc. announced that it has been approved by The Nasdaq Stock Market to list on The Nasdaq Capital Market effective at the open of the market on Wednesday, October 20, 2021, under the trading symbol ALPP.
- 10/14/2021
|
Nasdaq September 2021 Volumes and 3Q21 Statistics
- NEW YORK, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for September 2021, as well as quarterly volumes, estimated revenue capture, number of listings and index statistics for the quarter ended September 30, 2021 on its investor relations website. A data sheet showing the monthly volumes and quarterly capture rates can be found at: http://ir.nasdaq.com/financials/volume-statistics.
- 10/11/2021
|
Nasdaq leads US stocks lower as yields rise despite weak jobs report
- The US economy added 194,000 jobs in September, widely missing the 500,000 jobs that were expected.
- 10/08/2021
|
Nasdaq wagers on sports betting trend, sees retail brokers joining
- Sports betting will likely occur through exchanges and retail brokerages like Robinhood Markets Inc in the future, the head of North American markets at Nasdaq Inc said on Thursday.
- 10/07/2021
|
Better Buy: Cisco Systems or Every Nasdaq Stock?
- Investors' choices are more complicated than usual right now due to extreme movement from the broad market.
- 10/07/2021
|
Nasdaq: Debt limit breach could yield 'very' negative market response
- Nasdaq Inc Chief Executive Adena Friedman said on Wednesday that an extended delay in raising the U.S. debt limit would cause markets to react "very, very negatively."
- 10/06/2021
|
Biden to meet CEOs of J.P. Morgan, Intel, Nasdaq as White House warns failure to raise debt limit could set U.S. back decades
- President Joe Biden is scheduled to meet with a group of top U.S. business leaders on Wednesday amid a brawl over raising the U.S. debt limit, as the White House is warning that failure to raise the cap could set the country back decades.
- 10/06/2021
|
Pressure Builds on Lordstown Motors, but This Nasdaq Stock Could Be Tuesday's Big Winner
- Wall Street is hoping for a rebound after another drop on Monday.
- 10/05/2021
|
Nasdaq Stock Exchange President on public debuts: ‘There's a very healthy pipeline'
- Nasdaq Stock Exchange President Nelson Griggs joins Yahoo Finance's Alexis Christoforous to discuss the latest surge in public debuts. Don't Miss: Valley of Hype: The Culture That Built Elizabeth Holmes WATCH HERE: https://youtu.be/Sb179GLPNYE Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: https://youtu.be/gx-OzwHpM9k
- 10/04/2021
|
Tesla Sets Delivery Records, but This Nasdaq Stock Was the Big Premarket Winner Monday
- Markets are looking to open on a down note.
- 10/04/2021
|
Better Buy: Apple Stock or Every Nasdaq Stock?
- Investors need to balance risk and growth when choosing between Apple stock and the Nasdaq index.
- 10/03/2021
|
Nasdaq Appoints Toni Townes-Whitley to its Board of Directors
- NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ), today announced the appointment of Toni Townes-Whitley to its Board of Directors. Townes-Whitley is the former President of U.S. Regulated Industries at Microsoft where she led the company's sales strategy, execution, and P&L across a $16 billion portfolio of U.S. Financial Services & Insurance, Healthcare & Life Sciences, Federal, State & Local Government and Education industries.
- 09/30/2021
|
Here's Why Investing in Nasdaq (NDAQ) is a Prudent Move Now
- Nasdaq (NDAQ) is well poised on the back of organic growth in proprietary data products, effective capital deployment, and improved liquidity position.
- 09/29/2021
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date September 15, 2021
- NEW YORK, Sept. 24, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of September 15, 2021, short interest in 2,819 Nasdaq Global MarketSM securities totaled 8,628,581,482 shares compared with 8,628,020,542 shares in 2,803 Global Market issues reported for the prior settlement date of August 31, 2021. The mid-August short interest represents 3.48 days compared with 3.22 days for the prior reporting period.
- 09/24/2021
|
Nasdaq Teetering On The Edge Into Quad Witching
- Photo by Sigmund on Unsplash Equities bounced yesterday after weeks of sideways-to-downward price action, with Nasdaq-100 futures up 0.77% after bulls held the line near the 21-day Exponential Moving Average at about 15,390. However, the tech-focused index failed to close above the lower end of its previous range near 15,520 for the third day in a row, while many commonly followed technical indicators such as the MACD and Parabolic SAR are reflecting more bearish sentiment.
- 09/17/2021
|
Delisting of Securities of Abraxas Petroleum Corporation and Sequential Brands Group, Inc. from The Nasdaq Stock Market
- NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Abraxas Petroleum Corporation. Abraxas Petroleum Corporation's common stock was suspended on August 4, 2021 and has not traded on Nasdaq since that time.
- 09/16/2021
|
Nasdaq to Hold Third Quarter 2021 Investor Conference Call
- NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Third Quarter 2021 financial results announcement.
- 09/15/2021
|
Sporttrade to Leverage Nasdaq Surveillance Technology to Bolster Market Integrity of Sports Betting Platform
- Cloud based solution supports Sporttrade's efforts in building a fair, transparent and safe marketplace with robust surveillance processes Cloud based solution supports Sporttrade's efforts in building a fair, transparent and safe marketplace with robust surveillance processes
- 09/14/2021
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date August 31, 2021
- NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of August 31, 2021, short interest in 2,803 Nasdaq Global MarketSM securities totaled 8,628,020,542 shares compared with 8,606,983,029 shares in 2,794 Global Market issues reported for the prior settlement date of August 13, 2021. The end-of-August short interest represent 3.22 days average daily Nasdaq Global Market share volume for the reporting period, compared with 3.18 days for the prior reporting period.
- 09/10/2021
|
7 Stocks To Buy To Bet on Underappreciated CEOs
- We hear plenty of stories about overpaid CEOs. Here are seven stocks to buy whose CEOs aren't but still manage to deliver for shareholders.
- 09/10/2021
|
Only 1 of These 2 Nasdaq Stock Favorites Is Winning Today
- The other is taking a sizable hit.
- 09/08/2021
|
What To Expect From NASDAQ Stock Over The Next One Month?
- NASDAQ stock returned 2.6% in the last five trading days and currently trades close to $196 per share. The NASDAQ Inc., a global exchange group that provides trading, exchange technology, securities listing, and public company services globally, has seen its stock gain almost 48% YTD.
- 09/08/2021
|
‘Stocks Love Stimulus': Nasdaq Posts New Record High As ‘Worrisome' Jobs Report Boosts Relief Prospects
- Despite the job market posting its worst month since January, tech stocks surged to new highs on Friday.
- 09/03/2021
|
Nasdaq (NDAQ) Reports Mixed Volumes for August, Shares Down
- Nasdaq (NDAQ) August 2021 volume reflects increase in U.S. equity options volume but decrease in European options and futures volume.
- 09/03/2021
|
Abu Dhabi Securities Exchange (ADX) to Launch Derivatives Market, Leveraging Nasdaq Technology
- Nasdaq and ADX sign new market technology agreement
- 09/01/2021
|
Better Buy: Amazon or Every Nasdaq Stock?
- Investors have even more to think about right now than they normally do.
- 08/30/2021
|
Which Biotech Stock Will Shock the Market in 2022?
- Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?
- 08/27/2021
|
5 Stocks to Buy From Top Performing S&P 500 Finance Sector
- The Finance sector will keep witnessing impressive performance on the back of bullish investor sentiments. Let's check out Moody's (MCO), Nasdaq (NDAQ), Raymond James (RJF), MetLife (MET) & T.
- 08/27/2021
|
Nasdaq Halts Evolv Technologies Holdings, Inc. – Unit
- NEW YORK, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in Evolv Technologies Holdings, Inc. - Unit (Nasdaq: EVLVU) at 4:02:41 a.m. Eastern Time for "additional information requested" from the company at a last sale price of $9.83.
- 08/25/2021
|
Here's Why Chinese Tech Stocks Made Big Gains Today
- Even with recent gains, the Invesco China Technology ETF is still down roughly 14.5% in 2021.
- 08/24/2021
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date August 13, 2021
- NEW YORK, Aug. 24, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of August 13, 2021, short interest in 2,794 Nasdaq Global MarketSM securities totaled 8,606,983,029 shares compared with 8,508,823,975 shares in 2,770 Global Market issues reported for the prior settlement date of July 30, 2021. The mid-August short interest represents 3.18 days compared with 3.45 days for the prior reporting period.
- 08/24/2021
|
Diversify Your Portfolio While Beating the Market With This Company
- Nasdaq offers immediate tech diversification and growth optionality at a market capitalization well below its peers in the index and exchange industry.
- 08/24/2021
|
CrowdStrike Holdings, Inc. to Join the NASDAQ-100 Index Beginning August 26, 2021
- NEW YORK, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that CrowdStrike Holdings, Inc. (Nasdaq: CRWD), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) and the NASDAQ-100 Technology Index (Nasdaq: NDXT) prior to market open on Thursday, August 26, 2021. CrowdStrike Holdings, Inc. will replace Maxim Integrated Products, Inc. (Nasdaq: MXIM) in the NASDAQ-100 Index®, the NASDAQ-100 Equal Weighted Index and the NASDAQ-100 Technology Index.
- 08/23/2021
|
Can Microsoft Beat Apple to Become the Most Valuable Nasdaq Stock?
- The gap is narrowing once again.
- 08/20/2021
|
Precarious Market Action
- Precarious Market Action
- 08/20/2021
|
Top 5 High-Flying Low-Beta Stocks to Counter Market Volatility
- It will be prudent to invest in low-beta stocks with a favorable Zacks Rank that have performed impressively in the past three months. These are MMC, NDAQ, CB, PAYX and RSG.
- 08/19/2021
|
Bull Of The Day: Nasdaq (NDAQ)
- The exchange that oversees trading in most tech and bio tech stocks is a stock itself!
- 08/19/2021
|
This Stock Could Be Headed for a Crash
- It's a great company. But something's gotta give.
- 08/13/2021
|
Nasdaq Announces End-Of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 30, 2021
- NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of July 30, 2021, short interest in 2,770 Nasdaq Global MarketSM securities totalled 8,508,823,975 shares compared with 8,537,253,537 shares in 2,732 Global Market issues reported for the prior settlement date of July 15, 2021. The end-of-month July short interest represents 3.45 days compared with 2.95 days for the prior reporting period.
- 08/10/2021
|
4 Securities and Exchanges to Watch Out For Amid Industry Challenges
- Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CBOE, CME, NDAQ and OTCM. However, compliance with regulations remains a challenge.
- 08/10/2021
|
Long-Term Wealth Generation With Nasdaq Inc.
- Long-Term Wealth Generation With Nasdaq Inc.
- 08/10/2021
|
Nasdaq to Present at August 2021 Investor Conferences
- NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in August with webcasts available at Nasdaq's Investor Relations Website: ir.nasdaq.com/events.cfm.
- 08/09/2021
|
Statement from Nasdaq on SEC's Approval of Board Diversity Disclosure Listing Rule
- NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Nasdaq today released a statement following the U.S. Securities and Exchange Commission's (SEC) approval of the company's board diversity disclosure listing rule:
- 08/06/2021
|
Nasdaq Reports Strong Earnings Growth as Indexing Increases
- Growth is decent, but the stock is probably fully valued at these levels
- 08/06/2021
|
Nasdaq Will Implement Blockchain And Become A Disrupter, Says CEO Adena Friedman
- Nasdaq (NASDAQ:NDAQ) CEO Adena Friedman said that the exchange intends to apply blockchain to financial market infrastructure and become a disrupter in the space. What Happened: According to a Tuesday Fortune report, Friedman said that, currently, "[it] is just not in a position to be able to support the level of trading activity that we experience in the equities and options markets.
- 08/03/2021
|
Nasdaq Acquires Minority Stake in LeveL ATS
- NEW YORK and BOSTON, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) and LeveL ATS today announced Nasdaq has acquired a significant minority stake in LeveL ATS, a leading, independently operated US Equity Dark Pool trading venue. Through this investment, Nasdaq joins owners including Bank of America, Citi, and Fidelity. The terms of the transaction were not disclosed.
- 08/02/2021
|
It was an amazing day for Robinhood': Nasdaq Stock Exchange Pres.
- Nelson Griggs, Nasdaq Stock Exchange President, joins Yahoo Finance's Kristin Myers and Alexis Christoforous to discuss Robinhood's IPO, what that means for the IPO process moving forward, and outlook on the second half of the year. Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: https://youtu.be/gx-OzwHpM9k
- 07/29/2021
|
Nasdaq Stock Exchange President on Banner IPO Year and Remaining 2021 Outlook
- Nelson Griggs, Nasdaq Stock Exchange president, joined Cheddar's 'Closing Bell' to talk about the record number of IPOs just halfway through 2021, including the closely watched Robinhood debut. Subscribe to Cheddar Now on YouTube: https://chdr.tv/NowYT Subscribe to Need2Know in your favorite podcast app.
- 07/29/2021
|
Nasdaq, Inc. Prices €615 Million Senior Notes Offering
- NEW YORK, July 27, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (the “Company”) (Nasdaq: NDAQ) today announced that it priced a public offering of €615 million aggregate principal amount of 0.900% senior notes due 2033 (the “Offering”). The Company expects to use the net proceeds from the Offering, together with available cash balances, to refinance its existing 1.75% Senior Notes due 2023. The Offering is expected to close on July 30, 2021, subject to customary closing conditions.
- 07/27/2021
|
Nasdaq, Inc. Announces Proposed Senior Notes Offering
- NEW YORK, July 27, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (the “Company”) (Nasdaq: NDAQ) today announced that it plans to offer, subject to market and other conditions, Euro-denominated senior notes (the “Offering”). The Company expects to use the net proceeds from the Offering, together with available cash balances, to refinance its existing 1.75% Senior Notes due 2023.
- 07/27/2021
|
Earnings Estimates Moving Higher for Nasdaq (NDAQ): Time to Buy?
- Nasdaq (NDAQ) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 07/26/2021
|
A Dive Into Nasdaq's Q2 Earnings: They've Got The Beat!
- The second-quarter earnings report from Nasdaq (NASDAQ:NDQ) brought out an enthusiastic thumbs-up note from Piper Sandler & Co. The Latest Numbers: Nasdaq reported second-quarter net revenues of $846 million, a 21% year-over-year increase, with an annualized recurring revenue of $1.8 billion that was up 22% from the previous year.
- 07/22/2021
|
Nasdaq, Inc. Announces $475 Million Accelerated Stock Repurchase Program
- NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (the “Company”) (Nasdaq: NDAQ) today announced that it has entered into an accelerated stock repurchase agreement (“ASR”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) to repurchase $475 million of the Company's common stock. The ASR was entered into pursuant to the Company's share repurchase program, under which $1.46 billion remained available as of July 21, 2021.
- 07/21/2021
|
Nasdaq CEO on Private-Stock Marketplace, IPO Pipeline
- Jul.21 -- Nasdaq President and CEO Adena Friedman discusses the development of a private-stock marketplace, the IPO pipeline, and bringing retail investment trading volume into the Nasdaq marketplace. She speaks with Alix Steel on "Bloomberg Markets.
- 07/21/2021
|
Nasdaq CEO on how its solutions segment has become majority of business
- CNBC's "Squawk Box" team discusses Nasdaq's earnings report, showing a strong quarter, with Nasdaq CEO Adena Friedman.
- 07/21/2021
|
Nasdaq, Inc. (NDAQ) CEO Adena Friedman on Q2 2021 Results - Earnings Call Transcript
- Nasdaq, Inc. (NDAQ) CEO Adena Friedman on Q2 2021 Results - Earnings Call Transcript
- 07/21/2021
|
Nasdaq (NDAQ) Surpasses Q2 Earnings & Revenue Estimates
- Nasdaq's (NDAQ) second-quarter results reflect organic growth, favorable changes in foreign exchange rates, margin expansion and solid segmental performance.
- 07/21/2021
|
Nasdaq (NDAQ) Tops Q2 Earnings and Revenue Estimates
- Nasdaq (NDAQ) delivered earnings and revenue surprises of 9.83% and 2.70%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/21/2021
|
Recap: Nasdaq Q2 Earnings
- Shares of Nasdaq (NASDAQ:NDAQ) rose 1.2% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 23.38% year over year to $1.90, which beat the estimate of $1.70.
- 07/21/2021
|
Nasdaq Announces Quarterly Dividend of $0.54 Per Share
- NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.54 per share on the company's outstanding common stock. The dividend is payable on September 24, 2021 to shareholders of record at the close of business on September 10, 2021. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors.
- 07/21/2021
|
Nasdaq launches dealing platform for private companies
- Nasdaq Inc (NASDAQ:NDAQ) is to launch a dealing platform for privately-owned companies in a collaboration with a host of heavyweight Wall Street banks. Goldman Sachs, Citigroup, Silicon Valley's SVB and Morgan Stanley have put their names to the expansion of Nasdaq Private Market, which will become a standalone, independent company.
- 07/20/2021
|
NASDAQ Stock Is Poised For Mixed Results In Q2
- NASDAQ is scheduled to report its fiscal Q2 2021 results on Wednesday, July 21. We expect NASDAQ to top the consensus estimates of earnings and revenues.
- 07/20/2021
|
Nasdaq, SVB, Citi, Goldman Sachs, and Morgan Stanley Launch New Platform for Trading Private Company Stock
- Nasdaq Private Market to be spun out from Nasdaq and contributed to the joint venture Nasdaq Private Market to be spun out from Nasdaq and contributed to the joint venture
- 07/20/2021
|
Honeywell International Inc. to Join the NASDAQ-100 Index Beginning July 21, 2021
- NEW YORK, July 14, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Honeywell International Inc. (Nasdaq: HON), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) and the NASDAQ-100 Ex-Technology Index (Nasdaq: NDXX) prior to market open on Wednesday, July 21, 2021. Honeywell International Inc. will replace Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) in the NASDAQ-100 Index®, the NASDAQ-100 Equal Weighted Index and the NASDAQ-100 Ex-Technology Index.
- 07/14/2021
|
Reasons Why Nasdaq (NDAQ) Stock is an Attractive Bet Now
- Nasdaq (NDAQ) is well poised on the back of growth in Index business, organic growth, effective capital deployment and improved liquidity position.
- 07/14/2021
|
Nasdaq June 2021 Volumes And 2Q21 Statistics
- NEW YORK, July 12, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for June 2021, as well as quarterly volumes, estimated revenue capture, number of listings and index statistics for the quarter ended June 30, 2021 on its investor relations website. A data sheet showing the monthly volumes and quarterly capture rates can be found at: http://ir.nasdaq.com/financials/volume-statistics.
- 07/12/2021
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 12, 2021
- NEW YORK, July 12, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of June 30, 2021, short interest in 2,706 Nasdaq Global MarketSM securities totalled 8,643,173,593 shares compared with 8,647,515,959 shares in 2,679 Global Market issues reported for the prior settlement date of June 15, 2021. The end-of-June short interest represents 2.85 days compared with 3.24 days for the prior reporting period.
- 07/12/2021
|
Nasdaq Launches ESG Data Hub to Offer Investors Expert-led Sustainability Data
- Equileap, Ecogain and Munich Re among partners providing data from launch Equileap, Ecogain and Munich Re among partners providing data from launch
- 06/29/2021
|
Nasdaq Announces the Board of Directors of Its U.S. Exchanges
- NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today announced the election of all nominated directors to the boards of the U.S. exchanges operated by the company, which include The Nasdaq Stock Market LLC, Nasdaq PHLX LLC, Nasdaq BX, Inc., Nasdaq ISE, LLC, Nasdaq MRX, LLC, and Nasdaq GEMX, LLC:
- 06/28/2021
|
Nasdaq Welcomed 395 IPOs and 14 Exchange Transfers in the First Half of 2021
- 7 of the 10 largest IPOs by proceeds raised listed on Nasdaq
- 06/28/2021
|
Nasdaq's Adena Friedman Wins Big With IPOs
- The CEO of the exchange operator nurtures young companies and is working to fight financial crime.
- 06/25/2021
|
18th Consecutive Nasdaq Closing Cross Sets Record for Number of Shares Traded During 2021 Russell US Indexes Reconstitution
- NEW YORK, June 25, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Symbol: NDAQ) today announced the Nasdaq Closing Cross had a record day as it was used for the 18th consecutive year to rebalance Nasdaq-listed securities in the entire family of Russell U.S. Indexes, part of leading global index provider FTSE Russell, during their annual reconstitution.
- 06/25/2021
|
Nasdaq Completes Sale of U.S. Fixed Income Business to Tradeweb Markets
- NEW YORK, June 25, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today that it completed the sale of its U.S. fixed income business, Nasdaq Fixed Income (NFI), to Tradeweb Markets Inc. (Nasdaq: TW), a leading global operator of electronic marketplaces for rates, credit, equities and money markets.
- 06/25/2021
|
Nasdaq (NDAQ) to Boost Market Technology With Digital Asset
- Nasdaq (NDAQ) partners with Digital Asset to integrate Daml into its Marketplace Services Platform.
- 06/25/2021
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date June 15, 2021
- NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of June 15, 2021, short interest in 2,679 Nasdaq Global MarketSM securities totaled 8,647,515,959 shares compared with 8,683,450,119 shares in 2,654 Global Market issues reported for the prior settlement date of May 28, 2021. The mid-June short interest represents 3.24 days compared with 3.19 days for the prior reporting period.
- 06/24/2021
|
Nasdaq Announces Expected Closing Date for Sale of U.S. Fixed Income Business to Tradeweb Markets
- NEW YORK, June 22, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) announced today that all required regulatory and self-regulatory approvals have been obtained for the previously announced sale of its U.S. fixed income business, Nasdaq Fixed Income (NFI), to Tradeweb Markets Inc. (Nasdaq: TW), a leading global operator of electronic marketplaces for rates, credit, equities and money markets.
- 06/22/2021
|
Nasdaq to Hold Second Quarter 2021 Investor Conference Call
- NEW YORK, June 18, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its Second Quarter 2021 financial results announcement.
- 06/18/2021
|
Nasdaq Announces Results from 2021 Annual Meeting of Shareholders
- Ten Directors Re-elected
- 06/16/2021
|
Nasdaq, Smartsheet, Twilio, Vaxart, Zoom Video and More Friday Afternoon Analyst Calls
- With the trading day about halfway over, the markets were sliding lower to close out the week.
- 06/11/2021
|
US Giant Victory Capital Launches Crypto Funds In Nasdaq Partnership
- Victory Capital Management — a United States investment giant with $157.1 billion in assets under management as of the end of April — announced multiple new cryptocurrency index funds for accredited investors. What Happened: According to a Wednesday announcement, the new fund is the result of a collaboration with Nasdaq (NASDAQ:NDAQ) and crypto-focused asset manager Hashdex.
- 06/10/2021
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 28, 2021
- NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of May 28, 2021, short interest in 2,654 Nasdaq Global Market℠ securities totaled 8,683,450,119 shares compared with 8,678,246,449 shares in 2,645 Global Market issues reported for the prior settlement date of May 14, 2021. The end-of-May short interest represent 3.19 days average daily Nasdaq Global Market share volume for the reporting period, compared with 3.11 days for the prior reporting period.
- 06/09/2021
|
Why Gores Holdings VI Stock Climbed 11.3% Last Month
- The SPAC's merger with Matterport will likely close in the near future, and the augmented reality industry is heating up.
- 06/06/2021
|
7 Upcoming Dividend Increases Including Nasdaq
- 7 Upcoming Dividend Increases Including Nasdaq
- 06/03/2021
|
5 Stocks Trading Near 52-Week High That Can Climb Further
- Investors target stocks that have been on a bullish run lately. Stocks like TGT, BPOP, NDAQ ARW and IVZ that are seeing price strength have a high chance of carrying the momentum forward.
- 06/03/2021
|
Nasdaq (NDAQ) Reports Mixed Volumes for May, Stock Rises
- Nasdaq (NDAQ) reports 36.5% year over year rise in U.S. equity options volume for May while European options and futures volume drops 1.9% year over year.
- 06/03/2021
|
Nasdaq May 2021 Volumes
- NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for May 2021 on its investor relations website. A data sheet showing the monthly volumes and quarterly capture rates can be found at: http://ir.nasdaq.com/financials/volume-statistics.
- 06/02/2021
|
Why Should You Add Nasdaq (NDAQ) Stock to Your Portfolio?
- Nasdaq's (NDAQ) significant and leading positions in large, high growth markets like Index, Analytics, Market Technology, and IR & ESG Services bode well for growth.
- 06/02/2021
|
Nasdaq Acquires Emerging Carbon Removal Market Puro.earth
- Expansion of ESG strategy into new marketplace supports sustainability efforts of Nasdaq´s corporate clients Expansion of ESG strategy into new marketplace supports sustainability efforts of Nasdaq´s corporate clients
- 06/01/2021
|
Worried About the Tech Sell-Off? Consider These Safe Stocks
- These companies exhibit qualities like diverse revenue streams and growing backlogs, making them hard to keep down.
- 05/31/2021
|
Better Buy: Coinbase Stock or Every Nasdaq Stock?
- A pure-play crypto stock or the entire tech index? Read more to find out.
- 05/31/2021
|
Nasdaq Executives to Present at June 2021 Investor Conferences
- NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in June with webcasts available at Nasdaq's Investor Relations Website: ir.nasdaq.com/events.cfm.
- 05/25/2021
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 14, 2021
- NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of May 15, 2021, short interest in 2,645 Nasdaq Global Market℠ securities totaled 8,678,246,449 shares compared with 8,459,989,651 shares in 2,637 Global Market issues reported for the prior settlement date of April 30, 2021. The mid-May short interest represents 3.11 days compared with 3.21 days for the prior reporting period.
- 05/25/2021
|
Nasdaq: Moving To Neutral As Tech Stock Boom Has Played Out
- I've been bullish on Nasdaq previously as a safe way to get exposure to the tech stock boom. This occurred as expected, and the Nasdaq has performed admirably over the past 18 months.
- 05/23/2021
|
It's Not Payments For Order Flow, It's RegNMS
- Each link in the chain of cost centers from the order to the trade – customer, broker, wholesaler, exchange – is under the microscope after the GameStop fiasco. The wholesalers – Citadel, Virtu, and others – seem to be bearing the brunt of the blame.
- 05/16/2021
|
Nasdaq Announces 2021 Annual Meeting of Shareholders
- NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) has scheduled its 2021 Annual Meeting of Shareholders for June 15, 2021 at 9:00 AM ET. Shareholders of record will be able to vote and ask questions online during the meeting. The virtual meeting website will be accessible 15 minutes prior to the meeting start by visiting: www.virtualshareholdermeeting.com/NDAQ2021.
- 05/14/2021
|
The Exorbitant NMS Speed Game
- The National Market System (NMS), with more than 12 separately-located exchange transaction engines processing identical transactions, is expensive for no good reason. And there is a quick fix – colocated exchanges.
- 05/04/2021
|
Nasdaq April 2021 Volumes
- NEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for April 2021 on its investor relations website. A data sheet showing the monthly volumes and quarterly capture rates can be found at: http://ir.nasdaq.com/financials/volume-statistics.
- 05/04/2021
|
Dividend Increases: April 17-23, 2021
- This article series provides a weekly summary of dividend changes.
- 04/28/2021
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 15, 2021
- NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 15, 2021, short interest in 2,622 Nasdaq Global MarketSM securities totaled 8,587,890,404 shares compared with 8,451,076,714 shares in 2,626 Global Market issues reported for the prior settlement date of March 31, 2021. The mid-March short interest represents 2.86 days compared with 2.54 days for the prior reporting period.
- 04/26/2021
|
Delisting of Securities of Interpace Biosciences, Inc., Francesca's Holdings Corporation, and Wins Finance Holdings Inc. from The Nasdaq Stock Market
- NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Interpace Biosciences, Inc. Interpace Biosciences, Inc.'s common stock was suspended on February 25, 2021 and has not traded on Nasdaq since that time.
- 04/23/2021
|
A Better Alternative To The SEC's National Market System
- The SEC's National Market System (NMS) has come under fire during the GameStop Frenzy. This article compares a magnet market system to the NMS.
- 04/22/2021
|
Nasdaq CEO: Retail trading likely to be key focus for Biden's SEC chief
- Nasdaq CEO Adena Friedman says the Biden administration's top financial watchdog is likely to make retail trading a top priority.
- 04/21/2021
|
Alt-Milk Maker Oatly Files for IPO
- A new plant-based comestibles stock will soon hit the market.
- 04/21/2021
|
Nasdaq's (NDAQ) CEO Adena Friedman on Q1 2021 Results - Earnings Call Transcript
- Nasdaq's (NDAQ) CEO Adena Friedman on Q1 2021 Results - Earnings Call Transcript
- 04/21/2021
|
Nasdaq tops quarterly profit views on trading surge
- Nasdaq Inc reported a better-than-expected first-quarter profit on Wednesday, boosted by strength in its trading business against a backdrop of high market volatility and a surge in initial public offerings.
- 04/21/2021
|
Nasdaq (NDAQ) Beats on Q1 Earnings & Revenues, Ups Dividend
- Nasdaq's (NDAQ) Q1 results reflect organic growth, favorable changes in foreign exchange rates, margin expansion and solid segmental performance.
- 04/21/2021
|
Nasdaq (NDAQ) Surpasses Q1 Earnings and Revenue Estimates
- Nasdaq (NDAQ) delivered earnings and revenue surprises of 12.64% and 2.75%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 04/21/2021
|
Nasdaq Announces 10% Increase in Quarterly Dividend to $0.54 per Share
- NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.54 per share on the company's outstanding common stock. The dividend is payable on June 25, 2021 to shareholders of record at the close of business on June 11, 2021. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors.
- 04/21/2021
|
Nasdaq Reports First Quarter 2021 Results; Delivers 21% Increase in Revenue Compared to Prior Year
- NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the first quarter of 2021.
- 04/21/2021
|
7 Dividend Stocks That Should Increase Payouts
- With speculative stocks getting hit, now is time for dividend stocks. These seven offer solid yields and compelling income growth upside.
- 04/20/2021
|
NASDAQ Stock To Beat Revenue Estimates In Q1, Driven By Higher Trading Volumes?
- NASDAQ is scheduled to report its fiscal Q1 2021 results on Wednesday, April 21. We expect NASDAQ to edge ahead of the consensus estimates for revenues, while the earnings are likely to miss the expectations.
- 04/19/2021
|
Nasdaq's (NDAQ) to Report Q1 Earnings: What in the Cards?
- Nasdaq's (NDAQ) first-quarter results are likely to reflect benefits from its diversified product offerings and business model.
- 04/16/2021
|
Nasdaq (NDAQ) Earnings Expected to Grow: Should You Buy?
- Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/14/2021
|
From Harvard to Nasdaq listing: Grab CEO's ride to world's biggest SPAC deal
- The CEO of Grab, a popular app to book taxis, order food and make payments in Southeast Asia, has always been determined to win -- from making his firm the best-funded regional start-up to defeating behemoth Uber Technologies.
- 04/14/2021
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 31, 2021
- NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of March 31, 2021, short interest in 2,626 Nasdaq Global MarketSM securities totaled 8,451,076,714 shares compared with 8,163,912,977 shares in 2,610 Global Market issues reported for the prior settlement date of March 15, 2021. The end-of-March short interest represent 2.54 days average daily Nasdaq Global Market share volume for the reporting period, compared with 2.24 days for the prior reporting period.
- 04/12/2021
|
Nasdaq (NDAQ) Reports Mixed Q1 and March Volumes, Shares Up
- Nasdaq (NDAQ) reported mixed volumes for the first quarter and March 2021.
- 04/09/2021
|
Nasdaq March 2021 Volumes and 1Q21 Statistics
- NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for March 2021, as well as quarterly volumes, estimated revenue capture, number of listings and index statistics for the quarter ended March 31, 2021 on its investor relations website. A data sheet showing the monthly volumes and quarterly capture rates can be found at: http://ir.nasdaq.com/financials/volume-statistics.
- 04/08/2021
|
AST SpaceMobile Debuts on Nasdaq, CEO Says 'We Don't See Others Like Starlink As A Competitor'
- AST SpaceMobile (NASDAQ: ASTS) made its Nasdaq debut on Wednesday. The company went public via special purpose aquisition company (SPAC) New Providence Acquisition Corp (NASDAQ: NPA) with an estimated post-transaction enterprise value of $1.4 billion.
- 04/07/2021
|
6 Securities and Exchanges Set to Benefit From Trading Volatility
- 6 Securities and Exchanges Set to Benefit From Trading Volatility
- 04/06/2021
|
Why Gores Holdings VI Stock Dropped 22.9% in March
- The SPAC stock is up big since its market debut, but it's hardly immune to market volatility.
- 04/05/2021
|
This Soaring Nasdaq Stock Is Proof That the Market Is Broken
- The lesson is to beware of low-volume stocks.
- 03/31/2021
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 15, 2021
- NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of March 15, 2021, short interest in 2,610 Nasdaq Global MarketSM securities totaled 8,163,912,977 shares compared with 7,742,433,178 shares in 2,614 Global Market issues reported for the prior settlement date of February 26, 2021. The mid-March short interest represents 2.24 days compared with 2.31 days for the prior reporting period.
- 03/24/2021
|
Nasdaq Up in Pre-Market, +100% from Year-Ago Lows
- The tech-heavy index has grown a solid 100% over the past year, but is still around 5% off its all-time highs set about six weeks ago.
- 03/23/2021
|
Here's Why You Should Hold Nasdaq (NDAQ) in Your Portfolio
- Nasdaq's (NDAQ) focus on Market Technology and Information Services businesses, improving operating leverage and solid capital position make its worthy of retention in one???s portfolio.
- 03/23/2021
|
$1.6 Trillion Gone: Nasdaq Stock Implosion Gets Ugly
- Stocks in the Nasdaq 100, including technology giant Apple, consumer discretionary Tesla and Amazon, dropped roughly $1.6 trillion in value since the index's closing high this year on Feb.12. Worries about heating-up inflation are stoking a rally in 10-year Treasury yields.
- 03/22/2021
|
Coinbase Is Going Public. Here Are 3 Things You Should Know.
- Coinbase is well-positioned to ride on the growth of the crypto economy.
- 03/20/2021
|
Nasdaq (NDAQ) Ties Up With PureStream, Offers Execution Platform
- Nasdaq (NDAQ) partners with PureStream to boost its Market Technology segment.
- 03/17/2021
|
Why the Nasdaq Stock Market Is a Focal Point Now
- All eyes are on Nasdaq.
- 03/15/2021
|
Nasdaq Foundation Grant Program to Engage More Communities in Markets and Entrepreneurship
- Pledges Initial Financial Support to Herndon Directors Institute and Operation HOPE
- 03/10/2021
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 26, 2021
- NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 26, 2021, short interest in 2,614 Nasdaq Global MarketSM securities totaled 7,742,433,178 shares compared with 7,694,966,704 shares in 2,611 Global Market issues reported for the prior settlement date of February 12, 2021. The end-of-February short interest represent 2.31 days average daily Nasdaq Global Market share volume for the reporting period, compared with 2.15 days for the prior reporting period.
- 03/09/2021
|
Nasdaq (NDAQ) Reports Mixed February Volumes, Shares Gain
- Nasdaq (NDAQ) reported mixed volumes for February 2021. While U.S. equity options volume increased 53.5% year over year to 284 million contracts, European options and futures volume dropped 24.9% year over year to 6.9 million contracts
- 03/04/2021
|
Nasdaq February 2021 Volumes
- NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for February 2021 on its investor relations website. A data sheet showing the monthly volumes and quarterly capture rates can be found at: http://ir.nasdaq.com/financials/volume-statistics.
- 03/03/2021
|
Cardiol Therapeutics files application to list on the Nasdaq stock exchange
- Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) (FSE:CT9) announced Tuesday that it has submitted an application to uplist its shares to the tech-laden Nasdaq stock exchange in the US. In a statement, CEO David Elsley told investors that the firm sees it an “opportune time” for Cardiol to formally apply for an uplisting.
- 03/02/2021
|
One Hard-to-Believe Trading Fact
- Trading used to be way more expensive.
- 02/28/2021
|
3 Top Growth Stocks to Buy in a Market Crash
- Find out why you should be ready to pounce on these stocks.
- 02/27/2021
|
Nasdaq's rally comes in the face of bearish market breadth
- The Nasdaq Composite surged 1.0% in afternoon trading, but market internals are actually telling a rather bearish story. The number of Nasdaq-listed stocks declining topped advancers 2,259 to 1,632, and the volume of stocks losing ground is making up 54.5% of total volume.
- 02/26/2021
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 12, 2021
- NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 12, 2021, short interest in 2,611 Nasdaq Global MarketSM securities totaled 7,694,966,704 shares compared with 7,789,857,528 shares in 2,595 Global Market issues reported for the prior settlement date of January 29, 2021. The mid-February short interest represents 2.15 days compared with 2.47 days for the prior reporting period.
- 02/24/2021
|
Nasdaq: A Proven Leader Living Up To Its Name
- Nasdaq reported revenues with a constant increase over seven years, with 2020 figures having a growth rate of 15% versus the previous year.
- 02/22/2021
|
PyroGenesis Canada moves closer to joining the Nasdaq Stock Exchange
- PyroGenesis Canada Inc (TSE:PYR) (OTCQB:PYRNF) (FRA:8PY) said Thursday that its listing application with the Nasdaq Stock Exchange is advancing. The company said the US Securities and Exchange Commission (SEC) has recently approved its shares for listing in the US.
- 02/18/2021
|
NASDAQ Stock Has Surpassed Its Near Term Potential
- NDAQ, a global financial exchange group, has seen its stock increase from $73 to $142 off the recent March bottom – in comparison the S&P 500 index has increased by almost 75%.
- 02/16/2021
|
Nasdaq Completes Acquisition of Verafin
- NEW YORK and ST. JOHN'S, Newfoundland and Labrador, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ), a global technology company, announced today the completion of its acquisition of Verafin, an industry pioneer in anti-financial crime management solutions. The agreement to acquire Verafin was announced on November 19, 2020.
- 02/11/2021
|
Digital Museum Exhibit To Highlight Nasdaq's 50th Anniversary
- Nasdaq Inc (NASDAQ: NDAQ) is celebrating the 50th anniversary of its launch with a new digital exhibit created in partnership with New York's Museum of American Finance. What Happened: The exhibit will highlight the stories and artifacts from the company, which debuted on this date in 1971 as the first fully electronic quotation system — the company's acronym stands for National Association of Securities Dealers Automated Quotation.
- 02/08/2021
|
Delisting of Securities of Tandy Leather Factory, Inc. and Technical Communications Corporation from The Nasdaq Stock Market
- NEW YORK, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Tandy Leather Factory, Inc. Tandy Leather Factory, Inc.'s common stock was suspended on August 13, 2020 and has not traded on Nasdaq since that time.
- 02/08/2021
|
Nasdaq Receives Investment Canada Act Approval and Announces Expected Closing Date for its Acquisition of Verafin
- NEW YORK, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ), a global technology company, announced today that the Minister of Industry has approved the previously announced proposed acquisition of Verafin, an industry pioneer in anti-financial crime management solutions, in accordance with the terms of the Investment Canada Act. The approval was the last regulatory approval required for the proposed acquisition.
- 02/08/2021
|
Nasdaq Celebrates 50 Years of Innovation
- Digital exhibit with the Museum of American Finance and Heritage Werks Digital exhibit with the Museum of American Finance and Heritage Werks
- 02/08/2021
|
Nasdaq CEO Adena Friedman to Present at Goldman Sachs Technology and Internet Conference 2021
- NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) -- About Nasdaq
- 02/04/2021
|
Nasdaq Reports Strong Earnings From Heavy Trading Volumes. Is This Sustainable?
- Increased volume is driving earnings.
- 02/04/2021
|
Nasdaq's European Debt Market Showed Continued Growth in 2020
- STOCKHOLM, Sweden, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) saw its European Debt Market grow by 8 percent in 2020. Continued interest to list Euro Medium Term Note (EMTN) programs and strong demand for ESG investment opportunities have fueled the expansion. Issuers have also tapped the debt capital markets to raise funds to support Covid-19 pandemic mitigation efforts.
- 02/04/2021
|
Nasdaq January 2021 Volumes
- NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for January 2021, on its investor relations website.
- 02/02/2021
|
Nasdaq Agrees to Sell U.S. Fixed Income Business to Tradeweb Markets
- NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) announced today that it has entered into a definitive agreement to sell its U.S. fixed income business, Nasdaq Fixed Income (NFI), to an affiliate of Tradeweb Markets Inc. (Nasdaq: TW), a leading global operator of electronic marketplaces for rates, credit, equities and money markets.
- 02/02/2021
|
Delisting of Securities of Superconductor Technologies Inc.; Gulfport Energy Corporation; Apex Global Brands Inc.; Pareteum Corporation; and Youngevity International, Inc. from The Nasdaq Stock Market
- NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, of Superconductor Technologies Inc. Superconductor Technologies Inc.'s common stock was suspended on September 30, 2020 and has not traded on Nasdaq since that time.
- 02/01/2021
|
Nasdaq Named to 2021 Bloomberg Gender-Equality Index
- NEW YORK, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. today announced its inclusion in the 2021 Bloomberg Gender-Equality Index (GEI) for the first time. The GEI brings transparency to gender-related practices and policies at publicly listed companies increasing the breadth of environmental, social, governance (ESG) data available to investors.
- 01/29/2021
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 15, 2021
- NEW YORK, Jan. 27, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of January 15, 2021, short interest in 2,580 Nasdaq Global MarketSM securities totaled 8,357,995,856 shares compared with 8,444,669,455 shares in 2,570 Global Market issues reported for the prior settlement date of December 31, 2020. The mid-January short interest represents 3.18 days compared with 2.58 days for the prior reporting period.
- 01/27/2021
|
Nasdaq, Inc. (NDAQ) CEO Adena Friedman on Q4 2020 Results - Earnings Call Transcript
- Nasdaq, Inc. (NDAQ) CEO Adena Friedman on Q4 2020 Results - Earnings Call Transcript
- 01/27/2021
|
Investing activity around stocks like GameStop seems 'untenable', says former Nasdaq CEO
- Bob Greifeld, former Nasdaq chairman and CEO, joins "Squawk Alley" to discuss the short squeeze on stocks like GameStop and AMC.
- 01/27/2021
|
Nasdaq's (NDAQ) Q4 Earnings and Revenues Surpass Estimates
- Nasdaq's (NDAQ) Q4 results reflect growth in Market Services, Corporate Services, Investment Intelligence and Market Technology segments.
- 01/27/2021
|
Nasdaq CEO Adena Friedman on monitoring stock trading fueled by social media
- Retail investors are on the rise recently as market participants are seeing an increase in popularity in trading apps like Robinhood and the impact it is having on the market. Nasdaq CEO Adena Friedman joined "Squawk Box" on Wednesday to discuss.
- 01/27/2021
|
Nasdaq earnings boosted by option trading
- Nasdaq Inc. said its performance in the fourth quarter was helped along by rising demand among investors for option trading. The stock-exchange operator on Wednesday reported a profit of $224 million, or $1.34 a share, up from $202 million, or $1.21 a share, for the year-earlier period.
- 01/27/2021
|
Recap: Nasdaq Q4 Earnings
- Shares of Nasdaq (NASDAQ:NDAQ) rose 0.6% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 24.03% year over year to $1.60, which beat the estimate of $1.45.
- 01/27/2021
|
Nasdaq Reports Fourth Quarter and Full Year 2020 Results; Delivers Strong Growth in Revenue and EPS
- NEW YORK, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the fourth quarter of 2020 and full year 2020.
- 01/27/2021
|
Nasdaq's (NDAQ) Q4 Earnings Coming Up: What's in Store?
- Nasdaq's (NDAQ) fourth-quarter performance is likely to have benefited from its diversified product offerings and business model.
- 01/22/2021
|
Nasdaq Appoints Jeremy Skule Chief Strategy Officer
- NEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Today, Nasdaq (NDAQ) announced Jeremy Skule has been appointed to the position of Executive Vice President and Chief Strategy Officer. Expanding his scope in this new role, Skule will lead the Global Strategy Organization to drive strategic planning, mergers and acquisitions, divestitures, venture investing, NasdaqNext innovation, and will be responsible for the company's positioning as an innovative data, technology and analytics leader. In addition, he will also continue to oversee Nasdaq's Marketing and Communications division, now part of Global Strategy.
- 01/22/2021
|
Nasdaq (NDAQ) Introduces Enhanced Cloud-Based Risk Platform
- Nasdaq (NDAQ) unveils Nasdaq Risk Platform to boost the performance of its Market Technology segment.
- 01/15/2021
|
Nasdaq Resumes Trading in Generations Bancorp NY, Inc.
- NEW YORK, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading resumed today in Generations Bancorp NY, Inc. (Nasdaq: GBNY) at 8:15 a.m. Eastern Time on January 15, 2021. Trading in the company's stock was halted on January 14, 2021 at 17:10:16 Eastern Time.
- 01/15/2021
|
Nasdaq Halts Generations Bancorp NY, Inc.
- NEW YORK, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in Generations Bancorp NY, Inc. (Nasdaq: GBNY) at 17:10:16 Eastern Time on January 14, 2021, for "additional information requested" from the company at a last sale price of $10.01.
- 01/14/2021
|
Nasdaq (NDAQ) Q4 & December Volumes Mixed, Expense View Updated
- Nasdaq (NDAQ) reported mixed volumes for fourth-quarter and full year 2020.
- 01/14/2021
|
Nasdaq Issues Statement on Political Action Committee Donations
- NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The Board of Nasdaq's Political Action Committee announces changes to its PAC program following the violent attack at the U.S. Capitol on January 6. The PAC will pause political donations for the next several months as the 117th Congress begins its work for the American people. The PAC Board will also halt for the foreseeable future any contributions to elected officials who voted to object to the Electoral College certification.
- 01/13/2021
|
Nasdaq Launches New Risk Platform for the Sell-Side and Broker Clearing Industries
- Cloud-based risk platform built to support real-time, cross-asset risk management and exchange margin funding calculations
- 01/13/2021
|
Nasdaq Welcomed 79 Listings to its European Markets in 2020
- Increased from 63 European listings in 2019 to 79 listings in 2020; 14 switches from other markets
- 01/13/2021
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 31, 2020
- NEW YORK, Jan. 12, 2021 (GLOBE NEWSWIRE) -- At the end of the settlement date of December 31, 2020, short interest in 2,570 Nasdaq Global MarketSM securities totaled 8,444,669,455 shares compared with 8,245,773,085 shares in 2,569 Global Market issues reported for the prior settlement date of December 15, 2020. The end-of-December short interest represent 2.58 days average daily Nasdaq Global Market share volume for the reporting period, compared with 2.21 days for the prior reporting period.
- 01/12/2021
|
These Unlikely 2020 Nasdaq Stock Winners Are Soaring Again in 2021
- Have these stocks found lasting momentum?
- 01/12/2021
|
Better Buy: Nasdaq vs. Intercontinental Exchange
- Both have stock trading, but one has exposure to a hot sector.
- 01/07/2021
|
Nasdaq Led all Exchanges in 2020 Equity Options Trading
- Nasdaq-listed companies fuel investor demand for options trading Nasdaq-listed companies fuel investor demand for options trading
- 01/06/2021
|
3 Marijuana Stocks That Could Skyrocket in Just 2 Days
- The countdown is on.
- 01/04/2021
|
Former Nasdaq CEO on what tech valuations may look like in 2021
- CNBC's “Squawk Alley” team breaks down what's ahead for tech valuations in 2021 and market performance with Robert Greifeld, former Nasdaq CEO and chairman.
- 12/31/2020
|
Nasdaq Advances Corporate Sustainability Leadership in 2020
- Launched ‘Purpose Initiative' to Champion Inclusive Growth and Prosperity
- 12/30/2020
|
It's Crazy, but This Nasdaq Stock Really Is at All-Time Highs
- Even a beaten-down sector won't hold this company back.
- 12/29/2020
|
Nasdaq (NDAQ) Gains 20% YTD: Will the Rally Continue?
- Focus on Market Technology and Information Services businesses, improving operating leverage and solid capital position continue to drive Nasdaq (NDAQ).
- 12/29/2020
|
Is Now Your Chance to Buy the Nasdaq's 3 Worst Performing Stocks of 2020?
- Huge sell-offs sometimes point to opportunity, but investors have to be careful.
- 12/29/2020
|
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 15, 2020
- NEW YORK, Dec. 24, 2020 (GLOBE NEWSWIRE) -- At the end of the settlement date of December 15, 2020, short interest in 2,569 Nasdaq Global MarketSM securities totaled 8,245,773,085 shares compared with 8,129,866,207 shares in 2,550 Global Market issues reported for the prior settlement date of November 30, 2020. The mid-December short interest represents 2.21 days compared with 2.58 days for the prior reporting period.
- 12/24/2020
|
Is Nasdaq (NDAQ) Outperforming Other Finance Stocks This Year?
- Is (NDAQ) Outperforming Other Finance Stocks This Year?
- 12/24/2020
|
Nasdaq Welcomed 300 IPOs and 21 Exchange Transfers in 2020
- Leading U.S. exchange by number of IPOs and proceeds raised for the second consecutive year
- 12/17/2020
|
Nasdaq's Annual Global Compliance Survey 2020: Accelerating Surveillance Technology Demand From Financial Firms During COVID-19
- NEW YORK, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Today Nasdaq (Nasdaq: NDAQ) launched its 6th annual Global Compliance Survey produced in collaboration with Greenwich Associates. The survey gathers qualitative and quantitative feedback from more than 200 compliance professionals and executives in the financial industry worldwide, representing sell- and buy-side firms and market infrastructure organizations. Unique to the latest edition of the Global Compliance Survey, respondents cite external global factors as the primary driver of compliance process changes, surpassing regulatory scrutiny as the top driver of compliance process changes, a shift believed to be prompted by the current COVID-19-pandemic.
- 12/16/2020
|
The Top 3 Nasdaq Stocks to Buy in December
- Many analysts concur Nasdaq-listed robust stocks have the best prospects for outperformance. Here are three of the top Nasdaq stocks to own.
- 12/15/2020
|
Nasdaq-100's Annual Reconstitution: Expedia and Citrix Out, Peloton and Marvell Technology In
- Nasdaq Inc (NASDAQ: NDAQ) has announced the annual reconstitution of its Nasdaq-100 Index. The changes will come into effect on Dec. 21, prior to the market's open.
- 12/12/2020
|
Annual Changes to the Nasdaq-100 Index
- NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX), which will become effective prior to market open on Monday, December 21, 2020.
- 12/11/2020
|
Airbnb CEO Brian Chesky stunned into ‘humility' upon learning of the stock's wild Nasdaq debut
- Airbnb's debut today appeared to exceed all expectations—even those of its CEO, Brian Chesky. Today, the world watched as Airbnb Inc. made its grand debut on the Nasdaq during a time when travel, which is the beating heart of the company's business, stood at a global standstill.
- 12/10/2020
|
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 30, 2020
- NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- At the end of the settlement date of November 30, 2020, short interest in 2,550 Nasdaq Global MarketSM securities totaled 8,129,866,207 shares compared with 8,236,111,320 shares in 2,541 Global Market issues reported for the prior settlement date of November 13, 2020. The end-of-October short interest represent 2.85 days average daily Nasdaq Global Market share volume for the reporting period, compared with 3.03 days for the prior reporting period.
- 12/09/2020
|
Barclays Launches BARX Book for Equities, a New Single-Dealer Platform Developed in Partnership With Nasdaq
- NEW YORK--(BUSINESS WIRE)--Barclays today announced the launch of BARX Book for Equities, a new single-dealer platform developed in partnership with Nasdaq (Nasdaq: NDAQ). Hosted by Nasdaq on its leading market technology infrastructure, BARX Book for Equities provides institutional clients access to the bank's unique, principal liquidity for U.S.-listed single names and exchange-traded funds, and is Barclays' most recent innovation for equities within BARX, the firm's multi-asset electronic tr
- 12/08/2020
|
NASDAQ Stock Has Limited Growth Potential
- Having gained 72% since the March bottom, at the current price near $125 per share, we believe NASDAQ's stock has limited upside. NDAQ stock has increased from $73 to $125 off the recent bottom compared to the S&P 500 which increased by almost 65%.
- 12/08/2020
|
Nasdaq borrows $1.9 billion to buy financial crime-fighting platform Verafin
- Nasdaq Inc., the popular stock-index and data company, raised $1.9 billion on Monday in the bond market to help fund its purchase of anti-money-laundering and fraud-detection platform Verafin.
- 12/07/2020
|
Nasdaq, Inc. Prices $1.9 Billion Senior Notes Offering
- NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (the “Company”) (Nasdaq: NDAQ) today announced that it priced a public offering of $600,000,000 aggregate principal amount of 0.445% senior notes due 2022, $650,000,000 aggregate principal amount of 1.650% senior notes due 2031 and $650,000,000 aggregate principal amount of 2.500% senior notes due 2040 (the “Offering”). The Company expects to use the net proceeds from the Offering, together with cash on hand and proceeds of other debt, to fund the cash consideration payable by the Company in connection with its pending acquisition of Verafin Holdings Inc. (“Verafin”), to repay certain outstanding indebtedness of Verafin and its subsidiaries and to pay related expenses, and for general corporate purposes. The Offering is expected to close on December 21, 2020, subject to customary closing conditions.
- 12/07/2020
|
Nasdaq, Inc. Announces Proposed Senior Notes Offering
- NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (the “Company”) (Nasdaq: NDAQ) today announced that it plans to offer, subject to market and other conditions, senior notes (the “Offering”). The Company expects to use the net proceeds from the Offering, together with cash on hand and proceeds of other debt, to fund the cash consideration payable by the Company in connection with its pending acquisition of Verafin Holdings Inc. (“Verafin”), to repay certain outstanding indebtedness of Verafin and its subsidiaries and to pay related expenses, and for general corporate purposes.
- 12/07/2020
|
How Risky Is Nasdaq Stock?
- This tech-focused stock exchange parent company has a durable business model, but a new competitor looms.
- 12/07/2020
|
Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at NASDAQ 43rd Virtual Investor Conference (Transcript)
- Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at NASDAQ 43rd Virtual Investor Conference (Transcript)
- 12/04/2020
|
eBay, Inc. (EBAY) CEO Jamie Iannone on 43rd NASDAQ Virtual Investor Conference (Transcript)
- eBay, Inc. (EBAY) CEO Jamie Iannone on 43rd NASDAQ Virtual Investor Conference (Transcript)
- 12/03/2020
|
Nasdaq November 2020 Volumes
- NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for November 2020, on its investor relations website.
- 12/02/2020
|
Nasdaq CEO on diversity goals: Disclosure is the foundation of our markets
- “Disclosure is really the foundation of our markets and our economy,” Nasdaq President and CEO Adena Friedman told CNBC's “Squawk Box.” “We rely on companies to make full and accurate disclosures to inform investors so that investors can make their own decisions as to which companies they want to invest in and what they expect of the companies where they are an investor.
- 12/01/2020
|
Nasdaq to Advance Diversity through New Proposed Listing Requirements
- Standardized disclosure framework to drive greater transparency on corporate governance
- 12/01/2020
|
Nasdaq Ventures Announces Strategic Investment in Matter
- Further advances sustainable investing capabilities through transparent ESG information, analytics and reporting Further advances sustainable investing capabilities through transparent ESG information, analytics and reporting
- 12/01/2020
|
3 Healthcare IPOs to Watch This Month
- Sotera Health, Maravai Life Sciences, and Olema Pharmaceuticals all have an Initial Public Offering with the NASDAQ this month. Are these healthcare companies worth getting excited about?
- 11/21/2020
|
Nasdaq (NDAQ) to Buy Verafin, Eyes Anti FinCrime Leadership
- Nasdaq (NDAQ) expects the buyout of Verafin to help it become a leader in Anti FinCrime.
- 11/20/2020
|
Nasdaq Named to Dow Jones Sustainability Index for the Fifth Consecutive Year
- NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced it has been selected as a North American index component of the Dow Jones Sustainability Index (DJSI), one of the most prestigious environmental, social, and governance (ESG) ranking efforts, for the fifth consecutive year. Nasdaq maintains its industry leadership as the only stock exchange operator selected for inclusion in the North America index, and was among eight diversified financial services companies selected from the region this year.
- 11/20/2020
|
NDAQ Eyes Combeack After $2.75 Billion Verafin Buyout
- The shares of Nasdaq Inc (NASDAQ:NDAQ) are up 3% at $126.43 this morning, following news that the shares exchange operator entered a definitive agreement to purchase anti-financial crime software name Verafin in a $2.75 billion cash deal.
- 11/19/2020
|
Nasdaq to buy financial fraud detection firm Verafin for $2.75 billion
- Exchange operator Nasdaq Inc said on Thursday it would buy anti-financial crime software firm Verafin for $2.75 billion in cash, significantly expanding its reach in the regulatory technology market.
- 11/19/2020
|
Nasdaq to pay $2.75 billion in cash to buy anti-financial crime company Verafin
- Nasdaq Inc. announced Thursday a deal to buy privately held anti-financial crime management company Verafin for $2.75 billion in cash. Based in Canada, Verafin provides more than 2,000 financial institutions a cloud-based platform to detect, investigate and financial fraud and report money laundering.
- 11/19/2020
|
Nasdaq to Acquire Verafin, Creating a Global Leader in the Fight Against Financial Crime
- Accelerates Nasdaq's ongoing evolution into a leading SaaS technology provider.
- 11/19/2020
|
Barry Henthorn ReelTime CEO Releases Letter to Shareholders – Addresses NASDAQ Listing, Patent and Technology Strategy, and New VR Series
- Barry Henthorn ReelTime CEO Releases Letter to Shareholders – Addresses NASDAQ Listing, Patent and Technology Strategy, and New VR Series
- 11/18/2020
|
Nasdaq CEO Adena Friedman to Present at J.P. Morgan Ultimate Services Investor Conference 2020
- NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Ms. Friedman's presentation will be webcast at Nasdaq's Investor Relations Website: ir.nasdaq.com/events.cfm
- 11/18/2020
|
Nasdaq Launches Nordic Gross Return Futures for Single Stock Futures to Help Investors Manage Dividend Risk
- New suite of listed dividend neutral stock futures covers single stocks in Sweden, Norway, Denmark and Finland New suite of listed dividend neutral stock futures covers single stocks in Sweden, Norway, Denmark and Finland
- 11/17/2020
|
Better Buy: CME Group vs. Nasdaq
- One is subject to market forces, while the other is subject to financial engineering.
- 11/09/2020
|
Nasdaq October 2020 Volumes
- NEW YORK, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for October 2020, on its investor relations website.
- 11/03/2020
|
NASDAQ CEO Adena Friedman talks capitalism and reforming free markets
- NASDAQ CEO Adena Friedman: "I remain a true believer that capitalism is the best system that exists, we need to make sure everyone has access." #NASDAQ #AdenaFriedman #investing #capitalism Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
- 11/01/2020
|
Keeping U.S. competitive in race for global capital: NASDAQ CEO Adena Friedman discusses
- NASDAQ CEO Adena Friedman: U.S. public markets "should remain open, politics have come into the mix in recent months, cautious about making sure companies are vetted and audit firms live by same standards...make sure we don't choke off access to capital.
- 11/01/2020
|
A Volatile Stock Market Is Still Great for Nasdaq
- Volatility and volume combine for another strong quarter.
- 10/27/2020
|
Massive Opportunity In 'Digital Transformation' - Jon Markman Joins Alpha Trader (Podcast Transcript) (DJI)
- This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher talking (mostly) tech with Jon Markman, founder and president of Markman Capital Insight.
- 10/22/2020
|
Stock market live Thursday: Dow gains 100, banks lead amid rising yields, AT&T jumps 5.8%
- This is CNBC's markets live blog that will be updated throughout the day.
- 10/22/2020
|
NASDAQ Selling Pressure Keeps Bulls At Bay
- Stocks Analysis by Declan Fallon covering: S&P 500, US Small Cap 2000, SPDR S&P 500, NASDAQ Composite. Read Declan Fallon's latest article on Investing.com
- 10/22/2020
|
Nasdaq Promotes Chief Accountant to CFO
- Ann Dennison will succeed Michael Ptasznik, who will retire at the end of February.
- 10/21/2020
|
Finding The Buffett Balance For Your Portfolio As Major Economies Diverge
- Systemic difference had led to divergence in control of COVID-19 cases in major economies which should be reflected in our portfolio.
- 10/21/2020
|
Nasdaq Inc. (NDAQ) Q3 2020 Earnings Call Transcript | AlphaStreet
- Nasdaq Inc. (NASDAQ: NDAQ) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Ed Ditmire -- Vice President of Investor Relations
- 10/21/2020
|
Trends With Benefits #31: The Impact Of Retail Investors With Phil Mackintosh
- The last time I remember day trading getting the kind of coverage it has recently was in the late 1990s as personal computing power increased and internet access became more common.
- 10/21/2020
|
Nasdaq beats profit and revenue views
- Nasdaq Inc.'s revenue increased by a double-digit percentage while earnings also rose for the third quarter. Nasdaq's net income for the third quarter was...
- 10/21/2020
|
NASDAQ, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) | MarketScreener
|
Nasdaq : Reports Third Quarter 2020 Results; Delivers Broad-Based 13% Revenue Growth vs. Prior Year Period | MarketScreener
|
Nasdaq Reports Third Quarter 2020 Results; Delivers Broad-Based 13% Revenue Growth vs. Prior Year Period | MarketScreener
|
IBM Retirement Fund Purchases 1,044 Shares of Nasdaq, Inc. (NASDAQ:NDAQ)
- IBM Retirement Fund grew its position in shares of Nasdaq, Inc. (NASDAQ:NDAQ) by 39.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,718 shares of the financial services provider’s stock after acquiring an additional 1,044 shares during the […]
- 10/21/2020
|
Stimulus Talks Hit Dollar, Bonds; Tesla Earnings Due: What's up in Markets
- Stimulus Talks Hit Dollar, Bonds; Tesla Earnings Due: What's up in Markets
- 10/21/2020
|
Charting a successful technical test, S&P 500 nails the breakout point
- Technically speaking, the major U.S. benchmarks continue to digest an October breakout amid still bullish bigger-picture price action, writes Michael Ashbaugh.
- 10/20/2020
|
Stock market boom, new listings mint China billionaires at record pace
- Stock market boom, new listings mint China billionaires at record pace
- 10/20/2020
|
VXX: A Financial Storm Is Brewing, Good Time To Hedge (BATS:VXX)
- The market is eerily quiet despite the election and other catalysts, making a surge in volatility very possible.
- 10/19/2020
|
VPU: Best Of Breed In A Pack Of Dogs (NYSEARCA:VPU)
- The stocks of regulated public utilities traditionally appeal to investors attracted to their generous dividends and perceived stability.
- 10/19/2020
|
Don't Get Too Comfortable: October Is Not Over Yet
- Historically, October is an interesting month for stock market crashes. Despite the Fed's QE unlimited experiment, the economy is struggling to keep the recovery from stalling.
- 10/19/2020
|
Lessons From The Dot-Com Collapse
- We've seen this show before. In 2000, unrealistic expectations eventually burst, sending the Nasdaq down almost 80%.
- 10/19/2020
|
Huron Announces Third Quarter 2020 Earnings Release and Webcast
- Global professional services firm Huron (NASDAQ: HURN) will announce its financial results for the third quarter ended September 30, 2020, after the m
- 10/19/2020
|
Stock futures rise as traders weigh rising coronavirus cases, U.S. stimulus talks
- Futures rose as the number of coronavirus cases continues to rise while lawmakers remain at an impasse over a new stimulus deal.
- 10/18/2020
|
Nasdaq, The Stock, Not The Index, Is Trending Higher Within A Trend Channel (NASDAQ:NDAQ)
- Nasdaq is set to report third-quarter earnings results on Wednesday, and analysts expect the company to show earnings and revenue growing.
- 10/18/2020
|
Nasdaq, Inc. (NASDAQ:NDAQ) Shares Acquired by Avantax Advisory Services Inc.
- Avantax Advisory Services Inc. grew its position in Nasdaq, Inc. (NASDAQ:NDAQ) by 90.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,012 shares of the financial services provider’s stock after acquiring an additional 6,651 shares during the quarter. Avantax Advisory Services Inc.’s holdings in […]
- 10/18/2020
|
Make Up Your Mind, Already: Inside the Stock Market’s Indecisive Week
- If the world feels more mixed up than usual, take comfort in the fact that equity markets are reflecting that confusion—and holding up just fine.
- 10/17/2020
|
Stocks Jump Off Lows but Still Slide for a Third Day
- Stocks Analysis by Zacks Investment Research covering: Citigroup Inc, Bank of America Corp, JPMorgan Chase & Co, Vertex Pharmaceuticals Inc. Read Zacks Investment Research's latest article on Investing.com
- 10/16/2020
|
A Dip In CME Shares Before Election Day- New CME Products To Add To Your Trading And Investing Toolbox (NASDAQ:CME)
- The CME has been a one-way street higher since 2009. A new high, a rough March, and underperformance over the past months.
- 10/15/2020
|
Huron Announces Acquisition of Salesforce Industries Partner ForceIQ
- Global professional services firm Huron (NASDAQ: HURN) today announced it has entered into an agreement to acquire ForceIQ, a leading Salesforce Indus
- 10/15/2020
|
Protech Has A Clear Path To Triple (OTCMKTS:PTQQF)
- PTQQF continues to grow organically and through acquisition, expanding its EBITDA margins. PTQQF is now focused on introducing itself to US investors.
- 10/14/2020
|
Thor Industries: Accelerating Superpower In The Time Of An Unseen Waging War (NYSE:THO)
- Thor Industries, Inc. remained strong even if the automotive industry was one of the hardest-hit industries by the pandemic.
- 10/14/2020
|
CX Institutional Purchases 21,775 Shares of Nasdaq, Inc. (NASDAQ:NDAQ)
- CX Institutional raised its position in Nasdaq, Inc. (NASDAQ:NDAQ) by 12,164.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,954 shares of the financial services provider’s stock after purchasing an additional 21,775 shares during the period. CX Institutional’s holdings in Nasdaq were worth $2,694,000 […]
- 10/14/2020
|
Opening Bell: Futures, European Stocks Wobble Ahead Of Earnings; Gold, Dollar Up
- Market Overview Analysis by Investing.com (Pinchas Cohen/Investing.com) covering: GBP/USD, USD/JPY, USD/ZAR, XAU/USD. Read Investing.com (Pinchas Cohen/Investing.com)'s latest article on Investing.com
- 10/14/2020
|
Invesco Is Offering a Cheaper Version of Its Most Popular ETF. There’s a Downside.
- The Invesco NASDAQ 100 ETF allows for smaller investments, and has a lower expense ratio, than the Invesco QQQ Trust. Both track the Nasdaq’s 100 largest...
- 10/13/2020
|
Bull trend strengthens: S&P 500, Nasdaq clear 20-day volatility bands
- Technically speaking, the U.S. benchmarks’ bigger-picture backdrop has strengthened amid unseasonably constructive October price action, writes Michael...
- 10/13/2020
|
Nasdaq Offers Growth At A Reasonable Price (NASDAQ:NDAQ)
- Nasdaq operates one of the few American stock exchanges. The sector is highly regulated, with the few, well-trusted market operators leaving no room for potential entrants.
- 10/13/2020
|
Invesco is launching a new Nasdaq ETF to capitalize on the tech craze
- Invesco is looking to capitalize on the interest in technology and growth stocks by offering a new "junior" QQQ.
- 10/13/2020
|
Nasdaq, Inc. (NASDAQ:NDAQ) Receives $126.70 Average Price Target from Analysts
- Shares of Nasdaq, Inc. (NASDAQ:NDAQ) have been assigned an average recommendation of “Hold” from the thirteen analysts that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and six have assigned a buy recommendation to the company. The average 12 […]
- 10/13/2020
|
"Meet The Nasdaq" (NASDAQ:QQQ)
- With a gain of over 3% today, the Nasdaq is doing what it always does on Mondays – rally! Year to date, the Nasdaq is up an impressive 32.7%, putting it on pace for the first back-to-back annual gain of over 30% since 1998 and 1999.
- 10/13/2020
|
Highly-Ranked Cheap Stocks Under $25 to Buy in Q4
- Stocks Analysis by Zacks Investment Research covering: S&P 500, JPMorgan Chase & Co, Amazon.com Inc, Walmart Inc. Read Zacks Investment Research's latest article on Investing.com
- 10/13/2020
|
Making Up My Mind On MindMed (OTCMKTS:MMEDF)
- MindMed could be a big player in the psychedelic space with two upcoming catalysts. Two major Phase 2 clinical trials involving LSD.
- 10/12/2020
|
ProShares UltraPro QQQ: It's Vulnerable (NASDAQ:TQQQ)
- The ProShares UltraPro QQQ ETF is a leveraged and risky ETF that is volatile and vulnerable to news, events, and herd mentality among traders.
- 10/12/2020
|
Nasdaq Had An Amazing First Semester, But It Won't Be Easy To Keep The Momentum Going (NASDAQ:NDAQ)
- Nasdaq had an excellent H1 thanks to elevated volatility levels. The company spent in excess of $300M on shareholder rewards in the form of dividends and share repurchases.
- 10/12/2020
|
Q3 2020 EPS Estimates for Nasdaq, Inc. (NASDAQ:NDAQ) Boosted by Analyst
- Nasdaq, Inc. (NASDAQ:NDAQ) – Jefferies Financial Group raised their Q3 2020 EPS estimates for Nasdaq in a report issued on Wednesday, October 7th. Jefferies Financial Group analyst D. Fannon now expects that the financial services provider will post earnings per share of $1.43 for the quarter, up from their prior estimate of $1.37. Jefferies Financial […]
- 10/11/2020
|
Week Ahead: High Volatility On Stimulus Hopes To Continue After Equity Rally
- Market Overview Analysis by Investing.com (Pinchas Cohen/Investing.com) covering: XAU/USD, S&P 500, Dow Jones Industrial Average, US Small Cap 2000. Read Investing.com (Pinchas Cohen/Investing.com)'s latest article on Investing.com
- 10/11/2020
|
In A Crowded Industry, NVR Inc. Stands Out (NYSE:NVR)
- NVR, Inc. is a well-run company in the flourishing homebuilding sector.
- 10/10/2020
|
Financial markets have waited patiently for fiscal stimulus. That might change soon
- We may be retrenching to the stock market-economy disconnect of the spring, and some analysts think something's gotta give.
- 10/10/2020
|
S&P 500 Weekly Update: Dow Transports And Small Caps Lead This Leg Of The Rally
- The Dow Transports is at new highs, The Russell 2000 is at its highest level since the pre-COVID days. Global Composite PMIs are solidly in expansion territory.
- 10/10/2020
|
NASDAQ Jumps 4%+ This Week, While S&P, Dow Rise Over 3%
- Stocks Analysis by Zacks Investment Research covering: Citigroup Inc, Bank of America Corp, Goldman Sachs Group Inc, JPMorgan Chase & Co. Read Zacks Investment Research's latest article on Investing.com
- 10/10/2020
|
Industrial Stocks Are Getting Ready for 10 Years of Outperformance. Here’s How to Play It.
- Industrial stocks have lagged behind the S&P 500 index for the past 10 years. Better times are ahead.
- 10/09/2020
|
U.S. stocks end with gains as Dow enjoys best week since August
- U.S. stocks rose Friday to clinch weekly gains as investors monitored the prospects for another round of fiscal stimulus from Congress, with President Donald...
- 10/09/2020
|
Bank Of America Vs. JPMorgan Vs. Wells Fargo Vs. Citigroup: We Have A Winner
- The big four US banks show marked valuation differences that seem unwarranted on the P&L fundamentals.
- 10/09/2020
|
AM Best Affirms Credit Ratings of International General Insurance Holdings Limited’s Subsidiaries
- AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” of International Ge
- 10/09/2020
|
GameStop Announces Multi-year Strategic Partnership with Microsoft
- GRAPEVINE, Texas and REDMOND, Wash., Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) --
GRAPEVINE, Texas and REDMOND, Wash., Oct. 08, 2020 (GLOBE NEWSWIRE) --...
- 10/08/2020
|
GameStop Announces Multi-year Strategic Partnership with Microsoft
- GRAPEVINE, Texas and REDMOND, Wash., Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) -- GameStop Corp. (NYSE: GME) ("The Company") today announced that it has...
- 10/08/2020
|
The Dow Is Up Because Markets Haven’t Given Up Hopes for Stimulus
- Investors continue to be optimistic that Congress will be able to pass another round of government aid.
- 10/08/2020
|
Caribbean Operator Digicel Deploys Evolving Systems' Evolution Platform on Microsoft Azure for CVM Campaign Management Program
- ENGLEWOOD, Colo., Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) --
ENGLEWOOD, Colo., Oct. 08, 2020 (GLOBE NEWSWIRE) -- Evolving Systems, Inc. (NASDAQ: EVOL), a...
- 10/08/2020
|
Russell 2000 Continues To Perform Well. That's Bullish For Markets
- Stocks Analysis by Declan Fallon covering: S&P 500, US Small Cap 2000, iShares Russell 2000 ETF, NASDAQ Composite. Read Declan Fallon's latest article on Investing.com
- 10/08/2020
|
The End Of The Melt Up In The Third Quarter
- Today, I would like to share with the Seeking Alpha community parts of my third quarter letter to DM Martins Multi-Asset Fund's partners.
- 10/07/2020
|
Williams-Sonoma: An Invincible Warrior In This Invisible War (NYSE:WSM)
- Williams-Sonoma continues to thrive, given its solid fundamental health amidst the pandemic. For the last 10 years, the dividends kept increasing and would be higher for the next few years.
- 10/07/2020
|
ZEISS partners with Microsoft for better patient care through data-driven healthcare and to enhance quality and efficiency in manufacturing
- OBERKOCHEN, Germany and REDMOND, Wash., Oct. 7, 2020 /PRNewswire via COMTEX/ --
OBERKOCHEN, Germany and REDMOND, Wash., Oct. 7, 2020 /PRNewswire/ -- Today,...
- 10/07/2020
|
Stocks Drop as Stimulus Negotiations Called Off
- Stocks Analysis by Zacks Investment Research covering: Crocs Inc, Lam Research Corp, Sysco Corporation, Ecolab Inc. Read Zacks Investment Research's latest article on Investing.com
- 10/07/2020
|
Trump Stimulus Move Sends Stocks Sinking
- Oct 06, 2020 (Baystreet.ca via COMTEX) --
Stocks tumbled Tuesday, shedding earlier gains that came in the light of U.S. President Trump's return to the White...
- 10/06/2020
|
Charting a bullish Q4 start: S&P 500 extends rally from major support
- The major U.S. benchmarks are off to a constructive October start, rising atop key technical levels, writes Michael Ashbaugh.
- 10/06/2020
|
The End Of 2 Really Bad Economic Ideas
- An over-dependence on a globalized supply chain is ending, while a focus on manufacturing efficiency is getting replaced.
- 10/06/2020
|
Stock market live Tuesday: Dow drops 370, Trump says 'stop negotiating' stimulus, airlines hit hard
- This is CNBC's markets live blog that will be updated throughout the day.
- 10/06/2020
|
Dow closes 375 points lower as Trump calls end to fiscal stimulus talks until after election
- U.S. benchmark stock indexes fell Tuesday after President Donald Trump said he would end negotiations on a new fiscal stimulus package, sending jitters into...
- 10/06/2020
|
What Is The Nasdaq Saying To Whom?
- Prior to Friday, the performance of the NASDAQ Composite Index led all other stock price indices in performance.
- 10/06/2020
|
Rockwell Automation and Microsoft Expand Partnership to Simplify Industrial Transformation
- Microsoft and Rockwell are working to deliver innovative edge-to-cloud-based solutions.
- 10/06/2020
|
Tech Stocks Could Hit New Highs In 2021: UBS
- Tech stocks have seen a correction in September with the Nasdaq 100 index declining 5.7%, the biggest pullback since coronavirus led decline March. However,...
- 10/05/2020
|
Wall Street set to jump on stimulus hopes, hints of Trump hospital discharge
- Wall Street set to jump on stimulus hopes, hints of Trump hospital discharge
- 10/05/2020
|
Trump's diagnosis fuels uncertainty for skittish U.S. stock market
- Trump's diagnosis fuels uncertainty for skittish U.S. stock market
- 10/04/2020
|
CME Group Tackles Water Scarcity With New Futures Contract
- In partnership with Nasdaq Inc (NASDAQ: NDAQ), CME Group Inc (NASDAQ: CME), the world’s largest derivatives marketplace, formally announced it plans to launch a futures...
- 10/02/2020
|
Atlanticus Holdings: Quiet Turnaround Efforts Appear Set To Bear Fruit (NASDAQ:ATLC)
- Shares of Atlanticus closed on Sept. 30, 2020, at a price of $11.90, equaling a diluted market capitalization of $241 million.
- 10/01/2020
|
Dow clings to gains in choppy session as hopes for new fiscal stimulus dim
- U.S. stock benchmarks finished with modest gains in Thursday's session as investors followed the fitful attempts by lawmakers to pass another fiscal stimulus...
- 10/01/2020
|
From hungry squirrels to cyberattacks, exchange outages roil markets
- From hungry squirrels to cyberattacks, exchange outages roil markets
- 10/01/2020
|
'Incredible economic momentum' will drive stocks higher in Q4, Leuthold's Jim Paulsen says
- The Leuthold Group's Jim Paulsen builds part of his bullish case on diverging confidence levels between Wall Street and Main Street.
- 09/30/2020
|
Markets mixed after Trump-Biden debate; data lifts China
- Stocks are mixed in Asia after the debate between President Donald Trump and his Democratic challenger Joe Biden, with little sign the clash did much to sway investors
- 09/30/2020
|
Asian markets mixed, though economic data boosts Chinese stocks
- Stocks were mixed in Asia on Wednesday while upbeat manufacturing data lifted shares in China as investors studied the outcome of the debate between...
- 09/30/2020
|
Alibaba Expects First Profit From its Cloud Arm This Year
- Alibaba Expects First Profit From its Cloud Arm This Year
- 09/30/2020
|
Vertex Energy As A Shape-Shifter (NASDAQ:VTNR)
- Vertex Energy reported 2020 second quarter results in early August. Revenue in its primary segment declined 70% while revenue in the remaining two segments improved.
- 09/29/2020
|
Marvell: The Biggest Profits Are In The Beginning Of The 5G Rollout (NASDAQ:MRVL)
- Marvell Technology has seen its stock soar well beyond the rate of growth of the broader market. The company is profiting from its position in the 5G rollout.
- 09/29/2020
|
Find Strong Buy Stocks Near Highs Despite Volatility with this Screener
- Stocks Analysis by Zacks Investment Research covering: S&P 500, Atlas Air Worldwide Holdings, Owens & Minor Inc, Seaspan Corporation. Read Zacks Investment Research's latest article on Investing.com
- 09/29/2020
|
U.S. stock futures mostly flat after Monday's rally
- Stock futures were little changed after a sharp rise during Monday's session.
- 09/28/2020
|
Stock markets fell for the four-consecutive week - Born2Invest
- Our opening essay takes a short look at the emerging FinCEN scandal that investigates how dirty money is being laundered.
- 09/28/2020
|
S&P Bounces At Measured Move Target
- Stocks Analysis by Declan Fallon covering: US Small Cap 2000, S&P 500 Futures, NASDAQ Futures. Read Declan Fallon's latest article on Investing.com
- 09/28/2020
|
S&P 500 Weekly Update: Reasons To Sell Are Numerous, But The Long-Term Bullish Trend Trumps Them All
- Negatives are highlighted now, but the naysayers have no answers for the many positives in the economic data.
- 09/26/2020
|
Aerospace & Defense: Airline And Government Spending Turbulence Extends Downside Risk (BATS:ITA)
- Aerospace and Defense companies are in a difficult situation as the November election threatens to heighten military spending rancor.
- 09/25/2020
|
Friday's stock market rally in final hour of trade helping Nasdaq erase over 1% weekly skid
- U.S. stocks on Friday were ending a choppy week on a high note, which was helping the technology-laden Nasdaq Composite Index wipe out a more than 1% weekly...
- 09/25/2020
|
Market Internals Point Towards Further Selling (Technically Speaking For The Week Of 9/21-9/25)
- The jobs rebound is slowing. Stimulus talks may be back on.
- 09/25/2020
|
IPO Market Parties Like It’s 1999
- Even in the midst of a recession, investors are pouring money into newly public companies at levels on par with the dot-com era. A shift in the economy and low interest rates are helping drive the frenzy of activity.
- 09/25/2020
|
Cloud Startups Experience Wave of Pandemic-Fueled Investments
- Cloud-computing startups have landed new investments and customer accounts during the coronavirus pandemic as many companies have accelerated cloud-related projects to keep ahead of the competition.
- 09/25/2020
|
Big Tech: Not Yet A Bubble
- The bubble case: fear and facts. Sorting the FAANGs with bias-free metrics.
- 09/25/2020
|
Vodafone Scores a Victory in $3 Billion Tax Dispute With India
- Vodafone Scores a Victory in $3 Billion Tax Dispute With India
- 09/25/2020
|
Stock markets fall back as growth fears rise - business live
- Rolling coverage of the latest economic and financial news
- 09/24/2020
|
As wildfires approach Silicon Valley, tech firms struggle to find the backing to fight them
- As wildfires approach Silicon Valley, tech firms struggle to find the backing to fight them
- 09/24/2020
|
Jim Cramer recommends buying Big Tech, dividend stocks into further weakness
- CNBC's Jim Cramer said he expects there to be more volatility for the market ahead, but advised investors to consider stocks like Apple and PepsiCo when they reach appropriate prices.
- 09/23/2020
|
What to watch today: Dow set to pop after breaking multiday losing streaks
- Dow futures pointed to a strong gain at today's open, one day after the 30-stock benchmark broke a three-session losing streak.
- 09/23/2020
|
5 things to know before the stock market opens Wednesday
- Dow futures pointed to a gain at Wednesday's open, one day after the 30-stock benchmark broke a three-session losing streak.
- 09/23/2020
|
Opening Bell: Futures, Stocks Rally On Dip-Buying; USD Gains; Gold Struggles
- Market Overview Analysis by Investing.com (Pinchas Cohen/Investing.com) covering: GBP/USD, USD/JPY, AUD/USD, XAU/USD. Read Investing.com (Pinchas Cohen/Investing.com)'s latest article on Investing.com
- 09/23/2020
|
Nasdaq Launches Anti-Money Laundering Investigation Technology | Independent Newspapers Nigeria
- Nasdaq has announced the launch of the cloud-deployed Nasdaq Automated Investigator for AML, the first automated solution for investigating anti-money laundering (AML) for retail and commercial banks and other financial institutions. Designed, built, and offered in partnership with UK-based Caspian. Nasdaq Automated Investigator for AML further expands Nasdaq’s global efforts in combatting financial crime and promoting market integrity […]
- 09/22/2020
|
Private Advisor Group LLC Invests $362,000 in Nasdaq Inc (NASDAQ:NDAQ)
- Private Advisor Group LLC purchased a new position in shares of Nasdaq Inc (NASDAQ:NDAQ) during the second quarter, HoldingsChannel.com reports. The institutional investor purchased 3,032 shares of the financial services provider’s stock, valued at approximately $362,000. Several other large investors also recently bought and sold shares of NDAQ. Smithfield Trust Co. acquired a new position […]
- 09/22/2020
|
Selling Continues Across Indices
- Stocks Analysis by Declan Fallon covering: S&P 500, US Small Cap 2000, iShares Russell 2000 ETF, NASDAQ Composite. Read Declan Fallon's latest article on Investing.com
- 09/22/2020
|
Week In Review: Zai Lab To Raise Up To $845 Million In Hong Kong IPO
- Zai Lab of Shanghai is conducting a Hong Kong IPO that is expected to raise up to $845 million, offering 12.3% of the company's expanded number of shares.
- 09/21/2020
|
US household wealth hits record even as economy struggles
- Americans’ household wealth rebounded last quarter to a record high as the stock market quickly recovered from a pandemic-induced plunge in March
- 09/21/2020
|
Why Apple Is A Stock To Own, Not To Trade (NASDAQ:AAPL)
- I have been an odd Apple bull lately, believing for a few weeks that the stock has run too far, too fast in the past 12 to 18 months.
- 09/21/2020
|
Micron Technology: The Pendulum Has Swung (NASDAQ:MU)
- There are increasing indications that Micron has already entered the upcycle. Sentiment about Micron's stock has made a complete reversal from bearish to bullish in the last few days.
- 09/21/2020
|
On Corporate Credit Spreads, NASDAQ 100 And Sector Performance
- Stocks Analysis by Brian Gilmartin covering: Nasdaq 100, S&P 500, Caterpillar Inc, Amazon.com Inc. Read Brian Gilmartin's latest article on Investing.com
- 09/21/2020
|
TecDAX: Buying Opportunity in German Technology
- TecDAX is the strongest German index. Investors and traders buying dips should be able to achieve the highest returns as compared to other German indices.
- 09/20/2020
|
'Too Early For Victory Laps': Stock Market Update For The Week Ahead
- The Past Week, In A Nutshell
What Happened: Last week ended negative on weakness concentrated in heavily-weighted index constituents.
Remember This: “The Fed essentially...
- 09/20/2020
|
Stocks Slip for a Third Straight Week
- Stocks Analysis by Zacks Investment Research covering: Alphabet Inc Class A, Apple Inc, Amazon.com Inc, Alphabet Inc Class C. Read Zacks Investment Research's latest article on Investing.com
- 09/19/2020
|
Citigroup: The Path To A Double, Part 2 (NYSE:C)
- Citi is often derided as a near-basket case with a bad history and a messy business structure that doesn't work.
- 09/18/2020
|
Asian stocks set for higher open on central bank support
- Asian stocks set for higher open on central bank support
- 09/18/2020
|
ProShares Short QQQ ETF: A Timely Trade Idea (NYSEARCA:PSQ)
- To take advantage of a current market setup, I look at how PSQ can help to produce positive returns and diversification to a stock portfolio.
- 09/17/2020
|
The Psychology Of Money - Morgan Housel Talks With Alpha Trader (Podcast Transcript)
- This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher talking with Morgan Housel, partner at Collaborative Capital, and author of recently-published The Psychology of Money.
- 09/17/2020
|
CME Group to Launch First-Ever Water Futures Based on Nasdaq Veles California Water Index
- CME Group to Launch First-Ever Water Futures Based on Nasdaq Veles California Water Index | STL.News | Read business news at STL.News.
- 09/17/2020
|
What to watch today: Wall Street set to drop with tech stocks under continued pressure
- Technology stocks were set to resume their recent sell-off with the so-called FANG block all dipping at least 1% in today's premarket.
- 09/17/2020
|
Stock market live Thursday: Dow drops over 100 points, tech leads losses, Snowflake drops
- Investors remained on edge about the outlook of further coronavirus stimulus as well as the timing of a viable vaccine.
- 09/17/2020
|
VIG: I Don't Appreciate This Dividend Appreciation ETF (NYSEARCA:VIG)
- The Vanguard Dividend Appreciation ETF is often mentioned as a suitable choice for Dividend Growth Investors seeking a simple way to invest.
- 09/17/2020
|
August Income Report - The Tech Bubble 20 Years Later
- Take the time to make sure your portfolio will enjoy growth from the best of breed from many different sectors.
- 09/17/2020
|
Money Printing Alone Does Not Create Inflation, Got That?
- Stocks Analysis by Michael Kramer covering: Nasdaq 100, XAU/USD, XAG/USD, S&P 500. Read Michael Kramer's latest article on Investing.com
- 09/17/2020
|
Asia stocks set to dip as the Fed signals low rates for years; Australia's August jobs data ahead
- Investor reaction to recent announcements from the Fed will be watched, as members of the U.S. central bank's policymaking committee indicated the overnight rate could stay close to zero for years to reach its 2% inflation target.
- 09/16/2020
|
Nasdaq Comp's decline reflects big-tech weakness, but defies bullish breadth data
- The Nasdaq Composite undefined fell 0.3% amid weakness in shares of mega-capitalization technology companies but Nasdaq exchange breadth data pointed to...
- 09/16/2020
|
Nasdaq Launches Anti-Money Laundering AI Technology
- Shortly after reaching its all-time high, Nasdaq steps into the AML sector as it launched AI technology to detect money laundering.
- 09/16/2020
|
Stock market live Wednesday: Stocks fall as tech slides, Fed projects years of low rates, Snowflake doubles in IPO
- Stocks advanced Wednesday ahead of a key Federal Reserve policy announcement, but tech stocks dragged the market down in afternoon trading.
- 09/16/2020
|
FOMC Enters The Spotlight
- Market Overview Analysis by JFD Team covering: EUR/USD, GBP/USD, USD/JPY, USD/CHF. Read JFD Team's latest article on Investing.com
- 09/16/2020
|
Nasdaq Ramps Up Cloud Move
- Several of Nasdaq’s 28 markets in North America and Europe will be hosted in the public cloud in about five years, with all of its markets expected to migrate over the next decade, said Brad Peterson, the New York-based company’s chief technology and information officer.
- 09/15/2020
|
Andersen & Martini A/S : Offer to buy back shares | MarketScreener
|
ViacomCBS to rebrand CBS All Access streaming service as 'Paramount+'
- ViacomCBS to rebrand CBS All Access streaming service as 'Paramount+'
- 09/15/2020
|
U.S. Stock Benchmarks Open Higher
- The Dow industrials and S&P 500 opened higher. Shares of Oracle soared as investors cheered its deal with video-sharing app TikTok.
- 09/14/2020
|
TikTok Rally Unwinds A Bit But Risk-On Kicks Off The Week
- Market Overview Analysis by Boris Schlossberg covering: EUR/USD, DAX, Nikkei 225, Oracle Corporation. Read Boris Schlossberg's latest article on Investing.com
- 09/14/2020
|
Next Year Looks Rocky for the Stock Market No Matter Who Wins the Election
- Next year will be the first year of a new presidential term. And that’s a notoriously tricky time for the stock market. Here’s how to prepare.
- 09/12/2020
|
Stocks appear to be experiencing a textbook correction as payback for an August overshoot rally
- A picture of the market pullback in recent weeks could sit beside the definition of a correction in the dictionary.
- 09/12/2020
|
Next Year Looks Rocky for the Stock Market No Matter Who Wins the Election
- Next year will be the first year of a new presidential term. And that’s a notoriously tricky time for the stock market. Here’s how to prepare.
- 09/12/2020
|
Market Still Has Seller
- Stocks Analysis by Zacks Investment Research covering: Nasdaq 100, S&P 500, Apple Inc, Crocs Inc. Read Zacks Investment Research's latest article on Investing.com
- 09/12/2020
|
Cramer's week ahead: 'This market's badly in need of another stimulus package'
- "I know it's not a huge news week, but this market's badly in need of another stimulus package," the "Mad Money" host said.
- 09/11/2020
|
WSJ News Exclusive | NYSE Signals It Will Exit New Jersey if State Taxes Stock Trades
- The New York Stock Exchange plans to run one of its exchanges from a backup site in Chicago for a week as a demonstration of its readiness to quit the state over a proposed tax on financial transactions.
- 09/11/2020
|
Business Leaders Urge Mayor de Blasio to Stop New York City’s Decline
- More than 160 business leaders have signed a letter to Mayor Bill de Blasio warning of New York City’s deteriorating condition in the wake of the coronavirus pandemic and a growing anxiety over public safety and quality-of-life issues.
- 09/11/2020
|
New York business leaders warn de Blasio of risk posed by city’s perceived decline
- In a letter sent Thursday, the leaders said the pandemic has devastated the city’s economy, causing high levels of unemployment. They urged the Democratic...
- 09/11/2020
|
